Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.767370052043064,-2.8002638389664636,0.0,0.0,0.0,72/91,15.72%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;SRPRA;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;SSR1;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;ARL6IP1;RPL17;RPL23;SEC62;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;SRP14;RPL31;RPSA;RPS26;RPL36
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7681559372797488,-2.760501112004973,0.0,0.0,0.0,69/87,15.72%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;SEC61B;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;SRP14;RPL31;RPSA;RPS26;RPL36
prerank,protein targeting to ER (GO:0045047),-0.7490847620343362,-2.7493720091617737,0.0,0.0,0.0,78/99,18.41%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;SRPRA;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;SEC62;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;SGTB;SRP14;RPL31;RPSA;SPCS1;RPS26;RPL36;SRPRB;RPL13A;ZFAND2B;CHMP4B;CHMP4A;RPL35
prerank,cytoplasmic translation (GO:0002181),-0.7315916454474294,-2.6976843815380755,0.0,0.0,0.0,68/91,15.72%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;EIF3M;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;EIF2B3;RPS5;RPL36A;RPL6;RPL31;RPSA;RPS26;RPL36
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6632320521387164,-2.4842195628069446,0.0,0.0,0.0,80/110,20.81%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;PPP2R1A;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;SMG5;RPL31;RPSA;RPS26;RPL36;RNPS1;PABPC1;RPL13A;PNRC2;RPL35;RPL24;RPS13;HELZ2;RPL11;DHX34;EIF4A3
prerank,peptide biosynthetic process (GO:0043043),-0.5863568737083029,-2.328263368062654,0.0,0.0,0.0,70/153,15.07%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;PCSK5;RPS7;RPL39;ABCF1;RPL14;RPS17;RPL28;RPL34;EEF1A1;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;RPL31;HBS1L;RPSA;RPS26
prerank,translation (GO:0006412),-0.529373693906509,-2.1881722065373133,0.0,0.0,0.0,106/208,25.37%,RPS24;RPS12;LARS2;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;WARS2;EEF2K;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;ABCF1;RPL14;RPS17;RPL28;RPL34;EEF1A1;RPL12;RPL9;RPS25;GARS1;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;DARS2;RPL36A;RPL6;RPL31;HBS1L;RPSA;RPS26;ABCE1;RPL36;APEH;EEFSEC;RPL13A;RPL35;MRPL16;EEF2;COPS5;RPL24;RPS13;MRPL34;RPL11;CARS1;EEF1D;RSL24D1;IARS1;MRPS2;MRPS16;RPL22L1;MRPS21;MRPL10;MRPL13;TUFM;EEF1G;RPS27A;MRPS33;NDUFA7;EIF4EBP2;MRPL35;EEF1A2;GTPBP2
prerank,positive regulation of cell junction assembly (GO:1901890),-0.6362619006554076,-2.1515039117347934,0.0,0.00013205051317618065,0.001,18/56,8.32%,NRP1;NLGN1;CNTNAP2;NRXN1;GRID2;PTPRD;IL1RAPL1;PTPRJ;TEK;CAV1;CLSTN2;CLDN5;EPHB1;IL1RAP;SYNDIG1;KDR;EPHB2;MYOC
prerank,action potential (GO:0001508),-0.6625679101003252,-2.1245114768734323,0.0,0.00035213470180314835,0.002,18/44,15.36%,KCND2;ANK3;AKAP6;KCNJ2;SCN1A;SCN2A;KCNMB2;CACNA1G;SCN7A;KCNQ1;SCN3A;SCN9A;KCNB1;GPER1;GNA14;SCN8A;KCNE4;CACNA1H
prerank,glutamate receptor signaling pathway (GO:0007215),-0.6901752906103765,-2.090436325293382,0.0,0.0011620445159503897,0.009,22/37,15.43%,GRID2;GRIK2;GRIA4;GRM7;GRM5;GRM3;GRIK1;GRIN2B;GRIA2;GRM8;PTK2B;GRIA3;GRIK4;GRIN3A;APP;GRIN2A;GRM1;KCNB1;HOMER1;CDK5R1;GRIN1;GRIK3
prerank,regulation of synapse assembly (GO:0051963),-0.6365185960064266,-2.073535170504634,0.0,0.001728661263397274,0.016,18/46,10.88%,NLGN1;NRXN1;GRID2;MEF2C;PTPRD;ROBO2;IL1RAPL1;CLSTN2;GPC6;EPHB1;LRFN5;IL1RAP;IL1RAPL2;SYNDIG1;APP;EPHB2;SLITRK1;GPC4
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.6969219631369019,-2.0305038104183573,0.0,0.003697414368933058,0.038,9/25,7.01%,PDE4D;SPTBN1;PDE4B;RUNX1;ANXA1;PTPRC;RPS3;PLCG2;MAP3K7
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5033461757555663,-1.9890897199747504,0.0,0.009507636948685005,0.099,90/168,21.59%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;PPP2R1A;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;RPL12;RPL9;RPS25;CNOT2;RPL7A;RPS2;RPS9;RPS11;DCP1B;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;TNKS1BP1;RPL36A;RPL6;SMG5;RPL31;RPSA;RPS26;NBAS;RPL36;RNPS1;PABPC1;RPL13A;PNRC2;XRN2;RPL35;ERI1;RPL24;RPS13;HELZ2;RPL11;DHX34;LSM1;EIF4A3;DCP2;CNOT7;CNOT6L
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.8134590187634504,-1.988965725432311,0.0,0.008828520023778935,0.099,8/13,10.44%,PDE4D;SLC8A1;CAV1;ANK3;CAMK2D;CALM1;CALM2;CALM3
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.8235143920560428,-1.9821959183790665,0.0,0.009225929187242488,0.107,7/12,10.44%,PDE4D;CAV1;CAMK2D;GJD3;CALM1;CALM2;CALM3
prerank,dendrite self-avoidance (GO:0070593),-0.7675770198022752,-1.9580097330184247,0.0,0.013865303883498969,0.163,7/16,8.05%,BSG;CNTN4;NPTN;DSCAML1;CNTN6;ROBO4;EMB
prerank,neuron development (GO:0048666),-0.49672186938064,-1.9501216455805628,0.0,0.01478965747573223,0.186,41/141,9.94%,FRY;NLGN1;CNTNAP2;TENM2;MEF2C;PTPRM;CNTN4;EPHA5;TENM3;TGFB2;PLP1;TENM4;PBX3;RUNX1;ATP8A2;SH3GL2;UGCG;NTRK2;MYT1L;TMEM108;GPM6B;LYN;GSK3B;STX3;APOE;APP;STMN2;VSX1;B4GALT5;DCX;SRRM4;ULK1;LGI1;MYOC;GPRIN3;RASGRF1;ETV1;PPT1;RP1;PBX1;UHMK1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.5355015732719547,-1.9430328530921748,0.0,0.016139507165977635,0.212,30/88,13.77%,NRP1;PTPRM;TEK;CDH13;CAV1;BMPR2;VEGFC;THBS1;NRP2;SEMA5A;TIE1;PPP1R16B;CAV2;F3;ACVRL1;AKT3;KDR;APOE;ECM1;BMP2;PROX1;ATOH8;XDH;FGF2;FLT4;ITGB3;BMP4;HIF1A;PRKD1;VEGFA
prerank,positive regulation of nervous system development (GO:0051962),-0.5992087108857014,-1.9417769961810198,0.0,0.015679260932919135,0.216,14/42,11.24%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;CLSTN2;EPHB1;IL1RAP;SYNDIG1;SERPINF1;EPHB2;MME;NAP1L1;GPER1
prerank,regulation of fatty acid oxidation (GO:0046320),0.8549632820789761,1.937656870477118,0.0,0.4730934186633479,0.318,4/16,1.76%,PRKAG2;APPL2;PPARGC1A;PPARA
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.46719134208092566,-1.9336396354659213,0.0,0.01748348794452632,0.253,72/224,13.32%,NLGN1;DLG2;NRXN1;GRIK2;KCND2;SYT1;GRIA4;CACNB2;GRM7;GRM5;SLC12A7;CACNA1E;GRM3;SNAP25;CHRM3;GABRG3;GRIK1;HTR2C;GABRB3;GRIN2B;GRIA1;GRIA2;GABRB1;RIT2;GABRA3;PLP1;KCNQ3;GLRB;GRIA3;SLC1A2;DLGAP1;GABRA2;UNC13B;GRIK4;SLC1A1;APBA2;SYN2;PDE7B;GABRB2;MBP;GLRA3;MINK1;CALM1;PTCHD1;HTR2A;GRIN2A;CACNA1B;AMPH;SYPL1;CHRM2;GRM1;CAMK4;GLRA1;GABRG2;HTR1F;GABBR2;HTR7;CAMKK2;RPS6KA3;RPS6KA2;GABRA4;SLC12A4;GABRG1;NRXN2;HCRTR2;PRKAR1B;PRKAR2B;HOMER1;HTR4;SLC12A6;SNCA;GLRA2
prerank,positive regulation of synapse assembly (GO:0051965),-0.6659591975365765,-1.9277261155478425,0.0,0.019065578854770466,0.284,11/27,7.96%,NLGN1;NRXN1;GRID2;PTPRD;IL1RAPL1;CLSTN2;EPHB1;IL1RAP;SYNDIG1;SEMA4D;EPHB2
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.6804431157165959,-1.9100434954340701,0.0,0.02434531279284494,0.362,10/25,13.17%,NRP1;ITGA6;THBS1;AR;APP;PSEN1;BTBD10;PTH1R;ILK;SNCA
prerank,regulation of interleukin-2 production (GO:0032663),-0.5916819664093663,-1.909268938704662,0.0,0.023654265838515837,0.368,12/43,7.01%,PDE4D;SPTBN1;PDE4B;NAV3;CD34;RUNX1;HDAC7;ANXA1;PTPRC;RPS3;PLCG2;MAP3K7
prerank,negative regulation of vascular permeability (GO:0043116),-0.8024745434699508,-1.9084077893366773,0.0,0.02293277245493004,0.37,8/12,9.52%,SLIT2;PTPRJ;PDE3A;CLDN5;SH3GL2;RAMP2;CEACAM1;PDE2A
prerank,neuronal action potential (GO:0019228),-0.679048239077511,-1.8940129078714163,0.0,0.027297482083780064,0.44,11/22,15.36%,ANK3;SCN1A;SCN2A;KCNMB2;CACNA1G;SCN7A;SCN3A;SCN9A;GPER1;SCN8A;CACNA1H
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.7427328370640651,-1.891989761669349,0.002127659574468085,0.027303983032121046,0.453,11/17,10.04%,SERPINE2;TENM4;NOTCH1;HES1;TNFRSF1B;PTPRZ1;BIN1;BMP2;TGFB1;PTN;ID2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.6616354443491735,-1.884505345115722,0.0,0.02997057573124574,0.494,12/24,14.99%,NRP1;SEMA3C;SEMA6A;SEMA6D;SEMA5A;SEMA7A;SEMA3E;SEMA4D;SEMA3D;SEMA3G;VEGFA;SEMA4C
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.4681991881900778,-1.8830424249159523,0.0,0.029579314951464465,0.502,46/159,8.05%,NLGN1;ADGRL3;CDH11;GRID2;TENM2;LRRC4C;CADM1;PTPRM;PTPRD;ROBO2;HMCN1;IL1RAPL1;CDH8;CDH2;CDH13;PECAM1;KIRREL3;BSG;CLDN5;GPC6;CNTN4;UNC5D;LRFN5;NPTN;TENM3;PTPRT;TGFB2;ATP2C1;VCAM1;CDH10;TENM4;CDH12;CLDN11;NTNG1;DSCAML1;IGSF11;CNTN6;ICAM1;CDH6;PTPRF;ITGB1;CDH20;CDH19;CDH7;ROBO4;EMB
prerank,angiogenesis involved in wound healing (GO:0060055),-0.8338385552284505,-1.8826753066361852,0.002145922746781116,0.028632194029373243,0.503,8/11,13.77%,ADIPOR2;CD34;NDNF;KDR;GATA2;MCAM;ITGB3;VEGFA
prerank,positive regulation of developmental growth (GO:0048639),-0.5622377298075479,-1.877082795454733,0.0,0.03028358435507076,0.537,20/49,21.68%,GHR;SYT1;RIMS2;RIMS1;SEMA7A;CDKL5;NGF;NEDD4L;NTN1;SHTN1;SEMA4D;PPIB;AGRN;MAPT;SMURF1;BDNF;CPNE9;SYT2;L1CAM;TWF2
prerank,neural crest cell migration (GO:0001755),-0.5960698128293569,-1.8743588500282231,0.002421307506053269,0.0304312537461495,0.551,12/36,7.53%,NRP1;SEMA3C;ERBB4;SEMA6A;SEMA6D;FN1;SEMA5A;SEMA7A;SEMA3E;TBX1;SEMA4D;CORO1C
prerank,chemical synaptic transmission (GO:0007268),-0.4468644374724642,-1.8713044750226622,0.0,0.030800782198344135,0.567,99/284,17.14%,NLGN1;DLG2;NRXN1;GRID2;GRIK2;KCND2;SYT1;GRIA4;CACNB2;GRM7;GRM5;SLC12A7;CDH8;CACNA1E;GRM3;SNAP25;CHRM3;RIMS1;GABRG3;GRIK1;HTR2C;GABRB3;GRIN2B;GRIA1;GRIA2;LIN7A;GABRB1;RIT2;GABRA3;PLP1;KCNQ3;GLRB;GRIA3;SLC1A2;DLGAP1;PTPRN2;GABRA2;UNC13B;GRIK4;SLC1A1;APBA2;SYN2;PDE7B;SHISA6;GABRB2;MBP;GLRA3;DLGAP2;MINK1;CALM1;APOE;HSPA8;PTCHD1;HTR2A;GRIN2A;CACNA1B;AMPH;SYPL1;SLC1A4;CHRM2;GRM1;CAMK4;GLRA1;GABRG2;HTR1F;GABBR2;GRID1;HTR7;CAMKK2;RPS6KA3;RPS6KA2;GABRA4;SLC17A6;SLC12A4;ERC1;GABRG1;NRXN2;HCRTR2;PRKAR1B;PRKAR2B;HOMER1;HTR4;SLC12A6;SNCA;GLRA2;RPS6KA1;HTR1B;GRIN1;HRH1;SLC1A6;GRIK3;SLC12A5;SCN2B;NAPB;CHRNA7;CHRFAM7A;GABRA5;GABRE;STXBP3
prerank,epithelial tube morphogenesis (GO:0060562),-0.6110357572945324,-1.8676686437531813,0.0,0.03137200070609868,0.585,17/32,13.47%,SLIT2;MEF2C;COL4A1;PODXL;RYR2;ACVRL1;RASIP1;PAK1;SOX17;HES1;MET;RHOB;PKD1;BMP4;CTNNB1;MTSS1;ACVR1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.8389437450014428,1.859370788764776,0.0,0.9985925107355422,0.768,4/14,1.93%,ACTN2;ATP1B3;ANK2;LRRC38
prerank,axon development (GO:0061564),-0.5208268484555226,-1.8567174021169572,0.0,0.036135234546799545,0.636,28/78,14.09%,CTNNA2;GRM7;MAP1B;ANK3;KLF7;ACTB;CNTN4;RTN4;DCC;SEMA5A;PAK3;PLP1;NTNG1;S100A6;DSCAML1;SHTN1;APP;NRCAM;EPHB2;GAP43;S100B;SLITRK1;PLPPR4;MARK2;MAPT;RTN4RL1;ADGRB1;CDK5R1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.7458134968588671,-1.8554463744574599,0.0041928721174004195,0.03576682471171979,0.643,7/14,9.20%,GHR;PIK3R1;STAT3;LYN;SOCS2;PTK2;STAT5B
prerank,smooth muscle cell differentiation (GO:0051145),-0.793842523395873,-1.848406184280532,0.0,0.038617438964411936,0.677,11/12,19.51%,MEF2C;MRTFB;TBX18;MRTFA;TMEM204;HEY2;BMP4;MYOCD;EDNRB;APLNR;GATA6
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.6246691144217683,-1.8432822246536573,0.0025906735751295338,0.04071438525172619,0.698,11/29,12.58%,GRIK2;SLC4A10;MCTP1;SHISA6;SHISA9;APOE;APP;EPHB2;NETO1;ZDHHC2;NCDN
prerank,carnitine shuttle (GO:0006853),0.8502493068366815,1.8417256817924907,0.001937984496124031,0.9041981938003418,0.861,5/11,8.40%,PRKAG2;PRKAA2;CPT1A;SLC25A20;CPT2
prerank,limb development (GO:0060173),0.7289528652397316,1.8373250532849417,0.0017421602787456446,0.7312754977509676,0.875,7/28,8.24%,SMOC1;RSPO2;LRP4;GLI3;COMP;CHD7;IFT122
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.5968893403019809,-1.8291670605472456,0.0,0.04901159046939083,0.778,17/39,8.46%,ACTN4;GCNT2;THBS1;EFNA5;CASK;ACER2;NEXMIF;JAG1;NOTCH1;SEMA3E;AJAP1;FZD4;CORO2B;ADAM15;CORO1C;MYOC;SPOCK1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.6430983186302293,-1.8272529158207211,0.002398081534772182,0.049000898120145804,0.786,9/23,15.17%,SLIT2;BMP5;THBS1;LYN;STK10;PTK2;MSN;CMKLR1;RARRES2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6517565402315936,1.8257037769407136,0.001594896331738437,0.7031014384687804,0.918,16/50,9.30%,RORA;TULP3;FGFR2;DCDC2;FBXL17;TTC23;GLI3;SUFU;GAS1;SMO;RAB34;MGRN1;BTRC;IFT122;ZIC1;GLI1
prerank,synaptic membrane adhesion (GO:0099560),-0.7329114752240226,-1.818759090393523,0.002066115702479339,0.053691738657435054,0.827,8/14,10.88%,LRRC4C;PTPRD;GPC6;LRFN5;NTNG1;PTPRF;SLITRK1;GPC4
prerank,rRNA metabolic process (GO:0016072),-0.4588749310469079,-1.8121971146025058,0.0,0.05763843862929095,0.857,66/160,18.85%,RPS24;RPL8;RPL41;RPL13;RPLP2;RPS6;RPL18A;RPL37;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPL19;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;WDR3;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPL36A;RPL6;MAPT;EMG1;MDN1;RPL31;NOP53;TRIR;DDX10;NOL11;RPL36;TEX10;RPL13A;FBL;XRN2;RPL35;UTP15
prerank,axonogenesis (GO:0007409),-0.43285128473826645,-1.8108198799044233,0.0,0.05714643160691094,0.86,71/237,10.34%,NRP1;NRXN1;NRXN3;SPTBN1;SLIT2;CTNNA2;ROBO2;RPS6KA5;SEMA3C;UNC5C;LAMA1;SEMA6A;PIK3R1;SEMA6D;MAP1B;BSG;ANK3;SHANK3;KLF7;ACTB;ENAH;SH3KBP1;EPHB1;CNTN4;UNC5D;NOTCH3;DCC;NPTN;EPHA5;DAB1;EFNA5;NRP2;CXCL12;EPHA6;SEMA5A;PAK3;SEMA7A;LAMA2;EVL;GAB1;NTNG1;S100A6;DSCAML1;NOTCH1;HSP90AB1;SEMA3E;SHTN1;NTN4;CNTN6;APP;NRCAM;B4GALT5;EPHA7;SEMA4D;KIF5C;LAMA3;ULK1;LGI1;ROBO4;FEZ1;RELN;EPHB2;EMB;ULK2;PTK2;SLC9A6;TNR;S100B;SLITRK1;PLPPR4;HSP90AA1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.574432195232213,-1.8057071616625604,0.002617801047120419,0.06001849370965755,0.88,11/37,6.02%,NLGN1;GRID2;TENM2;CADM1;PTPRD;HMCN1;IL1RAPL1;TENM3;VCAM1;TENM4;ICAM1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5878379389866882,-1.8009743202374602,0.0,0.06271198916657889,0.893,18/35,18.06%,NRP1;SEMA3C;SEMA6A;SEMA6D;NRP2;SEMA5A;SEMA7A;SEMA3E;FLNA;MET;SEMA4D;PLXNA4;SEMA3D;SEMA3G;SEMA4C;PLXND1;ARHGDIA;SEMA4A
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.7393952085625615,1.800967692453194,0.008417508417508417,0.7290089352051066,0.965,6/21,8.44%,EYA1;EYA2;EYA4;MAP2K5;TERT;GDNF
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.7393952085625615,1.800967692453194,0.008417508417508417,0.7290089352051066,0.965,6/21,8.44%,EYA1;EYA2;EYA4;MAP2K5;TERT;GDNF
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.6048624680992498,-1.7947675752997783,0.005,0.0666943125215163,0.913,17/33,16.47%,NLGN1;NRG3;GRID2;GRIK2;LRRC4C;GRIK1;ABR;NGF;GRIK4;CACNA1B;RELN;GRID1;LRP8;FABP5;GRIK3;BDNF;CX3CR1
prerank,regulation of osteoblast differentiation (GO:0045667),0.5813640602721156,1.7932923853072489,0.0,0.722380956851301,0.982,13/82,4.77%,RANBP3L;SMOC1;TMEM64;BMP6;BMP7;WNT4;DDX5;IGF1;FGFR2;NPNT;BMPR1A;SUFU;SMAD6
prerank,aspartate family amino acid catabolic process (GO:0009068),0.765356192690361,1.7920994045911725,0.003552397868561279,0.6514116019851924,0.982,9/19,13.24%,DDO;ALDH7A1;ASPA;PIPOX;GOT2;OGDH;DLD;AASS;GCDH
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.6077494679762093,-1.790462967185946,0.0,0.06903371175784331,0.93,19/34,21.60%,GRID2;MEF2C;GABRG3;GRIN2B;GABRA3;GABRA2;GSK3B;GRIN2A;GLRA1;GABRG2;GABRA4;GABRG1;GRIN1;INSYN2A;GABRA5;GABRE;ARRB2;GABRA1;DRD2
prerank,positive regulation of chemotaxis (GO:0050921),-0.5633970259969385,-1.7903965848389385,0.0,0.06760986274620448,0.93,19/43,15.17%,NRP1;NTRK3;CDH13;TMSB4X;THBS1;SEMA5A;F3;KDR;STX3;MET;TGFB1;PTN;FGF2;P2RY12;EDN3;PRKD1;VEGFA;PPM1F;RARRES2
prerank,regulation of membrane repolarization (GO:0060306),-0.7272596204917777,-1.790093083171235,0.0021141649048625794,0.06642140812761886,0.932,7/13,8.00%,CAV1;AKAP6;CACNA2D1;KCNJ2;NEDD4L;YWHAE;KCNQ1
prerank,basement membrane organization (GO:0071711),-0.7394497340026315,-1.789201987690999,0.006237006237006237,0.06594979915198965,0.933,6/14,11.64%,FLRT2;COL4A1;NTNG1;RAMP2;NTN4;CTSS
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7829276757389418,-1.788330609169474,0.005917159763313609,0.06543367028906102,0.934,6/11,13.39%,NOS3;CALM1;GCH1;HSP90AA1;PRKG2;QDPR
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.7069714652370387,1.787101302262192,0.0016666666666666668,0.629925810094226,0.985,8/26,8.44%,EYA1;EYA2;EYA4;FGFR1;MAP2K5;TERT;PPP2R1B;GDNF
prerank,regulation of T cell migration (GO:2000404),-0.7022105408565186,-1.7851766657975794,0.002320185614849188,0.06667774147672556,0.939,6/18,9.22%,LRCH1;CD200;CXCL12;APP;APOD;DOCK8
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.7537764202570811,-1.7822760072054695,0.006160164271047228,0.06746765450124553,0.943,7/13,13.39%,NOS3;CALM1;GCH1;HSP90AA1;PRKG2;MTHFD1L;QDPR
prerank,histone H3-K4 methylation (GO:0051568),0.7044076560996613,1.7820193735590597,0.008460236886632826,0.6145319167042379,0.99,14/26,20.71%,KMT2A;CXXC1;CTR9;TET2;ASH2L;KMT2C;WDR82;KMT2D;BEND3;OGT;SETD1B;TET3;SETD1A;KDM6A
prerank,endoderm formation (GO:0001706),-0.5849636263668267,-1.779587929695313,0.0078125,0.0684669453222914,0.945,20/35,22.94%,COL8A1;COL12A1;FN1;COL6A1;COL4A2;SOX17;LAMA3;ITGA4;DUSP1;SOX7;SETD2;MMP15;ITGA5;COL11A1;ITGB2;INHBA;VTN;ITGA7;COL7A1;LHX1
prerank,regulation of dendrite development (GO:0050773),-0.5773461057990503,-1.7783042741419615,0.0,0.06800112352598578,0.945,18/37,13.07%,CSMD3;ADGRB3;HECW2;BMP5;MARK1;HECW1;DCC;CDKL5;NEDD4L;GSK3B;DAB2IP;SEMA4D;LZTS1;PTN;RAP2A;MFSD2A;VLDLR;LRP8
prerank,chloride transmembrane transport (GO:1902476),-0.5568226475323688,-1.7742064368261277,0.005141388174807198,0.07041413546238229,0.951,29/48,17.12%,SLC12A7;ANO4;GABRG3;GABRB3;ANO1;GABRB1;GABRA3;GLRB;SLC12A2;GABRA2;SLC1A1;ANO3;GABRB2;GLRA3;GLRA1;GABRG2;SLC12A8;GABRA4;SLC12A4;GABRG1;SLC12A6;GLRA2;CLCN1;ANO5;ANO2;CLCN3;SLC12A5;GABRA5;GABRE
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.47126553821599815,-1.7702849550629625,0.0,0.07285415455520138,0.958,32/107,8.65%,NLGN1;NRG3;GRID2;GRIK2;MEF2C;LRRC4C;SYT1;GRM7;GRM5;RIMS2;CDH2;CLSTN2;GRM3;MCTP1;RIMS1;DGKI;GRIK1;ABR;GRM8;SLC12A2;DLGAP1;NGF;GRIK4;TMEM108;DLGAP2;APP;CACNA1B;ITGB1;CNTNAP4;LGI1;RELN;GRM1
prerank,ganglion development (GO:0061548),-0.7497457918899642,-1.7690394505420823,0.002105263157894737,0.07274361603038723,0.961,3/11,2.99%,NRP1;UNC5C;NRP2
prerank,platelet aggregation (GO:0070527),-0.5861052358407004,-1.7683125645347813,0.0048543689320388345,0.07223618417334242,0.962,17/33,17.83%,ACTB;GNAS;ACTN1;UBASH3B;FN1;ACTG1;MYH9;PPIA;FLNA;MYL12A;P2RY12;ITGB3;ILK;MYL9;TYRO3;STXBP3;HSPB1
prerank,regulation of cation channel activity (GO:2001257),-0.4812278843231687,-1.7670942477660017,0.0,0.07178176370485535,0.963,40/89,15.27%,PDE4D;NLGN1;DLG2;FGF14;MEF2C;GRIA4;CACNB2;AHNAK;FGF12;ANK3;CAMK2D;LRRC7;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;KCNAB1;SHISA6;SHISA9;MINK1;CALM1;APP;CALM2;GRIN2A;ITGB1;RELN;NETO1;FGF13;FKBP1A;JPH2;CTSS;DAPK1;HOMER1;NOS1;SHANK1;SELENON;CACNG8;STAC;GRIN1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.6667546004397565,1.7657057305087613,0.0033500837520938024,0.6985019191206646,0.996,6/32,2.21%,PRKAG2;SORBS1;PRKAA2;PPARA;AVIL;ZBTB20
prerank,cellular response to zinc ion (GO:0071294),-0.7159988971898764,-1.760116815709107,0.0022026431718061676,0.07651887070182414,0.975,13/15,22.95%,GLRA1;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;GLRA2;MT3;MT2A;HVCN1
prerank,mesenchymal cell differentiation (GO:0048762),0.6243246629140142,1.759835433390697,0.0015384615384615385,0.6979533299730066,0.997,12/51,4.57%,RANBP3L;TGFBR3;BMP7;ROCK2;WNT4;DDX5;FGFR2;FBXL17;FGFR1;TGFBR1;FOXC1;LOXL3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.6209526564454784,-1.7593870354797205,0.0045351473922902496,0.0760264593893027,0.975,9/27,7.16%,CTNNA2;IL1RAPL1;MARK1;NTNG1;CCDC88A;MBOAT1;GSK3B;DISC1;PSEN1
prerank,cation transmembrane transport (GO:0098655),0.6332851400738995,1.7530116318273756,0.0,0.7036646449195701,0.997,10/44,7.03%,TRPM3;ATP1A2;TRPM6;SLC7A2;SFXN2;SLC25A20;SLC6A9;P2RX3;SLC22A5;TRPM5
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.7883637733006966,-1.7512800994541164,0.0,0.08277437329159815,0.98,10/10,21.22%,GABRG3;GABRA3;GABRA2;GABRB2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE;GABRA1
prerank,adherens junction organization (GO:0034332),-0.5400870291463902,-1.7504652645463983,0.005698005698005698,0.08238275190280323,0.981,18/48,12.06%,CDH11;CADM2;CADM1;CDH8;CDH2;CDH13;ACTB;CDH10;CDH12;RAMP2;CDH6;CDH20;CDH19;CDH7;SMAD7;PVR;CDH1;CTNNB1
prerank,cellular response to copper ion (GO:0071280),-0.6982551599549041,-1.7481952961444456,0.002145922746781116,0.08350544326978723,0.985,10/16,14.19%,MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;SNCA;MT3
prerank,maturation of 5.8S rRNA (GO:0000460),0.7540443093615279,1.7478386008357856,0.0,0.6993192553114447,0.997,2/17,0.30%,NSA2;MPHOSPH6
prerank,vasoconstriction (GO:0042310),-0.7613561716183609,-1.7469405866098877,0.006276150627615063,0.08332590536052654,0.986,7/11,16.55%,SLC8A1;EDNRA;ACTA2;EDN1;EDN3;EDNRB;PIK3C2A
prerank,long-chain fatty acid transport (GO:0015909),0.665732789704738,1.7365529673934592,0.008445945945945946,0.7612044259133592,1.0,8/30,9.67%,PRKAG2;ACSL1;PRKAA2;CPT1A;SLC25A20;SLC27A1;CPT2;SPX
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.7058520454837935,-1.7339095210954323,0.012552301255230125,0.09501330058503457,0.989,3/14,4.06%,ABCG2;SLCO2B1;HMOX2
prerank,heme catabolic process (GO:0042167),-0.7058520454837935,-1.7339095210954323,0.012552301255230125,0.09501330058503457,0.989,3/14,4.06%,ABCG2;SLCO2B1;HMOX2
prerank,chloride transport (GO:0006821),-0.49667945317579865,-1.7322211744659342,0.0,0.09549582405811557,0.99,34/74,17.12%,SLC4A10;SLC12A7;SLC26A7;CLIC4;ANO4;GABRG3;GABRB3;ANO1;GABRB1;GABRA3;GLRB;SLC12A2;GABRA2;SLC1A1;ANO3;GABRB2;GLRA3;GLRA1;GABRG2;SLC12A8;GABRA4;SLC12A4;CLIC5;GABRG1;SLC12A6;GLRA2;CLCN1;TTYH1;ANO5;ANO2;CLCN3;SLC12A5;GABRA5;GABRE
prerank,regulation of dendritic spine development (GO:0060998),-0.6535309401259681,-1.731618991687789,0.009029345372460496,0.09481609601160426,0.991,8/19,7.16%,NLGN1;MEF2C;PPFIA2;SHANK3;TANC2;GRIN3A;APOE;PSEN1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.6361030075239587,-1.7315062946137092,0.0066815144766146995,0.09362758671371711,0.991,10/20,14.99%,SEMA3C;SEMA6A;SEMA6D;SEMA5A;SEMA7A;SEMA3E;SEMA4D;SEMA3D;SEMA3G;SEMA4C
prerank,cellular glucan metabolic process (GO:0006073),0.8186517608731556,1.7304087870680342,0.007352941176470588,0.7737260729191697,1.0,3/11,3.00%,PRKAG2;PYGM;PHKB
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6056471891316244,-1.7266242326901584,0.004987531172069825,0.09782897173333947,0.992,12/24,16.21%,NRP1;PTPRJ;TEK;PIK3R1;KDR;IQSEC1;MYOC;DUSP3;VEGFA;PPM1F;LIMS1;ARF6
prerank,glycerolipid catabolic process (GO:0046503),-0.6674536541750995,-1.725763365347479,0.004291845493562232,0.09755598467871389,0.992,6/19,7.93%,ABHD2;PLA2G4A;GPCPD1;MGLL;ENPP6;GDPD1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.6448692742178324,-1.7226720760553649,0.00423728813559322,0.10006896423159334,0.992,6/18,11.72%,SLIT2;MTUS1;PTK2B;LYN;PTN;EDN3
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.6970076749910291,-1.717475059042207,0.0,0.10512648421939398,0.995,6/15,5.30%,NTRK3;CDH13;VEGFC;CXCL12;F3;KDR
prerank,regulation of presynapse assembly (GO:1905606),-0.6517629908334155,-1.7170941052263409,0.009111617312072893,0.1028464996832169,0.995,9/18,13.17%,PTPRD;IL1RAPL1;GPC6;LRFN5;IL1RAPL2;APP;SLITRK1;GPC4;SNCA
prerank,regulation of presynapse organization (GO:0099174),-0.6517629908334155,-1.7170941052263409,0.009111617312072893,0.1028464996832169,0.995,9/18,13.17%,PTPRD;IL1RAPL1;GPC6;LRFN5;IL1RAPL2;APP;SLITRK1;GPC4;SNCA
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.6245946252979546,-1.7163595927662996,0.0,0.10241632008937022,0.995,11/22,16.33%,NTRK3;SH3GL2;NGF;NTRK2;TMEM108;RAP1A;STMN2;MAPT;BDNF;ACAP2;WASF1
prerank,neuron cell-cell adhesion (GO:0007158),-0.703113249121801,-1.713964878991766,0.00408997955010225,0.1038255624624206,0.996,7/14,3.27%,NLGN1;NRXN1;NRXN3;ASTN2;NCAM2;CNTN4;ASTN1
prerank,positive regulation of behavior (GO:0048520),-0.7588541366586069,-1.708877286228163,0.005988023952095809,0.10868927302237938,0.996,4/10,7.68%,NLGN1;MEF2C;SGIP1;STRA6
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.7181107993549068,1.708228438886223,0.005208333333333333,0.9512618006027819,1.0,4/20,7.27%,C1QTNF3;WNT4;SIK1;GCK
prerank,regulation of gluconeogenesis (GO:0006111),0.6759746915651171,1.7079444900416165,0.0034423407917383822,0.9035740154915931,1.0,15/27,24.29%,C1QTNF3;PPARGC1A;SIK1;GCK;SIRT1;USP7;OGT;CLK2;CRY1;GNMT;EP300;PDK2;SELENOS;ARPP19;DGKQ
prerank,alpha-amino acid catabolic process (GO:1901606),0.669790140338088,1.7076480279063817,0.006932409012131715,0.8614242664828458,1.0,7/29,12.38%,DDO;PRODH;ACADSB;ALDH4A1;GOT2;FAH;MTRR
prerank,positive regulation of vasoconstriction (GO:0045907),-0.7131153849634613,-1.7040857309710962,0.0064794816414686825,0.11340498071570394,0.996,2/13,2.36%,CAV1;ADRA1B
prerank,substantia nigra development (GO:0021762),-0.5570332420956334,-1.7006268330302414,0.007978723404255319,0.11683046884268901,0.997,18/37,20.13%,ACTB;PLP1;GNB4;YWHAE;MBP;CALM1;CALM2;BASP1;DYNLL1;HSPA5;GLUD1;CALM3;FGF9;SUDS3;NDRG2;SIRT2;YWHAQ;PADI2
prerank,regulation of glucose import (GO:0046324),0.6591711074411487,1.6937668304458293,0.006472491909385114,0.9618925131495305,1.0,8/30,6.42%,PRKAG2;APPL2;OSBPL8;SORBS1;IGF1;RHOQ;ITLN1;CREBL2
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.6214780924007128,-1.6935397231391294,0.004357298474945534,0.12459126955383835,0.998,9/23,16.01%,SLC12A7;SLC12A2;ATP6V0A4;SLC9A7;SLC12A8;SLC12A4;SLC12A6;CLCN3;SLC12A5
prerank,2-oxoglutarate metabolic process (GO:0006103),0.7670339760978715,1.692575226462483,0.01098901098901099,0.9299275291464697,1.0,9/13,18.13%,ADHFE1;GPT2;GOT2;OGDH;IDH1;D2HGDH;GOT1;IDH2;PHYH
prerank,axon guidance (GO:0007411),-0.41306977974067227,-1.689633521604961,0.0,0.12903403398362598,1.0,60/201,9.71%,NRP1;NRXN1;NRXN3;SPTBN1;SLIT2;PTPRM;ROBO2;RPS6KA5;SEMA3C;UNC5C;LAMA1;SEMA6A;PIK3R1;SEMA6D;BSG;SHANK3;KLF7;ENAH;SH3KBP1;EPHB1;CNTN4;UNC5D;NOTCH3;DCC;NPTN;EPHA5;DAB1;EFNA5;NRP2;CXCL12;EPHA6;SEMA5A;SEMA7A;TMEFF1;LAMA2;EVL;CHN1;GAB1;DSCAML1;NOTCH1;NTN1;SEMA3E;NTN4;CNTN6;EPHA7;SEMA4D;KIF5C;LAMA3;LGI1;ROBO4;FEZ1;PLXNC1;RELN;EPHB2;EMB;PTK2;PLXNA4;TNR;GAP43;RHOH
prerank,cellular response to glucose starvation (GO:0042149),0.6182224683015848,1.6887325898040766,0.012558869701726845,0.9251576759986943,1.0,14/41,11.45%,PRKAG2;PRKAA2;MTMR3;CPEB4;PRKAG3;SESN1;SESN2;NUAK2;TP53;SIK1;PICK1;BRSK1;BECN1;IMPACT
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.6652375049076954,-1.6876424785521862,0.015909090909090907,0.13032756838521525,1.0,6/16,6.28%,KCNC2;NOS3;NDNF;GUCY1B1;APOE;GUCY1A1
prerank,positive regulation of protein secretion (GO:0050714),0.565713049556244,1.6857206938470999,0.005797101449275362,0.9168188261579768,1.0,17/69,9.99%,NNAT;BMP6;C1QTNF3;FRMD4A;WLS;IGF1;NLGN2;MCU;MYO18A;EZR;TLR4;PTPN23;GCK;RBP4;DNM1L;GOLPH3L;TCF7L2
prerank,mesonephros development (GO:0001823),0.8109251028583725,1.6847827843456273,0.0039603960396039604,0.890031033160152,1.0,3/11,1.09%,FGF1;BMP7;OSR1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.6018250413277787,-1.6846370277146387,0.01160092807424594,0.13345490922219555,1.0,11/24,15.94%,PDE4D;PDE3A;PDE3B;PDE11A;PEX5L;GNAI1;PDE2A;PRKAR1B;PRKAR2B;UBE2B;APLNR
prerank,negative regulation of cell adhesion (GO:0007162),-0.47531896481290137,-1.6845160171659102,0.0,0.1320873644821833,1.0,30/72,13.12%,SEMA6A;CDH13;GCNT2;PODXL;PDE3B;SEMA5A;ACER2;NEXMIF;ACVRL1;CYP1B1;JAG1;NOTCH1;PTPRC;FZD4;CORO2B;SEMA4D;TGFBI;PLXNC1;EPHB2;ARHGDIB;TGFB1;SPOCK1;PTK2;PLXNA4;ADAM22;DUSP1;CDH1;RASA1;LPXN;DMTN
prerank,regulation of sequestering of triglyceride (GO:0010889),0.7404201949210234,1.6816485165933188,0.023423423423423424,0.8854598678578702,1.0,3/15,5.39%,OSBPL8;PPARA;OSBPL11
prerank,ribosome biogenesis (GO:0042254),-0.41608431024567494,-1.6749966590245038,0.0,0.14450879607445755,1.0,70/187,19.06%,RPS24;RPL8;RPL41;RPL13;RPLP2;RPS6;RPL18A;RPL37;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPL19;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;XPO1;RPS17;RPL28;RPL34;WDR3;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPL36A;RPL6;EMG1;MDN1;MALSU1;RPL31;NOP53;DDX10;LTV1;ABCE1;NOL11;RPL36;TEX10;RPL13A;FBL;XRN2;RBIS;RPL35;UTP15;RAN
prerank,cellular response to purine-containing compound (GO:0071415),-0.7363932258267665,-1.672961574898301,0.0189873417721519,0.1458077757307173,1.0,7/10,21.43%,SLC8A1;RYR2;RYR3;P2RY1;TRPM2;CASQ2;GSTM2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.6308798268289526,1.6727661824145252,0.01692047377326565,0.9358944556650195,1.0,4/31,4.77%,RANBP3L;TMEM64;SUFU;SMAD6
prerank,endothelial cell migration (GO:0043542),-0.564588516085843,-1.6726869665227546,0.010362694300518135,0.14453744709630126,1.0,18/37,15.98%,NRP1;CDH13;NOS3;FAP;ID1;CCN3;CYP1B1;MYH9;PLEKHG5;STARD13;SOX18;EMP2;LPXN;VEGFA;SCG2;PTP4A3;PLXND1;NR4A1
prerank,negative regulation of axon extension (GO:0030517),-0.5683258717056003,-1.6685784935339223,0.0024691358024691358,0.1492699000943546,1.0,13/30,14.99%,SEMA3C;SEMA6A;SEMA6D;RTN4;SEMA5A;SEMA7A;SEMA3E;DIP2B;SEMA4D;SEMA3D;SEMA3G;MT3;SEMA4C
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.6912802376005037,-1.6675063532566203,0.006172839506172839,0.1493708969703663,1.0,7/13,13.77%,NRP1;COL4A1;ENG;SEMA3E;KDR;CTNNB1;VEGFA
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.7008481649589019,-1.666633152528904,0.008908685968819599,0.14914818396916613,1.0,4/13,5.75%,GRIK2;SLC4A10;SHISA6;SHISA9
prerank,lipid phosphorylation (GO:0046834),-0.7468490466730512,-1.6643345601398747,0.011857707509881422,0.15125889320034594,1.0,6/10,13.00%,DGKH;DGKB;DGKI;DGKK;DGKG;DGKZ
prerank,regulation of exocytosis (GO:0017157),-0.5008375008262885,-1.6637966745725303,0.0029069767441860465,0.1504813933131114,1.0,10/46,6.67%,STXBP6;SYT1;IL1RAPL1;RIMS2;CADPS;CLASP2;STXBP5L;RAB3C;ANXA1;RAB27A
prerank,cellular response to sterol (GO:0036315),0.7662305836244807,1.6632049840662277,0.023952095808383235,0.9945745134951524,1.0,5/13,7.03%,RORA;GRAMD1B;INSIG2;SMO;RORC
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5530615617032075,-1.660960782434345,0.007575757575757576,0.15372347740189654,1.0,14/32,7.96%,NLGN1;DLG2;MEF2C;GRIA4;LRRC7;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;APP;GRIN2A;RELN;EPHB2
prerank,thyroid hormone generation (GO:0006590),0.7975144501777944,1.657585983119138,0.0297029702970297,1.0,1.0,2/10,1.23%,SLC5A5;CPQ
prerank,positive regulation of tissue remodeling (GO:0034105),0.8271990054964582,1.6574796365947981,0.00931098696461825,0.9820855249217465,1.0,4/10,8.46%,ROCK2;IL18;IL12B;HRG
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.7322153847716437,-1.6551936805123955,0.018218623481781375,0.1610135923994896,1.0,6/11,14.66%,CACNB2;CAMK2D;CACNA2D1;BIN1;NOS1;SESTD1
prerank,negative regulation of viral life cycle (GO:1903901),-0.6648530910857047,-1.654780026154227,0.011086474501108648,0.15999621353165114,1.0,5/15,11.74%,GSN;LY6E;MID2;PPIA;IFITM3
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.5602021820000124,-1.654639905667681,0.012690355329949238,0.15866542885226145,1.0,16/32,13.12%,THBS1;CLASP2;CASK;ACER2;NEXMIF;ACVRL1;JAG1;SEMA3E;AJAP1;ADAM15;CORO1C;MYOC;APOD;FAM107A;RASA1;DMTN
prerank,detection of calcium ion (GO:0005513),-0.6808802363606389,-1.6543145385183662,0.016597510373443983,0.15759628517971813,1.0,6/13,10.44%,SYT1;RYR2;KCNMB2;CALM1;CALM2;CALM3
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.49587059714420656,-1.6537596265197885,0.0,0.1569288298585731,1.0,19/54,9.40%,KCNIP4;DPP10;CAV1;AKAP6;KCNJ3;KCNMA1;DPP6;KCNJ2;KCNN2;KCNIP1;KCNAB1;KCNMB2;GNG2;NEDD4L;YWHAE;FLNA;KCNQ1;BIN1;GABBR2
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.48516608665198957,-1.653353010495946,0.003257328990228013,0.1559398891836576,1.0,21/64,8.55%,UTRN;LIMCH1;CDH13;THBS1;EFNA5;PEAK1;CASK;ACER2;NEXMIF;PTK2B;ACTG1;JAG1;SEMA3E;GPM6B;GSK3B;AJAP1;MINK1;ADAM15;CORO1C;MYOC;PTK2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.46891617304033567,-1.6531943971154928,0.0,0.15461820480056476,1.0,28/75,15.98%,NRP1;TEK;CDH13;BMPR2;VEGFC;NRP2;SEMA5A;PPP1R16B;F3;AKT3;KDR;ECM1;ITGA4;BMP2;GATA2;AGTR1;PROX1;FGF2;FLT4;JCAD;ITGB3;BMP4;HIF1A;PRKD1;VEGFA;SCG2;APLNR;NR4A1
prerank,fatty acid transmembrane transport (GO:1902001),0.7032996223960605,1.6523564355994136,0.020257826887661142,1.0,1.0,6/19,8.40%,PRKAG2;PRKAA2;CPT1A;SLC25A20;SLC27A1;CPT2
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7018072331784801,-1.6499764704731656,0.017316017316017316,0.15831702690388538,1.0,3/11,3.67%,MECOM;CD34;RUNX1
prerank,endocardial cushion development (GO:0003197),-0.6137676735100652,-1.6490138456425185,0.016203703703703703,0.1584403003478512,1.0,10/21,13.47%,BMPR2;ENG;NOS3;TGFB2;ACVRL1;NOTCH1;HEYL;BMP2;BMP4;ACVR1
prerank,synaptic vesicle cycle (GO:0099504),-0.5412029701516168,-1.6441766731186156,0.022277227722772276,0.16468836953759244,1.0,8/30,14.55%,NLGN1;SNAP25;RIMS1;PCLO;SYNDIG1;SLC17A6;SNCA;SYT7
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6559161780694286,1.6436994025647103,0.018867924528301886,1.0,1.0,7/26,5.22%,CACNA1D;ACTN2;ATP1B3;ANK2;DLG1;NEDD4;KCNS1
prerank,regulation of macrophage migration (GO:1905521),-0.7265066954994593,-1.6425449985696925,0.022774327122153208,0.166413544831386,1.0,5/10,16.47%,MTUS1;CD200;PTK2B;P2RY12;CX3CR1
prerank,bicarbonate transport (GO:0015701),-0.5843654487973062,-1.640462467752887,0.014962593516209476,0.16823482202034531,1.0,4/25,6.92%,SLC4A10;SLC26A7;CA4;CA2
prerank,metal ion homeostasis (GO:0055065),-0.5311096487512357,-1.6403355370191888,0.0,0.1669020671351978,1.0,15/40,16.01%,SLC8A1;TMTC2;SLC12A7;CAV1;ANK3;SLC12A2;SLC12A8;SLC12A4;JPH2;SLC12A6;SNCA;MT3;SELENON;GRIN1;SLC12A5
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.6391026772390641,-1.6380845154378596,0.011235955056179775,0.169528629466257,1.0,9/18,12.01%,DAAM2;TENM4;NOTCH1;HES1;TNFRSF1B;PTPRZ1;TNFRSF21;PTN;OPALIN
prerank,lipid modification (GO:0030258),-0.528153499820576,-1.636701004247666,0.012315270935960592,0.17032115281305918,1.0,11/37,13.00%,DGKH;DGKB;DGKI;PLPP1;MBOAT1;PLPPR1;PLPPR5;PLPPR4;DGKK;DGKG;DGKZ
prerank,protein ADP-ribosylation (GO:0006471),0.6329359529572984,1.6353334905962975,0.02617801047120419,1.0,1.0,16/28,13.20%,ART5;PARP10;PARP14;TIPARP;SIRT5;PARP4;PARP12;TNKS2;SIRT3;PARP9;SIRT1;ZC3HAV1;PARP11;PARP6;SIRT4;ART4
prerank,modified amino acid transport (GO:0072337),0.7155014808849314,1.6330152232987774,0.030947775628626693,1.0,1.0,5/15,8.49%,SLC6A13;SLC16A12;PDPN;SLC19A1;CTNS
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6758450604537803,1.6326769902819267,0.025951557093425604,1.0,1.0,4/21,1.91%,CACNA1D;ANK2;KCNA5;SNTA1
prerank,carboxylic acid transport (GO:0046942),0.5673818531566239,1.631747567716482,0.0093603744149766,1.0,1.0,7/55,1.78%,SLC16A6;SLC13A3;SLC6A13;SLC6A12;SLC16A12;SLC16A11;SLC38A3
prerank,cyclooxygenase pathway (GO:0019371),0.7748701197194641,1.6296188225498431,0.03861003861003861,1.0,1.0,2/10,1.03%,PTGDS;PTGS1
prerank,neurotransmitter secretion (GO:0007269),-0.5068252934856917,-1.6269178504331867,0.0,0.18617456855873482,1.0,10/44,6.77%,NRXN1;SYT1;RIMS2;SNAP25;RIMS1;LIN7A;PCLO;PTPRN2;SYN2;HSPA8
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.6962269140298852,1.625553665451654,0.022304832713754646,1.0,1.0,3/17,1.15%,ATP1A2;BMP7;TFPI
prerank,extracellular matrix assembly (GO:0085029),-0.5845248384237607,-1.6230797627004871,0.014251781472684086,0.19133176141277317,1.0,9/23,11.28%,GAS6;NTNG1;GPM6B;RAMP2;NTN4;TGFB1;MYH11;TNXB;MFAP4
prerank,dendritic spine morphogenesis (GO:0060997),-0.6653272409234109,-1.6222074794548642,0.00646551724137931,0.19111565599013527,1.0,8/15,13.90%,CTNND2;DOCK10;SHANK3;EPHB1;PAK3;EPHB2;DIP2A;SHANK1
prerank,intracellular lipid transport (GO:0032365),0.6726605461021274,1.619271804028942,0.025179856115107913,1.0,1.0,7/21,11.10%,PRKAG2;PRKAA2;CPT1A;SLC25A20;CPT2;PLEKHA8;ARV1
prerank,regulation of neuron projection development (GO:0010975),-0.4061517959756767,-1.6169352821709873,0.0,0.1987800391678773,1.0,56/163,14.41%,CSMD3;CTNNA2;LRRC4C;IL1RAPL1;PPFIA2;MARK1;NTRK3;CDH2;ITGA6;SHANK3;ROR1;DCC;LRRC7;NPTN;TANC2;TENM3;RIT2;PAK3;CHN1;PTK2B;TOX;FUT9;NDNF;SERPINI1;CDKL5;NTNG1;CCDC88A;NTRK2;MBOAT1;LYN;GSK3B;ROR2;DAB2IP;PAK1;RAP1A;APOE;STMN2;DISC1;PRAG1;PSEN1;RELN;SPOCK1;PTN;SCARF1;TRPV4;PLPPR5;MFSD2A;MARK2;ABI3;PRKD1;CFL1;RET;RTN4RL1;CDK5R1;MT3;FES
prerank,sodium ion export across plasma membrane (GO:0036376),0.7512765278465643,1.6154008886345776,0.024344569288389514,1.0,1.0,3/13,6.17%,ATP1A2;ATP1B3;ATP4A
prerank,membrane repolarization (GO:0086009),0.7171854221418537,1.6152179771091844,0.0225140712945591,1.0,1.0,3/15,1.34%,ATP1A2;ATP1B3;KCND3
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5787028724977955,-1.6112492403234673,0.02511415525114155,0.2076247442649068,1.0,14/24,25.60%,PECAM1;VCAM1;F11R;ICAM1;SEMA4D;ITGB1;ITGA4;MSN;NT5E;SYK;ITGB2;CERCAM;FERMT3;SELP
prerank,acylglycerol metabolic process (GO:0006639),-0.5273520123965794,-1.611105792564491,0.0076726342710997444,0.20615361839787597,1.0,11/37,13.92%,DGKH;DGKB;ABHD2;CAV1;DGKI;MGLL;APOE;DGKK;DGKG;DGKZ;PNPLA3
prerank,myelination (GO:0042552),-0.502418753608578,-1.6099550299103118,0.008108108108108109,0.206675982673694,1.0,25/46,23.25%,ADGRG6;ACER3;MAL;PLP1;EPB41L3;NFASC;SCN2A;MBP;B4GALT5;PLLP;MYOC;MARVELD1;TNFRSF21;ABCD2;SCN8A;GAL3ST1;MAL2;CMTM8;MALL;TPPP;SIRT2;LGI4;MPZ;CXCR4;SOX10
prerank,negative regulation of gluconeogenesis (GO:0045721),0.7558709323627325,1.609458230055517,0.03383458646616541,1.0,1.0,3/11,7.27%,C1QTNF3;SIK1;GCK
prerank,regulation of cardiac conduction (GO:1903779),0.5556682151401453,1.6088229221936063,0.010432190760059613,1.0,1.0,11/54,6.24%,ATP1A2;ATP1B3;ANK2;CORIN;ITPR2;ITPR1;NPR1;SLC8A3;DMPK;NPR2;AHCYL1
prerank,neural crest cell development (GO:0014032),-0.49586380407381114,-1.6086674887628931,0.0025974025974025974,0.20743121290115968,1.0,17/44,18.48%,SEMA3C;ERBB4;SEMA6A;SEMA6D;CDH2;SEMA5A;SEMA7A;SEMA3E;TBX1;SEMA4D;CORO1C;SEMA3D;SEMA3G;SEMA4C;KLHL12;SEMA4A;SOX8
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.7400646912011493,1.6074580110930095,0.03076923076923077,1.0,1.0,4/13,3.46%,DAB2;BMP6;BMPR1A;TGFBR1
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.5244702319704522,-1.6052383885678885,0.01507537688442211,0.2123816119144165,1.0,12/36,10.43%,SLIT2;MEF2C;PTPRM;DCN;THBS1;ACVRL1;NOTCH1;DAB2IP;APOE;TGFB1;FGF2;ATP2B4
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.7048321382882019,1.6051130152787207,0.037243947858473,1.0,1.0,4/16,7.63%,AUTS2;KMT2A;CTR9;BCOR
prerank,nuclear migration (GO:0007097),0.7369041010000511,1.6044772087826882,0.03237410071942446,1.0,1.0,5/13,9.80%,SYNE2;SYNE3;CLMN;FBXW11;DOCK7
prerank,cellular response to drug (GO:0035690),-0.564608660487689,-1.6037540647524415,0.032407407407407406,0.21326157877953172,1.0,10/25,14.50%,MEF2C;PDE4B;ACER2;GAS6;TFRC;KCNQ1;RAP2A;AIM2;HTR1B;PPM1F
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6201647854189789,-1.603303109518177,0.022123893805309734,0.2122062660006775,1.0,10/18,10.64%,GRID2;GRIK2;CDH8;GRIK1;GRIA2;UNC13B;GRIK4;SLC1A4;GRID1;SLC17A6
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.7130443625920997,1.602992831389094,0.046263345195729534,1.0,1.0,5/15,12.91%,MOXD1;SMOX;SAT1;PAOX;ASMT
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.5283395584779699,-1.6020409902579853,0.020833333333333332,0.21322044829182116,1.0,11/35,7.33%,NLGN1;CDH11;CDH8;CDH13;ATP2C1;CDH10;CDH12;CDH6;CDH20;CDH19;CDH7
prerank,regulation of dendrite extension (GO:1903859),-0.6191346623964662,-1.6014465403448024,0.021413276231263382,0.2125347641663588,1.0,4/18,4.88%,SYT1;RIMS2;RIMS1;NEDD4L
prerank,energy reserve metabolic process (GO:0006112),0.683013535399399,1.6007027454612905,0.03169014084507042,1.0,1.0,4/19,3.00%,PRKAG2;LEPR;PYGM;PHKB
prerank,positive chemotaxis (GO:0050918),-0.6242084358135649,-1.5995206642837294,0.022222222222222223,0.21473117320036345,1.0,8/17,17.18%,NRP1;PTPRJ;SEMA5A;MET;FGF7;VEGFA;SCG2;SCRIB
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.5972277946391794,-1.5991302377187913,0.016706443914081145,0.2137063249079091,1.0,12/19,23.89%,NRP1;PTPRJ;TEK;KDR;MYOC;VEGFA;PPM1F;LIMS1;S100A10;SFRP1;THY1;MAP4K4
prerank,response to sterol (GO:0036314),0.7347388830943365,1.5980983441631609,0.05304518664047151,1.0,1.0,4/11,7.34%,RORA;TGFBR1;RORC;TGFBR2
prerank,bone development (GO:0060348),0.5875189609381434,1.5980284057269285,0.027375201288244767,1.0,1.0,8/39,6.69%,RANBP3L;DYM;FGFR2;AKAP13;SULF2;CYP26B1;TP53;SH3PXD2B
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.6412914967078036,-1.596694321305512,0.027896995708154508,0.2166718356833039,1.0,5/15,9.15%,TGFB2;TGFB3;TGFB1;IRAK3;SMAD7
prerank,positive regulation of locomotion (GO:0040017),-0.5648952045723981,-1.5963289600908488,0.016908212560386472,0.2156228914993987,1.0,10/27,15.17%,SPOCK2;THBS1;CAVIN1;NTN1;STX3;TGFB1;P2RY12;TWIST1;PPM1F;RARRES2
prerank,anion transport (GO:0006820),0.6062421845506293,1.5960242663036674,0.022838499184339316,1.0,1.0,6/33,5.94%,SLC22A6;SLC13A4;SLC13A3;VDAC2;SLC26A3;SLC19A1
prerank,regulation of receptor binding (GO:1900120),-0.7004378645516274,-1.5959067501184918,0.015317286652078774,0.21487094440886642,1.0,7/10,21.33%,GREM2;B2M;PTPRF;ADAM15;ATP2A3;BDNF;ATP2A2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5471056670159565,-1.5954536495071112,0.01674641148325359,0.2140897095172025,1.0,14/30,7.16%,PECAM1;ACTB;CLDN5;ESAM;LAMA2;F11R;SLC12A2;ACTG1;SLC1A1;LSR;MBP;OCLN;JAM2;ITGB1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.7205149452704547,1.5933683169444826,0.04570383912248629,1.0,1.0,3/14,3.17%,AUTS2;KMT2A;CTR9
prerank,regulation of small molecule metabolic process (GO:0062012),0.6278160595709484,1.5912048968765211,0.016366612111292964,1.0,1.0,9/28,11.94%,RORA;PPARA;PRKN;NCOR2;RORC;SIRT1;MLYCD;ARV1;TTC39B
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.5973689472373553,-1.5910612864986011,0.0262582056892779,0.22045528442809875,1.0,7/18,7.73%,NLGN1;RIMS2;RIMS1;GSK3B;RAP1B;RAP1A;PREPL
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.4671833064120205,-1.5908173425674406,0.002793296089385475,0.21919175564224527,1.0,19/57,14.61%,RPS24;RPS6;RPL26;RPL38;RPL7;RPS19;RPS28;RPL35A;RPS15;RPS16;RPL5;RPS7;RPL14;XPO1;RPS17;RPS25;EMG1;MALSU1;LTV1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.6266253154903455,1.5907714761803784,0.0353356890459364,1.0,1.0,9/26,16.01%,LGR4;APPL2;TLR3;GPS2;FLOT2;IRF1;LRRC14;TLR5;BIRC3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.4674819298428687,-1.5893535101689702,0.005681818181818182,0.22052435700422168,1.0,32/63,17.12%,SLC12A7;ANO4;GABRG3;GABRB3;ANO1;SLC26A2;GABRB1;GABRA3;GLRB;SLC12A2;GABRA2;SLC1A1;ANO3;GABRB2;SLC5A6;GLRA3;XPR1;GLRA1;GABRG2;SLC12A8;GABRA4;SLC12A4;GABRG1;SLC12A6;GLRA2;CLCN1;ANO5;ANO2;CLCN3;SLC12A5;GABRA5;GABRE
prerank,sphingolipid metabolic process (GO:0006665),-0.42059200919230316,-1.5888601615269222,0.0,0.2200815409976309,1.0,30/108,13.22%,ST6GALNAC3;ELOVL7;CERT1;SGMS1;ESYT2;SGMS2;ELOVL5;ACER3;PRKD3;ACER2;PPM1L;PLPP1;UGCG;SPTLC2;DEGS2;SPNS2;PSAP;PPP2R1A;GLTP;HEXB;B3GALNT1;PPT1;ELOVL6;ESYT3;CERS4;ENPP2;SERINC1;ASAH2;GAL3ST1;PRKD1
prerank,response to copper ion (GO:0046688),-0.6002853469691255,-1.5887804469647369,0.024444444444444446,0.21858893007975885,1.0,10/20,14.19%,MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;SNCA;MT3
prerank,endothelial cell proliferation (GO:0001935),-0.6067671255260874,-1.5871887514460885,0.023148148148148147,0.22019374164530647,1.0,6/17,4.30%,TEK;BMPER;BMPR2;SEMA5A;CD34;ACVRL1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.7314870108297182,1.5867063144084805,0.03932584269662921,1.0,1.0,3/11,1.42%,ACTN2;LEPROT;PICALM
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5736222047265321,-1.585865253346031,0.02830188679245283,0.22100595299345246,1.0,11/22,21.68%,SLIT2;GSN;TMSB4X;KANK3;KANK4;PFN2;KANK1;HIP1R;MYADM;SSH2;TWF2
prerank,endothelial cell differentiation (GO:0045446),-0.6866612316696467,-1.5855630035555102,0.019693654266958426,0.21990169546033983,1.0,7/12,12.21%,BMPR2;TIE1;ACVRL1;JAG1;KDR;PROX1;SOX18
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.43482144788162286,-1.5847377367281843,0.006825938566552901,0.21987750086721372,1.0,32/86,16.21%,NAV3;SEMA5A;NCK2;EVL;CARMIL1;PTK2B;CDC42EP3;PAK1;APOE;APP;RPS3;MET;STMN2;OCLN;PSEN1;BIN1;PROX1;TRPV4;CDK5RAP2;WDR1;EDN1;SYNPO2;MAPT;PFN2;CLIP1;CDK5R1;FES;CDC42EP2;CLU;NCK1;GPX1;ARF6
prerank,positive regulation of dendrite extension (GO:1903861),-0.6256222446175673,-1.5839446989408952,0.024070021881838075,0.21980045419098249,1.0,4/17,4.88%,SYT1;RIMS2;RIMS1;NEDD4L
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.36615572628301596,-1.5829929890360421,0.0,0.2199206975154163,1.0,133/306,25.78%,ST3GAL4;POLA1;RPS24;RPS12;RPL8;FUT9;EXT1;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;RPL18A;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;PTMA;APOE;RPL35A;RPLP0;RPS15;RPL30;RPS3;EEF2K;RPL19;RPS21;RPL4;B4GALT5;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;ABCF1;RPL14;RPS17;RPL28;RPL34;EEF1A1;POLD3;RPL12;RPL9;RPS25;EXT2;RPL7A;RPS2;RPS9;RPS11;NAP1L1;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;RPS4X;RPS5;RPL36A;RPL6;TAF1B;DUT;POLR2J;RPL31;HBS1L;RNASEH2A;RPSA;RPS26;TIPIN;RPL36;BCL3;RPA1;ORC5;GCNT1;RNPS1;ORC2;EEFSEC;BARD1;RPL13A;CDC45;BRIP1;RPL35;DNA2;PAX8;INHBA;EEF2;RFC4;COPS5;RPL24;RPS13;MRPL34;RPL11;POLD1;EEF1D;RSL24D1;MRPS16;RFC2;POLR2C;POLR2L;BLM;MRPS21;RECQL5;MLF1;MRPL10;MRPL13;TUFM;EEF1G;RPS27A;MRPS33;HOXD3;EIF4EBP2;MRPL35;EEF1A2;SET;GTPBP2;MCM6;RFC5
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.7373213134379997,1.5825945252119178,0.024208566108007448,1.0,1.0,6/13,12.27%,SORBS1;PRKCZ;ECHDC3;GKAP1;SIRT1;PTPN11
prerank,regulation of MAP kinase activity (GO:0043405),0.5083895765003382,1.5824484394236353,0.005772005772005772,1.0,1.0,14/92,6.37%,FGF1;ROBO1;BMP7;TPD52L1;KSR1;KIT;CD300A;PPEF2;FGFR1;ADRA2A;LRRK2;FLT1;TRIB2;PDGFRB
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.5356943744987459,-1.5817608111018244,0.01256281407035176,0.22042133887337503,1.0,16/32,14.17%,RHOJ;THBS1;MEOX2;HDAC7;HDAC9;NOTCH1;AKT3;KDR;ANXA1;GATA2;PTGS2;FGF2;JCAD;STARD13;VEGFA;SRPX2
prerank,negative regulation of TOR signaling (GO:0032007),0.5984032385536875,1.581157911907522,0.022988505747126436,1.0,1.0,20/36,19.83%,RNF152;PRKAA2;FNIP1;NPRL3;SESN1;DEPTOR;SESN2;ATM;NPRL2;UBR2;SIRT1;DEPDC5;FLCN;KPTN;TSC1;TMEM127;UBR1;TBC1D7;ITFG2;TSC2
prerank,positive regulation of axon extension (GO:0045773),-0.574758591947727,-1.5800027378739878,0.020930232558139535,0.2220829250329772,1.0,6/22,5.18%,NRP1;SEMA5A;SEMA7A;CDKL5;NTN1;SHTN1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.586991062799834,-1.5796350790392446,0.02040816326530612,0.22110611800632654,1.0,6/21,15.17%,MTUS1;THBS1;PTK2B;PTK2;CMKLR1;RARRES2
prerank,dendritic spine organization (GO:0097061),-0.5559049340220719,-1.5793497177290952,0.013953488372093023,0.22002549951000053,1.0,9/26,13.90%,CTNND2;DOCK10;SHANK3;EPHB1;PAK3;EPHB2;MTMR2;DIP2A;SHANK1
prerank,endodermal cell differentiation (GO:0035987),-0.5357092197734963,-1.5793058759368115,0.02107728337236534,0.2185955088186551,1.0,16/31,20.11%,COL8A1;COL12A1;FN1;COL6A1;COL4A2;LAMA3;ITGA4;SETD2;MMP15;CDC73;ITGA5;COL11A1;ITGB2;INHBA;VTN;ITGA7
prerank,positive regulation of cell projection organization (GO:0031346),-0.418549798401232,-1.5791637667290315,0.0,0.2173659981548297,1.0,37/115,9.95%,SLIT2;PTPRD;ROBO2;IL1RAPL1;NTRK3;ITGA6;ROR1;LRRC7;NPTN;TENM3;GRIP1;RIT2;CARMIL1;PTK2B;TOX;FUT9;NDNF;SERPINI1;CDKL5;NGF;NTRK2;LYN;ROR2;DAB2IP;TIAM1;FZD4;RAP1A;APOE;STMN2;PLXNC1;RELN;PTN;PLXNA4;SCARF1;MAP6;PLPPR5;SLITRK1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.6359059737457715,1.5790777238773752,0.031088082901554404,1.0,1.0,3/23,0.48%,UACA;BMP7;C1QTNF3
prerank,regulation of ruffle assembly (GO:1900027),-0.5617390930823227,-1.5783904735853167,0.02588235294117647,0.21707307760542652,1.0,8/23,12.78%,NLGN1;CAV1;EVL;RDX;P2RY12;EPS8;ABI3;PFN2
prerank,linoleic acid metabolic process (GO:0043651),0.6791798910920976,1.5760287440133627,0.039568345323741004,1.0,1.0,2/17,2.35%,ACSL1;ALOX12
prerank,epithelial cell development (GO:0002064),0.6619483121362405,1.5733631573257423,0.03866432337434095,1.0,1.0,5/20,8.51%,WNT5B;PKHD1;RILPL1;DACT2;LRTOMT
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.4797021962571312,-1.573202670207178,0.008241758241758242,0.2256350687574187,1.0,15/46,12.86%,NRP1;TMEFF2;TEK;PIK3R1;PARVB;PEAK1;FN1;LAMC3;NTNG1;NTN4;ITGA4;ITGA8;ITGB3;ILK;LPXN
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6508203364218644,-1.573096195591639,0.024742268041237112,0.2242696286061179,1.0,10/13,28.30%,CDH13;CD9;LDLR;ITGB1;SREBF2;SYK;ITGB2;CD81;ABCA1;CD36
prerank,response to ethanol (GO:0045471),-0.6503126811790235,-1.5727955870302672,0.02666666666666667,0.22344355368216978,1.0,8/14,15.27%,GRIN2B;ADCY7;GRIN3A;GRIN2A;GLRA1;GLRA2;SDF4;GRIN1
prerank,inhibitory synapse assembly (GO:1904862),-0.6894544224661926,-1.5700291735245726,0.029013539651837523,0.22730878005866414,1.0,6/11,10.88%,GABRB3;GABRA2;GABRB2;GABRG2;FGF13;LGI2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.7012770174306696,-1.5699485536892386,0.035789473684210524,0.22589672788238943,1.0,3/10,4.11%,CAV1;ANK3;KCNAB1
prerank,positive regulation of heart rate (GO:0010460),-0.6106138842975247,-1.569138626325347,0.016129032258064516,0.225960004925683,1.0,6/17,11.72%,PDE4D;RYR2;ADRA1B;KCNQ1;EDN1;EDN3
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5104992726414129,-1.568129206947383,0.0,0.22654380247498002,1.0,16/39,15.49%,RPS24;RPS6;RPS19;RPS28;RPS15;RPS16;RPS7;RPS17;WDR3;RPS25;RPS27;RPS5;EMG1;RPSA;LTV1;NOL11
prerank,negative regulation of calcium ion transport (GO:0051926),0.6891439033959506,1.5673369167697349,0.047080979284369114,1.0,1.0,2/15,3.65%,ATP1A2;ADRA2A
prerank,histone H3-K4 trimethylation (GO:0080182),0.7623262872475951,1.5669344427601906,0.04339622641509434,1.0,1.0,10/11,19.69%,KMT2A;CTR9;TET2;WDR82;KMT2D;BEND3;OGT;SETD1B;TET3;SETD1A
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6996119360276127,-1.5667820669997627,0.027833001988071572,0.22773346308484643,1.0,7/10,15.94%,PDE4D;PDE3A;PDE3B;PDE11A;PDE2A;UBE2B;APLNR
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5809658879854418,-1.5660068355046148,0.024330900243309004,0.2276144537886043,1.0,10/21,15.00%,PDE4D;CAV1;RASSF2;NCK2;SMAD7;CNKSR3;DDIT4;DMTN;PPM1F;NCK1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.4971828237371286,-1.5643451371864834,0.013477088948787063,0.22941463677665627,1.0,18/39,15.30%,NRP1;SLIT2;COL4A1;ENG;TIE1;RASIP1;SEMA3E;KDR;PAK1;MET;BMP2;SIX1;FGF2;PKD1;BMP4;CTNNB1;VEGFA;PAX2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5549086783161294,-1.5639493048328446,0.024630541871921183,0.22874491933080976,1.0,14/24,24.01%,PDE4D;AKAP6;CAMK2D;CALM1;CALM2;CALM3;FKBP1A;JPH2;NOS1;SELENON;CASQ2;GSTM2;JPH3;DMD
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5483741556992221,-1.5638404674404192,0.031914893617021274,0.22750559356874353,1.0,12/26,14.41%,NAV3;PAK1;RPS3;MET;STMN2;OCLN;TRPV4;CDK5RAP2;MAPT;CLIP1;CDK5R1;FES
prerank,B cell receptor signaling pathway (GO:0050853),-0.5249245666671938,-1.5630755272099854,0.02195121951219512,0.22769469986968832,1.0,13/32,18.37%,MEF2C;RFTN1;CD38;PTPRC;BMX;PLCG2;PLEKHA1;TEC;BCAR1;SH2B2;BLNK;SYK;BTK
prerank,odontogenesis (GO:0042476),0.5748912741245042,1.5629176722370228,0.0368,1.0,1.0,11/35,11.87%,OSR1;FGFR2;WNT6;GLI2;TUFT1;FOXC1;EDA;BCOR;COL1A2;HDAC1;AXIN2
prerank,positive regulation of dephosphorylation (GO:0035306),-0.5464772144661589,-1.5626631940766,0.012345679012345678,0.22700877537174272,1.0,11/27,14.43%,PPP1R16B;PPP2R5A;PPIA;CALM1;CALM2;CAMTA1;BMP2;TGFB1;CALM3;MTMR9;SPPL3
prerank,vascular transport (GO:0010232),0.5191232935938719,1.5617955108979662,0.00741839762611276,1.0,1.0,20/81,9.62%,ATP1A2;SLC22A8;SLC13A3;SLC6A13;SLC6A1;SLC24A3;LEPR;SLC16A12;SLC5A5;SLC38A3;SLC7A2;SLC5A3;SLC6A9;SLC19A1;SLC22A5;SLC27A1;SLC38A1;SLC1A3;LRP1;LRP3
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6796561878210803,1.5614461302421734,0.04659498207885305,1.0,1.0,5/16,10.66%,RORA;PRKN;RORC;SIRT1;MLYCD
prerank,photoreceptor cell development (GO:0042461),-0.6326227720853881,-1.5614221110342565,0.02288329519450801,0.2281767657554438,1.0,6/14,13.77%,RORB;DCX;RP1;MFSD2A;AHI1;VEGFA
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.644802328009066,1.5606874066199505,0.04936014625228519,1.0,1.0,5/21,6.91%,DAB2;BMP6;BMPR1A;TGFBR1;WWTR1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.6995567120766274,1.56008051601424,0.03954802259887006,1.0,1.0,2/15,5.49%,CPEB2;DDX3X
prerank,cardiac ventricle development (GO:0003231),-0.5798636319114381,-1.5597372443471909,0.02054794520547945,0.2300757407486828,1.0,7/20,9.52%,ENG;NOTCH1;HES1;STRA6;HEYL;HEY2;PDE2A
prerank,mesenchyme morphogenesis (GO:0072132),-0.6125818146027276,-1.5593833834390416,0.03146067415730337,0.22926545682764007,1.0,7/17,8.22%,ENG;NOS3;TGFB2;ACVRL1;NOTCH1;HEYL;BMP2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.6489417013437051,-1.5577189984038946,0.029978586723768737,0.2311348158144629,1.0,7/14,19.76%,DAB2IP;HSPA5;DDRGK1;BFAR;PTPN1;BCL2L11;COPS5
prerank,substrate-dependent cell migration (GO:0006929),-0.6286794217881391,-1.5570269699083106,0.034408602150537634,0.23107248835793348,1.0,7/14,10.23%,NRP1;VEGFC;NTN1;SHTN1;PTPRC;CD2AP;P2RY12
prerank,transport across blood-brain barrier (GO:0150104),0.51418335230187,1.5567676518399525,0.007374631268436578,1.0,1.0,20/83,9.62%,ATP1A2;SLC22A8;SLC13A3;SLC6A13;SLC6A1;SLC24A3;LEPR;SLC16A12;SLC5A5;SLC38A3;SLC7A2;SLC5A3;SLC6A9;SLC19A1;SLC22A5;SLC27A1;SLC38A1;SLC1A3;LRP1;LRP3
prerank,regulation of stem cell proliferation (GO:0072091),0.6611320197876298,1.5560581446453834,0.04562043795620438,1.0,1.0,4/17,8.39%,ACE;FBLN1;EIF2AK2;TERT
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.6145942620272545,1.5557412972933218,0.031141868512110725,1.0,1.0,3/26,1.62%,PRKAG2;LPGAT1;PRKAA2
prerank,eye development (GO:0001654),0.5423709361035534,1.5548394461678163,0.018957345971563982,1.0,1.0,10/54,7.54%,SMOC1;COL5A1;SHROOM2;FOXC1;CACNA1C;MEIS1;SH3PXD2B;FBN1;NIPBL;RBP4
prerank,detection of visible light (GO:0009584),0.6985170845218032,1.5543959500240152,0.03231939163498099,0.9939097868705565,1.0,5/16,11.75%,ABCA4;CEP250;GNAT2;RHO;CACNA2D4
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.46112903109233927,-1.5542913736903807,0.005847953216374269,0.2351226598440938,1.0,19/57,8.44%,NLGN1;DLG2;MEF2C;GRIA4;LRRC7;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;DLGAP1;SHISA6;SHISA9;DLGAP2;MINK1;APP;GRIN2A;RELN;NETO1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5933152427322959,-1.5541994678351405,0.02511415525114155,0.23386145883501594,1.0,9/18,26.09%,VCAM1;JAM2;ITGB1;ITGA4;ADD2;CX3CR1;GCNT1;SELP;ITGB7
prerank,negative regulation of ion transport (GO:0043271),0.6234684161637474,1.5538063122138484,0.02664298401420959,0.9848186417017267,1.0,5/24,3.86%,WNK4;ACTN2;SYT11;ADRA2A;NEDD4
prerank,gliogenesis (GO:0042063),-0.6193429214720365,-1.5536147766219188,0.030737704918032786,0.2335215655022843,1.0,7/15,15.42%,CDH2;CD9;TGFB2;ANXA1;RELN;PAX2;METTL3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.6109832562193839,1.5535524076350888,0.03827751196172249,0.9734570189390789,1.0,7/26,6.42%,OSBPL8;SORBS1;IGF1;RHOQ;ITLN1;BRAF;CREBL2
prerank,sodium ion transport (GO:0006814),0.5082432060076238,1.5535250049579434,0.006993006993006993,0.9608002011092205,1.0,8/85,1.99%,ATP1A2;SLC6A13;SLC6A1;SLC24A3;SLC6A12;ATP1B3;SLC5A5;SLC8A3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6648093502622598,-1.5534957274514967,0.027253668763102725,0.23237783248109528,1.0,6/11,22.96%,NRP1;PAK1;BCAR1;STMN1;SIRT2;HGF
prerank,ameboidal-type cell migration (GO:0001667),-0.4670170623601634,-1.553269185410782,0.010723860589812333,0.23150076632753297,1.0,22/51,18.48%,SEMA3C;ERBB4;SEMA6A;SEMA6D;SEMA5A;SEMA7A;CCN3;SEMA3E;TBX1;SEMA4D;CORO1C;ITGA4;PDLIM1;AMOT;SEMA3D;SEMA3G;PKN3;FAT2;SEMA4C;AMOTL1;SEMA4A;SOX8
prerank,sprouting angiogenesis (GO:0002040),-0.46985889395468444,-1.5517460407997767,0.011904761904761904,0.2332503413438052,1.0,16/51,5.33%,NRP1;SLIT2;TEK;BMPER;CDH13;RSPO3;ENG;CCBE1;VEGFC;THBS1;SEMA5A;PTK2B;ACVRL1;SEMA3E;KDR;RAMP2
prerank,positive regulation of histone methylation (GO:0031062),0.630399350745545,1.5512216750005583,0.04215851602023609,0.9654057891618477,1.0,9/24,16.98%,AUTS2;KMT2A;JARID2;CTR9;SIRT1;PHF1;OGT;TET1;SMAD4
prerank,phosphate ion homeostasis (GO:0055062),-0.7039511364010903,-1.5506114106354256,0.030425963488843813,0.23404541359614575,1.0,3/10,7.03%,SFRP4;XPR1;ENPP1
prerank,glycogen metabolic process (GO:0005977),0.6182093918654279,1.550221246489912,0.030560271646859084,0.9605980893179783,1.0,5/27,8.86%,PRKAG2;PYGM;PHKB;GYS1;PHKG1
prerank,triglyceride homeostasis (GO:0070328),0.6340169712218772,1.5495748352689451,0.03019538188277087,0.9529543566427608,1.0,7/26,12.36%,RORA;C1QTNF3;IL18;ANGPTL8;SIRT1;PLA2G12B;MLXIPL
prerank,cellular response to decreased oxygen levels (GO:0036294),0.5245276910225742,1.5494616781442248,0.015105740181268883,0.9417395668768624,1.0,13/65,9.72%,EPAS1;CPEB2;RORA;BMP7;SLC8A3;CPEB4;FAM162A;TP53;TERT;SIRT1;AK4;PICK1;NPEPPS
prerank,regulation of actomyosin structure organization (GO:0110020),0.7125854983731018,1.5491284101471927,0.06367041198501873,0.932736700737677,1.0,7/13,14.57%,ROCK2;FHOD1;AKAP13;ASAP3;CDC42;TSC1;ALMS1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.6238095740765266,1.548983370954703,0.04931972789115646,0.9224876057403725,1.0,3/23,2.32%,PRKAG2;BMP7;SPHK1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.7642466784714049,1.548836987969349,0.03875968992248062,0.9122769432031866,1.0,2/11,0.34%,DAB2;WNT5B
prerank,regulation of glycolytic process (GO:0006110),0.5266316405260401,1.5481667010908222,0.0206794682422452,0.9058122610678488,1.0,14/68,13.91%,PRKAG2;IGF1;PRKAA2;PPARA;ZBTB20;NUPR1;GCK;HDAC4;NUP42;NUP98;MLXIPL;NUP43;NCOR1;OGT
prerank,regulation of DNA repair (GO:0006282),0.5643949193014332,1.5476329637973274,0.019202363367799114,0.8988096197905384,1.0,14/44,14.03%,EYA1;EYA2;EYA4;BABAM2;RNF8;TRIP12;SIRT1;UBR5;AXIN2;UIMC1;KAT7;BABAM1;PML;SMCHD1
prerank,endothelial tube morphogenesis (GO:0061154),-0.7008484427558725,-1.5469261139148682,0.0389344262295082,0.23991301511126228,1.0,5/10,12.06%,ACVRL1;RHOB;STARD13;BMP4;CTNNB1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5437753604491193,1.5447897480772101,0.01943198804185351,0.9077686820391352,1.0,13/53,14.03%,EYA1;EYA2;DDX5;EYA4;BABAM2;NACC2;ATM;RNF8;FBH1;SIRT1;UIMC1;BABAM1;SMCHD1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.6057072729888021,1.543099170890398,0.04779411764705882,0.9089286858849112,1.0,7/28,9.35%,PRKAG2;PRKAA2;AVIL;MITF;SIRT5;CTNS;SIRT1
prerank,fat cell differentiation (GO:0045444),0.5272817588616125,1.5430488283264867,0.021021021021021023,0.899091663767036,1.0,19/57,17.32%,WNT5B;C1QTNF3;OSBPL8;PPARGC1A;ADIG;METRNL;SMAD6;OSBPL11;SIRT1;CBY1;TCF7L2;MKKS;FAM120B;ERAP1;PER2;BBS2;CLIP3;CTBP2;MED1
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.6665345543516544,-1.5412021562645786,0.027896995708154508,0.24981240625233753,1.0,6/12,10.34%,EPHB1;HSP90AB1;B4GALT5;MYCBP2;EPHB2;HSP90AA1
prerank,positive regulation of glucose import (GO:0046326),0.639740396673693,1.5404841072733813,0.03553299492385787,0.9054982967519682,1.0,6/21,6.42%,OSBPL8;SORBS1;IGF1;RHOQ;ITLN1;CREBL2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.47520106266403683,-1.5404073719238176,0.0103359173126615,0.24986358011354762,1.0,15/42,16.20%,UTRN;NRP1;PTPRJ;TEK;CDH13;PTK2B;KDR;GSK3B;MYOC;EMP2;VEGFA;PPM1F;LIMS1;RRAS;SKAP1
prerank,positive regulation of B cell proliferation (GO:0030890),-0.5333603373428281,-1.538879336120419,0.03225806451612903,0.2514659557808822,1.0,10/29,22.40%,MEF2C;TFRC;CD38;PTPRC;EPHB2;TIRAP;CD74;IRS2;CD320;CD81
prerank,positive regulation of MAP kinase activity (GO:0043406),0.5183717794579793,1.538498043540695,0.02066772655007949,0.9086107408172334,1.0,10/66,6.37%,FGF1;ROBO1;TPD52L1;KIT;SASH1;FGFR1;ADRA2A;LRRK2;FLT1;PDGFRB
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.68179718763057,-1.5382405677795763,0.03305785123966942,0.25133515426957637,1.0,7/10,24.83%,GHR;STAT3;LYN;STAT5B;PTPN1;PRLR;JAK2
prerank,neuron projection development (GO:0031175),-0.37849521142537457,-1.5381965666629707,0.004424778761061947,0.25000776934835145,1.0,54/168,16.19%,FRY;NLGN1;CNTNAP2;CTNND2;PTPRM;DCLK1;GRM7;DOCK10;SHANK3;EPHB1;CNTN4;NYAP2;PAK3;PLP1;EPB41L3;SH3GL2;NGF;TRIO;NRK;TMEM108;GPM6B;SHTN1;LYN;GSK3B;DAB2IP;STX3;MINK1;PAK1;APOE;APP;STMN2;ULK1;LGI1;EPHB2;MYOC;GPRIN3;SLC9A6;RASGRF1;UHMK1;MARK2;DIP2A;NCDN;MAP4;MAPT;ERCC6;GPM6A;SHANK1;CDK5R1;UBB;MYO16;STMN1;BDNF;BICDL1;PACSIN1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.6862765688344142,1.5379997334676916,0.06060606060606061,0.9014895899188079,1.0,12/15,25.06%,SPHK1;SIRT3;SAMD8;PLA2G6;SPHK2;NSMAF;SMPD3;SMPD2;TNFRSF1A;ORMDL3;ORMDL1;PRKCD
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.5693053440214431,-1.537121318867652,0.02891566265060241,0.2508783682996531,1.0,11/21,22.71%,GRIN2B;NGF;EPHA7;AIM2;MT3;USP50;GRIN1;PSMB9;SOX2;PYCARD;FYN
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.4185061750353634,-1.5370562638431438,0.0,0.24963821213576126,1.0,33/93,15.00%,PDE4D;NTRK3;CAV1;RASSF2;NCK2;BCAR3;GAS6;NGF;TFRC;HSP90AB1;PAK1;APP;TGFB1;SMAD7;CNKSR3;FNIP2;CD44;DDIT4;HSP90AA1;ATP2B4;TNKS1BP1;NOS1;PFN2;AXIN1;DMTN;SNCA;PRKD1;VEGFA;TXN;PINK1;TERF2IP;PPM1F;NCK1
prerank,blood vessel morphogenesis (GO:0048514),-0.45404815266590337,-1.5361032185084424,0.00819672131147541,0.25020524927351395,1.0,26/54,12.50%,NRP1;LAMA1;CDH2;CAV1;COL4A1;ENG;CCBE1;ID1;CYP1B1;RASIP1;SLC1A1;KDR;RAMP2;TBX1;ITGB8;SOX17;HES1;STRA6;TGFB1;PROX1;SMAD7;HEY2;FLT4;RASA1;SOX18;LOX
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.5501391059157232,-1.5351139512212892,0.03547671840354767,0.2508180435843442,1.0,8/24,8.32%,TEK;SEMA5A;NDNF;GAS6;KDR;RAMP2;ICAM1;GATA2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7045836838861652,1.5347889549550329,0.048828125,0.91270949948694,1.0,5/13,9.48%,RHOQ;LRRK2;OPA1;AK3;AK4
prerank,regulation of brown fat cell differentiation (GO:0090335),0.6734274663830762,1.5342459929359702,0.04554079696394687,0.9063488064212434,1.0,7/16,9.60%,BMP7;NAPEPLD;METRNL;RREB1;FNDC5;SIRT1;SOX13
prerank,regulation of cytoplasmic translation (GO:2000765),0.6979057860848034,1.5341820984935999,0.04887218045112782,0.8971671248583779,1.0,4/14,8.32%,CPEB2;CPEB4;ZCCHC13;CPEB3
prerank,diacylglycerol metabolic process (GO:0046339),-0.556535076242856,-1.5336091824140754,0.019650655021834062,0.2524059439462796,1.0,8/23,13.46%,DGKH;DGKB;PLCE1;DGKI;DGKK;DGKG;DGKZ;LIPE
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.6439287610225314,-1.5335119552415652,0.04670912951167728,0.2513099712382145,1.0,4/12,11.74%,GSN;LY6E;MID2;IFITM3
prerank,hematopoietic stem cell differentiation (GO:0060218),0.7259826408204353,1.533297231181473,0.06415094339622641,0.8937356157709947,1.0,4/10,12.63%,ACE;HOXB4;TP53;LMBR1L
prerank,positive regulation of synaptic transmission (GO:0050806),-0.4314788667969087,-1.5319453079411443,0.009259259259259259,0.25308261794110154,1.0,21/72,11.24%,NLGN1;NRXN1;GRIK2;SYT1;RIMS2;CLSTN2;SHANK3;SLC24A2;RIMS1;NPTN;GRIN2B;PTK2B;PLK2;APP;GRIN2A;LGI1;RELN;EPHB2;ZDHHC2;SHANK2;GPER1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6177306537674369,1.5317387394952848,0.056896551724137934,0.8943320645366349,1.0,12/23,22.24%,C1QTNF3;PPARA;NUPR1;SIK1;GCK;HDAC4;NCOR1;CLK2;CRY1;PLEK;GSK3A;EP300
prerank,positive regulation of interferon-beta production (GO:0032728),0.5816793756815396,1.5316445093670463,0.03372681281618887,0.8859151085220449,1.0,14/33,13.35%,OAS2;TLR3;TLR4;RNF135;DDX3X;TRIM56;RIPK2;MAVS;TOMM70;DHX58;PTPN11;IRF1;POLR3A;OAS3
prerank,peptidyl-lysine trimethylation (GO:0018023),0.6136940484480451,1.5309567841864082,0.030508474576271188,0.8814965911584642,1.0,13/26,19.69%,KMT2A;CTR9;KMT5C;TET2;KMT5B;WDR82;KMT2D;BEND3;OGT;SETD1B;TET3;SETD3;SETD1A
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.6937427396457146,1.5309346269210506,0.03838771593090211,0.8727479907611712,1.0,6/13,9.60%,BMP7;NAPEPLD;METRNL;RREB1;FNDC5;SOX13
prerank,cell-cell junction assembly (GO:0007043),-0.44345314452086554,-1.5308626328083106,0.011869436201780416,0.2539776244438387,1.0,22/63,10.63%,CDH11;CTNND2;CDH8;CDH2;ACTB;CLDN5;CD9;CDH10;EPB41L3;CDH12;ACTG1;CLDN11;GJC1;GJD3;RAMP2;CDH6;CDH20;CDH19;CDH7;SMAD7;TRPV4;WDR1
prerank,regulation of dopamine secretion (GO:0014059),0.5984955403069023,1.5308301859030713,0.04878048780487805,0.864645532646509,1.0,5/25,4.05%,SYT9;SYT11;SYT12;PRKN;DTNBP1
prerank,cGMP-mediated signaling (GO:0019934),-0.6571335644941837,-1.5303640224795785,0.02959830866807611,0.2536662262260563,1.0,6/13,9.52%,PDE3A;KCNC2;HTR2C;GUCY1B1;APOE;PDE2A
prerank,leukocyte tethering or rolling (GO:0050901),-0.5981748989696964,-1.5302205688052242,0.03263403263403263,0.25257001222823594,1.0,9/17,26.09%,VCAM1;JAM2;ITGB1;ITGA4;ADD2;CX3CR1;GCNT1;SELP;ITGB7
prerank,carbohydrate derivative catabolic process (GO:1901136),0.6485148978095977,1.5299467245633462,0.0518783542039356,0.861673227943404,1.0,6/18,8.43%,NGLY1;NEU2;ADAMTS9;DERA;SAMHD1;MANBA
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.6915124854471743,1.5295530351122835,0.05156537753222836,0.8556482355244721,1.0,3/13,7.27%,SORBS1;IGF1;GCK
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4376926037456652,-1.5292047767999988,0.018461538461538463,0.2532534241962885,1.0,29/70,22.71%,PIK3R1;MYO10;ACTB;ACTG1;HSP90AB1;DOCK1;LYN;ACTR2;PAK1;WIPF3;PLCG2;CRK;PTK2;ABI1;HSP90AA1;ACTR3;ELMO1;ARPC1B;ARPC5;ARPC4;NCK1;VAV1;WASF2;SYK;NCKAP1;WIPF1;YES1;ARPC3;FYN
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.5046448368255596,-1.5291802638488696,0.025,0.25196067550747264,1.0,11/34,12.67%,PDE4D;SLC8A1;PDE4B;RYR2;ATP1B1;CALM1;CALM2;KCNQ1;SMAD7;CALM3;NOS1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.4833446539233345,-1.5289101170558923,0.023195876288659795,0.25125361184126205,1.0,12/43,13.47%,MEF2C;ENG;RYR2;MICAL2;TBX3;NOTCH1;SOX17;HES1;VANGL2;SOX18;AHI1;ACVR1
prerank,histone H3-K36 demethylation (GO:0070544),0.7428410105543551,1.5286794843914253,0.064453125,0.8526809631193375,1.0,4/10,11.82%,KDM7A;KDM2B;KDM2A;RIOX2
prerank,retinoic acid metabolic process (GO:0042573),0.6870518752018424,1.527894902952374,0.05534351145038168,0.8494563935716938,1.0,3/14,7.48%,ALDH1A2;CYP26B1;SCPEP1
prerank,carbohydrate derivative transport (GO:1901264),-0.5939306829470986,-1.5274980297208807,0.03728070175438596,0.25287468013373554,1.0,9/18,15.37%,SCARB1;PLTP;ABCG1;SLC10A7;NPC2;MFSD2A;VLDLR;LBP;SLC29A1
prerank,secretion (GO:0046903),0.6771892347534809,1.5272016068186922,0.055984555984555984,0.8453225145787647,1.0,2/14,1.93%,SLC22A6;NPR1
prerank,histone lysine methylation (GO:0034968),0.5710934551344966,1.526711830571121,0.04152823920265781,0.8401962041072112,1.0,14/33,21.16%,KMT2A;CXXC1;SMYD3;ASH2L;PRDM5;WDR82;KMT2D;DOT1L;SETD1B;SETDB2;EHMT2;SETD3;KDM6A;N6AMT1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5860802314758972,-1.5266950695719859,0.038461538461538464,0.253210262379068,1.0,8/18,17.63%,HEG1;RASIP1;MET;KCTD10;MYOC;CUL3;STMN1;KANK1
prerank,kidney development (GO:0001822),0.5145989671705982,1.52639067819468,0.020864381520119227,0.8341142739927809,1.0,12/65,4.95%,BMP7;ACE;LRP4;WNT4;OSR1;GREB1L;GLI2;KANK2;TGFBR1;FOXC1;SULF2;CTSH
prerank,cellular response to starvation (GO:0009267),0.46883928714918466,1.525819658986131,0.009308510638297872,0.8300503093034213,1.0,32/147,11.45%,PRKAG2;RNF152;PRKAA2;PPARA;FNIP1;MTMR3;CPEB4;PRKAG3;NPRL3;SESN1;ATP6V0E1;LRRK2;LAMP2;SESN2;ATG5;NPRL2;NUAK2;ATP6V0B;TP53;SIK1;EIF2AK2;WIPI1;NUPR2;SIRT1;PICK1;BRSK1;BECN1;ATG7;ATP6V1D;ATP6V1E1;ATF2;IMPACT
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5889545478558275,-1.5249833407162217,0.03794642857142857,0.25547643488665955,1.0,13/18,16.55%,RHOJ;HDAC7;HDAC9;AKT3;KDR;ANXA1;GATA2;PTGS2;FGF2;JCAD;VEGFA;SRPX2;PIK3C2A
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6714524492457207,-1.52469958079953,0.03512396694214876,0.25484671079629995,1.0,5/10,19.59%,FN1;HSP90AB1;LAPTM4B;GATA6;TYROBP
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5274949990022764,1.5243645803486452,0.02674591381872214,0.831398078401368,1.0,7/61,3.04%,NOTCH2;ROBO1;AUTS2;LPAR1;IGF1;ALS2;AKAP13
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.7058671233285735,1.5242198496950718,0.06095238095238095,0.8247140704060403,1.0,3/12,7.27%,SORBS1;IGF1;GCK
prerank,protein mono-ADP-ribosylation (GO:0140289),0.7225874308971978,1.5239516778803432,0.061386138613861385,0.8188608454656783,1.0,8/11,10.70%,PARP10;PARP14;TIPARP;PARP4;PARP12;PARP9;PARP11;PARP6
prerank,membrane lipid biosynthetic process (GO:0046467),-0.45239607037608476,-1.5237524670803801,0.017964071856287425,0.25557471910565566,1.0,17/58,10.65%,ST3GAL4;ELOVL7;CERT1;SGMS1;SGMS2;ELOVL5;ACER3;PRKD3;ACER2;PPM1L;PLPP1;SPTLC2;DEGS2;SPNS2;ST8SIA6;ELOVL6;CERS4
prerank,regulation of focal adhesion assembly (GO:0051893),-0.45875812181816233,-1.5232807074618053,0.02476780185758514,0.25512692683065075,1.0,22/54,14.56%,NRP1;LIMCH1;PTPRJ;TEK;THBS1;CLASP2;EFNA5;PEAK1;ACTG1;ACVRL1;GPM6B;KDR;CORO1C;MYOC;APOD;PTK2;DUSP3;FAM107A;DMTN;VEGFA;PPM1F;LIMS1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.5695465664556746,1.5229861409382557,0.0352,0.8171129687112636,1.0,12/38,13.78%,BMP6;SASH1;IFNK;ANKRD17;PLSCR1;DDX60;LY96;DHX58;NMI;PRKCA;IFI35;ACOD1
prerank,ganglioside biosynthetic process (GO:0001574),-0.6138818067812208,-1.5221702290739918,0.050955414012738856,0.25618595840680614,1.0,6/15,8.77%,ST6GALNAC3;ST8SIA4;ST3GAL1;ST6GALNAC5;B4GALT5;ST8SIA6
prerank,regulation of amyloid fibril formation (GO:1905906),-0.6036817841742756,-1.5220778880554566,0.0455531453362256,0.25509518135374576,1.0,7/15,16.78%,APOE;APP;LDLR;PSEN1;CLU;IAPP;CHRNA7
prerank,negative regulation of cellular protein localization (GO:1903828),0.5649590399388216,1.5215573767417663,0.04433497536945813,0.8182041584164009,1.0,4/34,1.42%,ROCK2;ACTN2;LEPROT;PICALM
prerank,cAMP-mediated signaling (GO:0019933),-0.5466774259121269,-1.5213797429275158,0.03303964757709251,0.25510845210183614,1.0,9/24,5.44%,PDE4D;PDE3A;RIMS2;ADGRG6;AKAP6;ADCY2;EPHA5;PDE7B;CAP2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.4346562696007245,-1.5205278130179263,0.024464831804281346,0.25542491540743917,1.0,29/71,22.71%,PIK3R1;MYO10;ACTB;ACTG1;HSP90AB1;DOCK1;LYN;ACTR2;PAK1;WIPF3;PLCG2;CRK;PTK2;ABI1;HSP90AA1;ACTR3;ELMO1;ARPC1B;ARPC5;ARPC4;NCK1;VAV1;WASF2;SYK;NCKAP1;WIPF1;YES1;ARPC3;FYN
prerank,peptide hormone secretion (GO:0030072),-0.5295731097335379,-1.51920586848609,0.044009779951100246,0.2570236392422291,1.0,5/26,11.72%,RIMS2;LTBP4;ANXA1;EDN1;EDN3
prerank,response to interleukin-6 (GO:0070741),-0.6809412418726959,-1.518937016524759,0.0423728813559322,0.25638513362167464,1.0,5/10,11.88%,PID1;PTPRT;PTGIS;ST3GAL6;SBNO2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.6018302860916422,-1.5172935480908893,0.045871559633027525,0.2582057761251008,1.0,6/15,13.80%,ACTR2;ACTR3;TRIM27;ARPC1B;ARPC5;ARPC4
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6179453020069237,-1.5169856475316918,0.045454545454545456,0.2573574758736554,1.0,7/15,15.43%,GRM7;GRM5;GRM3;GRM8;GRM1;HOMER1;GRIK3
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.6156761673896185,1.5164586890574143,0.04475043029259897,0.839258345164464,1.0,5/25,4.88%,WNK4;ACTN2;ATP1B3;ANK2;SLC6A9
prerank,rRNA processing (GO:0006364),-0.37962418436661116,-1.5161679591498523,0.0,0.2577115677051506,1.0,79/172,24.15%,RPS24;RPL8;RPL41;RPL13;RPLP2;RPS6;RPL18A;RPL37;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPL19;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;RPL28;RPL34;WDR3;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;SART1;RPL36A;RPL6;EMG1;MDN1;RPL31;NOP53;DDX10;NOL11;RPL36;TEX10;RPL13A;FBL;XRN2;RPL35;ERI1;UTP15;NHP2;RPL24;NOP56;RPL11;TFB1M;MTREX;EXOSC10;RRP15;NOP58;IMP4;EXOSC4;EXOSC1;POP4
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5210298125560898,1.5157068602705281,0.03172205438066465,0.8365676305632371,1.0,16/61,14.03%,EYA1;EYA2;SMOC2;EYA4;BABAM2;USP9X;ATRX;PDGFRB;RNF8;SIRT1;UIMC1;RAD50;USP7;BABAM1;PML;SMCHD1
prerank,polyol biosynthetic process (GO:0046173),0.6607063347471551,1.514501484697278,0.0603290676416819,0.8367168400098298,1.0,5/16,9.75%,ISYNA1;CYP27A1;CYP2R1;ITPKB;PPIP5K2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7315197003417808,1.5138329608237788,0.0898876404494382,0.8332473307032552,1.0,2/11,1.47%,NECAB1;BACE2
prerank,regulation of histone methylation (GO:0031060),0.6949252893197694,1.5128058640144322,0.05319148936170213,0.8322324076968856,1.0,6/13,15.19%,JARID2;CTR9;NSD1;MTHFR;AASS;TET1
prerank,cardiac myofibril assembly (GO:0055003),0.6639715272307993,1.5114917512372756,0.06329113924050633,0.8328829513442974,1.0,6/15,10.73%,NEBL;CSRP3;OBSL1;PDGFRB;MEF2A;MYLK3
prerank,signal release from synapse (GO:0099643),-0.47403930426069557,-1.510370498955983,0.022727272727272728,0.268494245348415,1.0,9/43,6.77%,NRXN1;SYT1;SNAP25;RIMS1;LIN7A;PCLO;PTPRN2;SYN2;HSPA8
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.4309998036515213,-1.51009625501713,0.00911854103343465,0.26782624082933143,1.0,21/70,12.86%,NRP1;TMEFF2;MEF2C;TEK;PIK3R1;PARVB;ACTN1;PEAK1;FN1;LAMC3;NTNG1;NTN4;ITGA4;RELN;PROX1;ARL13B;ITGA8;ITGB3;ATF4;ILK;LPXN
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.4345137644256036,-1.509609715757197,0.02735562310030395,0.26756200742151226,1.0,16/55,10.88%,GPC5;GPC6;DCN;CEMIP;BGN;LUM;CSPG4;HSPG2;VCAN;SDC3;TGFB1;HEXB;FGF2;CD44;AGRN;GPC4
prerank,phospholipid transport (GO:0015914),-0.456498139889552,-1.509471937032366,0.03081232492997199,0.2665342604529726,1.0,21/52,14.29%,ATP10A;ATP8A1;ATP8B1;PITPNC1;ATP11A;ATP8A2;SCARB1;PLTP;APOE;ABCG1;LDLR;NPC2;ATP11C;PITPNB;TNFAIP8L3;MTTP;MFSD2A;PITPNA;TMEM30A;ATP8B2;ABCB4
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6612668594021751,-1.5085393670251857,0.05739514348785872,0.2672901708215219,1.0,5/11,11.30%,SEMA6A;THBS1;EPN2;KLF2;CREB3L1
prerank,metal ion export (GO:0070839),0.5855469378792009,1.5083608704196474,0.03735144312393888,0.8439557086798971,1.0,4/31,1.80%,ATP1A2;ATP1B3;KCND3;KCNA5
prerank,cell junction assembly (GO:0034329),-0.3967974723480664,-1.506999614827575,0.0,0.26900115431548116,1.0,28/100,7.82%,NLGN1;ADGRL3;CDH11;CTNND2;NRXN1;DNM3;CDH8;CDH2;KIRREL3;ITGA6;SHANK3;SPOCK2;ACTB;CLDN5;FN1;CDH10;DNER;CDH12;ACTG1;GJC1;VMP1;CDH6;FLNA;NRCAM;CDH20;CDH19;CDH7;LIMS2
prerank,response to zinc ion (GO:0010043),-0.5355589948737979,-1.5053812922013705,0.04225352112676056,0.27121941289441936,1.0,13/25,14.19%,PAM;GLRA1;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;CRIP1;GLRA2;MT3
prerank,stem cell differentiation (GO:0048863),0.5586854773300297,1.5052235267698748,0.04,0.8554573546807333,1.0,7/39,2.45%,ACE;OSR1;KIT;FGFR2;HOXB4;JARID2;FBXL17
prerank,peripheral nervous system development (GO:0007422),-0.541009267052844,-1.5051958288837664,0.03818615751789976,0.2703903159101477,1.0,14/23,30.20%,ADGRG6;SERPINI1;NGF;NFASC;SCN8A;ADGRB1;BDNF;SOX8;SOX10;ERBB3;NF1;ADGRB2;NTF3;GPC1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.7099777829317886,1.5051875416476606,0.055970149253731345,0.8487133882295077,1.0,5/12,12.27%,SORBS1;PRKCZ;GKAP1;SIRT1;PTPN11
prerank,dicarboxylic acid transport (GO:0006835),0.5977260612902265,1.5050763361769122,0.05460750853242321,0.84241523908264,1.0,7/28,9.88%,SLC22A6;SLC13A3;PDPN;SLC19A1;SLC26A1;SLC1A3;SLC25A12
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.7300675868071712,1.5048394837787544,0.07047619047619047,0.8300981742202147,1.0,3/10,11.75%,CEP250;GNAT2;CACNA2D4
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.7300675868071712,1.5048394837787544,0.07047619047619047,0.8300981742202147,1.0,3/10,11.75%,CEP250;GNAT2;CACNA2D4
prerank,positive regulation of fat cell differentiation (GO:0045600),0.5363150231505792,1.504834126300593,0.04213938411669368,0.8235329880436056,1.0,9/47,6.42%,TMEM64;BMP7;MEDAG;NAPEPLD;ADIG;METRNL;RREB1;FNDC5;CREBL2
prerank,lysine catabolic process (GO:0006554),0.7007096510690758,1.5047387935729337,0.056640625,0.8111686079434967,1.0,6/12,13.24%,ALDH7A1;PIPOX;OGDH;DLD;AASS;GCDH
prerank,lysine metabolic process (GO:0006553),0.7007096510690758,1.5047387935729337,0.056640625,0.8111686079434967,1.0,6/12,13.24%,ALDH7A1;PIPOX;OGDH;DLD;AASS;GCDH
prerank,excitatory postsynaptic potential (GO:0060079),-0.5809069734373915,-1.5031695053889573,0.0420353982300885,0.2733249992357049,1.0,5/19,7.11%,GRID2;MEF2C;GRIN2B;GSK3B;GRIN2A
prerank,prostaglandin biosynthetic process (GO:0001516),0.6423297659567562,1.5030888583052777,0.0686456400742115,0.8144365667198596,1.0,2/18,1.03%,PTGDS;PTGS1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.6269967978161526,1.50224067760359,0.0632688927943761,0.8127724221855012,1.0,4/22,10.48%,ALDH1A2;RBP1;CYP2R1;GC
prerank,positive regulation of interleukin-13 production (GO:0032736),0.711697641741017,1.5001044986163639,0.08771929824561403,0.8186721152231198,1.0,2/10,2.00%,PRKCZ;IL18
prerank,endocardial cushion morphogenesis (GO:0003203),-0.5764251873069501,-1.4998876066973572,0.05714285714285714,0.27874950539925997,1.0,9/18,13.47%,ENG;NOS3;TGFB2;ACVRL1;NOTCH1;HEYL;BMP2;BMP4;ACVR1
prerank,sodium ion transmembrane transport (GO:0035725),0.49025147315308365,1.4991579885654371,0.01694915254237288,0.8172633444173596,1.0,7/84,1.99%,ATP1A2;SLC6A13;SLC6A1;SLC24A3;SLC6A12;ATP1B3;SLC8A3
prerank,microvillus organization (GO:0032528),-0.6120952536026543,-1.4988147556477938,0.05627705627705628,0.27972902286587253,1.0,6/13,9.65%,FXYD5;RAP1B;MINK1;RAP1A;RAPGEF6;RAP2A
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.6169802818766906,-1.4975601630750985,0.042735042735042736,0.28093113559333643,1.0,5/15,10.00%,CDH13;PTPN12;CEACAM1;ERBB2;MVB12B
prerank,ERBB signaling pathway (GO:0038127),-0.43338381596353176,-1.4974871986352054,0.02046783625730994,0.27981743833874817,1.0,17/64,10.36%,RPS6KA5;ERBB4;PIK3R1;REPS2;PLCE1;PTPN12;IQGAP1;NCK2;GAB1;PTK2B;NRG2;TGFB1;PTK2;ERBIN;ERBB2;HSP90AA1;BCAR1
prerank,arachidonic acid metabolic process (GO:0019369),0.5599653815114215,1.4966007730487771,0.055077452667814115,0.8251589042558412,1.0,5/35,6.61%,PTGDS;PTGS1;ALOX12;EPHX1;DAGLA
prerank,ceramide transport (GO:0035627),-0.6377982929596429,-1.4957814317486096,0.05319148936170213,0.2819260530902428,1.0,6/12,14.29%,CERT1;PLTP;PSAP;GLTP;PLEKHA3;ABCB4
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6719943685124437,-1.4956340481775512,0.04395604395604396,0.2809321133831415,1.0,4/10,8.44%,SHANK3;NPTN;APP;NETO1
prerank,response to metal ion (GO:0010038),-0.42536420095561056,-1.4950177507329538,0.012121212121212121,0.2808945355616729,1.0,21/67,14.19%,CAV1;KCNMA1;THBS1;GPHN;NEDD4L;TRPC3;SLC25A13;CALM1;CALM2;TRPC1;PAM;PPP3CA;CALM3;MT1A;MT1X;HOMER1;CRIP1;MAPT;HIF1A;SNCA;MT3
prerank,regulation of catecholamine secretion (GO:0050433),0.5724152974887026,1.4945468316711763,0.06164383561643835,0.8303748199166762,1.0,5/29,4.05%,SYT9;SYT11;SYT12;PRKN;DTNBP1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.7014999931755889,1.4940872121265452,0.07485604606525911,0.8268094555622015,1.0,2/12,0.43%,NOTCH2;DOCK11
prerank,negative regulation of nuclear division (GO:0051784),0.6849002395260484,1.4928480136533644,0.0859375,0.8278498492204001,1.0,2/11,2.84%,BMP7;TOM1L2
prerank,regulation of TORC1 signaling (GO:1903432),0.5538778995516747,1.4927892607944315,0.06199021207177814,0.82214405072594,1.0,10/33,17.13%,RNF152;SESN1;GPR137;SESN2;ATM;DEPDC5;FLCN;KPTN;TELO2;RRAGD
prerank,neuron migration (GO:0001764),-0.4588356534521658,-1.49277402429383,0.03287671232876712,0.2841679882653845,1.0,24/48,15.01%,NRP1;ADGRL3;MEF2C;MARK1;ASTN2;MAP1B;ASTN1;NDNF;DNER;CDKL5;NTRK2;DISC1;NRCAM;DCX;RELN;SPOCK1;TUBGCP2;FGF13;DDIT4;MARK2;VEGFA;GPM6A;CDK5R1;TUBB2B
prerank,positive regulation of protein processing (GO:0010954),-0.5641870549863497,-1.4926060078249894,0.05263157894736842,0.283299410294669,1.0,6/19,16.72%,GSN;CCBE1;MYH9;NKD2;RHBDD1;CLEC3B
prerank,positive regulation of cell communication (GO:0010647),-0.5179977108572664,-1.4921202442755273,0.034739454094292806,0.28301813880630833,1.0,11/28,12.24%,GRIK2;SYT1;RIMS2;CLSTN2;ANK3;RIMS1;LGI1;EDN1;EDN3;HOMER1;ILK
prerank,histone modification (GO:0016570),0.4704328322533155,1.4921120000729935,0.02119205298013245,0.8195798587548648,1.0,29/109,17.45%,EYA1;EYA2;BRD8;CCNA2;EYA4;PADI6;USP3;CPA4;NSD1;BAZ1B;TBL1X;HUWE1;TBL1XR1;KAT6B;HDAC4;SIRT1;NSD3;HDAC1;AURKB;PRDM5;HLCS;SIN3A;MIER3;MTA2;EHMT2;CREBBP;EHMT1;SGF29;PADI4
prerank,ncRNA processing (GO:0034470),-0.3631247560290631,-1.4912430927555336,0.004524886877828055,0.28351187006893747,1.0,69/200,19.21%,RPS24;RPL8;RPL41;RPL13;RPLP2;RPS6;RPL18A;RPL37;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPL7;RPS19;RPL22;RPS28;RPL35A;RPLP0;RPS15;RPL30;RPL19;RPL4;RPL32;RPL21;RPS16;RPL18;RPL5;RPS7;RPL39;RPL14;RPS17;SMAD1;RPL28;RPL34;WDR3;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;DROSHA;RPL36A;RPL6;EMG1;MDN1;RPL31;NOP53;DDX10;METTL3;NOL11;RPL36;LIN28B;TEX10;RPL13A;FBL;XRN2;RPL35;UTP15;ADAT1
prerank,positive regulation of neuron migration (GO:2001224),-0.6488337407813812,-1.4910929128467043,0.05032822757111598,0.2826112649537242,1.0,4/11,5.82%,SEMA6A;SHTN1;ARHGEF2;DAB2IP
prerank,cellular protein metabolic process (GO:0044267),-0.34350241252894037,-1.4901257354239406,0.0,0.28327775939247946,1.0,119/396,15.79%,LTBP1;CDH2;MSRB3;ST8SIA4;CHRM3;CST3;FN1;RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;GAS6;RPL18A;RPS20;MGAT4A;ST3GAL1;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;IGFBP4;DAB2IP;RPL7;RPS19;RPL22;RPS28;APOE;RPL35A;RPLP0;APP;RPS15;MSLN;RPL30;RPS3;SFTPA1;SFTPA2;RPL19;RPS21;RPL4;PSEN1;IGFBP6;RPL32;UBE2G1;VCAN;RPL21;RPS16;RPL18;RPL5;PCSK5;RPS7;RPL39;ABCF1;RPL14;CKAP4;RPS17;CCN1;SIAH2;ST3GAL6;RPL28;RPL34;EEF1A1;SHISA5;RPL12;RPL9;FBXL2;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;PAPPA;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;SPARCL1;ZDHHC2;BMP4;RPS4X;RPS5;LCMT1;LOX;RPL36A;RPL6;LMCD1;UBE2D3;TMEM208;MMP15;CSNK1G3;RPL31;MFGE8;HBS1L;QPCT;SPPL3;RPSA;DUSP12;SPCS1;RPN1;SCG2;RPS26;MSRB2;PHEX;RPL36;GOLM1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.4602363659461476,-1.4899118348585916,0.029649595687331536,0.2824916439091414,1.0,13/46,3.62%,NLGN1;NRXN1;MEF2C;SYT1;GRM7;GRM5;CDH2;SHANK3;GRM3;DGKI;GRIK1;GRM8;PTK2B
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6388025219109449,-1.489797535102559,0.06060606060606061,0.28151111479086244,1.0,6/12,18.32%,PTPRJ;F3;APOD;SNCA;CBL;NDRG4
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.49388168904476026,-1.489731154487622,0.04336734693877551,0.28044341572440656,1.0,11/32,9.65%,ADGRB3;HECW2;PTPRD;IL1RAPL1;HECW1;CDKL5;NEDD4L;GSK3B;SEMA4D;LZTS1;RAP2A
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.4396913515587295,1.489033369346311,0.015151515151515152,0.8299957356733414,1.0,32/186,9.99%,DAB2;TMEM64;WWOX;RNF43;LRP4;BICC1;NXN;MCC;PRKN;TRABD2B;DKK3;RNF213;GLI3;APCDD1;CXXC4;VGLL4;LZTS2;APC2;WWTR1;UBAC2;PTPRU;INVS;TMEM170B;CSNK1A1;GLI1;LRP1;TLE1;HDAC1;SOX13;CBY1;GRB10;TCF7L2
prerank,prostaglandin metabolic process (GO:0006693),0.592287460429255,1.4885442319668936,0.04965753424657534,0.8269931208998123,1.0,2/26,1.03%,PTGDS;PTGS1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.7116869794372644,1.4885302592726344,0.09514925373134328,0.8212165770342744,1.0,3/10,7.30%,APPL2;CD300A;ANO6
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4256261038020678,-1.4884945583286553,0.0220125786163522,0.28160196990120445,1.0,29/73,22.71%,PIK3R1;MYO10;ACTB;ACTG1;HSP90AB1;DOCK1;LYN;ACTR2;PAK1;WIPF3;PLCG2;CRK;PTK2;ABI1;HSP90AA1;ACTR3;ELMO1;ARPC1B;ARPC5;ARPC4;NCK1;VAV1;WASF2;SYK;NCKAP1;WIPF1;YES1;ARPC3;FYN
prerank,apoptotic cell clearance (GO:0043277),-0.490978228966092,-1.4884538463377432,0.05542168674698795,0.2804662608912896,1.0,9/30,10.39%,RHOBTB1;XKR4;THBS1;SCARB1;GAS6;XKR6;ANXA1;RHOH;ITGB3
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6525038857258147,1.4882804159865066,0.07662835249042145,0.8167132004773426,1.0,3/17,1.76%,PRKAG2;PRKAA2;PPARA
prerank,transepithelial transport (GO:0070633),-0.5984556208016538,-1.487583946995032,0.04670912951167728,0.2809900060290561,1.0,4/15,4.70%,ABCG2;SLC12A2;SLC1A2;SLC1A1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.3874067450835332,-1.4867297417651641,0.0,0.2815137889372882,1.0,36/118,12.71%,ADGRB3;MEF2C;LRRC4C;HECW2;PID1;FMNL2;BMPER;PPFIA2;CDH2;SHANK3;HECW1;CLASP2;EFNA5;TANC2;PAK3;PHLDB1;CHN1;NEDD4L;GSK3B;TBX1;PAK1;SEMA4D;TSPAN12;LZTS1;TGFB1;CEACAM1;FGF2;FLT4;RAP2A;ERBB2;LFNG;MARK2;ABI3;CTNNB1;EMP2;MAPT
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.6508435356472964,-1.486722684373923,0.053061224489795916,0.2803348818456153,1.0,7/11,24.08%,GSN;ST18;FAS;HTRA2;LGALS9;PRR7;PLAUR
prerank,mononuclear cell differentiation (GO:1903131),-0.5343023789032975,-1.4864959053960858,0.039627039627039624,0.2795919941165586,1.0,11/24,15.38%,GAS6;MYH9;LYN;IKZF1;MT1G;BMP4;THOC5;VEGFA;TRPM2;RELB;IL31RA
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.6057733406361306,-1.4863957518576911,0.06479481641468683,0.27861221747394793,1.0,4/13,8.56%,PTPRT;PTPRC;HES1;MGAT5
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5648796595121425,-1.4862547454518915,0.0367816091954023,0.27772423762837056,1.0,9/19,15.66%,PTPRJ;GRM5;RYR2;VCAM1;KDR;PTPRC;DMTN;TRPM2;STIMATE
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4843907519050378,1.4853528161154206,0.01780821917808219,0.8269720835106389,1.0,11/85,4.42%,FGF1;TGFBR3;BMP6;OSR1;IGF1;FGFR2;MCC;LAMC1;PKHD1;NUPR1;FUT1
prerank,negative regulation of platelet activation (GO:0010544),-0.5842187606724483,-1.4852491221057034,0.06540084388185655,0.27852686000755833,1.0,7/16,10.26%,PRKG1;CD9;SERPINE2;NOS3;APOE;CEACAM1;PDGFA
prerank,glycerolipid metabolic process (GO:0046486),-0.6440768843727268,-1.4848504792792367,0.051440329218107,0.2781223899332503,1.0,6/11,19.39%,DGKB;DGKG;GAL3ST1;DGKZ;PNPLA3;PLA2G15
prerank,negative regulation of chemotaxis (GO:0050922),-0.49692103456628767,-1.4835683718437178,0.04177545691906005,0.2794993117077533,1.0,14/31,12.47%,SLIT2;ROBO2;SEMA3C;SEMA6A;SEMA6D;THBS1;SEMA5A;SEMA7A;NOTCH1;SEMA3E;SEMA4D;DUSP3;SEMA3D;SEMA3G
prerank,negative regulation of receptor binding (GO:1900121),-0.6408467280599779,-1.4835371047878059,0.06224066390041494,0.27838412940049967,1.0,4/10,9.26%,B2M;PTPRF;ADAM15;ATP2A3
prerank,organic acid transport (GO:0015849),0.4755265711821259,1.4835325484335902,0.02130681818181818,0.8307981986283183,1.0,18/94,8.70%,SLC22A6;SLC13A3;SLC6A13;ACSL1;SLC6A12;SLC38A4;SLC38A3;SLC7A11;SLC7A2;PDPN;SLC25A48;SLC10A4;SLC19A1;SLC27A1;GOT2;SLC26A1;SLC38A1;SLC51A
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6948939578355101,1.4834127013042002,0.07592592592592592,0.8257516035680041,1.0,7/13,16.21%,DDO;ASPA;GOT2;GLUL;ACOT8;QPRT;GOT1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.6297395501882171,1.482313176832316,0.06382978723404255,0.8261023025443032,1.0,3/18,6.00%,PRKAG2;PRKCB;BRAF
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6679412542569592,1.4822013167421941,0.09596928982725528,0.8210189460855702,1.0,4/13,5.45%,RNF152;SESN1;SESN2;ATM
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4876908065659506,1.4812156764544948,0.03550295857988166,0.8209485828475332,1.0,15/76,7.34%,UACA;BMP7;C1QTNF3;SASH1;DLG1;SPHK1;NFAT5;TLR3;EZR;TLR4;DDX3X;CD27;IL12B;EIF2AK2;PTPN22
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.38029647847302145,-1.481012027621084,0.004310344827586207,0.2821159502397109,1.0,33/138,10.36%,PTPRD;TEK;ERBB4;NTRK3;BMPR2;PTPRG;ROR1;EPHB1;MPZL1;LIFR;EPHA5;MERTK;PTPRT;EPHA6;TIE1;PTK2B;NGF;TRIO;NTRK2;IL6ST;KDR;LYN;ROR2;MET;PTPRF;EPHA7;EPHB2;PTK2;PTN;ABI1;FLT4;ERBB2;BCAR1
prerank,cardiac cell development (GO:0055006),-0.6612860463107768,-1.4806945354843877,0.04956896551724138,0.28163475790677905,1.0,5/11,13.77%,SLC8A1;JAG1;NOTCH1;MYH11;VEGFA
prerank,carboxylic acid catabolic process (GO:0046395),0.6929166233589803,1.4798064829235291,0.07915057915057915,0.8228668430936256,1.0,5/12,12.41%,RENBP;NPL;PON3;GNPDA1;ACOT8
prerank,regulation of ossification (GO:0030278),-0.47772119070628705,-1.4790734666670313,0.029339853300733496,0.2839246418526559,1.0,15/36,13.91%,MEF2C;BMPR2;SGMS2;TGFB2;NOTCH1;ZBTB16;ENPP1;ECM1;BMP2;PTN;S1PR1;BMP4;TWIST1;ACVR1;TXLNG
prerank,mesoderm formation (GO:0001707),-0.5647795517060801,-1.4785269294344132,0.060133630289532294,0.2838234094493199,1.0,6/17,14.64%,BMPR2;ITGB4;ITGB1;ITGA8;ITGB3;ITGA2
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5631443728210747,-1.478453921792058,0.06263982102908278,0.28280659141561526,1.0,10/17,31.48%,NLGN1;CACNA1G;RAB27A;KCNB1;CACNA1H;SYT10;DOC2B;STX1A;RAB3A;SCAMP5
prerank,lamellipodium organization (GO:0097581),-0.511849320693426,-1.477496761638327,0.04408352668213457,0.28369943531591735,1.0,14/29,13.12%,CDH13;ABLIM1;PARVB;CARMIL1;SPATA13;CCDC88A;ARHGEF7;ABLIM3;ITGB1;S1PR1;P2RY12;ABLIM2;SPEF1;DMTN
prerank,peptidyl-lysine modification (GO:0018205),0.4698128821975009,1.4758874189238256,0.024657534246575342,0.8385933422203864,1.0,33/99,23.21%,NNAT;EYA1;SENP3;LOXL1;LOXL3;PIAS1;SIRT5;NDUFAB1;SIRT3;HDAC4;SIRT1;CTH;NUP42;NUP98;SIRT4;NSMCE2;NUP43;VIPAS39;KAT2B;PIAS3;NUP155;SUMO1;PIAS4;NUP188;P3H4;ATP7A;UBE2I;NUP153;EP300;VPS33B;EEF1AKMT1;ESCO1;USPL1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.42475894334585274,-1.4758649363201584,0.0219435736677116,0.2859866890939115,1.0,22/67,14.56%,UTRN;NRP1;CDH13;FN1;VIT;CARMIL1;PTK2B;NDNF;ARHGEF7;DOCK1;GSK3B;FBLN2;FLNA;CRK;LIMS2;MYOC;CALR;ILK;EMP2;DMTN;PPM1F;LIMS1
prerank,positive regulation of signaling (GO:0023056),-0.48197215312008185,-1.475591883182466,0.041237113402061855,0.28542194413058525,1.0,16/37,17.66%,GRIK2;SYT1;RIMS2;CLSTN2;RIMS1;ECE1;LGI1;NSF;EDN1;EDN3;HOMER1;ILK;SNCA;NMU;SCRIB;CDKN2AIP
prerank,cardiac conduction system development (GO:0003161),0.5894942548298631,1.4740011148664312,0.07608695652173914,0.8431458018532716,1.0,3/24,3.18%,NOTCH2;GJB6;BMPR1A
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.48523427161435095,-1.4738866020976702,0.035175879396984924,0.2880601044426356,1.0,10/33,10.43%,MEF2C;THBS1;ACVRL1;MEOX2;NOTCH1;APOE;TGFB1;FGF2;STARD13;ATP2B4
prerank,lung development (GO:0030324),0.565968145698144,1.473866803810826,0.05254237288135593,0.8383009905963158,1.0,7/33,7.54%,FGF1;ERRFI1;FGFR2;GLI2;PDPN;LOXL3;RBP4
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5828445813800148,-1.4738431530857428,0.05416666666666667,0.28703830446784584,1.0,6/17,9.93%,MAML2;NOTCH3;NOTCH1;HEYL;WWC1;PBX1
prerank,histone lysine demethylation (GO:0070076),0.6033089889189385,1.4737984991070896,0.06618962432915922,0.8331235687981656,1.0,11/25,21.00%,KDM7A;KDM2B;KDM2A;HR;RIOX2;KDM3B;PHF2;KDM6B;KDM1A;KDM6A;RIOX1
prerank,positive regulation of cell division (GO:0051781),0.5351344471895035,1.4719773686413546,0.06724137931034482,0.8374230549951461,1.0,7/38,11.35%,FGF1;PKP4;FGFR2;CDC14A;AURKB;CDC14B;CDC42
prerank,prostanoid biosynthetic process (GO:0046457),0.6568474883752436,1.4718099443539063,0.07648183556405354,0.832963286526476,1.0,2/15,1.03%,PTGDS;PTGS1
prerank,skeletal system morphogenesis (GO:0048705),0.5417920844095359,1.4716853147924736,0.047619047619047616,0.828277154118295,1.0,11/42,9.73%,WWOX;FGFR2;HOXB4;FGFR1;TGFBR1;HOXB3;CYP26B1;HOXB9;HOXA3;HOXC4;DYNC2I1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4704348023400301,1.4716263088786787,0.027900146842878122,0.823313861235037,1.0,7/90,2.00%,EPAS1;ACSL1;PPARGC1B;APPL2;LEPR;PPARGC1A;IL18
prerank,cellular amino acid catabolic process (GO:0009063),0.48224365122141,1.470777791476314,0.024251069900142655,0.8224422597605506,1.0,22/87,13.24%,DDO;ALDH7A1;IVD;ASPA;PRODH;ACADSB;ALDH4A1;HNMT;PIPOX;BCAT2;GOT2;OGDH;DLD;GLUL;MCCC1;AASS;UROC1;FAH;ABAT;MTRR;ALDH6A1;GCDH
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.6506239929703679,1.4693649175256573,0.07088122605363985,0.8246780045841485,1.0,6/15,15.96%,DAB2;AAK1;WASL;NEU3;BMP2K;SMAP1
prerank,regulation of cell junction assembly (GO:1901888),-0.5147672367892683,-1.4689846913308016,0.03571428571428571,0.29574343638027245,1.0,8/27,6.59%,MEF2C;PRKCH;CLDN5;RUNX1;F11R;RAP1B;RAP1A;OCLN
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6117904825596272,1.4679377821621693,0.06349206349206349,0.8270480678706209,1.0,7/22,12.56%,SORBS1;PPARA;ZBTB20;F2;CREBL2;MLXIPL;SIRT4
prerank,sensory perception of sound (GO:0007605),0.47932331101544684,1.4664149386934688,0.031818181818181815,0.8301710864614793,1.0,15/88,8.94%,EYA1;CACNA1D;KIT;GSDME;WHRN;ALDH7A1;DCDC2;EML2;HOXA1;COL4A3;TBL1X;CDC14A;NIPBL;LRTOMT;EPS8L2
prerank,myofibril assembly (GO:0030239),0.5339215325580265,1.4662356446906966,0.05413533834586466,0.8259250467573631,1.0,9/42,6.37%,ACTN2;CSRP3;OBSL1;CFLAR;TMOD2;TMOD3;TPM1;KLHL41;PDGFRB
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.616717989995958,1.4650723501661713,0.06474820143884892,0.8271465847553993,1.0,10/21,21.38%,DCDC2;TTC23;SMO;RAB34;GLI1;EVC;STK36;IHH;GAS8;DLG5
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5405059361468562,1.4649647494734606,0.058823529411764705,0.822654152939698,1.0,7/41,13.91%,PRKAG2;LACC1;GCK;NUP42;NUP98;NUP43;OGT
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6605932409174591,-1.464682333933105,0.06693711967545639,0.3039348889676635,1.0,5/10,20.71%,PTPRC;CEACAM1;CX3CR1;ARRB2;LGALS9
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6771058380193185,1.4645926808669587,0.07578558225508318,0.8196789298082927,1.0,8/14,20.03%,AMACR;ACOXL;CRAT;ACOT8;ACOX3;EHHADH;ECI2;CROT
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.48492598345266397,-1.4641060896093443,0.038461538461538464,0.3039443142657222,1.0,12/35,6.19%,PDE4D;PDE3A;RIMS2;ADGRG6;AKAP6;ADCY2;EPHA5;HTR2C;PDE7B;GUCY1B1;CAP2;APOE
prerank,base conversion or substitution editing (GO:0016553),-0.6492468323646043,-1.4625918818699926,0.03991596638655462,0.306140177322279,1.0,4/11,15.42%,ADARB1;ADARB2;APOBEC1;METTL3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.44956549242593513,-1.4624180724246805,0.03488372093023256,0.30530078646332964,1.0,21/48,17.83%,RHOJ;TMSB4X;NOS3;THBS1;HDAC7;HDAC9;AKT3;KDR;ANXA1;GATA2;TGFB1;PTGS2;FGF2;JCAD;HIF1A;PRKD1;VEGFA;SRPX2;NUS1;PIK3C2A;HSPB1
prerank,early endosome to late endosome transport (GO:0045022),0.5982863148564465,1.4619909325363993,0.09075342465753425,0.82782080102335,1.0,14/20,25.11%,HOOK2;PTPN23;BECN1;ANKRD27;SNF8;HOOK3;EEA1;WDR91;WDR81;RAB7A;HOOK1;RILP;PIK3C3;KIF16B
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.531100057737003,-1.4617973071405554,0.03881278538812785,0.3055039410989853,1.0,6/25,8.94%,GRID2;MEF2C;GRIN2B;GSK3B;GRIN2A;GLRA1
prerank,response to muscle stretch (GO:0035994),-0.5898535038456744,-1.4611492046653929,0.06928406466512702,0.30587148753176924,1.0,6/15,12.06%,SLC8A1;CDH2;GSN;RYR2;PTK2;CTNNB1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.571070800438833,1.4605171032975486,0.07867132867132867,0.8306657665579559,1.0,10/31,9.73%,OSR1;FGFR2;HOXB4;TGFBR1;HOXB3;HOXB9;HOXA3;TGFBR2;HOXC4;DYNC2I1
prerank,mitochondrion distribution (GO:0048311),0.6710741355149079,1.4598407410581709,0.08745247148288973,0.8295103789999883,1.0,5/12,8.88%,TRAK1;LRRK2;CLUH;MEF2A;DNM1L
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5799079189118456,-1.4580936445954689,0.0640176600441501,0.31105455996874676,1.0,3/16,11.52%,CLDN5;CLDN11;CLDN14
prerank,protein export from nucleus (GO:0006611),0.580020599929797,1.4573294399137924,0.07363013698630137,0.8373755786251291,1.0,1/27,0.01%,RANBP3L
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.46525771082329326,-1.4564433345887313,0.033854166666666664,0.31347084711124906,1.0,12/39,9.38%,UTRN;FGF14;HECW2;FGF12;ANK3;HECW1;CAMK2D;FXYD5;NEDD4L;WNK2;NETO1;FGF13
prerank,negative chemotaxis (GO:0050919),-0.47624922425553073,-1.4556753401781912,0.05527638190954774,0.3141481708461338,1.0,14/33,12.47%,SLIT2;SEMA3C;UNC5C;SEMA6A;SEMA6D;SEMA7A;NTN1;SEMA3E;EPHA7;SEMA4D;PDGFA;ITGB3;SEMA3D;SEMA3G
prerank,positive regulation of myoblast differentiation (GO:0045663),0.6384846298396702,1.455159611004558,0.08865248226950355,0.8437285137295188,1.0,1/16,0.01%,RANBP3L
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.6404315905853601,-1.4548433632196645,0.07610993657505286,0.314617074743865,1.0,5/10,14.58%,HSP90AB1;SORL1;EGR1;HSP90AA1;CLU
prerank,cellular response to cadmium ion (GO:0071276),-0.5241444455856885,-1.4546211873964987,0.0702576112412178,0.3139466200628649,1.0,16/24,32.30%,MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;MT3;MT2A;MAPK8;HSF1;FOS;MAPK3;JUN;NCF1
prerank,ubiquinone metabolic process (GO:0006743),0.6449561951888936,1.4544091976688984,0.08812260536398467,0.8424776431983245,1.0,7/15,14.81%,FDXR;PDSS2;COQ8B;COQ10A;COQ5;COQ8A;COQ7
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.6990603435842693,1.4539351307229464,0.11359026369168357,0.8401679349877407,1.0,5/10,16.98%,KMT2A;RAPGEF3;CAMK1;SPHK2;SMAD4
prerank,anion transmembrane transport (GO:0098656),0.4971561232219391,1.4539341715403564,0.037257824143070044,0.8353114729357884,1.0,10/67,8.27%,SLC13A4;SLC13A3;SLC6A13;SLC16A12;SLC7A2;SFXN2;SLC6A9;SLC19A1;SLC27A1;SLC1A3
prerank,central nervous system development (GO:0007417),-0.35370736923147306,-1.4537861405660004,0.0,0.31451168068577606,1.0,61/250,10.92%,CNTNAP2;ADGRL3;ROBO2;ADGRL2;DCLK1;ZFHX3;CDH2;SLC2A1;GSN;COL4A1;WWP1;CNTN4;GRIK1;GRIN2B;ADAM23;TBX3;MAL;VIT;IL1RAPL2;SHROOM4;STAT3;PBX3;DNER;SERPINI1;SH3GL2;DSCAML1;ZBTB16;LSR;MBP;SNTG2;CNTN6;PDGFC;MARCKS;NRCAM;PTCH1;EPHA7;DCX;GRIN2A;MOG;HSPG2;VCAN;MEIS2;RELN;PTPRZ1;PCDH18;APOD;SPOCK1;PROX1;TUBGCP2;ADAM22;PPT1;S100B;ECRG4;RAB18;PBX1;DDIT4;UFM1;CDK5RAP2;RPS6KA3;PKD1;MFSD2A
prerank,response to cadmium ion (GO:0046686),-0.5101089784308221,-1.4533768920407162,0.05747126436781609,0.31425657052112915,1.0,16/26,32.30%,MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;MT3;MT2A;MAPK8;HSF1;FOS;MAPK3;JUN;NCF1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.6331876931880659,1.452304305469188,0.0898876404494382,0.8387947197105285,1.0,3/16,2.62%,FGF1;NPNT;FOXD1
prerank,regulation of striated muscle contraction (GO:0006942),0.5824692579760713,1.4514728895009334,0.08202443280977312,0.8382654919612275,1.0,3/27,1.99%,ATP1A2;ANK2;SLC8A3
prerank,atrial septum development (GO:0003283),0.6608255746307221,1.451295054803103,0.08181818181818182,0.8343713127243758,1.0,2/13,0.80%,NOTCH2;ANK2
prerank,xenobiotic transport (GO:0042908),-0.5555492799815744,-1.450964665864277,0.08902691511387163,0.318217192049544,1.0,3/17,3.07%,SLC47A1;ABCG2;SLC7A5
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.6127886689870538,-1.4505112500612287,0.06651884700665188,0.31799328615943423,1.0,8/13,32.05%,TBX3;NOTCH1;TGFB1;BMP4;SOX8;EID2B;SOSTDC1;ANKRD2
prerank,myoblast differentiation (GO:0045445),0.6510397432412776,1.4504811654231813,0.0933852140077821,0.8339871407618374,1.0,3/14,1.44%,EPAS1;DDX5;IGF1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5676545108377524,1.4503823877522852,0.052901023890784986,0.8297718015612447,1.0,7/30,9.56%,DAB2;DDX5;KLK2;NCOR2;SMARCA4;SIRT1;HDAC1
prerank,regulation of mitotic nuclear division (GO:0007088),0.5028946673742032,1.4501176165333711,0.053208137715179966,0.8265114140062836,1.0,8/55,6.37%,BMP7;IGF1;ANAPC15;OBSL1;TOM1L2;PHIP;CD28;PDGFRB
prerank,tRNA wobble uridine modification (GO:0002098),0.6384437751872424,1.4496023578923563,0.07984790874524715,0.8243289559679602,1.0,1/14,0.80%,TRMT9B
prerank,lipid translocation (GO:0034204),-0.535047719944467,-1.4492712291305458,0.07621247113163972,0.3195953763324678,1.0,9/21,14.29%,ATP10A;ATP8A1;ATP8B1;ATP11A;ATP8A2;ATP11C;TMEM30A;ATP8B2;ABCB4
prerank,epithelial cell morphogenesis (GO:0003382),0.622198477447693,1.4485783923497395,0.08426966292134831,0.8248959528827429,1.0,5/17,5.02%,COL22A1;PKHD1;COL18A1;RILPL1;DACT2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6979346379351246,1.4485748535774814,0.11287128712871287,0.8203952577126999,1.0,5/10,17.97%,OXSR1;ADAM17;WNK1;CCR2;WNT5A
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5448657222240865,1.44848310246185,0.05804311774461028,0.8163693642992771,1.0,4/37,2.95%,PRKAG2;BMP7;SPHK1;PPEF2
prerank,activation of protein kinase B activity (GO:0032148),0.5753349642613812,1.44830600073314,0.0626118067978533,0.812779175701144,1.0,8/29,8.75%,FGF1;OSBPL8;IGF1;IL18;ADRA2A;RICTOR;NRG1;PDPK1
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.6122642625801938,-1.4481968840175898,0.07494646680942184,0.3208050702456624,1.0,6/12,20.19%,JAG1;NOTCH1;HES1;N4BP2L2;NELFB;YTHDF2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6611371195780471,1.4481435595682226,0.09514925373134328,0.809144636969875,1.0,5/14,13.89%,TLR3;ANKRD17;DDX60;DHX58;TLR5
prerank,regulation of tube diameter (GO:0035296),0.6481883587901416,1.4478996025337247,0.1005586592178771,0.8015910922198163,1.0,3/13,1.93%,ROCK2;ACE;NPR1
prerank,vascular process in circulatory system (GO:0003018),0.6481883587901416,1.4478996025337247,0.1005586592178771,0.8015910922198163,1.0,3/13,1.93%,ROCK2;ACE;NPR1
prerank,triglyceride biosynthetic process (GO:0019432),0.6134070130577384,1.4464957892535968,0.08703374777975133,0.8040787727169564,1.0,4/18,7.28%,LPGAT1;MOGAT3;GPAT2;GK
prerank,monosaccharide transmembrane transport (GO:0015749),0.6366099414627995,1.4464846273062497,0.08333333333333333,0.799860001453502,1.0,3/16,9.53%,SLC2A12;SLC5A3;SLC45A3
prerank,protein localization to synapse (GO:0035418),-0.6123773122791141,-1.4462283329046464,0.06147540983606557,0.3238323588472338,1.0,5/12,13.90%,NLGN1;NRXN1;PCLO;NRXN2;SHANK1
prerank,regulation of insulin secretion (GO:0050796),0.45648735155663345,1.44605172564527,0.02880658436213992,0.7975278078036194,1.0,20/101,9.99%,NNAT;ADCY5;CACNA1D;ITPR2;ITPR1;STXBP4;KCNA5;PRKN;NLGN2;MCU;ADRA2A;RAPGEF3;DPP4;CACNA1C;GCK;RBP4;EIPR1;MIDN;PICK1;TCF7L2
prerank,regulation of secretion by cell (GO:1903530),-0.4299260237252189,-1.4459907110287267,0.01912568306010929,0.323147847061652,1.0,11/54,9.51%,MEF2C;SYT1;RIMS2;MCTP1;RIMS1;STXBP5L;RAB3C;ANXA1;DNAJC1;DISP1;NSF
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.4857350266951758,1.4454013083513868,0.03698224852071006,0.7964937403346557,1.0,15/72,12.27%,FGF1;FGFBP1;FGFR2;KL;POLR2A;FRS2;FGFR1;HNRNPH1;FLRT1;TIA1;POLR2D;FIBP;GTF2F1;KLB;PTPN11
prerank,epithelial to mesenchymal transition (GO:0001837),0.5166607807511265,1.4453512277931748,0.06595092024539877,0.7925606874971501,1.0,8/47,4.57%,TGFBR3;BMP7;ROCK2;WNT4;DDX5;FGFR1;TGFBR1;LOXL3
prerank,quinone biosynthetic process (GO:1901663),0.6510599517490353,1.4450400434909905,0.07824427480916031,0.7900335249741677,1.0,7/14,14.81%,FDXR;PDSS2;COQ8B;COQ10A;COQ5;COQ8A;COQ7
prerank,negative regulation of leukocyte migration (GO:0002686),-0.646198310796297,-1.444728797600775,0.06118143459915612,0.3246464267354823,1.0,3/10,1.98%,SLIT2;BMP5;CD200
prerank,GTP metabolic process (GO:0046039),0.6412849530204483,1.4445023331233149,0.08604206500956023,0.7883898999726774,1.0,5/15,9.48%,RHOQ;LRRK2;OPA1;AK3;AK4
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6026324534872671,1.4440636033853207,0.07894736842105263,0.7861812583316122,1.0,3/20,3.46%,EPAS1;PRKN;TGFBR1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.4712213550727298,-1.4437888889098076,0.0327455919395466,0.32543753283492055,1.0,16/39,19.77%,TEK;THBS1;SEMA5A;NDNF;GAS6;KDR;RAMP2;ICAM1;ITGA4;GATA2;GPER1;ECSCR;SCG2;PDCD4;RGCC;PAK4
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6906604696844844,1.443706804091503,0.09586466165413533,0.7839951538501497,1.0,5/11,8.77%,DAB2;PRKN;EZR;PTPN23;EIPR1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5377810277529282,-1.4435140016359649,0.08200455580865604,0.3248385418135556,1.0,8/20,15.42%,KCNB2;CAV1;PLCE1;CHRM3;CHRM2;ATP2B1;MYOCD;NMU
prerank,metanephric mesenchyme development (GO:0072075),0.6748559997327409,1.4409155607625905,0.11174242424242424,0.7931455776926464,1.0,2/10,1.09%,WNT4;OSR1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.595489077218873,-1.4404213125583387,0.08113590263691683,0.3302630834720874,1.0,3/12,10.92%,ACSL3;MTTP;MFSD2A
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.4223485965159904,-1.4398298132375265,0.011695906432748537,0.330453806077075,1.0,23/59,11.41%,CADM1;PTPRM;ROBO2;HMCN1;CDH2;CDH13;PECAM1;KIRREL3;BSG;CNTN4;NPTN;TENM3;PTPRT;DSCAML1;IGSF11;CNTN6;ITGB1;ROBO4;EMB;CEACAM1;PKD1;PVR;CDH1
prerank,regulation of glucose metabolic process (GO:0010906),0.5404158949499369,1.4397298411349562,0.08614864864864864,0.7946809719448236,1.0,8/34,13.91%,RORA;PRKN;RORC;SIRT1;SLC45A3;MLYCD;USP7;OGT
prerank,regulation of viral entry into host cell (GO:0046596),-0.4863892684038097,-1.4389679508345337,0.05343511450381679,0.3313336019180624,1.0,12/30,24.81%,GSN;HS3ST5;LY6E;MID2;TRIM14;TRIM27;IFITM3;CD74;TRIM68;LGALS9;IFITM1;IFITM2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5690677359249899,-1.4387188207221526,0.0556792873051225,0.33068456055487616,1.0,5/17,9.06%,SLIT2;CASK;SFRP4;TMEM204;PCSK6
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5149853362716474,-1.4385547680083237,0.060674157303370786,0.32980411714944025,1.0,3/22,0.98%,PDE4B;CACNB2;AHNAK
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.47054358625301645,-1.4384716962945008,0.0475,0.3287805808909813,1.0,10/33,7.53%,SLIT2;PTPRM;PTPRG;DCN;THBS1;EVL;ACVRL1;DAB2IP;APOE;CORO1C
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.4017989464862367,-1.4383704113692444,0.016556291390728478,0.3278088894275288,1.0,22/75,10.92%,CTNNA2;MEF2C;MAP1B;ANK3;KLF7;ACTB;CNTN4;DCC;PAK3;NTNG1;S100A6;DSCAML1;SHTN1;MINK1;APP;NRCAM;BTBD3;MAP6;S100B;SLITRK1;PLPPR4;MFSD2A
prerank,microvillus assembly (GO:0030033),-0.5739519922755728,-1.4372787299199457,0.066815144766147,0.3289679451055728,1.0,6/14,9.65%,FXYD5;RAP1B;MINK1;RAP1A;RAPGEF6;RAP2A
prerank,regulation of protein neddylation (GO:2000434),0.7057405020246956,1.4367306012464618,0.0888468809073724,0.8047052903799414,1.0,1/10,0.14%,EPAS1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.6525630305049509,-1.4363898526099341,0.05823293172690763,0.3298677224950716,1.0,5/10,8.90%,PRKG1;CD9;SERPINE2;RDX;CEACAM1
prerank,positive regulation of integrin activation (GO:0033625),-0.6234356192768616,-1.4361160610288095,0.0782608695652174,0.3293625064530911,1.0,5/11,16.20%,RASIP1;RAP1B;PIEZO1;P2RY12;SKAP1
prerank,carnitine metabolic process (GO:0009437),0.681530960517462,1.4359743421550328,0.11338289962825279,0.8041001523494811,1.0,6/12,12.41%,CPT1A;BBOX1;TMLHE;CPT2;ACADM;CRAT
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.618852497220294,-1.4347907650573923,0.07883817427385892,0.3310946533704103,1.0,3/11,5.42%,MEF2C;LYN;ANXA1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6155766986024072,-1.434689361444898,0.08705357142857142,0.32903345110726945,1.0,6/11,21.43%,CALM1;CALM2;CALM3;FKBP1A;CASQ2;GSTM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6155766986024072,-1.434689361444898,0.08705357142857142,0.32903345110726945,1.0,6/11,21.43%,CALM1;CALM2;CALM3;FKBP1A;CASQ2;GSTM2
prerank,positive regulation of metabolic process (GO:0009893),0.44811438224563155,1.4344244231679228,0.033093525179856115,0.8076104402630182,1.0,7/103,2.00%,EPAS1;ACSL1;PPARGC1B;APPL2;LEPR;PPARGC1A;IL18
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.5468277522390806,-1.4320298726748437,0.07526881720430108,0.333849109091989,1.0,7/18,14.09%,NAV3;CD34;HDAC7;PTPRC;TRIM27;HAVCR2;LAPTM5
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.6251588695563509,-1.431829950002893,0.055674518201284794,0.33312907543185516,1.0,6/11,21.86%,MERTK;CXCL12;GAS6;NOD2;CCL19;HCLS1
prerank,cellular response to organonitrogen compound (GO:0071417),-0.3878043509308072,-1.43142062556538,0.0036900369003690036,0.3328862738711374,1.0,29/99,15.28%,SLIT2;MEF2C;PDE3A;ACTB;AKAP6;HCN1;GABRB3;GABRB1;RYR3;GABRB2;RAP1B;RAP1A;KCNQ1;SH3BP4;GLRA1;EGR1;GABRG2;PDE2A;CAPN2;P2RY12;CDH1;CTNNB1;SPAAR;DMTN;GLRA2;HTR1B;P2RY1;TRPM2;HRH1
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.37421060435081427,-1.4311034311055464,0.01098901098901099,0.3324726498820583,1.0,31/124,14.09%,FRY;NLGN1;CNTNAP2;PTPRM;CNTN4;PLP1;CARMIL1;SH3GL2;TMEM108;GPM6B;LYN;GSK3B;STX3;LIMA1;APOE;APP;STMN2;PLEKHA1;ULK1;LGI1;MYOC;GPRIN3;RASGRF1;UHMK1;ARMC2;NCDN;MAP4;MAPT;ERCC6;GPM6A;CDK5R1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.4460596408875538,1.431089668152464,0.027210884353741496,0.8195259091713151,1.0,29/117,15.29%,ALDH1A2;ME2;IGF1;PCCA;PPARA;ECHDC3;ALOX12;LDHB;ACADSB;CPT1A;GPAT2;ACSBG2;ALDH4A1;CYP26B1;AMACR;NAAA;GOT2;SCPEP1;DLD;ACOT11;MCCC1;MECR;AASDH;ABAT;HLCS;PER2;THEM4;DLAT;GPAM
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.5151835218849629,1.4308266880457103,0.06462035541195477,0.8167819842642583,1.0,11/44,14.09%,PRKAG2;CYP27A1;ALOX12;INSIG2;AMACR;OSBPL9;TM7SF2;ACOT8;SRD5A2;LBR;PER2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.6068166984234602,-1.4303628431733526,0.07083333333333333,0.33301080330284927,1.0,4/12,10.79%,TMEFF2;AR;TGFB1;EDN1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6405061466993918,-1.4303589671828525,0.08260869565217391,0.3319000425363587,1.0,5/10,10.44%,PDE4B;CACNB2;CACNA2D1;CALM1;CALM3
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.6220753683425524,-1.4300264408394392,0.08958333333333333,0.33149747412777597,1.0,4/12,9.22%,CXCL12;APP;JAM2;DOCK8
prerank,bile acid and bile salt transport (GO:0015721),-0.5165886776061872,-1.4283275124904788,0.06993006993006994,0.333912321814872,1.0,6/24,9.00%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;CEACAM1;STARD5
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5807729037017124,-1.4282293491067952,0.07789473684210527,0.33301461189086035,1.0,4/15,6.31%,SCARB1;PLTP;APOE;ABCG1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5892822606539467,-1.4268238614559094,0.07039337474120083,0.334975177784281,1.0,9/13,20.17%,TGFB2;SEMA7A;PLCG2;TGFB3;TGFB1;IRAK3;LAPTM5;CD74;CUEDC2
prerank,"phagocytosis, engulfment (GO:0006911)",-0.464225537701786,-1.4262310197448134,0.04081632653061224,0.3352380855302485,1.0,10/36,10.69%,RHOBTB1;XKR4;GSN;THBS1;XKR6;MYH9;DOCK1;ARHGAP25;RHOH;ELMO1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.42323608988710765,-1.4253876180711653,0.03508771929824561,0.3358105765539959,1.0,19/54,18.10%,MEF2C;TMSB4X;NOS3;THBS1;ACVRL1;AKT3;KDR;APOE;GATA2;TGFB1;FGF2;ATP2B4;HIF1A;PRKD1;VEGFA;NUS1;ANGPT2;HSPB1;RGCC
prerank,response to progesterone (GO:0032570),-0.5525573258070455,-1.4245911039745822,0.08235294117647059,0.33654663990451594,1.0,6/18,8.45%,ABHD2;CAV1;THBS1;TGFB2;TGFB3;TGFB1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.6364549461597195,-1.423036562372947,0.0825147347740668,0.3387825415805007,1.0,5/10,20.79%,GALNT13;GALNT16;GALNT2;MGAT5B;POGLUT1
prerank,organic hydroxy compound transport (GO:0015850),-0.4651486173028274,-1.4226335457166037,0.043701799485861184,0.33848572985325714,1.0,9/36,9.00%,ABCC4;ATP8B1;SLCO1C1;SLC16A1;SLCO2B1;NPC2;STRA6;CEACAM1;STARD5
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6850332169394316,1.4220320104874224,0.1316793893129771,0.8550731777662531,1.0,8/10,25.26%,IVD;ACAD11;ACADM;GCDH;ETFDH;ACADS;ETFA;ETFB
prerank,negative regulation of interleukin-6 production (GO:0032715),0.560704517892568,1.4215861269452965,0.0774526678141136,0.8530738346111879,1.0,5/27,7.34%,C1QTNF3;SYT11;TLR4;ARRB1;PTPN22
prerank,ubiquinone biosynthetic process (GO:0006744),0.6355349226250677,1.4213465781328602,0.08795411089866156,0.8502490261953142,1.0,10/15,23.85%,FDXR;PDSS2;COQ8B;COQ10A;COQ5;COQ8A;COQ7;NDUFA9;COQ9;COQ6
prerank,regulation of plasminogen activation (GO:0010755),-0.5958007847733457,-1.4206496491998484,0.07966457023060797,0.34171565739097287,1.0,3/12,3.67%,SERPINE2;THBS1;RUNX1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6636915054699559,1.4197280656685645,0.13307984790874525,0.8538945074692333,1.0,7/12,16.16%,DAB2;NCOR2;SMARCA4;SIRT1;HDAC1;NCOR1;NODAL
prerank,cellular zinc ion homeostasis (GO:0006882),-0.49497274440527395,-1.4195330509258925,0.04597701149425287,0.3429562591848136,1.0,12/26,14.19%,SLC39A10;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;SLC30A1;SLC39A12;MT3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.47203557963723936,-1.4194694520185644,0.03950617283950617,0.34199367970901223,1.0,13/35,18.37%,HEG1;TGFB2;RASIP1;DAB2IP;MET;KCTD10;EPHB2;MYOC;CUL3;SPRY1;STMN1;KANK1;SPRY4
prerank,cellular metal ion homeostasis (GO:0006875),0.44527182163277873,1.4190657801166697,0.044349070100143065,0.8530622885310181,1.0,11/102,3.59%,ATP1A2;ATP13A5;SLC24A3;SLC41A1;ATP1B3;ANK2;ATP13A3;SLC8A3;PKHD1;CSRP3;DMPK
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5465931104741195,-1.4190326103792397,0.08258928571428571,0.3417997192444016,1.0,8/17,21.84%,PODXL;TGFB2;PIEZO1;P2RY12;RET;SKAP1;SYK;RAC3
prerank,BMP signaling pathway (GO:0030509),0.4872105325238254,1.4189827383919191,0.044444444444444446,0.8494637371928843,1.0,9/62,5.76%,TGFBR3;BMP6;BMP7;SMAD3;DDX5;BMPR1A;SMAD6;RGMB;USP9X
prerank,regulation of endothelial cell migration (GO:0010594),-0.3922637069289022,-1.4189422743296176,0.017064846416382253,0.34087093501901927,1.0,35/85,13.87%,NRP1;SLIT2;PTPRM;TEK;BMPER;RHOJ;BMPR2;DCN;THBS1;NRP2;PTK2B;SCARB1;ACVRL1;KDR;GPI;DAB2IP;FOXP1;APOE;RHOB;PTK2;PROX1;CALR;ATOH8;PTN;CEACAM1;FGF2;FLT4;BCAR1;ITGB3;EDN1;BMP4;EMP2;PRKD1;VEGFA;ADGRB1
prerank,neurotransmitter uptake (GO:0001504),0.6533149391040034,1.4184415922307294,0.13285457809694792,0.8481477046611814,1.0,4/12,9.52%,ATP1A2;SLC38A1;SLC1A3;GLUL
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.4059533086277321,-1.417003437630701,0.022292993630573247,0.3439767258337218,1.0,31/70,34.29%,B2M;PSMB2;MFSD6;CALR;PSMD14;PDIA3;NCF2;PSMC6;CYBA;IKBKB;PSMA4;PSMB9;TAP1;PSMD11;PSMB10;PSMD2;CYBB;PSMA2;PSMB3;SNAP23;PSMB5;PSMA7;CD36;FCGR1A;PSMF1;PSMD7;SEC22B;NCF1;PSMA5;PSMD4;PSME4
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6842305948331552,1.416927939555242,0.10666666666666667,0.8517887227138129,1.0,4/10,8.51%,ALDH7A1;HNMT;SMOX;LRTOMT
prerank,ribosomal large subunit assembly (GO:0000027),-0.5087048621520853,-1.4161131191640222,0.06768558951965066,0.3448177490089503,1.0,16/24,28.66%,RPL3;RPLP0;RPL5;RPL23A;RPL6;MDN1;NOP53;BRIX1;MRPL20;RPL24;RPL11;RSL24D1;RRS1;DDX28;FASTKD2;RPL10
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.6659757807928693,1.4157391796201308,0.09568480300187618,0.8538169620479042,1.0,4/10,9.83%,ST6GAL1;RENBP;NPL;GNPDA1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.45563382722885837,-1.4154304812043015,0.057441253263707574,0.3451336339139439,1.0,14/41,10.43%,SLC8A1;SLC24A2;RYR2;CACNA2D1;HTR2C;GRIN2B;RYR3;PTPRC;PLCG2;HTR2A;GRIN2A;FGF2;TRPV4;ATP2B4
prerank,phospholipid catabolic process (GO:0009395),-0.5150311076186997,-1.4152600104864645,0.0774487471526196,0.34444156787203506,1.0,6/24,11.87%,PLA2G4A;GPCPD1;ENPP6;GDPD1;ENPP2;SMPDL3A
prerank,T cell differentiation (GO:0030217),0.5177546137972329,1.414545933285101,0.07425742574257425,0.8556094646019601,1.0,11/40,12.63%,LEPR;KIT;GLI3;NHEJ1;CD28;PTPN22;CHD7;TCF7;SOX13;ADAM17;LMBR1L
prerank,regulation of lipid metabolic process (GO:0019216),0.45976470703290595,1.4143724247926586,0.03907380607814761,0.8524650216736289,1.0,15/88,8.30%,PRKAG2;RORA;NFYC;PPARA;CHD9;NCOR2;NFYB;GPS2;C1QTNF2;TBL1X;RORC;SMARCD3;ANGPTL8;NR1D2;TBL1XR1
prerank,negative regulation of histone methylation (GO:0031061),0.6771772276379757,1.4138573194857529,0.12476722532588454,0.8509867379726778,1.0,5/10,17.74%,JARID2;BCOR;AASS;PHF1;KDM1A
prerank,T cell migration (GO:0072678),-0.582742594656409,-1.413749190478285,0.08757637474541752,0.3467185347230333,1.0,7/13,29.86%,SLC12A2;S1PR1;CXCL16;MSN;CXCL10;PIK3CD;MYO1G
prerank,response to nitric oxide (GO:0071731),-0.5892175568705217,-1.413595191930575,0.0738255033557047,0.345928884859029,1.0,9/13,32.65%,KCNC2;GUCY1B1;FOXO1;TXN;MT3;CCL19;MMP3;AQP1;DPEP1
prerank,regulation of TOR signaling (GO:0032006),0.4791167900063863,1.4130981209649793,0.05718475073313783,0.8507641725697621,1.0,31/67,24.29%,PRKAA2;FNIP1;PKHD1;NPRL3;DEPTOR;NPRL2;UBR2;RICTOR;PIK3CA;SIRT1;ARAF;ROS1;DEPDC5;FLCN;TSC1;WDR24;RPTOR;TMEM127;UBR1;TELO2;RRAGD;TBC1D7;LAMTOR1;ITFG2;TSC2;GSK3A;DYRK3;TBCK;RRAGB;SLC38A9;DGKQ
prerank,organonitrogen compound catabolic process (GO:1901565),0.48170860167600116,1.4116942840688211,0.0701219512195122,0.8539379632705197,1.0,13/57,9.83%,ACE;CPQ;RENBP;NPL;NAALADL1;GGACT;TPP1;CLPX;CLN6;PLA2G6;NPEPPS;CTH;GNPDA1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.4052061624306909,-1.4114865065052478,0.022082018927444796,0.3494831386069209,1.0,30/67,34.29%,B2M;PSMB2;CALR;PSMD14;PDIA3;NCF2;PSMC6;CYBA;IKBKB;PSMA4;PSMB9;TAP1;PSMD11;PSMB10;PSMD2;CYBB;PSMA2;PSMB3;SNAP23;PSMB5;PSMA7;CD36;FCGR1A;PSMF1;PSMD7;SEC22B;NCF1;PSMA5;PSMD4;PSME4
prerank,peptide metabolic process (GO:0006518),0.4658218558084568,1.411320251772723,0.0649546827794562,0.8518292777305302,1.0,11/75,10.04%,AEBP1;ACE;CPQ;BACE2;GSTT1;MGAT3;NAALADL1;TPP1;CTNS;NPEPPS;GSTA3
prerank,regulation of protein localization to membrane (GO:1905475),-0.48931989277818416,-1.410171292775969,0.07075471698113207,0.35118460251337763,1.0,8/28,11.20%,SPTBN1;GPC5;GSN;ACTB;GPC6;AR;GPC4;ZDHHC2
prerank,transcription by RNA polymerase II (GO:0006366),0.39832285053763045,1.4101050813921518,0.009269988412514484,0.8539066615457291,1.0,71/305,16.38%,NOTCH2;RORA;MAF;THRB;GLIS3;DDX5;PPARGC1A;CCN2;PPARA;POLR2A;SOX5;NCOR2;CTR9;ELOF1;NR6A1;DTX1;PABPN1;ATOH1;RREB1;TTF2;PHAX;AFF4;ESRRA;TEAD3;TBL1X;WWTR1;RORC;TSC22D1;CCNT2;RPRD2;POLR2D;NR1D2;TBL1XR1;TEAD2;TFDP1;NR2C2;HDAC1;ELL;GTF2A1L;MED17;INTS10;GTF2F1;SCAF8;RTF1;RARG;MNT;ZBTB1;NOCT;TEAD1;NELFCD;TAF11;INTS2;DEAF1;NR3C2;INTS5;TBP;TAF4;NCOR1;PMF1;KAT2B;CTDP1;INTS3;NFKB1;TAF7;MED23;RXRA;TAF13;CPSF3;CREBBP;MED26;GTF2I
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6253518181431963,1.4099741056343238,0.12264150943396226,0.850571615350722,1.0,6/15,15.81%,PRODH;ALDH4A1;GGACT;GOT2;ABHD12;SARDH
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.5789938357022841,1.4095292052570214,0.10301953818827708,0.8488505161984377,1.0,4/23,5.56%,TGFBR3;FGFR2;TPM1;ADAMTS9
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5542932867604314,1.4092170616484965,0.06984667802385008,0.8464865488297266,1.0,9/29,12.56%,LPGAT1;SORBS1;PPARA;ZBTB20;CREBL2;SLC27A1;SLC45A3;MLXIPL;SIRT4
prerank,regulation of urine volume (GO:0035809),0.6761153346692593,1.409018315723829,0.13360323886639677,0.8436479050304544,1.0,4/10,13.48%,NPR1;NPR3;ADM;ADCY6
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.6332387364268124,-1.408943238416422,0.07770961145194274,0.3528224131486762,1.0,5/10,8.45%,CST3;FAP;NOTCH1;TNFRSF1B;TGFB1
prerank,regulation of heart contraction (GO:0008016),0.4536617086528507,1.4088512970362939,0.04033379694019471,0.8407487516232154,1.0,13/90,6.24%,ATP1A2;CELF2;ATP1B3;ANK2;CORIN;ITPR2;ITPR1;NPR1;SLC8A3;DMPK;TPM1;NPR2;AHCYL1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.592333611622912,-1.4086629741332795,0.07566462167689161,0.352360288096491,1.0,5/13,17.93%,NOS3;CYP1B1;GCH1;NOS1;CYB5R3
prerank,positive regulation of neuron projection development (GO:0010976),-0.3919678440700889,-1.4085816311386634,0.025236593059936908,0.3514205594639775,1.0,33/85,16.19%,BMP5;NTRK3;ITGA6;ROR1;LRRC7;NPTN;TENM3;RIT2;PTK2B;TOX;FUT9;NDNF;SERPINI1;NTRK2;LYN;ROR2;DAB2IP;RAP1A;APOE;STMN2;RELN;PTN;SCARF1;PLPPR5;MARK2;VLDLR;LRP8;PRKD1;RET;FES;COBL;BDNF;PACSIN1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.6434104593414482,1.4083436022025002,0.12524461839530332,0.839503630370118,1.0,4/13,5.77%,RENBP;LARGE1;MGAT3;PGM3
prerank,positive regulation of protein polymerization (GO:0032273),-0.4015304314639633,-1.4075784133815146,0.03184713375796178,0.3525437029785346,1.0,23/65,16.81%,NAV3;NCK2;EVL;CARMIL1;PTK2B;CDC42EP3;PAK1;RPS3;MET;OCLN;BIN1;CDK5RAP2;HSP90AA1;MAPT;PFN2;CLIP1;PINK1;CDK5R1;FES;CDC42EP2;NCK1;ARF6;TPPP
prerank,ERBB2 signaling pathway (GO:0038128),-0.47897215539699134,-1.407457914835137,0.0539906103286385,0.35170080207770676,1.0,9/31,10.34%,ERBB4;PIK3R1;PTPN12;GAB1;NRG2;MYOC;ERBIN;ERBB2;HSP90AA1
prerank,aminoglycan catabolic process (GO:0006026),-0.4809059893410561,-1.40701751129751,0.051470588235294115,0.35151194506199646,1.0,6/28,10.88%,GPC5;GPC6;HSPG2;SDC3;AGRN;GPC4
prerank,protein autoubiquitination (GO:0051865),0.4875053496191215,1.4064680344103397,0.05473372781065089,0.8444686888988893,1.0,16/61,16.33%,RNF220;SH3RF2;PRKN;RNF213;RNF181;RNF8;RNF141;SH3RF1;RNF41;RNF13;WWP2;DDB2;RNF115;AMFR;RNF146;RNF19B
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.6055431379991931,-1.405329948742622,0.09913793103448276,0.354113157081587,1.0,5/12,6.58%,PODXL;IQGAP1;PROM1;JAG1;BASP1
prerank,protein localization to cilium (GO:0061512),0.5493495776946793,1.4049459638235589,0.08620689655172414,0.8478184464363242,1.0,10/32,15.70%,TULP3;ZNF423;IFT122;WDR19;INVS;ATP6V1D;ROPN1;WDR35;RAB29;ARL6
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.6025385370951337,-1.404264401220433,0.10337552742616034,0.35530499428717366,1.0,7/11,24.08%,ANK3;LYN;RDX;JAK1;SYK;PRKCQ;PLAUR
prerank,neuromuscular process controlling balance (GO:0050885),-0.5815463412898653,-1.404138059637362,0.10082304526748971,0.35446395978480044,1.0,2/12,1.81%,NRXN1;PCDH15
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3804245305877028,1.4039401664345197,0.004310344827586207,0.8488782824770004,1.0,116/572,14.62%,PRDM6;AEBP1;DAB2;WWOX;BMP6;THRB;SMAD3;GLIS3;OSR1;FHL2;DDX5;MXI1;CUX1;DLG1;PPARA;FGFR2;PRKN;FOXP4;DNMT3A;GLI2;FNIP1;KANK2;ZHX2;ZNF568;MOSPD1;HDAC8;NR2F2;KCNIP3;NCOR2;CTR9;NR6A1;GLI3;MITF;SUFU;CXXC5;FOXC1;PHF21A;NFIB;NEDD4;PCGF2;IFI27;NACC2;EZR;FOXP2;CUX2;RREB1;NSD1;WWC2;OTP;MAP2K5;GPS2;USP9X;ATRX;LCOR;TP53;TBL1X;BHLHE41;SMURF2;RORC;NIPBL;LDB2;LDB1;BCOR;CBX7;MEF2A;KDM2B;SMARCA4;NR1D2;SPEN;TBL1XR1;CPEB3;NUPR2;IRX1;PARP9;HDAC4;SIRT1;NR2C2;HDAC1;SOX13;LARP7;ZFP90;FOXC2;TCF7L2;ZNF219;ATN1;AURKB;PRDM5;AASS;RTF1;NFATC3;RARG;MNT;WWP2;IMPACT;ZBTB1;SKOR1;CBX5;DICER1;ZNF148;DEAF1;ZMYM5;FRK;KMT5A;BEND3;SIN3A;CBX6;NCOR1;ZBTB32;SNAI1;PER2;FLCN;ACVR2B;GADD45A;ZKSCAN3;MIER3;HOXA7
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5949518340158565,-1.4035689828063531,0.09183673469387756,0.354555627878045,1.0,4/12,10.82%,SLIT2;BMP5;CCN3;DUSP1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.6126138696933516,-1.4032743318838456,0.1010989010989011,0.35414904073565145,1.0,7/11,32.89%,GPX1;CAT;PRDX1;GPX3;PRDX2;PRDX4;PRDX3
prerank,amyloid-beta metabolic process (GO:0050435),0.6110124938842694,1.4031658056578205,0.12915129151291513,0.8486481659902834,1.0,5/16,10.71%,ACE;BACE2;MGAT3;APH1B;DYRK1A
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.5734556749347751,-1.4031417176954082,0.09534368070953436,0.35335756958577386,1.0,7/13,26.86%,SYT1;CACNA1G;KCNB1;CACNA1H;SYT10;DOC2B;STX1A
prerank,regulation of neuron differentiation (GO:0045664),-0.39171903995184526,-1.4027856938901744,0.020710059171597635,0.35303684750444464,1.0,22/76,10.07%,NLGN1;MEF2C;ZFHX3;BRINP3;CNTN4;BRINP1;NGF;VWC2;ARHGEF2;TIAM1;BEND6;HES1;NRCAM;YWHAG;HEYL;BIN1;BMP2;SIX1;CALR;BRINP2;ID2;CDK5RAP2
prerank,steroid biosynthetic process (GO:0006694),0.4885936107140497,1.4027628668181586,0.07253086419753087,0.8468271856127233,1.0,8/56,6.67%,PRKAG2;CYP27A1;INSIG2;CYP21A2;AMACR;FDXR;OSBPL9;DHRS11
prerank,regulation of biomineral tissue development (GO:0070167),-0.48325105092572374,-1.401611716162178,0.07925407925407925,0.35453176332747105,1.0,11/26,13.91%,NOS3;SGMS2;GAS6;NOTCH1;ENPP1;ECM1;TGFB1;S1PR1;HEY2;TWIST1;TXLNG
prerank,chromatin assembly or disassembly (GO:0006333),0.6587412181871364,1.4007616082025318,0.125,0.8521525895562646,1.0,5/11,15.38%,HDAC8;CHAF1B;TP53;CDAN1;MTA2
prerank,melanosome organization (GO:0032438),0.556364479345697,1.4003360657709354,0.0996309963099631,0.8503653596662147,1.0,12/26,24.27%,SHROOM2;DTNBP1;PIKFYVE;BLOC1S6;HPS1;BLOC1S2;RAB29;KIF13A;AP1M1;SNAPIN;LYST;HPS4
prerank,mitotic sister chromatid cohesion (GO:0007064),0.6226039648032846,1.3998591208350823,0.13068181818181818,0.8488452128281754,1.0,7/16,19.19%,DSCC1;NIPBL;PDS5A;MAU2;REC8;RB1;PDS5B
prerank,regulation of keratinocyte proliferation (GO:0010837),0.580895892557797,1.3995041289775552,0.10714285714285714,0.8468901469596162,1.0,3/22,1.85%,NOTCH2;STXBP4;FGFR2
prerank,respiratory tube development (GO:0030323),0.5453759226776774,1.399156060602169,0.0963855421686747,0.8448494250570497,1.0,6/28,7.54%,FGF1;FGFR2;GLI2;PDPN;LOXL3;RBP4
prerank,nucleosome disassembly (GO:0006337),0.6175821481942142,1.398629413589705,0.11909262759924386,0.8402516278887691,1.0,6/14,9.12%,ARID2;HMGA1;SMARCD3;SMARCA4;SMARCC2;SMARCE1
prerank,chromatin disassembly (GO:0031498),0.6175821481942142,1.398629413589705,0.11909262759924386,0.8402516278887691,1.0,6/14,9.12%,ARID2;HMGA1;SMARCD3;SMARCA4;SMARCC2;SMARCE1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.39147609688927887,-1.3980854210007325,0.013029315960912053,0.3613948927451609,1.0,24/79,14.15%,SLIT2;BMPER;BMPR2;THBS1;HTRA3;CASK;VWC2;NOTCH1;VWC2L;EPN2;DAB2IP;SMAD5;SORL1;SMAD1;BMP2;SMAD7;FGF2;ATP2B4;CREB3L1;LEMD3;UBE2D3;SPRY1;BMPR1B;SMURF1
prerank,fatty acid beta-oxidation (GO:0006635),0.49222709022341143,1.3980517379334974,0.07396449704142012,0.8395695128655093,1.0,23/51,20.45%,IVD;ACAD11;AMACR;ACAD10;BDH2;CPT2;ACADM;ACOXL;MECR;CRAT;ACOT8;GCDH;ACOX3;ECHDC1;DECR1;EHHADH;SLC25A17;ECI2;ETFDH;CROT;ACADS;HADHA;HADH
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.38014141691816244,-1.3979826865026357,0.022388059701492536,0.36057222880473705,1.0,36/94,29.52%,RPS6KA5;IL1R1;IL1RAP;ST18;NOD1;NFKBIA;PSMB2;MAP3K7;IRAK3;PSMD14;EGR1;PSMC6;IKBKB;UBB;PSMA4;PSMB9;PELI1;NOD2;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;UBC;RPS27A;RELA;PSMB3;TAB1;PSMB5;PSMA7;MAP3K8;IRAK4;MAPK3;PSMF1;TOLLIP;PSMD7
prerank,regulation of protein dephosphorylation (GO:0035304),-0.4509870400129898,-1.3976448477011596,0.07253886010362694,0.36021172582898536,1.0,11/37,10.44%,PPP1R16B;PPP2R5A;PPIA;YWHAB;CALM1;CALM2;CAMTA1;TGFB1;PPP1R16A;MFHAS1;CALM3
prerank,cellular response to interleukin-2 (GO:0071352),-0.6135261059323949,-1.3976313353082817,0.10602910602910603,0.35808650970068767,1.0,5/11,20.08%,PTK2B;STAT5B;JAK1;SYK;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.6135261059323949,-1.3976313353082817,0.10602910602910603,0.35808650970068767,1.0,5/11,20.08%,PTK2B;STAT5B;JAK1;SYK;SHC1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.606487336248712,1.3975224692816361,0.11171171171171171,0.8384183548938248,1.0,7/18,15.24%,DAB2;EZR;PTPN23;SNX12;MAP2K1;MAP2K2;RAB21
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6300249057830316,-1.3969448162301035,0.09663865546218488,0.3585491791966454,1.0,5/10,18.32%,PTPRJ;PTPN12;APOD;SNCA;NDRG4
prerank,synaptic vesicle localization (GO:0097479),-0.587267478219651,-1.3965238092625532,0.08936170212765958,0.3584793589082033,1.0,5/13,13.26%,NLGN1;SYNDIG1;RAB27A;KIF5C;TMEM230
prerank,inorganic cation transmembrane transport (GO:0098662),0.39724807775949783,1.3951328975502573,0.019300361881785282,0.8455983941613671,1.0,31/268,8.66%,TRPM3;ATP1A2;SLC6A13;KCNK2;SLC6A1;CACNA1D;SLC24A3;SLC41A1;SLC6A12;ATP1B3;TRPM6;KCND3;KCNA5;LRRC38;SLC8A3;SLC30A10;ATP6V0E1;SLC30A2;CACNA1C;SLC6A9;KCNS1;P2RX3;ATP4A;CCDC51;TRPM5;ANO6;KCNH4;SLC39A13;SLC1A3;SLC6A4;KCNJ14
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5950292164733124,1.3941778365744915,0.10467289719626169,0.8464466855223374,1.0,4/20,3.91%,DAB2;PICALM;RHOQ;PPFIA1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6166754042256228,1.3941755757025462,0.11131059245960502,0.842960892259714,1.0,5/15,9.56%,WNT6;GLI2;FOXC1;EDA;HDAC1
prerank,neuron projection morphogenesis (GO:0048812),-0.3584571420363749,-1.394103359956782,0.0,0.36269149302514686,1.0,37/137,10.22%,NLGN1;CNTNAP2;CTNND2;CTNNA2;DCLK1;DOCK10;MAP1B;ANK3;SHANK3;KLF7;ACTB;EPHB1;CNTN4;DCC;NYAP2;IQGAP1;PAK3;EPB41L3;NGF;NTNG1;S100A6;TRIO;DSCAML1;NRK;SHTN1;DAB2IP;MINK1;PAK1;APP;NRCAM;EPHB2;SLC9A6;BTBD3;MAP6;S100B;SLITRK1;PLPPR4
prerank,fibrinolysis (GO:0042730),0.6433319644927287,1.3937566833609856,0.1324110671936759,0.8413794475953779,1.0,5/13,15.66%,KRT1;F2;SERPINE1;HRG;PLAT
prerank,epiboly involved in wound healing (GO:0090505),-0.5406009552042316,-1.3936251530423438,0.09513274336283185,0.3626842857140603,1.0,7/16,14.36%,TMEFF2;FLNA;MRTFA;CCN1;CEACAM1;CD44;CD151
prerank,establishment of endothelial barrier (GO:0061028),-0.478678292451969,-1.3926361174561104,0.08029197080291971,0.36403932584480925,1.0,13/29,12.21%,PDE4D;PECAM1;PPP1R16B;F11R;RAP1B;ICAM1;RAP1A;ROBO4;RDX;RAPGEF6;PDE2A;MSN;SOX18
prerank,arachidonate transport (GO:1903963),0.6566621583377924,1.3924978089601439,0.14694656488549618,0.8402137545547606,1.0,2/10,4.75%,ACE;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),0.6566621583377924,1.3924978089601439,0.14694656488549618,0.8402137545547606,1.0,2/10,4.75%,ACE;BDKRB2
prerank,positive regulation of hormone secretion (GO:0046887),0.599550305622002,1.39210140337826,0.1213768115942029,0.8385924041013727,1.0,2/17,2.52%,C1QTNF3;SPP1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.6628220082707126,1.3920573467664477,0.12992125984251968,0.83541919438186,1.0,2/10,3.65%,ATP1A2;ADRA2A
prerank,extracellular matrix organization (GO:0030198),-0.3273324508188785,-1.3917287935146538,0.0,0.36493680014567104,1.0,75/276,10.42%,COL8A1;FLRT2;VWF;ELN;COL25A1;LAMA1;COL12A1;TLL1;PECAM1;ADAMTSL3;ITGA6;SH3PXD2A;BSG;GSN;SPOCK2;COL6A3;COL4A1;ADAMTSL1;MFAP5;DCN;THBS1;COL15A1;FN1;ADAMTS5;TGFB2;LAMC3;COL6A1;VIT;VCAM1;COL4A2;DST;LAMA2;COL6A2;NDNF;F11R;GAS6;CYP1B1;ADAMTS17;BGN;FBN2;ITGB4;COLGALT2;GPM6B;COL14A1;KDR;LUM;COL23A1;ICAM1;ITGB8;APP;ADAMTS3;JAM2;TIMP2;ITGB1;ADAM15;COL8A2;TGFBI;HSPG2;VCAN;LAMA3;ITGA4;PPIB;ADAMTS6;MMP16;DPT;TGFB1;TNR;FGF2;CD47;ITGA8;CD44;CAPN2;PDGFA;ITGB3;AGRN
prerank,Rac protein signal transduction (GO:0016601),-0.5369024369165819,-1.3915398986215963,0.07982261640798226,0.3643457915060837,1.0,8/18,19.46%,CDH13;TIAM1;RHOH;EPS8;ELMO1;HACE1;WASF1;NCKAP1
prerank,regulation of T cell chemotaxis (GO:0010819),0.6519368956035854,1.3909346817727748,0.166015625,0.8371763676692736,1.0,5/11,17.97%,OXSR1;ADAM17;WNK1;CCR2;WNT5A
prerank,peptidyl-lysine acetylation (GO:0018394),0.675313704957653,1.3893030521972267,0.14893617021276595,0.8413909374485876,1.0,7/10,23.60%,SIRT1;KAT7;KAT2B;CREBBP;EP300;ESCO1;BAG6
prerank,activin receptor signaling pathway (GO:0032924),0.6264865450407711,1.3886507674612225,0.1464354527938343,0.8410639411845172,1.0,2/15,3.46%,SMAD3;TGFBR1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.39995986976482795,-1.3873476559011493,0.029315960912052116,0.37257994879392775,1.0,20/67,10.69%,NRP1;PIK3R1;VEGFC;NRP2;NCK2;PTK2B;DOCK1;KDR;CLEC14A;DAB2IP;CRK;PTK2;ABI1;NCF2;FLT4;HSP90AA1;BCAR1;ITGB3;CYBA;ELMO1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6789724474810283,1.3863839398554412,0.10371819960861056,0.8481026634689747,1.0,5/10,18.90%,ADRA2A;HBEGF;ADAM17;TGFA;BTC
prerank,protein K63-linked ubiquitination (GO:0070534),0.5145563932205667,1.3861183158068116,0.08978328173374613,0.8459544047430654,1.0,7/41,7.45%,RNF152;UBE2E2;PRKN;NEDD4;RNF135;TRIM56;RNF8
prerank,cellular response to BMP stimulus (GO:0071773),0.4736567303515571,1.3855601489295448,0.060781476121562955,0.8452141771060173,1.0,9/66,5.76%,TGFBR3;BMP6;BMP7;SMAD3;DDX5;BMPR1A;SMAD6;RGMB;USP9X
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4490375112542842,-1.3851070939975767,0.07874015748031496,0.37641571254193307,1.0,12/36,14.83%,CAV1;NOS3;NOSTRIN;SCARB1;CALM1;APOE;GCH1;HSP90AA1;ATP2B4;HIF1A;CYGB;NUS1
prerank,monocarboxylic acid transport (GO:0015718),0.4876414584660575,1.3850550380292028,0.08809891808346214,0.8442261350280278,1.0,8/51,6.89%,SLC16A6;SLC6A13;SLC6A12;SLC16A12;SLC16A11;SLC10A4;SLC16A13;SLC27A1
prerank,regulation of neuroinflammatory response (GO:0150077),0.5781216652132901,1.3850300899628254,0.1076388888888889,0.8410247995482529,1.0,5/19,6.61%,IGF1;IL18;SPHK1;NUPR1;DAGLA
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6023009114842355,-1.3850213347132483,0.08559498956158663,0.3755470928847058,1.0,6/11,8.00%,KCNJ3;KCNJ2;ATP1B1;YWHAE;ATP1A1;KCNQ1
prerank,hepaticobiliary system development (GO:0061008),0.5839390757272342,1.3848979165624746,0.108348134991119,0.838344285058821,1.0,6/20,13.89%,TGFBR3;WNT4;NIPBL;CDK5RAP3;PHF2;PRKCSH
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5883148737919117,-1.384719712465742,0.08370044052863436,0.37519648912727355,1.0,5/12,10.43%,SEMA6A;DCN;DAB2IP;XDH;ATP2B4
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.5877932724603451,1.3841078371672488,0.13011152416356878,0.8387264906322697,1.0,4/20,3.91%,DAB2;PICALM;RHOQ;PPFIA1
prerank,ephrin receptor signaling pathway (GO:0048013),-0.38335193495086317,-1.3834907933386542,0.03754266211604096,0.3769425410960825,1.0,31/82,14.09%,ARHGEF28;ACTB;EPHB1;EPHA5;GRIN2B;EFNA5;EPHA6;PAK3;NCK2;CHN1;ACTG1;ARHGEF7;LYN;ACTR2;TIAM1;PAK1;EPHA7;PSEN1;CRK;DNM1;EPHB2;ANKS1B;PTK2;AP2B1;ACTR3;AP2M1;ARPC1B;RASA1;ARPC5;ARPC4;CDK5R1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.672111493696459,1.383356276277202,0.12903225806451613,0.835576357508782,1.0,7/10,18.05%,SIRT3;PLA2G6;SPHK2;NSMAF;SMPD3;SMPD2;TNFRSF1A
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.672111493696459,1.383356276277202,0.12903225806451613,0.835576357508782,1.0,7/10,18.05%,SIRT3;PLA2G6;SPHK2;NSMAF;SMPD3;SMPD2;TNFRSF1A
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.43413114210235665,-1.3829936226984818,0.07238605898123325,0.37692196651264603,1.0,12/45,10.36%,RPS6KA5;PIK3R1;REPS2;PLCE1;IQGAP1;NCK2;GAB1;PTK2B;TGFB1;PTK2;ERBIN;BCAR1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5325192715400315,1.3828069248701669,0.1111111111111111,0.8345631228012332,1.0,6/32,2.92%,PPARGC1A;IGF1;PRKAA2;PPARA;ZBTB20;NUPR1
prerank,detection of mechanical stimulus (GO:0050982),-0.5158676403398946,-1.3823640290524917,0.12217194570135746,0.3772656826583303,1.0,6/19,12.06%,PIEZO2;CDH2;PIEZO1;PTK2;PKD1;CTNNB1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4740380449453614,-1.38212831729486,0.09487179487179487,0.37676412327585723,1.0,10/28,14.41%,NAV3;PAK1;RPS3;MET;OCLN;CDK5RAP2;MAPT;CLIP1;CDK5R1;FES
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5116031068865714,-1.3820199789239551,0.09598214285714286,0.37592723657002347,1.0,11/20,26.53%,GSN;THBS1;SFRP4;ITGA4;GPER1;ECSCR;PDCD4;RGCC;CD40;PLCG1;CCL2
prerank,tRNA wobble base modification (GO:0002097),0.6141957960912543,1.3788916672716236,0.11931818181818182,0.8491491184672907,1.0,1/14,0.80%,TRMT9B
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.6115246435650699,1.3783813275115004,0.12994350282485875,0.8481285151656508,1.0,6/15,12.36%,LPGAT1;PPARGC1A;PPARA;SLC45A3;MLYCD;MLXIPL
prerank,sympathetic nervous system development (GO:0048485),-0.5487671501376528,-1.377803945021373,0.11804008908685969,0.38488621326322936,1.0,2/15,2.99%,NRP1;NRP2
prerank,heart morphogenesis (GO:0003007),-0.42404640598794857,-1.3770897359129612,0.06936416184971098,0.38549822488807484,1.0,18/50,13.77%,FLRT2;ENG;NOS3;RYR2;TGFB2;TBX3;ACVRL1;NOTCH1;TBX1;SOX17;HES1;HEYL;BMP2;PTK2;HEY2;FKBP1A;ACVR1;VEGFA
prerank,cellular response to type I interferon (GO:0071357),0.5054600374783962,1.3762272459250708,0.09001636661211129,0.8510968376266156,1.0,14/41,16.59%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;STAT2;GBP2;SAMHD1;RSAD2;IRF1;OAS3;IFI35;IFNAR2;SP100
prerank,type I interferon signaling pathway (GO:0060337),0.5054600374783962,1.3762272459250708,0.09001636661211129,0.8510968376266156,1.0,14/41,16.59%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;STAT2;GBP2;SAMHD1;RSAD2;IRF1;OAS3;IFI35;IFNAR2;SP100
prerank,striated muscle contraction (GO:0006941),0.48098065678493146,1.376045110489485,0.07575757575757576,0.8487052090678305,1.0,11/53,9.18%,ATP1A2;CSRP3;RCSD1;PGAM2;DTNA;TPM1;KLHL41;ARHGEF11;CCDC78;PIK3CA;MYL4
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6568256791266616,1.3754368761685578,0.12546125461254612,0.8482221722663564,1.0,3/12,6.47%,IL18;IL17D;IL12B
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.46251070455760307,1.3752028871130346,0.07480916030534351,0.8461329309497193,1.0,15/66,12.29%,APPL2;UBE2E2;DLG1;KANK2;DDX3X;ANKRD17;PLK5;PTEN;RBL2;CCND3;HYAL1;TFDP1;RBL1;ADAM17;BRD7
prerank,response to histamine (GO:0034776),-0.6280328747601502,-1.3748934855255588,0.10865191146881288,0.38937096823398976,1.0,5/10,15.28%,GABRB3;GABRB1;GABRB2;GABRG2;HRH1
prerank,vesicle transport along actin filament (GO:0030050),-0.5141286809439236,-1.374654739842582,0.09429824561403509,0.3888247704389235,1.0,6/19,8.98%,MYO1D;ACTN4;MYO1B;FNBP1L;MYO5A;MYO6
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6573739820948703,1.373331251123999,0.158953722334004,0.8510988490560365,1.0,2/10,2.98%,DNMT3A;PCGF5
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.649493139268716,1.3730144371210724,0.13320825515947468,0.849432677362353,1.0,3/11,9.73%,COLEC12;TLR3;RIPK1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.41804556204192883,1.3722653108673595,0.035398230088495575,0.8497197985482096,1.0,20/152,8.65%,RNF220;WNT5B;LRRK1;LGR4;RSPO2;WLS;PTK7;FGFR2;LRRK2;SULF2;DDX3X;CAPRIN2;TBL1X;SMURF2;SMARCA4;TNKS2;ADGRA2;TBL1XR1;TERT;GPRC5B
prerank,aspartate family amino acid metabolic process (GO:0009066),0.6014265467499729,1.3721055557702497,0.13097345132743363,0.8473791060279959,1.0,10/18,16.82%,MSRA;ASPA;ASPG;GOT2;MTHFR;ADI1;SLC25A12;FOLH1;GOT1;MTHFD1
prerank,diol metabolic process (GO:0034311),-0.5120196446842191,-1.3716202779960904,0.11233480176211454,0.3947144758432503,1.0,8/19,11.77%,NOS3;PLPP1;DEGS2;CALM1;GCH1;HSP90AA1;PRKG2;ASAH2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5694131219654902,-1.3714936753130367,0.07982261640798226,0.39395045242312055,1.0,3/14,0.36%,PRKG1;SLIT2;MEF2C
prerank,acylglycerol homeostasis (GO:0055090),0.5885869897937273,1.3711868503787845,0.13464991023339318,0.8482973947544508,1.0,5/20,12.36%,RORA;IL18;ANGPTL8;PLA2G12B;MLXIPL
prerank,regulation of macroautophagy (GO:0016241),0.42969537959513115,1.3710314110551463,0.05761316872427984,0.8458980488755692,1.0,18/105,11.08%,PRKAG2;PRKAA2;SNX6;PRKAG3;SESN1;CASP3;ATP6V0E1;LRRK2;NEDD4;SESN2;SNX32;SMG1;ATP6V0B;PIK3CA;LARP1;SIRT1;ATP6V1D;ATP6V1E1
prerank,regulation of epithelial cell migration (GO:0010632),-0.4128751884983519,-1.3708017484914465,0.05333333333333334,0.3945904090172146,1.0,20/51,12.89%,BMPER;RHOJ;BMPR2;PTPRG;RTN4;CLASP2;TGFB2;EVL;DOCK1;DAB2IP;PLCG2;CORO1C;PTK2;PTN;CEACAM1;ENPP2;ADIPOR1;EMP2;PFN2;HIF1A
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5884000881387587,-1.3696941437850665,0.09433962264150944,0.39588817008398003,1.0,3/12,6.89%,MBNL1;TGFB2;PTCH1
prerank,neuron maturation (GO:0042551),-0.5272189861165472,-1.366486054350328,0.10344827586206896,0.4022681776637303,1.0,12/18,26.26%,ADGRB3;APP;B4GALT5;SRRM4;SCARF1;CLN5;C1QA;ANKS1A;LGI4;RND1;B4GALT6;C3
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5910411399951825,1.3664333025599307,0.13732394366197184,0.8634846274858818,1.0,4/17,4.75%,ATP1A2;CACNA1D;ANK2;CACNA1C
prerank,lamellipodium assembly (GO:0030032),-0.4834495664940164,-1.3664284490181586,0.0894854586129754,0.40131133148140957,1.0,14/26,13.12%,CDH13;ABLIM1;PARVB;CARMIL1;SPATA13;CCDC88A;ARHGEF7;ABLIM3;ITGB1;S1PR1;P2RY12;ABLIM2;SPEF1;DMTN
prerank,negative regulation of angiogenesis (GO:0016525),-0.37656530231863095,-1.3662957902306794,0.04498269896193772,0.4005106575678963,1.0,25/84,13.89%,PTPRM;TEK;SEMA6A;CLDN5;PDE3B;DCN;THBS1;TGFB2;COL4A2;SLC12A2;EPN2;SEMA3E;DAB2IP;SERPINF1;HSPG2;KLF2;STAB1;AMOT;ATP2B4;CREB3L1;CTNNB1;ISM1;ECSCR;ADGRB1;SPRED1
prerank,endothelial cell development (GO:0001885),-0.4952487626224023,-1.365936746781773,0.0779816513761468,0.40023533731685074,1.0,13/25,12.21%,PDE4D;PECAM1;COL15A1;PPP1R16B;RAP1B;ICAM1;RAP1A;MET;ROBO4;RDX;PDE2A;MSN;SOX18
prerank,mesonephric tubule development (GO:0072164),0.6017476124936889,1.3655593071290777,0.1286231884057971,0.8641909713425455,1.0,5/15,3.64%,BMP7;OSR1;FGFR2;NPNT;FOXC1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.4320909222832791,-1.3651249634992983,0.06361323155216285,0.4010871980538156,1.0,12/40,10.03%,MEF2C;BRINP3;BRINP1;NGF;VWC2;ARHGEF2;BEND6;NRCAM;HEYL;BMP2;PROX1;BRINP2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5228856585935857,1.3649695421509693,0.12211221122112212,0.8636275205623403,1.0,10/32,13.34%,FOXN3;BABAM2;ATM;DONSON;CDK5RAP3;BRSK1;CDC14B;UIMC1;FZR1;BABAM1
prerank,cellular response to nitrogen compound (GO:1901699),0.5770206655635667,1.3647936564002476,0.12589928057553956,0.8614053474671749,1.0,3/20,5.95%,ROCK2;CPS1;ATRX
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.6005022672307362,1.3640649457508314,0.1287313432835821,0.8615823378494081,1.0,5/15,13.15%,RENBP;LARGE1;MGAT3;GNPDA1;CHST3
prerank,regulation of microtubule depolymerization (GO:0031114),-0.4888737632675046,-1.3639580307788277,0.09476309226932668,0.4027778126910829,1.0,8/25,12.36%,MAP1B;NAV3;CLASP2;ARHGEF2;STMN2;FGF13;TRPV4;SPEF1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3604804822628431,1.3637480204399695,0.0,0.8599486498263731,1.0,295/1668,12.98%,PRDM6;AEBP1;EPAS1;HLF;ZKSCAN2;DAB2;FGF1;WWOX;RORA;MAF;BMP6;KDM7A;PPARGC1B;THRB;SMAD3;TFDP2;GLIS3;AUTS2;OSR1;ZIC2;TRAK1;KIT;FHL2;DDX5;PPARGC1A;MXI1;IGF1;RHOQ;NFYC;BRD8;CUX1;KMT2A;DLG1;PPARA;PKNOX2;SSBP2;CREBRF;FGFR2;ZFHX2;PRKN;FOXP4;IL18;IKZF2;FHOD1;CREB5;HOXB4;DNMT3A;GLI2;FNIP1;ZBTB20;ZNF160;HOXB6;KANK2;CSRP3;NPAS3;GABPB1;GABPB2;ZHX2;FOXD1;HOXC6;HOXA1;TNRC6A;ZNF568;ARID4A;MOSPD1;NFAT5;SOX5;PCGF5;HDAC8;PHIP;NR2F2;KCNIP3;NCOR2;CTR9;BMPR1A;ZNF697;ELF1;TSHZ3;NR6A1;GLI3;MITF;SUFU;ARNT2;CXXC5;FOXC1;PHF21A;MLLT10;NFIB;VGLL3;PCGF2;RFX8;HOXB3;VEZF1;IFI27;ZBTB38;MAFG;ASCL3;ATOH1;NACC2;ZNF462;NFYB;CREB3L2;TLR3;EZR;NHLH2;PRKCB;SMAD6;FOXP2;SALL4;CUX2;RREB1;CHD4;PPP1R13L;PIAS1;TLR4;MEIS1;FBXL19;NSD1;TEF;TET2;FZD5;ATM;DDX3X;WWC2;OTP;ARRB1;ARID3A;NCOA3;CAPRIN2;MAP2K5;GPS2;USP9X;CAMK1;SOD2;ATRX;ABHD14B;ESRRA;TEAD3;STAT2;LCOR;HMGA1;HOXB9;HOXA3;BAZ1B;HOXB5;TP53;TSHZ1;TBL1X;BCAS3;BCLAF3;CAMTA2;WWTR1;BHLHE41;SMURF2;RORC;MED12;SOX12;SERPINE1;MGA;CCNT2;SMARCD3;ZSCAN29;PLSCR1;NIPBL;ZIC5;LDB2;LDB1;LAGE3;BCOR;TNRC6B;ATAD2B;CBX7;ELF2;MEF2A;PTEN;KDM2B;SMARCA4;NR1D2;HOXC4;SRCAP;SPEN;SSBP3;ZSCAN25;TBL1XR1;CPEB3;KAT6B;ZIC1;KDM2A;SLTM;GDNF;TMF1;JMJD6;NUPR2;IRX1;SMARCC2;NEUROD4;TEAD2;KLF3;CALCOCO1;PARP9;SMARCE1;HDAC4;GLI1;ZBTB26;SIRT1;ZIC4;WASL;TFDP1;TCF7;RIPK2;NR2C2;HDAC1;SOX13;LARP7;RIPK1;MAVS;ZFP90;FOXC2;TCF7L2;TCF4;MOV10;HBP1;ZBTB8B;ZNF219;MYBL1;MED17;ATN1;HIVEP2;FOXL1;ZFP28;RBL1;GTF2F1;KMT2C;ZFP3;AURKB;THRAP3;ABL1;PRDM5;AASS;RTF1;ZBTB6;SAP18;ZKSCAN5;ZNF569;ZNF367;NFATC3;RARG;HR;MNT;ATF2;ZFX;RBBP8;PRKDC;ZMIZ2;WWP2;BAZ1A;IMPACT;MLLT6;TFAP2D;ZNF467;ZBTB1;SKOR1;MYBL2;CBX5;TEAD1;ZMIZ1;DICER1;ZSCAN22;NOP2;KDM3B;CCDC62;ZNF148;HES6;ZNF235;BRWD3;HOXB2;BRD7;FOXA2;DEAF1;MLXIPL;NR3C2;TGFA;BRD9;ZMYM5;IRF1;ZKSCAN7;PHF2;FRK;ZNF483;KMT2D;KAT7;ZXDC;PBX4;ZBTB48;FOXJ2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.4836023169361254,-1.3637306697281688,0.09006928406466513,0.4021828031846975,1.0,6/23,21.04%,CADM1;PIK3R6;PVR;ARRB2;LGALS9;RAET1E
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.36350933677709557,-1.3634785590325218,0.024390243902439025,0.40165400210468544,1.0,29/100,12.48%,TEK;PIP5K1B;NTRK3;PIK3R1;ROR1;DCN;FN1;PIP4K2A;TGFB2;PPP1R16B;GAB1;NTRK2;KDR;LYN;ROR2;PDGFC;DAB2IP;SEMA4D;MYOC;PTK2;CEACAM1;FBXL2;FGF2;PIK3AP1;PDGFA;PIK3IP1;GPER1;UNC5B;TWIST1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.4954776407314688,1.3628434026728802,0.0851063829787234,0.8609400463025939,1.0,6/41,7.21%,ACSL1;PTGS1;ALOX12;EPHX1;DAGLA;SCD5
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.5096842689123453,-1.3627004106143639,0.10199556541019955,0.4023757583117652,1.0,10/20,28.14%,CHRM3;CHRM2;AGRN;CDK5R1;GNB1;LYPD1;CHRNA7;RGS10;LY6H;RGS8
prerank,respiratory system development (GO:0060541),0.514250373137817,1.3621544059964428,0.09950248756218906,0.8609217510144932,1.0,7/32,7.55%,FGF1;FGFR2;GLI2;PDPN;LOXL3;RBP4;CHD7
prerank,ribosome assembly (GO:0042255),-0.4209071134262351,-1.3619821992293122,0.05597964376590331,0.4030252848397506,1.0,21/47,21.96%,RPL3;RPS19;RPS28;RPLP0;RPS15;RPL5;RPL23A;RPS27;RPS5;RPL6;MDN1;NOP53;RPSA;BRIX1;RPS27L;MRPL20;RPL24;RPL11;RSL24D1;NPM1;MRPS2
prerank,mesenchyme development (GO:0060485),0.60214248470922,1.3609988983962849,0.14864864864864866,0.8630858765194215,1.0,3/15,3.46%,BMP7;FGFR2;TGFBR1
prerank,microglial cell activation (GO:0001774),-0.5087968655973991,-1.360647416507985,0.10047846889952153,0.4049350285017447,1.0,11/21,28.50%,APP;MAPT;SNCA;CLU;CX3CR1;ITGB2;C1QA;TYROBP;JAK2;GRN;IFNGR1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.5542352421732419,1.3605105094426355,0.12431444241316271,0.8622038873058536,1.0,4/24,3.91%,DAB2;PICALM;RHOQ;PPFIA1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4939550972013627,-1.3597973664573286,0.10574712643678161,0.40574414195487385,1.0,6/22,11.24%,PDE3B;PPP2R5A;APOD;CEACAM1;CCDC3;GPER1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5916836878415211,-1.359219320760479,0.11297071129707113,0.4061167632822439,1.0,6/12,18.29%,HSPA5;SEC62;SEC61B;SGTB;CHMP4B;CHMP4A
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5268377308360757,-1.3589649072233154,0.11007025761124122,0.4056253715458539,1.0,7/18,10.99%,MDFIC;GSK3B;OTUD7B;APOD;MFHAS1;UFM1;CABP1
prerank,cellular response to interleukin-6 (GO:0071354),-0.47999312122309257,-1.3588835666037933,0.08373205741626795,0.4047572995680875,1.0,9/26,11.88%,PID1;PTPRT;ST18;STAT3;PTGIS;IL6ST;ST3GAL6;JAK1;SBNO2
prerank,signal peptide processing (GO:0006465),-0.5923254799154701,-1.3588615603707797,0.11928429423459244,0.4037229026394606,1.0,5/11,23.85%,PCSK5;SPPL3;SPCS1;CLN5;PARL
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.5036736950359385,-1.3587267736153448,0.10476190476190476,0.4029119668591913,1.0,11/21,21.93%,TOX;DISC1;PROX1;NAP1L1;CTNNB1;VEGFA;CX3CR1;DLL4;DISP3;DRD2;MDK
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.6129081907316832,-1.3585474400312008,0.11554621848739496,0.40226418914110906,1.0,3/10,5.34%,CXCL12;GAS6;LYN
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5772580736077856,1.3583481849946137,0.12776831345826234,0.8687193474963296,1.0,4/20,2.07%,ROCK2;RHOQ;DLG1;FHOD1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.445929759887175,-1.3582941585933792,0.08883248730964467,0.40179774147087505,1.0,17/34,19.07%,NRP1;SEMA6A;VEGFC;GAB1;NOTCH1;KDR;RAMP2;ANXA1;DAB2IP;FLT4;MT1G;PRKD1;VEGFA;NUS1;NR4A1;HSPB1;DLL4
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.443805820631907,-1.3582886106584036,0.08866995073891626,0.4007570177938571,1.0,17/32,26.21%,AKAP6;CEMIP;CALM1;CALM2;TRPC1;CALM3;JPH2;GPER1;SNCA;APLNR;GSTM2;NPSR1;HAP1;THY1;F2R;CXCL10;PLCG1
prerank,ceramide metabolic process (GO:0006672),-0.4117089330596185,-1.3579928246264505,0.05026455026455026,0.40034120502512655,1.0,11/49,11.77%,ST6GALNAC3;SGMS1;SGMS2;ACER3;ACER2;PLPP1;SPTLC2;DEGS2;PPP2R1A;CERS4;ASAH2
prerank,cilium-dependent cell motility (GO:0060285),0.5596678345800572,1.357940228515209,0.11226252158894647,0.8675133789299481,1.0,1/22,0.21%,CFAP44
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.47655726046497704,-1.3576533061115954,0.10046728971962617,0.4000434094834576,1.0,6/27,2.27%,PDE4D;PDE4B;CAV1;CTNNA3;RYR2;CAMK2D
prerank,membrane assembly (GO:0071709),-0.4474874324195784,-1.3575996576442761,0.07729468599033816,0.39909791660378546,1.0,8/34,4.66%,NLGN1;NRXN1;SPTBN1;PTPRD;IL1RAPL1;ANK3;RFTN1;UGCG
prerank,regulation of metal ion transport (GO:0010959),0.5923284713707242,1.3572678225566686,0.16635514018691588,0.8674656955293819,1.0,3/16,2.04%,ANK2;DLG1;SLC30A10
prerank,striated muscle tissue development (GO:0014706),-0.45438582344055317,-1.3568318900227019,0.08629441624365482,0.39977898427490893,1.0,8/29,4.11%,SGCZ;MEF2C;SGCD;PGM5;BMP5;CAV1;BMPR2;MYL6
prerank,retinoid metabolic process (GO:0001523),0.4533775538620689,1.3567726849008215,0.06351550960118169,0.8665438834794504,1.0,13/71,7.54%,ALDH1A2;ABCA4;NAPEPLD;ALDH1A1;RBP1;AKR1B10;CYP26B1;APOM;RHO;PNLIP;DHRS3;SCPEP1;RBP4
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5275508988710125,1.3565329566633582,0.1245674740484429,0.8645834311222096,1.0,5/25,6.76%,ERRFI1;PPARA;SNX6;SLC6A9;CNRIP1
prerank,regulation of potassium ion transport (GO:0043266),0.5115243315355612,1.356466493547909,0.1386986301369863,0.8618513175721463,1.0,7/31,3.65%,CACNA1D;ACTN2;ANK2;DLG1;KCNA5;KCNIP3;ADRA2A
prerank,sphingolipid biosynthetic process (GO:0030148),-0.3839690646613519,-1.3558184236752928,0.04024767801857585,0.4011270386571284,1.0,15/71,6.90%,ELOVL7;CERT1;SGMS1;SGMS2;ELOVL5;ACER3;PRKD3;ACER2;PPM1L;PLPP1;SPTLC2;DEGS2;SPNS2;ST8SIA1;ST6GALNAC5
prerank,regulation of neuron migration (GO:2001222),-0.467625998968064,-1.3553320768980643,0.07511737089201878,0.4012069927668321,1.0,7/26,5.82%,CTNNA2;SEMA6A;NEXMIF;NTNG1;SHTN1;ARHGEF2;DAB2IP
prerank,regulation of phospholipase activity (GO:0010517),0.6610234645283672,1.355293018033626,0.16367265469061876,0.8642343777270091,1.0,4/10,9.36%,FGFR2;FGFR1;PDPK1;LRP1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5363587528687699,1.3548079448239192,0.11908646003262642,0.8633594714156554,1.0,4/30,5.59%,ROBO1;LPAR1;AKAP13;ARRB1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.38161759973661274,-1.3548014439280571,0.037267080745341616,0.4014226692916159,1.0,24/73,14.04%,NTRK3;CAV1;BCAR3;GAS6;NGF;TFRC;HSP90AB1;PAK1;APP;TGFB1;FNIP2;CD44;HSP90AA1;ATP2B4;TNKS1BP1;NOS1;PFN2;AXIN1;SNCA;PRKD1;VEGFA;TXN;PINK1;TERF2IP
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.5118210368937364,-1.3544517062326844,0.1056338028169014,0.4011619908768207,1.0,10/19,31.45%,THBS1;PTK2;MPP1;CMKLR1;RARRES2;MDK;JAM3;MAPK3;BST1;CSF1R
prerank,histone H3-K9 demethylation (GO:0033169),0.6483065543408023,1.3538979022211473,0.15860735009671179,0.8643610127154718,1.0,3/11,11.87%,KDM7A;HR;KDM3B
prerank,neuromuscular junction development (GO:0007528),0.5464326207503828,1.353783817787833,0.12886597938144329,0.8619229383727839,1.0,7/24,8.47%,PDZRN3;LRP4;UNC13C;LRRK2;NEDD4;CACNB3;PPFIBP2
prerank,calcium ion transport into cytosol (GO:0060402),-0.5041811434026412,-1.3531588209766385,0.11165048543689321,0.4031400589950967,1.0,11/21,17.86%,SLC8A1;RYR2;CACNA2D1;GRIN2B;GRIN2A;TRPV4;ATP2B4;JPH2;TRPM2;GRIN1;ITPR3
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5795811127465822,1.352983010011127,0.14156079854809436,0.8624384959856908,1.0,4/18,6.92%,GPR137;TLR3;TLR4;FBN1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.40860576692339573,-1.3528829419928112,0.06017191977077364,0.40274123163364073,1.0,16/51,14.15%,BMPER;GREM2;BMPR2;HTRA3;VWC2;NOTCH1;VWC2L;SMAD5;SORL1;SMAD1;BMP2;SMAD7;LEMD3;UBE2D3;BMPR1B;SMURF1
prerank,negative regulation of cell differentiation (GO:0045596),0.39923167954222133,1.3524112181822385,0.035443037974683546,0.8620085436999839,1.0,18/181,6.91%,RANBP3L;COL5A1;TMEM64;RORA;BMP7;SMAD3;OSR1;PPARA;CTR9;SUFU;TGFBR1;DTX1;SMAD6;MEIS1;GPS2;LDLRAD4;TRIB2;WWTR1
prerank,catecholamine metabolic process (GO:0006584),0.5934616157651631,1.3523165738176588,0.14711359404096835,0.8595284103582858,1.0,3/14,8.51%,SNCAIP;PRKN;LRTOMT
prerank,neuron projection fasciculation (GO:0106030),-0.6069031284011882,-1.3516008577075471,0.1237721021611002,0.4045919927380888,1.0,6/10,14.09%,CNTN4;RTN4;SEMA5A;NRCAM;EPHB2;CDK5R1
prerank,gene expression (GO:0010467),-0.30803779316551133,-1.3510483547643266,0.0,0.40473717492975764,1.0,136/348,25.23%,RPS24;RPS12;RPL8;RPL41;RPS23;RPL13;RPS8;RPLP2;RPS6;ADARB1;AGFG1;ADARB2;RPL18A;ELAVL4;RPS20;RPL37;RPS29;RPS15A;RPL3;RPL26;RPL37A;RPL38;RPL27A;RPLP1;RPS18;RPL7;RPS19;RPL22;RPS28;PTMA;RPL35A;RPLP0;RPS15;RPL30;RPS3;RPL19;RPS21;TSPAN14;RPL4;RPL32;RPL21;RPS16;RPL18;SYNCRIP;RPL5;RPS7;SORL1;RPL39;TASP1;ABCF1;RPL14;RPS17;RPL28;RPL34;EEF1A1;RPL12;RPL9;RPS25;RPL7A;RPS2;RPS9;RPS11;RPS10;RPL23A;RPL17;RPL23;RPL27;RPL10A;RPS27;RPL29;DROSHA;HNRNPK;NUP210;RPS4X;RPS5;CHTOP;RPL36A;RPL6;SMG5;THOC5;TAF1B;APOBEC1;POLR2J;RPL31;HBS1L;GLE1;RPSA;RPS26;GALNT2;RBM15B;RPL36;BCL3;ANGPT2;HHEX;RNPS1;EIF4E;NXT1;TSPAN17;RPL13A;XRN2;RPL35;PAX8;COPS5;NUP107;WDR33;RPL24;RBM3;RPS13;MRPL34;RPL11;EIF4A3;RSL24D1;TSPAN33;POM121;MRPS16;POLR2C;POLR2L;TSPAN15;MRPS21;MLF1;MRPL10;MRPL13;NCBP2;ZC3H11A;RPS27A;STUB1;RBM8A;MRPS33;SRSF6;NUP93;NUP85;NUP50;HOXD3;EIF4EBP2;MRPL35;EEF1A2
prerank,protein modification by small protein conjugation (GO:0032446),0.38158221024538747,1.3508907038135387,0.01853997682502897,0.8628473606506313,1.0,91/361,19.26%,RNF220;EPAS1;EYA1;RNF152;PDZRN3;RNF43;ASB2;PRKN;FBXL17;SPSB1;TRIM63;RNF213;CTR9;DTX1;CAND2;NEDD4;RNF151;ATG10;PIAS1;RNF135;KLHL41;ARRB1;USP9X;RNF181;SPSB4;MGRN1;UBR2;SMURF2;RNF8;FBXW11;HUWE1;FBH1;BTRC;CDK5RAP3;KLHL7;EIPR1;RNF34;SIRT1;NUP42;ZSWIM8;ATG7;RTF1;UBE2M;RNF41;NUP98;FBXW8;FBXO4;PRKDC;WWP2;PEX10;DCUN1D5;CUL4A;CUL9;UBA6;FBXO10;NUB1;ASB5;USP7;NSMCE2;TRIM62;NUP43;ASB12;FBXO11;DTX3;SDE2;PEX14;UBE2H;AMFR;PIAS3;ANAPC16;BIRC6;NUP155;UBR1;RNF7;UBE2E1;KCTD13;SYVN1;PEX5;CDC34;RNF25;RNF20;CCDC22;ARIH1;MIB2;ASB1;SUMO1;PIAS4;NUP188;KLHL18;MIB1;UBA5
prerank,cardiac muscle cell contraction (GO:0086003),-0.5047039149282319,-1.3500717626405654,0.10738255033557047,0.40587367477274156,1.0,8/19,5.59%,FGF12;GSN;CAMK2D;CACNA2D1;KCNJ2;SCN1A;CACNA1G;ATP1A1
prerank,homocysteine metabolic process (GO:0050667),0.6402412069849891,1.3499325569459495,0.16184971098265896,0.8640756883066284,1.0,5/11,12.38%,CPS1;MTHFR;CTH;NOX4;MTRR
prerank,ceramide biosynthetic process (GO:0046513),-0.4309393359889674,-1.3498283086212037,0.06,0.40545324453769144,1.0,10/40,11.77%,ST6GALNAC3;ST8SIA4;SGMS1;SGMS2;SPTLC2;DEGS2;ST6GALNAC5;ST8SIA6;CERS4;ASAH2
prerank,lipid biosynthetic process (GO:0008610),0.44244282197436025,1.3491808617381071,0.07605633802816901,0.8644596501683381,1.0,10/77,7.40%,ACSL1;PRKAA2;AGPAT4;GPAT2;CYP21A2;FDXR;DHRS11;PDSS2;SCD5;NDUFAB1
prerank,regulation of cellular localization (GO:0060341),0.4791067207076842,1.3491611447172138,0.09615384615384616,0.861709532839628,1.0,7/46,5.21%,PARD6G;ADCY5;STXBP4;PRKN;LRRK2;STXBP2;MAP2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5917202711057002,1.3487000926486257,0.14100185528756956,0.8608561084155009,1.0,5/17,12.33%,BMP6;SASH1;LY96;TRIB1;PRKCA
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6275381647491891,1.3482562596787133,0.19011406844106463,0.8596676463953765,1.0,2/12,1.42%,ROCK2;PICALM
prerank,regulation of wound healing (GO:0061041),-0.4248878890949811,-1.3480281183249785,0.07084468664850137,0.408604303074126,1.0,12/42,9.38%,CAV1;CASK;ACTG1;ANXA1;AJAP1;OCLN;ITGB1;CD109;CRK;EPHB2;PTK2;FGF2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4057220669874287,1.347260112322068,0.06291834002677377,0.86119085519637,1.0,36/138,16.31%,NOTCH2;RORA;THRB;PPARGC1A;CCN2;PPARA;POLR2A;NCOR2;NR6A1;ESRRA;TEAD3;TBL1X;WWTR1;RORC;POLR2D;NR1D2;TBL1XR1;TEAD2;NR2C2;HDAC1;MED17;GTF2F1;RARG;TEAD1;TAF11;NR3C2;TBP;TAF4;NCOR1;KAT2B;TAF7;MED23;RXRA;TAF13;CREBBP;MED26
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.559665491858578,1.346746646503482,0.131175468483816,0.8606227456208347,1.0,4/23,6.97%,TGFBR3;SMAD3;DKK3;SMURF2
prerank,ureteric bud development (GO:0001657),0.581066637896582,1.3465925061522388,0.14583333333333334,0.8584630976605112,1.0,5/17,3.64%,BMP7;OSR1;FGFR2;NPNT;FOXC1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.38641690725586036,1.346411165582701,0.035842293906810034,0.8564903966130114,1.0,38/248,9.99%,RNF220;DAB2;TMEM64;LRRK1;LGR4;WLS;LRP4;BICC1;PTK7;FGFR2;MCC;PRKN;DKK3;GLI3;LRRK2;LZTS2;DDX3X;CAPRIN2;APC2;TBL1X;WWTR1;SMURF2;UBAC2;PTPRU;TNKS2;BTRC;ADGRA2;TBL1XR1;GPRC5B;INVS;TMEM170B;CSNK1A1;GLI1;TLE1;HDAC1;SOX13;UBR5;TCF7L2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.38823773281249224,-1.3463806140847085,0.04953560371517028,0.4113430030997826,1.0,19/63,22.40%,MEF2C;VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;CD38;PTPRC;EPHB2;TIRAP;NCK1;CD74;IRS2;CCL19;CD320;CD86;CD276;CD81
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5319255920322075,1.3463457878815523,0.12563667232597622,0.8540168734022344,1.0,8/29,16.40%,SMAD3;ZC3H7B;SNIP1;HNRNPA2B1;TUT4;DICER1;PUS10;TUT7
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.48178866185784347,1.345975363640293,0.10613598673300166,0.8528019628476409,1.0,17/46,16.30%,LGR4;LAMA4;ZNF423;ALDH1A1;NPR3;PCTP;TLR4;NOVA1;ACOT11;DOCK7;FOXC2;ADAM17;FLCN;ACVR2B;MAP2K6;NRDC;RB1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4853513428512595,1.3454918092835928,0.11127819548872181,0.8521581666980503,1.0,5/45,3.46%,DAB2;BMP6;BMP7;BMPR1A;TGFBR1
prerank,peptide cross-linking (GO:0018149),-0.47482055211849994,-1.344948552445573,0.10632911392405063,0.4135264673526882,1.0,4/25,5.42%,THBS1;FN1;NDNF;ANXA1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6236339767657936,1.3444575937576693,0.19047619047619047,0.8537270378019313,1.0,6/10,24.29%,USP7;OGT;GNMT;PDK2;SELENOS;DGKQ
prerank,regulation of stress fiber assembly (GO:0051492),0.4486742942141648,1.3443945816390068,0.09131075110456553,0.8512880300499193,1.0,16/74,5.17%,ARHGAP28;ROCK2;LPAR1;CGNL1;CCN2;ARHGEF10L;ARHGEF18;FHOD1;PPM1E;TGFBR1;ASAP3;CLASP1;ARHGAP6;PPFIA1;RAPGEF3;TPM1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.49388032337112736,-1.3443456284262025,0.10909090909090909,0.41390124660289007,1.0,7/23,10.79%,MAP3K5;TNFRSF11A;DAB2IP;PAK1;RPS3;MAP3K7;EDN1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.3331012188694122,-1.3440897534140994,0.02336448598130841,0.41343959271356756,1.0,42/163,19.78%,PDE4D;MEF2C;PDE4B;PTPRJ;PIK3R1;RFTN1;PAK3;INPP5D;PSMB2;CD38;PAK1;PTPRC;BMX;PLCG2;PLEKHA1;MAP3K7;MOG;TNFRSF21;PSMD14;TEC;PSMC6;BCAR1;EIF2B3;IKBKB;SH2B2;RBCK1;SPPL3;BTN3A3;NCK1;PSMA4;NFKBIZ;PSMB9;BLNK;SKAP1;SKP1;SYK;PSMD11;BTK;PSMB10;PRKCQ;PSMD2;TXK
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.4728944446523072,-1.3435351841831897,0.12807881773399016,0.413704707993238,1.0,10/25,21.75%,CTNNA3;CD200;VCAM1;ITGB1;ITGA4;ITGB3;ITGA5;ITGB2;ITGA7;PKP2
prerank,positive regulation of ion transport (GO:0043270),0.47494097830335374,1.3434951069333214,0.11642743221690591,0.8522733063860719,1.0,8/48,8.44%,CACNA1D;ACTN2;ANK2;DLG1;ADRA2A;AHCYL1;ANO6;GDNF
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.5028907929969655,-1.3430728275903954,0.13111111111111112,0.41383448287505975,1.0,7/18,28.13%,PIK3R1;USP13;NCK1;BCL2L11;ERN1;TMEM259;PMAIP1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.54639846999207,1.3430379546248912,0.13181019332161686,0.851525758407284,1.0,6/26,9.56%,DAB2;KANK2;NCOR2;SMARCA4;SIRT1;HDAC1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.6173104952663597,1.342996505657149,0.15769944341372913,0.848973134155783,1.0,1/12,0.35%,ACSL1
prerank,gene silencing by miRNA (GO:0035195),0.5185329490180478,1.3429484875660773,0.12965964343598055,0.8464886114037061,1.0,16/32,26.19%,TNRC6A;ZC3H7B;SNIP1;TNRC6B;MOV10;AJUBA;DICER1;TNRC6C;WTIP;RBM4;XPO5;AGO1;SPOUT1;AGO4;AGO2;PUM2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5567190775375059,1.3418531368556563,0.14736842105263157,0.8486024951743152,1.0,2/23,0.80%,ATP1A2;ANK2
prerank,synapse assembly (GO:0007416),-0.3894493705077105,-1.3414798357697377,0.05172413793103448,0.41665311895387014,1.0,22/67,11.41%,NLGN1;ADGRL3;NRXN1;GRID2;DNM3;CDH2;KIRREL3;SHANK3;SPOCK2;GABRB3;LRRTM3;DNER;GABRA2;GABRB2;NRCAM;GABRG2;FGF13;SLITRK1;LGI2;SHANK2;NRXN2;CDH1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.4904978909201666,1.3413394704484156,0.11885895404120443,0.8480579608310986,1.0,14/43,18.62%,FOXN3;BABAM2;ATM;DONSON;CDK5RAP3;BRSK1;CDC14B;HUS1;UIMC1;FZR1;BABAM1;INTS3;CLSPN;NBN
prerank,neuron projection organization (GO:0106027),-0.5482120354867575,-1.341111399686072,0.1314655172413793,0.4164716293877914,1.0,5/15,9.30%,GSK3B;PLS1;APP;PSEN1;ABCD2
prerank,digestive tract development (GO:0048565),0.5187152387064593,1.3410680304265985,0.1306532663316583,0.8466006364123256,1.0,8/32,9.30%,KIT;CLMP;FGFR2;GLI2;GLI3;SMO;NIPBL;GLI1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.569868611598491,-1.3409828012826177,0.13882863340563992,0.41571979532800285,1.0,6/12,26.87%,PIK3R1;DAB2IP;PTPN1;BCL2L11;ERN1;ATF6
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5624839435336695,1.340864512635631,0.14031971580817051,0.8447304423081485,1.0,2/19,0.51%,BMP6;AFDN
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.3454774394126317,-1.3408584394887555,0.01762114537444934,0.41500028667037947,1.0,33/151,10.26%,NRP1;TEK;BMPER;ERBB4;NTRK3;PDE8A;GCNT2;ROR1;HTR2C;SEMA7A;PTK2B;GAS6;NOTCH1;NTRK2;KDR;TNFRSF11A;ROR2;PDGFC;ICAM1;PTPRC;RAP1A;APOE;APP;ACKR3;HTR2A;BMP2;TGFB1;MFHAS1;TNFAIP8L3;FGF2;FLT4;CD44;PDGFA
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.50482774699065,-1.340749784432694,0.13304721030042918,0.41423759310714886,1.0,6/18,3.62%,NLGN1;NRXN1;RIMS2;SHANK3;RIMS1;PTK2B
prerank,sensory perception of chemical stimulus (GO:0007606),-0.5417852898768556,-1.3406922954231857,0.13245033112582782,0.41333882004743383,1.0,6/15,21.60%,GNAS;UBR3;GNAL;SYT10;ADCY3;DRD2
prerank,wound healing (GO:0042060),0.4627899076205511,1.340283255638708,0.08792846497764531,0.8443924226249707,1.0,11/62,8.46%,FGF1;SMAD3;SYT11;IGF1;MYOF;CFLAR;TGFBR1;TPM1;FER1L5;FUT10;NRG1
prerank,regulation of catabolic process (GO:0009894),-0.5204633490026966,-1.3402021321114195,0.11261261261261261,0.41349051449092233,1.0,7/18,18.69%,FAP;NEDD4L;ITGB1;ZDHHC2;RARRES2;CHEK2;HPGD
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6282634435954408,1.3400929447684626,0.1806083650190114,0.842489835617928,1.0,2/12,2.92%,IL18;NUPR1
prerank,melanocyte differentiation (GO:0030318),0.6318632801139143,1.3400906156759822,0.17738791423001948,0.8398853525506569,1.0,3/11,3.39%,LRMDA;KIT;MITF
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5988489163662729,-1.339593392263661,0.1351931330472103,0.41394293062086446,1.0,4/10,8.92%,SEMA6A;DCN;DAB2IP;XDH
prerank,ether lipid biosynthetic process (GO:0008611),-0.6047062656292705,-1.3394003235434806,0.1223175965665236,0.4133881476328625,1.0,5/10,24.51%,PLA2G4A;LPCAT2;AGPS;GNPAT;DHRS7B
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.49566532796571017,1.3393221390166947,0.12721417069243157,0.840416895522912,1.0,6/41,13.91%,PRKAG2;GCK;NUP42;NUP98;NUP43;OGT
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.5675120469888055,-1.338781960166898,0.1406926406926407,0.41382579559307425,1.0,7/13,25.47%,RPS15;XPO1;LTV1;ABCE1;RAN;NPM1;RRS1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6227402859991514,1.3378808773448825,0.17153996101364521,0.8440227812939552,1.0,5/11,14.02%,DDX5;TP53;RIPK1;MAP2K1;MAP2K2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.46969104077004964,1.3377702279999486,0.10256410256410256,0.8417926648181431,1.0,9/56,6.74%,DAB2;BMP6;BMP7;BMPR1A;PMEPA1;TGFBR1;SMAD6;LDLRAD4;TWSG1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.6064076633510892,-1.3361063931398776,0.11016949152542373,0.4189959585731224,1.0,7/10,28.28%,APOE;TMEM30A;ABCB4;TRIAP1;PRELID1;ABCA3;DBI
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.42159460153708833,-1.3360720661708234,0.09358288770053476,0.4180808556683699,1.0,18/41,15.39%,ANK3;AKAP6;KCNJ3;KCNMA1;KCNJ2;KCNN2;KCNMB2;GNG2;FLNA;KCNQ1;GABBR2;CTSS;NOS1;ACE2;KCNJ6;GNB1;STAC;KCNJ12
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.46491323049820293,1.3360549002204485,0.10204081632653061,0.8462069473133981,1.0,10/55,10.40%,WWOX;TPD52L1;GSDME;NUPR1;TGFBR1;BID;TP53;DNM1L;RIPK1;BECN1
prerank,response to purine-containing compound (GO:0014074),-0.5297932734499288,-1.3345514156116587,0.12134831460674157,0.4205124727544899,1.0,5/17,15.03%,RYR2;ABCC9;TRPC3;P2RY1;TRPM2
prerank,ketone body metabolic process (GO:1902224),0.643637919337153,1.3342633794593128,0.16515426497277677,0.8510059133361483,1.0,5/10,8.71%,OXCT1;ACSS3;BDH1;BDH2;HMGCS2
prerank,Wnt signaling pathway (GO:0016055),0.4265435928066281,1.3337973151239357,0.0776978417266187,0.8502670997867514,1.0,18/92,11.85%,WNT5B;WLS;NXN;WNT4;WNT6;FZD8;LRRK2;FZD5;DDX3X;PTEN;BTRC;RYK;CSNK1A1;TCF7;TCF7L2;USP34;RARG;PORCN
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5369914690994181,1.332494129119866,0.14038128249566725,0.8531920119440977,1.0,10/26,17.96%,UBE2E2;DDX3X;ANKRD17;CCND3;HYAL1;TFDP1;ADAM17;RPTOR;KMT2E;EIF4G1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.44115357336768246,1.3321770341907868,0.09006211180124224,0.8519994040618888,1.0,14/85,8.94%,EYA1;CACNA1D;GSDME;WHRN;ALDH7A1;DCDC2;EML2;HOXA1;COL4A3;TBL1X;CDC14A;NIPBL;LRTOMT;EPS8L2
prerank,peptide catabolic process (GO:0043171),0.546653350389872,1.331909165156558,0.13556338028169015,0.8504479658024326,1.0,6/23,9.72%,ACE;CPQ;CTSH;NAALADL1;TPP1;NPEPPS
prerank,artery morphogenesis (GO:0048844),-0.456661411241953,-1.3316864576022172,0.08716707021791767,0.42627683256333104,1.0,12/30,11.37%,NRP1;BMPR2;ENG;TGFB2;JAG1;NOTCH1;TBX1;HES1;STRA6;SMAD7;HEY2;BMP4
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5610337419961526,-1.3307492775149636,0.14655172413793102,0.4275016613617359,1.0,5/13,8.51%,DCN;BGN;CSPG4;VCAN;HEXB
prerank,protein auto-ADP-ribosylation (GO:0070213),0.6189709236738147,1.3300758034072817,0.18613861386138614,0.8556571515888648,1.0,6/12,10.70%,PARP10;TIPARP;PARP12;TNKS2;PARP11;PARP6
prerank,regulation of cholesterol esterification (GO:0010872),-0.5877011147314044,-1.329179078761544,0.13618677042801555,0.4301738172008432,1.0,5/10,19.80%,APOE;ABCG1;AGTR1;STARD4;AGT
prerank,mRNA destabilization (GO:0061157),0.4952221879057961,1.328286581899136,0.13266998341625208,0.8606733451741995,1.0,9/38,17.07%,ROCK2;TUT4;POLR2D;CPEB3;MOV10;YTHDF3;ZFP36L1;TUT7;PLEKHN1
prerank,nucleoside catabolic process (GO:0009164),0.6246695293849794,1.3279941275416616,0.18110236220472442,0.8593862520782904,1.0,3/11,6.52%,UPB1;DPYD;DERA
prerank,regulation of innate immune response (GO:0045088),0.4532752841127144,1.3268741730454834,0.1,0.8615685022812188,1.0,18/57,16.01%,APPL2;RNF135;IFNK;TKFC;PTPN22;PLSCR1;SAMHD1;PARP9;DHX58;NMI;PTPN11;IRF1;IFI35;ERAP1;ACOD1;USP18;IFNAR2;BIRC3
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4854890401244385,-1.326456542136037,0.10278372591006424,0.4357225715915521,1.0,5/21,6.42%,PRKCH;SLC39A10;PTPRC;FOXP1;RPS3
prerank,heart looping (GO:0001947),-0.4283094343923862,-1.3260923690280884,0.07672634271099744,0.4355151686943939,1.0,9/39,13.23%,MEF2C;ENG;MICAL2;TBX3;NOTCH1;SOX17;VANGL2;SOX18;AHI1
prerank,negative regulation of cell activation (GO:0050866),-0.5533404893568357,-1.3260196625360305,0.13203463203463203,0.4346412843572248,1.0,6/14,11.24%,CD200;NOS3;APOE;LDLR;PDGFA;GPER1
prerank,fatty acid metabolic process (GO:0006631),0.4189824106202382,1.3256511854310635,0.07104557640750671,0.864172759751842,1.0,28/115,17.08%,ACSL1;PPARGC1A;PPARA;ECHDC3;ALOX12;CEL;ACADSB;CPT1A;GPAT2;ACSBG2;NAAA;NDUFAB1;PON3;CPT2;ACADM;ACOT11;MECR;MLYCD;AASDH;CRAT;ACOT8;PER2;THEM4;ACBD5;GPAM;NUDT19;SGPL1;ACOT12
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6262672235032126,1.325643024935781,0.17399267399267399,0.8616455421735248,1.0,2/11,2.04%,PPARA;SLC30A10
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5394787004370091,1.3240819709660259,0.1474820143884892,0.8656110874782207,1.0,3/22,3.65%,TIMP3;SH3D19;ADRA2A
prerank,protein homotetramerization (GO:0051289),0.47588888334150536,1.3239405763050205,0.11846153846153847,0.8637072199208102,1.0,8/49,9.81%,ALDH1A2;APPL2;UPB1;SOD2;SAMHD1;SSBP1;CBY1;CTH
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.37214335447964875,-1.3239010517290262,0.0625,0.4387531629073522,1.0,19/76,16.21%,NRP1;TEK;NTRK3;SEMA5A;NCK2;EVL;CARMIL1;PTK2B;CDC42EP3;BIN1;PROX1;WDR1;EDN1;SYNPO2;PFN2;FES;CDC42EP2;NCK1;ARF6
prerank,axonal fasciculation (GO:0007413),-0.5625049455367435,-1.3234400113207934,0.1364562118126273,0.438914677819147,1.0,5/12,7.96%,CNTN4;RTN4;SEMA5A;NRCAM;EPHB2
prerank,metal ion transport (GO:0030001),-0.3669077849426937,-1.3228309799244795,0.05660377358490566,0.4393519894900853,1.0,29/86,15.03%,SLC8A1;CALCRL;CAV1;CACNA1E;RYR2;CACNA2D1;TPT1;ATP2C1;RYR3;GRIN3A;TRPC3;ATP2B2;RAMP2;TRPC4;NIPAL2;TRPC1;CACNA1B;PSEN1;NDFIP2;ATP2A3;TRPV4;SELENOK;SLC30A1;RAMP1;MT3;NIPA1;TRPC5;CACNG8;TRPM2
prerank,negative regulation of ATPase activity (GO:0032780),0.5777807528493101,1.322790679986628,0.16111111111111112,0.8660030460429606,1.0,5/16,14.28%,IFIT1;TP53;SIRT1;TNNI3;TSC1
prerank,positive regulation of type 2 immune response (GO:0002830),0.5876863331635076,1.3226901803629838,0.18401486988847585,0.86387796697071,1.0,3/14,9.33%,PRKCZ;IL18;RSAD2
prerank,response to fatty acid (GO:0070542),-0.5224607553986704,-1.3225727247824883,0.13852813852813853,0.4389918330737932,1.0,5/17,20.05%,PID1;FOXO1;SCD;NR1H4;IRS1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5952771515524641,-1.3224804682281248,0.15368421052631578,0.4381448426294892,1.0,3/10,8.37%,LRCH1;CD200;APOD
prerank,proton transmembrane transport (GO:1902600),0.5017894499906965,1.3221923792870032,0.15025906735751296,0.863443848821468,1.0,3/36,6.17%,ATP1A2;ATP6V0E1;ATP4A
prerank,response to prostaglandin E (GO:0034695),0.6432591936707334,1.3220568714251466,0.181640625,0.8615180407774151,1.0,1/10,0.31%,TGFBR3
prerank,regulation of platelet aggregation (GO:0090330),-0.5185517196911974,-1.3218632729922881,0.13544018058690746,0.4385610926314194,1.0,6/17,8.90%,PRKG1;CD9;SERPINE2;F11R;LYN;CEACAM1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5841884074650269,-1.321651910201693,0.14171656686626746,0.4380522780645951,1.0,4/10,4.47%,PDE3B;ACER2;NEXMIF;CYP1B1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3655733012397474,-1.3214453058947595,0.05226480836236934,0.4375015109458739,1.0,40/86,22.96%,NRP1;GHR;PTPRJ;PECAM1;EFNA5;PTK2B;ARHGEF2;PTPRC;APP;PLCG2;EPHA7;CSPG4;SEMA4D;RELN;TGFB1;TEC;CD44;PDGFA;ITGB3;ENPP2;SAMSN1;LRP8;FGF7;DMTN;ACVR1;VEGFA;CD74;PDCL3;ITGA5;ITGB2;VTN;AGT;SFRP1;CNOT7;IL6R;HCLS1;CD81;FYN;THBS4;HGF
prerank,neuromuscular synaptic transmission (GO:0007274),0.5570383716845693,1.3212664781467949,0.162748643761302,0.8622561380641598,1.0,7/18,20.47%,FCHSD2;DTNA;KIF1B;TSPOAP1;ERC2;CHRNB1;TBC1D24
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.5842835677142927,1.3211688410043705,0.17424242424242425,0.8602306629919624,1.0,3/16,5.31%,UPB1;DPYD;TET2
prerank,positive regulation of DNA repair (GO:0045739),0.4774023886865187,1.3209821319741113,0.12254160363086233,0.8584864695182975,1.0,10/46,14.73%,EYA1;EYA2;EYA4;BABAM2;RNF8;SIRT1;UIMC1;BABAM1;SMCHD1;MGMT
prerank,neurotransmitter biosynthetic process (GO:0042136),0.5968474440340494,1.3207415648043381,0.16798418972332016,0.8570377524187826,1.0,3/14,8.61%,MOXD1;DAGLA;SLC6A4
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3742330491287453,-1.3206322916545614,0.07598784194528875,0.4383954199762522,1.0,21/72,12.16%,TEK;NTRK3;PIK3R1;ROR1;DCN;FN1;TGFB2;GAB1;NTRK2;KDR;LYN;ROR2;PDGFC;SEMA4D;MYOC;PTK2;FGF2;PIK3AP1;PDGFA;GPER1;UNC5B
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.54671029386217,-1.320265987921976,0.14225941422594143,0.4382336789386922,1.0,6/13,22.10%,TGFB1;MAPT;SYK;ITGB2;TYROBP;SOD1
prerank,lipid oxidation (GO:0034440),0.6159689167221343,1.32000723442901,0.18026565464895636,0.8576310307739108,1.0,2/12,2.35%,PPARGC1A;ALOX12
prerank,membrane depolarization (GO:0051899),-0.43918424393322714,-1.319862836147779,0.0975,0.43811670353995746,1.0,10/32,12.17%,CAV1;CACNA1E;SCN1A;SCN2A;CACNA1G;SCN7A;CACNA1B;SCN3A;SCN9A;SCN8A
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5660080554659758,1.3197984419567366,0.18229166666666666,0.8559698940234562,1.0,9/18,19.69%,KMT2A;SETD7;KMT2D;SETD1B;EHMT2;EHMT1;ASH1L;SETD3;SETD1A
prerank,sodium ion homeostasis (GO:0055078),0.5546148421084763,1.3197461628224552,0.16878402903811252,0.8537660324263763,1.0,2/21,0.71%,ATP1A2;ATP1B3
prerank,protein localization to mitochondrion (GO:0070585),0.6264800351423916,1.3195140927453555,0.171875,0.8522952225567647,1.0,2/11,3.86%,HK2;LRRK2
prerank,positive regulation of transmembrane transport (GO:0034764),0.6134891231153163,1.3192674722152964,0.1882998171846435,0.8508874043335235,1.0,7/13,19.12%,ACSL1;BRAF;ANO6;AZIN1;CLIP3;C2CD5;AZIN2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2977735386044966,-1.318441744373915,0.009523809523809525,0.4405522284762244,1.0,114/390,17.05%,NRP1;FLRT2;ARHGEF28;GHR;PTPRJ;TEK;GRB14;ERBB4;NTRK3;PIK3R1;ACTB;PTPRG;ROR1;EPHB1;MPZL1;VEGFC;EPHA5;MERTK;UBASH3B;ATP6V0A1;GRIN2B;EFNA5;PTPRT;NRP2;EPHA6;TIE1;PAK3;COL4A2;NCK2;STAT3;CHN1;GAB1;PTK2B;BCAR3;ACTG1;CAV2;NGF;NTRK2;ARHGEF7;DOCK1;KDR;LYN;GSK3B;ROR2;PDGFC;ACTR2;TIAM1;PAK1;AP3S1;NAMPT;MET;SOCS2;EPHA7;FOXO1;PSEN1;ATP6V0A4;CRK;DNM1;SORT1;EPHB2;ANKS1B;PTK2;AP2B1;ABI1;NCF2;FGF2;FLT4;ERBB2;DDIT4;PDGFA;HSP90AA1;BCAR1;ITGB3;ACTR3;CYBA;ELMO1;AP2M1;TIAL1;ARPC1B;RASA1;SH2B2;MTSS1;FGF7;ARPC5;COL1A1;PRKD1;AHI1;POLR2J;FGF9;RET;VEGFA;ARPC4;SPRED1;CDK5R1;FES;FGFR3;NUS1;NCK1;RARRES2;STMN1;GRIN1;IL31RA;EIF2AK3;ANGPT2;BDNF;CBL;BLNK;VAV1;GFRA2;PIK3C2A;RBFOX2;APC;TYRO3;WASF2
prerank,clathrin-dependent endocytosis (GO:0072583),0.5157711000803958,1.3179374771268624,0.16089965397923875,0.8538459623683318,1.0,3/26,2.14%,DNAJC6;PICALM;FCHSD2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.49146099258806536,-1.3178970562834775,0.15935334872979215,0.4408199075892994,1.0,9/20,14.19%,NOTCH1;SMAD5;SMAD1;BMP2;RUNX2;ATF4;HIF1A;VEGFA;MT3
prerank,cardiac muscle cell action potential (GO:0086001),0.510441843659604,1.317753146207836,0.15551839464882944,0.8523004694366129,1.0,4/30,1.34%,ATP1A2;CACNA1D;ANK2;KCND3
prerank,regulation of cell growth (GO:0001558),-0.32025548929919184,-1.3175408949098957,0.02197802197802198,0.44072450723126594,1.0,52/204,16.25%,NRG3;APBB2;SLIT2;PTPRJ;LTBP4;BMPR2;AKAP6;PLCE1;CAMK2D;RTN4;TGFB2;PAK5;ACVRL1;CCN3;TFRC;NET1;SOX17;SOCS2;ENPP1;ADAM15;LGI1;PPP2R1A;RERG;SH3BP4;TGFB1;SPOCK1;AGTR1;SERTAD2;CEACAM1;BTG1;CXCL16;PPT1;H3-3A;ERBB2;FRZB;KIF26A;RPS6KA3;BCAR1;SLC25A33;MFSD2A;FAM107A;CDKN1A;JADE1;TAF9B;EI24;RPS6KA1;MT3;PTCH2;DCBLD2;RASGRP2;CCDC85B;EGLN2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5787325131493719,-1.3168404968773901,0.1425661914460285,0.4413031232540121,1.0,4/11,12.05%,LYN;MFHAS1;CYBA;TIRAP
prerank,contractile actin filament bundle assembly (GO:0030038),0.5924493159294029,1.3166578957821458,0.150093808630394,0.8518690499973736,1.0,4/15,5.59%,SORBS1;PHACTR1;FAM171A1;ARRB1
prerank,stress fiber assembly (GO:0043149),0.5924493159294029,1.3166578957821458,0.150093808630394,0.8518690499973736,1.0,4/15,5.59%,SORBS1;PHACTR1;FAM171A1;ARRB1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.5110202681186032,-1.3166393146749706,0.15098468271334792,0.44075258242283094,1.0,4/18,11.20%,SPTBN1;ACTB;AR;ZDHHC2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.5519134227673359,-1.3160882966947267,0.15384615384615385,0.4410511258899626,1.0,5/14,10.43%,SLC8A1;SLC24A2;CACNA2D1;TRPV4;ATP2B4
prerank,glycerol metabolic process (GO:0006071),0.6311446670870682,1.3158773536382087,0.20817120622568094,0.8526099912562235,1.0,4/10,16.21%,GK5;TKFC;GK;GOT1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.513722957279803,-1.3158468277937359,0.1503267973856209,0.4406287993925118,1.0,3/17,1.12%,NRP1;TEK;NTRK3
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.5099618349718384,-1.315731872459425,0.1489841986455982,0.43988666949249294,1.0,9/18,19.63%,RPS6KA5;CD200;EPHA5;RELN;LRP8;PRKD1;VEGFA;CRTC2;ADCY8
prerank,regulation of ATP metabolic process (GO:1903578),0.4626206690221707,1.315461727552287,0.1165644171779141,0.8517056745042066,1.0,10/54,16.26%,PRKAG2;GCK;AK4;NUP42;NUP98;NUP43;BEND3;OGT;SPHK2;NUP155
prerank,negative regulation of metabolic process (GO:0009892),0.45426778329785694,1.3147749730602267,0.12832550860719874,0.8522474144755003,1.0,17/54,16.30%,LGR4;LAMA4;ZNF423;ALDH1A1;NPR3;PCTP;TLR4;NOVA1;ACOT11;DOCK7;FOXC2;ADAM17;FLCN;ACVR2B;MAP2K6;NRDC;RB1
prerank,amide transport (GO:0042886),-0.45504876116233317,-1.3144592054031692,0.12980769230769232,0.4419769602461898,1.0,8/26,8.48%,ABCG2;CERT1;PLTP;SLC5A6;AQP11;SLC38A5;GLTP;DISP1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4157333094895983,1.3138856575525713,0.10416666666666667,0.8533604169404755,1.0,23/108,10.27%,WWOX;RSPO2;RNF43;WLS;NXN;PTK7;FGFR2;PRKN;DCDC2;TRABD2B;APCDD1;CXXC4;LRRK2;SULF2;VGLL4;SMARCA4;BTRC;TERT;LRP1;TLE1;CBY1;GRB10;FOXL1
prerank,protein localization to membrane (GO:0072657),-0.3227858145013894,-1.3137327818295175,0.02304147465437788,0.4425926892394264,1.0,48/187,11.47%,NLGN1;KCNIP4;DLG2;NRXN1;SPTBN1;DPP10;CACNB2;KCNB2;CAV1;BSG;ANK3;SHANK3;DPP6;EFR3B;LRRC7;CLASP2;MAP7;LIN7A;RFTN1;EPB41L3;ATP1B1;F11R;GAS6;MYO5A;EHD4;RAMP2;RAB3C;RAP1A;NKD2;FLNA;SH3GLB1;TSPAN14;PTCH1;EHD2;ITGA4;FRMPD1;RDX;PTN;RAPGEF6;FGF13;RAP2A;AGRN;ARL5A;KCNB1;ZDHHC2;NRXN2;CDH1;PACS2
prerank,brain development (GO:0007420),-0.33744641324662306,-1.3136169701102791,0.04721030042918455,0.4418296899554447,1.0,30/136,10.07%,CNTNAP2;ADGRL3;CTNNA2;ROBO2;ADGRL2;ZFHX3;CDH2;SHANK3;COL4A1;CNTN4;GRIN2B;SHROOM4;PBX3;DSCAML1;PTCH1;EPHA7;GRIN2A;HSPG2;MEIS2;RELN;PCDH18;APOD;PROX1;TUBGCP2;PPT1;RAB18;PBX1;DDIT4;UFM1;CDK5RAP2
prerank,positive regulation of cellular component movement (GO:0051272),-0.4786192754149286,-1.3136139552570176,0.13947990543735225,0.44084171590670773,1.0,9/24,15.01%,ACTN4;SPOCK2;CAVIN1;NTN1;LYN;RPS19;TWIST1;VEGFA;TUBB2B
prerank,ribosomal small subunit assembly (GO:0000028),-0.514147933990323,-1.31329901441232,0.15698924731182795,0.44061072174451515,1.0,8/16,18.84%,RPS19;RPS28;RPS15;RPS27;XRCC5;RPS5;RPSA;RPS27L
prerank,positive regulation of protein binding (GO:0032092),-0.3872040808100088,-1.3132417047658456,0.07331378299120235,0.43977439694855486,1.0,26/56,22.78%,CAV1;CLDN5;EPB41;B2M;GSK3B;TIAM1;APOE;APP;PSEN1;DACT1;BMP2;RALB;ADD2;PKD1;FKBP1A;BMP4;SPPL3;BDNF;HIPK2;MEN1;HIP1R;RAN;VTN;RPL11;TRIB3;FLOT1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.5121875624862683,-1.311856411876859,0.1388888888888889,0.4421464762164136,1.0,10/18,29.02%,CCT8;CCT2;CCT6A;NHP2;CCT7;DCP2;EXOSC10;RUVBL2;DKC1;NAF1
prerank,positive regulation of reproductive process (GO:2000243),-0.44432914864699213,-1.3111433035836977,0.11380145278450363,0.4428219637568092,1.0,12/31,21.61%,PDE3A;LHFPL2;GLRA1;PGAM4;VEGFA;CFAP69;CACNA1H;SIRT2;INHBA;SYDE1;TACR3;PRDM9
prerank,nervous system development (GO:0007399),-0.30246401678601376,-1.3108878237812498,0.0,0.44234863220051174,1.0,89/429,10.07%,LSAMP;NLGN1;ADGRL3;NRXN1;DNM3;MEF2C;ROBO2;DCLK1;MBNL1;ERBB4;SEMA6A;CDH2;ADGRG6;KIRREL3;FGF12;SLC2A1;GSN;SHANK3;SPOCK2;ST8SIA4;RBFOX1;WWP1;EPHB1;NAV3;CNTN4;CHRM3;MERTK;GRIK1;EFNA5;ADAM23;FN1;TBX3;SEMA5A;MAL;IL1RAPL2;MOBP;EVL;STAT3;NELL1;APAF1;GLRB;DNER;SERPINI1;SH3GL2;NGF;NFASC;SCN2A;JAG1;DSCAML1;APBA2;MYT1L;ZBTB16;GPM6B;MBP;SNTG2;CNTN6;PDGFC;MARCKS;RBFOX3;HES1;FKTN;MET;NRCAM;DCX;PCDH1;SRRM4;MOG;SREBF2;VCAN;LGI1;DACT1;FEZ1;RELN;EPHB2;PTPRZ1;TGFB1;SPOCK1;CHRM2;PROX1;BTBD3;PTN;ADAM22;FGF13;FGF2;PPT1;S100B;ECRG4;SLITRK1;CDK5RAP2
prerank,circulatory system development (GO:0072359),-0.3470842111325383,-1.3108873318797574,0.04964539007092199,0.4413656352400662,1.0,34/118,13.47%,MEF2C;TEK;ZFPM2;ERBB4;NTRK3;FGF12;HEG1;PLCE1;FN1;TGFB2;MICAL2;ECE1;ACVRL1;HDAC9;NOTCH1;RAMP2;TBX1;SOX17;HSPG2;STRA6;PCSK5;BMP2;TGFB1;PDLIM1;HEY2;FLT4;ID2;PKD1;RBM20;SOX18;CDKN1A;CRIP1;PDLIM3;ACVR1
prerank,platelet degranulation (GO:0002576),-0.3533594594189701,-1.3107679710361602,0.059027777777777776,0.4406704229596105,1.0,44/118,19.27%,PCDH7;ABCC4;VWF;ACTN4;PECAM1;TMSB4X;CD9;VEGFC;THBS1;ACTN1;FN1;TGFB2;GAS6;LYN;OLA1;LHFPL2;CALM1;APP;FLNA;PSAP;TGFB3;CD109;ECM1;TAGLN2;TGFB1;PDGFA;ITGB3;WDR1;FAM3C;RAB27B;PROS1;CDC37L1;VEGFA;CLU;RARRES2;ALDOA;NHLRC2;MAGED2;CLEC3B;BRPF3;MANF;QSOX1;TUBA4A;CHID1
prerank,regulation of cellular pH (GO:0030641),-0.4445061385270602,-1.310623630579288,0.12814070351758794,0.44006242521976463,1.0,6/29,12.97%,SLC4A10;SLC9A2;CA2;SLC9A6;SLC9A7;SLC9B1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.352271947988762,1.310424535513291,0.001059322033898305,0.8651430995372952,1.0,157/807,14.62%,PRDM6;AEBP1;DAB2;WWOX;BMP6;BMP7;THRB;SMAD3;TFDP2;GLIS3;WNT4;OSR1;ZIC2;FOXN3;FHL2;DDX5;MXI1;CUX1;DLG1;PPARA;FGFR2;PRKN;FOXP4;ZNF423;DNMT3A;JARID2;GLI2;FNIP1;KANK2;ZHX2;SNX6;FOXD1;ZNF568;DKK3;ARID4A;MOSPD1;HDAC8;NR2F2;KCNIP3;NCOR2;CTR9;TSHZ3;NR6A1;GLI3;MITF;SUFU;CXXC5;FOXC1;PHF21A;PCGF2;IFI27;ZBTB38;NACC2;VGLL4;LOXL3;EZR;FOXP2;CUX2;RREB1;NSD1;WWC2;OTP;SFMBT1;MAP2K5;GPS2;USP9X;CBFA2T2;LCOR;HMGA1;LBH;ZNF318;TP53;TBL1X;BHLHE41;SMURF2;RORC;NIPBL;LDB2;LDB1;FBXW11;BCOR;CBX7;MEF2A;KDM2B;SMARCA4;NR1D2;BTRC;RBM15;SPEN;TBL1XR1;CPEB3;KAT6B;KDM2A;NRG1;NUPR2;IRX1;SMARCC2;NIBAN2;PARP9;SMARCE1;HDAC4;SCML4;SIRT1;TLE1;NR2C2;HDAC1;SOX13;CBY1;LARP7;SPINDOC;ZFP90;CHMP1A;FOXC2;TCF7L2;ZNF219;ATN1;AURKB;PRDM5;AASS;RTF1;SAP18;RARG;MNT;BAHD1;WWP2;IMPACT;ZBTB1;SKOR1;CBX5;DICER1;ZNF148;UIMC1;BRD7;DEAF1;MLXIPL;ZMYM5;IRF1;FRK;KAT7;KMT5A;BEND3;SIN3A;PML;CBX6;TLE2;BCL7A;NCOR1;ZBTB32;CRYAB;SNAI1;PER2;FLCN;ACVR2B;GADD45A;ZKSCAN3;MIER3;HOXA7
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.4721429081630419,-1.3097372430326244,0.10638297872340426,0.441339050236089,1.0,6/23,6.44%,GHR;ERBB4;PTK2B;CYP1B1;NOTCH1;HES1
prerank,cellular sodium ion homeostasis (GO:0006883),0.5800708424173736,1.309477240678761,0.18864468864468864,0.8665543327332644,1.0,2/15,0.71%,ATP1A2;ATP1B3
prerank,endocrine system development (GO:0035270),0.5568252135263787,1.3092956149611903,0.18072289156626506,0.8648902964255663,1.0,4/21,3.46%,WNT4;GLI2;DKK3;TGFBR1
prerank,embryonic heart tube development (GO:0035050),-0.5432921396773139,-1.3090915929913396,0.13704496788008566,0.4418421805281451,1.0,7/14,22.25%,RYR2;SOX17;HES1;SOX18;ACVR1;NDRG4;TBX2
prerank,granulocyte chemotaxis (GO:0071621),-0.38494306486835983,-1.3089218122708417,0.08870967741935484,0.44124722510956976,1.0,13/55,20.37%,PDE4B;BSG;TGFB2;ANXA1;PPIA;PPIB;EDN1;EDN3;SCG2;CCL13;SYK;ITGB2;CCL19
prerank,sterol biosynthetic process (GO:0016126),0.4965900529697328,1.3089032957960591,0.14309210526315788,0.8639882823418352,1.0,2/33,2.51%,PRKAG2;INSIG2
prerank,muscle organ development (GO:0007517),-0.39314777633561393,-1.3085573873741636,0.09065934065934066,0.441090414170499,1.0,11/54,6.46%,UTRN;MEF2C;SGCD;COL6A3;MKX;LAMA2;TEAD4;SGCE;TBX1;SMTN;FKTN
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.5405495494634466,-1.3085490102846842,0.1703056768558952,0.44014372011945474,1.0,5/13,11.44%,LTBP1;GREM2;FBN2;BMP2;NRROS
prerank,aortic valve development (GO:0003176),-0.4290867287328558,-1.308321528006574,0.09855072463768116,0.43972013591954406,1.0,16/34,12.48%,SLIT2;ROBO2;ELN;BMPR2;NOS3;TIE1;JAG1;NOTCH1;TNFRSF1B;HEYL;NFATC1;BMP2;TGFB1;HEY2;BMP4;TWIST1
prerank,engulfment of apoptotic cell (GO:0043652),-0.5227260922812842,-1.3078326337876665,0.12933025404157045,0.43991981158207444,1.0,6/15,13.87%,RHOBTB1;XKR4;THBS1;XKR6;RHOH;ADGRB1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.5149741747279312,1.307409440419694,0.166383701188455,0.8676777774670987,1.0,13/27,24.56%,BRD8;CPA4;KAT6B;KAT7;KAT2B;CREBBP;SGF29;TAF6L;RUVBL1;EP300;BAG6;MSL3;PHF20
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.601642927098816,1.306891266505048,0.1794871794871795,0.867482432739098,1.0,3/12,4.95%,THRB;BRD8;CTSH
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5682061430845072,-1.306532142359366,0.1483050847457627,0.4420178499486233,1.0,5/11,11.37%,ZFPM2;TGFB2;JAG1;HEY2;BMP4
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.553568954577577,1.306479811173401,0.17843866171003717,0.866866318526635,1.0,4/18,3.53%,ROCK2;PICALM;EPHA4;CASP3
prerank,sodium-independent organic anion transport (GO:0043252),-0.5955292723096427,-1.306472330182585,0.15212981744421908,0.44120339356834604,1.0,7/10,29.32%,SLCO1C1;SLCO2B1;SLCO4A1;SLC16A2;SLCO5A1;SLCO2A1;SLCO1B1
prerank,generation of neurons (GO:0048699),-0.32453498784809104,-1.3052785831110376,0.020202020202020204,0.4429854548683607,1.0,42/190,10.31%,NRP1;ADGRL3;MEF2C;PTPRD;IL1RAPL1;MARK1;ASTN2;MAP1B;TGFB2;TAFA1;ASTN1;RUNX1;FUT9;NDNF;DNER;CIT;CDKL5;ACSL3;NTRK2;MYT1L;ATP2B2;MYEF2;FZD4;HES1;MET;DISC1;NRCAM;ACSL4;DCX;LHX6;RELN;HEYL;WNT9A;SIX1;SPOCK1;ATOH8;TUBGCP2;HEY2;FGF13;ERBB2;DDIT4;RUNX2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5468489919444613,1.3051683979333446,0.15328467153284672,0.8697993494709808,1.0,4/21,6.69%,PPARA;PRKN;SLC30A10;SIRT5
prerank,regulation of Rac protein signal transduction (GO:0035020),0.5774789119332788,1.3048288089333453,0.1614100185528757,0.86884153052438,1.0,3/16,6.19%,AUTS2;ALS2;ARHGAP17
prerank,regulated exocytosis (GO:0045055),-0.325464076101959,-1.3044030511154476,0.021929824561403508,0.4440045920182877,1.0,50/173,15.64%,PCDH7;ABCC4;SYT1;VWF;ACTN4;RIMS2;PECAM1;TMSB4X;CD9;SNAP25;RIMS1;VEGFC;THBS1;ACTN1;FN1;TGFB2;PCLO;GAS6;RAB31;MYH9;LYN;OLA1;LHFPL2;CALM1;APP;FLNA;PSAP;TGFB3;CD109;ECM1;TAGLN2;TGFB1;PDGFA;ITGB3;WDR1;FAM3C;RAB27B;PROS1;RAB11FIP1;RAB11FIP5;SNCA;CDC37L1;VEGFA;SDF4;SYT7;CLU;SYNGR2;RARRES2;ALDOA;NHLRC2
prerank,mesoderm development (GO:0007498),-0.5034080476330582,-1.3039872400025396,0.15172413793103448,0.4439424416333904,1.0,7/18,18.37%,TBX3;TIE1;TBX1;BMX;IKZF1;VEGFA;BTK
prerank,dendrite morphogenesis (GO:0048813),-0.43297313265023313,-1.303901446862096,0.12658227848101267,0.4431967356894426,1.0,12/35,9.13%,CTNND2;CTNNA2;DOCK10;SHANK3;KLF7;EPHB1;PAK3;MINK1;EPHB2;BTBD3;PTN;MAP6
prerank,regulation of axon extension (GO:0030516),-0.4251810451615879,-1.3033258871068159,0.12032085561497326,0.4436557198479731,1.0,12/37,14.19%,RTN4;SEMA7A;CDKL5;NTN1;SHTN1;GSK3B;APOE;NRCAM;DIP2B;SEMA3G;MAPT;MT3
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4833878204164486,1.3031666753859488,0.14705882352941177,0.8731749360746187,1.0,7/40,3.18%,BMP6;BMP7;WNT4;OSR1;KL;WNT6;BMPR1A
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.45138757962551623,1.303142435495715,0.12850812407680945,0.8709120791569523,1.0,16/58,13.34%,PAXX;POLM;BABAM2;DNTT;ATM;UVRAG;NHEJ1;RNF8;KDM2A;XRCC4;IFFO1;PRKDC;UIMC1;RAD50;NSMCE2;BABAM1
prerank,protein-DNA complex disassembly (GO:0032986),0.5621055665053417,1.3030711000753175,0.18181818181818182,0.8688371593605163,1.0,6/16,9.12%,ARID2;HMGA1;SMARCD3;SMARCA4;SMARCC2;SMARCE1
prerank,positive regulation of biosynthetic process (GO:0009891),0.47918657162617173,1.3027308838644265,0.14937106918238993,0.8679076591748585,1.0,8/40,6.42%,SORBS1;WNT4;PPARA;ZBTB20;SLC5A3;TLR4;F2;CREBL2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5026579977853173,1.3025743956239286,0.16749585406301823,0.8661578231385407,1.0,2/26,3.65%,ATP1A2;ADRA2A
prerank,receptor internalization (GO:0031623),-0.41107677232281986,-1.3019054985151266,0.10123456790123457,0.4459767147442773,1.0,14/44,13.30%,DNM3;CALCRL;CAV1;CD9;RAB31;TFRC;RAMP2;ACKR3;ITGB1;DNM1;CEACAM1;AP2M1;SNCA;RAMP1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.43655548384832954,1.301891179564587,0.10771470160116449,0.8665661124328441,1.0,17/74,10.58%,EYA1;EYA2;IGF1;EYA4;CFLAR;PHIP;TGFBR1;DDX3X;MAP2K5;SERPINE1;TERT;GDNF;HTT;RNF34;RIPK1;TCF7L2;SH3RF1
prerank,actomyosin structure organization (GO:0031032),0.431997003740515,1.3017670627689897,0.11223021582733812,0.8647677750430023,1.0,15/75,6.52%,ROCK2;ACTN2;SORBS1;CSRP3;FRMD6;PHACTR1;TMOD2;EPB41L5;MYO18A;FAM171A1;TMOD3;TPM1;KLHL41;ARRB1;CDC42BPG
prerank,triglyceride metabolic process (GO:0006641),0.4676921900524969,1.3017372268114908,0.12933753943217666,0.8626269966459366,1.0,8/48,9.35%,LPGAT1;MOGAT3;GPAT2;CPS1;GK5;GK;APOBR;SIRT1
prerank,Rho protein signal transduction (GO:0007266),0.45979122708584375,1.3011956295468667,0.1342062193126023,0.8625249865878898,1.0,16/53,12.27%,CELSR1;ARHGAP29;ROCK2;RHOD;ADRA2A;PDPN;ARHGAP6;ARHGEF11;COL1A2;ARHGEF1;EPS8L2;CTNNAL1;PHACTR4;CDC42;EPS8L1;CDC42EP1
prerank,cellular potassium ion homeostasis (GO:0030007),0.6086665438895452,1.3011752269299686,0.17716535433070865,0.86032277181506,1.0,2/13,0.71%,ATP1A2;ATP1B3
prerank,response to interleukin-4 (GO:0070670),-0.5917105591276187,-1.3011641086565195,0.1437371663244353,0.44672801471188384,1.0,1/10,0.47%,LEF1
prerank,sterol metabolic process (GO:0016125),0.4460470304463866,1.3011126831867288,0.10692771084337349,0.8582713225394648,1.0,12/60,13.25%,PRKAG2;CYP27A1;INSIG2;LIPA;CYP21A2;CYP26B1;FDXR;CLN6;SULT2B1;ARV1;TM7SF2;LBR
prerank,intracellular cholesterol transport (GO:0032367),-0.526364246376128,-1.3008519847487858,0.13729508196721313,0.44647376579496506,1.0,8/15,21.98%,ABCG1;LDLR;NPC2;STARD4;RELCH;LDLRAP1;OSBP;LRP6
prerank,insulin secretion (GO:0030073),-0.4800845944287522,-1.3008458783163044,0.1368909512761021,0.44554180295889756,1.0,4/19,12.80%,RIMS2;PTPRN2;ANXA1;RAB11FIP5
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5841503791535042,1.3008350784207228,0.1773308957952468,0.8571795949606484,1.0,3/15,7.06%,IGF1;PRKN;OPA1
prerank,renal system development (GO:0072001),0.4582944700876603,1.3007805600783289,0.125193199381762,0.8551722865104383,1.0,8/52,3.93%,ACE;LRP4;WNT4;GREB1L;GLI2;TGFBR1;FOXC1;SULF2
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.6349428893581072,1.3003168136281729,0.20408163265306123,0.8547119667658736,1.0,3/10,9.35%,JARID2;ATRX;SIRT1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.41541654101257086,-1.3002429436886898,0.1,0.4460425223750975,1.0,9/42,13.23%,MEF2C;ENG;MICAL2;TBX3;NOTCH1;SOX17;VANGL2;SOX18;AHI1
prerank,modulation by symbiont of host process (GO:0044003),-0.5854745812763661,-1.2997649647535743,0.1529175050301811,0.44613601598216296,1.0,6/10,23.94%,B2M;UBB;MRC1;PGK1;UBC;RPS27A
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5221803181451427,-1.2991549558939517,0.1504237288135593,0.4465819934400541,1.0,9/15,30.58%,RYR2;SRPRA;SRP14;SPCS1;SRPRB;ZFAND2B;EDEM1;RAB3GAP2;SEC61A1
prerank,dopamine metabolic process (GO:0042417),0.5464904306728379,1.2988680330025393,0.17328519855595667,0.8579050131662944,1.0,3/18,1.98%,MOXD1;SNCAIP;PRKN
prerank,negative regulation of chemokine production (GO:0032682),0.5893576396563102,1.298585587615504,0.18164794007490637,0.8567631399250354,1.0,2/14,5.70%,C1QTNF3;MAP2K5
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.40927568403556003,1.2984790045564296,0.10653409090909091,0.85498696550572,1.0,14/101,9.35%,FGF1;ROBO1;TPD52L1;KIT;FGFR1;ADRA2A;LRRK2;DDX3X;CAMK1;FLT1;PDGFRB;SLC27A1;CCND3;SIRT1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.49643308556639465,1.2983408516517827,0.15,0.8533268116144981,1.0,5/30,6.50%,ACE;KIT;HOXB4;FLT1;TP53
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5915826379773219,-1.2980577657379793,0.15368852459016394,0.44830313460571714,1.0,4/10,9.31%,DGKH;PRKD3;PLPP1;GAP43
prerank,neutrophil migration (GO:1990266),-0.378823161946217,-1.2974934354945182,0.10498687664041995,0.4486537115630698,1.0,27/58,37.97%,PDE4B;PECAM1;BSG;TGFB2;PPIA;PPIB;EDN1;EDN3;CCL13;SYK;ITGB2;CCL19;PRTN3;CXCL10;PIK3CD;CCL2;IRAK4;JAML;CXCL5;CCL11;CXCL1;PIP5K1C;CCL4;PF4;PPBP;CCL8;PIK3CG
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5584510887930203,-1.2967800179077722,0.164,0.44927135520706096,1.0,10/11,43.27%,STAT3;IL6ST;JAK1;JAK2;STAT4;IL27RA;IL12A;STAT1;EBI3;CANX
prerank,regulation of filopodium assembly (GO:0051489),-0.4252712393972506,-1.2962458039467677,0.1111111111111111,0.44961178837650545,1.0,16/38,16.21%,NRP1;NLGN1;TENM2;PIK3R1;MYO10;FNBP1L;PPP1R16B;TGFB3;GAP43;PLPPR5;AGRN;FXR1;DMTN;GPM6A;TRPM2;ARF6
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.3865144963224302,-1.295884359388926,0.07466666666666667,0.44952867750730535,1.0,15/52,11.24%,SPTBN1;DPP10;PRKCH;PIK3R1;EPB41;EPB41L2;STX3;PLS1;NKD2;GNAI1;ITGB1;EPHB2;EFCAB7;ATP2B4;GPER1
prerank,regulation of blood circulation (GO:1903522),0.4854293750595733,1.2956579812214388,0.15656565656565657,0.8618460694533456,1.0,5/34,5.17%,CELF2;ACE;DMPK;BDKRB2;TPM1
prerank,response to thyroid hormone (GO:0097066),0.588965954556228,1.2954095705842161,0.1963302752293578,0.8606415369960455,1.0,3/13,4.95%,THRB;BRD8;CTSH
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4822144090170435,-1.295275249519798,0.15384615384615385,0.4499024390213165,1.0,8/20,21.33%,CAMK2D;PSEN1;SELENOK;PACS2;KCTD17;THADA;BCAP31;ATP2A2
prerank,heart development (GO:0007507),-0.33140550828785953,-1.2951369581344567,0.05511811023622047,0.44923364498348034,1.0,41/150,13.77%,SGCZ;MEF2C;SGCD;FLRT2;TEK;BMP5;ZFPM2;ERBB4;NTRK3;FGF12;HEG1;BMPR2;PLCE1;FN1;TGFB2;MICAL2;ECE1;ACVRL1;HDAC9;NOTCH1;RAMP2;TBX1;SOX17;STRA6;PCSK5;BMP2;TGFB1;PTK2;PDLIM1;ID2;PKD1;FKBP1A;BMP4;RBM20;SOX18;CDKN1A;CRIP1;PDLIM3;ACVR1;MYOCD;VEGFA
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5173858376096806,-1.2939911529766106,0.18284424379232506,0.4509703471605996,1.0,5/16,10.36%,NRP1;PTPRJ;PDGFC;PDGFA;BCAR1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5404375764381445,-1.293915456070622,0.16877637130801687,0.4502254027830271,1.0,8/13,29.81%,SORL1;GCC2;TMEM30A;CD81;SEC16B;SAR1B;TMEM30B;SAR1A
prerank,regulation of integrin activation (GO:0033623),-0.5125764173503051,-1.2937352166693907,0.15766738660907129,0.4496803885467423,1.0,9/15,32.43%,RASIP1;RAP1B;PIEZO1;FBLIM1;SKAP1;KIF14;SELP;JAM3;PTGER4
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5953162037002164,1.2931016881835307,0.2188679245283019,0.8671628788027278,1.0,3/12,4.07%,PTPN14;NEDD4;IFI27
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5067110731852315,-1.2924810106831048,0.16326530612244897,0.45165859077785514,1.0,5/17,12.54%,PRKG1;MEF2C;TGFB3;GPER1;CDKN1A
prerank,positive regulation of cell differentiation (GO:0045597),0.36923413286634443,1.2918291867735725,0.054696789536266346,0.8700775536430344,1.0,43/237,12.16%,RANBP3L;DAB2;TMEM64;BMP6;BMP7;SMAD3;WNT4;IGF1;RIN2;CCN2;MEDAG;IL18;HOXB4;NPNT;ADIG;SOX5;FGFR1;BMPR1A;TGFBR1;FOXC1;PDPN;ATOH1;PPP1R13L;CAMK1;CREBL2;WWTR1;TGFBR2;MEF2A;IGFBP3;GDNF;GPRC5B;NEUROD4;NBL1;LRP3;BLOC1S6;TCF4;ABL1;SUCO;CDC42;IMPACT;NOCT;AXIN2;ATRAID
prerank,calcium ion import into cytosol (GO:1902656),-0.5299503722761977,-1.291144965477717,0.15753424657534246,0.4539117953373,1.0,5/15,10.43%,SLC8A1;SLC24A2;CACNA2D1;TRPV4;ATP2B4
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.46604817319319786,-1.2902761239016696,0.13769751693002258,0.4550428078986202,1.0,6/22,8.56%,GHR;ERBB4;CYP1B1;NOTCH1;HES1;MGAT5
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5552098575108705,1.2900066529323089,0.19337016574585636,0.8751703305461529,1.0,3/16,5.34%,APPL2;PPARA;F2
prerank,regulation of superoxide anion generation (GO:0032928),-0.5257816298133172,-1.2899996356817365,0.15592515592515593,0.4547179757543112,1.0,6/14,22.10%,TGFB1;MAPT;SYK;ITGB2;TYROBP;SOD1
prerank,negative regulation of wound healing (GO:0061045),-0.4421083883798195,-1.2897779434985561,0.1497584541062802,0.4543273672514383,1.0,11/28,10.79%,SERPINE2;CLASP2;CASK;CD34;SLC12A2;AJAP1;APOE;CD109;CRK;FGF2;EDN1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.3589552923039464,-1.2890576452888054,0.06209150326797386,0.45505957050258034,1.0,22/73,10.39%,NRP1;ITGBL1;FN1;SEMA7A;DST;PTK2B;MYH9;DOCK1;ITGB4;ITGB8;ITGB1;ADAM15;LAMA3;PTK2;CUL3;PTN;CEACAM1;TEC;CD47;ERBIN;BCAR1;ITGB3
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6007356351131413,1.2883704273241015,0.1988527724665392,0.8794786981097203,1.0,5/11,15.62%,RENBP;UAP1L1;PGM3;GNPDA1;GFPT1
prerank,glucose homeostasis (GO:0042593),0.41838835474189845,1.2880683195655793,0.1251778093883357,0.8784619066185745,1.0,12/83,9.99%,APPL2;LEPR;PPARGC1A;BACE2;PRKAA2;HK2;MCU;ADRA2A;GCK;RBP4;SIRT1;TCF7L2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5326666124412711,-1.2876391916847467,0.15644820295983086,0.45740141837483234,1.0,7/13,27.83%,B3GALT1;B3GALNT1;B3GALT5;B3GNT3;B3GNT2;B4GAT1;B3GNT6
prerank,neuron differentiation (GO:0030182),-0.3226967128008108,-1.287145717849844,0.02912621359223301,0.45763813122791286,1.0,33/165,10.31%,TENM2;MEF2C;PTPRD;IL1RAPL1;EPHA5;TENM3;TGFB2;TENM4;PBX3;RUNX1;FUT9;ATP8A2;ACSL3;UGCG;NTRK2;MYT1L;ATP2B2;MYEF2;RORB;FZD4;MET;ACSL4;VSX1;LHX6;WNT9A;SPOCK1;ATOH8;PPT1;ERBB2;PBX1;DDIT4;ID2;RUNX2
prerank,regulation of interferon-beta production (GO:0032648),0.45451493019992484,1.286357384987058,0.139937106918239,0.883010340459601,1.0,15/46,14.43%,OAS2;TLR3;TLR4;RNF135;DDX3X;TRIM56;RIPK2;MAVS;TOMM70;DHX58;PTPN11;IRF1;POLR3A;OAS3;PPM1B
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5384837260262062,1.2860337078764077,0.1950354609929078,0.8820820380498193,1.0,6/22,10.68%,AEBP1;AKAP13;MAP2;PIK3CA;ABL1;PRUNE1
prerank,regulation of fat cell differentiation (GO:0045598),0.4309672822323409,1.285951940824072,0.12371134020618557,0.8801580867062829,1.0,12/74,9.62%,TMEM64;RORA;SMAD3;MEDAG;ADIG;GPS2;TRIB2;CREBL2;WWTR1;RORC;SIRT1;LRP3
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.4081716994521895,-1.2857243394932696,0.11570247933884298,0.459900803531807,1.0,15/42,14.56%,GCNT2;VIT;NDNF;NOTCH1;FBLN2;MINK1;FZD4;CORO2B;CORO1C;SPOCK1;PTK2;EMP2;DMTN;PPM1F;LIMS1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4132583818685929,1.2847710227186573,0.1285310734463277,0.8825974535213923,1.0,14/95,9.35%,DAB2;TGFBR3;SMAD3;PPARA;SNX6;DKK3;PMEPA1;TGFBR1;SMAD6;LDLRAD4;SMURF2;TGFBR2;PDPK1;SIRT1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.457277105504669,-1.284390121552835,0.13856812933025403,0.46204287064687954,1.0,7/25,7.93%,NLGN1;MEF2C;SHANK3;SHISA6;SHISA9;MINK1;RELN
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5558526795206161,-1.2843602508825989,0.17718940936863545,0.46118882304639097,1.0,2/12,0.36%,PRKG1;MEF2C
prerank,negative regulation of hydrolase activity (GO:0051346),0.45568781893931953,1.2842635884514582,0.143317230273752,0.8824146118205038,1.0,7/49,6.81%,CPEB2;SH3RF2;LRRK2;GMIP;MAP2;BCAS3;SH2D4A
prerank,positive regulation of protein acetylation (GO:1901985),0.5885637876012046,1.2839253068076169,0.22291666666666668,0.8815980468152789,1.0,4/12,5.82%,PRKAA2;RAPGEF3;DDX3X;CAMK1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5364438002219301,1.282891774695241,0.20535714285714285,0.8836247096533651,1.0,11/20,22.89%,AMPD3;LHPP;AK3;AK4;NT5C2;AMPD2;ADSS1;GART;GMPR2;ADSL;GMPS
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5122205583612726,1.2828521807898638,0.17777777777777778,0.8815725484137755,1.0,14/27,20.37%,FBXL17;PPP1CB;TP53;SIK1;FBXL12;PML;PER2;RBM4;PER3;CRY1;CRTC1;FBXL22;MTA1;PDE6B
prerank,nucleic acid-templated transcription (GO:0097659),0.47441017934234664,1.2827095223493643,0.1456,0.8799409695677678,1.0,7/42,8.39%,THRB;POLR2A;DTX1;CREBL2;POLR2D;MEF2A;TERT
prerank,sulfur amino acid metabolic process (GO:0000096),0.5274439770213954,1.28255726302755,0.18181818181818182,0.8783864915766548,1.0,7/24,12.38%,MSRA;CPS1;MTHFR;ADI1;CTH;NOX4;MTRR
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4486886637262203,-1.2825382366203675,0.13170731707317074,0.4644912814748475,1.0,10/26,8.85%,NLGN1;NRXN1;RIMS2;SHANK3;RIMS1;PTK2B;TMEM108;APP;RELN;MTMR2
prerank,regulation of phosphatase activity (GO:0010921),0.5086557234859358,1.2824788510229082,0.1788756388415673,0.8765856450747835,1.0,4/24,8.60%,SH3RF2;SH2D4A;CDK5RAP3;HTT
prerank,synaptic vesicle exocytosis (GO:0016079),-0.4106141212110818,-1.2815791178697475,0.11627906976744186,0.46585078216871145,1.0,7/40,5.87%,SYT1;RIMS2;SNAP25;RIMS1;PCLO;UNC13B;STX3
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.4930059170005735,-1.281368965824005,0.14754098360655737,0.4654214658689613,1.0,9/18,25.02%,FLNA;ERBB2;ATF4;EIF2AK3;MAF1;UTP15;PHF8;POLR2L;LYAR
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5934676703871506,1.28084963774252,0.192090395480226,0.880887573009106,1.0,2/12,0.71%,WNK4;ATP1B3
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.5123283116154349,-1.280573387409821,0.16885964912280702,0.4663705931375047,1.0,7/15,16.34%,STOX2;TGFB2;CELF4;UBR3;SCEL;USP22;NR5A2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.5581669199549416,1.2800418189832141,0.1970260223048327,0.8819198072310105,1.0,2/16,1.27%,PPARGC1B;DDX5
prerank,epithelial cell-cell adhesion (GO:0090136),0.6095382692732504,1.2789294709081083,0.20527306967984935,0.8840381771454005,1.0,2/11,2.63%,KIT;PLEKHA7
prerank,regulation of response to biotic stimulus (GO:0002831),0.4974333938311476,1.2787025172333264,0.18493150684931506,0.8828124252494043,1.0,10/28,16.01%,APPL2;RNF135;TKFC;PTPN22;SAMHD1;DHX58;IRF1;ERAP1;ZMPSTE24;BIRC3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5845154049944968,1.2783129039817294,0.18297101449275363,0.8822587171307532,1.0,3/14,6.47%,IL18;IL17D;IL12B
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4931452646139373,1.2781463351760185,0.18604651162790697,0.8807671877872791,1.0,9/33,11.58%,UBE2E2;STXBP4;DDX3X;ANKRD17;CCND3;HYAL1;GLI1;TFDP1;ADAM17
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.524113744470829,-1.2779549761085212,0.17567567567567569,0.4716367996136705,1.0,7/14,31.45%,THBS1;PTK2;CMKLR1;RARRES2;MDK;MAPK3;CSF1R
prerank,regulation of cell-cell adhesion (GO:0022407),-0.4046195495054711,-1.2773851926164121,0.11202185792349727,0.4720795282007405,1.0,15/39,11.41%,PTPRG;PODXL;EFNA5;TENM3;FUT9;JAG1;MINK1;EPHA7;TGFB1;PTK2;CEACAM1;SMAD7;CD47;ZDHHC2;CDH1
prerank,manganese ion transport (GO:0006828),-0.5280473617688964,-1.2773463186884648,0.17819706498951782,0.4712490090178781,1.0,7/14,15.04%,ATP2C1;TRPC3;TRPC4;TRPC1;TRPC6;TRPC5;TRPC7
prerank,cellular response to lipid (GO:0071396),0.37282034503274014,1.277316704596705,0.06353240152477764,0.8818198618683109,1.0,18/191,7.12%,ATP1A2;WNT5B;RORA;ADCY5;ROCK2;TFPI;PTK7;WNT6;ADCY1;SPP1;CTR9;PABPN1;TLR4;ATM;NCOA3;LCOR;RORC;SERPINE1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5480690403715489,1.2771996052874501,0.19649122807017544,0.877996518414746,1.0,3/20,2.21%,IGF1;PRKAA2;ZBTB20
prerank,positive regulation of glycolytic process (GO:0045821),0.5480690403715489,1.2771996052874501,0.19649122807017544,0.877996518414746,1.0,3/20,2.21%,IGF1;PRKAA2;ZBTB20
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6145348186129462,1.2770258282269045,0.2275449101796407,0.8765296356160669,1.0,2/10,3.85%,UPB1;DPYD
prerank,regulation of viral genome replication (GO:0045069),0.4437242888827183,1.2768755295049081,0.14992272024729522,0.874970411880041,1.0,15/56,13.47%,PPARA;IFIT1;OAS2;PARP10;DDX3X;CD28;EIF2AK2;PLSCR1;LARP1;RSAD2;ZC3HAV1;MAVS;SRPK2;OAS3;HACD3
prerank,negative regulation of heart contraction (GO:0045822),0.5994653579937725,1.2765558511605977,0.2184557438794727,0.8741404219091876,1.0,1/11,0.08%,ATP1A2
prerank,negative regulation of secretion by cell (GO:1903531),-0.4118872639405676,-1.276497275645453,0.10459183673469388,0.47246095321451265,1.0,11/38,16.27%,STXBP6;IL1RAPL1;GRM7;NOTCH1;ANXA1;APOE;TNFRSF1B;SLC30A1;SNCA;HTR1B;ERP29
prerank,photoperiodism (GO:0009648),0.5101007063645343,1.2763604584201595,0.18006993006993008,0.872716296203315,1.0,14/28,20.37%,FBXL17;PPP1CB;TP53;SIK1;FBXL12;PML;PER2;RBM4;PER3;CRY1;CRTC1;FBXL22;MTA1;PDE6B
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.3809348446691637,-1.276282325624594,0.07871720116618076,0.47202781690474954,1.0,18/65,16.11%,HIP1;PTPRJ;CDH13;SH3KBP1;PTPN12;BCAR3;SH3GL2;CCDC88A;ARHGEF7;DAB2IP;CEACAM1;MVB12B;DUSP3;GPER1;PTPN3;SPRY1;ZFYVE28;CBL
prerank,negative regulation of protein metabolic process (GO:0051248),-0.39221127871829703,-1.2762465598325845,0.10497237569060773,0.47116671121207093,1.0,16/48,20.57%,FMN2;HSP90AB1;APOE;FLNA;LDLR;IRAK3;ITGB3;EDN1;CD84;ADGRB1;CLU;IAPP;EDNRB;SIRT2;CYP51A1;MAD2L1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.34289327061416486,1.2762361436797258,0.01037344398340249,0.8710442319786256,1.0,131/834,11.70%,EPAS1;HLF;DAB2;FGF1;WWOX;RORA;BMP6;PPARGC1B;THRB;SMAD3;TFDP2;GLIS3;AUTS2;OSR1;PPARGC1A;IGF1;RHOQ;BRD8;KMT2A;PPARA;SSBP2;CREBRF;FGFR2;PRKN;IL18;FHOD1;HOXB4;GLI2;CSRP3;GABPB1;GABPB2;HOXA1;MOSPD1;NFAT5;PCGF5;HDAC8;PHIP;NR2F2;BMPR1A;ELF1;GLI3;MITF;ARNT2;FOXC1;MLLT10;NFIB;HOXB3;VEZF1;ZBTB38;ASCL3;ZNF462;NFYB;TLR3;NHLH2;RREB1;TLR4;MEIS1;TET2;FZD5;ATM;DDX3X;ARRB1;NCOA3;CAPRIN2;MAP2K5;GPS2;CAMK1;ATRX;ABHD14B;ESRRA;HMGA1;TP53;TBL1X;BCAS3;BCLAF3;CAMTA2;WWTR1;MED12;SOX12;SERPINE1;CCNT2;SMARCD3;PLSCR1;LDB2;LDB1;LAGE3;ATAD2B;MEF2A;SMARCA4;NR1D2;HOXC4;SSBP3;TBL1XR1;KAT6B;TERT;GDNF;APLN;TMF1;JMJD6;CALCOCO1;HDAC4;GLI1;SIRT1;WASL;TFDP1;RIPK2;NR2C2;HDAC1;LARP7;ELL;RIPK1;MAVS;FOXC2;TCF7L2;TCF4;MYBL1;MED17;RBL1;GTF2F1;KMT2C;THRAP3;ABL1;NFATC3;RARG;ATF2;PRKDC;ZMIZ2;MLLT6;MYBL2;TEAD1;ZMIZ1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.4408943562750163,-1.2757676507678843,0.17307692307692307,0.47134659294051806,1.0,8/27,8.00%,SLC47A1;SLC7A5;SLC1A2;SLC1A1;SLC7A1;SLC25A13;SLC1A4;SLC38A5
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.39224483788898895,-1.2752043085859925,0.12941176470588237,0.4717721187815766,1.0,25/48,24.99%,PDE4D;AKAP6;CAMK2D;UBASH3B;PTK2B;CEMIP;CALM1;CALM2;TRPC1;CALM3;FKBP1A;JPH2;GPER1;NOS1;SNCA;SELENON;APLNR;CASQ2;GSTM2;JPH3;NPSR1;THY1;DMD;F2R;CXCL10
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3791808030487214,1.275031516278384,0.08970976253298153,0.8737575719722935,1.0,39/166,16.31%,NOTCH2;RORA;THRB;PPARGC1A;CCN2;PPARA;POLR2A;NCOR2;NR6A1;TAF1D;ESRRA;TEAD3;TBL1X;WWTR1;RORC;POLR2D;NR1D2;TBL1XR1;TEAD2;NR2C2;HDAC1;MED17;GTF2F1;RARG;TEAD1;TAF11;NR3C2;POLR1G;TBP;TAF4;NCOR1;KAT2B;BRF1;TAF7;MED23;RXRA;TAF13;CREBBP;MED26
prerank,carbohydrate homeostasis (GO:0033500),0.4281774095671172,1.2750108460668692,0.13602391629297458,0.8717392387840668,1.0,8/67,7.54%,APPL2;LEPR;BACE2;PRKAA2;MCU;ADRA2A;GCK;RBP4
prerank,dicarboxylic acid metabolic process (GO:0043648),0.4493241768253365,1.2743344316013043,0.12244897959183673,0.8721571871949504,1.0,18/52,19.92%,ME2;ADHFE1;GPT2;SLC19A1;GOT2;MTHFR;OGDH;IDH1;ALDH1L1;MTRR;ACOT8;D2HGDH;GOT1;MTHFD1;IDH2;PHYH;FOLR2;ACLY
prerank,cholesterol transport (GO:0030301),-0.40234523482413054,-1.2743058466448185,0.11142061281337047,0.4729106536097619,1.0,15/45,21.36%,CAV1;SCARB1;LIMA1;APOE;ABCG1;LDLR;NPC2;STARD5;STX12;STARD4;CLU;RELCH;LDLRAP1;OSBP;STARD3
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5217287315715367,-1.2736060195036272,0.1953781512605042,0.473599685390282,1.0,7/14,14.83%,NRP1;VEGFC;GAB1;KDR;FLT4;VEGFA;NUS1
prerank,regulation of blood coagulation (GO:0030193),-0.44601841849159396,-1.2735823674247924,0.14388489208633093,0.4727065922439306,1.0,11/27,13.12%,CAV1;ST3GAL4;SERPINE2;THBS1;FAP;CD34;APOE;EPHB2;EDN1;ENPP4;DMTN
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.48763704130445185,-1.2735289617299947,0.15611814345991562,0.4718832856028061,1.0,8/17,16.56%,SFRP4;TMEM100;ATOH8;BTG1;FGF2;BMP4;AHI1;RFX3
prerank,positive regulation of macrophage migration (GO:1905523),-0.48021457422895314,-1.273421707629321,0.17798594847775176,0.4712223854771392,1.0,5/19,15.17%,THBS1;PTK2;P2RY12;CMKLR1;RARRES2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.5011096231349635,1.273054461924157,0.17035775127768313,0.8751941819573038,1.0,5/30,6.97%,TGFBR3;SMAD3;DKK3;TWSG1;SMURF2
prerank,T cell proliferation (GO:0042098),-0.5307480978252095,-1.2725426450413029,0.17685589519650655,0.47228072366387847,1.0,3/13,10.86%,CADM1;DOCK8;MSN
prerank,regulation of cartilage development (GO:0061035),-0.4769075267754322,-1.2721514621525611,0.17687074829931973,0.47231559848112226,1.0,7/18,13.96%,BMPR2;TRPS1;ZBTB16;BMP2;BMP4;PTHLH;BMPR1B
prerank,cellular response to organic cyclic compound (GO:0071407),0.38992772734657877,1.2718531089929432,0.09542483660130718,0.8778313153336179,1.0,19/141,7.03%,ATP1A2;RORA;ADCY5;ROCK2;TFPI;SLC5A5;ADCY1;IL18;SPP1;CASP3;LRRK2;RAPGEF3;EZR;SLC26A3;NCOA3;P2RX3;TIPARP;LCOR;RORC
prerank,carboxylic acid transmembrane transport (GO:1905039),0.47439402576031386,1.2718429462114793,0.17627677100494235,0.8758042927653403,1.0,7/40,7.87%,SLC13A3;SLC38A4;SLC38A3;SLC7A11;SLC19A1;SLC27A1;SLC38A1
prerank,neuropeptide signaling pathway (GO:0007218),-0.38262269961391604,-1.2717644783728212,0.10256410256410256,0.4723215639460117,1.0,14/58,16.69%,SORCS1;SORCS3;GLRB;GLRA3;SORL1;SORT1;GLRA1;CYSLTR1;HCRTR2;CYSLTR2;GLRA2;NXPH2;NMU;CPE
prerank,chordate embryonic development (GO:0043009),0.4415087090581794,1.271545052453184,0.1540880503144654,0.8748928202435922,1.0,11/55,7.55%,ALDH1A2;BMP7;FGFR2;ZNF568;FGFR1;TGFBR1;ARNT2;SULF2;FUT8;RBP4;CHD7
prerank,outflow tract septum morphogenesis (GO:0003148),-0.4524440666847438,-1.2713796534878081,0.1415525114155251,0.4723664803760913,1.0,9/24,5.71%,NRP1;ROBO2;SEMA3C;ZFPM2;BMPR2;ENG;TGFB2;NRP2;TBX1
prerank,synapse organization (GO:0050808),-0.3350037425179906,-1.2710152342802572,0.04296875,0.4723109052673624,1.0,28/125,7.16%,NLGN1;ADGRL3;CTNND2;NRXN1;DNM3;APBB2;LRRC4C;PTPRD;CACNB2;GRM5;PPFIA2;CDH2;KIRREL3;ANK3;SHANK3;SPOCK2;GPC6;LRFN5;PAK3;GPHN;DNER;NTNG1;UNC13B;SEMA3E;APP;NRCAM;PTPRF;PSEN1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5132050643261702,1.270721513945326,0.20437956204379562,0.8760303648440795,1.0,4/24,7.27%,SORBS1;IGF1;PPP1R3B;GCK
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.48872576211349855,1.2707109381586463,0.1632996632996633,0.8740352381873189,1.0,4/31,3.65%,SYT9;SYT11;SYT12;ADRA2A
prerank,glycolipid metabolic process (GO:0006664),-0.3966445619405226,-1.2699154287304255,0.10880829015544041,0.47408228648446227,1.0,11/47,10.37%,ST6GALNAC3;ST3GAL4;ESYT2;UGCG;PSAP;GLTP;ST3GAL6;HEXB;ST8SIA6;B3GALNT1;ESYT3
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.44722480639102724,-1.2695249129907769,0.1493212669683258,0.47402973175493285,1.0,8/26,11.01%,PDE8A;PTPN12;IQGAP1;DAB2IP;EEF1A1;STAT5B;ERBB2;DUSP3
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.43612590550729285,1.2686181747805174,0.1424287856071964,0.8798809571795434,1.0,6/61,9.69%,PRKAG2;PPARA;NCOR2;SIRT5;SIRT1;AZIN1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.58618718582329,1.2683172502668059,0.20555555555555555,0.8789908449963169,1.0,4/14,7.34%,IL18;IL12B;TGFBR2;PTPN22
prerank,regulation of acute inflammatory response (GO:0002673),-0.48749123542172357,-1.2681620884952471,0.17391304347826086,0.47635683311149724,1.0,3/18,7.80%,OSMR;IL6ST;PTGES
prerank,cellular response to ketone (GO:1901655),0.4746981860353718,1.2679595018579803,0.18167456556082148,0.8783636622216943,1.0,4/35,2.52%,ADCY5;ROCK2;ADCY1;SPP1
prerank,positive regulation of heart contraction (GO:0045823),0.5265389443142647,1.2679071696610957,0.19473684210526315,0.8765529991121889,1.0,1/19,0.08%,ATP1A2
prerank,neutrophil activation involved in immune response (GO:0002283),-0.28926955350909866,-1.2678418582391298,0.0,0.47615992968881155,1.0,104/428,19.59%,PTPRB;ATP8A1;PTPRJ;PECAM1;GSN;SNAP25;LRRC7;ATP6V0A1;CST3;ADGRE5;IQGAP1;B2M;FTH1;APAF1;ATP11A;HMOX2;NFASC;RAB31;PTPRN2;HSP90AB1;PRG2;GPI;ACTR2;PPIA;RAP1B;PTPRC;RAP1A;CD93;STK10;CTSD;PSAP;CTSC;RAB27A;TSPAN14;HSPA8;TIMP2;PSEN1;TNFRSF1B;DYNLL1;PGLYRP1;NPC2;SLC44A2;FTL;CKAP4;OSTF1;MME;EEF1A1;HEXB;CTSB;STOM;CEACAM1;PSMD14;CRACR2A;CD47;DOCK2;RAB18;CD44;HSP90AA1;CYBA;IMPDH1;XRCC5;GOLGA7;CTSS;ENPP4;HRNR;SLC2A3;ARPC5;TNFAIP6;LRG1;SRP14;PGAM1;FABP5;TMEM30A;QPCT;SCAMP1;DOK3;RAB6A;TRPM2;ALDOA;CCT8;APEH;PKM;CAT;CCT2;PDXK;STXBP3;SVIP;SYK;RAB37;GCA;CYB5R3;C3AR1;PSMD11;CTSZ;ITGB2;CAND1;SLC27A2;QSOX1;TMEM63A;EEF2;SPTAN1;PSMD2;ATP11B;TYROBP
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.529381913579315,1.2677515435506255,0.22202486678507993,0.8751060146273566,1.0,3/20,2.05%,ATP1A2;ATP1B3;LACC1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.43987993527451025,-1.2674629265197201,0.13725490196078433,0.4761259938962182,1.0,8/28,18.53%,ANK3;CEMIP;MTCL1;ERBB2;KCNB1;DMTN;GDI1;ITGB2
prerank,transition metal ion transport (GO:0000041),-0.4115649627841985,-1.2671062924349812,0.1382716049382716,0.4760861168378566,1.0,14/35,15.04%,ATP2C1;FTH1;TFRC;TRPC3;TRPC4;TRPC1;TRPC6;ATOX1;SLC30A1;SLC31A1;MT3;TRPC5;TTYH1;TRPC7
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.45430505465298177,-1.2664501562013193,0.15402298850574714,0.47667861882177015,1.0,11/25,26.29%,HIP1;RTN4;BCAR3;CCDC88A;GPER1;CBL;HIP1R;AGT;HAP1;PLAUR;CNOT9
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.3186629762381857,-1.2661348880054237,0.05454545454545454,0.47658139026386603,1.0,25/151,8.20%,ST3GAL4;ELOVL7;CERT1;SGMS1;PLA2G4A;SGMS2;ELOVL5;ACER3;PRKD3;ACER2;GPHN;PPM1L;PLPP1;CEPT1;SPTLC2;DEGS2;SPNS2;APOE;GCH1;B4GALT5;SLC44A5;PAM;PCSK5;SLC44A2;LPCAT2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5536131936849797,-1.2659675632806853,0.19421487603305784,0.4760680070531924,1.0,3/11,13.88%,ANXA1;SMAD7;SOCS5
prerank,cellular response to chemical stress (GO:0062197),0.4053095662881902,1.2659448375293505,0.11707988980716254,0.8799690906911656,1.0,17/96,10.63%,CPEB2;MSRA;PPARGC1A;PRKAA2;MGAT3;LRRK2;SESN2;SOD3;ATM;DDX3X;ALDH3B1;NOX1;SOD2;PIK3CA;NOX4;ATG7;ABL1
prerank,neutrophil degranulation (GO:0043312),-0.28815923837369406,-1.2647787740432277,0.0,0.47798068186847054,1.0,103/425,19.59%,PTPRB;ATP8A1;PTPRJ;PECAM1;GSN;SNAP25;LRRC7;ATP6V0A1;CST3;ADGRE5;IQGAP1;B2M;FTH1;APAF1;ATP11A;HMOX2;NFASC;RAB31;PTPRN2;HSP90AB1;PRG2;GPI;ACTR2;PPIA;RAP1B;PTPRC;RAP1A;CD93;STK10;CTSD;PSAP;CTSC;RAB27A;TSPAN14;HSPA8;TIMP2;PSEN1;TNFRSF1B;DYNLL1;PGLYRP1;NPC2;SLC44A2;FTL;CKAP4;OSTF1;MME;EEF1A1;HEXB;CTSB;STOM;CEACAM1;PSMD14;CRACR2A;CD47;DOCK2;RAB18;CD44;HSP90AA1;CYBA;IMPDH1;XRCC5;GOLGA7;CTSS;ENPP4;HRNR;SLC2A3;ARPC5;TNFAIP6;LRG1;SRP14;PGAM1;FABP5;TMEM30A;QPCT;SCAMP1;DOK3;RAB6A;TRPM2;ALDOA;CCT8;APEH;PKM;CAT;CCT2;PDXK;STXBP3;SVIP;RAB37;GCA;CYB5R3;C3AR1;PSMD11;CTSZ;ITGB2;CAND1;SLC27A2;QSOX1;TMEM63A;EEF2;SPTAN1;PSMD2;ATP11B;TYROBP
prerank,retrograde axonal transport (GO:0008090),-0.49608280329996535,-1.2645037732700066,0.18421052631578946,0.47773720763132077,1.0,3/16,4.92%,DLG2;DST;TMEM108
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5525090185799407,1.264299384292353,0.21052631578947367,0.884429600009545,1.0,4/16,9.67%,ACE;KLK2;ADM;SPX
prerank,regulation of protein transport (GO:0051223),-0.4356407823614552,-1.264187089533069,0.16957605985037408,0.47752066559463424,1.0,10/27,18.42%,STXBP5L;DNAJC1;HSPA8;DISP1;NDFIP2;GAPVD1;PPM1F;DNAJA1;P3H1;PTPN1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.616591032611241,1.2635910723440138,0.22896281800391388,0.8850520310438398,1.0,3/10,3.86%,ATP1A2;OSR1;NEDD4
prerank,mRNA splice site selection (GO:0006376),0.4968704985511224,1.2629379660241078,0.18877551020408162,0.8856694130299475,1.0,11/30,20.07%,CELF2;SRSF5;PRPF39;KHDC4;LUC7L3;SFSWAP;PSIP1;SRSF1;SRSF10;SNRPC;SF1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.414761030132613,1.2628837746636385,0.13343108504398826,0.8838361385505804,1.0,16/87,12.27%,FGF1;FGFBP1;FGFR2;KL;POLR2A;FRS2;FGFR1;HNRNPH1;FLRT1;TIA1;POLR2D;HYAL1;FIBP;GTF2F1;KLB;PTPN11
prerank,ear morphogenesis (GO:0042471),0.5332467671751073,1.2628772277153695,0.19152854511970535,0.8818469384442709,1.0,6/20,8.37%,OSR1;FGFR2;HOXA1;NIPBL;CHD7;ZIC1
prerank,sulfur compound transport (GO:0072348),0.501708668955688,1.2625992003725102,0.1724137931034483,0.8808764307452372,1.0,5/27,7.86%,SLC13A4;SLC6A13;SLC35F3;SLC27A1;SLC26A1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4182306092432887,-1.2619467605313541,0.1417910447761194,0.48181612725963635,1.0,8/35,8.92%,MEF2C;PTPRM;CAV1;THBS1;CAV2;APOE;ATOH8;XDH
prerank,regulation of microglial cell activation (GO:1903978),0.5676000906140827,1.2618304306506496,0.22043010752688172,0.8818073031957755,1.0,2/15,2.32%,SYT11;SPHK1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5373097925065232,1.2615297713206022,0.1967509025270758,0.880952227220935,1.0,8/18,14.02%,DDX5;NCOR2;TP53;TERT;RIPK1;MAP2K1;NCOR1;MAP2K2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4548697393147417,1.2609229649802596,0.17452830188679244,0.8812796427631596,1.0,6/43,3.18%,BMP6;BMP7;WNT4;IGF1;NPNT;BMPR1A
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5356510315967311,1.260849632697064,0.20341880341880342,0.8795719886457011,1.0,7/20,15.30%,TNRC6A;MOV10L1;TNRC6B;MOV10;AJUBA;TNRC6C;WTIP
prerank,amino sugar biosynthetic process (GO:0046349),0.5694985128060301,1.2598437204217272,0.22037037037037038,0.8814244236482487,1.0,5/12,15.62%,RENBP;UAP1L1;PGM3;GNPDA1;GFPT1
prerank,oligosaccharide metabolic process (GO:0009311),-0.3942608207202431,-1.2591560263336279,0.12432432432432433,0.48758032502878956,1.0,15/46,17.10%,ST6GALNAC3;ST3GAL4;ST8SIA4;FUT9;ST6GAL2;ST8SIA1;ST6GALNAC5;B3GALT1;ST3GAL6;ST8SIA6;B3GALT5;MAN1B1;AMY1A;AMY1B;AMY1C
prerank,regulation of transport (GO:0051049),-0.4057293154586415,-1.258953974354394,0.13131313131313133,0.4870977867501754,1.0,14/36,16.82%,NRP1;ICA1;ACTB;EPB41;ACTG1;REEP5;WWC1;MYO6;GAPVD1;SNCA;PINK1;FES;ICA1L;DNAJA1
prerank,regulation of protein localization to cell surface (GO:2000008),0.47440191267006143,1.2589451951688082,0.1793570219966159,0.8828589134760335,1.0,3/33,1.42%,ACTN2;LEPROT;PICALM
prerank,macroautophagy (GO:0016236),0.39333830257873914,1.2588293392647325,0.1308016877637131,0.8812775013072169,1.0,28/118,18.19%,PRKAG2;PRKAA2;PRKN;MTMR3;PRKAG3;LAMP2;ATG10;UVRAG;ATG5;WIPI1;AMBRA1;LIX1L;TOMM70;BECN1;ATG7;CSNK2A2;CSNK2A1;VIPAS39;MFN2;ACBD5;VPS37A;SNF8;VPS4A;SNX14;CHMP4C;ZFYVE1;SQSTM1;MFN1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.5373850943839173,-1.2581967666979603,0.17894736842105263,0.4880070679270948,1.0,7/12,27.83%,B3GALT1;B3GALNT1;B3GALT5;B3GNT3;B3GNT2;B4GAT1;B3GNT6
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.5294430763109289,1.2580532247541565,0.19924098671726756,0.8823195692257114,1.0,7/19,15.62%,RENBP;UAP1L1;PGM3;GNPDA1;SLC35D1;GMPPB;GFPT1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.4695475996200545,1.2578498118156747,0.17054263565891473,0.8811297462654614,1.0,6/39,9.99%,NNAT;NLGN2;MCU;GCK;RBP4;TCF7L2
prerank,response to muramyl dipeptide (GO:0032495),-0.5234252211975373,-1.257828003142749,0.1921487603305785,0.48802500275959154,1.0,7/12,18.20%,NOD1;ARHGEF2;ERBIN;VIM;NOD2;TRIM41;IRF5
prerank,visual system development (GO:0150063),0.472459381797117,1.2577037256707382,0.19023569023569023,0.8797892230623499,1.0,5/37,7.54%,SMOC1;FOXC1;MEIS1;SH3PXD2B;RBP4
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.524195061569519,-1.2575620614816405,0.18376068376068377,0.4877303014154596,1.0,9/13,29.81%,SORL1;TMEM30A;BCAP31;CD81;SEC16B;SAR1B;EDEM1;TMEM30B;SAR1A
prerank,negative regulation of translation (GO:0017148),0.41287276883177865,1.2575065476685197,0.13578500707213578,0.8785783056724912,1.0,13/87,10.36%,CPEB2;ROCK2;CPEB4;IGF2BP1;DDX3X;EIF2AK2;SAMD4A;LARP1;CPEB3;IGF2BP2;CNOT10;LSM14A;YTHDF3
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.385984703295765,1.2574399602319155,0.11914323962516733,0.8769302530194377,1.0,23/128,11.82%,TGFBR3;BMP6;BMP7;SMAD3;APPL2;PRKCZ;DDX5;ARHGEF18;BMPR1A;TGFBR1;SMAD6;RGMB;USP9X;TWSG1;SMURF2;TGFBR2;COL1A2;CDH5;SIRT1;ZFYVE16;ZMIZ2;ZMIZ1;GDF15
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5213191043029368,-1.257306356128315,0.19801980198019803,0.48743472717148256,1.0,5/12,26.86%,SNAP25;STX3;STX1B;SNAP23;STX1A
prerank,muscle cell differentiation (GO:0042692),0.4867613991529736,1.257267743968787,0.19001610305958133,0.8757161343070594,1.0,5/32,3.63%,WNT5B;RORA;NEBL;DUSP29;SPEG
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5811672632458674,1.2572589911228946,0.22138836772983114,0.873835958142838,1.0,2/12,1.76%,PPARGC1A;PPARA
prerank,response to iron ion (GO:0010039),0.5905821011312699,1.2572488388878058,0.226691042047532,0.8719577064541352,1.0,1/12,0.40%,BMP6
prerank,regulation of protein secretion (GO:0050708),0.38731890911029365,1.2565502854106376,0.12880886426592797,0.872649775972008,1.0,20/119,9.70%,BMP6;CACNA1D;FRMD4A;ITPR2;IGF1;ITPR1;KCNA5;ADRA2A;MYO18A;RAPGEF3;EZR;DPP4;CACNA1C;IL12B;GCK;EIPR1;DNM1L;GOLPH3L;RSAD2;PICK1
prerank,RNA metabolic process (GO:0016070),0.38738119209912986,1.2564003804301258,0.11612903225806452,0.8713083638518753,1.0,31/127,16.46%,CELF2;POLR2A;RBMS2;TP53RK;PCBP2;PABPN1;HNRNPR;HNRNPH1;DDX3X;SIDT2;HNRNPA2B1;POLR2D;LAGE3;ATXN2;RBM39;EXOSC7;NOVA1;SND1;TENT2;RBMS1;TBRG4;GTF2F1;HNRNPL;DICER1;WTAP;HNRNPC;SNRNP40;RBM4;TFIP11;HNRNPM;PAPOLG
prerank,regulation of myelination (GO:0031641),-0.440371203981726,-1.2558889609006663,0.1705607476635514,0.48983053865954257,1.0,11/25,24.20%,TENM4;JAM2;TNFRSF1B;PTPRZ1;TNFRSF21;PTN;EIF2AK3;TPPP;SIRT2;LGI4;KIF14
prerank,cardiac muscle tissue development (GO:0048738),0.44463601310168477,1.2556716805231176,0.17530487804878048,0.8722549682742091,1.0,11/50,9.63%,NOTCH2;BMP7;GJB6;CSRP3;AKAP13;BMPR1A;ADAMTS9;SIK1;RBP4;NRG1;CBY1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4444570246556677,-1.255462699429413,0.15945330296127563,0.4898705182654246,1.0,5/24,1.96%,NRP1;NLGN1;TENM2;PIK3R1;FNBP1L
prerank,acidic amino acid transport (GO:0015800),0.5520140322855207,1.2554243699529897,0.23649906890130354,0.8713015381452832,1.0,2/17,0.37%,SLC6A13;SLC6A1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3538379591594696,1.2553098100693951,0.06390532544378698,0.8697836716668099,1.0,74/327,16.35%,DENND4A;RORA;PPARGC1B;FOXN3;TULP3;PPARGC1A;NFYC;SSBP2;POLR2A;ZNF423;CXXC1;CRABP2;CTR9;MITF;SUFU;TGFBR1;ARNT2;FOXC1;ZBTB38;NFYB;RREB1;BNC2;NSD1;IFNK;WWC2;ASCC2;SBNO1;ATRX;ESRRA;HMGA1;CREBL2;TP53;WWTR1;SOX12;LDB1;CHD7;NR1D2;KAT6B;TEAD2;TCF7;NSD3;NR2C2;SOX13;CCAR1;ZNF219;MYBL1;AJUBA;ABL1;ZKSCAN5;ATF2;MLLT6;SKOR1;MYBL2;ZMIZ1;HES6;MLXIPL;PHF1;KMT2D;KAT7;NFIA;DNM2;PML;ACVR2B;CELSR2;ATXN1L;APBB3;ACVR1B;WTIP;MED23;MZF1;TGIF2;RB1;CREBBP;GPBP1L1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.545416048652543,1.2553091501716058,0.19854280510018216,0.8678990250297651,1.0,6/16,14.03%,KMT5C;KMT5B;PARP9;PRKDC;PNKP;SMCHD1
prerank,regulation of BMP signaling pathway (GO:0030510),-0.35633414869246305,-1.2553074766051977,0.12171052631578948,0.4893389485146413,1.0,21/73,14.15%,BMPER;BMPR2;ENG;HTRA3;ACVRL1;VWC2;NOTCH1;VWC2L;SFRP4;SMAD5;SORL1;SMAD1;CCN1;BMP2;PCSK6;SMAD7;BMP4;LEMD3;UBE2D3;BMPR1B;SMURF1
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.28590601729362575,-1.2550935549106859,0.008130081300813009,0.4888759889291372,1.0,94/348,14.40%,NRP1;LIMCH1;GHR;PTPRJ;RPS6KA5;TEK;BMP5;ERBB4;NTRK3;CAV1;PECAM1;PDE8A;BMPR2;ENG;RASSF2;VEGFC;NPTN;NIBAN1;EFNA5;TGFB2;IQGAP1;PTK2B;BCAR3;GAS6;NGF;ACVRL1;CEMIP;TFRC;NTRK2;HSP90AB1;KRAS;ARHGEF2;KDR;LYN;TBX1;PDGFC;PPIA;PAK1;CALM1;PTPRC;RAP1A;APP;CALM2;CARD14;PLCG2;LIMK2;TGFB3;CSPG4;SEMA4D;RELN;CCN1;BMP2;TGFB1;PTK2;RALB;DDRGK1;TEC;FGF2;FLT4;RAP2A;FNIP2;ERBB2;CAMKK2;CD44;PDGFA;HSP90AA1;ITGB3;ATP2B4;CALM3;ENPP2;GPER1;FXR1;BMP4;XRCC5;ILK;TNKS1BP1;FAS;CDKN1A;NOS1;MMD;PFN2;AXIN1;LRP8;FGF7;SNCA;PRKD1;ACVR1;FGF9;VEGFA;TXN;PINK1;TERF2IP;MT3;P2RY1
prerank,positive regulation of insulin secretion (GO:0032024),0.4726959273477045,1.2550632747235166,0.179080824088748,0.8669570518048498,1.0,7/36,9.99%,NNAT;NLGN2;MCU;GCK;RBP4;PLA2G6;TCF7L2
prerank,T cell receptor signaling pathway (GO:0050852),-0.3214874111058379,-1.2547178781555242,0.06437768240343347,0.488886213248401,1.0,49/138,27.70%,PDE4D;PDE4B;PTPRJ;PIK3R1;RFTN1;PAK3;INPP5D;PSMB2;PAK1;PTPRC;PLCG2;MAP3K7;MOG;TNFRSF21;PSMD14;TEC;PSMC6;BCAR1;EIF2B3;IKBKB;RBCK1;SPPL3;BTN3A3;NCK1;PSMA4;NFKBIZ;PSMB9;SKAP1;SKP1;PSMD11;PSMB10;PRKCQ;PSMD2;TXK;CD276;FYN;PSMA2;THY1;RELA;STOML2;PSMB3;PIK3CD;PLCG1;ICOSLG;PSMB5;LCP2;CARD11;PSMA7;EIF2B2
prerank,anterior/posterior pattern specification (GO:0009952),0.44038410791909854,1.2545289309354373,0.16486902927580893,0.8670658695712586,1.0,11/53,8.07%,WLS;HOXB4;HOXB6;HOXC6;TGFBR1;HOXB3;HOXB9;HOXA3;HOXB5;BHLHE41;HOXC4
prerank,positive regulation of cell migration (GO:0030335),-0.302070317636933,-1.2543899279916548,0.033112582781456956,0.48871089442782684,1.0,73/253,13.77%,NRP1;LEF1;SEMA3C;ACTN4;SEMA6A;NTRK3;SEMA6D;CDH13;CAV1;PECAM1;ITGA6;BMPR2;GCNT2;PODXL;RTN4;THBS1;CLASP2;FN1;TGFB2;CXCL12;SEMA5A;SEMA7A;STAT3;CARMIL1;GAB1;PTK2B;ACTG1;F3;CEMIP;NOTCH1;ARHGEF7;SEMA3E;DOCK1;SHTN1;ARHGEF2;KDR;ROR2;PDGFC;DAB2IP;TIAM1;PAK1;PTPRC;PLCG2;SEMA4D;ITGB1;VSIR;EPHB2;CCN1;PPP3CA;BMP2;MYOC;HSPA5;TGFB1;PTK2;MGAT5;RDX;DDRGK1;CXCL16;PDGFA;BCAR1;EDN1;ENPP2;TWIST2;GPER1;FAM107A;SEMA3D;SEMA3G;HIF1A;DMTN;COL1A1;ACVR1;RET;VEGFA
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4775722823209153,1.2537792879416232,0.17567567567567569,0.8679617125970325,1.0,9/34,13.78%,LGR4;CD300A;TLR3;TLR4;GPS2;RAB7B;LY96;LRRC14;ACOD1
prerank,response to steroid hormone (GO:0048545),0.4803531679915425,1.2536558710842756,0.1865546218487395,0.8665996950760783,1.0,4/31,3.37%,ATP1A2;TFPI;PAQR7;CATSPERD
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5444330265113806,1.2534461578868374,0.20943396226415095,0.8655757400557584,1.0,2/17,1.91%,ANK2;SNTA1
prerank,cellular response to alkaloid (GO:0071312),-0.49410234233806605,-1.2530499386415854,0.18706697459584296,0.4911070657413415,1.0,8/17,22.82%,SLC8A1;RYR2;RYR3;HTR1B;CASP6;CASQ2;GSTM2;BLM
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.45899477674290645,-1.25263472726157,0.18820861678004536,0.4911325797314784,1.0,9/21,9.18%,NOS3;PTK2B;GAS6;NOTCH1;ASPN;ENPP1;ECM1;TGFB1;HEY2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5199240562964081,1.252397983378693,0.2152777777777778,0.8675870781362396,1.0,3/23,2.21%,IGF1;PRKAA2;ZBTB20
prerank,central nervous system neuron differentiation (GO:0021953),-0.41961374962890285,-1.2516861869603255,0.17105263157894737,0.49247462121332003,1.0,8/33,12.71%,GRID2;MDGA2;TOX;NTRK2;SPOCK1;PROX1;CTNNB1;MAPT
prerank,positive regulation of T cell activation (GO:0050870),-0.36025365131691434,-1.2511383995028886,0.12209302325581395,0.49284837476240545,1.0,21/62,23.72%,VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;PTPRC;DOCK8;CD47;RHOH;NCK1;NOD2;PRKCQ;CCL19;LGALS9;PYCARD;MDK;CD86;CD276;CD81;THY1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.4306565664100277,-1.2509359106240567,0.16136919315403422,0.4924410324111644,1.0,12/27,20.68%,UTRN;FGF12;CAMK2D;FXYD5;NEDD4L;ATP2B4;PTPN3;NOS1;SCN2B;FXYD6;COMMD1;SCN1B
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3346587433644645,1.2502569580630378,0.012257405515832482,0.8736826656317465,1.0,188/1082,13.69%,EPAS1;HLF;DAB2;FGF1;WWOX;RORA;BMP6;PPARGC1B;BMP7;THRB;SMAD3;TFDP2;GLIS3;AUTS2;WNT4;OSR1;ZIC2;PPARGC1A;PICALM;IGF1;RHOQ;BRD8;KMT2A;PPARA;SSBP2;CREBRF;FGFR2;PRKN;IL18;FHOD1;ZNF423;CREB5;HOXB4;GLI2;CSRP3;NPAS3;CXXC1;SPP1;GABPB1;GABPB2;HOXA1;MOSPD1;NFAT5;PCGF5;HDAC8;PHIP;NR2F2;BMPR1A;ELOF1;ELF1;GLI3;MITF;TGFBR1;ARNT2;FOXC1;MLLT10;NFIB;CAND2;HOXB3;VEZF1;ZBTB38;ASCL3;ZNF462;NFYB;CREB3L2;TLR3;NHLH2;RREB1;RGMB;TLR4;MEIS1;NSD1;TET2;FZD5;ATM;DDX3X;TRIM56;ARRB1;NCOA3;CAPRIN2;MAP2K5;GPS2;CAMK1;ATRX;ABHD14B;ESRRA;HMGA1;LBH;CREBL2;ZNF318;TP53;TBL1X;BCAS3;BCLAF3;AFAP1L2;CAMTA2;WWTR1;ARHGEF11;RORC;MED12;SOX12;SERPINE1;CCNT2;SMARCD3;PLSCR1;LDB2;LDB1;LAGE3;FBXW11;ATAD2B;ELF2;MEF2A;SMARCA4;NR1D2;HOXC4;BTRC;SSBP3;TBL1XR1;KAT6B;ZIC1;GDNF;TMF1;JMJD6;SMARCC2;TEAD2;NIBAN2;CALCOCO1;PARP9;HDAC4;GLI1;SIRT1;WASL;TFDP1;NSD3;RIPK2;NR2C2;HDAC1;ELL;RIPK1;MAVS;ZFP90;FOXC2;TCF7L2;TCF4;MYBL1;MED17;RBL1;GTF2F1;SCAF8;KMT2C;THRAP3;ABL1;DYRK1A;NFATC3;RARG;ATF2;PRKDC;ZMIZ2;MLLT6;MYBL2;MSANTD1;TEAD1;ZMIZ1;PHF5A;CCDC62;HOXB2;BRD7;FOXA2;DEAF1;MLXIPL;WDR43;IRF1;KMT2D;KAT7;ZXDC;EDRF1;PBX4;ZBTB48;FOXJ2;DHX33;NFIA;SIN3A;DNM2;MAP2K1;MLLT11;ATF6B;PML;PTOV1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5934764524317433,1.2500975733602635,0.24169741697416974,0.8723897751143751,1.0,3/11,7.34%,TGFBR3;TGFBR1;TGFBR2
prerank,synaptic vesicle membrane organization (GO:0048499),-0.48146956586494544,-1.2487916614578491,0.170995670995671,0.49677837592388696,1.0,10/17,35.68%,SNAP25;STX3;SYNGR2;STX1B;SNAP23;AP3D1;STX1A;SYP;SYNGR1;PRRT2
prerank,neuron remodeling (GO:0016322),-0.5569230923913535,-1.2484926413851796,0.18789144050104384,0.4965966780547447,1.0,7/10,26.26%,ADGRB3;APP;SCARF1;C1QA;ANKS1A;RND1;C3
prerank,positive regulation of embryonic development (GO:0040019),0.5325168025895637,1.2483750895150572,0.22508591065292097,0.8771582438925956,1.0,5/19,12.32%,WNT4;OSR1;NIBAN2;NR2C2;FOXA2
prerank,positive regulation of cell growth (GO:0030307),-0.3445295655233985,-1.2480600974235019,0.10689655172413794,0.4967254436768761,1.0,24/96,14.15%,SYT1;RIMS2;AKAP6;RIMS1;TGFB2;SEMA7A;CDKL5;NGF;NEDD4L;NTN1;SHTN1;SEMA4D;LGI1;CXCL16;H3-3A;ERBB2;RPS6KA3;SLC25A33;EDN1;MFSD2A;MAPT;TAF9B;RPS6KA1;SMURF1
prerank,signal transduction by p53 class mediator (GO:0072331),0.47252716152766283,1.2480536941784688,0.20672268907563024,0.8764493902407462,1.0,5/30,6.50%,DDX5;FHIT;SESN2;ATRX;TP53
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5368537504215478,1.247948399678872,0.20517560073937152,0.8749999516975043,1.0,3/16,4.75%,ATP1A2;ANK2;CACNA1C
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.586399269887066,1.2478370058430392,0.22960151802656548,0.8735220821886619,1.0,2/11,7.83%,GNAT2;GNAT3
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.4636131843060469,-1.2478337847856629,0.17209302325581396,0.49641389280558385,1.0,5/20,9.63%,FAR2;ACSL3;ACSL4;PPT1;SCD
prerank,cellular response to fluid shear stress (GO:0071498),-0.5330306973499489,-1.2476111368597078,0.21670428893905191,0.4960785485556568,1.0,4/12,12.92%,MEF2C;SREBF2;KLF2;MTSS1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.42312768895976416,-1.2475198039333923,0.15180722891566265,0.4954114223748577,1.0,10/31,14.98%,CTNNA2;MEF2C;CDH2;HDAC9;CDON;ID2;BOC;CTNNB1;MYOCD;MAPK12
prerank,cellular calcium ion homeostasis (GO:0006874),-0.32435549495772226,-1.2474654074067788,0.0622568093385214,0.4946531035199112,1.0,39/133,12.96%,SLC8A1;CAV1;SLC24A2;RYR2;CAMK2D;NPTN;HTR2C;STIM2;CXCL12;TPT1;ATP2C1;ATP1B1;SLC35G1;CAV2;TRPC3;YWHAE;ATP2B2;TRPC4;MICU3;SLC10A7;HTR2A;TRPC1;TRPC6;PSEN1;CALR;ATP2A3;TRPV4;ATP2B4;EDN1;PTH1R;GPER1;SELENOK;SMDT1;PACS2;HCRTR2;ATP2B1;EDN3;SLC30A1;MCUB
prerank,regulation of hydrolase activity (GO:0051336),-0.35693425956154085,-1.2473811232262113,0.13583815028901733,0.493937566477101,1.0,17/71,8.88%,PRKG1;CHN2;CAV1;FGD5;EPHA5;EFNA5;CHN1;RASIP1;NTRK2;DAB2IP;CRK;PLXNC1;ARHGAP15;PTK2;RDX;PLXNA4;RAPGEF6
prerank,anterior/posterior axis specification (GO:0009948),0.5552159308376946,1.2469637975980317,0.22659176029962547,0.8750061665347009,1.0,2/15,5.39%,WLS;FZD5
prerank,positive regulation of binding (GO:0051099),-0.34319344705136295,-1.246950252830715,0.08571428571428572,0.49415538561740957,1.0,34/84,20.74%,CAV1;CLDN5;EPB41;B2M;NGF;GSK3B;TIAM1;APOE;APP;HES1;MET;PSEN1;DACT1;BMP2;RALB;ADD2;PKD1;FKBP1A;BMP4;TXN;SPPL3;STMN1;HIPK2;DHX9;KDM4D;MEN1;SIRT2;CLN5;HIP1R;RAN;VTN;HMBOX1;RPL11;EDF1
prerank,long-term memory (GO:0007616),-0.4738504756138348,-1.2466452697558794,0.18052256532066507,0.49393541953734965,1.0,5/19,13.90%,APOE;LDLR;RASGRF1;CAMK4;SHANK1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.38335671436794794,1.24660984742559,0.12632978723404256,0.8745284683329209,1.0,21/112,11.82%,WWOX;TGFBR3;SMAD3;APPL2;WNT4;PRKCZ;ARHGEF18;SOX5;BMPR1A;TGFBR1;SMAD6;USP9X;TWSG1;TGFBR2;COL1A2;CDH5;SIRT1;CRKL;ZMIZ2;ZMIZ1;GDF15
prerank,snRNA metabolic process (GO:0016073),0.5350010645150873,1.246425488142627,0.20075757575757575,0.8734305836264022,1.0,9/17,21.65%,INTS10;INTS2;INTS5;INTS3;INTS7;INTS1;INTS8;INTS4;TUT1
prerank,neutral amino acid transport (GO:0015804),-0.4388304209250218,-1.246340194695993,0.17225950782997762,0.4937940037274548,1.0,10/28,12.52%,SLC6A6;SLC1A5;SLC7A5;SLC38A6;SLC1A1;SLC1A4;SLC38A5;SLC43A2;SLC6A7;SLC43A1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.556455606973866,-1.2462187945799037,0.19668737060041408,0.49317032946727385,1.0,4/10,19.19%,BASP1;BMP4;PAX2;PAX8
prerank,phospholipid translocation (GO:0045332),-0.43919745719637976,-1.2459420500533827,0.18686868686868688,0.49294952643941353,1.0,10/28,14.29%,ATP10A;ATP8A1;ATP8B1;ATP11A;ATP8A2;ATP11C;MFSD2A;TMEM30A;ATP8B2;ABCB4
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.3698754147176478,-1.244928201463863,0.11878453038674033,0.49451785322938147,1.0,14/52,11.24%,SPTBN1;DPP10;PRKCH;PIK3R1;ATP2C1;ACSL3;STX3;PLS1;NKD2;ITGB1;EPHB2;ATP2B4;ZDHHC2;GPER1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.4819382267779547,-1.244844791292665,0.18666666666666668,0.4938265501303029,1.0,8/18,28.14%,CHRM3;CHRM2;AGRN;CDK5R1;GNB1;OPRM1;RGS10;RGS8
prerank,sensory organ development (GO:0007423),0.4398393738249298,1.2448115966892466,0.184,0.8775060036360298,1.0,7/51,7.55%,SMOC1;SHROOM2;FOXC1;MEIS1;SH3PXD2B;RBP4;CHD7
prerank,primary alcohol metabolic process (GO:0034308),0.49555614082864635,1.2442024600501251,0.22410865874363328,0.8779916690583033,1.0,5/25,7.54%,IGF1;NAPEPLD;NAAA;DHRS3;RBP4
prerank,receptor metabolic process (GO:0043112),-0.37897378372471274,-1.243925014414385,0.12266666666666666,0.49500051228862463,1.0,21/53,19.16%,DNM3;CALCRL;CAV1;CD9;RAB31;TFRC;RAMP2;SH3GLB1;ACKR3;ITGB1;DNM1;TGFB1;AP2M1;SNCA;RAMP1;SMURF1;EHD3;SYK;ITGB2;ARRB2;LDLRAP1
prerank,regulation of cell communication (GO:0010646),-0.4098979120023429,-1.2434234769059416,0.13138686131386862,0.49538222285087424,1.0,10/35,7.77%,SLC8A1;RYR2;CAMK2D;MGLL;UGCG;ANXA1;TBX18;SOCS2;CRK;YWHAG
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.44820537142872413,1.243319145762633,0.1900958466453674,0.8794348711819767,1.0,6/47,7.27%,C1QTNF3;ROCK2;WNT4;SIK1;SLC27A1;GCK
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5112870374409388,1.2431756756648609,0.19744058500914077,0.8780995273947434,1.0,6/23,8.24%,TULP3;GLI3;SUFU;MGRN1;BTRC;IFT122
prerank,DNA methylation (GO:0006306),0.5143077947691336,1.2430836814075672,0.20446735395189003,0.8766218018203524,1.0,12/23,24.16%,DNMT3A;ATRX;PICK1;MTRR;BEND3;EHMT2;EHMT1;KMT2E;METTL4;N6AMT1;DMAP1;PPM1D
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5674821314013674,1.243015053768589,0.25,0.8750464698304277,1.0,5/13,12.23%,ATG10;ATG7;UBA6;DESI1;DESI2
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.44296352164820707,-1.2426547459664103,0.1623529411764706,0.49634322747616005,1.0,5/24,10.94%,ANK3;CEMIP;MTCL1;ERBB2;KCNB1
prerank,positive regulation of nervous system process (GO:0031646),-0.4782330446117695,-1.2425239710701768,0.1951219512195122,0.4957152892861578,1.0,5/18,7.20%,RIMS2;RIMS1;TENM4;UNC13B;TNFRSF1B
prerank,Golgi localization (GO:0051645),0.5781466321887105,1.2424802559154533,0.23217922606924643,0.8751778317177632,1.0,6/11,20.24%,TBCCD1;UVRAG;CDC42;ARHGAP21;HOOK3;RIPOR1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5658472010528708,1.2424315229068659,0.22857142857142856,0.8735444443279444,1.0,5/14,8.39%,ATRX;ACD;TPP1;TNKS2;TERT
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.43833969413560353,-1.2424144575294003,0.19775280898876405,0.4951082343425055,1.0,4/24,5.34%,SLIT2;CXCL12;CCN3;LYN
prerank,regulation of gene expression (GO:0010468),0.33085645219261767,1.2422826411741588,0.019689119170984457,0.8724312918246624,1.0,147/903,12.87%,PRDM6;DENND4A;NOTCH2;FGF1;ROBO1;RORA;BMP6;PPARGC1B;BMP7;AFDN;SLC24A3;SMAD3;ROCK2;ANK2;WNT4;OSR1;FOXN3;TULP3;PPARGC1A;PICALM;IGF1;NFYC;PRKAA2;SSBP2;AFF3;WNT6;PRKN;POLR2A;ZNF423;SON;CXXC1;FOXD1;TNRC6A;CRABP2;CTR9;BMPR1A;ZC3H7B;MITF;SUFU;TGFBR1;ARNT2;FOXC1;SNRNP70;PARP10;DTNBP1;PCBP2;ZBTB38;PABPN1;MBNL2;ZNF462;NFYB;TLR3;EZR;PARP14;SMO;CTSH;CUX2;RREB1;BNC2;TLR4;NSD1;IGF2BP1;HNRNPH1;IFNK;ATM;DDX3X;WWC2;ASCC2;SBNO1;TIPARP;ATRX;AFF4;BRAF;ESRRA;CLK4;CD28;HMGA1;CREBL2;IL12B;TP53;WWTR1;SOX12;TOB2;PTPN22;PLSCR1;LDB1;CHD7;TNRC6B;NR1D2;RBL2;LARP1;KAT6B;TERT;GDNF;HRG;APLN;IGF2BP2;NOVA1;CDH5;TEAD2;CALCOCO1;PARP9;HDAC4;SIRT1;C1D;TCF7;TLE1;NSD3;NR2C2;HDAC1;SOX13;LRP3;UBR5;CCAR1;MOV10;DHH;ZNF219;MYBL1;RBL1;CRKL;PIK3R3;AJUBA;SRPK2;ABL1;PRDM5;ZKSCAN5;ATF2;C1QTNF1;HNRNPL;WWP2;MLLT6;SKOR1;NOCT;HMG20B;MYBL2;GLMN;DICER1;ZNF148;HES6;ATRAID;MLXIPL;FLOT2;TDG;PHF1;SNX12;KMT2D;KAT7
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5640543900812094,1.2420093642299046,0.2199248120300752,0.8716531369082016,1.0,2/14,2.00%,PRKCZ;IL18
prerank,myelin maintenance (GO:0043217),-0.5487370853065597,-1.2417621222080657,0.2079002079002079,0.4957926181128402,1.0,6/10,23.09%,EPB41L3;ABCD2;PRX;CLU;SOD1;CXCR4
prerank,regulation of axon guidance (GO:1902667),-0.564248149760861,-1.2416262973940637,0.21711899791231734,0.4952470802685431,1.0,4/10,15.01%,NRP1;MYCBP2;VEGFA;TUBB2B
prerank,liver development (GO:0001889),0.4780764404687775,1.2416209246478482,0.1930116472545757,0.871310588922865,1.0,2/32,1.03%,TGFBR3;WNT4
prerank,positive regulation of nuclear division (GO:0051785),0.4892193158123945,1.2415009420427046,0.22631578947368422,0.8699704345798849,1.0,4/25,6.37%,IGF1;PHIP;CD28;PDGFRB
prerank,positive regulation of neurogenesis (GO:0050769),-0.35469336022462433,-1.2413850557462376,0.1157556270096463,0.49494481766043547,1.0,20/68,12.06%,SLIT2;PTPRD;ROBO2;IL1RAPL1;SHANK3;NPTN;CDKL5;NGF;NTRK2;TIAM1;DISC1;SERPINF1;PLXNC1;MME;PLXNA4;MAP6;NAP1L1;SLITRK1;GPER1;CTNNB1
prerank,cell-matrix adhesion (GO:0007160),-0.3371062442782248,-1.2413658873910378,0.07407407407407407,0.4941061468674988,1.0,25/95,12.49%,ITGBL1;PPFIA2;THSD1;PTPRK;ACTN1;PEAK1;FN1;VCAM1;CD34;ARHGEF7;ITGB4;SGCE;TIAM1;BCAM;ITGB8;MSLN;ITGB1;ADAM15;ITGA4;ITGA8;CD44;ITGB3;PKD1;ILK;EMP2
prerank,primary miRNA processing (GO:0031053),0.6004830309849318,1.2412414353880503,0.27755905511811024,0.8691607915452685,1.0,2/10,7.11%,SMAD3;HNRNPA2B1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4251364233984163,1.2410643390300018,0.18055555555555555,0.8680797183220559,1.0,19/63,16.59%,WWOX;IGF1;CFLAR;PHIP;FGFR1;DEPTOR;TGFBR1;BID;HTT;RIPK1;TCF7L2;SH3RF1;TMC8;ITGAV;PML;AGTR2;LGALS3;BIRC6;SP100
prerank,regulation of phosphate metabolic process (GO:0019220),-0.4961418375375967,-1.2410559758634119,0.20465116279069767,0.4940086014329584,1.0,8/16,18.70%,PSEN1;IKBKB;SMG5;PGAM1;SRPX2;BARD1;SIRT2;TIGAR
prerank,negative regulation of cell motility (GO:2000146),-0.3320613455205638,-1.2408239085413737,0.09774436090225563,0.4936694583639082,1.0,19/108,4.48%,TMEFF2;FRMD5;SLIT2;LIMCH1;DACH1;PTPRJ;CLIC4;CLDN5;MCTP1;ENG;NAV3;PTPRK;SPOCK3;PTPRT;SRGAP1;ADARB1;ACVRL1;CYP1B1;JAG1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5278788330360483,1.240798340904403,0.20113851992409867,0.8672478480420012,1.0,3/18,6.47%,IGF1;IL18;IL12B
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.5518069874489421,-1.2407661243160872,0.21193415637860083,0.4929369606833057,1.0,4/10,26.53%,HSPA5;ATF4;EIF2AK3;CCL2
prerank,keratinocyte differentiation (GO:0030216),-0.4161403357480465,-1.2401663087198664,0.17067307692307693,0.49346770656989253,1.0,9/29,21.92%,CLIC4;JAG1;UGCG;ANXA1;TXNIP;SCEL;EXPH5;WNT16;ASAH1
prerank,regulation of mitochondrial fission (GO:0090140),0.5104748077769257,1.2392808945000842,0.20426287744227353,0.8708558805179176,1.0,8/24,11.94%,PRKN;MCU;LRRK2;STAT2;MYO19;DNM1L;CYRIB;RALBP1
prerank,negative regulation of proteolysis (GO:0045861),0.4608095659852226,1.2386748805911452,0.17781402936378465,0.8713831681015407,1.0,7/34,6.96%,TIMP3;EPHA4;LRRK2;GAS1;F2;TM4SF20;KNG1
prerank,calcium ion transmembrane transport (GO:0070588),0.3972528910317397,1.2383587888754182,0.1486111111111111,0.8708085472862999,1.0,12/86,7.30%,TRPM3;CACNA1D;SLC24A3;TRPM6;SLC8A3;MCU;CACNA1C;SLC25A23;MICU1;CACNB3;TRPM5;ANO6
prerank,pore complex assembly (GO:0046931),0.5291210742213022,1.238349145385003,0.22263450834879406,0.8690784766449888,1.0,4/19,10.91%,AFDN;PLEKHA7;ANO6;NUP98
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.48352976247492946,-1.2381023944926284,0.20935412026726058,0.497621450383783,1.0,3/17,4.11%,ANK3;AKAP6;KCNAB1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.530026974773175,1.2380227075836174,0.2247787610619469,0.8685418378557832,1.0,1/18,0.08%,ATP1A2
prerank,regulation of autophagy (GO:0010506),0.3582331263950765,1.2379912516364793,0.08684863523573201,0.8669529184699779,1.0,24/216,7.47%,PRKAG2;RNF152;LEPR;ITPR1;PRKAA2;PRKN;SNX6;MTMR3;PRKAG3;NUPR1;GPR137;CASP3;ATP6V0E1;TPCN1;LRRK2;NEDD4;SNX32;FZD5;ATM;WDR41;NPRL2;ATP6V0B;PTPN22;PIP4K2C
prerank,"phototransduction, visible light (GO:0007603)",0.5507683067336743,1.237754742402338,0.2239089184060721,0.8660307369537751,1.0,2/14,5.76%,ABCA4;RHO
prerank,fatty acid transport (GO:0015908),0.5454547143997484,1.2376638664241362,0.20404411764705882,0.8646343560582583,1.0,4/17,7.36%,ACSL1;SLC5A8;SLC27A1;GOT2
prerank,chondrocyte differentiation (GO:0002062),0.4673713023224334,1.237527819439201,0.19117647058823528,0.8634051047805015,1.0,6/32,4.64%,WNT5B;OSR1;SOX5;NFIB;SULF2;CREB3L2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4594515541392339,-1.2370088849973222,0.18793503480278423,0.49923347137669793,1.0,8/20,13.90%,NLGN1;SHANK3;APOE;PSEN1;RELN;LLPH;LRP8;SHANK1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5065120061747548,-1.2367246886770908,0.18640350877192982,0.4990438347103538,1.0,3/14,12.33%,THBS1;IRAK3;CMKLR1
prerank,cell junction organization (GO:0034330),0.4184080684573229,1.23664960152888,0.14411764705882352,0.8648140476577818,1.0,9/71,3.91%,SDK1;SLC6A1;SMAD3;LRP4;SDK2;SLC8A3;PKHD1;NLGN2;PPFIA1
prerank,epithelium development (GO:0060429),0.38688441227126963,1.2365896776741752,0.1483957219251337,0.8633230838391159,1.0,13/107,8.24%,ALDH1A2;WNT4;OSR1;ERRFI1;FGFR2;KANK2;DAG1;CPT1A;LOXL3;SMO;TPP1;BDH2;IFT122
prerank,regulation of vasculogenesis (GO:2001212),-0.5138521285738186,-1.2364773638480164,0.2184873949579832,0.49875798672177074,1.0,9/14,15.16%,CD34;KDR;RAP1A;TMEM100;CEACAM1;XDH;HEY2;EMP2;RRAS
prerank,regulation of T cell proliferation (GO:0042129),-0.3629314371489942,-1.2359236726797223,0.10495626822157435,0.49921206163244164,1.0,9/61,8.57%,VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;PTPRC;TNFRSF1B;TNFRSF21
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.344259994477028,1.2351217371089729,0.07949308755760369,0.8668963375372225,1.0,81/366,16.39%,DENND4A;RORA;PPARGC1B;FOXN3;TULP3;PPARGC1A;NFYC;SSBP2;POLR2A;ZNF423;CXXC1;CCNA2;CRABP2;CTR9;MITF;SUFU;TGFBR1;ARNT2;FOXC1;ZBTB38;NFYB;RREB1;BNC2;NSD1;IFNK;WWC2;ASCC2;SBNO1;ATRX;ESRRA;DSCC1;ANKRD17;HMGA1;CREBL2;TP53;WWTR1;SOX12;LDB1;CHD7;ATXN2;NR1D2;KAT6B;TEAD2;TCF7;NSD3;NR2C2;SOX13;CCAR1;ZNF219;MYBL1;AJUBA;ABL1;ZKSCAN5;ATF2;MLLT6;SKOR1;MYBL2;HES6;MLXIPL;PHF1;KMT2D;KAT7;NFIA;ORC3;DNM2;PML;ACVR2B;TSC1;CELSR2;ATXN1L;APBB3;ACVR1B;WTIP;MED23;MZF1;EHMT2;TGIF2;RB1;CREBBP;GPBP1L1;SMC3
prerank,mitochondrion organization (GO:0007005),0.3697757414037818,1.2350911067265922,0.10143042912873862,0.8652755149298788,1.0,51/165,19.96%,TRAK1;PPARGC1A;HK2;PRKN;CHCHD3;GABPB1;IFIT2;PYROXD2;BID;LRRK2;AFG1L;SAMM50;MIGA2;ESRRA;SIRT5;CLUH;NIPSNAP2;OPA1;TIMM44;MEF2A;MTFR2;TWNK;TERT;SIRT3;TMEM11;DNM1L;SSBP1;ADCK1;CXADR;TOMM70;NDUFS1;SIRT4;DNM2;MFN2;ATP5F1D;RAB29;PITRM1;TIMM10;FMC1;SLC25A36;MSTO1;MTX2;MTFP1;TRAK2;MFN1;RHOT1;TIMM17B;RAB5IF;AFG3L2;ATP7A;WDR81
prerank,potassium ion import across plasma membrane (GO:1990573),0.45027468480147614,1.2347712160595354,0.18971061093247588,0.8647369295880523,1.0,3/41,0.87%,ATP1A2;ATP1B3;KCNJ13
prerank,presynapse assembly (GO:0099054),-0.4827432201622811,-1.2343621247236476,0.21123595505617979,0.5018848407753069,1.0,5/16,3.66%,NLGN1;PTPRD;IL1RAPL1;LRRTM3;PCLO
prerank,purine ribonucleotide transport (GO:0015868),-0.47694079566637393,-1.2336996305842245,0.19956140350877194,0.5025047046466301,1.0,3/16,3.31%,ABCC4;LRRC8C;LRRC8D
prerank,artery development (GO:0060840),-0.4393501129140549,-1.2336451484640307,0.1828978622327791,0.5017647231595532,1.0,10/23,9.52%,NRP1;ROBO2;BMPR2;ENG;ACVRL1;TBX1;HES1;STRA6;SMAD7;PDE2A
prerank,potassium ion transport (GO:0006813),0.3804156180745523,1.2330248258539487,0.14325068870523416,0.8693693975687162,1.0,8/120,1.93%,ATP1A2;KCNK2;SLC24A3;ATP1B3;KCNJ13;KCND3;KCNA5;LRRC38
prerank,necroptotic process (GO:0070266),0.5377774201542045,1.232802293732686,0.23224568138195778,0.8684948551498328,1.0,5/16,10.97%,TLR3;TLR4;DNM1L;RIPK1;LY96
prerank,adenine nucleotide transport (GO:0051503),-0.4760949775641681,-1.2327998341422102,0.18223234624145787,0.5028646623000222,1.0,3/17,3.31%,ABCC4;LRRC8C;LRRC8D
prerank,cellular response to oxygen levels (GO:0071453),0.5930260507473631,1.2323858019356468,0.23461538461538461,0.8683638633856673,1.0,4/10,20.56%,CPEB4;PICK1;ATP6V0D1;CCDC115
prerank,actin filament bundle assembly (GO:0051017),0.46252956637422016,1.2319583628702055,0.2031496062992126,0.8682692799738048,1.0,6/33,6.38%,PAWR;SHROOM2;RHOD;EZR;BAIAP2L1;BAIAP2
prerank,protein localization to cell periphery (GO:1990778),-0.3133720074905777,-1.2314236262790024,0.06938775510204082,0.5053048555022007,1.0,37/133,12.49%,KCNIP4;SPTBN1;DPP10;CACNB2;KCNB2;CAV1;BSG;ANK3;DPP6;EFR3B;CLASP2;MAP7;LIN7A;EPB41L3;ATP1B1;F11R;GAS6;MYO5A;EHD4;RAMP2;RAB3C;RAP1A;NKD2;FLNA;TSPAN14;PTCH1;EHD2;RDX;RAPGEF6;FGF13;RAP2A;KCNB1;ZDHHC2;CDH1;PACS2;IKBKB;EMP2
prerank,atrioventricular valve development (GO:0003171),-0.5010349996582468,-1.2313182670441716,0.19957081545064378,0.5047191826419115,1.0,9/14,21.11%,BMPR2;TGFB2;NOTCH1;HEYL;BMP2;ACVR1;APLNR;ZFPM1;SLIT3
prerank,positive regulation of B cell activation (GO:0050871),-0.37416266966557166,-1.2308805468300974,0.1388888888888889,0.5049377267997586,1.0,13/50,18.37%,MEF2C;SH3KBP1;TFRC;CD38;PTPRC;EPHB2;HMCES;TIRAP;NOD2;CD74;SYK;IRS2;BTK
prerank,regulation of multicellular organism growth (GO:0040014),-0.47883917466333603,-1.2304178987329986,0.20412371134020618,0.5051789220053989,1.0,6/15,10.92%,GHR;APP;PTCH1;PPIB;STAT5B;MFSD2A
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3834593390062533,1.2301111830045164,0.1394422310756972,0.8734090357947125,1.0,15/129,8.65%,RNF220;LRRK1;LGR4;WLS;PTK7;FGFR2;LRRK2;DDX3X;CAPRIN2;TBL1X;SMURF2;TNKS2;ADGRA2;TBL1XR1;GPRC5B
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.4473641789909144,-1.2300881830129091,0.19130434782608696,0.505038416427437,1.0,8/21,19.13%,PPP1R16B;YWHAE;GSK3B;YWHAB;MFHAS1;FKBP1A;CRY2;PPP1R11
prerank,regulation of fibroblast migration (GO:0010762),-0.4601644337007644,-1.2300824295995219,0.17817371937639198,0.5042132498017492,1.0,9/20,9.38%,PRR5L;THBS1;ARHGEF7;ITGB1;CORO1C;TGFB1;PTK2;GNA12;FGF2
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.47154655163452985,-1.2287936596605433,0.20638297872340425,0.5062933058677904,1.0,7/18,8.63%,LTBP1;CD200;FN1;TGFB2;CD34;ITGB8;PTGS2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.3948245528545014,-1.2280684931053505,0.16071428571428573,0.5072259068891899,1.0,13/36,13.77%,ENG;RASSF2;PPP2R5A;PDGFC;CALM1;CALM2;EPHA7;ENPP1;RAP2A;PDGFA;CALM3;TNKS1BP1;VEGFA
prerank,positive regulation of axonogenesis (GO:0050772),-0.3916395851269422,-1.2280596079535202,0.16034985422740525,0.5063923044339216,1.0,14/43,9.95%,SLIT2;ROBO2;SEMA7A;CDKL5;NGF;NTRK2;NTN1;SHTN1;TIAM1;SEMA4D;PLXNC1;PLXNA4;MAP6;SLITRK1
prerank,sulfation (GO:0051923),0.5909936885794946,1.2278550311314735,0.24427480916030533,0.8797837994534351,1.0,2/11,9.11%,UST;SULT2B1
prerank,regulation of vasoconstriction (GO:0019229),-0.4288623388248074,-1.2273348038792495,0.16341463414634147,0.5073002156578945,1.0,9/27,12.72%,CAV1;BMPR2;CHRM3;ADRA1B;ECE1;KCNMB2;AGTR1;ATP2B1;ACE2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5132820159789547,-1.2272170794705217,0.19875776397515527,0.5067485127660792,1.0,4/13,8.86%,NRP1;NRP2;PLXNC1;PLXNA4
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.40397476422568745,-1.2270171645768397,0.1671018276762402,0.5063992923443394,1.0,17/34,21.93%,NRP1;CARMIL1;ARHGEF7;DOCK1;FLNA;CRK;LIMS2;MYOC;CALR;ILK;DMTN;LIMS1;MYADM;CSPG5;S100A10;RAC3;MDK
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5017137220716053,-1.2266097158877562,0.22653061224489796,0.5065493135240485,1.0,9/14,26.53%,THBS1;ITGA4;GPER1;ECSCR;PDCD4;RGCC;CD40;PLCG1;CCL2
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5389558490692224,-1.2263845910466011,0.2297872340425532,0.506121968236885,1.0,3/11,9.15%,PTPRC;CEACAM1;SMAD7
prerank,response to calcium ion (GO:0051592),-0.3277052926192576,-1.2262801998564488,0.09027777777777778,0.5055812256649769,1.0,19/102,7.04%,NLGN1;MEF2C;SYT1;CAV1;CLIC4;KCNMA1;RYR2;CAMK2D;THBS1;IQGAP1;KCNMB2;RYR3;TRPC3;SLC25A13;CPNE8;CALM1;CALM2;PLCG2;TRPC1
prerank,negative regulation of phagocytosis (GO:0050765),0.5338933393679947,1.2261990047379814,0.2351851851851852,0.883992661559517,1.0,4/17,7.38%,SYT11;CD300A;FER1L5;PLSCR1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.4907940106749032,1.2260179245480212,0.21853146853146854,0.8829536383908646,1.0,10/23,24.41%,CASP3;DNASE1L1;FBH1;DICER1;DFFB;DFFA;DNASE1L2;CECR2;REXO4;H1-0
prerank,T cell mediated immunity (GO:0002456),-0.5036508056953652,-1.2257174744489956,0.19911504424778761,0.5059999303624864,1.0,4/13,14.73%,CADM1;JAG1;EMP2;BTN3A3
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5493907593719912,1.2251383114237884,0.24952380952380954,0.8844273507937914,1.0,3/14,9.53%,PPARGC1A;SIRT1;SLC45A3
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.43933835207381666,1.2247352159096447,0.17884914463452567,0.8842354614041688,1.0,5/45,3.89%,BMP7;SMAD3;TOM1L2;FOXC1;GAS1
prerank,stabilization of membrane potential (GO:0030322),0.5149948836745919,1.2244781935029894,0.2326007326007326,0.8834573096157012,1.0,1/16,0.26%,KCNK2
prerank,SNARE complex assembly (GO:0035493),-0.5344401397363596,-1.223856019163945,0.2350597609561753,0.5096269471846065,1.0,2/10,4.59%,STXBP6;VAMP4
prerank,positive regulation of viral genome replication (GO:0045070),0.4810184526295105,1.223798430913025,0.22110552763819097,0.8841514947228001,1.0,8/29,13.47%,PPARA;TOP2B;IFIT1;DDX3X;CD28;LARP1;SRPK2;HACD3
prerank,negative regulation of neuron projection development (GO:0010977),0.4271406820328849,1.2237526451464296,0.19374068554396423,0.8826024254647986,1.0,10/56,8.38%,EFNB2;LRP4;LPAR1;EPHA4;PTPN9;NGEF;RUFY3;CBFA2T2;PTEN;DENND5A
prerank,negative regulation of cell cycle process (GO:0010948),0.4179544618554356,1.2230950659409288,0.17834394904458598,0.8832511169036837,1.0,15/61,16.92%,BMP7;TFDP2;TOM1L2;PCGF2;MGA;TFDP1;NME6;AURKB;RBBP8;CBX5;WAPL;EHMT2;VPS4A;EHMT1;CHMP4C
prerank,cellular response to interleukin-15 (GO:0071350),-0.5028931047923084,-1.2229742365258467,0.20930232558139536,0.5100203202526508,1.0,3/13,9.41%,STAT3;STAT5B;JAK1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.5028931047923084,-1.2229742365258467,0.20930232558139536,0.5100203202526508,1.0,3/13,9.41%,STAT3;STAT5B;JAK1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4947627983573923,1.2227888336888988,0.2336283185840708,0.8826343255512816,1.0,4/22,3.53%,ROCK2;PICALM;EPHA4;CASP3
prerank,myelin assembly (GO:0032288),-0.5433564391972934,-1.2225210161497153,0.2392638036809816,0.5101818659248858,1.0,3/10,3.60%,CD9;TENM4;EPB41L3
prerank,negative regulation of cell communication (GO:0010648),-0.45875516263436256,-1.22231025510454,0.20754716981132076,0.5098898822020126,1.0,9/21,25.57%,UBASH3B;HHIP;GLRA1;KIF26A;ACVR1;SOCS5;PTPN1;OPRM1;ERBB3
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3945301298828316,1.2222893045912195,0.16096866096866097,0.8828024480301765,1.0,16/87,9.36%,NOTCH2;CELSR1;ROCK2;RHOQ;RHOBTB2;RHOD;ARHGAP18;RAPGEF3;EZR;ARHGAP17;PDGFRB;BAIAP2;RICTOR;PIK3CA;HRG;LRP1
prerank,positive regulation of phosphorylation (GO:0042327),-0.29049047081125673,-1.2218024348554204,0.030864197530864196,0.5102030220955316,1.0,68/240,14.68%,NRP1;LIMCH1;TEK;ERBB4;NTRK3;PECAM1;ITGA6;PDE8A;ROR1;ENG;EPHB1;VEGFC;THBS1;NPTN;EPHA5;MERTK;NIBAN1;EFNA5;EPHA6;TIE1;GAS6;TFRC;NTRK2;KRAS;KDR;LYN;ROR2;TBX1;AR;PPIA;PAK1;APP;MET;CARD14;LIMK2;EPHA7;SEMA4D;PSEN1;EPHB2;CCN1;BMP2;BTBD10;TGFB1;PTK2;RALB;FGF2;FLT4;RAP2A;ERBB2;CAMKK2;HSP90AA1;ITGB3;GPER1;FXR1;BMP4;ILK;FAS;PFKFB1;HIF1A;AXIN1;FGF7;FGF9;RET;VEGFA;PINK1;MT3;P2RY1;FGFR3
prerank,positive regulation of bone mineralization (GO:0030501),0.46579829111409876,1.2206148050027201,0.21911037891268534,0.8872914740370322,1.0,6/35,3.18%,BMP6;BMP7;WNT4;OSR1;KL;BMPR1A
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5501713422717261,1.2204414469628284,0.2547892720306513,0.8862421085803304,1.0,5/13,15.62%,RENBP;UAP1L1;PGM3;GNPDA1;GFPT1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.49649746590718374,1.2203503753831877,0.24738675958188153,0.8848572620414147,1.0,4/24,5.65%,ROCK2;ERRFI1;FOXC1;NCOA3
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4415351818883117,1.2202968313778244,0.2,0.8833531446411952,1.0,6/46,5.16%,DUSP29;FBLN1;TIMP3;DLG1;EZR;TLR4
prerank,regulation of myoblast differentiation (GO:0045661),0.46395249300635816,1.2201453814193026,0.20385232744783308,0.8822075664590499,1.0,1/32,0.01%,RANBP3L
prerank,cholesterol efflux (GO:0033344),-0.4518838319612124,-1.2199889402888666,0.19080459770114944,0.5137017732512642,1.0,5/20,11.29%,SCARB1;APOE;ABCG1;NPC2;STX12
prerank,mitochondrial membrane organization (GO:0007006),0.47395931342538994,1.219658754596918,0.23333333333333334,0.8823545138569924,1.0,10/32,18.19%,CHCHD3;SAMM50;OPA1;TMEM11;MICOS10;MFN2;MICOS13;IMMT;MTX2;MFN1
prerank,macrophage activation (GO:0042116),-0.40025176627412984,-1.2191510647004575,0.18048780487804877,0.514865603512379,1.0,13/34,19.15%,FOXP1;CD93;APP;PLCG2;DYSF;SBNO2;MAPT;SNCA;CLU;LBP;SYK;ITGB2;C1QA
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.31011524353862724,-1.2189955011996882,0.09090909090909091,0.5143680239427653,1.0,36/149,14.95%,PRKCH;RPS6KA5;CAV1;ROR1;IL1RAP;STAT3;MID2;NOD1;TFRC;NFKBIA;ARHGEF2;TNFRSF11A;AR;PPIA;TRAF5;APP;RPS3;CARD14;MAP3K7;RTKN2;DDRGK1;IRAK3;TRIM14;ERC1;TRIM27;TIRAP;IKBKB;AIM2;PRKD1;RBCK1;CARD16;TERF2IP;TRIM37;CLU;UBB;MTDH
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.42170797402075166,-1.2187992371200416,0.20512820512820512,0.5140420745233477,1.0,11/27,14.38%,PDE4D;CACNB2;AHNAK;CAMK2D;YWHAE;CALM1;CALM2;FKBP1A;JPH2;NOS1;SELENON
prerank,positive regulation of ERAD pathway (GO:1904294),-0.5116806739474296,-1.2186449586736308,0.22269807280513917,0.5135647945097708,1.0,5/13,26.54%,CAV1;USP13;BCAP31;UBQLN2;TMEM259
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.4483125171809461,-1.218334964914853,0.2354368932038835,0.5134314139608389,1.0,17/22,47.49%,PSMB2;PSMA4;PSMB9;PSMB10;PSMA2;PSMB3;PSMB5;PSMA7;PSMA5;ENC1;PSME4;PSMB8;PSMB11;NFE2L2;PSMB1;PSMB7;PSMA8
prerank,smooth muscle tissue development (GO:0048745),-0.5496883041880081,-1.217979008802689,0.2376237623762376,0.5133640630150174,1.0,5/10,11.37%,ENG;PTCH1;STRA6;PROX1;BMP4
prerank,protein heterooligomerization (GO:0051291),-0.4723995318121763,-1.2173645419640164,0.19858156028368795,0.5140396890207832,1.0,5/17,15.27%,KCNC2;GRIN2B;MAT2A;PKD1;GRIN1
prerank,metanephros development (GO:0001656),0.48365327656909085,1.2170960370720143,0.22638146167557932,0.8901588785268917,1.0,6/26,8.44%,BMP7;OSR1;FOXD1;CTSH;NIPBL;GDNF
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.4097876978726383,-1.2169269963615124,0.18932038834951456,0.5142193227948487,1.0,16/32,28.65%,CAV1;AKAP6;CEMIP;TRPC3;TRPC1;GPER1;SNCA;GRIN1;APLNR;NPSR1;THY1;F2R;CXCL10;PLCG1;P2RX7;CASQ1
prerank,glycoprotein catabolic process (GO:0006516),0.5261802829222647,1.2165642101222494,0.23290203327171904,0.8903084166867017,1.0,4/17,8.43%,NGLY1;NEU2;ADAMTS9;MANBA
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.45176304560189845,-1.2153622527555648,0.20044052863436124,0.516978403233592,1.0,6/21,10.66%,CAV1;PLTP;NFKBIA;APOE;PTCH1;EEPD1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3397184175321903,1.2149917965287291,0.10440835266821345,0.8943109356552694,1.0,39/308,9.87%,EPAS1;DAB2;ACSL1;PPARGC1B;C1QTNF3;SMAD3;APPL2;LEPR;PPARGC1A;NPR1;IL18;FOXD1;SOX5;BMPR1A;TGFBR1;FOXC1;ADRA2A;PDPN;KMT5C;SMO;RREB1;NCOA3;CD28;KMT5B;IL12B;EIF2AK2;SLC27A1;WWTR1;SMURF2;SERPINE1;TGFBR2;TERT;CPT2;GDNF;NIBAN2;SIRT1;LRP1;NR2C2;GRB10
prerank,positive regulation of ruffle assembly (GO:1900029),-0.49447048610544364,-1.2146628551275598,0.22736418511066397,0.5178043609983954,1.0,3/13,10.24%,NLGN1;P2RY12;EPS8
prerank,presynapse organization (GO:0099172),-0.5275000944206767,-1.2145493985860516,0.24536082474226803,0.5172698967678679,1.0,2/10,3.65%,NLGN1;LRRTM3
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.50659502079476,-1.2143838080885272,0.23251028806584362,0.5168260505663733,1.0,4/12,14.72%,APOE;LDLR;CLU;IAPP
prerank,positive regulation of telomerase activity (GO:0051973),-0.41053868952736494,-1.2142969956926264,0.16706443914081145,0.5162027356366551,1.0,16/33,29.15%,PARM1;HSP90AB1;NEK7;HSP90AA1;XRCC5;CTNNB1;CCT2;PRKCQ;HMBOX1;PTGES3;MAP2K7;KLF4;TNKS;DKC1;NAF1;MAPK3
prerank,entry into host (GO:0044409),-0.5085909346456237,-1.2137372833911,0.24897959183673468,0.5167111022420108,1.0,5/13,16.11%,PPIA;MET;CDH1;CTNNB1;CBL
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3803017164919772,1.213539670168974,0.14051841746248295,0.8980140726271627,1.0,10/113,3.46%,NOTCH2;FGF1;BMP6;OSR1;IGF1;STXBP4;FGFR2;LAMC1;PKHD1;TGFBR1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4413110113881996,1.2132475567503038,0.191869918699187,0.8973364498251128,1.0,9/44,5.17%,ROCK2;LPAR1;CCN2;ARHGEF10L;FHOD1;PPM1E;TGFBR1;RAPGEF3;TPM1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5350890486321931,1.212804723766064,0.2471042471042471,0.8972729511317441,1.0,2/13,2.62%,ERRFI1;SNX6
prerank,autonomic nervous system development (GO:0048483),-0.46168749595275965,-1.2127343225530398,0.22573839662447256,0.5182810402365295,1.0,5/17,18.48%,NRP1;FN1;KIF26A;EDNRB;SOX8
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3206089510909687,1.2115366840128583,0.011077542799597181,0.9000115741846468,1.0,286/1646,14.09%,DENND4A;EPAS1;HLF;ZKSCAN2;RORA;MAF;KDM7A;PPARGC1B;BMP7;SMAD3;TFDP2;GLIS3;WNT4;OSR1;ZIC2;FOXN3;TULP3;TRAK1;KIT;DDX5;PPARGC1A;MXI1;PICALM;IGF1;NFYC;CUX1;KMT2A;PPARA;PKNOX2;SSBP2;CREBRF;ZFHX2;FOXP4;IKZF2;POLR2A;ZNF423;CREB5;HOXB4;JARID2;GLI2;ZBTB20;ZNF160;HOXB6;NPAS3;CXXC1;SPP1;ZHX2;SNX6;FOXD1;HOXC6;HOXA1;ZNF568;DKK3;ARID4A;NFAT5;SOX5;PCGF5;CRABP2;PHIP;NR2F2;NCOR2;CTR9;ZNF697;ELF1;TSHZ3;NR6A1;GLI3;MITF;SUFU;TGFBR1;ARNT2;FOXC1;NFIB;VGLL3;CAND2;RFX8;HOXB3;VEZF1;ZBTB38;MAFG;ASCL3;ATOH1;NACC2;VGLL4;NFYB;LOXL3;CCNA1;CREB3L2;NHLH2;PRKCB;SMAD6;FOXP2;SALL4;CUX2;RREB1;CHD4;PPP1R13L;RGMB;BNC2;PIAS1;MEIS1;FBXL19;NSD1;TEF;IFNK;WWC2;TRIM56;ARRB1;ASCC2;ARID3A;SFMBT1;SBNO1;SOD2;ATRX;ESRRA;TEAD3;CBFA2T2;STAT2;LCOR;HMGA1;LBH;HOXB9;CREBL2;HOXA3;BAZ1B;ZNF318;HOXB5;TP53;TSHZ1;TBL1X;AFAP1L2;CAMTA2;WWTR1;BHLHE41;SMURF2;ARHGEF11;RORC;MED12;SOX12;MGA;CCNT2;SMARCD3;ZSCAN29;NIPBL;ZIC5;LDB1;CHD7;FBXW11;BCOR;ELF2;MEF2A;KDM2B;SMARCA4;NR1D2;HOXC4;SRCAP;BTRC;RBM15;SPEN;ZSCAN25;TBL1XR1;KAT6B;ZIC1;KDM2A;SLTM;NRG1;JMJD6;NUPR2;IRX1;SMARCC2;NEUROD4;TEAD2;NIBAN2;KLF3;CALCOCO1;PARP9;SMARCE1;HDAC4;GLI1;ZBTB26;SCML4;SIRT1;ZIC4;TFDP1;TCF7;TLE1;NSD3;NR2C2;HDAC1;SOX13;CBY1;SPINDOC;CCAR1;ZFP90;CHMP1A;FOXC2;TCF7L2;TCF4;HBP1;ZBTB8B;ZNF219;MYBL1;MED17;HIVEP2;FOXL1;ZFP28;ZFP3;AJUBA;THRAP3;ABL1;PRDM5;DYRK1A;ZBTB6;SAP18;ZKSCAN5;ZNF569;ZNF367;NFATC3;HR;MNT;ATF2;ZFX;RBBP8;BAHD1;ZMIZ2;WWP2;BAZ1A;MLLT6;TFAP2D;ZNF467;ZBTB1;SKOR1;MYBL2;MSANTD1;CBX5;TEAD1;ZMIZ1;PHF5A;ZSCAN22;NOP2;KDM3B;ZNF148;HES6;ZNF235;BRWD3;UIMC1;HOXB2;BRD7;FOXA2;DEAF1;MLXIPL;NR3C2;TGFA;BRD9;IRF1;ZKSCAN7;PHF1;PHF2;ZNF483;KMT2D;KAT7;ZXDC;EDRF1;PBX4;ZBTB48;FOXJ2;KMT5A;PRKAR1A;NFIA;SIN3A;DNM2;MAP2K1;MLLT11;ATF6B;PML;TLE2;PSIP1;BCL7A;NCOR1;ZBTB32;CRYAB;OGT;ILF2;MAP2K2;SNAI1;PER2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5476718178870243,1.2111154434201215,0.2645985401459854,0.8997779582016053,1.0,2/13,5.45%,DDX5;ATM
prerank,positive regulation of developmental process (GO:0051094),-0.30114475616732883,-1.210742919533763,0.05627705627705628,0.5222491646187739,1.0,43/164,14.02%,NLGN1;NRXN1;SLC6A6;BMP5;SHANK3;BMPR2;DCN;RTN4;CLASP2;GRIP1;PHLDB1;TFRC;ARHGEF7;ZBTB16;HSP90AB1;KDR;AR;DAB2IP;FZD4;APOE;BASP1;B4GALT5;PSEN1;CORO1C;SORL1;RELN;BMP2;PTN;RPS6KA3;ENPP2;HMCES;BMP4;EDN3;LLPH;VLDLR;LRP8;CFL1;ACVR1;VEGFA;SHANK1;BMPR1B;RPS6KA1;PINK1
prerank,lymphocyte chemotaxis (GO:0048247),-0.40039976251717474,-1.2096469270972239,0.19148936170212766,0.5241680473005988,1.0,11/34,26.53%,CYP7B1;SLC12A2;GAS6;CXCL16;CCL13;CH25H;CCL19;HSD3B7;CXCL10;PIK3CD;CCL2
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.474176041134974,-1.2096372344816075,0.21961620469083157,0.523356814644335,1.0,4/17,9.06%,HDAC9;PCSK5;SORT1;PCSK6
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.36509213658796325,1.2095395041764272,0.15323645970937913,0.9035601357702259,1.0,36/148,16.15%,PRKAG2;PRKAA2;PRKAG3;TP53RK;CHD4;PPP1R13L;ATM;TP53;RICTOR;CDK5RAP3;PDPK1;RNF34;HDAC1;AURKB;RBBP8;HUS1;NOP2;TAF11;CSNK2A2;CSNK2A1;MAPKAP1;BRD7;RAD50;TOP3A;USP7;PPP1R13B;KMT5A;TBP;PML;TAF4;MAP2K6;CCNG1;MTA2;TAF7;EHMT2;TAF13
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.4493700844629157,-1.208756995724335,0.21153846153846154,0.5245460493767216,1.0,9/21,9.43%,HS6ST2;NDST3;HS6ST3;HS3ST4;HS3ST5;EXT1;XYLT1;GLCE;EXT2
prerank,snRNA processing (GO:0016180),0.5242140003400716,1.2085471877984566,0.24904942965779467,0.905473127238474,1.0,9/16,21.65%,INTS10;INTS2;INTS5;INTS3;INTS7;INTS1;INTS8;INTS4;TUT1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.4177237808297247,-1.2076511332965854,0.2236842105263158,0.5264267537927565,1.0,7/27,19.39%,PLA2G4A;GPCPD1;ENPP6;GDPD1;ENPP2;PLA2G4E;PLA2G15
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3445294183567941,-1.2075912485211893,0.1347305389221557,0.5257202612417751,1.0,19/76,12.12%,MAML2;NOS3;NOTCH3;TGFB2;STAT3;CCN3;JAG1;NOTCH1;IL6ST;EPN2;BEND6;TSPAN14;PRAG1;SREBF2;JAG2;GATA2;LFNG;MFNG;TM2D3
prerank,keratan sulfate catabolic process (GO:0042340),0.5543085887377535,1.2074732426742623,0.26325757575757575,0.90773289430322,1.0,2/11,5.05%,OGN;FMOD
prerank,canonical Wnt signaling pathway (GO:0060070),0.4020608498474033,1.2071310861231657,0.17761194029850746,0.9072190878664504,1.0,13/68,11.85%,WNT5B;WNT4;WNT6;FZD8;LRRK2;FZD5;PTEN;RYK;CSNK1A1;TCF7;TCF7L2;RARG;PORCN
prerank,protein K48-linked ubiquitination (GO:0070936),0.4236622292264659,1.2067335310919658,0.20579268292682926,0.9068905953699705,1.0,16/54,17.39%,RNF152;UBE2E2;PRKN;IFI27;NHLRC4;TTC3;RNF8;RNF34;UBR5;UBE2H;RNF115;AMFR;RNF146;UBE2E1;SYVN1;CDC34
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.47972945957786484,-1.2063548158245414,0.2175824175824176,0.5277882383576992,1.0,4/15,20.44%,HECW2;CENPE;CDC23;NEK6
prerank,protein dephosphorylation (GO:0006470),0.36700566698163084,1.206201702303617,0.1625487646293888,0.9071178652498467,1.0,29/135,12.27%,EYA1;PTPN13;EYA2;DUSP29;PPP2R2B;PTPN14;PTPN9;MTMR3;PPEF2;EYA4;PPP1CB;PPM1E;TNS2;LHPP;DAPP1;PTPRU;PTPN22;FBXW11;PTEN;PP2D1;BTRC;PPP2R1B;PTPN21;DUSP10;CDC14B;PPP2R5E;PTPN4;CTDSP2;PTPN11
prerank,negative regulation of developmental growth (GO:0048640),-0.4127711642094549,-1.2054992557022817,0.19477434679334918,0.5291291354808529,1.0,12/30,14.68%,RTN4;DCC;PTCH1;DIP2B;ULK1;ULK2;WWC1;FGF13;SEMA3G;CDKN1A;MT3;FGFR3
prerank,histone deubiquitination (GO:0016578),0.5060194392133661,1.20543290586393,0.23369565217391305,0.9081958731648407,1.0,7/18,19.48%,USP3;USP49;UIMC1;USP7;EPOP;USP21;USP16
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.4268745019831295,1.205408490351622,0.20793650793650795,0.9066136343034815,1.0,16/57,14.35%,FOXN3;BABAM2;ATM;TP53;DONSON;CDK5RAP3;BRSK1;EME2;CDC14B;ATF2;PRKDC;HUS1;UIMC1;FZR1;BABAM1;SDE2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5757613585206087,1.2050627010392614,0.2751004016064257,0.9061507977047862,1.0,7/11,16.73%,ENPP3;CTPS2;SLC19A2;THTPA;NT5C3A;TPK1;SLC25A19
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4829861975741406,-1.2050213321206018,0.2386117136659436,0.5294412314886869,1.0,7/15,8.00%,KCNJ3;KCNJ2;KCNN2;ATP1B1;YWHAE;ATP1A1;KCNQ1
prerank,magnesium ion transport (GO:0015693),0.5592809004762777,1.204845670578562,0.28442028985507245,0.90526621504334,1.0,4/12,14.32%,SLC41A1;MRS2;NIPA2;MAGT1
prerank,maturation of LSU-rRNA (GO:0000470),0.4744125068962676,1.204817229260355,0.24035087719298245,0.9036997965971726,1.0,7/26,18.39%,NSA2;DDX18;NOP2;RSL1D1;MRPL1;ZNHIT6;WDR12
prerank,"transcription, DNA-templated (GO:0006351)",0.3541795158230408,1.2046900393385422,0.14694894146948942,0.9024783804010945,1.0,41/207,16.15%,MAF;THRB;GLIS3;DDX5;POLR2A;SOX5;CTR9;DTX1;ATOH1;RREB1;TTF2;AFF4;CREBL2;TP53;TSC22D1;CCNT2;POLR2D;MEF2A;TWNK;TFDP1;ELL;GTF2A1L;GTF2F1;RTF1;MNT;NOCT;NELFCD;TAF11;HIPK3;DEAF1;POLR3A;TBP;TAF4;PMF1;CTDP1;NFKB1;BRF1;TAF7;FUBP3;TTF1;TAF13
prerank,regulation of protein phosphorylation (GO:0001932),-0.2831155649166993,-1.2043644662004094,0.02531645569620253,0.5301541401641638,1.0,71/256,14.40%,SLIT2;LIMCH1;PID1;TEK;BMPER;GRM5;PRR5L;ERBB4;NTRK3;PECAM1;PDE8A;ENG;PLCE1;VEGFC;NPTN;NIBAN1;EFNA5;FN1;SH3GL2;GAS6;CCDC88A;TFRC;NTRK2;KRAS;PPP2R5A;KDR;LYN;TBX1;DAB2IP;PPIA;PAK1;APP;CARD14;OCLN;LIMK2;EPHA7;SEMA4D;CORO1C;EPHB2;CCN1;BMP2;TGFB1;PTK2;RALB;DNAJC10;XDH;FGF2;FLT4;RAP2A;FNIP2;ERBB2;CAMKK2;PDGFA;HSP90AA1;ITGB3;GPER1;FXR1;BMP4;ATF4;ILK;FAS;AXIN1;FGF7;FGF9;VEGFA;PINK1;TERF2IP;NOP53;CCDC88C;MT3;P2RY1
prerank,regulation of neuron projection arborization (GO:0150011),-0.49319901274710953,-1.2036384392058923,0.22272727272727272,0.5310887772142828,1.0,4/15,10.92%,GRIP1;NTNG1;FZD4;MFSD2A
prerank,negative regulation of cellular component movement (GO:0051271),0.5321708114225207,1.20363025966399,0.2722222222222222,0.9047058850938849,1.0,3/15,2.28%,TGFBR3;FBLN1;PKHD1
prerank,regulation of interleukin-1 production (GO:0032652),-0.49116816022741927,-1.2035705998766764,0.2320675105485232,0.5304149940061016,1.0,4/15,8.90%,GAS6;ANXA1;FOXP1;CEACAM1
prerank,pyroptosis (GO:0070269),0.5307007271113203,1.2033586475283533,0.2669172932330827,0.9040212925782936,1.0,1/15,1.39%,GSDME
prerank,regulation of vacuole organization (GO:0044088),0.5019358824096166,1.2029028826735837,0.2338568935427574,0.9039073911199856,1.0,5/20,11.12%,MTMR3;NPRL3;NPRL2;PIKFYVE;IFT88
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.47038593664218026,-1.2028340669472812,0.24153498871331827,0.5312746223740837,1.0,10/16,42.81%,CADM1;PVR;RAET1E;RASGRP1;LAMP1;IL12A;CRTAM;KLRD1;CD160;KLRK1
prerank,regulation of B cell proliferation (GO:0030888),-0.37296858213652767,-1.2023968785444483,0.20512820512820512,0.5316025093841822,1.0,13/44,22.40%,MEF2C;TFRC;LYN;CD38;PTPRC;EPHB2;TNFRSF21;TIRAP;CD74;IRS2;TYROBP;CD320;CD81
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4332345799077499,1.2022445036910494,0.20443740095087162,0.9046647278204875,1.0,4/44,0.80%,WNK4;ACTN2;ATP1B3;ANK2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5317826255690943,1.2021459869265148,0.2585278276481149,0.9033481084186267,1.0,5/15,7.38%,FGFR2;HOXA1;TGFBR1;TGFBR2;NIPBL
prerank,positive regulation of stem cell differentiation (GO:2000738),0.528600470417777,1.2021455471314035,0.2695167286245353,0.9017163063636003,1.0,3/16,3.64%,HOXB4;SOX5;FOXC1
prerank,positive regulation of TOR signaling (GO:0032008),0.4414688320987039,1.2017840699587017,0.2300163132137031,0.9013886910450303,1.0,17/40,26.68%,FNIP1;GPR137;RICTOR;PIK3CA;FLCN;WDR24;RPTOR;TELO2;RRAGD;LAMTOR1;RRAGB;SLC38A9;SIK3;HTR6;RRAGC;SEC13;GPR137B
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.4044732278355978,-1.201676060838853,0.2004950495049505,0.5324376352028266,1.0,4/29,7.62%,RPS8;RPS19;RPS21;RPS16
prerank,potassium ion homeostasis (GO:0055075),0.4928027772019584,1.2014410115036975,0.24910394265232974,0.90098775615007,1.0,2/23,0.71%,ATP1A2;ATP1B3
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.3303665946806389,-1.2013161294258374,0.12142857142857143,0.5325155646013787,1.0,32/84,15.16%,NRP1;TEK;BMPR2;TMSB4X;NOS3;THBS1;NRP2;SEMA5A;PTK2B;SCARB1;AKT3;KDR;GPI;FOXP1;MET;RHOB;GATA2;TGFB1;PROX1;CALR;ATOH8;FGF2;FLT4;BCAR1;ITGB3;EDN1;BMP4;HIF1A;PRKD1;VEGFA;NUS1;RRAS
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.33546567933325655,-1.2010952481286772,0.15562913907284767,0.5322521537107281,1.0,21/72,15.25%,SLIT2;SHANK3;NAV3;CLASP2;KANK3;KANK4;ARHGEF2;LIMA1;APOE;STMN2;LDLR;HSPA8;FGF13;TUBB4A;SPEF1;PFN2;SNCA;SHANK1;CLU;IAPP;STMN1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.4378435955080736,-1.2010675797680779,0.2161520190023753,0.5314936028985726,1.0,8/24,14.98%,CTNNA2;MEF2C;CDH2;CDON;BOC;CTNNB1;MYOCD;MAPK12
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.3671490795472144,-1.2007550947846708,0.1830238726790451,0.5314075789120745,1.0,14/47,20.60%,GRM5;NFKBIA;APOE;APP;TGFB1;AGTR1;EDN1;EDNRB;EIF4E;PUM3;INHBA;RBM4B;AGT;RBM3
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5187897033310663,1.2005098853896325,0.2650375939849624,0.9026929992777524,1.0,1/16,0.73%,LEPROT
prerank,negative regulation of viral genome replication (GO:0045071),0.44146654009471065,1.2000688222440081,0.237012987012987,0.902546660820767,1.0,12/40,16.95%,IFIT1;OAS2;PARP10;EIF2AK2;PLSCR1;RSAD2;ZC3HAV1;MAVS;SRPK2;OAS3;MPHOSPH8;ILF3
prerank,barbed-end actin filament capping (GO:0051016),0.5145974624870963,1.1993396819804645,0.26258992805755393,0.9020405340536612,1.0,4/18,6.82%,ADD3;AVIL;CAPZB;TRIOBP
prerank,actin filament capping (GO:0051693),0.5145974624870963,1.1993396819804645,0.26258992805755393,0.9020405340536612,1.0,4/18,6.82%,ADD3;AVIL;CAPZB;TRIOBP
prerank,nuclear export (GO:0051168),0.3977668050516838,1.1992431139082622,0.18248175182481752,0.9007353899108319,1.0,20/80,21.34%,RANBP3L;SRSF5;PHAX;POLDIP3;NUP42;RANBP3;NXF1;SRSF11;DESI1;SARNP;NUP155;NEMF;CCHCR1;SRSF1;CDC40;NUP188;U2AF1;SRSF7;U2AF2;NUP153
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.46685212123636033,-1.1991580468747458,0.22935779816513763,0.5335976119907624,1.0,6/17,20.05%,STAT3;SOCS2;STAT5B;JAK1;IRS2;IRS1
prerank,cellular response to interleukin-7 (GO:0098761),-0.46685212123636033,-1.1991580468747458,0.22935779816513763,0.5335976119907624,1.0,6/17,20.05%,STAT3;SOCS2;STAT5B;JAK1;IRS2;IRS1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.45382161946155763,-1.1989630803458702,0.2389937106918239,0.5332507771462828,1.0,4/18,3.62%,NLGN1;NRXN1;SHANK3;PTK2B
prerank,lytic vacuole organization (GO:0080171),0.45678968757824595,1.198756144815767,0.21996615905245348,0.9008026962771467,1.0,13/32,20.57%,HOOK2;LRRK2;TPP1;CLN6;ARSB;HPS1;MBTPS1;ZKSCAN3;HOOK3;MYO7A;LAMTOR1;TPCN2;SNAPIN
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.49950500799424424,1.1986928865090636,0.2555147058823529,0.8994051623668643,1.0,5/21,7.00%,ADCY5;NPR1;ADCY1;NPR2;ADCY9
prerank,histone H2B ubiquitination (GO:0033523),0.5799615512618266,1.1986143272458514,0.271484375,0.8980518757453403,1.0,4/10,18.43%,CTR9;RNF8;UBE2E1;RNF20
prerank,sarcomere organization (GO:0045214),0.47659059568757306,1.198609037079106,0.22132471728594508,0.8964732245045032,1.0,3/27,5.17%,ACTN2;CSRP3;TPM1
prerank,eye morphogenesis (GO:0048592),0.5065993215488177,1.1985279026152282,0.25830258302583026,0.8951520422138898,1.0,6/19,11.14%,COL5A1;SHROOM2;FBN1;NIPBL;IFT122;RARG
prerank,response to estradiol (GO:0032355),-0.3979604082054301,-1.1982013079145928,0.19953596287703015,0.5343518337469275,1.0,8/31,12.06%,ESR1;STAT3;ANXA1;SOCS2;TGFB1;STAT5B;GPER1;CTNNB1
prerank,positive regulation of lyase activity (GO:0051349),0.5403985280155882,1.1981474485607586,0.25996204933586337,0.8949279149649843,1.0,3/14,9.72%,CACNA1D;CACNA1C;STIM1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.4031706466101548,-1.1978825880877129,0.18719211822660098,0.5342735100981378,1.0,7/29,4.11%,KCNIP4;DPP10;FGF12;DPP6;KCNN2;KCNIP1;KCNAB1
prerank,neurotransmitter transport (GO:0006836),-0.3387060076316332,-1.1977425527136676,0.1437308868501529,0.5337866038192323,1.0,15/73,7.19%,NRXN1;SYT1;PPFIA2;SNAP25;RIMS1;CASK;LIN7A;SLC1A2;PTPRN2;GABRA2;UNC13B;SLC1A1;SYN2;HSPA8;GLS
prerank,cellular response to interleukin-4 (GO:0071353),-0.5500569377734554,-1.1967935409544581,0.24493927125506074,0.5351658293810306,1.0,1/10,0.47%,LEF1
prerank,negative regulation of cell growth (GO:0030308),-0.30438730841978484,-1.1967313756891338,0.10256410256410256,0.5344654856877211,1.0,40/121,21.11%,APBB2;SLIT2;PTPRJ;BMPR2;RTN4;DCC;TGFB2;ACVRL1;CCN3;SOX17;ENPP1;DIP2B;ADAM15;ULK1;PPP2R1A;RERG;SH3BP4;TGFB1;ULK2;SERTAD2;BTG1;FGF13;PPT1;FRZB;SEMA3G;CDKN1A;JADE1;EI24;MT3;DCBLD2;CCDC85B;NDRG3;SIPA1;CDKN2AIP;INHBA;DCUN1D3;RTN4R;ESR2;SFRP1;SLIT3
prerank,negative regulation of cell migration (GO:0030336),-0.3067909138929597,-1.1966736079773566,0.09803921568627451,0.5337835776314545,1.0,30/137,9.65%,TMEFF2;SLIT2;LIMCH1;DACH1;PTPRJ;CLIC4;PTPRG;CLDN5;MCTP1;ENG;NAV3;PTPRK;CLASP2;PTPRT;SRGAP1;NEXMIF;EVL;ADARB1;ACVRL1;CYP1B1;JAG1;DAB2IP;RHOB;ADAM15;CORO1C;ARHGDIB;CALR;SMAD7;FGF2;RAP2A
prerank,hexose biosynthetic process (GO:0019319),0.4385968113554226,1.1966152248839736,0.22979397781299524,0.8985678251866054,1.0,14/42,17.88%,PPARGC1A;SORD;CHST15;PGAM2;GOT2;RBP4;SLC25A12;SLC25A11;PGM1;PER2;SLC25A10;GOT1;SLC37A4;CRY1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.4803970448720003,-1.1960778024150283,0.27450980392156865,0.5343080684339891,1.0,3/14,8.63%,OSMR;IL6ST;PTGS2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5254642389299953,-1.1960320841063325,0.24849699398797595,0.5335781921843255,1.0,4/11,8.63%,CD200;THBS1;CD34;PTGS2
prerank,DNA catabolic process (GO:0006308),0.5614950676218156,1.195673231564775,0.29245283018867924,0.9003987429770036,1.0,5/11,22.81%,DNASE1L1;FBH1;DFFB;DNASE1L2;REXO4
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3892062308740246,1.1950960438020573,0.1972027972027972,0.9007648128548885,1.0,7/86,3.46%,DAB2;BMP6;BMP7;ZNF423;FOXD1;BMPR1A;TGFBR1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.5742806869293404,1.1949015643248875,0.3041825095057034,0.8999453464588415,1.0,1/11,0.51%,AFDN
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.43136227117702486,1.1940896461197787,0.2432,0.901220295725352,1.0,10/43,11.69%,SMAD3;DDX5;PPARA;NFIB;TP53;SMARCA4;TERT;APLN;NFATC3;TEAD1
prerank,response to leucine (GO:0043201),0.5710205725485659,1.1937109517766578,0.3041825095057034,0.8993903338545761,1.0,6/10,17.13%,SESN1;SESN2;UBR2;RPTOR;UBR1;RRAGD
prerank,cellular response to leucine (GO:0071233),0.5710205725485659,1.1937109517766578,0.3041825095057034,0.8993903338545761,1.0,6/10,17.13%,SESN1;SESN2;UBR2;RPTOR;UBR1;RRAGD
prerank,positive regulation of response to wounding (GO:1903036),-0.4288716503150526,-1.1934516770372345,0.23972602739726026,0.53893459993514,1.0,11/24,21.93%,ACTG1;ANXA1;OCLN;ITGB1;PTK2;PTN;SCARF1;DMTN;KANK1;VTN;MDK
prerank,regulation of angiogenesis (GO:0045765),-0.29113605421596833,-1.1932923148666275,0.1,0.5384943083228159,1.0,53/192,13.89%,PTPRM;TEK;BMPER;RHOJ;SEMA6A;CLDN5;PDE3B;DCN;NOS3;VEGFC;THBS1;TGFB2;SEMA5A;TIE1;COL4A2;PPP1R16B;GAB1;CD34;RUNX1;PTGIS;F3;CYP1B1;SEMA3E;KDR;RAMP2;DAB2IP;ITGB8;SERPINF1;RHOB;PIK3R6;ITGB1;TSPAN12;HSPG2;ECM1;STAB1;GATA2;CEACAM1;BTG1;AMOT;FGF2;ERBB2;ATP2B4;HIPK1;CTNNB1;TWIST1;EMP2;ISM1;HIF1A;PRKD1;VEGFA;ECSCR;ADGRB1;SPRED1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.48228896551808614,1.1931752116750398,0.26608695652173914,0.8997583222058257,1.0,8/26,14.57%,ROCK2;PRKN;FHOD1;ASAP3;CDC42;VIL1;TSC1;ALMS1
prerank,epithelial cell migration (GO:0010631),-0.3924134247990138,-1.1927406912515988,0.21683673469387754,0.5390164647623927,1.0,14/37,15.79%,NRP1;CDH13;NOS3;FAP;CYP1B1;ANLN;PLEKHG5;STARD13;LPXN;PKN3;FAT2;SCG2;PTP4A3;PLXND1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.43362227667709297,-1.192536939870334,0.20506912442396313,0.5386886778854435,1.0,8/24,14.04%,DACH1;BMPR2;ACVRL1;RPS3;XRCC5;CDKN1A;ERCC1;TERF2IP
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.3118611066651561,-1.1922627156156145,0.12179487179487179,0.5385325898025908,1.0,26/110,14.77%,ADGRL3;ADGRB3;ADGRL4;ADGRL2;CALCRL;ADGRG6;GNAS;ADCY2;ADRA1B;ADGRE5;ADCY7;GNG2;RAMP2;ADCY4;S1PR1;LGR5;PTH1R;GPER1;PTHLH;RAMP1;ADGRB1;GPR26;ADGRG1;IAPP;GNAL;GNB1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.5194302604312968,-1.1918733959619314,0.25153374233128833,0.5386664026560234,1.0,4/11,10.63%,SEMA5A;STMN2;TRPV4;WDR1
prerank,neuron projection extension (GO:1990138),-0.3999968719954523,-1.191343944713206,0.17941952506596306,0.5391385645072289,1.0,14/32,12.76%,NRP1;MAP1B;IQGAP1;NRP2;SEMA5A;SH3GL2;TMEM108;HSP90AB1;ULK1;ULK2;SLC9A6;HSP90AA1;CTNNB1;LLPH
prerank,neutrophil chemotaxis (GO:0030593),-0.351689057546631,-1.1912579192866664,0.18652849740932642,0.5385224315068865,1.0,24/53,37.97%,PDE4B;BSG;TGFB2;PPIA;PPIB;EDN1;EDN3;CCL13;SYK;ITGB2;CCL19;CXCL10;PIK3CD;CCL2;JAML;CXCL5;CCL11;CXCL1;PIP5K1C;CCL4;PF4;PPBP;CCL8;PIK3CG
prerank,protein sumoylation (GO:0016925),0.4259936887816195,1.1910478965194125,0.21786833855799373,0.9057205434249082,1.0,13/49,21.34%,EYA1;PIAS1;NUP42;NUP98;NSMCE2;NUP43;PIAS3;NUP155;SUMO1;PIAS4;NUP188;UBE2I;NUP153
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3801995163717597,-1.1909791385658821,0.18159203980099503,0.5383739437499908,1.0,9/39,8.98%,MYO1D;ACTN4;PPFIA2;MYO1B;FNBP1L;TANC2;MYO5A;DYNC1I1;MYO6
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.35319236217237837,1.190733780923252,0.1814720812182741,0.90520984766393,1.0,43/182,15.24%,NOTCH2;ROBO1;SLC24A3;ROCK2;WNT4;PICALM;IGF1;PRKAA2;PRKN;TNRC6A;BMPR1A;PARP10;PARP14;SMO;TIPARP;RIN3;CD28;PTPN22;TNRC6B;ATXN2;RBL2;TERT;APLN;PARP9;SIRT1;HDAC1;LRP3;MOV10;RBL1;CRKL;WWP2;NOCT;DICER1;ZNF148;FLOT2;SNX12;MAP2K1;MAP2K2;FLCN;TNRC6C;NFKB1;TET1;ANXA7
prerank,positive regulation of cellular component organization (GO:0051130),0.3741897288018204,1.190631413492087,0.18653576437587657,0.9040059905026832,1.0,20/107,9.36%,DAB2;BMP7;LRP4;FNIP1;TRABD2B;FRMPD4;TGFBR1;BID;RAPGEF3;ADGRL1;MPP7;ANAPC2;CAMK1;PTPN23;NOX1;ASAP1;NRG1;CDH5;HYAL1;LRP1
prerank,sulfate transport (GO:0008272),0.5426222457189191,1.190549818845425,0.2641165755919854,0.9027380905434557,1.0,1/14,0.15%,SLC13A4
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.4805337313497573,1.1903912729830033,0.24821428571428572,0.9017253428645058,1.0,4/28,4.13%,ARHGAP28;FCHSD2;ARHGAP18;NAA80
prerank,response to amino acid starvation (GO:1990928),0.40208619268225965,1.1902505907938017,0.2268041237113402,0.9006215881027559,1.0,22/72,19.47%,RNF152;NPRL3;SESN1;ATP6V0E1;SESN2;NPRL2;ATP6V0B;EIF2AK2;LARP1;ATP6V1D;ATP6V1E1;ATF2;IMPACT;DEPDC5;FLCN;KPTN;WDR24;RPTOR;RRAGD;ATP6V0D1;LAMTOR1;ITFG2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3640560126445078,-1.189963732947467,0.17579250720461095,0.5399439603634868,1.0,13/47,8.69%,NRP1;ACTN4;EFNA5;CARMIL1;ARHGEF7;DOCK1;FLNA;CRK;CORO1C;LIMS2;MYOC;PTK2;CALR
prerank,ESCRT III complex disassembly (GO:1904903),0.5663983062908341,1.1899567711977261,0.2771317829457364,0.8986005891624537,1.0,6/10,28.40%,CHMP1A;VPS4A;CHMP2A;IST1;VTA1;CHMP1B
prerank,ESCRT complex disassembly (GO:1904896),0.5663983062908341,1.1899567711977261,0.2771317829457364,0.8986005891624537,1.0,6/10,28.40%,CHMP1A;VPS4A;CHMP2A;IST1;VTA1;CHMP1B
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4499093682165246,1.1897940836670537,0.23344947735191637,0.8976249778470455,1.0,9/35,12.44%,PPARGC1B;DDX5;PMEPA1;NEDD4;TMF1;CALCOCO1;UBR5;ZMIZ1;NR3C2
prerank,positive regulation of cyclase activity (GO:0031281),0.5300140479023626,1.1892134902206268,0.277882797731569,0.8980341441369974,1.0,3/14,9.72%,CACNA1D;CACNA1C;STIM1
prerank,glucan catabolic process (GO:0009251),0.5217644702329032,1.1891333306046967,0.2625,0.89676696822263,1.0,4/15,8.86%,PYGM;PHKB;MGAM;PHKG1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.4173867537651961,-1.1891319047553788,0.20512820512820512,0.5411262473417484,1.0,9/28,14.08%,MAP3K5;DAB2IP;DNAJC10;ATP2A3;AIFM1;TMEM117;SELENOK;ATF4;BBC3
prerank,regulation of synapse maturation (GO:0090128),-0.5368523117269053,-1.1884257012700408,0.25384615384615383,0.5419878872748621,1.0,4/10,7.93%,NRXN1;DAB2IP;ARHGEF15;RELN
prerank,neutrophil mediated immunity (GO:0002446),-0.2724387742645789,-1.1878656686407651,0.0,0.5425780579705054,1.0,103/432,19.59%,PTPRB;ATP8A1;PTPRJ;PECAM1;GSN;SNAP25;LRRC7;ATP6V0A1;CST3;ADGRE5;IQGAP1;B2M;FTH1;APAF1;ATP11A;HMOX2;NFASC;RAB31;PTPRN2;HSP90AB1;PRG2;GPI;ACTR2;PPIA;RAP1B;PTPRC;RAP1A;CD93;STK10;CTSD;PSAP;CTSC;RAB27A;TSPAN14;HSPA8;TIMP2;PSEN1;TNFRSF1B;DYNLL1;PGLYRP1;NPC2;SLC44A2;FTL;CKAP4;OSTF1;MME;EEF1A1;HEXB;CTSB;STOM;CEACAM1;PSMD14;CRACR2A;CD47;DOCK2;RAB18;CD44;HSP90AA1;CYBA;IMPDH1;XRCC5;GOLGA7;CTSS;ENPP4;HRNR;SLC2A3;ARPC5;TNFAIP6;LRG1;SRP14;PGAM1;FABP5;TMEM30A;QPCT;SCAMP1;DOK3;RAB6A;TRPM2;ALDOA;CCT8;APEH;PKM;CAT;CCT2;PDXK;STXBP3;SVIP;RAB37;GCA;CYB5R3;C3AR1;PSMD11;CTSZ;ITGB2;CAND1;SLC27A2;QSOX1;TMEM63A;EEF2;SPTAN1;PSMD2;ATP11B;TYROBP
prerank,activation of adenylate cyclase activity (GO:0007190),0.44765176632790615,1.187645777150078,0.24873949579831933,0.9003004907316811,1.0,3/35,1.98%,ADCY5;LGR4;ADCY1
prerank,cellular response to hormone stimulus (GO:0032870),0.395809455859831,1.1873368557747301,0.20588235294117646,0.8999101615284395,1.0,10/69,7.27%,ATP1A2;THRB;TFPI;SLC5A5;BRD8;ADRA2A;CTSH;NCOA3;BCAS3;GCK
prerank,glucose import (GO:0046323),-0.4922329469672433,-1.1869973261518416,0.2712215320910973,0.5438511306632015,1.0,3/13,12.80%,SLC2A1;SORT1;SLC2A3
prerank,RNA destabilization (GO:0050779),0.5177475315781989,1.186795248906281,0.2857142857142857,0.9002668688650967,1.0,3/18,10.36%,ROCK2;ZC3H18;YTHDF3
prerank,regulation of kinase activity (GO:0043549),-0.3218221430404205,-1.1860117185556653,0.1598639455782313,0.5453900330143573,1.0,23/89,12.71%,TEK;ERBB4;NTRK3;ROR1;EPHB1;PLCE1;EPHA5;MERTK;EPHA6;TIE1;NTRK2;KDR;ROR2;MET;EPHA7;EPHB2;EEF1A1;FLT4;ERBB2;CAMKK2;NLRC5;EMP2;MAPT
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.5213538691276496,-1.1853387905478463,0.2647058823529412,0.5461688415679381,1.0,6/11,27.82%,TERF1;CCT8;CCT2;CCT6A;CCT7;DKC1
prerank,regulation of establishment of protein localization (GO:0070201),-0.48837141514992355,-1.185223777263916,0.24380165289256198,0.5456437905468794,1.0,5/13,16.82%,CTSD;CORO2B;GAPVD1;PTP4A3;DNAJA1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4182562515944288,1.1850717926907253,0.21630094043887146,0.9047772048905844,1.0,9/51,5.17%,ROCK2;LPAR1;CCN2;ARHGEF10L;FHOD1;PPM1E;TGFBR1;RAPGEF3;TPM1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.48589462817007956,-1.1848486811553802,0.2594142259414226,0.5456729869681757,1.0,8/15,21.77%,RPL5;RPS7;SMAD7;RPL23;MAD2L1;RPL11;BAG5;BAG2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.5295565268400477,1.184432444374611,0.28884826325411334,0.9054324828169271,1.0,2/14,0.89%,ACE;CORIN
prerank,organic anion transport (GO:0015711),-0.33651929585746165,-1.1841714267620258,0.1952054794520548,0.5466197487573908,1.0,10/76,6.92%,SLC4A10;ABCC4;ABCG2;SLC26A7;SLCO1C1;LRRC8C;LRRC8D;SLCO2B1;CA4;CA2
prerank,response to ionizing radiation (GO:0010212),0.39829173847282484,1.1839834861120695,0.23615160349854228,0.9055225924453005,1.0,23/70,20.25%,EYA1;BABAM2;ATM;NHEJ1;TP53;RNF8;XRCC4;SIRT1;BRSK1;HUS1;UIMC1;BABAM1;GADD45A;BRAT1;INTS3;CLK2;INTS7;MAPK14;MTA1;FANCD2;LIG4;TANK;RAD9A
prerank,monocyte differentiation (GO:0030224),-0.5293430432142264,-1.183713558436307,0.27524752475247527,0.5468410515183476,1.0,6/10,15.38%,MYH9;MT1G;BMP4;THOC5;VEGFA;IL31RA
prerank,positive regulation of cell development (GO:0010720),-0.3941659522973262,-1.1834976295865927,0.21707317073170732,0.5465350656173491,1.0,9/31,19.59%,PDE3A;SERPINF1;MME;NAP1L1;GPER1;BMP4;CX3CR1;RFX3;TYROBP
prerank,actin nucleation (GO:0045010),-0.43677187085393265,-1.1832695485534523,0.25176470588235295,0.5462441162821018,1.0,6/21,13.80%,ACTR2;ACTR3;TRIM27;ARPC1B;ARPC5;ARPC4
prerank,iron ion transmembrane transport (GO:0034755),-0.5310334639257974,-1.1832074275875257,0.27906976744186046,0.5455904015851564,1.0,5/10,28.24%,SCARA5;SLC40A1;SLC25A28;SLC39A14;SLC25A37
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4420441794009154,-1.1830395116452954,0.24890829694323144,0.5451780754178726,1.0,8/19,15.28%,PLCE1;PPP3R1;NFATC1;PPP3CA;EDN1;EDN3;PPP3CC;HRH1
prerank,Notch signaling involved in heart development (GO:0061314),0.5514993261015371,1.1829466058081863,0.2888015717092338,0.9076313739710737,1.0,1/11,0.19%,NOTCH2
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.4218656151484978,-1.1827047339276184,0.23809523809523808,0.5451779666057031,1.0,4/25,1.39%,SLC8A1;TMTC2;CAV1;ANK3
prerank,skeletal system development (GO:0001501),0.35735371593048376,1.1825369377910224,0.19206145966709348,0.9075569393543595,1.0,25/148,9.22%,WWOX;BMP6;BMP7;DYM;IGF1;FGFR2;GLI2;SOX5;NPR3;AKAP13;FGFR1;SUFU;TGFBR1;SULF2;CREB3L2;COL9A2;SH3PXD2B;COL13A1;FBN1;COMP;RBP4;CHD7;COL1A2;EXTL1;HYAL1
prerank,oxoacid metabolic process (GO:0043436),0.47444503364339996,1.1818638320532324,0.2669983416252073,0.9083698621775264,1.0,4/27,12.05%,DDO;ABHD14B;SULT2B1;TPST1
prerank,limb morphogenesis (GO:0035108),-0.4452205102893737,-1.1818511797852882,0.24611973392461198,0.5464979731418359,1.0,5/20,7.71%,MBNL1;TGFB2;TBX3;PTCH1;PCSK5
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3801234606315581,1.181808842368395,0.19577464788732393,0.9070468171497208,1.0,30/104,16.65%,KSR1;SLC8A3;CCNA2;PPEF2;CCNA1;DDX3X;UVRAG;CAMK1;TRIB2;SLC27A1;CCNT2;CCND3;CDK5RAP3;HTT;CDC25A;SIRT1;GTPBP4;CCNB2;IRGM;ABL1;TRIB1;MAP2K1;MAP2K2;GADD45A;CCNG1;SNF8;RPTOR;RB1;CCNE1;TELO2
prerank,protein ubiquitination (GO:0016567),0.3255037586932241,1.1813737609360055,0.1259500542888165,0.9070866743113829,1.0,104/471,19.26%,RNF220;EPAS1;RNF152;PDZRN3;SH3RF2;UBE2E2;RNF43;ASB2;SASH1;PRKN;FBXL17;SPSB1;TRIM63;RNF213;CTR9;DTX1;CAND2;NEDD4;RNF151;RNF135;FBXL19;KLHL41;ARRB1;USP9X;RNF181;SPSB4;MGRN1;UBR2;SMURF2;RNF8;FBXW11;RNF141;HUWE1;TRIP12;FBH1;RNF217;TNKS2;BTRC;RNF19A;KLHL7;EIPR1;RNF34;HERC6;SIRT1;NPEPPS;UBR5;FBXO22;ZSWIM8;FBXL12;SH3RF1;RTF1;RNF41;FBXW8;FBXO4;RNF13;PRKDC;WWP2;PEX10;CUL4A;CUL9;UBA6;FBXO10;NUB1;ASB5;USP7;TRIM62;ASB12;DDB2;FBXO11;DTX3;FBXL20;SDE2;DZIP3;LONRF1;PEX14;UBE2H;RNF115;RMND5A;AMFR;RNF31;ANAPC16;RNF146;BIRC6;RNF19B;UBR1;RNF7;UBE2E1;KCTD13;SYVN1;PEX5;CDC34;RNF25;FBXW10;RNF20;CCDC22;TAF1;ARIH1;MIB2;ASB1;NHLRC3;UBE4B;FBXL22;KLHL18;MIB1
prerank,membrane raft organization (GO:0031579),-0.4724802568405112,-1.1812997678171993,0.23404255319148937,0.5470443754874902,1.0,7/15,24.46%,RFTN1;PPT1;EMP2;MYADM;S100A10;FLOT1;NAXE
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3142277047268376,-1.1811105233548422,0.099601593625498,0.5466572301691803,1.0,37/114,27.67%,ACTN4;TMSB4X;ST18;PTK2B;TNFRSF11B;NFKBIA;PSMB2;TNFRSF11A;TRAF5;CARD14;TNFRSF1B;PSMD14;PSMC6;ILK;IKBKB;AIM2;LIMS1;PSMA4;PSMB9;EDAR;MAP3K14;TRAF1;TNFRSF25;PSMD11;PSMB10;PSMD2;PYCARD;TXNDC17;PSMA2;RELA;JAK2;TNFSF8;PSMB3;CD40;PSMB5;CDIP1;PSMA7
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.5166681333144069,-1.180922898450122,0.24649298597194388,0.5462836517971645,1.0,9/12,41.00%,GNL3L;CCT8;CCT2;CCT6A;CCT7;DKC1;CCT3;GNL3;CCT5
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4971156380223686,1.1808489801337616,0.27205882352941174,0.9073535028903769,1.0,2/17,0.55%,ROBO1;EFNB2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.4265577978957039,-1.1806257281874453,0.2292134831460674,0.5461764350386128,1.0,10/24,24.47%,CXCL12;TPT1;ACKR3;CD44;TAF9B;CLU;CD74;TRIAP1;CCAR2;SNAI2
prerank,positive regulation of transferase activity (GO:0051347),-0.3055930230882444,-1.1804643160454114,0.12272727272727273,0.5457783245288882,1.0,34/142,14.68%,TEK;ERBB4;NTRK3;ROR1;CD200;EPHB1;EPHA5;MERTK;EPHA6;PARM1;TIE1;NTRK2;HSP90AB1;NEK7;KDR;ROR2;MET;EPHA7;SORL1;EPHB2;TGFB1;FLT4;RPS2;ERBB2;HSP90AA1;SERINC1;XRCC5;CTNNB1;ARRDC4;AXIN1;SERINC5;RET;PINK1;FGFR3
prerank,receptor clustering (GO:0043113),-0.4054103326326827,-1.1804539207638167,0.2206896551724138,0.544999341994249,1.0,9/27,11.23%,NLGN1;DLG2;NRXN1;LRRC7;FLNA;ITGA4;PTN;AGRN;NRXN2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5013737948604162,1.1799655513268643,0.266304347826087,0.9089894379536526,1.0,5/19,9.78%,TLR3;TLR4;DDX3X;RIPK2;MAVS
prerank,regulation of cellular component size (GO:0032535),0.4619533180226293,1.1793524041441477,0.2656514382402707,0.9095379416466184,1.0,10/30,15.84%,PICALM;PEX11A;EZR;RIN3;PTEN;PEX11B;RARG;RAB22A;VAV3;RPTOR
prerank,cellular response to interleukin-1 (GO:0071347),-0.2986763140477635,-1.1790438421685747,0.12612612612612611,0.5476188837181839,1.0,48/143,29.52%,RPS6KA5;IL1R1;IL1RAP;ST18;NOD1;PTGIS;NFKBIA;PSMB2;DAB2IP;MAP3K7;IRAK3;PSMD14;EGR1;CD47;PSMC6;IKBKB;HIF1A;UBB;PSMA4;PSMB9;PELI1;NOD2;CCL13;SKP1;PSMD11;PSMB10;PSMD2;CCL19;HAS2;SFRP1;PYCARD;PSMA2;UBC;RPS27A;RELA;HYAL2;PSMB3;TAB1;CD40;CCL2;PSMB5;PSMA7;MAP3K8;IRAK4;MAPK3;PSMF1;TOLLIP;PSMD7
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3333103852726654,-1.178830310323,0.1610738255033557,0.5472790144330654,1.0,21/75,13.89%,PTPRM;TEK;SEMA6A;CLDN5;PDE3B;DCN;THBS1;TGFB2;COL4A2;SEMA3E;DAB2IP;SERPINF1;HSPG2;STAB1;AMOT;ATP2B4;CTNNB1;ISM1;ECSCR;ADGRB1;SPRED1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3539344648273588,-1.1786791899486238,0.17350157728706625,0.5468369595262382,1.0,22/55,34.29%,FBXL7;PSMB2;PSMD14;PSMC6;ATF5;PSMA4;PSMB9;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;PSMB3;FHL1;PSMB5;PSMA7;PSMF1;PSMD7;AURKA;PSMA5;PSMD4;PSME4
prerank,regulation of developmental growth (GO:0048638),-0.3972367911178943,-1.1785555059245905,0.22302158273381295,0.5463577488802237,1.0,10/29,14.68%,GHR;GSK3B;APOE;APP;NRCAM;SIX1;STAT5B;MFSD2A;SPAAR;FGFR3
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.42445557978414944,1.1784068805524317,0.24416796267496113,0.9113779313193519,1.0,6/48,13.91%,PRKAG2;GCK;NUP42;NUP98;NUP43;OGT
prerank,organophosphate biosynthetic process (GO:0090407),0.44124561734379203,1.178294726589197,0.2649434571890145,0.9102886830494424,1.0,14/37,20.17%,AGPAT4;GPAT2;CPS1;GK5;MOCOS;GK;ITPKB;PPIP5K2;GPAM;TPK1;NFS1;IP6K3;PCYT2;MOCS1
prerank,negative regulation of gene expression (GO:0010629),0.33570139376649616,1.1779767881220047,0.1381345926800472,0.9098978771579742,1.0,64/302,15.76%,NOTCH2;ROBO1;LGR4;SLC24A3;ROCK2;WNT4;SYT11;PICALM;IGF1;PRKAA2;PRKN;DNMT3A;JARID2;TNRC6A;NCOR2;BMPR1A;PARP10;PARP14;SRGN;SMO;IGF2BP1;DDX3X;TIPARP;CD28;EIF2AK2;TWSG1;PTPN22;TNRC6B;SAMD4A;RBL2;LARP1;CPEB3;TERT;APLN;IGF2BP2;CNOT10;PARP9;SIRT1;HDAC1;LRP3;MOV10;LSM14A;RBL1;CRKL;WWP2;NOCT;DICER1;ZNF148;DDX6;FLOT2;PHF1;SNX12;MAP2K1;NCOR1;MAP2K2;FLCN;TSC1;KAT2B;TNRC6C;NFKB1;ANXA7;MPHOSPH8;SETDB2;RBM4
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.47165960241621707,1.1774973358407872,0.2736842105263158,0.9101063600023522,1.0,7/27,3.91%,ARHGAP28;CGNL1;PRKN;ARHGEF18;CLASP1;ARHGAP6;PPFIA1
prerank,prostanoid metabolic process (GO:0006692),0.5439996410961481,1.1774366549692037,0.30111524163568776,0.9087890101790194,1.0,2/13,9.98%,PTGS1;PTGR2
prerank,actin filament bundle organization (GO:0061572),0.44353195485896524,1.1773485685151757,0.24290220820189273,0.9075809139935884,1.0,6/33,6.38%,PAWR;SHROOM2;RHOD;EZR;BAIAP2L1;BAIAP2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.48309093908633866,1.177165230086474,0.2793594306049822,0.9066878084059213,1.0,9/23,22.62%,NMT2;METAP2;RHO;FNTB;SAG;FNTA;PDE6B;GRK4;CAMKMT
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.43575184752099033,1.1771057322183938,0.26485568760611206,0.9053556709009588,1.0,6/37,9.01%,APPL2;PPARA;TLR4;F2;IL17D;IL17RA
prerank,hyaluronan catabolic process (GO:0030214),-0.4476341330355268,-1.1770818253511988,0.24475524475524477,0.5489907957034703,1.0,5/18,9.92%,CEMIP;TGFB1;HEXB;FGF2;CD44
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3672632086390769,1.1769324681059818,0.1906779661016949,0.9044770707643011,1.0,10/107,3.59%,ATP13A5;SLC24A3;SLC41A1;ANK2;ATP13A3;SLC8A3;SLC30A10;PKHD1;CSRP3;DMPK
prerank,alpha-amino acid metabolic process (GO:1901605),0.42742439935604615,1.176863552233404,0.2564885496183206,0.9032287271314745,1.0,13/45,12.51%,ASPA;ASPG;CPS1;KYAT3;GPT2;GOT2;MTHFR;SRR;GLUL;SLC25A12;NOX4;MTRR;FOLH1
prerank,bicellular tight junction assembly (GO:0070830),0.42186305324156886,1.1767025238706061,0.2532467532467532,0.9022918641956162,1.0,9/46,13.42%,PARD6G;AFDN;DLG1;MPP7;CDH5;RAB13;PATJ;PRKCI;PARD3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4642775572459753,1.1764731812886984,0.2639593908629442,0.9016319034724981,1.0,7/27,14.06%,DDX5;ATM;YJU2;SIRT1;DYRK1A;KMT5A;SNAI1
prerank,regulation of amyloid-beta formation (GO:1902003),0.44403080037856296,1.176184613501054,0.24267100977198697,0.9011909245401469,1.0,5/34,3.53%,ROCK2;PICALM;IGF1;EPHA4;CASP3
prerank,inorganic cation import across plasma membrane (GO:0098659),0.38974804399211554,1.1760656976113433,0.22372372372372373,0.9000941271647446,1.0,5/75,1.99%,ATP1A2;SLC6A1;ATP1B3;KCNJ13;SLC8A3
prerank,regulation of peptide hormone secretion (GO:0090276),0.38868824611425906,1.17580565341488,0.23880597014925373,0.8994848205701225,1.0,12/67,9.70%,CACNA1D;ITPR2;ITPR1;KCNA5;ADRA2A;RAPGEF3;DPP4;CACNA1C;GCK;CHD7;EIPR1;PICK1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.46129381993934615,-1.17564830853461,0.2350230414746544,0.5515901343069224,1.0,10/19,9.43%,CSGALNACT1;HS6ST2;NDST3;HS6ST3;HS3ST5;EXT1;XYLT1;GLCE;NDST4;EXT2
prerank,male meiosis I (GO:0007141),0.526492834944772,1.1755537676981618,0.29853479853479853,0.8988837495871195,1.0,4/16,12.98%,CCNA1;MOV10L1;MYBL1;FOXJ2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.38951736807728765,1.1747996585904072,0.23512747875354106,0.9001203584762111,1.0,22/76,18.65%,DAB2;SH3RF2;PRKN;LRRK2;PIAS1;TRIB2;PTEN;RNF217;CDK5RAP3;RNF19A;CSNK1A1;FBXO22;TRIB1;NUB1;DNAJB2;ZYG11B;HECTD1;RNF19B;CCDC22;TAF1;ARIH1;SUMO1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.419974356517252,-1.1746856705752247,0.23933649289099526,0.5530229561205168,1.0,10/24,16.75%,PTK2B;APOE;CTSC;PSMD14;PKD1;PINK1;UBB;GPX1;USP14;UBE3A
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4893966641713681,1.1746457323048416,0.27979274611398963,0.8991602007420991,1.0,3/20,4.75%,ATP1A2;ANK2;CACNA1C
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.5263509440669276,-1.1744370564241589,0.2857142857142857,0.5527898200380079,1.0,8/10,46.00%,SMAD7;NFKBIZ;RC3H2;MALT1;IL4;ZC3H12A;FOXP3;TBX21
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.34588589995676705,-1.1743913179395664,0.19948186528497408,0.5521131184605436,1.0,11/53,15.28%,CALCRL;CHRM3;HTR2C;ANXA1;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5139491015764103,1.1743683929617386,0.2849462365591398,0.898643481824166,1.0,3/16,6.37%,PIGN;PIGW;PIGQ
prerank,negative regulation of MAPK cascade (GO:0043409),0.3818318460794533,1.1740921162861266,0.22531293463143254,0.8981020241566693,1.0,10/87,5.16%,BMP7;DUSP29;FBLN1;TIMP3;DLG1;CD300A;PPEF2;DAG1;EZR;TLR4
prerank,regulation of ion transport (GO:0043269),0.38257428656434045,1.1738520974387534,0.22321428571428573,0.8974692577730206,1.0,16/76,11.43%,SYT9;KCNJ13;SYT11;SYT12;KCNA5;PRKN;SNX6;NEDD4;DTNBP1;SIK1;GDNF;KCNJ14;HTR1A;RAB11B;SCN10A;WWP2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5233769976393032,1.1736538758752573,0.29609929078014185,0.896679041498687,1.0,2/15,1.44%,ROCK2;IGF1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.3766989624426029,1.1733828480115338,0.1903409090909091,0.8961572670486024,1.0,18/87,11.82%,TGFBR3;SMAD3;APPL2;PRKCZ;ARHGEF18;BMPR1A;TGFBR1;SMAD6;FMOD;USP9X;TWSG1;TGFBR2;COL1A2;CDH5;SIRT1;ZMIZ2;ZMIZ1;GDF15
prerank,regulation of microtubule-based process (GO:0032886),-0.3760246511746204,-1.1730497276410912,0.1978319783197832,0.5544902039280788,1.0,14/36,16.95%,CLASP2;EFNA5;PHLDB1;GSK3B;MAP6;ERBB2;MARK2;FAM107A;TRIM36;MAPT;BICD2;ATF5;TPPP;APC
prerank,C4-dicarboxylate transport (GO:0015740),-0.49034332323520624,-1.1730002880174482,0.27074235807860264,0.5538297465356641,1.0,4/14,5.29%,LRRC8D;SLC1A2;SLC1A1;SLC25A13
prerank,cardiac muscle cell differentiation (GO:0055007),-0.4312497282774418,-1.172630202898087,0.2642857142857143,0.5538825525045681,1.0,7/21,13.77%,SLC8A1;MEF2C;BMP2;MYH11;ACVR1;MYOCD;VEGFA
prerank,electron transport chain (GO:0022900),0.5285975981522106,1.1725130934056776,0.2825278810408922,0.8977470695777675,1.0,2/15,5.35%,PPARGC1A;POR
prerank,negative regulation of kinase activity (GO:0033673),0.40383017597604265,1.1724887497925596,0.2267884322678843,0.8963869623692243,1.0,8/62,8.75%,PRKAG2;PPM1E;DEPTOR;DTNBP1;NPRL2;TRIB2;WWTR1;PDPK1
prerank,central nervous system neuron development (GO:0021954),-0.4682600548968847,-1.172065338968728,0.288135593220339,0.5543541256015685,1.0,6/15,12.71%,NTRK2;HSP90AB1;B4GALT5;LHX6;HSP90AA1;MAPT
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.4770306292275388,-1.1719583734247332,0.26464646464646463,0.553801285617729,1.0,8/15,29.02%,CCT8;CCT2;CCT6A;NHP2;CCT7;RUVBL2;DKC1;NAF1
prerank,lipid transport (GO:0006869),-0.3190180336472472,-1.1711145218650434,0.14046822742474915,0.5550283603958148,1.0,23/97,9.78%,ABCC4;ATP8A1;ATP8B1;SLCO1C1;CERT1;PPARD;PITPNC1;SCARB1;PLTP;SLCO2B1;UGCG;SPNS2;APOE;ABCG1;LDLR;NPC2;GLTP;PITPNB;CEACAM1;STARD5;ABCD2;TNFAIP8L3;MTTP
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4753400628640108,1.1709430146459947,0.2950530035335689,0.9002436969425498,1.0,6/24,3.91%,ARHGAP28;CGNL1;ARHGEF18;CLASP1;ARHGAP6;PPFIA1
prerank,positive regulation of MAPK cascade (GO:0043410),0.3378349654197878,1.1709287607514325,0.17901234567901234,0.8988578339244805,1.0,24/245,6.57%,NOTCH2;FGF1;ROBO1;ROCK2;LPAR1;TPD52L1;KSR1;PRKCZ;KIT;GSDME;IGF1;CCN2;FGFR2;SLC30A10;NPNT;FGFR1;ADRA2A;LRRK2;ARRB1;BRAF;EPHA8;FLT1;PDGFRB;EIF2AK2
prerank,maturation of SSU-rRNA (GO:0030490),-0.37878965221826344,-1.1704724381861926,0.21204819277108433,0.5558408485269372,1.0,5/34,8.78%,RPS8;RPS19;RPS28;RPS16;WDR3
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.37555816617254867,-1.1701953755030974,0.208,0.5557032698659744,1.0,18/40,20.71%,PTK2B;RPL5;RPS7;XPO1;PTK2;GNA12;RPL23;RAD23B;FOXF2;AXIN1;LAPTM5;SMURF1;CLU;HIPK2;UBE3A;PDCL3;COMMD1;RPL11
prerank,protein localization to vacuole (GO:0072665),-0.49709059189359917,-1.1701074858098854,0.2697768762677485,0.5551305619195034,1.0,9/13,35.78%,RTN4;SH3GLB1;SH3BP4;RNF128;CD81;LMBRD1;SZT2;LAMTOR4;MFSD1
prerank,mRNA metabolic process (GO:0016071),0.3794588862327393,1.1697081621360446,0.20804438280166435,0.9013901582147925,1.0,25/90,21.54%,DDX5;PPARGC1A;SON;PCBP2;HNRNPR;SRSF5;TP53;HNRNPA2B1;CNOT10;TBRG4;PRPF18;SRSF11;HIPK3;SCAF11;PRPF3;CPSF3;USP39;ALKBH5;SRSF1;PCF11;U2AF1;DXO;SRSF7;U2AF2;SF3B2
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4553602101052103,-1.169632175401249,0.25217391304347825,0.5554744339046305,1.0,4/16,11.14%,CAV1;HS3ST5;TRIM14;TRIM27
prerank,regulation of monooxygenase activity (GO:0032768),-0.42209342012562495,-1.1694024350717485,0.25295508274231676,0.5552042225057215,1.0,7/23,13.77%,CAV1;NOS3;NOSTRIN;CALM1;HSP90AA1;SNCA;CYGB
prerank,regulation of neuron death (GO:1901214),-0.32596234656286605,-1.1691367583865384,0.17684887459807075,0.5550503229518615,1.0,38/82,23.31%,GRID2;MEF2C;MAP3K5;CD200;EPHB1;DCC;GRIN2B;TRIM2;CD34;GSK3B;TNFRSF1B;SORL1;BTBD10;EGR1;DDIT4;NENF;MAPT;SNCA;CLU;UBB;EGLN2;FAIM2;CHRNA7;DHCR24;HTRA2;CHMP4B;CHMP4A;CTSZ;ITGB2;C1QA;TYROBP;EGLN3;AKT1S1;GRM4;SNCG;FYN;LANCL1;CHGA
prerank,protein targeting to peroxisome (GO:0006625),0.4583691358963699,1.1688041691150333,0.27692307692307694,0.9028977238277504,1.0,11/29,17.34%,ZFAND6;PEX11B;PXMP2;PEX10;PEX14;ACBD5;PEX19;RAB8B;SLC25A17;PEX16;PEX5
prerank,membrane repolarization during action potential (GO:0086011),-0.48810693308436737,-1.1682967831129518,0.29243353783231085,0.5563233801461681,1.0,5/13,8.00%,KCNJ2;ATP1B1;YWHAE;ATP1A1;KCNQ1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5369480761092288,1.1682954034213053,0.30671506352087113,0.9032034992996385,1.0,7/12,22.34%,PTEN;BTRC;CDC14B;FZR1;GOLGA2;UBE2S;GORASP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.32876330927628683,-1.1682785195205858,0.174496644295302,0.5555712984441619,1.0,32/80,18.81%,MAP3K5;THBS1;NOD1;GAS6;NGF;YWHAE;TNFSF10;CTSD;EPHA7;SIAH2;CD44;GRAMD4;ARL6IP1;RPS6KA3;GPER1;SOX7;DAPK1;SNCA;VEGFA;RPS6KA1;CARD16;MT3;PPM1F;PAX2;GPX1;SYK;SOX2;DHCR24;HTRA2;CYCS;FOXL2;BCAP31
prerank,cellular response to hypoxia (GO:0071456),0.3649524997066944,1.1682609548064091,0.21391076115485563,0.901872105369438,1.0,5/126,1.99%,EPAS1;CPEB2;RORA;BMP7;SLC8A3
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.5247742395202868,-1.168177744550462,0.2804878048780488,0.5550514520966636,1.0,6/10,16.82%,CORO2B;NDFIP2;MAPT;PPM1F;TERF1;DNAJA1
prerank,cellular response to amino acid starvation (GO:0034198),0.3928325301401077,1.1679841487108797,0.2540381791483113,0.9013845925071989,1.0,21/71,19.47%,RNF152;NPRL3;SESN1;ATP6V0E1;SESN2;NPRL2;ATP6V0B;EIF2AK2;ATP6V1D;ATP6V1E1;ATF2;IMPACT;DEPDC5;FLCN;KPTN;WDR24;RPTOR;RRAGD;ATP6V0D1;LAMTOR1;ITFG2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.48021689157691433,-1.1677700114877119,0.26124197002141325,0.5552537567034136,1.0,4/14,10.05%,THBS1;MEOX2;NOTCH1;STARD13
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3797842758353041,-1.1677570655117249,0.22572815533980584,0.554500405963505,1.0,8/35,6.44%,GHR;ERBB4;CAV1;CYP1B1;NOTCH1;NLK;PTPRC;HES1
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3317814977789829,-1.167570515199294,0.15755627009646303,0.5541702510874142,1.0,19/72,10.24%,NRP1;ARHGEF28;HEG1;RIT2;ARHGEF3;F11R;RASIP1;NET1;ARHGEF2;STARD8;APOE;MET;PRAG1;KCTD10;MYOC;ARHGDIB;CUL3;STARD13;EPS8
prerank,regulation of cellular component movement (GO:0051270),0.42152076915036557,1.167480573519344,0.24960505529225907,0.9016973966070325,1.0,12/49,11.58%,TGFBR3;ROCK2;PKHD1;ARHGAP18;TGFBR1;PDPN;NRG1;DIAPH1;HBEGF;ZSWIM8;ABL1;ADAM17
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3915419490322029,-1.1660608549066542,0.2356020942408377,0.5570161804349693,1.0,12/33,11.30%,BMPER;RHOJ;SEMA6A;THBS1;PPP1R16B;EPN2;KLF2;SMAD1;CEACAM1;FGF2;JAK1;CREB3L1
prerank,regulation of cellular respiration (GO:0043457),-0.4523761479684125,-1.1659460410792155,0.2650334075723831,0.5565098250742546,1.0,4/17,14.08%,PRDM16;PNPT1;CBFA2T3;NOP53
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5144673870112225,1.1653525298723253,0.30511463844797176,0.9075447073739663,1.0,3/14,7.06%,PRKN;LRRK2;OPA1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5634993412647289,1.1653182238186768,0.2926829268292683,0.9048013846281833,1.0,4/10,13.82%,PPARA;NUPR1;HDAC4;NCOR1
prerank,negative regulation of glycolytic process (GO:0045820),0.5634993412647289,1.1653182238186768,0.2926829268292683,0.9048013846281833,1.0,4/10,13.82%,PPARA;NUPR1;HDAC4;NCOR1
prerank,amino acid import (GO:0043090),0.4791262529133759,1.165038084015764,0.2787769784172662,0.9043614796098205,1.0,3/21,4.62%,SLC6A13;SLC6A1;SFXN2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.4963133566308034,1.1639993931427353,0.3007380073800738,0.9063744360049922,1.0,1/17,0.83%,LPGAT1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.49822374361701766,1.163919965539375,0.2833935018050541,0.9051858900023664,1.0,6/18,17.62%,PPARA;PTPN22;MIA3;WNK1;GPNMB;LAX1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.5312176410955758,1.1637793332220498,0.31401869158878504,0.9042839678275432,1.0,3/12,10.49%,FYCO1;UVRAG;IRGM
prerank,muscle tissue development (GO:0060537),-0.4940271640608311,-1.163274431808974,0.2795031055900621,0.5619032697897762,1.0,6/13,11.37%,PGM5;ENG;PTCH1;CSRP2;STRA6;BMP4
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.47870256002050976,-1.1632472687100535,0.2631578947368421,0.561171034050435,1.0,5/13,10.70%,NFKBIA;YWHAB;FLNA;GOPC;PKD1
prerank,negative regulation of transposition (GO:0010529),0.5231033421765138,1.16287883884945,0.3021978021978022,0.9057662572889034,1.0,5/16,16.40%,UBR2;TUT4;MOV10;MYBL1;TUT7
prerank,protein localization to organelle (GO:0033365),0.356765584364472,1.1623364937469909,0.2062415196743555,0.9061863426453094,1.0,24/133,15.83%,BMP7;ANK2;TULP3;ZNF423;CSRP3;OBSL1;CEP250;LRRK2;LAMP2;DDX3X;TRAM2;TIA1;UBAC2;GBP2;IFT122;PIKFYVE;ATP6V1D;DCP1A;ROPN1;STX5;WDR35;MICALL1;ARL6;BBS2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4239609065238794,-1.1623331728341197,0.275,0.562652646447145,1.0,7/21,11.53%,MEF2C;HSP90AB1;CALM1;CALM2;BMP2;CALM3;MTMR9
prerank,negative regulation by host of viral process (GO:0044793),0.5575038860097541,1.1620775346672918,0.31521739130434784,0.9056660139707,1.0,1/10,1.98%,PRKN
prerank,spliceosomal complex assembly (GO:0000245),0.41784042819679923,1.1619508106060763,0.27874015748031494,0.9046956789455851,1.0,13/46,22.74%,CELF2;SRSF5;KHDC4;LUC7L3;SRPK2;SCAF11;USP39;PRPF6;SRSF1;SRSF10;SF1;SF3B1;GCFC2
prerank,sterol transport (GO:0015918),-0.4472977416921323,-1.1616055083899177,0.2611607142857143,0.5636137216068624,1.0,9/19,32.22%,CAV1;LDLR;NPC2;LDLRAP1;OSBP;STARD3;CD36;MSR1;NPC1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3257201792761837,1.1615936061750938,0.16608187134502925,0.9044375913814922,1.0,45/348,10.61%,FGF1;ROBO1;BMP6;BMP7;AFDN;SLC24A3;SMAD3;ROCK2;ANK2;OSR1;PPARGC1A;IGF1;WNT6;PRKN;FOXD1;TNRC6A;MAGI2;MITF;TGFBR1;DTNBP1;TLR3;EZR;SMO;CTSH;CUX2;TLR4;ATM;DDX3X;ARRB1;MAP2K5;BRAF;CD28;TP53;PTPN22;PLSCR1;TNRC6B;CDH5;CALCOCO1;TLE1;LRP3;PICK1;UBR5;MOV10;PIK3R3;SRPK2
prerank,regulation of astrocyte differentiation (GO:0048710),-0.497474820942986,-1.1613861142590463,0.2654320987654321,0.5633374344365205,1.0,6/12,10.04%,SERPINE2;NOTCH1;HES1;BIN1;BMP2;ID2
prerank,female gonad development (GO:0008585),0.4786419478179964,1.161258042934164,0.2912801484230056,0.9041847765167721,1.0,2/19,3.08%,KIT;NR2F2
prerank,steroid catabolic process (GO:0006706),0.5624105908633897,1.1606052575954025,0.324853228962818,0.9050640055243211,1.0,1/10,2.52%,SPP1
prerank,protein tetramerization (GO:0051262),0.3943438895302214,1.1605786378277572,0.2478386167146974,0.9037825529456794,1.0,9/67,9.81%,ALDH1A2;APPL2;UPB1;KRT1;SOD2;SAMHD1;SSBP1;CBY1;CTH
prerank,regulation of neurotransmitter transport (GO:0051588),-0.46592679303692663,-1.1604184424279673,0.26526315789473687,0.5649407860084467,1.0,3/16,2.23%,MEF2C;MCTP1;RIMS1
prerank,negative regulation of leukocyte activation (GO:0002695),-0.458194521070766,-1.1603378124034038,0.2648305084745763,0.5643680986778151,1.0,6/15,15.38%,CD200;LRFN5;GPER1;HAVCR2;CD84;IL31RA
prerank,extracellular structure organization (GO:0043062),0.3363800129400538,1.160138812017725,0.1918819188191882,0.9038850893409106,1.0,32/204,8.64%,SMOC1;COL5A1;ADAM12;ADAMTS10;LAMA4;COL22A1;LAMC2;COL4A5;SMOC2;ITGA9;LAMC1;NPNT;SPP1;COL18A1;COL4A3;LOXL1;ADAMTS2;TGFBR1;ADAMTS15;DAG1;ITGA10;ADAMTSL5;ADAMTS9;COL9A2;COL13A1;FBN1;SERPINE1;COMP;COL4A4;COL1A2;MMP19;COL27A1
prerank,programmed necrotic cell death (GO:0097300),0.49519759299658517,1.1594169877828708,0.2776735459662289,0.9048466498978035,1.0,5/18,10.97%,TLR3;TLR4;DNM1L;RIPK1;LY96
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.37404759809166277,-1.1594043651406525,0.2222222222222222,0.5658834002535078,1.0,12/39,16.11%,PTPRJ;SH3KBP1;PTPN12;SH3GL2;ARHGEF7;DAB2IP;ERBB2;DUSP3;PTPN3;SPRY1;ZFYVE28;CBL
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4789846644582524,1.1592731124609144,0.2802013422818792,0.9039560749046113,1.0,3/21,4.12%,ROCK2;ERRFI1;MAFG
prerank,regulation of DNA recombination at telomere (GO:0072695),0.48248315243305573,1.159011571602951,0.2900355871886121,0.9020651361004769,1.0,4/19,7.53%,POLR2A;ATRX;ACD;POLR2D
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.48248315243305573,1.159011571602951,0.2900355871886121,0.9020651361004769,1.0,4/19,7.53%,POLR2A;ATRX;ACD;POLR2D
prerank,protein K11-linked ubiquitination (GO:0070979),0.45803971202413063,1.1583617211531845,0.2883031301482702,0.9028189098342773,1.0,3/27,5.78%,UBE2E2;PRKN;ANAPC2
prerank,cellular response to peptide (GO:1901653),-0.34588542319113225,-1.1583441736162292,0.22465753424657534,0.5676802111182484,1.0,15/56,12.51%,GRM5;CAV1;CACNA2D1;VCAM1;NOD1;ARHGEF2;GSK3B;ICAM1;APP;GRIN2A;PSEN1;ITGA4;RPL23;GPER1;VIM
prerank,negative regulation of biosynthetic process (GO:0009890),0.5156140024457481,1.1579905864248596,0.28825622775800713,0.9027514249359279,1.0,2/16,2.04%,PPARA;SLC30A10
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.4937991465446294,1.1577816342067127,0.28698752228163993,0.9020837141234306,1.0,6/19,16.03%,POLD2;AMPD3;TERT;AMPD2;POLL;APRT
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.37993112815517494,-1.1573592374831205,0.2347417840375587,0.5691925804236223,1.0,8/30,11.60%,SPTBN1;ANK3;RAB31;VAMP4;PREPL;NSF;GCC2;GOLGA7
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.36374925897992477,-1.1569702936003563,0.23850574712643677,0.5693638231798118,1.0,16/44,17.96%,THBS1;GAS6;NGF;YWHAE;SIAH2;CD44;ARL6IP1;RPS6KA3;SNCA;VEGFA;RPS6KA1;CARD16;MT3;PAX2;GPX1;DHCR24
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.4596597677797569,-1.156778058679363,0.2731182795698925,0.5690384915142449,1.0,5/16,8.77%,ST6GALNAC3;ST8SIA4;ST8SIA1;ST6GALNAC5;ST8SIA6
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5333531150170969,1.1559151915385166,0.3132295719844358,0.9069837232262371,1.0,2/12,7.54%,TLR4;RBP4
prerank,regulation of endocytic recycling (GO:2001135),0.5426986510103271,1.155778360604454,0.30666666666666664,0.9061067019797263,1.0,3/11,10.14%,ACTN2;EIPR1;RAB11B
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.41757126255639654,-1.1557464466669398,0.23787528868360278,0.5705820711955277,1.0,8/22,11.04%,AKAP6;RYR2;ATP1B1;VMP1;CALM1;CALM2;CALM3;JPH2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5100309694428559,1.155485975691585,0.30978260869565216,0.905773048025738,1.0,4/16,16.81%,APPL2;SIRT4;NCOR1;ERLIN2
prerank,focal adhesion assembly (GO:0048041),0.4800290870326591,1.1550432091867384,0.3023255813953488,0.9058693932716266,1.0,3/21,2.19%,ACTN2;SORBS1;RHOD
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4414756907222233,1.1547523633960146,0.2597623089983022,0.9054613497315475,1.0,5/33,9.30%,APPL2;STXBP4;PLK5;PTEN;GLI1
prerank,embryonic skeletal system development (GO:0048706),0.4348714351019823,1.1546650050602085,0.2694214876033058,0.9043984606846183,1.0,11/35,13.29%,OSR1;HOXB4;SULF2;HOXB3;HOXB9;HOXA3;RBP4;HOXC4;DYNC2I1;DEAF1;SULF1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.5344411189468642,1.1545338342369462,0.3333333333333333,0.9034346494766284,1.0,9/14,29.19%,SEC31B;MIA3;SEC31A;SCAP;SEC24C;SEC24A;SEC13;SEC24D;SEC23B
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4237762637208122,1.1540531098548368,0.270935960591133,0.9036804242677208,1.0,7/40,6.37%,LPAR1;KIT;LPAR2;FGFR1;ARHGAP6;FLT1;PDGFRB
prerank,positive regulation of ossification (GO:0045778),0.4287513802129428,1.1539052987026042,0.2818471337579618,0.9028248643278816,1.0,6/39,3.18%,BMP6;BMP7;WNT4;OSR1;KL;BMPR1A
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.368099121308172,-1.1537315110319064,0.24561403508771928,0.5744597476234089,1.0,12/39,7.95%,ROBO2;MAML2;NOS3;TGFB2;STAT3;CCN3;JAG1;NOTCH1;IL6ST;EPN2;TSPAN14;JAG2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.41679431338570616,-1.1536325858659178,0.2681818181818182,0.5738802687343593,1.0,8/21,11.01%,LIMCH1;EFNA5;PEAK1;ACTG1;GPM6B;CORO1C;PTK2;DUSP3
prerank,negative regulation of cell projection organization (GO:0031345),0.4167270193610192,1.153557965760455,0.27838258164852253,0.9026008757191119,1.0,7/48,8.38%,EFNB2;LPAR1;EPHA4;PTPN9;CBFA2T2;PTEN;DENND5A
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5254853628303141,-1.153343358305221,0.2905263157894737,0.5737478709141818,1.0,2/10,5.71%,ACTN4;TBX1
prerank,regulation of synapse organization (GO:0050807),-0.4038414995950655,-1.152925368651413,0.27053140096618356,0.5740070971051164,1.0,4/26,4.04%,CTNNA2;MEF2C;IL1RAPL1;CDKL5
prerank,response to cholesterol (GO:0070723),0.5037734456536282,1.1527681845373414,0.30919765166340507,0.9038935516235981,1.0,4/17,7.34%,GRAMD1B;TGFBR1;SMO;TGFBR2
prerank,regulation of cellular response to heat (GO:1900034),-0.32658159496105194,-1.1527141618294188,0.19637462235649547,0.5737041270696392,1.0,32/77,29.93%,CAMK2D;CD34;YWHAE;HSP90AB1;GSK3B;HSPA8;HSP90AA1;NUP210;MAPT;DNAJC2;HSPB8;RPA1;FKBP4;CAMK2B;HSPH1;NUP107;DNAJB1;PTGES3;AKT1S1;BAG5;BAG2;POM121;CCAR2;NUP93;NUP85;NUP50;MLST8;NUP54;HSF1;MAPK3;RPA3;CAMK2A
prerank,establishment of protein localization to membrane (GO:0090150),0.39206396040390656,1.152515242772196,0.26165413533834586,0.9033687718846605,1.0,26/66,24.34%,AFDN;SYNE3;BID;RAB3IP;BRAF;PIKFYVE;RAB11B;ZDHHC18;ZDHHC1;MYO1C;PRKCI;PARD3;MICALL1;VPS37A;ARL6;RABGEF1;ZDHHC23;GORASP2;NECTIN3;ZDHHC12;GORASP1;SDCBP;ICMT;ZDHHC19;RAB10;RAB3GAP1
prerank,cellular component assembly (GO:0022607),-0.2736218451155388,-1.1525033812672563,0.11052631578947368,0.573448230729708,1.0,51/253,13.12%,NLGN1;SPTBN1;RHOJ;SLC2A1;GSN;ANK3;ACTB;MYO1B;REPS2;RIMS1;RTN4;PARVB;IL1RAP;LIN7A;PTK2B;LRRTM3;PCLO;ACTG1;SKAP2;GAS6;VMP1;GPM6B;LIMA1;PLS1;FLNA;HES1;OCLN;DCX;CD2AP;PPP2R1A;ELOB;LIMS2;TGFB1;TUBGCP2;RP1;RHOH;ADD2;SHROOM1;ARL6IP1;EPS8;PDGFA;CALD1;CAPZA2;CLDN14;FAM107A;ILK;SPEF1;FAS;LPXN;MDN1;DMTN
prerank,lysosome organization (GO:0007040),0.43110641396236654,1.1521042954772698,0.27197346600331673,0.9033709731869185,1.0,13/36,20.57%,HOOK2;LRRK2;TPP1;CLN6;ARSB;HPS1;MBTPS1;ZKSCAN3;HOOK3;MYO7A;LAMTOR1;TPCN2;SNAPIN
prerank,regulation of regulated secretory pathway (GO:1903305),0.4351378550025744,1.1517206823730248,0.2977624784853701,0.9032567443939212,1.0,5/34,4.05%,SYT9;SYT11;SYT12;LRRK2;DTNBP1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3144595224863372,-1.151309929624618,0.16065573770491803,0.5755367497721057,1.0,32/91,22.56%,ABCG2;SCARA5;SLC39A10;FTH1;HMOX2;TFRC;SLC40A1;APP;FBXL5;FTL;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;ATOX1;SLC30A1;SLC31A1;SLC39A12;MT3;SLC22A17;ISCU;SKP1;CAND1;GLRX3;IREB2;MT2A;SOD1;CYBRD1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4744541995294401,1.1512841285405235,0.3125,0.9033825319886472,1.0,2/22,1.52%,MAN1A2;MAN1C1
prerank,regulation of extracellular matrix organization (GO:1903053),0.5097736277979257,1.1510837256943751,0.30335097001763667,0.9027226369824112,1.0,1/15,0.12%,AEBP1
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.45077350310556585,-1.1506521255220417,0.28199566160520606,0.5755257902932348,1.0,7/16,13.12%,THBS1;CLASP2;ACVRL1;CORO1C;APOD;FAM107A;DMTN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.45077350310556585,-1.1506521255220417,0.28199566160520606,0.5755257902932348,1.0,7/16,13.12%,THBS1;CLASP2;ACVRL1;CORO1C;APOD;FAM107A;DMTN
prerank,neural tube development (GO:0021915),0.5092918508979674,1.1505390949055017,0.3057199211045365,0.9031622144548851,1.0,1/15,0.34%,ALDH1A2
prerank,positive regulation of phagocytosis (GO:0050766),-0.36192029341895177,-1.1498790936129766,0.24,0.5765911098704638,1.0,12/47,10.68%,PTPRJ;MERTK;GAS6;RAB31;PTPRC;RAB27A;GATA2;CALR;CD47;DOCK2;C4B;CYBA
prerank,import into cell (GO:0098657),0.41612785448989575,1.1497552497329764,0.2841091492776886,0.9043734580361061,1.0,8/41,9.52%,ATP1A2;SLC6A13;SLC5A3;SLC19A1;SLC27A1;SLC38A1;SLC1A3;GLUL
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.4644092275665793,-1.1495514090695784,0.2967479674796748,0.576592824457133,1.0,5/15,13.29%,RTN4;REEP1;RAB18;ARL6IP1;ATL2
prerank,glucose transmembrane transport (GO:1904659),-0.43290586854386903,-1.1494183939622638,0.2680652680652681,0.5761243843955692,1.0,5/18,18.25%,SLC2A1;PPARD;SORT1;SLC2A3;SLC45A1
prerank,synaptic vesicle endocytosis (GO:0048488),0.43027867366823913,1.1493015398649336,0.2908496732026144,0.9045210955711799,1.0,6/33,4.58%,DNAJC6;PICALM;NLGN2;STON1;CEL;SYNJ2
prerank,cell-substrate junction assembly (GO:0007044),0.44272171507076896,1.1491149164137826,0.2895174708818636,0.9037594320630689,1.0,5/33,2.19%,ACTN2;SORBS1;LAMC2;LAMC1;RHOD
prerank,aortic valve morphogenesis (GO:0003180),-0.38879125211782095,-1.1484855665466174,0.25,0.5776283092842385,1.0,13/30,12.48%,SLIT2;ROBO2;ELN;NOS3;TIE1;JAG1;NOTCH1;HEYL;NFATC1;TGFB1;HEY2;BMP4;TWIST1
prerank,B cell activation (GO:0042113),-0.32842334814679003,-1.1482964691081856,0.20113314447592068,0.5772841027172169,1.0,10/68,7.96%,MEF2C;PTPRJ;TPD52;VCAM1;HDAC9;PTPRC;PLCG2;ITGB1;ITGA4;EPHB2
prerank,regulation of cholesterol efflux (GO:0010874),-0.3913848586056873,-1.148069928255804,0.25995316159250587,0.5770364738369473,1.0,7/30,10.66%,CAV1;PLTP;NFKBIA;APOE;PTCH1;SREBF2;EEPD1
prerank,protein oxidation (GO:0018158),0.5418109349243139,1.1479297117512166,0.3302411873840445,0.9064835867923131,1.0,2/11,4.57%,LOXL1;LOXL3
prerank,positive regulation of cholesterol transport (GO:0032376),-0.392926001850927,-1.147030003521763,0.24178403755868544,0.5786813463138152,1.0,7/27,14.29%,CAV1;PLTP;NFKBIA;APOE;PTCH1;EEPD1;ABCB4
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.31405803956138767,-1.1469182545636536,0.1793103448275862,0.5781990108848621,1.0,34/92,15.16%,NRP1;TEK;BMPR2;RTN4;THBS1;CLASP2;TGFB2;NRP2;PTK2B;SCARB1;DOCK1;EPB41L4B;KDR;GPI;IQSEC1;FOXP1;PLCG2;RHOB;PROX1;CALR;ATOH8;FGF2;FLT4;BCAR1;ITGB3;EDN1;ENPP2;BMP4;HIF1A;FGF7;PRKD1;VEGFA;PPM1F;RRAS
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5411114354200813,1.1468388102819143,0.34296724470134876,0.9074332169673893,1.0,6/11,26.19%,TNRC6A;TNRC6C;RBM4;AGO1;AGO4;AGO2
prerank,miRNA mediated inhibition of translation (GO:0035278),0.5411114354200813,1.1468388102819143,0.34296724470134876,0.9074332169673893,1.0,6/11,26.19%,TNRC6A;TNRC6C;RBM4;AGO1;AGO4;AGO2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3758714271954424,1.146805573340988,0.27601809954751133,0.906200170631956,1.0,17/85,14.24%,DENND4A;NOTCH2;IGF1;ARHGEF18;KANK2;AKAP13;ARHGAP17;SYNGAP1;EPS8L2;OPHN1;CRKL;EPS8L1;MAPKAP1;DENND4C;OGT;MFN2;FLCN
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.4916296338309187,-1.1466991650267222,0.2958579881656805,0.5779525722907009,1.0,4/12,4.53%,SYT1;RIMS2;RIMS1;UNC13B
prerank,cellular amide metabolic process (GO:0043603),0.36643682852869514,1.1462193778814949,0.24142857142857144,0.906831675517694,1.0,26/102,19.62%,AEBP1;ST6GAL1;PCCA;NAPEPLD;PM20D1;NAAA;SLC19A1;MTHFR;ALDH1L1;ACOT11;MCCC1;MLYCD;MTRR;ACOT8;HLCS;THEM4;CERK;NSMAF;SMPD3;SGPL1;MTHFD1;ACOT12;SMPD2;MCCC2;FOLR2;AASDHPPT
prerank,DNA methylation or demethylation (GO:0044728),0.48728157024206215,1.1461442222172222,0.3108348134991119,0.9044374118562942,1.0,7/19,17.67%,DNMT3A;ATRX;MTRR;BEND3;EHMT2;EHMT1;KMT2E
prerank,DNA alkylation (GO:0006305),0.48728157024206215,1.1461442222172222,0.3108348134991119,0.9044374118562942,1.0,7/19,17.67%,DNMT3A;ATRX;MTRR;BEND3;EHMT2;EHMT1;KMT2E
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.320933178527104,-1.1458107688546615,0.23174603174603176,0.5793510380396211,1.0,17/80,10.47%,NRP1;NLGN1;TENM2;PIK3R1;FNBP1L;PLCE1;CCDC88A;ACTR2;CDC42EP3;OCLN;TGFB3;ANLN;PLPPR5;P2RY12;EPS8;AGRN;ACTR3
prerank,membrane organization (GO:0061024),-0.27454030041955935,-1.14552147493852,0.11702127659574468,0.579259693810062,1.0,43/227,11.27%,SGCZ;DNM3;SPTBN1;HIP1;SGIP1;SYT1;ANK3;ACTB;FNBP1;SH3KBP1;CERT1;FNBP1L;REPS2;RIMS1;REEP1;ATP2C1;STON2;ACTG1;SH3GL2;AGFG1;CCDC88A;TFRC;VAMP4;EPN2;ACTR2;FZD4;SH3GLB1;LDLR;HSPA8;AMPH;DNM1;CORO1C;BIN1;LPCAT2;GLTP;DYSF;CHRM2;AP2B1;PPT1;TRIP10;ACTR3;PDCD6IP;AP2M1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.4170892198355046,-1.1454127984744773,0.27472527472527475,0.5787083648006117,1.0,9/24,14.19%,NOTCH1;KLF2;HSPA5;CREB3L1;ATF4;HIF1A;GCN1;VEGFA;MT3
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.31230813799743257,-1.1453981281310985,0.17253521126760563,0.5779817374576175,1.0,33/107,22.78%,PIK3R1;MAP3K5;THBS1;NIBAN1;RASGRF2;GSK3B;DAB2IP;HSPA5;DDRGK1;DNAJC10;RASGRF1;PDIA3;ATP2A3;AIFM1;UFM1;TMEM117;SELENOK;CREB3L1;ATF4;BBC3;NCK1;EIF2AK3;RHBDD1;TMX1;BCL2L11;BCAP31;CASP4;RCN3;CFTR;ATP2A2;TRIB3;THBS4;FLOT1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4187650264569668,1.1452779744003863,0.29763779527559053,0.9059739812122283,1.0,7/40,8.88%,IGF1;PRKN;BID;FAM162A;TP53;OPA1;DNM1L
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.41141086394300963,1.1449441988013835,0.2900641025641026,0.9057965963612585,1.0,9/48,9.41%,ADCY5;NPR1;ADCY1;AMPD3;NPR2;ADCY9;PANK1;SLC26A1;DCAKD
prerank,negative regulation of anoikis (GO:2000811),-0.4622155475180488,-1.1448052205372188,0.28602620087336245,0.5786524102627923,1.0,4/14,8.55%,CAV1;NOTCH1;ITGB1;PTK2
prerank,cell part morphogenesis (GO:0032990),-0.4786124510377429,-1.1443459780629377,0.30042918454935624,0.5790109999587545,1.0,6/13,28.97%,PID1;PNPT1;WASF1;CSPG5;NUBPL;FIS1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.42833218767283615,1.1441336059500185,0.27388535031847133,0.9071470145670779,1.0,6/36,7.34%,SH3RF2;DLG1;PRKN;EZR;GPS2;PTPN22
prerank,cytoskeleton organization (GO:0007010),-0.29513425985789743,-1.1439477645694993,0.17358490566037735,0.5791742550601319,1.0,19/114,6.96%,FMNL2;ARHGAP10;RHOBTB1;SEMA6A;MARK1;FGD5;SH3KBP1;PLCE1;MAST4;MICAL2;RND3;DST;EPB41L3;PCLO;PAK5;ARAP3;STRIP2;APOE;RHOB
prerank,cellular response to increased oxygen levels (GO:0036295),-0.49881299458720674,-1.1439193412163828,0.30515463917525776,0.5784635375121592,1.0,3/11,12.36%,CAV1;FOXO1;FAS
prerank,negative regulation of fat cell differentiation (GO:0045599),0.43389148185246956,1.1436322675520212,0.2964169381107492,0.9075291202875492,1.0,7/34,9.62%,RORA;SMAD3;GPS2;TRIB2;WWTR1;SIRT1;LRP3
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.4943736483871328,1.1436234435404324,0.30943396226415093,0.9062347108952731,1.0,2/17,1.91%,ANK2;SNTA1
prerank,cellular response to fatty acid (GO:0071398),-0.5005334124684181,-1.1430233718085794,0.3125,0.5798113266735154,1.0,1/12,0.40%,PID1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.498122528305625,-1.1427106995204592,0.3186372745490982,0.5797862792011368,1.0,4/10,16.21%,EPB41L4B;IQSEC1;FGF7;ARF6
prerank,defense response to virus (GO:0051607),0.36431543419218426,1.1427047147066973,0.25787965616045844,0.908038425344232,1.0,24/100,15.46%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;NDUFAF4;TLR3;RNF135;TRIM56;STAT2;EIF2AK2;PLSCR1;SAMHD1;RSAD2;MAVS;MOV10;ATG7;ZDHHC1;IRF1;AKAP1;OAS3;ACOD1;IFNAR2;NT5C3A
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.4983899750104219,-1.1419498594696236,0.29508196721311475,0.5809017662602542,1.0,3/11,19.80%,ABCG1;AGTR1;AGT
prerank,cellular response to dsRNA (GO:0071359),0.5160712102532009,1.1419266185519137,0.30726256983240224,0.909316343304291,1.0,2/15,2.84%,COLEC12;IFIT1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.46199132941838644,1.1414045482927155,0.30434782608695654,0.9083891262277409,1.0,1/23,0.24%,DAB2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.46199132941838644,1.1414045482927155,0.30434782608695654,0.9083891262277409,1.0,1/23,0.24%,DAB2
prerank,positive regulation of signal transduction (GO:0009967),0.33065594054157327,1.141047417231581,0.1902439024390244,0.9083047917077752,1.0,28/238,6.25%,FGF1;ROBO1;BMP6;RSPO2;WLS;TSPAN5;SORBS1;TPD52L1;PRKCZ;IGF1;SMOC2;SASH1;FGFR2;DCDC2;NLGN2;PHIP;TTC23;TGFBR1;AAK1;LRRK2;SULF2;LOXL3;PRKCB;SMO;CUX2;GPS2;RAB34;GKAP1
prerank,gland development (GO:0048732),0.39856095996359286,1.1409551142345862,0.2647058823529412,0.9073035301808969,1.0,9/59,8.46%,TGFBR3;WNT4;FGFR2;GLI2;DKK3;TGFBR1;EZR;CDK5RAP3;NRG1
prerank,hemopoiesis (GO:0030097),0.36685568122755247,1.140516993405431,0.26203966005665724,0.9073692568539082,1.0,13/87,7.34%,NOTCH2;TGFBR3;KIT;KMT2A;FGFR2;ZNF160;MEIS1;TET2;PGM3;FLT1;TP53;FUT10;TGFBR2
prerank,regulation of actin filament-based process (GO:0032970),0.380584957957445,1.140205319973801,0.2600896860986547,0.9070584669306668,1.0,14/70,10.63%,CELSR1;ROCK2;RHOQ;RHOBTB2;RHOD;ARHGAP18;EZR;ARHGAP17;PDGFRB;BAIAP2;RICTOR;HRG;LRP1;ABL1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5415403789576028,1.1401603438087584,0.32695984703632885,0.9058837079192595,1.0,2/12,2.84%,COLEC12;IFIT1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.4094210489026405,-1.1401024254409404,0.2731707317073171,0.5846392177268286,1.0,9/25,12.19%,CSGALNACT1;NDST3;FUT9;EXT1;NDST4;B3GALT1;B3GALNT1;EXT2;B3GALT5
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.42673498369431184,-1.1391910560422462,0.27586206896551724,0.5859214018820276,1.0,6/21,12.36%,NAV3;CLASP2;ARHGEF2;STMN2;FGF13;SPEF1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.38560382513671587,1.139122988817158,0.27113702623906705,0.9079198590840417,1.0,22/68,20.59%,RHOQ;AMPD3;LRRK2;ABHD14B;OPA1;SULT2B1;ACOT11;AK3;AK4;NT5C2;MLYCD;TPST1;ACOT8;THEM4;AMPD2;ACOT12;MFN1;ADSS1;ACLY;CROT;ACSF2;GMPR2
prerank,calcium ion homeostasis (GO:0055074),0.360018064187842,1.1388198034009132,0.24643874643874644,0.9076013504439014,1.0,9/95,3.59%,ATP13A5;SLC24A3;ANK2;ATP13A3;FAM20A;SLC8A3;PKHD1;CSRP3;DMPK
prerank,negative regulation of cation channel activity (GO:2001258),-0.3876732016765744,-1.1386951588211547,0.2780612244897959,0.5863154426143203,1.0,9/26,21.60%,KCNAB1;CALM1;CALM2;EPHB2;CALM3;FKBP1A;CASQ2;GSTM2;DRD2
prerank,atrial septum morphogenesis (GO:0060413),0.5576589567750767,1.1379661264926548,0.3290203327171904,0.9090363178144355,1.0,1/10,0.19%,NOTCH2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4436019801464275,1.137803568869028,0.29965156794425085,0.9082377119376318,1.0,10/26,19.04%,ERRFI1;SNX6;ADRA2A;HBEGF;ADAM17;TGFA;GPRC5A;SOCS4;BTC;ZGPAT
prerank,axon extension (GO:0048675),-0.41653950432801345,-1.1376472721059645,0.2942583732057416,0.5881592572150389,1.0,10/23,10.34%,NRP1;SLIT2;MAP1B;NRP2;SEMA5A;HSP90AB1;ULK1;ULK2;SLC9A6;HSP90AA1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3422465780838939,1.137157258790337,0.24129032258064517,0.908924208103664,1.0,21/161,9.99%,DAB2;TMEM64;LRP4;BICC1;MCC;PRKN;DKK3;GLI3;LZTS2;APC2;WWTR1;UBAC2;PTPRU;INVS;TMEM170B;CSNK1A1;GLI1;TLE1;HDAC1;SOX13;TCF7L2
prerank,intestinal lipid absorption (GO:0098856),-0.503322587783008,-1.1370279919673276,0.3152610441767068,0.5888374214163992,1.0,3/11,6.74%,UGCG;LIMA1;LDLR
prerank,membrane depolarization during action potential (GO:0086010),0.46058516124308774,1.1367460191059535,0.3010033444816054,0.9089677004473947,1.0,3/26,4.75%,ATP1A2;CACNA1D;CACNA1C
prerank,regulation of cell migration (GO:0030334),0.3136161458487437,1.1365146317420827,0.17406143344709898,0.9084078638694982,1.0,69/382,11.71%,DAB2;FGF1;ROBO1;WNT5B;AFDN;SH3RF2;SYNE2;ROCK2;APPL2;ACE;KIT;LAMC2;IGF1;ZMYND8;SASH1;KIF2A;PLXNA2;EPHA4;RHOD;SPHK1;LMO4;SRGAP2;SRGAP3;PHACTR1;ARID2;MAGI2;MITF;MGAT3;TGFBR1;ADRA2A;PDPN;DAG1;RUFY3;SMO;CTSH;TPM1;SEMA3B;ATM;TBCCD1;SOD2;LDLRAD4;FLT1;PDGFRB;CPNE3;SERPINE1;PTPRU;LDB2;LDB1;PTEN;CDH5;AMOTL2;GTPBP4;CCAR1;HBEGF;FER;CYRIB;TRIP6;SLURP1;ARSB;YTHDF3;PIK3R3;CASS4;RNF41;DUSP10;MMP14;VIL1;MYLK;ADAM17;OSGIN1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4168173568313228,1.1363450229564123,0.30250783699059564,0.9077034697210283,1.0,7/40,7.34%,DAB2;SMAD3;TGFBR1;FOXC1;PDPN;WWTR1;TGFBR2
prerank,positive regulation of response to external stimulus (GO:0032103),0.35334149936435294,1.1357991777313259,0.24246395806028834,0.9082381600866843,1.0,24/128,13.78%,BMP6;SASH1;IL18;NAPEPLD;TLR3;TLR4;F2;IFNK;ANKRD17;PDGFRB;IL12B;SERPINE1;PLSCR1;HRG;GPRC5B;IL17RA;DDX60;RIPK1;LY96;DHX58;NMI;PRKCA;IFI35;ACOD1
prerank,cation transport (GO:0006812),0.34055757849467433,1.1356777912251033,0.21494102228047182,0.9073671137645952,1.0,16/167,7.65%,TRPM3;ATP1A2;SLC41A1;KCNJ13;TRPM6;SLC5A5;KCND3;KCNA5;SLC8A3;SLC22A18;SLC6A9;KCNS1;SLC5A8;TRPM5;ANO6;KCNH4
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.35238354832913327,-1.1353432803161212,0.24797843665768193,0.5922548916275814,1.0,11/51,15.17%,VEGFC;THBS1;CXCL12;GAS6;PTK2;CALR;PTN;EDN3;CMKLR1;VEGFA;RARRES2
prerank,muscle contraction (GO:0006936),0.3464740178063807,1.134893234851629,0.24444444444444444,0.9086392872495375,1.0,18/126,9.20%,ROCK2;ACTN2;SORBS1;SNTA1;MYOF;TMOD2;PABPN1;PGAM2;TLN1;BDKRB2;DTNA;TMOD3;TPM1;KLHL41;ARHGEF11;CHRNG;MYL4;NMUR1
prerank,icosanoid biosynthetic process (GO:0046456),-0.5104973836553168,-1.134814976183474,0.30060120240480964,0.5927370992965487,1.0,5/10,29.00%,PLA2G4A;LTA4H;FADS1;ALOX5AP;MGST2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.38658170657316104,1.1346521254090316,0.27669172932330827,0.9081558502641726,1.0,7/66,3.79%,ROBO1;TGFBR3;FGFR2;MCC;NUPR1;NR2F2;NFIB
prerank,negative regulation of growth (GO:0045926),-0.2931292449214399,-1.134293145665108,0.1821705426356589,0.5932596320414011,1.0,29/121,10.60%,APBB2;SLIT2;PTPRJ;BMPR2;RTN4;TGFB2;ACVRL1;CCN3;NOTCH1;SOX17;ENPP1;ADAM15;PPP2R1A;RERG;SH3BP4;TGFB1;SERTAD2;BTG1;PNPT1;PPT1;FRZB;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5139361114867644,1.1340335287267562,0.3269230769230769,0.9089133775553334,1.0,5/14,17.97%,OXSR1;ADAM17;WNK1;CCR2;WNT5A
prerank,response to exogenous dsRNA (GO:0043330),0.4909278066209437,1.1338693923958783,0.3233644859813084,0.9081627596260425,1.0,4/18,5.44%,COLEC12;IFIT1;TLR3;IFNK
prerank,plasma membrane organization (GO:0007009),0.38636184187491257,1.1337952395064121,0.2621951219512195,0.9071261872694227,1.0,12/61,11.52%,COL5A1;ANK2;SYT11;MYOF;FER1L5;ANO6;PLSCR1;PLSCR2;TLCD2;ARV1;BIN3;A4GALT
prerank,positive regulation of cell death (GO:0010942),0.3912555599361484,1.1337714426029155,0.26126126126126126,0.9059426186402145,1.0,10/59,11.87%,SLC6A13;EFNB2;PICALM;PRODH;LRRK2;LRP1;RIPK2;RIPK1;RARG;AXIN2
prerank,vasculogenesis (GO:0001570),-0.3740084297006611,-1.1335063738780033,0.2814814814814815,0.5943193812102568,1.0,14/32,13.89%,CAV1;ENG;RASIP1;NOTCH1;KDR;RAMP2;ITGB8;SOX17;TGFB1;HEY2;RASA1;SOX18;VEGFA;SPRED1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.33113073493287987,1.1327479414335375,0.22795969773299748,0.9080746011226734,1.0,31/199,9.93%,ROBO1;LGR4;ROCK2;LRP4;LAMA4;SYT11;MCC;ZNF423;ALDH1A1;NPR3;NFIB;PCTP;SMAD6;SRGN;APOM;TLR4;IL17D;WWC2;SFMBT1;PTPN23;LDLRAD4;TWSG1;PTEN;SLC6A4;NOVA1;ADM;ACOT11;CHSY1;SPX;DOCK7;FOXC2
prerank,external encapsulating structure organization (GO:0045229),0.3292181524173933,1.1326260374992925,0.22580645161290322,0.907206809800017,1.0,31/205,8.64%,SMOC1;COL5A1;ADAM12;ADAMTS10;LAMA4;COL22A1;LAMC2;COL4A5;SMOC2;ITGA9;LAMC1;NPNT;SPP1;COL18A1;COL4A3;LOXL1;ADAMTS2;ADAMTS15;DAG1;ITGA10;ADAMTSL5;ADAMTS9;COL9A2;COL13A1;FBN1;SERPINE1;COMP;COL4A4;COL1A2;MMP19;COL27A1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4809653844283716,-1.1326131145251035,0.31610337972166996,0.5956349262814343,1.0,3/13,9.18%,TMSB4X;PSEN1;HEY2
prerank,aminoglycan metabolic process (GO:0006022),-0.5066697482176241,-1.1325552612332248,0.30060120240480964,0.5950137434601733,1.0,6/10,25.17%,XYLT1;B3GAT2;CHST9;B3GALT6;B3GAT3;B3GAT1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.43714826070121826,1.1320029257500097,0.3177257525083612,0.9080305849123558,1.0,5/30,4.75%,CACNA1D;ANK2;KCNA5;SNTA1;CACNA1C
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4829332293530712,1.1316254427338497,0.30939226519337015,0.9079401771603655,1.0,1/17,0.26%,FGF1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.4247479849396438,1.1313966550618137,0.2971246006389776,0.9074543957385061,1.0,8/37,10.40%,GSDME;NUPR1;BID;NACC2;TP53;FBH1;DNM1L;BECN1
prerank,positive regulation of cell population proliferation (GO:0008284),-0.25222963795920883,-1.1312309147028352,0.08791208791208792,0.5973330821980114,1.0,81/423,12.54%,MEF2C;PID1;LEF1;KITLG;PRKCH;BMP5;ZFPM2;ERBB4;NTRK3;CDH13;OSMR;CLDN5;GCNT2;LIFR;VEGFC;THBS1;FN1;ACER3;TGFB2;TBX3;ACER2;PTK2B;TOX;RPS6;GAS6;S100A6;NOTCH1;NTRK2;IL6ST;KRAS;RPS15A;KDR;LYN;TNFRSF11A;TBC1D8;TBX1;PDGFC;AR;STX3;TIAM1;PAK1;PTPRC;FOXP1;NAMPT;HES1;TGFB3;MEIS2;AQP11;SSR1;RTKN2;CCN1;BMP2;TGFB1;PTK2;PROX1;CUL3;CALR;DDRGK1;PTN;FGF2;FLT4;S100B;RPS9;CD47;NAP1L1;ERBB2;ID2;PDGFA;RPL23;SLC25A33;EDN1;ESM1;SHANK2;GPER1;BMP4;EDN3;RPS4X;CHTOP;PTHLH;EMP2;CDKN1A
prerank,response to ATP (GO:0033198),-0.4363220891697678,-1.1311342562636963,0.2908704883227176,0.5968104721346583,1.0,5/18,14.40%,ABCC9;RYR3;TRPC3;P2RY12;P2RY1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.39170765423359577,1.1309502988399784,0.28592814371257486,0.9076556566861314,1.0,17/59,15.04%,ROCK2;OXSR1;TGFBR1;LRRK2;CDC42BPG;TGFBR2;PDPK1;DYRK1A;PRKDC;CSNK2A2;CSNK2A1;PRKCA;HIPK3;WNK1;MAP2K1;CAD;ACVR1B
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.46496421801143883,-1.1308120760198517,0.3238512035010941,0.5967995432473906,1.0,5/13,18.42%,HSPA5;DDRGK1;NCK1;BFAR;PTPN1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4899787861330742,1.1306796202518843,0.29842931937172773,0.9072184303448537,1.0,4/16,8.86%,PYGM;PHKB;MGAM;PHKG1
prerank,cytosolic calcium ion transport (GO:0060401),-0.38308135552544875,-1.130657463911029,0.2814070351758794,0.5963476730596523,1.0,10/28,12.96%,SLC8A1;RYR2;CACNA2D1;SLC35G1;MICU3;ATP2A3;JPH2;SMDT1;ATP2B1;MCUB
prerank,regulation of steroid metabolic process (GO:0019218),0.4712775493238136,1.1304680346897322,0.314878892733564,0.906627498589605,1.0,11/23,24.29%,RORA;RORC;ARV1;TTC39B;EPHX2;LAMTOR1;NR5A1;GNB3;ABCA2;STAR;DGKQ
prerank,secretory granule organization (GO:0033363),0.5419746398488454,1.129678393124126,0.3574144486692015,0.9079106707681723,1.0,5/10,22.69%,DTNBP1;SRGN;BLOC1S2;VPS33B;LYST
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.54450652026765,1.1293055018822138,0.3333333333333333,0.9078664621966356,1.0,1/10,1.21%,KIT
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.36708116820119585,-1.1292304886906754,0.25906735751295334,0.599130670685973,1.0,7/38,6.02%,BMP5;NOS3;THBS1;TNFSF10;ARHGEF2;GSK3B;ICAM1
prerank,response to cytokine (GO:0034097),0.3458545797158092,1.1289681374846416,0.24966622162883845,0.9076960282837067,1.0,24/141,12.44%,ALDH1A2;PTPN13;SMAD3;TIMP3;PTPN14;AFF3;PTPN9;SPHK1;NFAT5;CASP3;IKBKE;TRIM56;PTPN23;EIF2AK2;PLSCR1;MAPKAPK3;HDAC4;RIPK1;CD274;PTPN4;PTPN11;FOXA2;PRKCA;NUB1
prerank,mitochondrion morphogenesis (GO:0070584),-0.5016230504839766,-1.1286566953220734,0.3247311827956989,0.5996963585622574,1.0,3/11,16.33%,PID1;PNPT1;WASF1
prerank,positive regulation of type I interferon production (GO:0032481),0.3725866438815601,1.1285693292427446,0.26029411764705884,0.9077226296224634,1.0,20/73,16.31%,OAS2;TLR3;TLR4;RNF135;DDX3X;TRIM56;PTPN22;RIPK2;MAVS;TOMM70;PRKDC;DHX58;PTPN11;IRF1;POLR3A;DHX33;OAS3;NFKB1;STAT6;CREBBP
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3474218152884648,-1.1277308378161868,0.2622478386167147,0.6011842503185922,1.0,12/48,8.69%,NRP1;PTPRD;IL1RAPL1;CARMIL1;CDKL5;ARHGEF7;DOCK1;FLNA;CRK;LIMS2;MYOC;CALR
prerank,neuron projection regeneration (GO:0031102),-0.5042406554689608,-1.1276309367264625,0.33264462809917356,0.6006511482287471,1.0,3/10,13.86%,PTN;GAP43;RTN4RL1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.46575521062787373,1.127340968513377,0.3211009174311927,0.9105357268874731,1.0,8/20,11.28%,ACE;IGF1;BMPR1A;PDGFRB;SERPINE1;IGFBP3;LRP1;TRIB1
prerank,long-chain fatty acid import into cell (GO:0044539),0.5455820663599202,1.127206069036819,0.34980988593155893,0.9097239215396626,1.0,3/10,9.67%,ACSL1;SLC27A1;SPX
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3597760802522139,-1.1272060391021301,0.26861702127659576,0.6009014902688493,1.0,13/37,16.81%,CLASP2;EFNA5;PHLDB1;GSK3B;STMN2;MAP6;MARK2;FAM107A;TRIM36;MAPT;BICD2;STMN1;TPPP
prerank,negative regulation of protein modification process (GO:0031400),-0.31153931580780386,-1.1270131927937819,0.21511627906976744,0.6005841358032348,1.0,20/79,10.43%,SLIT2;PID1;PRR5L;NTRK3;NIBAN1;PPP1R16B;SH3GL2;LYN;GSK3B;DAB2IP;PPIA;YWHAB;OCLN;CORO1C;EPHB2;TGFB1;DNAJC10;XDH;MFHAS1;ATP2B4
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5220417808381661,1.1270084733515633,0.34099616858237547,0.9091167160887381,1.0,1/12,0.46%,BMP7
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.46212251470203125,1.126931915890606,0.34397163120567376,0.9081334183603468,1.0,4/20,3.86%,ACTN2;OSR1;ADRA2A;NEDD4
prerank,plasma membrane tubulation (GO:0097320),-0.47285757988210775,-1.126891951233403,0.3153526970954357,0.6000729268554781,1.0,5/13,18.29%,FNBP1L;CAVIN2;EHD2;PACSIN1;CHMP4A
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.44268541287391683,1.1263582643244203,0.3217993079584775,0.9087950091394347,1.0,2/29,1.44%,NOTCH2;IGF1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.45492851856631156,1.1261912002442596,0.3321492007104796,0.9080822421181722,1.0,11/25,24.41%,IGF1;NSD1;NIBAN2;SIN3A;PER2;DOT1L;RB1;POU4F1;MSX2;MAD2L2;H1-0
prerank,regulation of protein localization (GO:0032880),0.3838490924384727,1.1258630813174308,0.2931297709923664,0.9079107473945779,1.0,6/58,5.82%,AFDN;PICALM;DLG1;AAK1;MAP2;CAMK1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3391878529828662,1.1258333632003759,0.2554557124518614,0.9067768356237128,1.0,24/166,9.53%,SMAD3;LPGAT1;SORBS1;PPARGC1A;IGF1;SMOC2;GLI2;LARP4B;DUOXA1;SLC6A9;TLR4;DDX3X;CD28;PDGFRB;POLDIP3;SLC27A1;GCK;LDB1;SAMD4A;PAOX;CPEB3;GLI1;SIRT1;SLC45A3
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.4149214988401786,1.1251105039473677,0.3021702838063439,0.9079010549209187,1.0,8/33,12.29%,DLG1;KANK2;NACC2;PLK5;PTEN;RBL2;RBL1;BRD7
prerank,chromosome organization (GO:0051276),0.3524723096057308,1.1249357549546437,0.27600554785020803,0.907311294032255,1.0,31/99,20.20%,TOP2B;HDAC8;SETD7;MTHFR;LDB1;SMARCA4;SIRT1;HDAC1;TCF7L2;ABL1;BAHD1;MSH3;AXIN2;CUL4A;PHF1;CDAN1;HMGN3;DDB2;DOT1L;LRWD1;NUP155;EHMT1;CENPV;TCF7L1;PADI4;EZH1;COPS8;CENPT;XPA;LIG4;BRWD1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5054987954067616,1.1248165819048517,0.3559928443649374,0.9064588691707589,1.0,2/14,1.44%,SYT11;IGF1
prerank,positive regulation of gene expression (GO:0010628),0.31005852389642924,1.1247716873514964,0.195338512763596,0.9053788195533282,1.0,58/442,11.33%,FGF1;ROBO1;BMP6;BMP7;C1QTNF3;AFDN;SLC24A3;SMAD3;ROCK2;ANK2;OSR1;DDX5;PPARGC1A;IGF1;WNT6;PRKN;POLR2A;FOXD1;TNRC6A;MITF;TGFBR1;LARP4B;ADRA2A;TAF1D;DTNBP1;TLR3;EZR;SMO;CTSH;CUX2;TLR4;ATM;DDX3X;BRAF;CD28;BAZ1B;POLDIP3;TP53;EIF2AK2;PTPN22;PLSCR1;TNRC6B;SAMD4A;CPEB3;CDH5;CALCOCO1;TLE1;LRP3;RIPK1;UBR5;MOV10;YTHDF3;PIK3R3;SRPK2;DYRK1A;ATF2;C1QTNF1;PRKDC
prerank,replicative senescence (GO:0090399),0.5092598887121759,1.1247540527813842,0.3370577281191806,0.904206456969855,1.0,4/12,8.39%,ATM;TP53;SERPINE1;TERT
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4448600930976485,1.1242247487158648,0.3173758865248227,0.9046242561857795,1.0,3/27,1.32%,SYT9;SYT11;SYT12
prerank,positive regulation of TORC1 signaling (GO:1904263),0.4959907478080265,1.1242200411685166,0.30303030303030304,0.9034118473789007,1.0,7/16,26.68%,GPR137;FLCN;TELO2;RRAGD;RRAGB;SIK3;GPR137B
prerank,regulation of T cell cytokine production (GO:0002724),-0.45260818666660496,-1.1239306991618314,0.31905781584582443,0.6064235422755355,1.0,4/15,9.15%,B2M;MAP3K7;TNFRSF1B;SMAD7
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4589820038326013,1.1236453414687089,0.313758389261745,0.9040894755258925,1.0,7/24,13.50%,IL12B;PTPN22;PARP9;MAVS;TOMM70;ZDHHC1;SIN3A
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.538717971709624,1.1236201693068542,0.3431952662721893,0.9029537301868493,1.0,1/10,0.40%,BMP6
prerank,protein deacylation (GO:0035601),0.459437514389618,1.1235590896639074,0.3333333333333333,0.9019480462300369,1.0,8/23,13.50%,ABHD17C;SIRT5;LYPLA1;SIRT3;HDAC4;SIRT1;HDAC1;SIN3A
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.3744223944177924,-1.1232088542798322,0.2773722627737226,0.6073739732369957,1.0,8/33,10.23%,PDE3B;TGFB2;ACER2;NEXMIF;CYP1B1;LYN;PTK2;P2RY12
prerank,heart trabecula morphogenesis (GO:0061384),0.483987841872688,1.122917753163182,0.3295238095238095,0.9027970337192428,1.0,6/18,8.46%,TGFBR3;BMP7;BMPR1A;TGFBR1;RBP4;NRG1
prerank,positive regulation of kinase activity (GO:0033674),-0.2953115377799303,-1.12211791122032,0.20078740157480315,0.6092902214890072,1.0,30/107,12.78%,TEK;ERBB4;NTRK3;ROR1;EPHB1;RASSF2;EPHA5;MERTK;IQGAP1;EPHA6;TIE1;PTK2B;GAS6;NTRK2;KDR;ROR2;PTPRC;RAP1A;MET;EPHA7;RELN;EPHB2;CCN1;PTK2;FLT4;ERBB2;XRCC5;CDKN1A;MAPT;MMD
prerank,mitochondrion localization (GO:0051646),0.46417808420811135,1.1220883379061168,0.3172043010752688,0.9042498912191134,1.0,8/19,18.19%,TRAK1;LRRK2;MEF2A;MFN2;BRAT1;MSTO1;TRAK2;MFN1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4615763935509617,-1.1220825679621471,0.3240343347639485,0.6085916963979059,1.0,7/13,26.53%,KDR;IL33;NAMPT;EDN1;NOD2;JAK2;CCL2
prerank,regulation of intracellular pH (GO:0051453),-0.36489362362978806,-1.1219134629436753,0.2868020304568528,0.6081776597936328,1.0,10/34,22.43%,SLC4A10;SLC9A2;CA2;SLC9A6;SLC9A7;SLC9B1;GPR89A;GPR89B;CFTR;SLC4A2
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.28354904550067855,-1.1212080199671912,0.16363636363636364,0.6091426005048662,1.0,30/150,10.34%,KITLG;HIP1;PTPRJ;TEK;ERBB4;PIK3R1;ESR1;GCNT2;ENG;RTN4;THBS1;SEMA5A;GAB1;GAS6;F3;NRG2;HSP90AB1;MET;ITGB1;MYOC;TGFB1;PTK2;MFHAS1;TNFAIP8L3;FGF2;PIK3AP1;ERBB2;P2RY12;PDGFA;HSP90AA1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3259863654305858,-1.1208176463627322,0.23255813953488372,0.609385966159132,1.0,13/67,11.28%,ATP8B1;CAV1;MYO10;PODXL;TBC1D1;PPP1R16B;CDKL5;TBC1D8;TBC1D5;RDX;GAP43;TBC1D2B;FXR1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.36572814886160554,1.1203301126571128,0.28312412831241285,0.9086493901313388,1.0,30/85,23.65%,DAB2;SH3RF2;PRKN;NUPR1;LRRK2;PIAS1;TRIB2;RNF217;RNF19A;CSNK1A1;FBXO22;TRIB1;NUB1;DNAJB2;ZYG11B;HECTD1;RNF19B;TAF1;ARIH1;SUMO1;ZER1;USP5;FMR1;GSK3A;ANKIB1;ARIH2;PRICKLE1;KCNE2;BAG6;PSMD10
prerank,retina homeostasis (GO:0001895),-0.40254170586959465,-1.11998792938215,0.302540415704388,0.6105085985857496,1.0,4/23,3.94%,POTEF;ACTB;B2M;ACTG1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.47287701250719777,1.1199606588009814,0.3302411873840445,0.9074137317239086,1.0,6/20,12.68%,IVD;ACADSB;BCAT2;DLD;MCCC1;ALDH6A1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.47287701250719777,1.1199606588009814,0.3302411873840445,0.9074137317239086,1.0,6/20,12.68%,IVD;ACADSB;BCAT2;DLD;MCCC1;ALDH6A1
prerank,response to amyloid-beta (GO:1904645),-0.3476422431869958,-1.1194741367340775,0.2702702702702703,0.6109716507979811,1.0,10/44,7.59%,GRM5;CACNA2D1;VCAM1;GSK3B;ICAM1;APP;GRIN2A;CACNA1B;PSEN1;ITGA4
prerank,cellular response to oxidative stress (GO:0034599),0.35020031169932864,1.1191862451761887,0.27066666666666667,0.9086418219320342,1.0,12/118,6.50%,CPEB2;MSRA;PPARGC1A;PRKAA2;MGAT3;LRRK2;SESN2;SOD3;TPM1;ALDH3B1;SOD2;TP53
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5184204871309623,1.1189913592062959,0.3442028985507246,0.9080025440378011,1.0,5/12,18.70%,HDAC8;WAPL;AXIN2;RB1;FEN1
prerank,vesicle transport along microtubule (GO:0047496),0.45285496182678747,1.1188781717970755,0.32321428571428573,0.9071739385827742,1.0,8/23,17.78%,TRAK1;FYCO1;FBXW11;HTT;KIF1C;KIF5B;TRAK2;KIF13A
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4799352669167892,1.1186214451516399,0.33691756272401435,0.9068481718210483,1.0,7/19,9.30%,TGFBR3;FGFR2;BMPR1A;TGFBR1;VGLL4;RBP4;GLI1
prerank,cellular macromolecule catabolic process (GO:0044265),0.39493315759269504,1.1186154918103042,0.2993920972644377,0.9056639943635941,1.0,11/49,11.41%,PRKN;NGLY1;NEU2;ADAMTS9;SIDT2;DNASE1L1;EXOSC7;MANBA;SND1;RIPK1;MAGEC2
prerank,positive regulation of programmed cell death (GO:0043068),-0.268814450565885,-1.1185140140893162,0.11042944785276074,0.6126431477817699,1.0,86/272,21.40%,SLIT2;ITGA6;MAP3K5;RASSF2;KCNMA1;MCF2L;ABR;RASGRF2;ARHGEF3;APAF1;CSRNP3;RPS6;NGF;CYP1B1;UNC13B;TRIO;ARHGEF9;ARHGEF7;NET1;TNFSF10;ARHGEF2;SFRP4;DAB2IP;TIAM1;CTSD;ARHGEF17;TGFB3;RYBP;RHOB;FOXO1;PSEN1;ITGB1;BIN1;BMP2;PLEKHG5;AIFM1;ARHGEF26;FRZB;RPS6KA2;GPER1;BMP4;ATF4;CTNNB1;DAPK1;FAS;SNCA;SUDS3;GADD45G;LAPTM5;CLU;KLF11;IAPP;UBB;PHLDA3;CRADD;VAV1;TOP2A;DNAJA1;APC;RNPS1;SCRIB;CASP2;BARD1;DIABLO;SYK;PHLDA1;HTRA2;IRF5;APH1A;STPG1;RNF122;BCL2L11;FOXL2;HIP1R;CALHM2;PREX1;PNMA2;GADD45B;DCUN1D3;ECT2;DAPK2;TIAM2;SFRP1;MAP3K11;PYCARD;MCF2
prerank,response to unfolded protein (GO:0006986),-0.3448031316690282,-1.1184152668559526,0.25675675675675674,0.6120995995869349,1.0,18/48,20.86%,HSP90AB1;DAB2IP;HSPA8;HSPA5;TMBIM6;PACRG;HSP90AA1;TM7SF3;HSPB8;SERPINH1;RHBDD1;DNAJA1;HSPB1;PTPN1;HSPE1;HSPH1;DNAJB1;HSPA4L
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.4332381945866919,-1.1180685832927768,0.302771855010661,0.6121124452956904,1.0,8/17,18.68%,CALM1;CALM2;SMAD7;DDIT4;CALM3;DMTN;SPRED1;SIRT2
prerank,sphingolipid catabolic process (GO:0030149),-0.4465018687548618,-1.1178392528479713,0.3403805496828753,0.611866847805762,1.0,6/15,11.87%,ACER3;ACER2;PPT1;ENPP2;ASAH2;SMPDL3A
prerank,intestinal absorption (GO:0050892),-0.46519861491990655,-1.1177468155671,0.3380855397148676,0.6112915786461419,1.0,3/13,8.00%,F11R;UGCG;KCNQ1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.4753622956326425,-1.1175718502401484,0.34101382488479265,0.611028942476256,1.0,5/13,27.34%,RPS21;ABT1;RRS1;KRI1;NOL9
prerank,positive regulation of chromosome organization (GO:2001252),0.5048504595584743,1.117202041547276,0.37084870848708484,0.9089026177154016,1.0,8/15,26.39%,ATRX;RAD50;PML;NBN;FEN1;LIG4;PPP1R10;RTEL1
prerank,regulation of autophagosome maturation (GO:1901096),0.5029523309462953,1.1171460395257897,0.3578154425612053,0.9078820942680699,1.0,4/13,16.17%,FYCO1;UVRAG;IRGM;TBC1D25
prerank,erythrocyte differentiation (GO:0030218),0.4064892324728371,1.117098995667781,0.3201267828843106,0.9068018675352097,1.0,3/44,3.53%,TGFBR3;KIT;CASP3
prerank,diterpenoid metabolic process (GO:0016101),0.39183659189741604,1.1168507990950771,0.29675425038639874,0.906383353426486,1.0,11/55,9.36%,ABCA4;NAPEPLD;ALDH1A1;RBP1;AKR1B10;APOM;RHO;PNLIP;DHRS3;RBP4;LRP1
prerank,Rap protein signal transduction (GO:0032486),-0.5029683742787006,-1.116481256867468,0.3241525423728814,0.6129651437281562,1.0,4/10,9.65%,RAP1B;PLK2;RAP1A;RAP2A
prerank,response to hydroxyurea (GO:0072710),0.533343925918534,1.1161859920897086,0.35902255639097747,0.907267941453957,1.0,5/11,21.07%,ATRX;KAT7;DDI1;RTF2;FMR1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.4821936389958962,-1.1156105373361267,0.3270042194092827,0.6142969890532743,1.0,3/11,10.82%,SLIT2;CCN3;DUSP1
prerank,regulation of cellular protein localization (GO:1903827),-0.3486706722436466,-1.1153446628272992,0.27,0.6141912181110355,1.0,13/45,16.05%,GPC5;GPC6;HSP90AB1;RALB;HSP90AA1;GPC4;CTNNB1;SETD2;MAPT;RAB11FIP5;PPM1F;VCPIP1;BDNF
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5098064351908517,1.1149654523549382,0.33535353535353535,0.90876281023897,1.0,1/12,1.22%,FHL2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5098064351908517,1.1149654523549382,0.33535353535353535,0.90876281023897,1.0,1/12,1.22%,FHL2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.45707132219501173,1.1149560929713416,0.3320964749536178,0.9075911089989107,1.0,3/22,9.35%,BMP7;TP53;SIRT1
prerank,apical protein localization (GO:0045176),0.5265645517646182,1.1145789734455391,0.3493282149712092,0.9076481439375093,1.0,3/10,2.25%,CELSR1;SHROOM2;SHROOM3
prerank,granulocyte differentiation (GO:0030851),-0.4354233977522983,-1.1145761434922186,0.2857142857142857,0.6152590526618292,1.0,4/18,14.29%,LEF1;CBFA2T3;CDKN1A;TAL1
prerank,zinc ion homeostasis (GO:0055069),-0.38156315405826824,-1.1145062981120437,0.30162412993039445,0.6146533338987888,1.0,12/28,14.19%,SLC39A10;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;SLC30A1;SLC39A12;MT3
prerank,positive regulation of intracellular transport (GO:0032388),0.4170117481796535,1.1141109042720228,0.324459234608985,0.9079422674116507,1.0,6/38,8.77%,ACTN2;STX18;NEDD4;RUFY3;BCAS3;EIPR1
prerank,positive regulation of apoptotic process (GO:0043065),-0.26604256295340706,-1.1140814164839206,0.1643835616438356,0.6148775574235864,1.0,94/293,21.40%,SLIT2;ITGA6;MAP3K5;RASSF2;KCNMA1;MCF2L;ABR;TGFB2;RASGRF2;FAP;ARHGEF3;APAF1;CSRNP3;RPS6;PTGIS;NGF;CYP1B1;UNC13B;TRIO;ARHGEF9;ARHGEF7;NET1;TNFSF10;ARHGEF2;SFRP4;DAB2IP;TIAM1;RPS3;CTSD;ARHGEF17;TGFB3;RYBP;RHOB;EPHA7;FOXO1;PSEN1;ITGB1;BIN1;BMP2;BTG1;PLEKHG5;AIFM1;ARHGEF26;FRZB;RPS6KA2;GPER1;BMP4;ATF4;CTNNB1;DAPK1;FAS;SNCA;SUDS3;GADD45G;CDK5R1;CLU;KLF11;IAPP;UBB;PHLDA3;CRADD;VAV1;TOP2A;DNAJA1;MYBBP1A;APC;RNPS1;SCRIB;CASP2;BARD1;DIABLO;PHLDA1;HTRA2;IRF5;APH1A;STPG1;RNF122;SIRT2;BCL2L11;FOXL2;HIP1R;CALHM2;PREX1;PNMA2;GADD45B;DCUN1D3;ECT2;PTRH2;DAPK2;TIAM2;SFRP1;MAP3K11;PYCARD;MCF2
prerank,cortical cytoskeleton organization (GO:0030865),0.40949563956746976,1.1134968349978593,0.31768388106416273,0.9087044335240839,1.0,7/41,4.66%,ROCK2;RHOQ;DLG1;RHOBTB2;FHOD1;RHOD;EZR
prerank,negative regulation of response to stimulus (GO:0048585),-0.328824137387991,-1.113352758017133,0.2792022792022792,0.6159669937778178,1.0,16/60,14.58%,SLIT2;KLF7;MCTP1;UBASH3B;CASK;CD34;YBX1;AKT3;LYN;HHIP;AQP11;KIF26A;TWIST1;ACVR1;SOCS5;CLU
prerank,response to peptide (GO:1901652),-0.3721138554288775,-1.1128889499305414,0.3095823095823096,0.6162921402228825,1.0,15/33,28.39%,STAT3;ANXA1;GNAI1;CACNA1B;STAT5B;ERBIN;EIF2B3;CHRNA7;NOD2;IRF5;IRS1;FYN;STAT4;EIF2B2;MMP3
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.35450672373471115,1.1125635926730637,0.27520435967302453,0.9104412796513836,1.0,38/100,23.65%,DAB2;SH3RF2;FHIT;PRKN;LRRK2;PIAS1;TRIB2;RNF217;RNF19A;CSNK1A1;FBXO22;ARAF;TRIB1;GLMN;DESI1;NUB1;USP7;OGT;DNAJB2;ZYG11B;HECTD1;TLK2;RNF19B;HFE;TAF1;ARIH1;SUMO1;ZER1;USP5;CAMLG;GSK3A;ANKIB1;TRIM39;SDCBP;ARIH2;PRICKLE1;BAG6;PSMD10
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5253975162528466,1.1122615360881594,0.3445544554455445,0.910210218407034,1.0,3/12,3.79%,GLI2;EPHA4;NFIB
prerank,sensory perception of smell (GO:0007608),-0.4841040504599823,-1.1121371911253508,0.346723044397463,0.6173599181910163,1.0,4/11,21.60%,UBR3;SYT10;ADCY3;DRD2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3819908458138804,-1.111880536604026,0.292817679558011,0.6172195951500609,1.0,6/30,6.02%,BMP5;NOS3;TNFSF10;ARHGEF2;GSK3B;ICAM1
prerank,potassium ion transmembrane transport (GO:0071805),0.3392608059083737,1.1116093397125464,0.2770083102493075,0.9109815025541109,1.0,8/135,1.93%,ATP1A2;KCNK2;SLC24A3;ATP1B3;KCNJ13;KCND3;KCNA5;LRRC38
prerank,regulation of cellular component organization (GO:0051128),-0.2888396762070723,-1.1114852607991121,0.1935483870967742,0.6174194627640649,1.0,34/135,16.25%,NRG3;HIP1;CDH13;LTBP4;PLCE1;CAMK2D;RIT2;STON2;PAK5;TFRC;NET1;DAB2IP;RAP1B;RAP1A;APOE;SOCS2;HSPA8;SEMA4D;SPOCK1;AGTR1;IRAK3;CEACAM1;HJURP;HSP90AA1;BCAR1;FAM107A;SNX17;PINK1;ATF5;ERMN;PTCH2;RASGRP2;PACSIN1;EGLN2
prerank,regulation of muscle contraction (GO:0006937),0.4453269745209712,1.1113582489632299,0.3415061295971979,0.9106074200487736,1.0,2/26,5.17%,ATP1A2;TPM1
prerank,negative regulation of GTPase activity (GO:0034260),0.4560726966684237,1.111351341531711,0.3151183970856102,0.9094455221942751,1.0,4/22,6.72%,CPEB2;LRRK2;GMIP;BCAS3
prerank,regulation of adaptive immune response (GO:0002819),-0.42016088605571356,-1.1112678261015498,0.30296127562642367,0.6171939029045008,1.0,6/18,21.19%,ADCY7;IL6ST;TRIM27;SAMSN1;SKAP1;PYCARD
prerank,L-glutamate transmembrane transport (GO:0015813),-0.507197125024998,-1.1111593909841508,0.33535353535353535,0.6167074309836714,1.0,3/10,5.29%,SLC1A2;SLC1A1;SLC25A13
prerank,organelle fusion (GO:0048284),0.45587483600750156,1.1109462304497117,0.31893687707641194,0.9096070883401078,1.0,8/22,22.35%,CHCHD3;MIGA2;OPA1;MFN2;EEA1;MFN1;AFG3L2;STX4
prerank,response to peptide hormone (GO:0043434),0.4018620816708024,1.1109447376781476,0.32516339869281047,0.9084270292279637,1.0,10/43,15.99%,TGFBR3;ROCK2;STAT2;SLC27A1;SIRT1;OGT;TSC1;EIF2B1;ZFP36L1;STAT6
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2958214661172221,-1.1107716040859954,0.22448979591836735,0.616903253068493,1.0,11/91,6.05%,NRP1;HIP1;SYT1;RIMS2;CDH13;STXBP5L;RIT2;STON2;SCARB1;RAB3C;PTPRC
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.2461849128980664,-1.110502849131462,0.15714285714285714,0.6168010660018288,1.0,106/509,14.09%,NLGN1;KITLG;HIP1;PTPRJ;TEK;VWF;ACTN4;ERBB4;NTRK3;PIK3R1;CDH13;CAV1;ESR1;GCNT2;ROR1;ENG;DCN;RTN4;ADRA1B;THBS1;FN1;TGFB2;IQGAP1;RIT2;SEMA5A;ATP2C1;GAB1;MID2;NOD1;BCAR3;CAV2;GAS6;F3;RPS20;TFRC;NRG2;NTRK2;RPL37;HSP90AB1;TNFSF10;ALPK1;KDR;LYN;ROR2;TBX1;PDGFC;DAB2IP;PTPRC;PLK2;TRAF5;APP;RPS15;FLNA;RPS3;MET;PLCG2;MAP3K7;TNFRSF19;SEMA4D;ITGB1;ECM1;SLC44A2;RELN;RTKN2;BMP2;MYOC;TGFB1;PTK2;SHISA5;WWC1;NDFIP2;MFHAS1;TNFAIP8L3;FGF2;FLT4;S100B;PLEKHG5;PIK3AP1;ERBB2;JCAD;P2RY12;TRIM14;PDGFA;RPL23;HSP90AA1;FKBP1A;TRIM27;GPER1;REL;TIRAP;UNC5B;ILK;IKBKB;FGF7;PRKD1;FGF9;RET;VEGFA;RBCK1;TXN;CARD16;PINK1;TERF2IP;PPM1A;BBC3;LAPTM5
prerank,regulation of cellular catabolic process (GO:0031329),0.38138613370285057,1.1103799659201847,0.3028919330289193,0.9090110424464403,1.0,24/62,24.04%,ITPR1;PRKN;MTMR3;NUPR1;GPR137;LRRK2;ATM;WDR41;PIP4K2C;ABL1;DEPDC5;WDR24;RPTOR;WDR91;RRAGD;TYSND1;USP33;TPCN2;MTMR4;CISD2;EP300;BOK;RRAGB;RMC1
prerank,protein maturation (GO:0051604),0.3566551994266133,1.1103774800363595,0.2784992784992785,0.9078348125624283,1.0,16/95,15.40%,AEBP1;NNAT;TSPAN5;SRGN;METAP2;NDUFAB1;APH1B;MMP14;ADAM17;NFU1;PCSK7;OGT;SDE2;ISCA1;PITRM1;NAA16
prerank,snRNA transcription (GO:0009301),0.37402441127891706,1.1102996942122694,0.3125,0.9068942442848066,1.0,24/70,23.35%,POLR2A;PHAX;CCNT2;RPRD2;POLR2D;ELL;INTS10;GTF2F1;TAF11;INTS2;INTS5;TBP;INTS3;TAF13;INTS7;INTS1;INTS8;INTS4;POLR2G;GTF2A1;SP1;TAF8;USPL1;POLR2F
prerank,negative regulation of signal transduction (GO:0009968),0.31947093566081874,1.1102634789546642,0.24815724815724816,0.9058355993322589,1.0,45/249,12.06%,WWOX;LGR4;LEPROT;RNF43;NXN;PRKCZ;TULP3;KANK2;TRABD2B;DKK3;GLI3;SUFU;APCDD1;CXXC4;LRRK2;NEDD4;SULF2;VGLL4;CYP26B1;PRKCB;TNS2;ARRB1;GPS2;IL12B;MGRN1;PIP4K2C;PTEN;IGFBP3;BTRC;IFT122;HRG;APLN;NIBAN2;LRP1;TLE1;CBY1;GRB10;PHACTR4;CNMD;TRIB1;MMP14;WWP2;GDF15;CSNK2A2;CSNK2A1
prerank,amino acid transport (GO:0006865),0.39081838332424224,1.1091515483707695,0.3202511773940345,0.9081309198411405,1.0,7/49,4.27%,SLC6A12;SLC38A4;SLC38A3;SLC7A11;SLC7A2;PDPN;SLC25A48
prerank,acylglycerol biosynthetic process (GO:0046463),0.44672826024868684,1.1083721415347223,0.34205933682373474,0.909260490320557,1.0,4/23,7.28%,LPGAT1;MOGAT3;GPAT2;GK
prerank,response to ketone (GO:1901654),-0.3941058245728314,-1.1081050182038492,0.325,0.6218842829446568,1.0,7/24,8.45%,SLIT2;ABHD2;CAV1;THBS1;TGFB2;TGFB3;TGFB1
prerank,negative regulation of lipid storage (GO:0010888),0.46712918362095635,1.1076078905448195,0.358974358974359,0.9104255171586668,1.0,2/19,1.76%,OSBPL8;PPARA
prerank,regulation of cell differentiation (GO:0045595),0.3337859346966137,1.1071233609596631,0.2804718217562254,0.9107631679422249,1.0,22/148,8.84%,SMOC1;DDX5;CCN2;FGFR2;ZFHX2;FGFR1;TGFBR1;CLASP1;DAG1;PRKCB;PPP1R13L;KLHL41;GPS2;APC2;CAMK1;SIK1;EIF2AK2;RORC;NR1D2;CDK5RAP3;GDNF;NEUROD4
prerank,regulation of cell projection organization (GO:0031344),-0.4688710040700055,-1.1065645123324634,0.3297644539614561,0.6248316500099221,1.0,5/13,20.37%,NTNG1;SEMA4D;MFSD2A;ERMN;CCL19
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4799429135274166,1.106457543483138,0.36981132075471695,0.9116628232514399,1.0,2/15,3.65%,SH3D19;ADRA2A
prerank,regulation of B cell activation (GO:0050864),-0.3982418044154583,-1.106414908135792,0.29398148148148145,0.6244314565859812,1.0,14/25,42.71%,SH3KBP1;SAMSN1;LAPTM5;NOD2;AHR;TNFAIP3;FOXJ1;THEMIS2;BANK1;IL4;CD22;IL4I1;IL6;FCGR2B
prerank,negative regulation of viral transcription (GO:0032897),-0.4590743478513719,-1.106387300140782,0.3400447427293065,0.623732284696119,1.0,4/13,11.74%,MID2;TRIM14;TRIM27;IFITM3
prerank,megakaryocyte differentiation (GO:0030219),0.5265930943576055,1.1062783344239817,0.37675350701402804,0.9109809746776758,1.0,1/11,1.21%,KIT
prerank,epidermal cell differentiation (GO:0009913),-0.34596630406821083,-1.1059085621401012,0.287598944591029,0.6241016618890064,1.0,11/41,21.92%,CLIC4;JAG1;UGCG;ANXA1;TXNIP;SCEL;CTNNB1;WNT16;GATA6;ERCC2;ASAH1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.35574070719547934,1.1057553456865803,0.30014224751066854,0.9114434314855784,1.0,19/88,16.18%,BMP7;SMAD3;STX18;FNIP1;TRABD2B;BID;MPP7;NRG1;CDH5;HYAL1;AJUBA;VIL1;PRKCA;SDC4;LGALS3;FAF1;SMPD3;SNF8;VPS4A
prerank,regulation of protein acetylation (GO:1901983),0.5009995571115591,1.1053343352008176,0.35260115606936415,0.9115616382952847,1.0,4/12,9.35%,RAPGEF3;DDX3X;CAMK1;SIRT1
prerank,defense response to bacterium (GO:0042742),0.3531002458733031,1.10512439662134,0.30674002751031637,0.9110176181372094,1.0,19/105,14.48%,COLEC12;OAS2;TLR3;TLR4;DEFB1;ANKRD17;IL12B;GBP7;SERPINE1;GBP2;PLA2G6;MAVS;IRGM;ANXA3;ADAM17;CAMP;OAS3;GBP6;CFP
prerank,positive regulation of phospholipase activity (GO:0010518),0.453373278937746,1.1049962919619225,0.33515482695810567,0.910260349180938,1.0,6/22,8.75%,KIT;FGFR2;FGFR1;FLT1;PDGFRB;PDPK1
prerank,endomembrane system organization (GO:0010256),0.3257840068102338,1.103980034315981,0.2598225602027883,0.9122451835082951,1.0,55/178,19.11%,FAM174B;DYM;HOOK2;MYOF;OBSL1;ALS2;SEC31B;DMPK;CLASP1;LRRK2;MYO18A;SRGN;ATL1;ARFGEF2;BCAS3;FER1L5;HUWE1;TLCD2;LEMD2;HTT;DNM1L;TRAPPC12;GOLPH3L;CSNK1A1;RAB43;FBXW8;RAB22A;CDC42;A4GALT;MIA3;TRAPPC11;PLEKHF1;REEP4;TANGO2;ARHGAP21;SEC23IP;RAB29;VPS51;GOLGA5;GOLGA8B;VPS4A;HOOK3;NUP155;RAB30;WASHC5;PI4K2B;OPTN;COG4;PHETA1;NPLOC4;SQSTM1;SEC31A;GORASP2;GOLGA2;LAMTOR1
prerank,secondary palate development (GO:0062009),0.4882429087617169,1.1038882414886497,0.32093933463796476,0.9113720591239982,1.0,3/14,7.55%,TGFBR3;TGFBR2;CHD7
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.43495778440916,-1.1036343392808854,0.3394495412844037,0.6289143120741265,1.0,6/17,19.71%,MID1;TGFB2;LYN;SEMA4C;NOD2;KLHDC10
prerank,positive regulation of coagulation (GO:0050820),-0.4947200167217315,-1.1036339656458851,0.35625,0.6273690680641164,1.0,4/10,13.12%,ST3GAL4;THBS1;ENPP4;DMTN
prerank,positive regulation of hemostasis (GO:1900048),-0.4947200167217315,-1.1036339656458851,0.35625,0.6273690680641164,1.0,4/10,13.12%,ST3GAL4;THBS1;ENPP4;DMTN
prerank,nitric oxide metabolic process (GO:0046209),-0.45240322408914374,-1.103503118739855,0.33402922755741127,0.6269013049825167,1.0,5/14,17.93%,NOS3;CYP1B1;GCH1;NOS1;CYB5R3
prerank,ERK1 and ERK2 cascade (GO:0070371),0.4630582322317326,1.1031694023828367,0.33636363636363636,0.9124878322023846,1.0,6/21,15.26%,IGF1;CTSH;ITGAV;MAP2K1;MAP2K2;ZFP36L1
prerank,regulation of protein polymerization (GO:0032271),0.42854820297154944,1.103145221825422,0.35148514851485146,0.9114128310133744,1.0,6/35,10.68%,ARHGAP28;FCHSD2;ARHGAP18;MAP2;ABL1;PRUNE1
prerank,synaptonemal complex assembly (GO:0007130),0.491594733626382,1.102550236036487,0.34600760456273766,0.9109799135466264,1.0,7/15,25.31%,TEX12;REC8;STAG3;P3H4;SYCE2;BAG6;TRIP13
prerank,synaptonemal complex organization (GO:0070193),0.491594733626382,1.102550236036487,0.34600760456273766,0.9109799135466264,1.0,7/15,25.31%,TEX12;REC8;STAG3;P3H4;SYCE2;BAG6;TRIP13
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.38830714837223296,-1.1025465972928539,0.3047404063205418,0.6284633467530492,1.0,8/23,14.77%,PDE4B;RYR2;GNG2;KCNQ1;ATP2B4;ATF4;SNCA;GNB1
prerank,apical junction assembly (GO:0043297),0.3867449803153614,1.1024663165789834,0.3312,0.9100859481207779,1.0,3/53,1.68%,PARD6G;AFDN;DLG1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.35943849575291037,-1.1022911645470965,0.3052109181141439,0.6283083022038648,1.0,9/34,11.01%,PTPRB;PTPRJ;PTPN12;UBASH3B;PTPRT;PTPRF;PTPRZ1;DUSP1;DUSP3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.384126023747042,-1.1022878566956624,0.3355855855855856,0.627546656382744,1.0,14/27,21.28%,CSGALNACT1;DCN;CHSY3;BGN;XYLT1;CSPG4;VCAN;CHST12;B3GAT2;CHST9;CHST7;B3GAT3;CSPG5;BCAN
prerank,lipid homeostasis (GO:0055088),0.3841781162750976,1.1017429114373225,0.33746130030959753,0.9112618627812671,1.0,11/57,13.59%,PRKAA2;ZBTB20;RBP1;DDX3X;TLCD2;NR1D2;SIRT1;ADCK1;ACOXL;MLXIPL;ACOX3
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3365740306290108,1.1015725462426769,0.2864721485411141,0.9106644521788503,1.0,32/140,11.96%,ARHGAP28;ARHGAP29;CGNL1;RHOQ;ARHGEF18;RHOD;ARHGEF16;SRGAP2;SRGAP3;ARHGAP18;FGD4;SYDE2;ARHGAP9;NGEF;AKAP13;ARHGAP6;GMIP;ARHGAP26;ARHGAP17;ARHGEF11;ARHGEF12;ARHGAP23;ARHGEF1;OPHN1;CYRIB;ARHGAP12;FGD1;OCRL;SOS2;CDC42;RALBP1;ITGAV
prerank,protein homooligomerization (GO:0051260),0.3496864291267187,1.10124557746719,0.30631868131868134,0.9105602318142182,1.0,18/114,9.81%,ALDH1A2;APPL2;UPB1;ALS2;RNF213;CLYBL;ITLN1;NACC2;RNF135;P2RX3;SOD2;ATL1;MICU1;SAMHD1;JMJD6;SSBP1;CBY1;CTH
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4844408140554344,1.1011163244816349,0.35663082437275984,0.9098079684993258,1.0,7/16,22.89%,AMPD3;LHPP;AMPD2;ADSS1;GART;ADSL;GMPS
prerank,positive regulation of sodium ion transport (GO:0010765),-0.46321306907832804,-1.100887679954842,0.33191489361702126,0.6302205063128348,1.0,6/12,24.64%,ANK3;CNKSR3;NOS1;SCN1B;PKP2;GPD1L
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3039252647074776,1.100886733535353,0.23548740416210295,0.9094816050523009,1.0,87/476,14.06%,RORA;BMP7;SMAD3;WNT4;ZIC2;PPARGC1A;PICALM;IGF1;KMT2A;PPARA;ZNF423;CREB5;GLI2;NPAS3;CXXC1;SPP1;PHIP;NR2F2;ELF1;GLI3;MITF;TGFBR1;ARNT2;FOXC1;NFIB;CAND2;CREB3L2;RREB1;RGMB;NSD1;TRIM56;HMGA1;LBH;CREBL2;ZNF318;TP53;TBL1X;AFAP1L2;ARHGEF11;RORC;MED12;SMARCD3;FBXW11;ELF2;SMARCA4;NR1D2;BTRC;TBL1XR1;KAT6B;ZIC1;JMJD6;SMARCC2;TEAD2;NIBAN2;CALCOCO1;PARP9;HDAC4;GLI1;NSD3;HDAC1;ZFP90;FOXC2;TCF4;MYBL1;MED17;THRAP3;DYRK1A;MSANTD1;TEAD1;ZMIZ1;PHF5A;BRD7;FOXA2;DEAF1;MLXIPL;IRF1;ZXDC;EDRF1;PBX4;ZBTB48;DNM2;MAP2K1;MLLT11;PML;ILF2;MAP2K2;SNAI1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.5004382318087888,1.1007995178609518,0.3726235741444867,0.908617966347725,1.0,2/14,3.85%,UPB1;DPYD
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.48788262402355265,-1.1007218762253939,0.3625,0.6298706414688655,1.0,4/10,4.88%,HECW2;HECW1;CAMK2D;NEDD4L
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3582418372545197,1.1006586711979995,0.3060941828254848,0.9079119342396524,1.0,14/95,6.99%,HS3ST3A1;UST;HS3ST3B1;OGN;NDST1;CHST15;CHST11;HS2ST1;HS3ST6;ST3GAL3;FMOD;B4GALT1;DSE;PXYLP1
prerank,regulation of proteolysis (GO:0030162),-0.34355189190543567,-1.1004665571717136,0.31203931203931207,0.6297493798603963,1.0,7/48,7.46%,CAV1;LTBP4;SERPINE2;CST3;DNAJC1;GSAP;PERP
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3234126983904037,1.1002473602168534,0.28287841191067,0.9080476910084826,1.0,38/190,14.43%,UACA;RORA;BMP7;C1QTNF3;CGNL1;ITPR1;PRKAA2;PPARA;FNIP1;PKHD1;PPEF2;NPRL3;DEPTOR;MAGI2;DAG1;VGLL4;DDX3X;WWC2;NPRL2;MGRN1;UBR2;PTEN;RNF34;SIRT1;TLE1;RIPK1;CYRIB;AJUBA;ARHGAP12;PHLPP2;NMI;MAPKBP1;IFI35;DEPDC5;FLCN;TSC1;THEM4;PPM1B
prerank,lipid droplet organization (GO:0034389),-0.4060726689367347,-1.1000361973397002,0.3163716814159292,0.6300666539248728,1.0,8/22,28.62%,PPIA;RAB18;PNPLA3;CDS1;SQLE;AUP1;CDS2;FAF2
prerank,regulation of anoikis (GO:2000209),-0.4089893555851991,-1.0998396778856343,0.33182844243792325,0.6298042526556086,1.0,8/19,19.92%,CAV1;NOTCH1;ITGB1;PTK2;ANKRD13C;MYBBP1A;ITGA5;PTRH2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.41915447577075354,-1.0996952980454104,0.3256880733944954,0.6293886430245598,1.0,7/19,13.47%,BMPR2;TGFB2;NOTCH1;HEYL;BMP2;HEY2;ACVR1
prerank,nucleosome organization (GO:0034728),0.38051501588692377,1.0991543492866709,0.3328173374613003,0.9102276508273275,1.0,11/55,9.12%,ARID2;CHAF1B;ATRX;HMGA1;SMARCD3;RNF8;SMARCA4;SRCAP;KAT6B;SMARCC2;SMARCE1
prerank,blood vessel diameter maintenance (GO:0097746),0.417222897497439,1.0990252647431105,0.34175084175084175,0.9094958432237287,1.0,6/34,7.48%,ROCK2;ACE;NPR1;CPS1;BDKRB2;SCPEP1
prerank,negative regulation of DNA replication (GO:0008156),0.5095343502590464,1.098880009626842,0.37333333333333335,0.9087622636740446,1.0,4/13,13.17%,PDS5A;GTPBP4;WAPL;CDAN1
prerank,androgen metabolic process (GO:0008209),0.4667011502267398,1.098578091711577,0.33826247689463956,0.9086052989610889,1.0,3/18,17.32%,SPP1;SRD5A2;MED1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3779919613456025,1.0981447546426655,0.3249258160237389,0.9088350278823651,1.0,6/59,7.78%,ALDH1A2;CYP27A1;AMACR;OSBPL9;NDUFAB1;SRR
prerank,cellular respiration (GO:0045333),0.4098709845643902,1.0978510887038835,0.3555926544240401,0.908582802804298,1.0,14/41,19.65%,PPARGC1A;MTFR2;SIRT3;COQ10A;UQCRC2;NDUFS1;COX10;LYRM7;SDHAF4;ATP5F1D;SDHB;NDUFS4;ETFDH;UQCRC1
prerank,serine family amino acid metabolic process (GO:0009069),0.49421339581750323,1.097797983834153,0.37294332723948814,0.9076165861985057,1.0,7/16,26.12%,SRR;CTH;SEPSECS;MTHFD1;THNSL2;CBS;CDO1
prerank,steroid metabolic process (GO:0008202),0.3648421430439121,1.0977679868203474,0.3072463768115942,0.9065955703086146,1.0,12/72,12.67%,CYP27A1;LIPA;CYP21A2;CYP26B1;AMACR;FDXR;DHRS11;CYP2R1;SULT2B1;GC;ARV1;SRD5A2
prerank,regulation of inclusion body assembly (GO:0090083),0.5224214613646334,1.0974202610649118,0.3803088803088803,0.9065434139323028,1.0,1/11,1.24%,SNCAIP
prerank,carbohydrate catabolic process (GO:0016052),0.41028804971628097,1.0971622389439153,0.33225806451612905,0.906237027527652,1.0,7/38,9.52%,HK2;NEU2;PGAM2;DERA;GCK;MANBA;NEU3
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.29233939599665165,-1.09715314855584,0.26523297491039427,0.6347131963264894,1.0,45/109,30.01%,PIK3R1;LYN;PSMB2;PAK1;CALM1;PLCG2;MAP3K7;PPP3R1;NFATC1;PPP3CA;PSMD14;TEC;PSMC6;IKBKB;PSMA4;PSMB9;VAV1;SKP1;SYK;PSMD11;BTK;PSMB10;PRKCQ;PSMD2;SHC1;SOS1;PSMA2;MAP2K7;RELA;PSMB3;TAB1;PLCG1;PSMB5;NR4A3;LCP2;CARD11;MAPK8;PSMA7;FOS;MAPK3;PSMF1;PSMD7;JUN;MAP2K4;MALT1
prerank,ganglioside metabolic process (GO:0001573),-0.4139327217015707,-1.097150408379517,0.34451901565995524,0.6339486152320459,1.0,5/20,8.77%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;HEXB;ST8SIA6
prerank,cellular response to amyloid-beta (GO:1904646),-0.3572205419492109,-1.0970634467074676,0.30952380952380953,0.6334107043730813,1.0,9/35,7.59%,GRM5;CACNA2D1;VCAM1;GSK3B;ICAM1;APP;GRIN2A;PSEN1;ITGA4
prerank,fatty acid oxidation (GO:0019395),0.3803618068099062,1.0969212608099155,0.3358208955223881,0.9058981581070915,1.0,20/57,22.19%,PPARGC1A;ALOX12;ACAD11;ACAD10;BDH2;CPT2;ACADM;MECR;ECHDC1;DECR1;EHHADH;SLC25A17;PHYH;ECI2;CROT;ACADS;HADHA;HADH;ECHS1;HAO1
prerank,positive regulation of cartilage development (GO:0061036),-0.4278248275235149,-1.0962009179691046,0.35377358490566035,0.634766178912716,1.0,7/17,18.23%,BMPR2;ACVRL1;ZBTB16;BMP2;BMP4;BMPR1B;PKDCC
prerank,regulation of activated T cell proliferation (GO:0046006),0.42274302873076575,1.0958835348999147,0.3316062176165803,0.9079231489987669,1.0,7/30,18.04%,IGF1;IL18;IL12B;CD274;PRKAR1A;IGFBP2;AGER
prerank,T cell activation (GO:0042110),0.3733569017960002,1.0954576629248272,0.32540861812778604,0.9080910603672663,1.0,9/69,7.55%,LEPR;KIT;KIF13B;DPP4;IFNK;NHEJ1;CD28;PTPN22;CHD7
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3719773784522042,-1.0954449070686194,0.33676092544987146,0.6358023540950275,1.0,7/29,12.99%,ESR1;RUNX1;PAK1;DDRGK1;CNOT2;UFM1;AXIN1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3711760864729586,1.0954230676094365,0.32882882882882886,0.9070628030964413,1.0,21/69,21.09%,POLR2A;PHAX;CCNT2;RPRD2;POLR2D;ELL;INTS10;GTF2F1;TAF11;INTS2;INTS5;TBP;INTS3;TAF13;INTS7;INTS1;INTS8;INTS4;POLR2G;GTF2A1;SP1
prerank,cell projection organization (GO:0030030),-0.37566571052735015,-1.0953729683456523,0.3022113022113022,0.6352145158066689,1.0,7/30,10.26%,RHOJ;GSN;PARVB;ITGB1;RHOH;P2RY12;PDGFA
prerank,glycoprotein biosynthetic process (GO:0009101),-0.3080987485602122,-1.0949744425941919,0.2987012987012987,0.6353793977383747,1.0,19/79,15.64%,CSGALNACT1;ST3GAL4;ST8SIA4;BMPR2;GCNT2;FUT9;XYLT1;ST8SIA1;B4GALT5;B3GALT1;ST3GAL6;ST8SIA6;B3GALNT1;DAD1;B3GALT5;BMPR1B;CHST12;NUS1;CHST9
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4683030662740035,1.094817476551222,0.34806629834254144,0.9077593965316689,1.0,2/17,3.18%,NOTCH2;BMPR1A
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4808733973276216,1.09481187525748,0.3587360594795539,0.9066656386510357,1.0,4/16,3.18%,TGFBR3;IGF1;FGFR2;BMPR1A
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.44819292400178257,1.0947265934139079,0.34973637961335674,0.9058255601202198,1.0,3/23,8.44%,WNT5B;SMO;GDNF
prerank,sensory perception of light stimulus (GO:0050953),0.35376823249842393,1.0945154234386918,0.3300561797752809,0.9053747561811946,1.0,11/87,7.85%,ZIC2;WHRN;EML2;COL18A1;EYA4;RGS16;IMPG2;GNAT2;OPA1;DHRS3;RABGGTA
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.3332582525475274,-1.0944803314945766,0.29102167182662536,0.6358435364068754,1.0,31/50,47.49%,PSMB2;PSMD14;PSMC6;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;PSMA2;PSMB3;PSMB5;OAZ1;PSMA7;OAZ2;ODC1;PSMF1;PSMD7;PSMA5;PSMD4;PSME4;PSMD3;OAZ3;PSMC2;PSMD1;PSMB8;PSMC3;PSMD8;PSMB11;PSMB1;PSMB7;PSMA8
prerank,maintenance of protein location in nucleus (GO:0051457),-0.4162622239390394,-1.0944360440300915,0.3476190476190476,0.6351740650592084,1.0,9/20,29.52%,SYNE1;MORC3;BCL3;BARD1;SKP1;SUN2;RANGAP1;CHCHD10;PARK7
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4441291791295807,1.0940855331639199,0.3443478260869565,0.905509285844232,1.0,2/22,3.34%,ROCK2;PPP4R4
prerank,heterochromatin assembly (GO:0031507),0.4506130614478011,1.0938480704319988,0.34285714285714286,0.9050834505522605,1.0,9/20,21.14%,HMGA1;SIRT1;HDAC1;BAHD1;BEND3;SMCHD1;CENPV;EZH1;MBD2
prerank,B cell proliferation (GO:0042100),-0.4260253366495147,-1.093815217349251,0.3658008658008658,0.6359489380985399,1.0,2/17,6.05%,MEF2C;PTPRC
prerank,response to axon injury (GO:0048678),-0.41361723300661174,-1.09369390551299,0.3538812785388128,0.6354783081657801,1.0,6/18,22.10%,APOD;GAP43;P2RY12;RTN4RL1;TYROBP;SOD1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.37060132205925955,-1.0935816042374404,0.30023640661938533,0.635016385989597,1.0,14/29,31.81%,RAD23B;UBB;RPA1;CETN2;GTF2H1;GTF2H4;GTF2H5;ERCC2;UBC;RPS27A;DDB1;RPA3;ERCC3;RPA2
prerank,diol biosynthetic process (GO:0034312),-0.4488681254450788,-1.0927920213486109,0.3291139240506329,0.6362745907380495,1.0,6/15,13.39%,ACER3;ACER2;SPTLC2;GCH1;ASAH2;QDPR
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.47902800678684276,1.092713723729603,0.34980988593155893,0.9073627819402538,1.0,5/15,13.94%,STAT2;SAMHD1;YTHDF3;OAS3;USP18
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.4947002341970096,-1.092543705396848,0.33980582524271846,0.6361292377650141,1.0,6/10,34.76%,CCT8;CCT2;CCT6A;CCT7;DKC1;CCT3
prerank,positive regulation of organelle organization (GO:0010638),0.41275843588715055,1.0921538684158127,0.35927152317880795,0.9079113530325121,1.0,4/32,5.81%,PPARGC1A;STX18;FYCO1;UVRAG
prerank,heart contraction (GO:0060047),0.3981768962990827,1.0920122185731393,0.35303514376996803,0.9072478509484223,1.0,6/41,9.18%,ATP1A2;ACE;CSRP3;TPM1;PIK3CA;MYL4
prerank,negative regulation of cell population proliferation (GO:0008285),0.30432202465948865,1.0915495049564172,0.27904328018223234,0.9076386664419693,1.0,69/351,14.29%,TGFBR3;ALDH1A2;APPL2;FBLN1;OGN;GSDME;FGFBP1;PTPN14;MCC;KANK2;COL18A1;CD300A;NUPR1;COL4A3;ARID2;MAGI2;IGFBP7;SPEG;PARP10;PDPN;IFIT3;NACC2;VGLL4;SMAD6;TNS2;CLMN;IFNK;SOD2;HMGA1;IL12B;TP53;EIF2AK2;SSTR3;DLG3;PTPRU;RBP4;PTEN;KDM2B;IGFBP3;HRG;NUPR2;NIBAN2;SULT2B1;TFDP1;GTPBP4;SLURP1;NOX4;RNF41;DUSP10;RARG;MNT;TRIB1;GLMN;AXIN2;NMI;ATRAID;BRD7;IRF1;FRK;IFI35;PODN;MAP2K1;PML;DNAJB2;MFN2;PER2;FLCN;TSC1;KAT2B
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.422724524907735,-1.0915353089504969,0.3468085106382979,0.6378212915807016,1.0,8/18,27.82%,CORO2B;CCT8;PTP4A3;CCT2;CCT6A;CCT7;CEP135;DKC1
prerank,androgen receptor signaling pathway (GO:0030521),0.4969184782070707,1.0915169029421394,0.3564154786150713,0.9066293527535,1.0,4/11,11.70%,DDX5;PMEPA1;TMF1;ZMIZ1
prerank,negative regulation of defense response (GO:0031348),0.3559972043985623,1.0912609339712593,0.3172932330827068,0.9062985001330132,1.0,13/77,14.43%,RORA;C1QTNF3;PPARA;PCBP2;METRNL;GPS2;ENPP3;CDH5;DHX58;NMI;MAPKBP1;ACOD1;PPM1B
prerank,ethanol metabolic process (GO:0006067),0.4952068911575326,1.0911214762011396,0.37375745526838966,0.9056366713482797,1.0,2/12,7.88%,ALDH1A1;ALDH2
prerank,in utero embryonic development (GO:0001701),0.43724332260024584,1.0908364135924855,0.3548951048951049,0.9054101388265738,1.0,6/25,7.55%,FGFR2;ZNF568;TGFBR1;ARNT2;FUT8;CHD7
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.47029029066357775,-1.0905622594275814,0.3528138528138528,0.6394024186623518,1.0,4/12,8.07%,CAV1;CTNNA3;RYR2;BIN1
prerank,regulation of cytoplasmic transport (GO:1903649),0.5154908173322741,1.0898974324910562,0.3816793893129771,0.907228074621236,1.0,4/11,14.02%,LRRK2;USP7;MAP2K1;MAP2K2
prerank,glycogen catabolic process (GO:0005980),0.47378774828096265,1.089703548826505,0.3568965517241379,0.9067078696272789,1.0,3/15,8.86%,PYGM;PHKB;PHKG1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.513810751373774,1.089182804596491,0.36923076923076925,0.9072605495730262,1.0,2/10,12.40%,TLR4;MIA3
prerank,positive regulation of cell adhesion (GO:0045785),-0.3070019169709921,-1.08890251884516,0.28664495114006516,0.6426567172381262,1.0,20/74,14.56%,FRMD5;ZFHX3;PTPRJ;TGFB2;CXCL12;VIT;NDNF;EPB41L4B;FBLN2;STX3;PPP3CA;SMAD7;CD47;ERBB2;P2RY12;RET;VEGFA;ADGRG1;PPM1F;LIMS1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.4802839172097153,-1.0888059575628228,0.3705263157894737,0.6421142830401617,1.0,3/11,10.43%,NOTCH1;FOXO1;ATP2B4
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.48507898172357145,-1.0886662405349026,0.3682008368200837,0.6416984505965707,1.0,3/10,8.32%,DCN;KDR;MYOC
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4438353075602399,-1.0884553021179464,0.36054421768707484,0.6414801147281415,1.0,4/15,9.33%,PTK2B;KDR;BMX;TEC
prerank,regulation of cell development (GO:0060284),0.40603609393915047,1.0884247828101685,0.34933774834437087,0.9085432032098122,1.0,8/36,14.09%,NOTCH2;BHLHE41;ADGRA2;DOCK7;FBXO22;PRUNE1;HES6;PER2
prerank,cAMP biosynthetic process (GO:0006171),0.5301861413763048,1.0883753689681643,0.39156626506024095,0.9075818022862119,1.0,3/10,7.00%,ADCY5;ADCY1;ADCY9
prerank,calcium ion import (GO:0070509),-0.36403023256408,-1.0882894856343341,0.3289817232375979,0.6411297762994324,1.0,10/28,12.96%,SLC8A1;CACNB2;CACNA1E;CACNA1G;TRPC4;MICU3;CACNA1B;TRPV4;SMDT1;MCUB
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3975376174924681,1.088236683294227,0.3399014778325123,0.906906679287196,1.0,7/38,12.06%,LEPROT;PRKN;LRRK2;FZD5;HUWE1;NPEPPS;CSNK2A2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4032287923478654,1.0881737178418618,0.37271214642262895,0.905994511736913,1.0,11/41,12.65%,ACE;EPHA4;ADRA2A;DLG3;GPRC5B;HBEGF;NOX4;CASS4;ADAM17;TGFA;SRCIN1
prerank,tight junction assembly (GO:0120192),0.3854608849233627,1.0879110797049185,0.3397129186602871,0.9056695332951219,1.0,3/49,1.68%,PARD6G;AFDN;DLG1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.27498073727040967,-1.086667700288518,0.2518796992481203,0.6442953695889088,1.0,35/152,14.77%,ADGRL3;ADGRB3;ADGRL4;ADGRL2;CALCRL;ADGRG6;GNAS;ADCY2;ADRA1B;ADGRE5;GRM8;ADCY7;RAMP2;ADCY4;PSAP;GNAI1;CHRM2;GNA12;S1PR1;HTR1F;PDE2A;P2RY12;LGR5;PTH1R;GPER1;GNA14;PTHLH;RAMP1;ADGRB1;GPR26;HTR1B;ADGRG1;GNAO1;IAPP;GNAL
prerank,negative regulation of dephosphorylation (GO:0035305),0.4619778708546173,1.0864600147416716,0.35304990757855825,0.9089397252157553,1.0,2/18,6.81%,SH3RF2;SH2D4A
prerank,histone H3 deacetylation (GO:0070932),0.4726168827999452,1.0863477470197085,0.3694852941176471,0.9081961275186846,1.0,5/15,14.09%,HDAC8;HDAC4;SIRT1;HDAC1;PER2
prerank,positive regulation of protein sumoylation (GO:0033235),0.5263377121408948,1.086296869258672,0.40185185185185185,0.9072649735175375,1.0,4/10,18.96%,PIAS1;HDAC4;PIAS3;PIAS4
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.44003925674181427,-1.0861876976443026,0.3782608695652174,0.6446946145103278,1.0,7/14,36.66%,ENTPD1;ENTPD2;ENTPD3;NUDT9;NUDT16;NUDT15;ENTPD5
prerank,glycosphingolipid metabolic process (GO:0006687),-0.3427848571639495,-1.0855026668323058,0.3132832080200501,0.6455874843609977,1.0,10/42,10.37%,ST6GALNAC3;ESYT2;UGCG;ST8SIA1;PSAP;ST6GALNAC5;GLTP;HEXB;B3GALNT1;ESYT3
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.34263889343145637,1.0853594719665989,0.3292349726775956,0.9090396724727843,1.0,24/102,17.05%,CPEB2;ADCY5;SORBS1;RHOQ;ADCY1;SLC30A10;INSIG2;ADCY9;GCK;PDPK1;FER;RAB13;PRKDC;PRKCI;PRKAR1A;ADCY6;DENND4C;KAT2B;NFKB1;ZFP36L1;GOT1;RAB8B;PRKACB;C2CD5
prerank,negative regulation of protein polymerization (GO:0032272),-0.3774582247766549,-1.0853576826402753,0.335,0.6451667668538313,1.0,13/27,21.68%,SLIT2;KANK3;KANK4;STMN2;TUBB4A;PFN2;SNCA;STMN1;KANK1;HIP1R;MYADM;SSH2;TWF2
prerank,visual perception (GO:0007601),0.35569215092130607,1.084864055658384,0.34813753581661894,0.9094021298273538,1.0,11/84,7.85%,ZIC2;EML2;COL18A1;CEP250;EYA4;RGS16;IMPG2;GNAT2;OPA1;DHRS3;RABGGTA
prerank,histone ubiquitination (GO:0016574),0.4597422564045713,1.0848391133487574,0.3612565445026178,0.9084054047350472,1.0,4/21,7.66%,CTR9;UBR2;RNF8;HUWE1
prerank,smoothened signaling pathway (GO:0007224),0.41384466356147226,1.0841228865493775,0.3493150684931507,0.9093970016609374,1.0,12/32,18.83%,CC2D2A;GLI2;GLI3;SMO;GLI1;DHH;TMEM231;STK36;EVC2;TMEM17;TCTN3;IHH
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.36017104367577973,1.0837905085352415,0.31601731601731603,0.9093607973862339,1.0,15/78,14.09%,DAB2;SH3RF2;PRKN;LRRK2;PIAS1;TRIB2;RNF217;RNF19A;CSNK1A1;FBXO22;TRIB1;FZR1;NUB1;DNAJB2;ZYG11B
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4768213063703784,1.0837427772697728,0.3704379562043796,0.9084269078995599,1.0,4/15,13.25%,TLR4;DDX3X;EIF2AK2;DHX33
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5119812989754351,1.0837147050145166,0.3803921568627451,0.9074349171863156,1.0,2/11,3.11%,EFNB2;FRS2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.472681572703308,1.0835073138953362,0.38581314878892736,0.9069772050455892,1.0,3/18,3.73%,SMAD3;CLASP1;PDPN
prerank,negative regulation of phosphorylation (GO:0042326),0.3464603040875788,1.08272937324592,0.3218884120171674,0.9082495868408272,1.0,17/85,11.45%,BMP7;PTPN13;FBLN1;PPARA;PRKN;NUPR1;LRRK2;NPRL2;WWTR1;PTEN;IGFBP3;CDK5RAP3;HDAC4;SIRT1;CRKL;PRKDC;IMPACT
prerank,positive regulation of cell motility (GO:2000147),0.31547583337327656,1.0825315123287103,0.2979242979242979,0.9077851899391245,1.0,36/205,12.33%,DAB2;FGF1;WNT5B;SH3RF2;SYNE2;ROCK2;KIT;LAMC2;IGF1;RHOD;SPHK1;TGFBR1;ADRA2A;PDPN;RUFY3;SMO;CTSH;SEMA3B;ATM;SOD2;FLT1;PDGFRB;CPNE3;CDH5;CCAR1;HBEGF;FER;TRIP6;PIK3R3;CASS4;MMP14;VIL1;MYLK;ADAM17;MYO1C;PRKCA
prerank,signal transduction in response to DNA damage (GO:0042770),0.37589726244174104,1.0825004329667882,0.3692077727952167,0.9067952309865941,1.0,25/49,28.43%,BID;SESN2;ATM;ATRX;TP53;DONSON;ABL1;HUS1;GADD45A;DOT1L;CEP63;CLSPN;INTS7;NBN;MAPK14;RAD9A;CASP9;CDC5L;MAD2L2;NDRG1;TIPRL;USP28;E2F7;CHEK1;GRB2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.29124606893680016,-1.0824350715669442,0.302158273381295,0.6507809286020853,1.0,32/104,30.01%,RPS6KA5;PAK3;KRAS;LYN;PSMB2;PAK1;PLCG2;MAP3K7;PSMD14;PSMC6;IKBKB;RELB;PSMA4;PSMB9;SKP1;SYK;ICAM2;PSMD11;PSMB10;PSMD2;TYROBP;FYN;PSMA2;RELA;PSMB3;TAB1;PSMB5;CARD11;PSMA7;PSMF1;PSMD7;MALT1
prerank,cellular response to lectin (GO:1990858),-0.29124606893680016,-1.0824350715669442,0.302158273381295,0.6507809286020853,1.0,32/104,30.01%,RPS6KA5;PAK3;KRAS;LYN;PSMB2;PAK1;PLCG2;MAP3K7;PSMD14;PSMC6;IKBKB;RELB;PSMA4;PSMB9;SKP1;SYK;ICAM2;PSMD11;PSMB10;PSMD2;TYROBP;FYN;PSMA2;RELA;PSMB3;TAB1;PSMB5;CARD11;PSMA7;PSMF1;PSMD7;MALT1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.4833719916402146,1.0818083342408202,0.35239852398523985,0.9078450027050868,1.0,3/15,8.75%,FGF1;FUT1;PDPK1
prerank,cell differentiation in spinal cord (GO:0021515),-0.4779115248027608,-1.0813143895161768,0.38412017167381973,0.6527337460508529,1.0,1/10,0.35%,MDGA2
prerank,regulation of histone acetylation (GO:0035065),0.41536261034813254,1.0812500947277932,0.3689655172413793,0.908423385564666,1.0,5/33,5.82%,PPARGC1A;KMT2A;RAPGEF3;ARRB1;CAMK1
prerank,regulation of protein ubiquitination (GO:0031396),0.34381842263344925,1.0807873711834968,0.34106412005457026,0.9086810153272388,1.0,14/108,9.68%,SH3RF2;NXN;SASH1;PRKN;SPHK1;HDAC8;TGFBR1;LRRK2;ARRB1;FANCI;HUWE1;CDK5RAP3;RIPK2;GTPBP4
prerank,pulmonary valve morphogenesis (GO:0003184),0.46175787034266647,1.0801858970787097,0.36804308797127466,0.9094430636028425,1.0,2/17,0.29%,NOTCH2;ROBO1
prerank,V(D)J recombination (GO:0033151),0.5110058236144039,1.0796899358890664,0.38076923076923075,0.9098824279048399,1.0,4/11,21.43%,XRCC4;PRKDC;LIG4;LIG1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.3876229101376511,-1.079387554563419,0.3440366972477064,0.6568331851833235,1.0,12/25,38.46%,HSPA8;HSPA5;HSPE1;DNAJB1;PTGES3;HSPA13;ERO1A;HSPA1L;HSPA9;DNAJB4;ST13;SDF2L1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.2890789783268488,-1.0787833790225265,0.30357142857142855,0.6575200170883394,1.0,32/105,30.01%,RPS6KA5;PAK3;KRAS;LYN;PSMB2;PAK1;PLCG2;MAP3K7;PSMD14;PSMC6;IKBKB;RELB;PSMA4;PSMB9;SKP1;SYK;ICAM2;PSMD11;PSMB10;PSMD2;TYROBP;FYN;PSMA2;RELA;PSMB3;TAB1;PSMB5;CARD11;PSMA7;PSMF1;PSMD7;MALT1
prerank,glycoprotein metabolic process (GO:0009100),0.3737719673536483,1.0783895846001093,0.3441358024691358,0.9125621831375721,1.0,14/53,13.89%,MAN1A2;MAN1C1;LARGE1;NGLY1;NEU2;ADAMTS9;FUT8;ST6GALNAC6;MANBA;GAL3ST4;CNMD;MAN2A1;GANC;PRKCSH
prerank,regulation of signal transduction (GO:0009966),-0.2651601782696038,-1.078074498941064,0.22897196261682243,0.6585289591826037,1.0,45/190,13.88%,ESR1;RSPO3;PLCE1;RGS3;LIFR;MDFIC;UBASH3B;RGS5;KCTD8;RGS6;SEMA5A;NCK2;RUNX1;MGLL;UGCG;TMEM108;IGFBP4;PPIA;APP;HHIP;SOCS2;PTCH1;PRAG1;IGFBP6;TSPAN12;CRK;SREBF2;TMEM204;PPP2R1A;YWHAG;FRMPD1;TGFB1;LFNG;KIF26A;MFNG;RGS4;GLRX2;HOMER1;ILK;AXIN1;PRKD1;ACVR1;RGS20;RGS12;SOCS5
prerank,cell projection assembly (GO:0030031),-0.3947465481331051,-1.0778499005513662,0.37587006960556846,0.6582829152357706,1.0,5/22,10.26%,RHOJ;GSN;PARVB;RHOH;PDGFA
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4391440610591369,1.077782951352092,0.37653239929947463,0.9133080399545889,1.0,3/26,2.17%,ROCK2;PICALM;EPHA4
prerank,regulation of bone mineralization (GO:0030500),0.3818305721763067,1.0776060623553687,0.34579439252336447,0.912779784345312,1.0,9/55,7.63%,BMP6;BMP7;WNT4;OSR1;KL;BMPR1A;SRGN;ANO6;BCOR
prerank,cell-cell junction organization (GO:0045216),0.36194035004928593,1.0774248150268286,0.35797101449275365,0.9122796572196696,1.0,8/79,2.77%,SDK1;AFDN;SMAD3;PKP4;SDK2;PKHD1;NLGN2;ARVCF
prerank,negative regulation of interleukin-17 production (GO:0032700),0.522683596729929,1.0773363713871165,0.38779527559055116,0.9114717377602028,1.0,2/10,6.47%,TLR4;IL12B
prerank,apoptotic mitochondrial changes (GO:0008637),0.4131604408689985,1.0765738469843928,0.3599320882852292,0.9126961794300629,1.0,6/32,10.52%,HK2;IFIT2;BID;SOD2;DNM1L;NDUFS1
prerank,negative regulation of apoptotic process (GO:0043066),0.29643953597407197,1.076456200883236,0.30434782608695654,0.9119912824650462,1.0,54/444,9.73%,NOTCH2;DAB2;SH3RF2;OSR1;FHL2;PPARGC1A;IGF1;PRKAA2;PRKN;SLC30A10;RETREG1;FNIP1;PKHD1;GRK5;SPHK1;ALOX12;SON;SNX6;CPEB4;RNF213;NUPR1;CFLAR;PHIP;CASP3;PDPN;IFIT3;BID;TNFAIP8;ZFAND6;BABAM2;MYO18A;SMAD6;CTSH;DDX3X;CD27;MAP2K5;SOD2;AVEN;BRAF;CD28;NUAK2;TP53;OPA1;COMP;ANXA5;KDM2B;PIK3CA;GDNF;NIBAN2;SIRT1;TLE1;RIPK2;HDAC1;RIPK1
prerank,dephosphorylation (GO:0016311),-0.2755383110188229,-1.076415057800558,0.2777777777777778,0.6609971027299899,1.0,29/147,11.01%,PTPRB;PTPRM;PTPRD;PTPRJ;PTPRG;PTPN12;PPM1H;PTPRK;PTPRT;PPM1L;PLPP1;PTPRN2;PLPPR1;PPP1R12A;PPP2R5A;PTPRC;PTPRF;ALPL;MTMR6;PPP2R1A;PTPRZ1;PPP3CA;PTPRE;MTMR2;PLPPR5;PLPPR4;DUSP1;MTMR7;DUSP3
prerank,postsynaptic membrane organization (GO:0001941),-0.41507507801774784,-1.0763738418720041,0.38266384778012685,0.6603301340145172,1.0,5/17,6.19%,NLGN1;NRXN1;SHANK3;GPHN;APOE
prerank,regulation of DNA replication (GO:0006275),0.38364555001446116,1.0763082016643528,0.3606811145510836,0.9113683379097153,1.0,16/49,16.63%,GLI2;CCNA2;ZBTB38;DSCC1;ANKRD17;PDS5A;GLI1;GTPBP4;WAPL;KAT7;CDAN1;ORC3;FAF1;EHMT2;SMC3;USP37
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.284842231530488,-1.0761771259983952,0.2916666666666667,0.6600176727678261,1.0,38/117,23.55%,CALCRL;ADCY2;ADCY7;MYH9;GNG2;RAMP2;LYN;PLK2;ADCY4;PLCG2;PTGDR;HTR7;PTH1R;CYSLTR1;PRKAR1B;CYSLTR2;PRKAR2B;HTR4;PTHLH;RAMP1;IAPP;GNB1;VIPR2;SYK;GPR45;ADCY3;ADCY8;PRKAR2A;GPR176;HRH2;ADCYAP1R1;YES1;MC5R;NPSR1;CD81;FYN;LHCGR;RHBDF2
prerank,response to insulin (GO:0032868),0.35646213507944574,1.0761541521420332,0.34057971014492755,0.9107524081273349,1.0,20/80,17.05%,CPEB2;SORBS1;RHOQ;INSIG2;SLC27A1;GCK;PDPK1;SIRT1;FER;RAB13;PRKDC;PRKCI;DENND4C;OGT;TSC1;KAT2B;ZFP36L1;GOT1;RAB8B;C2CD5
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.3241049878893371,-1.0760999730169398,0.32710280373831774,0.6594283250033105,1.0,21/53,34.29%,PSMB2;PSMD14;PSMC6;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;BCKDK;PSMA2;PSMB3;PSMB5;OAZ1;PSMA7;OAZ2;ODC1;PSMF1;PSMD7;PSMA5;PSMD4;PSME4
prerank,neuromuscular process (GO:0050905),-0.4322195604354173,-1.0759099257316473,0.34841628959276016,0.6590783745581659,1.0,4/16,7.68%,NRXN1;GCH1;MYCBP2;STRA6
prerank,organelle fission (GO:0048285),0.4308910984146402,1.075130039916255,0.37542087542087543,0.9127699848425379,1.0,11/24,17.51%,PRKN;PEX11A;OPA1;PEX11B;MTFR2;DNM1L;ACOT8;DNM2;PEX19;WASHC5;MTFP1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.4069766545002487,-1.0747579080461869,0.36778846153846156,0.6612366639048519,1.0,5/19,6.59%,PRKCH;CLDN5;RUNX1;F11R;OCLN
prerank,negative regulation of endocytosis (GO:0045806),0.432635686931754,1.0747509846387642,0.38543516873889877,0.9128886554040444,1.0,3/24,2.79%,SYT11;PICALM;CD300A
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4510739164550433,1.0746974486368075,0.3738656987295826,0.9120043965806454,1.0,4/20,6.75%,SLC8A3;MCU;SLC25A23;MICU1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3301969716237974,-1.0740218628902187,0.3163265306122449,0.6622466357392022,1.0,18/47,19.80%,PID1;THBS1;PLCG2;RAB27A;TGFB1;AGTR1;XDH;CYBA;CDKN1A;MAPT;ACE2;ADGRB1;GRIN1;SYK;ITGB2;ROMO1;TYROBP;AGT
prerank,positive regulation of protein transport (GO:0051222),0.3616014180541413,1.0730421967423118,0.35745937961595275,0.9158634927414177,1.0,9/67,9.15%,BMP6;FRMD4A;IGF1;MYO18A;EZR;RUFY3;BCAS3;DNM1L;GOLPH3L
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.3505290083006563,-1.0726769564608212,0.3546666666666667,0.6646579177232531,1.0,12/36,14.77%,LEF1;GNG2;NLK;CALM1;FZD4;MAP3K7;PPP3R1;NFATC1;PPP3CA;CTNNB1;GNAO1;GNB1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5052201694190916,1.0726755701646808,0.36259541984732824,0.9158086955219059,1.0,3/11,11.47%,DONSON;FBH1;MSH3
prerank,cartilage development (GO:0051216),0.3796468591740331,1.0725526415589113,0.3441358024691358,0.9151454345514217,1.0,6/49,4.64%,WNT5B;OSR1;SOX5;NFIB;SULF2;CREB3L2
prerank,negative regulation of macrophage activation (GO:0043031),-0.4179427189733835,-1.0725308709901764,0.37272727272727274,0.6642424759530103,1.0,4/16,6.74%,CD200;LRFN5;PTPRC;LDLR
prerank,isotype switching (GO:0045190),0.5139769806800855,1.072511456457029,0.39147286821705424,0.9142129108046138,1.0,6/10,31.16%,RNF8;EXOSC3;LIG4;HSPD1;BATF;MSH6
prerank,defense response to symbiont (GO:0140546),0.3473969278854734,1.072012140125664,0.3649851632047478,0.9146790708853286,1.0,21/92,15.46%,IFIT1;IFIT2;OAS2;IFIT3;IFI27;NDUFAF4;TLR3;TRIM56;STAT2;EIF2AK2;PLSCR1;SAMHD1;RSAD2;MAVS;MOV10;ATG7;IRF1;OAS3;ACOD1;IFNAR2;NT5C3A
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3866771707064322,-1.071473038252541,0.36179775280898874,0.666117682438419,1.0,5/23,18.32%,PLA2G4A;MBOAT1;PLA2G12A;ABHD4;PLA2G4E
prerank,histone deacetylation (GO:0016575),0.3918539390954963,1.0712857598990917,0.37735849056603776,0.91581130749503,1.0,16/43,23.66%,HDAC8;TBL1X;TBL1XR1;HDAC4;SIRT1;HDAC1;PRDM5;SIN3A;PER2;MIER3;MTA2;MTA1;RCOR1;REST;MIDEAS;MSL3
prerank,embryonic organ development (GO:0048568),0.36536556330858977,1.0701586102072433,0.3575757575757576,0.9181701762544169,1.0,14/61,10.09%,KIT;KMT2A;FGFR2;GLI2;BMPR1A;GLI3;TEAD3;COL13A1;TGFBR2;RBP4;IFT122;GDNF;TEAD2;FLT3LG
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.46416781641861965,1.0696912746557508,0.3702359346642468,0.9185487939176383,1.0,5/16,19.02%,TOP2B;FANCM;EME2;MSH4;SLX4
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4217104529347596,1.0694471692553948,0.39347079037800686,0.9182408079733649,1.0,3/26,3.65%,ADCY5;STXBP4;ADRA2A
prerank,protein kinase A signaling (GO:0010737),0.48230169993814387,1.069356972572847,0.3967391304347826,0.9174724975273154,1.0,5/12,17.03%,TCP11X2;EZR;RAB13;TCP11;PRKACB
prerank,protein trimerization (GO:0070206),-0.43378647031505535,-1.0692732627241237,0.3899782135076253,0.6699804898607854,1.0,6/14,12.09%,SCARA5;SLC1A5;SLC1A2;DISP1;PNPT1;MLKL
prerank,protein homotrimerization (GO:0070207),-0.43378647031505535,-1.0692732627241237,0.3899782135076253,0.6699804898607854,1.0,6/14,12.09%,SCARA5;SLC1A5;SLC1A2;DISP1;PNPT1;MLKL
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.2740375578642341,-1.0690198078321,0.2923728813559322,0.6698294951587117,1.0,56/145,31.20%,FBXL7;YWHAE;RAD51B;PSMB2;DYNLL1;PPP2R1A;YWHAG;PSMD14;TUBA1A;HAUS2;PSMC6;TUBB4A;CDK5RAP2;HSP90AA1;KCNH5;PRKAR2B;HAUS5;PSMA4;PSMB9;CEP78;SKP1;CETN2;PSMD11;PSMB10;TUBA4A;SSNA1;PSMD2;CEP131;PSMA2;DTL;CCP110;HMMR;TPX2;KIF14;MECP2;NEDD1;HAUS4;CEP135;PSMB3;ACTR1A;NDE1;HAUS6;FHL1;CEP76;PSMB5;CCND1;PSMA7;CENPF;CDC7;PSMF1;PSMD7;AURKA;CDK1;CEP43;BRD4;CSNK1D
prerank,negative regulation of neuron death (GO:1901215),-0.2923501893800259,-1.0688807481579268,0.3103448275862069,0.6694129251581548,1.0,34/93,19.61%,MEF2C;CD200;PTK2B;CD34;NDNF;NGF;NTRK2;GSK3B;APOE;TGFB3;TNFRSF1B;SORL1;PTPRZ1;SIX1;BTBD10;FOXQ1;TOX3;PPT1;RASA1;ATF4;UNC5B;NENF;SNCA;PINK1;MT3;FBXO7;BDNF;TYRO3;HTRA2;CRLF1;CHMP4B;CHMP4A;VSTM2L;SIX4
prerank,second-messenger-mediated signaling (GO:0019932),-0.2993889767622906,-1.0688221701965743,0.3186119873817035,0.6687826348514481,1.0,28/82,20.28%,MCTP1;PLCE1;CHRM3;NOS3;RYR2;NDNF;GUCY1B1;KSR2;APOE;GUCY1A1;PLCG2;ACKR3;PPP2R1A;AGTR1;CAMKK2;P2RY12;EDN1;EDN3;NOS1;EDNRB;HRH1;EIF2AK3;CX3CR1;BTK;MCTP2;RCAN3;AGT;PPP1R9A
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3559949512668369,-1.0678282203702802,0.3564102564102564,0.6704616454637993,1.0,13/33,20.05%,PIK3R1;NYAP2;PIK3C2B;PLEKHA1;HTR2A;ERBB2;EDN1;MYO16;PIK3C2A;PIK3R5;TYRO3;SIRT2;IRS1
prerank,muscle cell development (GO:0055001),0.4235543033107898,1.0678211446135715,0.3698630136986301,0.921055490048042,1.0,4/30,2.06%,NEBL;ANK2;IGF1;MYOF
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.33648674474275164,-1.067684076225014,0.35911602209944754,0.6700469929475517,1.0,12/44,16.21%,GSN;NCK2;EVL;CARMIL1;PTK2B;CDC42EP3;BIN1;PFN2;ARPC4;CDC42EP2;NCK1;ARF6
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5219976636783554,1.0670303895458733,0.39501039501039503,0.9225702788140552,1.0,3/10,12.36%,LPGAT1;SLC45A3;MLXIPL
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3497817405239916,1.0668956051875966,0.3485540334855403,0.9219375013954582,1.0,8/78,3.91%,DAB2;SORBS1;PICALM;RHOQ;DLG1;PTPN9;ARHGEF16;PPFIA1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.3188711100787159,-1.066860455803636,0.34411764705882353,0.671365356893643,1.0,17/53,16.89%,HSP90AB1;DAB2IP;APOE;XPO1;DDRGK1;PSMD14;GNA12;PSMC6;PKD1;RAD23B;FOXF2;ECSCR;PINK1;UBB;GPX1;USP14;GABARAPL2
prerank,lipoprotein localization (GO:0044872),0.4961963667335379,1.066553122226908,0.40576923076923077,0.9218656221737745,1.0,4/11,13.02%,PRKCB;LRP1;MIA3;UNC119B
prerank,positive regulation of immune effector process (GO:0002699),0.42575841150000476,1.066498493821626,0.3708609271523179,0.9209960524122184,1.0,6/27,11.40%,APPL2;MYO18A;ANKRD17;IL12B;DDX60;DHX58
prerank,negative regulation of signaling (GO:0023057),-0.37945630095359806,-1.066478932397992,0.37028301886792453,0.6715844618047582,1.0,7/25,18.42%,UBASH3B;HHIP;GLRA1;KIF26A;ACVR1;SOCS5;PTPN1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.374591549132385,1.066045269495195,0.3613312202852615,0.9212263036626807,1.0,13/50,13.40%,SASH1;SPHK1;NFAT5;TLR3;TLR4;DDX3X;CD27;IL12B;EIF2AK2;TRIP6;NMI;NR3C2;IFI35
prerank,response to glucocorticoid (GO:0051384),-0.37676548859681636,-1.0649543967684498,0.34032634032634035,0.6746490866690059,1.0,5/26,21.11%,SLIT2;ANXA1;FAM107A;BCL2L11;SLIT3
prerank,positive regulation of natural killer cell activation (GO:0032816),0.49905902191152063,1.064453458663243,0.3740875912408759,0.9250257196673255,1.0,4/13,13.82%,IL18;IL12B;ZBTB1;AXL
prerank,glycolipid biosynthetic process (GO:0009247),0.3978249969477573,1.0644183490386023,0.38870967741935486,0.9240685060739354,1.0,6/38,6.37%,GBGT1;LARGE1;PIGN;ST3GAL5;PIGW;PIGQ
prerank,regulation of GTPase activity (GO:0043087),0.31502598194463255,1.0643646585167006,0.34438775510204084,0.9231786469964053,1.0,18/177,4.59%,CPEB2;DOCK11;AFDN;PKP4;PICALM;SIPA1L1;PLXNA2;EPHA4;SRGAP2;FGD4;ARHGAP9;ALS2;NGEF;RGS16;ASAP3;LRRK2;GMIP;RAPGEF3
prerank,regulation of interleukin-13 production (GO:0032656),0.4823533955948958,1.0643322588391864,0.41541353383458646,0.9222256788881821,1.0,2/13,2.00%,PRKCZ;IL18
prerank,receptor-mediated endocytosis (GO:0006898),-0.2780071050459181,-1.0640338571661012,0.33448275862068966,0.6761191050786833,1.0,30/132,11.27%,LRP1B;DNM3;SGIP1;CALCRL;CAV1;CD9;FNBP1L;SCARB1;CAV2;RAB31;TFRC;TMEM108;RAMP2;APOE;SNAP91;LDLR;ACKR3;ITGB1;HSPG2;DNM1;SORL1;STAB1;CALR;AP2B1;SCARF1;CXCL16;PPT1;HSP90AA1;CTSL;AP2M1
prerank,cardiac muscle cell development (GO:0055013),-0.4024014661169177,-1.0640067945374534,0.375,0.6754188229978577,1.0,5/20,9.58%,SORBS2;SLC8A1;FHOD3;HEY2;MYH11
prerank,positive regulation of hydrolase activity (GO:0051345),-0.270791701289829,-1.0634152263211956,0.2757201646090535,0.6761250676103031,1.0,29/137,10.44%,DOCK9;DOCK10;ITGA6;RGS7;CD200;RGS6;F11R;BCAR3;CDKL5;CAV2;ARHGEF7;NET1;GSK3B;TBC1D30;CALM1;RAP1A;CALM2;RPS3;PSAP;SEMA4D;ITGB1;BMP2;MTCL1;RASGRF1;RAPGEF6;DOCK8;ERBB2;AGRN;CALM3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3255070382926217,1.0633579361256642,0.344,0.9240414116283637,1.0,10/142,5.34%,ATP1A2;ADCY5;SMAD3;LPAR1;CCR9;ACKR2;LPAR2;BDKRB2;CACNA1C;F2
prerank,negative regulation of autophagy (GO:0010507),0.37164590733079306,1.0627056881002943,0.37094281298299847,0.9249997680251524,1.0,16/54,18.90%,LEPR;NUPR1;SNRNP70;LRRK2;SMG1;PTPN22;PIK3CA;TAB2;ATG7;TSC1;ZKSCAN3;TLK2;MCL1;TBC1D14;EIF4G1;GOLGA2
prerank,nucleic acid metabolic process (GO:0090304),0.357585385174728,1.062084269657363,0.37915407854984895,0.9257591111319304,1.0,21/69,20.42%,POLR2A;PCBP2;DNTT;HNRNPR;POLG;HNRNPH1;DNASE1L1;HNRNPA2B1;POLR2D;ATXN2;GTF2F1;HNRNPL;RAD50;WTAP;HNRNPC;HNRNPM;DNASE1L2;FEN1;MMS19;DXO;POLR2G
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4641344006948635,1.0619911927222703,0.39138240574506283,0.9249922781006089,1.0,7/17,17.74%,PRKN;YJU2;RNF34;SIRT1;DYRK1A;SNAI1;KDM1A
prerank,regulation of neuron apoptotic process (GO:0043523),-0.28748569784238237,-1.0618289532489371,0.31,0.6793962889138173,1.0,36/96,22.10%,GRID2;MEF2C;TGFB2;PTK2B;TRIM2;NDNF;NGF;NTRK2;APOE;TGFB3;EPHA7;PTPRZ1;SIX1;FOXQ1;TOX3;PPT1;KCNB1;RASA1;ATF4;CTNNB1;UNC5B;PINK1;CDK5R1;MT3;BDNF;EGLN2;FAIM2;TYRO3;CRLF1;VSTM2L;SIX4;EGLN3;AKT1S1;GRM4;MDK;SOD1
prerank,dendritic cell differentiation (GO:0097028),-0.38461688480761524,-1.0616008151759564,0.3835294117647059,0.679182703919608,1.0,8/22,24.74%,GAS6;LYN;CAMK4;TRPM2;IRF8;CCL19;LGALS9;PRTN3
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.3703378931199387,-1.061448677984553,0.3656716417910448,0.678788744945888,1.0,7/29,13.89%,BMP5;DAB2IP;IL17RD;SMAD7;ADIPOR1;SPRY1;SPRED1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5164311124331329,1.0614047567922331,0.4196078431372549,0.9257283410322219,1.0,2/10,7.34%,FGFR2;TGFBR2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.3272552371708908,-1.0614002654895214,0.3504531722054381,0.6781516166408474,1.0,21/50,25.39%,THBS1;GAS6;NGF;YWHAE;SIAH2;CD44;ARL6IP1;RPS6KA3;SNCA;VEGFA;RPS6KA1;CARD16;MT3;PAX2;GPX1;DHCR24;RFFL;TRIAP1;HGF;PLAUR;KLF4
prerank,glial cell development (GO:0021782),-0.36903833717858986,-1.0613723403893143,0.3691588785046729,0.6774681287118178,1.0,14/25,34.02%,APP;NRROS;EIF2B3;MT3;TPPP;CSPG5;MDK;SOX10;NF1;EIF2B2;PRDM8;EIF2B5;TLR2;MYRF
prerank,lipoprotein transport (GO:0042953),0.5049445127932946,1.0610930292706013,0.40039447731755423,0.9255809532766259,1.0,4/10,13.02%,PRKCB;LRP1;MIA3;UNC119B
prerank,muscle cell migration (GO:0014812),-0.4813225334939809,-1.0609511513227432,0.423728813559322,0.6777124787055631,1.0,5/10,23.03%,CCN3;SIX1;ITGB3;THBS4;AAMP
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.4594337868659828,-1.0607185877201264,0.4110429447852761,0.6775186921229283,1.0,2/11,6.60%,CDH13;PLCG2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.41640376753693015,-1.0602351782348356,0.3922413793103448,0.6779053524089514,1.0,9/16,19.07%,THBS1;PPP1R16B;GATA2;AGTR1;FGF2;JCAD;VEGFA;APLNR;DLL4
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4050065467548165,-1.0601919979700132,0.3696581196581197,0.6772335480888023,1.0,6/17,13.51%,CAV1;KLF7;AJAP1;CEACAM1;APOLD1;MAFF
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4017165437732946,1.0595779694629432,0.38879456706281834,0.9291735815275696,1.0,6/34,12.71%,IGF1;PHIP;CD28;PDGFRB;TGFA;NSMCE2
prerank,zinc ion transport (GO:0006829),0.44075801798000597,1.0594504745076212,0.39501779359430605,0.9285053139154111,1.0,3/21,8.11%,SLC30A10;SLC30A2;SLC39A13
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.41893091878956207,1.059368732925384,0.3976897689768977,0.9277235807528447,1.0,3/29,5.17%,TGFBR3;FGFR2;TPM1
prerank,negative regulation of defense response to virus (GO:0050687),0.5040163306724081,1.0592927041127902,0.4111969111969112,0.9269253484189718,1.0,2/10,14.43%,PCBP2;PPM1B
prerank,amino acid import across plasma membrane (GO:0089718),-0.3732455077363607,-1.0588916101696222,0.37122969837587005,0.6796516626422183,1.0,8/24,7.84%,SLC6A6;SLC47A1;SLC1A5;SLC7A5;SLC1A2;SLC1A1;SLC7A1;SLC1A4
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.45519003779813566,1.0580838602175535,0.373134328358209,0.9294156068135397,1.0,5/18,15.34%,NXF2;PABPN1;POLDIP3;NXF1;SARNP
prerank,negative regulation of programmed cell death (GO:0043069),0.29526077958907065,1.0576654498543863,0.36251402918069586,0.9296163178031491,1.0,41/355,9.73%,NOTCH2;DAB2;SH3RF2;OSR1;FHL2;IGF1;PRKAA2;PKHD1;KANK2;GRK5;SPHK1;SON;NUPR1;CFLAR;PHIP;CASP3;PDPN;IFIT3;BID;TNFAIP8;ZFAND6;BABAM2;MYO18A;SMAD6;CTSH;DDX3X;CD27;AVEN;BRAF;CD28;NUAK2;TP53;OPA1;COMP;ANXA5;GDNF;NIBAN2;SIRT1;RIPK2;HDAC1;RIPK1
prerank,actin filament organization (GO:0007015),0.31524733023790974,1.0570457405340028,0.3519695044472681,0.9303545919613511,1.0,28/151,11.40%,NEBL;CGNL1;DLG1;SHROOM2;RHOBTB2;AVIL;FHOD1;RHOD;SHROOM3;INPPL1;TMOD2;MYO5C;MCU;RUFY3;TMOD3;TPM1;BAIAP2L1;ARHGAP17;MPRIP;BAIAP2;TRIOBP;MYO19;WASL;CASS4;ARHGAP12;CDC42;BIN3;VIL1
prerank,actin filament network formation (GO:0051639),-0.46412749658000274,-1.0570066324480725,0.41561181434599154,0.6834803995199564,1.0,4/11,6.11%,ACTN1;CARMIL1;FHOD3;PLS1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.411320990031911,1.0569264272284613,0.39285714285714285,0.9296734410329724,1.0,3/30,5.53%,ACSL1;HACD4;HACD1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.452041957276627,-1.0568826847464374,0.40208333333333335,0.6830120868769074,1.0,10/13,40.70%,HSP90AB1;STX3;TYROBP;GPD1L;RANGRF;TMEM35A;TM9SF4;ABCA7;MAP1A;TNF
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.28083000529354823,-1.0567811998899903,0.31954887218045114,0.6825164008333608,1.0,37/116,23.55%,CALCRL;ADCY2;ADCY7;MYH9;GNG2;RAMP2;LYN;PLK2;ADCY4;PLCG2;PTGDR;HTR7;PTH1R;CYSLTR1;PRKAR1B;CYSLTR2;PRKAR2B;HTR4;PTHLH;RAMP1;IAPP;GNB1;VIPR2;SYK;GPR45;ADCY3;ADCY8;PRKAR2A;GPR176;HRH2;ADCYAP1R1;YES1;MC5R;NPSR1;FYN;LHCGR;RHBDF2
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.4640046724526036,-1.0567734976015475,0.4110169491525424,0.6817686665182907,1.0,3/10,20.10%,SACS;SORL1;DNAJB1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3623686691274966,-1.056761626613925,0.3780487804878049,0.6810474198484597,1.0,8/30,8.51%,CSGALNACT1;DCN;CHSY3;NDNF;BGN;CSPG4;VCAN;HEXB
prerank,ion homeostasis (GO:0050801),-0.35115731262611266,-1.0560644182873322,0.381294964028777,0.6820050477340772,1.0,6/30,7.27%,SLC4A10;CAMK2D;UNC80;NEDD4L;KLHL3;WNK2
prerank,regulation of protein export from nucleus (GO:0046825),0.43039990126938904,1.056036957913629,0.38917975567190227,0.9312467193731387,1.0,6/23,9.99%,PTPN14;IFI27;RAPGEF3;CAMK1;TP53;TCF7L2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3687228091328304,1.0559108167125433,0.39689922480620154,0.9305927408108063,1.0,7/54,8.06%,HS3ST3A1;HS3ST3B1;NDST1;HS2ST1;HS3ST6;PXYLP1;CLN6
prerank,alcohol catabolic process (GO:0046164),0.5124739863034955,1.0558627449426845,0.4288461538461538,0.9296899677187661,1.0,2/10,3.74%,CYP27A1;CEL
prerank,muscle tissue morphogenesis (GO:0060415),0.4660804802627156,1.0556149694545414,0.40414507772020725,0.929409320750465,1.0,1/16,0.31%,TGFBR3
prerank,positive regulation of protein maturation (GO:1903319),-0.45818185401435174,-1.0552962792464369,0.4101010101010101,0.6831362124008719,1.0,4/11,21.77%,CCBE1;NKD2;RHBDD1;BAG2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4647086084418943,1.0544526029693537,0.3977055449330784,0.9318695085379237,1.0,11/16,31.35%,NAA80;NAA20;KAT2B;NAA16;CREBBP;EP300;AANAT;NAA50;NAA15;NAA60;NAA40
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.4750699362249913,1.0542971209408178,0.417910447761194,0.9313164343023859,1.0,2/15,1.51%,FGF1;SMOC2
prerank,regulation of nervous system development (GO:0051960),-0.3428683068651274,-1.0542419795388496,0.3712121212121212,0.6849832568613858,1.0,14/37,24.20%,TENM4;HES1;TNFRSF1B;HEYL;PTPRZ1;PTN;HEY2;CTNNB1;CX3CR1;SIRT2;YTHDF2;LGI4;GBX1;KIF14
prerank,cellular response to unfolded protein (GO:0034620),-0.37061814157381767,-1.0541271481925876,0.3925233644859813,0.6844910404776251,1.0,9/26,18.42%,DAB2IP;HSPA8;HSPA5;TMBIM6;PACRG;TM7SF3;HSPB8;RHBDD1;PTPN1
prerank,double-strand break repair (GO:0006302),0.32112012939580115,1.053835013606645,0.3690322580645161,0.9317091889431507,1.0,37/158,20.38%,EYA1;PAXX;POLM;BABAM2;DNTT;ATM;NHEJ1;BAZ1B;RNF8;SAMHD1;FBH1;KDM2A;XRCC4;PARP9;IFFO1;EME2;RBBP8;PRKDC;HUS1;UIMC1;RAD50;NSMCE2;BABAM1;ZFYVE26;TDP2;POLL;NBN;SUMO1;FEN1;RAD51D;PIAS4;SLX4;APTX;MTA1;XRCC3;LIG4;MCM9
prerank,cilium organization (GO:0044782),0.3097511716521783,1.0530917737161325,0.35031055900621116,0.9328392014772616,1.0,58/209,19.22%,CFAP44;AVIL;CC2D2A;PKHD1;DCDC2;CEP250;CPLANE2;RILPL1;RAB3IP;CYS1;RHO;PTPN23;ASAP1;EXOC2;CCDC28B;SSTR3;CEP162;CDC14A;IFT122;WDR19;CATIP;DYNC2I1;MKKS;TMEM231;CLUAP1;CDC14B;ATP6V1D;IFT88;OCRL;GALNT11;PDE6D;TTC17;ROPN1;UNC119B;WDPCP;CFAP410;WDR35;EXOC4;EXOC3;PARVA;B9D2;ARL6;RP2;BBS2;STK36;RFX2;RAB8B;RILPL2;PIBF1;TMEM237;TRAPPC14;ATP6V0D1;TMEM17;TCTN3;PCM1;CEP164;OFD1;PCNT
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.4189611661691668,-1.0530890170750384,0.36231884057971014,0.6862995663264045,1.0,9/15,22.94%,SIX1;BMP4;VEGFA;PAX2;SOX8;PAX8;SIX4;AGT;LHX1
prerank,negative regulation of phosphatase activity (GO:0010923),0.4236187512377919,1.0530564114869774,0.40341880341880343,0.9319261640750197,1.0,3/25,6.81%,SH3RF2;PPP4R4;SH2D4A
prerank,aorta development (GO:0035904),0.47847474127147166,1.052996354641239,0.3897338403041825,0.931074307009258,1.0,4/14,9.36%,ROBO1;ADAMTS9;PDGFRB;LRP1
prerank,regulation of transmembrane transport (GO:0034762),-0.3556425208451569,-1.0529290930850153,0.3669950738916256,0.685903231342584,1.0,12/31,16.02%,SLC2A1;ACTB;KCNJ3;KCNJ2;NEDD4L;OCLN;ACE2;SNCA;KCNJ8;KCNJ6;KCNJ12;PIM1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.41911643443499613,1.052317997560114,0.40933572710951527,0.932026080129683,1.0,10/25,23.64%,FBXL17;NGLY1;ZYG11B;UFD1;CLPP;ZER1;TOR1A;DERL1;BAG6;RNF5
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.355659556782939,-1.052224626359836,0.4,0.6867400521686999,1.0,10/30,22.49%,DACH1;BMPR2;ACVRL1;GNL3L;CDKN1A;TERF1;STN1;MEN1;DCP2;EXOSC10
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3740668886871701,-1.052168891702285,0.3657957244655582,0.6861098716893619,1.0,8/26,12.67%,NOS3;ACER3;ACER2;CYP1B1;SPTLC2;GCH1;ASAH2;NOS1
prerank,rRNA transcription (GO:0009303),-0.4099534606028783,-1.0514771272006658,0.3961456102783726,0.6870253321625147,1.0,4/17,12.98%,CAVIN1;SPIN1;GTF3C5;TAF1B
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4433422968965345,1.0509289485770659,0.42077464788732394,0.9349600626112322,1.0,4/21,6.75%,SLC8A3;MCU;SLC25A23;MICU1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.48631269105488284,1.0508125134097013,0.4223826714801444,0.934313055721315,1.0,4/12,7.77%,CD300A;ELF1;PTPN22;ELF2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.46762719435285416,1.0506426759240592,0.39357429718875503,0.9337937103767788,1.0,3/13,11.08%,PPARA;NFIB;NFATC3
prerank,positive regulation of secretion (GO:0051047),0.5022059771848175,1.0505851909797534,0.40943396226415096,0.9329308055549167,1.0,1/11,1.93%,NPR1
prerank,collagen fibril organization (GO:0030199),0.3408857697960676,1.0505792724133953,0.37464387464387466,0.9319249191556972,1.0,16/88,8.64%,COL5A1;COL22A1;COL26A1;LAMC2;COL4A5;COL18A1;COL4A3;LOXL1;ADAMTS2;TGFBR1;LOXL3;COL9A2;COL13A1;COL4A4;COL1A2;COL27A1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.45397447086408216,-1.0505084234214372,0.4166666666666667,0.6887287331824712,1.0,2/11,1.12%,GHR;PIK3R1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4175114532426149,1.0504635052884967,0.3896551724137931,0.931257829246463,1.0,5/26,9.57%,PPARA;SLC30A10;SLC5A3;TLR4;PIKFYVE
prerank,polyol metabolic process (GO:0019751),0.37927442754939117,1.0504572332689885,0.380718954248366,0.9302727161598071,1.0,10/46,11.18%,ISYNA1;NUDT4;INPPL1;SLC5A3;PLCD3;PTEN;ITPKB;PLCD1;PPIP5K2;OCRL
prerank,macrophage activation involved in immune response (GO:0002281),-0.43809597005721135,-1.050340281515255,0.4240506329113924,0.6883552496795025,1.0,7/13,19.59%,PLCG2;DYSF;SBNO2;LBP;CX3CR1;SYK;TYROBP
prerank,membrane lipid catabolic process (GO:0046466),-0.4702842292099347,-1.0503235563839486,0.3972055888223553,0.6876292899326784,1.0,4/10,19.10%,CYP1B1;PPT1;ENPP2;SMPDL3B
prerank,endochondral bone morphogenesis (GO:0060350),-0.4602116838494138,-1.0502331786503147,0.40973630831643004,0.6870971103367762,1.0,7/11,15.49%,MEF2C;BMPR2;TRPV4;BMP4;BMPR1B;FGFR3;TMEM119
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.34946408663016604,-1.0500443369344175,0.3669950738916256,0.6867743588180328,1.0,10/31,11.23%,DLG2;LRRC7;LIN7A;MTCL1;RAP2A;ERBIN;WDR1;PDCD6IP;MSN;MARK2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4290047963042454,1.0498522443938956,0.40819964349376114,0.93106012759091,1.0,8/24,15.62%,LEPR;PPARGC1A;COQ10A;NDUFS1;COX10;LYRM7;SDHAF4;GFPT1
prerank,cellular response to cytokine stimulus (GO:0071345),-0.24088334002717532,-1.0498517844143507,0.19791666666666666,0.6865208849068325,1.0,79/416,13.07%,PID1;LEF1;LRCH1;GHR;IL1RAPL1;PTPRJ;PIK3R1;IL1R1;GREM2;OSMR;AKAP6;PTPN12;LIFR;IL1RAP;FN1;PTPRT;CXCL12;VCAM1;STAT3;INPP5D;SLC12A2;MAOA;GAS6;PTGIS;F3;IL6ST;ARHGEF2;GSK3B;ANXA1;RO60;DAB2IP;STX3;ICAM1;RPS3;AQP4;SOCS2;HSPA8;FOXO1;ITGB1;TNFRSF1B;CRK;SYNCRIP;PTPRZ1;MME;ST3GAL6;TGFB1;TNFRSF21;PTGS2;IRAK3;EGR1;S1PR1;STAT5B;DOCK8;PNPT1;TEC;IFNGR2;FGF2;JAK1;PDE2A;CD47;GBP4;ERBIN;HSP90AA1;MT1X;IL4R;DUSP1;GPER1;ASAH2;SBNO2;DAPK1;YBX3;IKBKB;TWIST1;VIM;CDKN1A;CNTFR;AIM2;HIF1A;LRP8
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.4719669952774862,-1.0494484917225235,0.40824742268041236,0.6866998167923736,1.0,6/10,26.53%,KDR;IL33;NAMPT;NOD2;JAK2;CCL2
prerank,regulation of interferon-alpha production (GO:0032647),0.4265324828635979,1.0491268689263529,0.38030560271646857,0.9321698352108992,1.0,5/23,9.78%,TLR3;TLR4;DDX3X;RIPK2;MAVS
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.4101336908040054,1.048859914604811,0.41935483870967744,0.9319355260868039,1.0,5/31,5.17%,TGFBR3;FGFR2;BMPR1A;TGFBR1;TPM1
prerank,acyl-CoA metabolic process (GO:0006637),0.4024393930323992,1.0487845965670377,0.38682432432432434,0.9311427202512791,1.0,9/35,17.08%,SUCLG2;OGDH;HMGCS2;ACOT11;MLYCD;ACOT8;SUCLA2;THEM4;ACOT12
prerank,positive regulation of cell cycle process (GO:0090068),0.3371472286696417,1.0484473456342451,0.36443148688046645,0.9311736044602972,1.0,20/91,20.40%,PKP4;IGF1;PHIP;ATRX;CD28;PDGFRB;CDC14A;PLSCR1;AURKB;CDC14B;CDC42;TGFA;CENPV;DYNC1LI1;PKN2;FEN1;BTC;CEP120;XRCC3;CEP295
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3465112574315543,1.048361233709566,0.38088445078459343,0.9304041524917428,1.0,11/74,7.93%,DAB2;SMAD3;TGFBR1;CLASP1;FOXC1;PDPN;DAG1;LDLRAD4;WWTR1;TGFBR2;PTEN
prerank,cellular response to growth factor stimulus (GO:0071363),0.3152577195097224,1.0481800350880843,0.38058748403575987,0.9299482253887917,1.0,18/151,7.34%,WWOX;BMP6;BMP7;SMAD3;APPL2;WNT4;SPHK1;SOX5;BMPR1A;MAGI2;TGFBR1;FOXC1;GAS1;MAP2K5;FLT1;PLK5;CPNE3;TGFBR2
prerank,positive regulation of viral process (GO:0048524),0.358538632229354,1.048009162296304,0.39236641221374047,0.9294299397144233,1.0,15/60,16.18%,PPARA;POLR2A;IFIT1;DDX3X;CD28;POLR2D;LARP1;GTF2F1;KPNA6;SRPK2;NELFCD;HACD3;AXL;CTDP1;VPS4A
prerank,calcium ion transport (GO:0006816),0.32766348589681565,1.0477986955641658,0.3713490959666203,0.9290486578177548,1.0,12/113,7.30%,TRPM3;CACNA1D;SLC24A3;ANK2;TRPM6;ITPR1;SLC8A3;CACNA1C;MICU1;CACNB3;TRPM5;ANO6
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.34608748782470333,-1.0476602118760823,0.3945409429280397,0.6904012490165127,1.0,7/36,12.89%,NRP1;SHANK3;ITGB1;RELN;EPHB2;EDN1;HIF1A
prerank,reverse cholesterol transport (GO:0043691),-0.4451827601529233,-1.0476308279375062,0.4184549356223176,0.6897114136975403,1.0,4/13,14.58%,SCARB1;APOE;ABCG1;CLU
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3908058276307542,1.0467024227157622,0.4039408866995074,0.9311975050044012,1.0,5/38,4.75%,CACNA1D;ANK2;KCND3;KCNA5;CACNA1C
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4364827602423219,-1.0463678923574815,0.4147465437788018,0.6920141131903109,1.0,10/13,32.95%,PDE8A;MET;TXN;HGF;GPR37L1;NR4A3;PYCR1;PARK7;RACK1;GPR37
prerank,ion transport (GO:0006811),0.3233979915830144,1.0461327849260444,0.38114754098360654,0.9318377819062114,1.0,13/111,8.49%,TRPM3;WNK4;SLC24A3;SLC5A5;SLC8A3;VDAC2;SLC26A3;SLC5A8;SLC20A2;ANO6;SLC26A1;SLC1A3;CTNS
prerank,regulation of peptidase activity (GO:0052547),-0.39574196254324556,-1.046085920536755,0.39909297052154197,0.6919678051067623,1.0,5/19,14.98%,CAV1;CST3;ECM1;PINK1;MAPK12
prerank,UV protection (GO:0009650),-0.4703210965203519,-1.0454143738916146,0.42386831275720166,0.6928879482280167,1.0,5/10,20.22%,MFAP4;SDF4;GPX1;CAT;ERCC2
prerank,negative regulation of transport (GO:0051051),0.36641234877229345,1.0453655387161076,0.401854714064915,0.9330743040294482,1.0,13/51,15.10%,SYT11;PRKN;FER1L5;PLSCR1;PTEN;NRG1;WWP2;ITGAV;SNX12;EPHA3;PIP4P2;CRYAB;LGALS3
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.45456959280863546,1.0451040034051362,0.41818181818181815,0.9328084893401215,1.0,1/17,0.83%,LPGAT1
prerank,regulation of osteoclast differentiation (GO:0045670),0.39820377057515427,1.0450741151686764,0.4085667215815486,0.9318953188784669,1.0,5/33,6.92%,GPR137;TLR3;TLR4;IL12B;FBN1
prerank,leukotriene biosynthetic process (GO:0019370),-0.4278952722230034,-1.0450138886325826,0.3884297520661157,0.6931279539036124,1.0,6/14,33.07%,PLA2G4A;GGT7;LTA4H;ALOX5AP;MGST2;GGT1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.32688009671819224,-1.044837276051078,0.3770949720670391,0.6927868170705085,1.0,11/47,11.60%,STXBP6;SPTBN1;ANK3;EXOC6;RAB31;VAMP4;PREPL;GOPC;NSF;GCC2;GOLGA7
prerank,icosanoid secretion (GO:0032309),0.4712070673866923,1.0448162861507253,0.4180790960451977,0.9316529807446617,1.0,2/12,4.75%,ACE;BDKRB2
prerank,neural crest cell differentiation (GO:0014033),-0.40626968164302946,-1.044655871098125,0.408207343412527,0.6924567803579003,1.0,2/18,1.17%,MEF2C;CDH2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.43372447932547253,1.0446555822657346,0.4116575591985428,0.9310981873555733,1.0,7/21,15.74%,CEL;CYP26B1;LDHD;FAH;ACOT8;ACBD5;NUDT19
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.3602107822238353,-1.0445731599657586,0.37889688249400477,0.6919102035990492,1.0,9/30,17.31%,CXCL12;TPT1;RPS3;ACKR3;CD44;TWIST1;THOC5;CLU;CD74
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3477973075600327,-1.044516574704358,0.39054726368159204,0.6912982156612892,1.0,9/32,10.44%,PPP1R16B;HSP90AB1;PPP2R5A;PPIA;CALM1;CALM2;CAMTA1;TGFB1;CALM3
prerank,regulation of water loss via skin (GO:0033561),-0.41321172766392167,-1.0443778246884445,0.4197802197802198,0.6901423857266908,1.0,5/15,15.25%,UGCG;LSR;MET;HRNR;STMN1
prerank,establishment of skin barrier (GO:0061436),-0.41321172766392167,-1.0443778246884445,0.4197802197802198,0.6901423857266908,1.0,5/15,15.25%,UGCG;LSR;MET;HRNR;STMN1
prerank,skeletal muscle contraction (GO:0003009),0.4399298514665965,1.0443672627699443,0.4049733570159858,0.9309281810667329,1.0,4/19,13.06%,RCSD1;CCDC78;TNNI3;TNNC1
prerank,covalent chromatin modification (GO:0016569),0.4763037398694432,1.0443607075926347,0.4159132007233273,0.9299490094842229,1.0,4/14,12.66%,SIRT1;HDAC1;AURKB;HLCS
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3500008807842222,-1.0441076796354378,0.3854166666666667,0.690043619466713,1.0,12/34,14.68%,TEK;PIK3R1;PTK2B;DAB2IP;TGFB1;PTK2;TNFAIP8L3;FGF2;P2RY12;PIK3IP1;PRKD1;FGFR3
prerank,cellular response to osmotic stress (GO:0071470),0.4353393865066471,1.0440740293273552,0.40669014084507044,0.9297723827199673,1.0,7/21,15.26%,OXSR1;RCSD1;DDX3X;MYLK;LRRC8E;ZFAND1;ZFP36L1
prerank,negative regulation of cell junction assembly (GO:1901889),0.41939294683993333,1.0437998628231364,0.40545144804088584,0.9295294991052144,1.0,6/25,9.70%,ROCK2;ACE;ARHGAP6;BCAS3;PTEN;PHLDB2
prerank,nucleotide metabolic process (GO:0009117),0.43896130743351736,1.0430894548063883,0.4014336917562724,0.9305251951519267,1.0,7/23,16.79%,FHIT;NMNAT1;ENPP3;AK4;CTPS2;AK8;NMNAT2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.4923315183167299,1.0426030735690826,0.41420118343195267,0.930958196685714,1.0,3/10,9.87%,APPL2;PRKCB;GRB10
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.3196940687271668,-1.0425780404631262,0.3431952662721893,0.6930068096210278,1.0,4/48,3.07%,PDE4D;PDE4B;IL1R1;SLC7A5
prerank,regulation of fibrinolysis (GO:0051917),0.48375050896325794,1.0424894481626164,0.40973630831643004,0.9302979076143235,1.0,4/13,8.46%,F11;F2;SERPINE1;HRG
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.3383170766819381,-1.0423874343910806,0.39949748743718594,0.6927601188067134,1.0,7/35,4.98%,NRP1;TEK;NTRK3;ESAM;PTK2B;F11R;SEMA3E
prerank,serine family amino acid biosynthetic process (GO:0009070),0.4878303885407479,1.042304127341716,0.4277673545966229,0.9298829861475514,1.0,5/12,21.92%,SRR;CTH;PHGDH;MTHFD1;CBS
prerank,response to organophosphorus (GO:0046683),-0.4278474472233952,-1.042149807029925,0.4298056155507559,0.6926075084656951,1.0,2/16,4.89%,ABCC9;TRPC3
prerank,cellular protein modification process (GO:0006464),0.27767218516985054,1.0421043559676249,0.3353596757852077,0.92942407812236,1.0,171/982,14.43%,PRKAG2;EPAS1;UST;WNK4;PTPN13;ROCK2;APLP2;UBE2E2;DUSP29;ITIH2;OXSR1;MSRA;PRKCZ;ASB2;SERPIND1;CP;FAM20A;PRKAA2;PTPN14;LAMC1;PTPN9;GRK5;MACROD1;OBSL1;SPP1;LARGE1;SPSB1;MTMR3;PRKAG3;PPEF2;PPP1CB;PPM1E;NGLY1;FGFR1;BMPR1A;LOXL1;TGFBR1;DMPK;IGFBP7;AAK1;PARP10;CEL;LRRK2;TP53RK;NAA80;KRT1;FUT1;DCAF11;PRKCB;PARP14;ST3GAL3;IKBKE;ATG10;LHPP;DAPP1;METAP2;FBXL19;ST3GAL5;ATM;PRRT1;KLHL41;CAMK1;TIPARP;BRAF;ATG5;SPSB4;NUAK2;TRIB2;CDC42BPG;SIK1;EIF2AK2;SIRT5;LGALS1;TRIOBP;FUT10;FBN1;KNG1;PARP4;WIPI1;PTPRU;TGFBR2;PTPN22;FBXW11;RABGGTA;PTEN;IGFBP3;PP2D1;TNKS2;BTRC;RYK;SIRT3;PPP2R1B;MANBA;COQ8B;PDPK1;NUCB1;PTPN21;PARP9;CSNK1A1;RCE1;SIRT1;ASB15;ZC3HAV1;PICK1;CTH;FBXO22;LRRC41;RAB11B;MKNK1;FER;DCAF10;BRSK1;RAB13;FBXL12;ATG7;AURKB;SRPK2;ABL1;PARP6;DYRK1A;MYLK3;UBE2M;ARAF;DUSP10;FBXW8;FBXO4;CDC14B;FNTB;TRIB1;PRKDC;SOCS3;PPP2R5E;PTPN4;WWP2;MAPK6;ASB14;PORCN;CUL4A;CUL9;CSNK2A1;CTDSP2;FBXO10;PRKCA;HIPK3;MIA3;NUB1;MAN2A1;ASB5;SIRT4;HLCS;MAPK10;MAP3K1;FRK;MBTPS1;PRKCI;ART4;WNK1;BMP2K;ASB12;DDB2;MAP2K1;ROS1;COQ8A;GRK3;PRKCSH;FBXO11;SERPINC1;ACVR2B;FBXL20;DUSP2;PPM1B
prerank,positive regulation of vacuole organization (GO:0044090),-0.4644181026610258,-1.0420305975780666,0.42362525458248473,0.6921543744319626,1.0,7/10,28.79%,PIP4K2A;SH3GLB1;RALB;PIP4K2B;LRSAM1;GRN;RAB3GAP2
prerank,superoxide anion generation (GO:0042554),0.47145315914691677,1.0419661606450492,0.41291585127201563,0.9288204805014076,1.0,3/13,10.42%,ALOX12;NOX1;NOX4
prerank,carbohydrate biosynthetic process (GO:0016051),-0.38799535522159967,-1.0419609470247788,0.4197247706422018,0.6915758582994876,1.0,7/21,12.19%,ST3GAL4;FUT9;ST6GALNAC5;B3GALT1;ST3GAL6;ST8SIA6;B3GALT5
prerank,peroxisome organization (GO:0007031),0.4262367118478676,1.0416705665707195,0.3950617283950617,0.9286974200255695,1.0,8/25,17.16%,PEX11A;PEX11B;DNM1L;PEX10;ACOT8;PEX14;PEX19;PEX16
prerank,cell differentiation in hindbrain (GO:0021533),-0.45665923840596134,-1.0415989320078387,0.4072494669509595,0.6917024779834965,1.0,2/11,8.60%,GRID2;PROX1
prerank,regulation of intracellular signal transduction (GO:1902531),0.28719292951660164,1.0415517783267587,0.3966850828729282,0.9280582575946171,1.0,88/420,15.50%,PRKAG2;FGF1;ARHGAP28;PTPN13;ARHGAP29;RHOQ;PRKAA2;DLG1;ARHGEF18;RHOD;PKHD1;ARHGEF16;SRGAP2;SRGAP3;ARHGAP18;FGD4;SYDE2;ARHGAP9;PRKAG3;NGEF;AKAP13;ARHGAP6;LRRK2;AKAP12;ZFAND6;GMIP;TP53RK;EZR;ARHGAP26;CHD4;PPP1R13L;ATM;WWC2;ARHGAP17;LBH;TP53;RICTOR;ARHGEF11;ARHGEF12;PTPN22;PIP4K2C;ARHGAP23;PTEN;ARHGEF1;PDPK1;RNF34;OPHN1;HDAC1;AURKB;ARAF;RNF41;ARHGAP12;FGD1;OCRL;SOS2;RBBP8;CDC42;HUS1;NOP2;TAF11;RALBP1;ITGAV;CSNK2A2;CSNK2A1;MAPKAP1;BRD7;RAD50;TOP3A;USP7;PPP1R13B;KMT5A;PRKAR1A;TBP;ROS1;PML;TAF4;ULK4;ARHGAP21;FLCN;MOB3B;MAP2K6;SPHK2;AKAP7;CCNG1;STK4;MTA2;TAF7;VAV3
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4388856088727757,1.0411416205033914,0.3996447602131439,0.9282114319159479,1.0,4/20,9.33%,PRKCZ;IL18;FZD5;RSAD2
prerank,ventricular septum morphogenesis (GO:0060412),0.4088000320046626,1.0396282534846286,0.4217687074829932,0.9315411221881068,1.0,4/27,3.46%,ROBO1;TGFBR3;BMPR1A;TGFBR1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.27454196640065626,-1.0394687881431797,0.3484848484848485,0.6962634507730433,1.0,24/121,10.81%,NRP1;GHR;PTPRJ;GRM5;ERBB4;PECAM1;EFNA5;STAT3;PTK2B;GAS6;IL6ST;ARHGEF2;LYN;PTPRC;HES1;PLCG2;CSPG4;SEMA4D;RELN;TGFB1;TEC;CD44;ITGB3;ENPP2
prerank,regulation of postsynapse organization (GO:0099175),-0.3593727242467464,-1.0394116815618328,0.3922518159806295,0.6956426707612632,1.0,10/28,14.09%,IL1RAPL1;PPFIA2;SHANK3;TANC2;CDKL5;ABI3;HOMER1;ABHD17B;CFL1;CDK5R1
prerank,cellular response to organic substance (GO:0071310),0.32522298567351154,1.0392685542421907,0.3791208791208791,0.9315788464229856,1.0,18/116,7.34%,PTPN13;SMAD3;PTPN14;IL18;PTPN9;SPHK1;NFAT5;BMPR1A;TGFBR1;ADRA2A;LRRK2;NCOA3;MAP2K5;PTPN23;TIPARP;PLK5;CPNE3;TGFBR2
prerank,negative regulation of binding (GO:0051100),0.3435897167876718,1.0392114364194853,0.39764359351988215,0.9307460155429785,1.0,24/81,19.18%,DAB2;ARHGAP28;IFIT1;IFIT2;LRRK2;SMO;CAMK1;GTPBP4;GTF2F1;AURKB;TMC8;WAPL;STYX;DNAJB2;EFHB;PEX14;TFIP11;PEX19;SP100;KDM1A;SUMO1;GOLGA2;USP33;ITGB1BP1
prerank,regulation of cytoskeleton organization (GO:0051493),0.3255154363999211,1.039034703613135,0.39014647137150466,0.930276915928878,1.0,18/108,10.63%,CELSR1;ROCK2;RHOQ;PRKAA2;RHOBTB2;RHOD;ARHGAP18;CLASP1;EZR;ARHGAP17;PDGFRB;BAIAP2;RICTOR;HRG;DIAPH1;LRP1;PHLDB2;ABL1
prerank,regulation of establishment of cell polarity (GO:2000114),0.45936802179891084,1.0385280682994897,0.4077328646748682,0.9307471425512808,1.0,6/16,12.82%,ROCK2;RUFY3;BCAS3;CDH5;CYRIB;KRIT1
prerank,brain morphogenesis (GO:0048854),-0.44649752329133263,-1.038482665760389,0.4261954261954262,0.6970838909894597,1.0,2/12,1.42%,CTNNA2;SHANK3
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.42943275170409595,1.0379313889523205,0.42114384748700173,0.9315039458406972,1.0,3/21,4.75%,ATP1A2;ANK2;CACNA1C
prerank,protein lipidation (GO:0006497),0.3538956924011149,1.0372711088463493,0.41063515509601184,0.9323458451306255,1.0,11/59,11.85%,PIGN;ATG10;PIGW;ATG5;PIGQ;WIPI1;GLUL;ATG7;ZDHHC18;ZDHHC1;PORCN
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4953349952539887,1.0370510341360117,0.410958904109589,0.9319616131772134,1.0,3/10,16.52%,EMC2;EMC1;EMC3
prerank,potassium ion export across plasma membrane (GO:0097623),0.46937460949712045,1.0369050008361929,0.423828125,0.9314071942214486,1.0,2/13,1.80%,KCND3;KCNA5
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.43950112466392727,1.0368930865315875,0.43119266055045874,0.9304731232845159,1.0,3/17,7.00%,AKAP13;ADRA2A;ADCY9
prerank,regulation of lamellipodium organization (GO:1902743),0.47647121885854904,1.036737507489896,0.4071294559099437,0.9299796317850926,1.0,6/14,14.16%,CAPZB;PDPN;FER;CDC42;VIL1;CARMIL2
prerank,blood vessel endothelial cell migration (GO:0043534),0.4173308906534377,1.0364614853322849,0.42397137745974955,0.9298050196428751,1.0,2/22,0.55%,ROBO1;EFNB2
prerank,mitochondrial fusion (GO:0008053),0.44894497608222933,1.0362275387069766,0.43309859154929575,0.929492545302513,1.0,6/18,19.70%,CHCHD3;MIGA2;OPA1;MFN2;MFN1;AFG3L2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.31251138190641453,1.035591659688997,0.38917525773195877,0.9302873795664007,1.0,25/150,11.45%,PRKAG2;PTPN13;FBLN1;PRKCZ;ERRFI1;PRKN;PPEF2;PPM1E;DEPTOR;PMEPA1;LRRK2;DTNBP1;SMAD6;LDLRAD4;TRIB2;WWTR1;PTEN;IGFBP3;CDK5RAP3;PDPK1;MVP;CRKL;TRIB1;PRKDC;IMPACT
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3837649306926114,-1.0355506096529645,0.41333333333333333,0.7035424888842465,1.0,11/21,21.28%,CSGALNACT1;DCN;CHSY3;BGN;CSPG4;VCAN;CHST12;CHST9;CHST7;CSPG5;BCAN
prerank,epidermis development (GO:0008544),0.3600789813034258,1.0355063535297393,0.4044776119402985,0.9295712331939591,1.0,7/56,9.56%,LAMC2;CCN2;FGFR2;CRABP2;SVEP1;GLI1;HDAC1
prerank,regulation of coagulation (GO:0050818),-0.4500736271615209,-1.0354555021031202,0.44956140350877194,0.7030244905598793,1.0,3/11,7.96%,CAV1;HS3ST5;EPHB2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3199269762211583,-1.0342544387515573,0.39775910364145656,0.7052497315515305,1.0,11/51,6.00%,CNTNAP2;DCLK1;NYAP2;EPB41L3;NGF;TRIO;NRK;SHTN1;DAB2IP;MINK1;PAK1
prerank,serine family amino acid catabolic process (GO:0009071),0.5032274153155123,1.0341815494941162,0.43661971830985913,0.9324092980677808,1.0,4/10,21.92%,DLD;THNSL2;AMT;CBS
prerank,regulation of mRNA processing (GO:0050684),0.3934022327048058,1.033888458577903,0.42248722316865417,0.9323038923629681,1.0,9/32,10.61%,SON;PABPN1;AHCYL1;TIA1;RBM39;SLTM;JMJD6;LARP7;SRPK2
prerank,cGMP biosynthetic process (GO:0006182),0.4852937754080374,1.0336055112101932,0.3988212180746562,0.9321369253608311,1.0,2/10,6.12%,NPR1;NPR2
prerank,positive regulation of cellular protein localization (GO:1903829),0.3459564852565615,1.033391569254603,0.409288824383164,0.9317881428928446,1.0,11/69,9.10%,SYT11;PRKAA2;PRKN;CEP250;SESN2;SLC5A3;F2;WWTR1;CDK5RAP3;TRAPPC12;PARP9
prerank,negative regulation of cytokine production (GO:0001818),0.31095949171062,1.0328524985486012,0.4052980132450331,0.9322992319487093,1.0,19/163,7.34%,C1QTNF3;LGR4;APPL2;SYT11;PPARA;PCBP2;EZR;IKBKE;SSC5D;SRGN;TLR4;RNF135;F2;ARRB1;MAP2K5;TRIB2;IL12B;TWSG1;PTPN22
prerank,cellular response to virus (GO:0098586),0.39355373199380084,1.0325149295537634,0.4,0.9323443727927608,1.0,4/30,10.49%,GSDME;DDX3X;TOMM70;IRGM
prerank,glycine metabolic process (GO:0006544),0.4852612718478122,1.0324944685517556,0.444015444015444,0.9314397564899518,1.0,2/12,8.99%,GCAT;DLD
prerank,clathrin coat assembly (GO:0048268),-0.4120446586636057,-1.032438438446161,0.4276315789473684,0.7089002006623811,1.0,3/15,6.80%,HIP1;SGIP1;NSG2
prerank,cellular glucose homeostasis (GO:0001678),0.37468307994055916,1.0323085603005773,0.4186046511627907,0.9310197739926307,1.0,4/41,2.21%,PPARGC1A;PRKAA2;HK2;ZBTB20
prerank,aminoglycan biosynthetic process (GO:0006023),0.37037971146639265,1.0322396802909704,0.4148264984227129,0.9302599966453878,1.0,5/49,4.34%,HS3ST3A1;HS3ST3B1;NDST1;HS2ST1;HS3ST6
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3422767442120941,-1.0320422732025132,0.4090909090909091,0.7090951898452021,1.0,13/35,20.37%,HIP1;SGIP1;B2M;SNAP91;PPT1;HNRNPK;CLU;CBL;ARF6;HIP1R;LDLRAP1;VTN;CCL19
prerank,transition metal ion homeostasis (GO:0055076),0.4002869059411257,1.0317388026171554,0.41487603305785126,0.9307116617852115,1.0,3/28,1.98%,CP;PICALM;PRKN
prerank,skin development (GO:0043588),0.3444483276457348,1.0312717788319279,0.39461883408071746,0.9310843263932546,1.0,5/65,5.02%,COL5A1;ERRFI1;ALOX12;CASP3;DACT2
prerank,respiratory electron transport chain (GO:0022904),0.46235287863135605,1.0311631142421864,0.4335154826958106,0.9304522024569598,1.0,4/14,18.94%,PPARGC1A;SLC25A12;SDHB;ETFDH
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.47594814674036096,1.03082038106018,0.4225621414913958,0.9304742579100928,1.0,1/11,0.65%,ACTN2
prerank,negative regulation of viral process (GO:0048525),0.3605530739165116,1.0303941881994116,0.4241486068111455,0.9307760698529934,1.0,13/57,13.65%,IFIT1;OAS2;PARP10;EIF2AK2;PLSCR1;RSAD2;ZC3HAV1;LARP7;MAVS;SRPK2;TRIM62;OAS3;PML
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.4192193773220688,-1.0302352079202433,0.44842105263157894,0.7128768070635917,1.0,4/14,10.70%,TMSB4X;NFKBIA;G3BP2;PKD1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.40946658533691416,-1.0298736068063048,0.4143763213530655,0.7130457704074673,1.0,4/16,6.84%,CXCL12;TPT1;RPS3;ACKR3
prerank,aorta morphogenesis (GO:0035909),-0.40227429411342663,-1.0291447642991964,0.4168466522678186,0.7140336493536362,1.0,6/17,9.18%,ENG;ACVRL1;JAG1;TBX1;PROX1;HEY2
prerank,autophagy of peroxisome (GO:0030242),0.4893597390283173,1.0285155535311057,0.43702290076335876,0.9350367359294429,1.0,6/12,26.80%,ATM;ACBD5;PEX5;SQSTM1;PIK3C3;TRAPPC8
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4487446343091056,1.02831659171884,0.44563279857397503,0.9346941839716741,1.0,5/16,12.62%,ANK2;LRRK2;UBAC2;MIA3;TAPT1
prerank,MAPK cascade (GO:0000165),-0.24411736604656267,-1.0282740692983388,0.391304347826087,0.7154348054104419,1.0,82/295,20.08%,DLG2;SPTBN1;MEF2C;KITLG;TEK;ERBB4;PIK3R1;SHANK3;RASAL2;MAP3K5;RASGRP3;LRRC7;GRIN2B;RIT2;RASGRF2;NRG2;NRK;YWHAE;KRAS;MBP;KDR;PSMB2;DAB2IP;YWHAB;MINK1;PAK1;CALM1;IL17RD;MET;MAP3K7;ZDHHC9;TGFB1;PTK2;CUL3;RASGEF1A;PEBP1;RASGRF1;PSMD14;FGF13;FGF2;JAK1;ERBB2;PSMC6;CAMKK2;PDGFA;PRKG2;GOLGA7;RASA1;IKBKB;PTPN3;FGF7;ABHD17B;SPTB;FGF9;RET;SPRED1;MT3;FGFR3;UBB;MAPK12;SCG2;GRIN1;IL31RA;PSMA4;PSMB9;GFRA1;GFRA2;SHOC2;SKP1;IRS2;PSMD11;MEN1;SPTBN2;CAMK2B;PSMB10;PRKCQ;SPTAN1;RASA3;PSMD2;PPP1CC;IRS1;SHC1
prerank,regulation of axonogenesis (GO:0050770),0.36234763750080246,1.028200264458969,0.411214953271028,0.93408320952043,1.0,6/51,2.17%,ROBO1;LRP4;KIF13B;SIPA1L1;PLXNA2;EPHA4
prerank,protein localization to plasma membrane (GO:0072659),0.3186842610140246,1.0280068584658222,0.4153225806451613,0.9336726647250027,1.0,16/129,6.76%,AFDN;ROCK2;ACTN2;ATP1B3;ANK2;TSPAN5;TTC7B;DLG1;FYB1;KCNIP3;EZR;TMEM150A;RAB34;FYB2;PIGW;CACNB3
prerank,long-term synaptic potentiation (GO:0060291),-0.3803998868515799,-1.0279657061409144,0.40572792362768495,0.7154345408392654,1.0,6/21,7.11%,SLC24A2;NPTN;GRIN2B;PTK2B;PLK2;GRIN2A
prerank,neural tube closure (GO:0001843),0.38988892980242146,1.0278191674994694,0.4092465753424658,0.9332502143778239,1.0,14/34,23.33%,CELSR1;LMO4;MTHFR;KDM2B;IFT122;PHACTR4;DEAF1;MTHFD1;VASP;FOLR1;TSC2;FUZ;PRICKLE1;DVL3
prerank,regulation of RNA export from nucleus (GO:0046831),-0.4517592099298283,-1.0277722515836107,0.4559139784946237,0.7151889401387758,1.0,4/11,24.22%,SETD2;DHX9;NCBP2;IWS1
prerank,embryonic limb morphogenesis (GO:0030326),0.3880656810031045,1.027660600050291,0.43261231281198004,0.9327639973803502,1.0,8/34,11.14%,OSR1;AFF3;GLI3;CYP26B1;CACNA1C;NIPBL;HDAC1;RARG
prerank,cardiac muscle contraction (GO:0060048),0.3815383236373258,1.0274966700474977,0.42857142857142855,0.9322376851747894,1.0,5/34,9.18%,ATP1A2;CSRP3;TPM1;PIK3CA;MYL4
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.30040734921410883,-1.0274101597038738,0.42356687898089174,0.7153747025547941,1.0,24/69,21.19%,PTPRJ;THBS1;STAT3;ARHGEF2;IL33;PTPRC;APP;PLCG2;PSEN1;EPHB2;CYBA;TIRAP;HAVCR2;TWIST1;CLU;LBP;DHX9;NOD2;SYK;HSPB1;TYROBP;CCL19;LGALS9;PYCARD
prerank,ceramide catabolic process (GO:0046514),-0.42082304042903185,-1.0272607562965785,0.4240506329113924,0.715015660394975,1.0,4/14,11.77%,ACER3;ACER2;HEXB;ASAH2
prerank,actin filament-based transport (GO:0099515),-0.3780019443696557,-1.0270582146115947,0.4068181818181818,0.7147511806338601,1.0,5/21,4.23%,MYO1D;ACTN4;MYO1B;FNBP1L;MYO5A
prerank,regulation of protein processing (GO:0070613),-0.3882899508631944,-1.0268188367782858,0.40877598152424943,0.7145642308017794,1.0,5/21,10.91%,SERPINE2;CCBE1;RUNX1;NKD2;TMEM59
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.42820124194470793,-1.0265110493220466,0.44782608695652176,0.714618375048214,1.0,6/14,14.56%,FLNA;LIMS2;EMP2;DMTN;PRKD1;LIMS1
prerank,Ras protein signal transduction (GO:0007265),0.3169205158343891,1.0264745692772557,0.4029451137884873,0.9340890108777975,1.0,21/137,10.35%,CELSR1;ARHGAP29;ROCK2;KSR1;IGF1;RHOD;CCNA2;ADRA2A;PDPN;ARHGAP6;RAPGEF3;RREB1;TP53;ARHGEF11;COL1A2;ARHGEF1;EPS8L2;RRAS2;CTNNAL1;PHACTR4;CRKL
prerank,acylglycerol catabolic process (GO:0046464),-0.3576369292111064,-1.026234090765492,0.42528735632183906,0.7145399372324395,1.0,5/30,13.92%,ABHD2;MGLL;LIPE;FABP5;PNPLA3
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2880213431252749,1.0260776445639925,0.41430192962542567,0.9343004408394585,1.0,88/336,20.38%,UBE2E2;PAXX;STXBP4;MACROD1;BID;BABAM2;KMT5C;ZBTB38;USP3;SUSD6;IKBKE;ATM;UVRAG;RAD54L;PLK5;BAZ1B;KMT5B;TP53;SETD7;PARP4;NIPBL;RNF8;SAMHD1;TRIP12;FBH1;NUPR2;PDS5A;SIRT1;UBR5;ASH2L;WDR76;BRSK1;ABL1;ATF2;RBBP8;PRKDC;MSH3;ZBTB1;HUS1;DCUN1D5;CBX5;CUL4A;UBA6;IGHMBP2;FANCA;RAD50;SIRT4;PNKP;PHF1;POLE2;MCM7;DDB2;PML;GADD45A;DOT1L;MAP2K6;MGMT;BRAT1;INTS3;CEP63;VAV3;TLK2;MCL1;ZBTB40;MBD4;PIDD1;CRY1;OGG1;TAF1;NBN;SUMO1;FEN1;MAPK14;RAD51D;SLX4;MMS19;YAP1;PDS5B;APTX;USP16;XPA;BCL6;ASF1A;XRCC3;TANK;RAD9A;NCOA6;MCM9
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.34772731348830105,-1.025937062929039,0.4226044226044226,0.7144738965964448,1.0,13/29,21.68%,SLIT2;SHANK3;KANK3;KANK4;LIMA1;PFN2;SHANK1;FKBP4;KANK1;HIP1R;MYADM;SSH2;TWF2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3530618389904564,1.0258621334500615,0.4229559748427673,0.9339662910832088,1.0,12/65,9.35%,SMAD3;PPARA;SNX6;PMEPA1;TGFBR1;SMAD6;LDLRAD4;FBN1;SMURF2;TGFBR2;PDPK1;SIRT1
prerank,regulation of organelle assembly (GO:1902115),0.34245836552230774,1.0253873722564828,0.4028985507246377,0.934357650809677,1.0,14/72,11.12%,STX18;DCDC2;MTMR3;NPRL3;TBC1D16;EZR;ATG5;NPRL2;RABEP2;ATXN2;TRAPPC12;PIKFYVE;SDCCAG8;IFT88
prerank,regulation of protein import into nucleus (GO:0042306),-0.3326666978069396,-1.0253109633907014,0.412532637075718,0.7153199903997911,1.0,11/36,11.41%,PIK3R1;MDFIC;FLNA;PSEN1;APOD;TGFB1;UFM1;EFCAB7;CABP1;BMP4;CDH1
prerank,extracellular matrix disassembly (GO:0022617),-0.3085564983756595,-1.0245283087198067,0.40166204986149584,0.716575993589167,1.0,12/53,13.31%,TLL1;BSG;GSN;ADAMTS5;TIMP2;ADAM15;MMP16;CD44;CAPN2;CTSL;CTSS;MMP15
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3622567105790137,1.024379070461028,0.41679873217115687,0.9362256133297501,1.0,12/46,13.99%,OGN;IGF1;IL18;NOX1;PDGFRB;IL12B;IGFBP3;TCF7L2;TRIB1;PRKDC;RBPMS2;MFN2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.363619680122512,-1.0240624964806428,0.42488262910798125,0.716991332025061,1.0,11/25,24.04%,SLIT2;EVL;TBC1D30;LIMK2;ABI3;PFN2;KANK1;ODF2L;ARHGAP44;CCP110;PLXNB3
prerank,embryonic digestive tract development (GO:0048566),0.4305471545649098,1.0239313023186818,0.43992932862190814,0.9365341712920017,1.0,4/18,7.38%,FGFR2;GLI2;GLI3;NIPBL
prerank,regulation of exosomal secretion (GO:1903541),0.43016537482874395,1.0237869150951178,0.4222222222222222,0.9359562941330088,1.0,8/19,22.43%,PRKN;SDC4;SMPD3;SNF8;VPS4A;CHMP2A;RAB7A;SDCBP
prerank,regulation of protein catabolic process (GO:0042176),-0.27449747544446007,-1.0236761759255129,0.37722419928825623,0.7172186589612842,1.0,25/99,18.68%,HECW2;WWP1;HECW1;FMN2;NEDD4L;GSK3B;DAB2IP;PLK2;FLNA;FOXO1;DACT1;SORL1;EEF1A1;IRAK3;NSF;ZDHHC2;AXIN1;ADGRB1;SMURF1;HACE1;EGLN2;APC;BARD1;CHEK2;SIRT2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.37970375382669147,1.0234555751856007,0.45063694267515925,0.9359365381406072,1.0,7/44,10.36%,ROCK2;TNRC6A;TNRC6B;CPEB3;ZC3HAV1;MOV10;YTHDF3
prerank,plasma membrane repair (GO:0001778),0.4801368328642545,1.0231809028474805,0.4505050505050505,0.9357316805978593,1.0,3/13,6.80%,SYT11;MYOF;FER1L5
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.23892323122947196,-1.0231647781709408,0.36,0.7177651965075502,1.0,56/291,14.77%,SLIT2;MEF2C;PID1;PDE4B;PDE3A;KCNC2;ACTB;ESR1;BRINP3;AKAP6;HCN1;PTPRK;PTK2B;BRINP1;RYR3;GNG2;GUCY1B1;LYN;RORB;TBX1;DAB2IP;RAP1B;FZD4;RAP1A;RPS3;FOXO1;TNFRSF1B;KCNQ1;WNT9A;SH3BP4;GLRA1;EGR1;PDE2A;CAMKK2;BRINP2;CAPN2;P2RY12;ATP2B4;GPER1;SBNO2;TIRAP;DAPK1;VIM;MAPT;SPAAR;DMTN;PRKD1;GLRA2;RET;CARD16;MT3;ABCB4;P2RY1;FES;LBP;GNB1
prerank,positive regulation of catabolic process (GO:0009896),-0.2994138910675788,-1.022210969842618,0.3813813813813814,0.7193581545735187,1.0,18/65,17.51%,HECW2;WWP1;HECW1;NEDD4L;GSK3B;DAB2IP;PLK2;FOXO1;DACT1;VSIR;SORL1;NSF;AXIN1;SMURF1;HACE1;EGLN2;APC;BARD1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.35824600971617315,1.02190053287195,0.4479495268138801,0.938363534103767,1.0,10/52,13.13%,TFDP2;LEPROT;BID;FZD5;TP53;HUWE1;TFDP1;NPEPPS;CSNK2A2;PPP1R13B
prerank,regulation of protein modification process (GO:0031399),-0.3141899786407514,-1.021470524986165,0.41778975741239893,0.7204521457017017,1.0,19/50,18.67%,GRM5;FN1;PPP1R16B;CCDC88A;LYN;FKTN;CORO1C;PPIB;PTK2;PPP1R16A;FNIP2;SPRED1;NOP53;CCDC88C;MT3;HPF1;HSPB1;KDM4D;PUM3
prerank,ovarian follicle development (GO:0001541),0.45519763414293885,1.0213953120660328,0.43761996161228406,0.9387999523074066,1.0,1/13,1.21%,KIT
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.22969766144297502,-1.0213610502386072,0.36486486486486486,0.7199746848212688,1.0,117/532,18.87%,GHR;PTPRJ;RPS6KA5;ACTN4;PIK3R1;ADIPOR2;IL1R1;GREM2;OSMR;TMSB4X;CAMK2D;LIFR;MID1;IL1RAP;FN1;CXCL12;ST18;VCAM1;B2M;STAT3;INPP5D;PTK2B;NOD1;MAOA;F3;TNFRSF11B;NFKBIA;UGCG;IL6ST;ANXA1;PSMB2;TNFRSF11A;IL33;STX3;PPIA;RAP1B;ICAM1;TRAF5;RPLP0;CARD14;SOCS2;HSPA8;ACKR3;MAP3K7;FOXO1;ITGB1;TNFRSF1B;CRK;PTPRZ1;TGFB1;PTGS2;IRAK3;CEACAM1;PSMD14;EGR1;S1PR1;STAT5B;TEC;IFNGR2;FGF2;JAK1;PSMC6;CD44;HSP90AA1;IL4R;MSN;IFITM3;PITPNA;ILK;ADIPOR1;IKBKB;TWIST1;VIM;CDKN1A;CNTFR;AIM2;HIF1A;TALDO1;LRP8;CFL1;VEGFA;SOCS5;MT3;JUNB;LIMS1;LBP;UBB;IL31RA;PSMA4;PSMB9;PIM1;CBL;VAV1;CAPZA1;AIP;EDAR;NDN;PELI1;NOD2;CCL13;SKP1;SYK;MAP3K14;SOX2;TRAF1;IRS2;PDCD4;IL22;CRLF1;IRF5;TNFRSF25;PSMD11;IRF2;ITGB2;CAMK2B;BCL2L11;PSMB10
prerank,modification-dependent protein catabolic process (GO:0019941),0.3016905452611994,1.0212769830589454,0.42,0.9381927433626004,1.0,49/193,19.26%,RNF43;ASB2;ANAPC15;PRKN;SPSB1;RNF213;NEDD4;ARRB1;ANAPC2;SPSB4;UBR4;SMURF2;TTC3;RNF8;TRIP12;RNF217;BTRC;RNF19A;RNF34;FBXO22;AURKB;RNF13;UBA6;FZR1;FBXO10;NUB1;FBXO11;UBE2H;AMFR;ANAPC16;RNF146;BIRC6;RNF19B;WDR91;RNF7;UFD1;UBE2E1;SYVN1;CDC34;NPLOC4;SQSTM1;NDFIP1;RNF20;TAF1;ARIH1;KCTD21;USP33;UBE4B;MIB1
prerank,modulation by host of viral genome replication (GO:0044827),0.4659025994376753,1.0209885128318972,0.4359925788497217,0.9380395421294434,1.0,2/13,4.07%,PRKN;IFI27
prerank,icosanoid metabolic process (GO:0006690),0.37287579585658603,1.0203554356901618,0.4176372712146423,0.9388405044867966,1.0,6/40,7.73%,PTGS1;ALOX12;EPHX1;DAGLA;PON3;ABCC10
prerank,renal absorption (GO:0070293),0.4781085151427578,1.0203397247957395,0.44692737430167595,0.9379296510070139,1.0,1/10,0.45%,WNK4
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3293802592401582,-1.0202067249058686,0.39577836411609496,0.7220208113476643,1.0,17/39,17.83%,ACTB;GNAS;ACTN1;UBASH3B;FN1;ACTG1;MYH9;PPIA;FLNA;MYL12A;P2RY12;ITGB3;ILK;MYL9;TYRO3;STXBP3;HSPB1
prerank,regulation of actin filament polymerization (GO:0030833),-0.29183606882853697,-1.0195269153751394,0.3987730061349693,0.7230161747935419,1.0,25/69,21.86%,SLIT2;ESAM;KANK3;PAK3;NCK2;EVL;CARMIL1;PTK2B;KANK4;CDC42EP3;BIN1;RASA1;PFN2;CDC42EP2;NCK1;ARF6;KANK1;HIP1R;NCKAP1;MYADM;SSH2;GBA2;PYCARD;TWF2;HCLS1
prerank,cellular component disassembly (GO:0022411),-0.30840303192999047,-1.0186981046852897,0.43258426966292135,0.7243469444136849,1.0,12/53,13.31%,TLL1;BSG;GSN;ADAMTS5;TIMP2;ADAM15;MMP16;CD44;CAPN2;CTSL;CTSS;MMP15
prerank,heart process (GO:0003015),-0.414316939522695,-1.018519780247236,0.44081632653061226,0.7240310420119584,1.0,2/14,0.41%,SGCZ;SGCD
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.3780873236739616,-1.017938176804019,0.4243119266055046,0.724720641131892,1.0,6/21,17.21%,CAV1;GSK3B;CTNNB1;AXIN1;APC;PPP1CA
prerank,regulation of membrane depolarization (GO:0003254),-0.38125420156161566,-1.017838048055939,0.4319654427645788,0.7242121360180633,1.0,9/18,27.33%,CAMK2D;NEDD4L;SMAD7;PTPN3;SCN2B;SCN1B;GPD1L;FHL1;RANGRF
prerank,actin cytoskeleton reorganization (GO:0031532),0.3466883753627735,1.017175649550491,0.42668621700879766,0.9458797888136429,1.0,11/63,6.94%,AUTS2;KIT;SIPA1L1;PTK7;NPHS2;PHACTR1;MCU;DTNBP1;EZR;CDC42BPG;RICTOR
prerank,amino acid transmembrane transport (GO:0003333),0.3689746634157385,1.0169141814245046,0.43086816720257237,0.9456714347405096,1.0,5/45,4.62%,SLC6A13;SLC38A4;SLC38A3;SLC7A11;SFXN2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.27002387451462745,-1.0168584824392588,0.39338235294117646,0.7259401015710466,1.0,30/104,16.37%,BMPER;CAV1;BMPR2;HTRA3;CCN3;VWC2;NOTCH1;VWC2L;PRDM16;ASPN;SMAD5;IL17RD;CD109;SORL1;SMAD1;BMP2;TGFB1;SMAD7;FKBP1A;LEMD3;UBE2D3;ACVR1;SPRY1;SPRED1;BMPR1B;PPM1A;SMURF1;UBB;CILP;HIPK2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.387580571486906,-1.016568171089497,0.45869565217391306,0.7259081903907033,1.0,5/17,14.09%,PTPRJ;CEACAM1;DUSP3;DGKZ;LAPTM5
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.40406349342036924,1.016562931770393,0.44350758853288363,0.945741113647408,1.0,16/29,22.95%,SMARCA4;TERT;TCF7;TLE1;HDAC1;ASH2L;TCF7L2;AXIN2;KMT2D;TLE2;CREBBP;TCF7L1;PYGO2;RUVBL1;EP300;BCL9
prerank,phosphatidylserine metabolic process (GO:0006658),0.3871344250429291,1.0165350696803854,0.4442595673876872,0.9448605973177041,1.0,11/32,21.45%,OSBPL8;PLA1A;SLC27A1;PLSCR1;ABHD12;OSBPL10;PLA2G5;MBOAT2;LPCAT4;PLAAT3;PTDSS1
prerank,peroxisomal membrane transport (GO:0015919),0.4019692770358434,1.016255550087149,0.43154246100519933,0.9446970238958443,1.0,10/27,17.34%,PEX11B;PXMP2;PEX10;PEX14;ACBD5;PEX19;RAB8B;SLC25A17;PEX16;PEX5
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.445462889586848,1.016184434223707,0.44324324324324327,0.9439677513716481,1.0,2/17,4.75%,ATP1A2;CACNA1C
prerank,regulation of macrophage activation (GO:0043030),-0.34458645475015137,-1.0161231091592902,0.43455497382198954,0.7263111423502914,1.0,8/30,17.31%,CD200;LRFN5;THBS1;IL33;MFHAS1;LBP;IL31RA;CD74
prerank,camera-type eye morphogenesis (GO:0048593),0.4851338468910095,1.0160549495741136,0.449438202247191,0.9433604854302198,1.0,3/10,8.24%,SHROOM2;KDM2B;IFT122
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.2757047641920552,-1.0156533551415792,0.40604026845637586,0.7267187183972842,1.0,27/98,19.80%,PID1;SLCO1C1;THBS1;PPARD;ECE1;NFKBIA;SFRP4;TBC1D5;APOE;TGFB1;AGTR1;XDH;NSF;STARD4;CDKN1A;ACE2;SNCA;AHI1;VEGFA;MT3;SCRIB;ATAD1;ARRB2;PAX8;INHBA;ROMO1;AGT
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.45759503597840007,1.0155905838133372,0.4521575984990619,0.943687323657078,1.0,2/15,2.90%,WNT5B;RNF213
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.44050593032818863,1.0154102490736834,0.4484629294755877,0.9432830236037417,1.0,3/18,5.53%,ACSL1;ACSBG2;HACD1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.28763895320151694,-1.0152858369579436,0.41455696202531644,0.7268757973418698,1.0,15/76,12.33%,GRM5;ESR1;PLCE1;ADRA1B;HTR2C;ANO1;HTR2A;AGTR1;CHRM2;GRM1;P2RY12;PTH1R;GNA14;HOMER1;CMKLR1
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2549263136468668,-1.015251155014243,0.3884297520661157,0.7262092106559618,1.0,41/159,20.20%,STXBP6;HIP1;SGIP1;RTN4;NCK2;VAMP4;HSP90AB1;RPL38;TIAM1;NSG2;PDE4DIP;BIN1;SMAD1;TGFB1;IMMP2L;ANLN;AIFM1;HSP90AA1;CYBA;FKBP1A;AP2M1;PSMG2;MAPT;AXIN1;SNCA;CLU;NCK1;PIK3C2A;DHX9;DNAAF3;CCT2;CENPE;CHMP4B;CHMP4A;PSMD11;CASQ2;TBCE;HIP1R;POMP;NUP107;PTGES3
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4194436801656599,-1.0149949077829503,0.44288577154308617,0.7261565155094125,1.0,3/13,2.22%,PID1;TMSB4X;NOS3
prerank,cellular response to retinoic acid (GO:0071300),0.3745774320048564,1.0146160295367592,0.44208809135399674,0.9445155336312628,1.0,4/42,5.45%,WNT5B;PTK7;WNT6;ATM
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.4834838312549127,1.0143651618724474,0.4637964774951076,0.9442741762937618,1.0,3/10,17.64%,HK2;GFPT1;PFKM
prerank,T-helper cell differentiation (GO:0042093),-0.4146302472906003,-1.0143445286570176,0.4682713347921225,0.7269701366821064,1.0,2/14,6.10%,LEF1;FOXP1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.4691967741147244,1.0142187881230749,0.4659498207885305,0.9437572019640038,1.0,3/12,12.33%,PRKCB;CCNB2;PRKCA
prerank,negative regulation of cell development (GO:0010721),0.4070169054263333,1.0135807287540952,0.4358523725834798,0.9446260661751622,1.0,3/25,6.92%,APPL2;IGF1;FBN1
prerank,positive regulation of lipid localization (GO:1905954),0.47690780541164973,1.0135418700297,0.46332046332046334,0.9438123626222552,1.0,3/11,14.88%,IKBKE;LRP1;NFKB1
prerank,Golgi organization (GO:0007030),0.31661364846437084,1.012950114492425,0.42857142857142855,0.9444934074859759,1.0,34/112,18.90%,FAM174B;DYM;OBSL1;CLASP1;LRRK2;MYO18A;PLK5;BCAS3;HUWE1;HTT;TRAPPC12;GOLPH3L;CSNK1A1;RAB43;FBXW8;CDC42;TRAPPC11;VTI1A;STX5;TANGO2;ARHGAP21;SEC23IP;RAB29;VPS51;GOLGA5;GOLGA8B;RAB30;PI4K2B;OPTN;COG4;NPLOC4;GORASP2;BET1;GOLGA2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.39936570119769854,1.0124861853808722,0.42517006802721086,0.9448781890574341,1.0,9/27,15.30%,DDX5;TP53;TNRC6B;RIPK1;AJUBA;DDX6;MAP2K1;MAP2K2;WTIP
prerank,regulation of actin filament-based movement (GO:1903115),-0.4519980731981995,-1.0123770524757694,0.45,0.7311141555497196,1.0,2/10,0.65%,PDE4D;PDE4B
prerank,negative regulation of blood pressure (GO:0045776),-0.42384596051393697,-1.0123054364291113,0.4488517745302714,0.7305403154199783,1.0,2/13,2.22%,BMPR2;NOS3
prerank,error-prone translesion synthesis (GO:0042276),-0.37255871540787333,-1.0117001309394533,0.43863636363636366,0.7312689255577819,1.0,13/21,33.78%,REV3L;PRIMPOL;UBB;RPA1;RFC4;RFC2;POLK;UBC;RPS27A;RFC5;RPA3;RPA2;POLI
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.34636176787236506,-1.0116319846011095,0.4367816091954023,0.730686361322818,1.0,9/28,11.73%,SHANK3;GSK3B;APOE;APP;RELN;EPHB2;PTN;ZDHHC2;FAM107A
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3486518409519615,1.0114122115080961,0.4350453172205438,0.9469267267094826,1.0,14/56,19.15%,UBE2E2;DDX3X;ANKRD17;CCND3;HYAL1;CDC25A;TFDP1;ADAM17;NSMCE2;RPTOR;RB1;KMT2E;EIF4G1;KLHL18
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4497828538036494,-1.0112872032111306,0.4642857142857143,0.7308337679123331,1.0,3/10,14.31%,ESR1;PSMC6;ATF7IP
prerank,negative regulation of developmental process (GO:0051093),-0.28440574791421963,-1.010610307035065,0.42433234421364985,0.7317747963876323,1.0,17/69,14.68%,KLF7;NOS3;DCC;CST3;GAS6;TFRC;NOTCH1;GRIN3A;TBX1;ARHGEF15;BMP2;TGFB1;HEY2;BMP4;MAPT;PINK1;FGFR3
prerank,negative regulation of mitochondrion organization (GO:0010823),0.38330542821917357,1.0105750791023382,0.4382207578253707,0.94837403503037,1.0,5/33,9.44%,IGF1;PRKN;OPA1;HUWE1;ADCK1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.31159219917446035,1.010372853394423,0.45170068027210886,0.9479965214832731,1.0,22/119,11.35%,PTPN13;TTC7B;INPPL1;PI4KA;MTMR3;PIGN;SYNJ2;SMG1;PLEKHA2;TMEM150A;PIGW;PIGQ;SLC27A1;PIP4K2C;PTEN;PIK3CA;ITPKB;PIKFYVE;PLEKHA8;PIK3R3;OCRL;SOCS3
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.4311151686820906,-1.010348751787435,0.4579646017699115,0.7316931074567334,1.0,5/13,21.60%,GRM3;GABBR2;EDNRB;PALM;DRD2
prerank,regulation of leukocyte activation (GO:0002694),-0.4056455683457795,-1.0100353689312402,0.4432773109243697,0.7316902765641575,1.0,5/14,17.31%,CD200;LYN;MFHAS1;GPER1;CD74
prerank,regulation of endopeptidase activity (GO:0052548),0.34726831296091987,1.0098509299077447,0.43846153846153846,0.9484764743617717,1.0,9/59,9.56%,TIMP3;SERPIND1;PICALM;KNG1;SERPINE1;SERPINA9;HRG;APH1B;HDAC1
prerank,ventricular septum development (GO:0003281),0.3741606134676767,1.0097388030496606,0.4624,0.9478570850409265,1.0,4/37,3.46%,ROBO1;TGFBR3;BMPR1A;TGFBR1
prerank,activation of phospholipase C activity (GO:0007202),0.396670051303099,1.0096677622521195,0.45768566493955093,0.947135211268939,1.0,3/29,3.81%,LPAR1;LPAR2;ARHGAP6
prerank,mitochondrion transport along microtubule (GO:0047497),-0.42992464498547106,-1.00962232833223,0.44421487603305787,0.7320062033443508,1.0,6/13,23.64%,SYBU;MAPT;HIF1A;UBB;SPAST;NEFL
prerank,regulation of gastrulation (GO:0010470),0.465316263405424,1.0093108477090373,0.4610051993067591,0.9471587690532444,1.0,5/14,12.32%,OSR1;CLASP1;DAG1;PHLDB2;FOXA2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4414150838599127,1.009225399310624,0.45359019264448336,0.9464850940004351,1.0,7/18,14.46%,ROCK2;RUFY3;BCAS3;CDH5;CYRIB;KRIT1;LLGL2
prerank,negative regulation of locomotion (GO:0040013),-0.4304946767682793,-1.009219975740592,0.46458333333333335,0.7322806075078783,1.0,4/12,11.01%,FRMD5;SPOCK3;CRK;DUSP3
prerank,positive regulation of translational initiation (GO:0045948),0.4419775978337633,1.009218932574009,0.4684014869888476,0.9455749278790528,1.0,7/18,21.04%,DDX3X;POLR2D;LARP1;YTHDF3;BOLL;POLR2G;RPS6KB2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.42357792426747665,1.0085959646184313,0.45563139931740615,0.9464009373399057,1.0,2/22,1.44%,ROCK2;IGF1
prerank,regulation of MAPK cascade (GO:0043408),0.3041394541271353,1.00822301275839,0.41818181818181815,0.9464917260061834,1.0,16/157,6.41%,TGFBR3;ROCK2;LPAR1;KSR1;KIT;GSDME;IGF1;FGFR2;PKHD1;PPEF2;FGFR1;ADRA2A;DAG1;EPHA8;FLT1;LBH
prerank,purine-containing compound salvage (GO:0043101),0.47572591247730106,1.0078956441562466,0.45136186770428016,0.9464492546336771,1.0,4/12,20.59%,AMPD3;AMPD2;APRT;GMPR2
prerank,epithelial cell differentiation (GO:0030855),0.32640065580640154,1.0078532054870606,0.43043478260869567,0.9456316161099794,1.0,8/88,9.56%,DAB2;MAF;FGFR2;CPT1A;TPP1;BDH2;GLI1;HDAC1
prerank,amyloid fibril formation (GO:1990000),-0.3080725753726816,-1.0078467674363925,0.43597560975609756,0.7349069137857639,1.0,17/51,14.92%,GSN;CST3;B2M;APP;TSPAN14;TGFBI;HSPG2;SORL1;SIAH2;H3-3A;FKBP1A;ITM2B;MAPT;SNCA;MFGE8;IAPP;UBB
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.4709720466383348,1.0078406506847604,0.461839530332681,0.9447341901485296,1.0,5/11,20.74%,ARRB1;ADM;GRK3;SAG;ARR3
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4214461596561717,1.0075491093148476,0.4614035087719298,0.9446384167377484,1.0,3/20,8.92%,IGF1;FOXC1;NIBAN2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.43961909690409084,1.0074757782690438,0.43357933579335795,0.9439257428046288,1.0,8/17,28.89%,EMC2;EMC1;EMC3;CAMLG;GET4;BAG6;UBL4A;SGTA
prerank,regulation of interferon-gamma production (GO:0032649),-0.2881184787552905,-1.0073051889016433,0.4426751592356688,0.7355503450893405,1.0,18/71,21.19%,PDE4D;PDE4B;IL1R1;SLC7A5;GAS6;VSIR;CD47;TRIM27;HAVCR2;LAPTM5;NR1H4;SCRIB;ZFPM1;INHBA;TLR7;TXK;LGALS9;PYCARD
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.4216039309616927,-1.0071253942442142,0.4906832298136646,0.7352422424842878,1.0,6/13,31.52%,ALG6;ALG8;ALG9;ALG13;ALG3;DPAGT1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.43891883938876786,1.0070310135946943,0.45863309352517984,0.9442198583498539,1.0,3/17,8.88%,BID;SOD2;DNM1L
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.40844981859179913,-1.0067466933740876,0.44567627494456763,0.7354340389850474,1.0,7/15,13.77%,TMSB4X;SEMA5A;KDR;MET;FGF2;PRKD1;VEGFA
prerank,cellular response to hydroxyurea (GO:0072711),0.4880219801002934,1.006626482925455,0.45454545454545453,0.9444388634394368,1.0,4/10,21.07%,ATRX;DDI1;RTF2;FMR1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.39784197567103674,-1.006563181705652,0.465324384787472,0.7351534364954453,1.0,7/17,16.78%,RTN4;NTRK2;APOE;SORL1;BIN1;CLU;CHRNA7
prerank,protein deacetylation (GO:0006476),0.3665146836049682,1.0065332023947577,0.44393241167434716,0.9438029207107992,1.0,12/41,15.38%,TBL1X;SIRT5;TBL1XR1;SIRT3;HDAC4;SIRT1;HDAC1;PRDM5;SIRT4;SIN3A;MIER3;MTA2
prerank,DNA conformation change (GO:0071103),0.42689070608987956,1.0062392704172334,0.44808743169398907,0.9436917719041639,1.0,3/17,12.54%,TOP2B;ABL1;TOP3A
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.2890960094631635,-1.0061970226853554,0.45987654320987653,0.735317134520746,1.0,25/73,22.11%,PTPRJ;THBS1;STAT3;ARHGEF2;IL33;PTPRC;APP;PLCG2;PSEN1;EPHB2;CYBA;TIRAP;HAVCR2;TWIST1;CLU;LBP;DHX9;NOD2;SYK;HSPB1;TYROBP;CCL19;LGALS9;PYCARD;CD86
prerank,negative regulation of cyclase activity (GO:0031280),-0.42025355528525943,-1.0057380145867683,0.4642857142857143,0.7356877233452367,1.0,5/14,21.60%,GRM3;GABBR2;EDNRB;PALM;DRD2
prerank,organelle disassembly (GO:1903008),0.38831161146358445,1.005460285753826,0.4623287671232877,0.9448870892949806,1.0,11/33,19.26%,RETREG1;PLK5;KLC1;KIF5B;ZFAND1;ATG2A;STX5;TEX264;GFM2;GOLGA2;UBA5
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3559458928065392,-1.0054103761268431,0.4275184275184275,0.735775855743993,1.0,8/25,10.44%,CAV1;CTNNA3;RYR2;CAMK2D;TBX18;CALM1;FGF13;CALM3
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.31092302423725193,-1.0051834551769632,0.45989304812834225,0.7356133007264337,1.0,14/45,21.34%,CAMK2D;MID1;VCAM1;B2M;ICAM1;IFNGR2;JAK1;CD44;IRF5;IRF2;CAMK2B;IRF8;TRIM68;MT2A
prerank,fatty acid catabolic process (GO:0009062),0.34202640739353446,1.0050785443327919,0.43946188340807174,0.9450563405286373,1.0,23/67,22.19%,PCCA;CEL;ACAD11;ACAD10;BDH2;CPT2;ACADM;MECR;ACOT8;ECHDC1;ACBD5;DECR1;NUDT19;EHHADH;SLC25A17;PHYH;ECI2;CROT;ACADS;HADHA;HADH;ECHS1;HAO1
prerank,homeostasis of number of cells (GO:0048872),-0.4280004615678519,-1.0047512048656264,0.4562899786780384,0.7359664964115491,1.0,3/12,4.65%,NOS3;CCN3;NOTCH1
prerank,piRNA metabolic process (GO:0034587),0.426491743073075,1.004424900764257,0.46853146853146854,0.9459058765622662,1.0,5/19,21.04%,GPAT2;MOV10L1;MYBL1;EXD1;ASZ1
prerank,response to retinoic acid (GO:0032526),0.3440326641636989,1.004341536363321,0.44929797191887677,0.9452363817767235,1.0,7/59,7.54%,WNT5B;PTK7;WNT6;CTSH;ATM;OVCA2;RBP4
prerank,regulation of defense response to virus by host (GO:0050691),0.3914750795800193,1.004237897445371,0.45024469820554647,0.9446098222453512,1.0,7/30,13.50%,IL12B;PTPN22;PARP9;MAVS;TOMM70;ZDHHC1;SIN3A
prerank,negative regulation of cell cycle (GO:0045786),0.332821417315571,1.0033893880836855,0.46279761904761907,0.9460278081131049,1.0,6/73,3.89%,BMP7;SMAD3;NUPR1;NR2F2;FOXC1;GAS1
prerank,regulation of apoptotic process (GO:0042981),-0.2235420260582078,-1.0033172937607648,0.5,0.7387605189149369,1.0,180/676,20.23%,GRID2;SLIT2;MEF2C;LEF1;HIP1;TEK;ARHGAP10;ACTN4;PIK3R1;ITGA6;MAP3K5;RASSF2;FMN2;KCNMA1;RTN4;THBS1;ACTN1;MCF2L;ABR;TBX3;TPT1;RASGRF2;ACER2;RNF144B;PTK2B;ARHGEF3;TRIM2;APAF1;CSRNP3;RPS6;GAS6;NGF;CYP1B1;TFRC;UNC13B;TRIO;NFKBIA;ARHGEF9;ARHGEF7;IL6ST;NET1;TNFSF10;ARHGEF2;KDR;GSK3B;ANXA1;SFRP4;DAB2IP;TIAM1;PPIA;CD38;PTMA;PLK2;PHLPP1;FLNA;RPS3;CTSD;CARD14;SOCS2;ARHGEF17;TGFB3;RYBP;RHOB;FOXO1;SEMA4D;PSEN1;ITGB1;PERP;BIN1;BMP2;SIAH2;HSPA5;PTK2;CALR;DDRGK1;CTSB;VDAC1;TMBIM6;TOX3;PPT1;ANP32A;FLT4;PLEKHG5;AIFM1;CD44;UFM1;ARHGEF26;FRZB;ARL6IP1;HSP90AA1;RPS6KA3;BCAR1;RPS6KA2;ERC1;MAGED1;GPER1;HNRNPK;BMP4;RASA1;ATF4;CTNNB1;DAPK1;ANKRD13C;LCMT1;FAS;IKBKB;SERPINB9;LRP8;SNCA;AHI1;CFL1;SUDS3;TAF9B;VEGFA;GADD45G;RPS6KA1;PINK1;NOP53;MT3;ATF5;DNAJA3;CLU;KLF11;IAPP;CASP6;UBB;MTDH;PHLDA3;PAX2;IL31RA;CRADD;BFAR;BCL3;PIM1;CBL;EGLN2;VAV1;FAIM2;CAT;RHBDD1;TOP2A;DNAJA1;ARHGDIA;APC;RNPS1;NR1H4;SCRIB;CASP2;PIM2;CD74;BARD1;DIABLO;PHLDA1;HSPB1;DHCR24;HTRA2;IRF5;TNFRSF25;APH1A;SOX8;STPG1;RNF122;BCL2L11;FOXL2;HIP1R;CALHM2;PAX8;PREX1;PNMA2;GADD45B;GATA6;SIX4;COPS5;DCUN1D3;AGT;ECT2;IER3IP1;SHC1;EGLN3;DAPK2
prerank,apoptotic process (GO:0006915),-0.24599142873937183,-1.0028001106243212,0.4520547945205479,0.7392607526014702,1.0,44/203,14.80%,HIP1;MAGI3;SEMA6A;RTN4;DCC;EFNA5;MAL;PPARD;FAP;PTK2B;PAK5;APAF1;CIT;SCN2A;NFKBIA;ZBTB16;PLAGL1;TBX1;PPIA;APP;RHOB;MAP3K7;TNFRSF19;FOXO1;PRUNE2;ADAM15;PPP2R1A;TNFRSF21;VDAC1;AIFM1;DDIT4;ELMO1;FXR1;GLRX2;PAEP;DAPK1;FAS;RFK;JADE1;BBC3;TRPC5;DAP;IAPP;CASP6
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.423339838800049,-1.0027680696040004,0.48118811881188117,0.7385974054208714,1.0,3/13,9.18%,RYR2;NOTCH1;HEY2
prerank,epithelial structure maintenance (GO:0010669),0.47164072912272925,1.0026044786863926,0.4552380952380952,0.9472333897414033,1.0,2/11,10.27%,RBP4;CXADR
prerank,regulation of aerobic respiration (GO:1903715),-0.4051033821801122,-1.0025391338497827,0.45217391304347826,0.7383787405800541,1.0,4/15,14.08%,CBFA2T3;SLC25A33;PINK1;NOP53
prerank,histone H2A monoubiquitination (GO:0035518),0.4360784298382577,1.0025085610119602,0.4419047619047619,0.9465734963127371,1.0,5/17,13.60%,PCGF5;PCGF2;BCOR;KDM2B;DDB2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.39562049575739155,1.002467057970043,0.45826235093696766,0.945785798194115,1.0,5/27,9.09%,NAPEPLD;NAAA;ETNK2;SLC27A1;PLA2G6
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.37228669545702636,-1.0024319384800067,0.4509394572025052,0.7379168103284419,1.0,6/21,9.36%,SLIT2;TGFB2;DAB2IP;CD2AP;EPHB2;ARHGAP25
prerank,negative regulation of response to wounding (GO:1903035),-0.38144553839551065,-1.0021814366077728,0.43577981651376146,0.7377987666406132,1.0,9/19,22.06%,CASK;AJAP1;CD109;CRK;FGF2;RTN4RL1;RTN4R;MDK;GIT1
prerank,protein import into peroxisome membrane (GO:0045046),0.4166001178618329,1.002045790536941,0.4607142857142857,0.9460284174204368,1.0,9/22,17.34%,PEX11B;PXMP2;PEX14;ACBD5;PEX19;RAB8B;SLC25A17;PEX16;PEX5
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.3911820978716378,1.0019578563304756,0.46102819237147596,0.9453439665687394,1.0,6/28,9.87%,APPL2;PRKCZ;PRKCB;TNS2;PIP4K2C;GRB10
prerank,regulation of mitochondrion organization (GO:0010821),0.35692836089061886,1.0014672218756062,0.46859903381642515,0.9457704012740319,1.0,13/47,18.50%,PPARGC1A;PRKN;LRRK2;FZD5;STAT2;MYO19;DNM1L;CYRIB;CSNK2A2;FLCN;VPS35;SQSTM1;RHOT1
prerank,protein acetylation (GO:0006473),0.3898152004631616,1.0007959878591681,0.45546218487394957,0.9467176764954928,1.0,7/30,16.31%,SPHK1;NAA80;DSCC1;SIRT1;KAT2B;NAA16;CREBBP
prerank,pulmonary valve development (GO:0003177),0.4269909078294204,0.9999451227182673,0.4891696750902527,0.948046671698846,1.0,2/18,0.29%,NOTCH2;ROBO1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.37476108497814825,-0.9998667087233183,0.4696261682242991,0.7427789814908771,1.0,6/19,11.23%,DLG2;CLIC4;LRRC7;MTCL1;ERBIN;MARK2
prerank,regulation of transferase activity (GO:0051338),0.4431750715643287,0.9998243767513239,0.45996275605214154,0.947454572370546,1.0,4/17,7.44%,ATM;PARP4;LDB2;LDB1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.33946829195688233,-0.9997502874884473,0.44634146341463415,0.7423066419603711,1.0,15/30,38.46%,HSPA8;HSPA5;CCT2;HSPE1;DNAJB1;PTGES3;HSPA13;ERO1A;ENTPD5;HSPA1L;HSPA9;DNAJB4;ST13;UGGT1;SDF2L1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33124102555415375,0.9997392324751473,0.4511834319526627,0.9467967487026729,1.0,8/75,6.60%,ROCK2;TULP3;NMT2;GRK5;RGS16;METAP2;RHO;MGRN1
prerank,organophosphate ester transport (GO:0015748),-0.3638751810094451,-0.9997040428506591,0.4484304932735426,0.7416991061755825,1.0,9/24,11.96%,PITPNC1;SCARB1;PLTP;LDLR;NPC2;PITPNB;TNFAIP8L3;MTTP;PITPNA
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.27275093261689987,-0.9994848560953206,0.44666666666666666,0.7414976325145931,1.0,17/88,8.69%,STXBP6;MYO1B;SORCS1;CLINT1;FTH1;SH3GL2;MYO5A;EXOC6;DOP1B;CLVS1;APP;HSPA8;AP1S2;SORL1;SORT1;FTL;GOPC
prerank,N-glycan processing (GO:0006491),0.42150689123459184,0.9993606063606767,0.45207956600361665,0.946890404272137,1.0,6/18,13.89%,MAN1A2;MAN1C1;FUT8;MAN2A1;GANC;PRKCSH
prerank,positive regulation of vasculature development (GO:1904018),0.3250631011519693,0.9993439131830091,0.47711511789181693,0.9460314502181825,1.0,16/94,9.72%,FGF1;ADAM12;SMOC2;SASH1;HK2;SPHK1;RAPGEF3;PRKCB;CTSH;FLT1;SERPINE1;PDPK1;CDH5;HYAL1;SIRT1;STIM1
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.27096007788756593,-0.998850941116552,0.44483985765124556,0.7423634971448317,1.0,21/98,11.24%,SPTBN1;DPP10;PRKCH;PIK3R1;ANK3;CEMIP;YWHAE;STX3;YWHAB;PLS1;NKD2;ITGB1;PPP3R1;YWHAG;EPHB2;MTCL1;ERBB2;EFCAB7;ATP2B4;KCNB1;GPER1
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.33414529874105203,-0.9988219800767061,0.468586387434555,0.7416987971391935,1.0,7/33,6.96%,MAP3K5;CYP1B1;NET1;ANXA1;RPS3;PLEKHA1;RHOB
prerank,regulation of sodium ion transport (GO:0002028),0.37842684904374824,0.9987311185038511,0.4744645799011532,0.9468041428012138,1.0,6/34,6.54%,WNK4;DLG1;SNTA1;NEDD4;AHCYL1;SIK1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.45595347324744384,0.9986809011330459,0.4679611650485437,0.9460591142920833,1.0,3/12,12.68%,DPYD;CTPS2;ALDH6A1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.3395622727373174,-0.9984829632454997,0.4889975550122249,0.74175650769706,1.0,10/31,18.42%,DAB2IP;HSPA8;HSPA5;TMBIM6;PACRG;TM7SF3;HSPB8;UBE2W;RHBDD1;PTPN1
prerank,peptidyl-methionine modification (GO:0018206),0.46808028655152933,0.9979456616359449,0.486652977412731,0.947130180462974,1.0,3/12,15.40%,METAP2;NAA20;NAA16
prerank,regulation of microtubule polymerization (GO:0031113),-0.32814300616194103,-0.9976887593531089,0.47337278106508873,0.7428684074206474,1.0,14/40,15.25%,NAV3;PAK1;RPS3;MET;STMN2;OCLN;TUBB4A;CDK5RAP2;MAPT;CLIP1;SNCA;CDK5R1;FES;STMN1
prerank,O-glycan processing (GO:0016266),0.34986605180218766,0.9970974228306414,0.47641509433962265,0.9484523592102309,1.0,4/54,4.87%,GXYLT2;ST6GAL1;GALNT12;ST3GAL3
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3574392192572808,-0.9968897180428431,0.47619047619047616,0.7440945445387267,1.0,7/24,12.36%,NAV3;CLASP2;ARHGEF2;LIMA1;STMN2;FGF13;SPEF1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4268522760074111,0.9965880767643395,0.45309734513274336,0.948924178968476,1.0,4/19,8.46%,ROBO1;SMOC2;IL12B;HRG
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.26637641898320763,-0.9964816617997914,0.4471830985915493,0.7443383501957008,1.0,30/112,17.83%,PTPRJ;THBS1;STAT3;CD34;GAS6;ARHGEF2;IL33;PTPRC;FOXP1;APP;PLCG2;PSEN1;VSIR;EPHB2;IRAK3;CD47;CYBA;TRIM27;TIRAP;HAVCR2;TWIST1;CLU;LBP;CX3CR1;DHX9;CHRNA7;NR1H4;NOD2;SYK;HSPB1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3439616714996773,0.9961052879628132,0.4508320726172466,0.9493623879222545,1.0,9/57,9.44%,PPARGC1A;PRKN;MCU;BID;FAM162A;TP53;HTT;DNM1L;ADCK1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.47005922354686785,0.996025947406299,0.45714285714285713,0.9487001812983444,1.0,3/13,3.18%,TGFBR3;FGFR2;BMPR1A
prerank,negative regulation of blood coagulation (GO:0030195),0.3663202987607882,0.9959489953309032,0.45517241379310347,0.9479902383780509,1.0,11/38,16.34%,TFPI;F11;KRT1;F2;KNG1;SERPINE1;HRG;C1QTNF1;F8;PLAT;PDGFRA
prerank,regulation of immunoglobulin production (GO:0002637),-0.35860095461447783,-0.9955514072412899,0.45794392523364486,0.7458945871082444,1.0,3/23,7.96%,GPI;PTPRC;EPHB2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.43207156124468765,0.9953999873181099,0.4581005586592179,0.9486011896161435,1.0,5/16,13.35%,HMGA1;TWNK;SSBP1;MCM7;MCM2
prerank,protein O-linked glycosylation (GO:0006493),0.3175987834737792,0.9950968201225798,0.47538677918424754,0.9485165216280997,1.0,9/96,5.77%,GXYLT2;TRAK1;ST6GAL1;TMTC4;GALNT12;LARGE1;ST3GAL3;TET2;PGM3
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.38459574171372224,-0.9948642117739377,0.49099099099099097,0.7468390025721013,1.0,5/18,18.28%,LYN;BCAR1;CMKLR1;SH2B2;C3AR1
prerank,activation of protein kinase A activity (GO:0034199),0.4357280016663201,0.9947089069459912,0.4731182795698925,0.9486590633345562,1.0,5/16,13.48%,ADCY5;ADCY1;ADCY9;PRKAR1A;ADCY6
prerank,receptor catabolic process (GO:0032801),0.4018318300041696,0.9945911622979756,0.4725663716814159,0.948102751440422,1.0,6/24,14.64%,RNF43;NEDD4;UVRAG;BECN1;CLTC;AP2A1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.36136261521997026,-0.9943368364102945,0.47344110854503463,0.7474356845148721,1.0,11/22,30.10%,RAD23B;UBB;CETN2;GTF2H1;GTF2H4;GTF2H5;ERCC2;UBC;RPS27A;DDB1;ERCC3
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.29155840018625107,-0.9943148992945702,0.4349112426035503,0.7467660076240047,1.0,14/67,9.84%,GHR;TEK;ERBB4;PTK2B;KDR;LYN;BMX;RELN;EPHB2;PTK2;ABI1;TEC;FLT4;ERBB2
prerank,genitalia development (GO:0048806),-0.4155202435057058,-0.9941920116111326,0.4666666666666667,0.7463166507883373,1.0,4/12,12.26%,TBX3;STRA6;PKD1;FOXF2
prerank,gluconeogenesis (GO:0006094),0.368267104682762,0.9941669169016178,0.4668769716088328,0.948325770699751,1.0,12/39,17.88%,PPARGC1A;PGAM2;GOT2;RBP4;SLC25A12;SLC25A11;PGM1;PER2;SLC25A10;GOT1;SLC37A4;CRY1
prerank,AMP metabolic process (GO:0046033),0.4529477372351125,0.9936856665689024,0.4850187265917603,0.9487892155524996,1.0,6/13,20.77%,AMPD3;AK3;AK4;AMPD2;ADSS1;ADSL
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3047354841378875,0.9936655726560587,0.48157894736842105,0.9479486679160063,1.0,17/132,10.49%,RNF152;IGF1;SH3D19;PRKAA2;PPARA;ZBTB20;ADRA2A;TPCN1;LRRK2;VGLL4;EZR;NPRL2;ZC3H18;ZC3HAV1;MOV10;ZSWIM8;IRGM
prerank,regulation of phospholipase C activity (GO:1900274),0.4427122597190178,0.9936530172326551,0.46332046332046334,0.9470862852828418,1.0,5/15,10.63%,KIT;FGFR1;FLT1;PDGFRB;ABL1
prerank,positive regulation of blood coagulation (GO:0030194),-0.3893980215119459,-0.993469765545088,0.4690831556503198,0.747455911872113,1.0,5/17,13.12%,ST3GAL4;THBS1;F3;ENPP4;DMTN
prerank,negative regulation of peptidase activity (GO:0010466),-0.3028131158063216,-0.9931851939497893,0.4959785522788204,0.7474053841810714,1.0,9/47,8.46%,SPOCK2;SERPINE2;CST3;SPOCK3;SERPINI1;SERPINF1;TIMP2;ECM1;SPOCK1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.3827140760532971,-0.9929391451136992,0.4645308924485126,0.7472936096525916,1.0,1/17,0.39%,CADM1
prerank,activation of protein kinase activity (GO:0032147),0.31305112085174996,0.9928968459161662,0.48732394366197185,0.9481477605599548,1.0,13/106,8.75%,FGF1;ADCY5;OSBPL8;IGF1;ADCY1;IL18;ADRA2A;TLR3;RICTOR;ADCY9;TGFBR2;NRG1;PDPK1
prerank,spinal cord development (GO:0021510),0.46364341731597186,0.992709134135021,0.4656188605108055,0.9477325418326241,1.0,3/12,7.08%,GLI2;LOXL3;SOX12
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.37690111430198736,-0.9925355951061254,0.46887966804979253,0.7475269184201325,1.0,6/17,10.44%,HSP90AB1;PPP1R12A;CALM1;PTPRC;CALM2;CALM3
prerank,regulation of cholesterol storage (GO:0010885),-0.39522254073844265,-0.9918577285164353,0.4697286012526096,0.7484581577823742,1.0,4/15,7.44%,PPARD;SCARB1;ABCG1;SREBF2
prerank,vasodilation (GO:0042311),-0.42300226688434905,-0.9917930813743627,0.48026315789473684,0.7478801978826043,1.0,5/13,12.67%,KCNMA1;NOS3;KLF2;GPER1;NOS1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4345271136316058,0.9917805883710257,0.48398576512455516,0.9493400033639561,1.0,2/16,1.44%,ROCK2;IGF1
prerank,primary neural tube formation (GO:0014020),0.3848670169816078,0.9911895397962839,0.46337308347529815,0.9500663138687548,1.0,6/30,12.35%,CELSR1;LMO4;MTHFR;IFT122;PHACTR4;DEAF1
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.41469545674104014,-0.9910851120462187,0.48306997742663654,0.7489387262203256,1.0,3/13,11.87%,ENTPD1;ENPP1;SMPDL3A
prerank,regulation of ERAD pathway (GO:1904292),-0.43571648351728903,-0.9909689935873454,0.5021367521367521,0.7484597219928137,1.0,2/11,8.03%,AQP11;USP13
prerank,negative regulation of protein ubiquitination (GO:0031397),0.35262318569221135,0.9907657845719166,0.4783950617283951,0.9503118288141812,1.0,8/50,14.09%,SH3RF2;NXN;HDAC8;ARRB1;GTPBP4;ABL1;OGT;PER2
prerank,supramolecular fiber organization (GO:0097435),0.27809748755276203,0.9905960293896928,0.47266514806378135,0.9498880836983522,1.0,36/333,6.82%,COL5A1;TSPAN5;COL22A1;COL26A1;SNCAIP;CGNL1;LAMC2;COL4A5;DLG1;SHROOM2;HOOK2;KIF2A;RHOBTB2;AVIL;PRKN;RHOD;SHROOM3;INPPL1;COL18A1;COL4A3;TMOD2;MYO5C;LOXL1;ADAMTS2;TGFBR1;LOXL3;RUFY3;TMOD3;TPM1;KLHL41;COL9A2;USP9X;ARHGAP17;MPRIP;COL13A1;TRIOBP
prerank,negative regulation of neuron differentiation (GO:0045665),0.40793345864766495,0.9902974397243856,0.4651600753295669,0.9498014535203403,1.0,2/22,3.66%,BMP7;DTX1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4361615966866046,0.9901255994861543,0.4678362573099415,0.9493646718930792,1.0,7/15,24.43%,ZC3H12B;DICER1;ZC3H12C;NYNRIN;POP7;POP1;LACTB2
prerank,oligodendrocyte development (GO:0014003),-0.40138074178336175,-0.9899789662500705,0.47959183673469385,0.750159584163103,1.0,10/15,34.02%,PLP1;B4GALT5;EIF2B3;TPPP;SOX10;B4GALT6;EIF2B2;PRDM8;EIF2B5;MYRF
prerank,tube closure (GO:0060606),0.38062066014170504,0.9898750759727867,0.47715736040609136,0.9491010165027364,1.0,11/31,20.99%,CELSR1;LMO4;MTHFR;IFT122;PHACTR4;DEAF1;MTHFD1;VASP;FOLR1;TSC2;FUZ
prerank,urogenital system development (GO:0001655),0.4720343439135563,0.9897397302972885,0.47513812154696133,0.9485613314223595,1.0,1/11,1.09%,OSR1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.45047902195983364,0.9896997570346079,0.5019157088122606,0.9477962896088187,1.0,3/13,4.75%,ANK2;KCNA5;CACNA1C
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4288363733115972,0.9891993826312018,0.4898336414048059,0.948272023992063,1.0,2/16,4.81%,LEPROT;PARP14
prerank,positive regulation of GTPase activity (GO:0043547),0.2915715554307294,0.9887495979465508,0.4724602203182375,0.9485867644559606,1.0,16/188,4.59%,DOCK11;AFDN;ARHGAP29;PKP4;PICALM;SIPA1L1;ARHGEF16;SRGAP2;SYDE2;ALS2;NGEF;RGS16;TBC1D16;ASAP3;GMIP;RAPGEF3
prerank,lipoprotein biosynthetic process (GO:0042158),0.46305611381205364,0.9884490994409104,0.4796905222437137,0.9485454436660788,1.0,4/11,11.85%,ATG10;WIPI1;ATG7;PORCN
prerank,regulation of phosphorylation (GO:0042325),0.30807530658450627,0.9881787924857914,0.4619718309859155,0.9483621386871992,1.0,22/120,14.24%,PRKAG2;BMP7;FNIP1;PHIP;SESN2;ROPN1L;STAT2;GCK;LDB2;LDB1;CDH5;SIRT1;NUP42;FER;NUP98;GLMN;ROPN1;NUP43;MCM7;PML;OGT;FLCN
prerank,L-amino acid transport (GO:0015807),-0.3415337005671014,-0.9881583668241111,0.4699074074074074,0.7538925149272601,1.0,7/28,8.00%,SLC7A5;SLC1A2;SLC1A1;SLC7A1;SLC25A13;SLC1A4;SLC38A5
prerank,glutamine family amino acid metabolic process (GO:0009064),0.38371711861886965,0.987974509775962,0.4848993288590604,0.9480381295235248,1.0,9/33,16.21%,PRODH;CPS1;ALDH4A1;GOT2;GLUL;SIRT4;ART4;CAD;GOT1
prerank,positive regulation of cytokinesis (GO:0032467),0.37410293628346214,0.987954417274272,0.4694244604316547,0.947210446218375,1.0,5/32,11.35%,PKP4;CDC14A;AURKB;CDC14B;CDC42
prerank,cellular response to nutrient levels (GO:0031669),0.3351139948439826,0.9878192272563624,0.4707692307692308,0.9466897589563819,1.0,17/62,19.05%,PRKAA2;PPARA;FNIP1;LRRK2;LAMP2;WIPI1;NUPR2;SIRT1;ATG7;FLCN;TSC1;RPTOR;EHMT2;RRAGD;ZFYVE1;EIF4G1;USP33
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.41700960485000915,-0.9877115104377873,0.48218029350104824,0.7542209490306344,1.0,7/13,19.63%,SHANK3;APP;RELN;EPHB2;ZDHHC2;CHRNA7;ADCY8
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.42832652560486484,-0.9874581397733521,0.475103734439834,0.7541406095789366,1.0,4/11,16.58%,STAT3;LIMD1;FXR1;DHX9
prerank,positive regulation of potassium ion transport (GO:0043268),0.3621532006394046,0.9872672353173454,0.4796084828711256,0.9473616005296355,1.0,4/38,3.65%,ACTN2;ANK2;DLG1;ADRA2A
prerank,cellular lipid catabolic process (GO:0044242),-0.34306146443799085,-0.9871330952114431,0.4894117647058824,0.7542097236108526,1.0,9/27,19.39%,PPARD;CYP1B1;ENPP2;LPIN3;MT3;AOAH;SIRT2;SMPDL3B;PLA2G15
prerank,digestive tract morphogenesis (GO:0048546),0.4382912181794775,0.9869210595561647,0.45936395759717313,0.9474153162466616,1.0,5/14,16.34%,FGFR2;NIPBL;GLI1;RBPMS2;PDGFRA
prerank,regulation of autophagosome assembly (GO:2000785),0.3744867249629472,0.9869019881354624,0.4833887043189369,0.946590362027378,1.0,8/33,11.12%,MTMR3;NUPR1;NPRL3;LRRK2;NPRL2;PIP4K2C;PIKFYVE;IFT88
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.40230375104873906,0.9867695718380542,0.48816029143898,0.9460562752584439,1.0,5/21,17.12%,IGF1;BMPR1A;FOXJ2;MFN2;MEF2D
prerank,regulation of cellular metabolic process (GO:0031323),0.35005338549157533,0.9860262581443155,0.4786729857819905,0.9471360701702504,1.0,20/45,25.11%,PPARA;PRKN;NCOR2;TBC1D16;ANGPTL8;RNF34;RNF41;AGPAT1;COQ7;BCO2;VPS35;MKLN1;LAMTOR1;ACLY;GNB3;ABCA2;PDK2;PM20D2;FOXM1;KIF16B
prerank,protein catabolic process (GO:0030163),0.3361432473754315,0.9856305813259636,0.4969230769230769,0.9473165963579078,1.0,13/59,13.10%,PRKN;NGLY1;LAMP2;NEU2;ADAMTS9;TPP1;CLPX;CLN6;MANBA;RIPK1;RNF41;MAGEC2;DDI1
prerank,Notch signaling pathway (GO:0007219),-0.29104692261624887,-0.9856165894271166,0.4879356568364611,0.7572411605205831,1.0,14/59,9.93%,SORBS2;MAML2;NOTCH3;YBX1;JAG1;NOTCH1;HES1;PSEN1;JAG2;HEYL;BMP2;WWC1;HEY2;PBX1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.41914307441457777,0.9853248317705565,0.481216457960644,0.9472654167033671,1.0,1/19,1.44%,IGF1
prerank,regulation of JUN kinase activity (GO:0043506),-0.33327532939167337,-0.9850501902317139,0.44254278728606355,0.7579113706954712,1.0,8/33,10.79%,MAP3K5;TNFRSF11A;DAB2IP;PAK1;RPS3;MAP3K7;AIDA;EDN1
prerank,regulation of telomere maintenance (GO:0032204),0.39606265141389946,0.9850256197863536,0.49312714776632305,0.9471949936992357,1.0,13/26,26.90%,HDAC8;SMG1;ATRX;RAD50;USP7;PML;TINF2;NBN;YLPM1;SMG6;PPP1R10;RTEL1;UPF1
prerank,regulation of cell adhesion (GO:0030155),0.30393193008653024,0.985014753614968,0.48751642575558474,0.9463589543220144,1.0,25/129,12.40%,ROCK2;PKP4;FBLN1;IL18;PLXNA2;EPHA4;RHOD;PKHD1;PPP1CB;C2CD4B;FUT1;DACT2;TPM1;ATM;EPHA8;IL12B;KNG1;TNFRSF18;HRG;HYAL1;ABL1;ITGAV;PTPN11;PRKCA;MIA3
prerank,skeletal muscle organ development (GO:0060538),0.39283462173876565,0.984967706765211,0.4791318864774624,0.9456156846214598,1.0,4/26,3.02%,IGSF8;CSRP3;LARGE1;CFLAR
prerank,embryonic hemopoiesis (GO:0035162),0.4551654294785831,0.9849515060138977,0.4816955684007707,0.9447931276979323,1.0,4/12,10.09%,KIT;KMT2A;TGFBR2;FLT3LG
prerank,motile cilium assembly (GO:0044458),0.4605603595667627,0.9846024992950019,0.448210922787194,0.9448600781613342,1.0,7/12,25.46%,E2F4;CCDC39;BBOF1;CCDC40;SPATA6;RSPH6A;BBS5
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4076199318900107,0.9843058726940185,0.46494464944649444,0.9448009137317743,1.0,3/20,5.59%,PPARGC1A;PRKAA2;ARRB1
prerank,positive regulation of telomere maintenance (GO:0032206),0.37932960079811345,0.9841656601909077,0.47603305785123967,0.9442899180390026,1.0,10/31,19.02%,ATM;ATRX;HNRNPA2B1;TNKS2;AURKB;RAD50;PNKP;PML;NBN;SLX4
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3213459212458927,0.9840714270733959,0.4782608695652174,0.9436925143466582,1.0,18/77,16.75%,IGF1;PRKN;CFLAR;PHIP;TGFBR1;DDX3X;OPA1;HTT;RIPK1;TCF7L2;SH3RF1;ITGAV;CSNK2A2;CSNK2A1;LGALS3;BIRC6;RB1;MCL1
prerank,intermediate filament organization (GO:0045109),-0.38105216669833614,-0.9839701266070168,0.48578199052132703,0.7598625413244958,1.0,6/17,25.87%,VIM;BFSP2;PKP2;NEFL;GFAP;DES
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3873383937580059,0.9839542544566395,0.45104895104895104,0.9431363330852445,1.0,6/23,12.74%,ERRFI1;SNX6;SH3BP5;MVP;SRCIN1;GPRC5A
prerank,response to amino acid (GO:0043200),-0.33222424990929256,-0.9838257510238683,0.4891566265060241,0.7594827573356254,1.0,9/31,15.27%,GLRB;GLRA3;SH3BP4;GLRA1;TMBIM6;CAPN2;SPAAR;GLRA2;GRIN1
prerank,placenta development (GO:0001890),-0.4150502106874733,-0.983819835090346,0.5170212765957447,0.7587635295106557,1.0,7/12,33.61%,PTK2;CUL7;SOD1;ADAM19;PLAC1;E2F8;PPARG
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.276530202115982,-0.983714035151663,0.5093167701863354,0.7582985364431338,1.0,30/75,24.71%,SLC8A1;PTPRJ;HEG1;RASIP1;LYN;DAB2IP;APOE;SORL1;IRAK3;UCHL1;DUSP1;BMP4;PRKAR1B;PRKAR2B;MYOCD;SPRY1;HHEX;APC;MEN1;SPRY4;PTPN1;PRKAR2A;AGT;PYCARD;LRP6;STK38;PAQR3;TFAP4;HYAL2;PKIG
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2715849629735276,0.9835395843821815,0.49327354260089684,0.9433579152008554,1.0,76/417,14.09%,BMP7;TFDP2;WNT4;ZIC2;FOXN3;ZNF423;JARID2;ZHX2;SNX6;FOXD1;ZNF568;DKK3;ARID4A;NR2F2;NCOR2;TSHZ3;GLI3;ZBTB38;NACC2;VGLL4;LOXL3;FOXP2;SFMBT1;CBFA2T2;HMGA1;LBH;ZNF318;TP53;BHLHE41;SMURF2;NIPBL;LDB1;FBXW11;BCOR;SMARCA4;NR1D2;BTRC;RBM15;SPEN;KAT6B;NRG1;SMARCC2;NIBAN2;SMARCE1;HDAC4;SCML4;SIRT1;TLE1;HDAC1;SOX13;CBY1;SPINDOC;CHMP1A;TCF7L2;ZNF219;PRDM5;SAP18;EIF4A2;BAHD1;WWP2;CBX5;ZNF148;UIMC1;BRD7;DEAF1;MLXIPL;IRF1;KAT7;KMT5A;SIN3A;PML;TLE2;BCL7A;NCOR1;CRYAB;PER2
prerank,RNA biosynthetic process (GO:0032774),0.3786717747475492,0.9833491948026964,0.4726962457337884,0.9429493707653893,1.0,10/31,16.15%,POLR2A;TTF2;TERT;TBP;TAF4;POLA2;BRF1;TAF7;TTF1;TAF13
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.44996639115726045,0.9833115963757898,0.4909090909090909,0.9422013172268573,1.0,5/15,15.45%,TNRC6A;TNRC6B;CPEB3;TNRC6C;TENT4B
prerank,lymphocyte proliferation (GO:0046651),-0.3561351654762202,-0.9832009716261317,0.4651685393258427,0.7587405172609245,1.0,3/22,10.86%,MEF2C;PTPRC;MSN
prerank,positive regulation of secretion by cell (GO:1903532),0.3293587228601016,0.9830752748842688,0.4716417910447761,0.9419527906836795,1.0,7/70,4.66%,BMP6;FRMD4A;IGF1;CLASP1;DTNBP1;MYO18A;EZR
prerank,positive regulation of vasculogenesis (GO:2001214),-0.44969127774868334,-0.9828646432479712,0.483739837398374,0.7587995395709214,1.0,5/10,8.90%,CD34;KDR;RAP1A;TMEM100;CEACAM1
prerank,response to estrogen (GO:0043627),-0.3281543427387503,-0.982332830415161,0.48687350835322196,0.7593871602209977,1.0,7/31,21.03%,CAV1;ESR1;AR;SERPINB9;NCOA4;ARID5A;SFRP1
prerank,stress granule assembly (GO:0034063),0.4020579946969199,0.982201718550976,0.4648648648648649,0.9433959332606172,1.0,8/20,17.14%,DDX3X;ATXN2;LSM14A;YTHDF3;DDX6;UBAP2L;ATXN2L;OGFOD1
prerank,UV-damage excision repair (GO:0070914),-0.4247655609865155,-0.9818249153369953,0.49372384937238495,0.7598706572649481,1.0,3/12,12.57%,POLA1;POLD3;ERCC1
prerank,positive regulation of DNA binding (GO:0043388),0.3749842172231387,0.9817645886033808,0.47540983606557374,0.9436900479649687,1.0,3/31,3.64%,IGF1;PRKN;FOXC1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3878300519743902,0.9817439067071924,0.4991181657848324,0.9428954691834809,1.0,2/26,1.44%,FHL2;IGF1
prerank,negative regulation of JNK cascade (GO:0046329),0.3844681331779383,0.9815147524911013,0.49491525423728816,0.9426541431178971,1.0,7/31,13.82%,SH3RF2;PRKN;GPS2;PTPN22;DUSP10;HIPK3;NCOR1
prerank,mitotic recombination (GO:0006312),0.43061374633812366,0.9812065001420196,0.4823529411764706,0.9426356853271499,1.0,7/15,19.85%,TPRKB;TEP1;MSH3;RAD50;NSMCE2;RAD51D;XRCC3
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.24719955571788962,-0.9810969492566559,0.48672566371681414,0.7609318501023261,1.0,53/173,25.59%,SPTBN1;ANK3;GRIA1;GAS6;VAMP4;CTSC;DYNC1I1;LMAN2L;DYNLL1;CUL3;GOPC;KDELR3;DYNC1LI2;NSF;COG5;DCTN4;CAPZA2;TMED1;PROS1;TMED5;CNIH1;ATL2;SPTB;TMED4;LMAN2;CAPZA1;TMED7;KLHL12;COPE;CTSZ;SPAST;SPTBN2;ATL3;BCAP31;TFG;SPTAN1;TMED9;IER3IP1;MCFD2;VAPA;BCAP29;TRAPPC2L;TMED10;COL7A1;SEC16B;TMED2;SAR1B;DCTN6;TRAPPC3;ACTR1A;RAB1B;ARFGAP2;COG1
prerank,post-translational protein modification (GO:0043687),0.27679326449745745,0.9806603010788695,0.509090909090909,0.943202678212876,1.0,50/332,14.34%,EPAS1;APLP2;ITIH2;ASB2;SERPIND1;CP;LAMC1;OBSL1;SPP1;SPSB1;IGFBP7;DCAF11;FBXL19;KLHL41;ATG5;SPSB4;DSCC1;LGALS1;FBN1;KNG1;FBXW11;RABGGTA;IGFBP3;BTRC;NUCB1;ASB15;FBXO22;LRRC41;RAB11B;DCAF10;RAB13;FBXL12;UBE2M;FBXW8;FBXO4;SOCS3;ASB14;CUL4A;CUL9;FBXO10;MIA3;NUB1;ASB5;MBTPS1;ASB12;DDB2;PRKCSH;FBXO11;SERPINC1;FBXL20
prerank,actin-myosin filament sliding (GO:0033275),0.36093091497160595,0.9799439409009316,0.4858490566037736,0.9433875752433711,1.0,5/38,13.06%,ACTN2;TPM1;MYL4;TNNI3;TNNC1
prerank,muscle filament sliding (GO:0030049),0.36093091497160595,0.9799439409009316,0.4858490566037736,0.9433875752433711,1.0,5/38,13.06%,ACTN2;TPM1;MYL4;TNNI3;TNNC1
prerank,proteolysis (GO:0006508),0.2792496001129823,0.9798462032872453,0.5,0.9427984818599848,1.0,41/252,15.78%,AEBP1;ACE;CPQ;BACE2;TRABD2B;SUFU;CASP3;DPP4;CPA4;SRGN;CTSH;DPP8;METAP2;ADAMTS9;TPP1;CLPX;TBL1X;MMP19;APH1B;NPEPPS;BMP1;MMP14;ADAM17;DESI1;DESI2;ATG4D;FOLH1;MBTPS1;ERAP1;PCSK7;OGT;SDE2;CAPN15;ATG4C;PITRM1;TMPRSS5;ADAMTS7;ZMPSTE24;PLAT;CELA3A;ANPEP
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.33187860810884595,0.9798285079599794,0.4798206278026906,0.9420105475135906,1.0,10/62,11.78%,POLR2A;CTR9;ELOF1;AFF4;CCNT2;POLR2D;ELL;GTF2F1;RTF1;NELFCD
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.38199077907515144,-0.9797138199295986,0.510250569476082,0.7635684802978062,1.0,11/19,35.38%,SLCO1C1;APP;KLF2;CHRNA7;PAX8;KLF4;MAPK8;HPN;MTPN;TMEM106A;GATA3
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.37765581479587296,-0.9795356721423342,0.47465437788018433,0.7633216135897203,1.0,2/20,2.36%,PDE4D;ADRA1B
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3663542647323713,0.9790567233542754,0.4698205546492659,0.9431626632909794,1.0,6/36,11.68%,TFDP2;PCGF2;MGA;TFDP1;RBBP8;CBX5
prerank,negative regulation of cellular process (GO:0048523),0.26693141837927387,0.9789170612166345,0.5361702127659574,0.9426553394846002,1.0,89/521,14.31%,TGFBR3;ALDH1A2;BMP7;SMAD3;APPL2;FBLN1;SYT11;GSDME;FGFBP1;CCN2;PTPN14;NPR1;PRKN;PLXNA2;PKHD1;KANK2;SRGAP2;COL18A1;NUPR1;COL4A3;ARID2;MAGI2;IGFBP7;SPEG;PDPN;IFIT3;SESN2;NACC2;VGLL4;SMAD6;TNS2;DACT2;CLMN;IFNK;DDX3X;CAPRIN2;SOD2;ATG5;HMGA1;TP53;EIF2AK2;UBR2;FER1L5;SSTR3;KNG1;DLG3;PTPRU;PLSCR1;PTEN;SMARCA4;IGFBP3;OSGIN2;HRG;NUPR2;NIBAN2;SULT2B1;HYAL1;SIRT1;GTPBP4;CHMP1A;MYBL1;SLURP1;BECN1;NOX4;NME6;RNF41;RARG;MNT;IMPACT;OSGIN1;GLMN;AXIN2;NMI;BRD7;MIA3;IRF1;FRK;PPP1R13B;IFI35;PODN;PIP4P2;MAP2K1;PML;CRYAB;DNAJB2;FLCN;TSC1;KAT2B;AGTR2
prerank,positive regulation of JNK cascade (GO:0046330),-0.27758429327258904,-0.9786787679760339,0.4796511627906977,0.7646263072685346,1.0,25/70,21.19%,MAP3K5;RASSF2;SH3RF3;PTK2B;DAB2IP;MINK1;TRAF5;APP;TNFRSF19;ANKRD6;MFHAS1;FLT4;TIRAP;AXIN1;GADD45G;MBIP;HIPK2;EDAR;NOD2;TRAF1;WNT16;GADD45B;CCL19;MAP3K11;PYCARD
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3172219904175492,-0.978197466899431,0.47959183673469385,0.7651389819450761,1.0,20/37,31.81%,POLD3;ERCC1;UBB;RPA1;GTF2H1;GTF2H4;GTF2H5;RFC4;ERCC2;POLD4;POLD1;RFC2;POLK;UBC;RPS27A;RFC5;DDB1;RPA3;ERCC3;RPA2
prerank,oogenesis (GO:0048477),-0.38937015180786155,-0.9780105360189612,0.5055928411633109,0.7648730699630744,1.0,6/15,26.22%,FMN2;PTN;METTL3;MEI4;MDK;NANOS3
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.2437786274594452,-0.9779878500782765,0.4975609756097561,0.7641822702530686,1.0,42/175,21.97%,PID1;ACTN4;TMSB4X;ST18;PTK2B;TNFRSF11B;NFKBIA;ARHGEF2;PSMB2;TNFRSF11A;DAB2IP;TRAF5;RPS3;CARD14;TNFRSF1B;TNFRSF21;PSMD14;ERBIN;PSMC6;GPER1;ILK;YBX3;IKBKB;AIM2;LIMS1;PSMA4;PSMB9;DHX9;EDAR;CCL13;MAP3K14;TRAF1;TNFRSF25;PSMD11;PSMB10;PSMD2;CCL19;HAS2;SFRP1;PYCARD;ASAH1;TXNDC17
prerank,retinal metabolic process (GO:0042574),0.4554928315921162,0.9779784874945481,0.4815533980582524,0.9442774423670012,1.0,1/12,1.07%,ABCA4
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3281571289578668,0.9779246806005238,0.47172619047619047,0.9435940271416577,1.0,10/64,11.78%,POLR2A;CTR9;ELOF1;AFF4;CCNT2;POLR2D;ELL;GTF2F1;RTF1;NELFCD
prerank,motor neuron axon guidance (GO:0008045),-0.39350547363649324,-0.9776542165742922,0.5010845986984815,0.7642466455027853,1.0,5/15,9.71%,SLIT2;TMEFF1;CHN1;NTN1;RHOH
prerank,positive regulation of cation channel activity (GO:2001259),0.3539490525404956,0.9774405087049667,0.46942148760330576,0.9440458170903654,1.0,3/40,1.93%,ACTN2;ANK2;LRRC38
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.34150224261197826,0.9772086759820776,0.4604651162790698,0.9438540396845613,1.0,14/48,16.41%,ELOF1;TAF1D;HMGA1;BAZ1B;ATAD2B;ZMIZ2;ZMIZ1;MYO1C;POLR1G;PHF2;TBP;KAT2B;SPHK2;ARID1B
prerank,myoblast fusion (GO:0007520),-0.4149735249338667,-0.9771885728936257,0.47912087912087914,0.764643487929708,1.0,5/12,6.96%,ADGRB3;CD9;ADAMTS5;PTGFRN;JAM2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3890932049456567,0.9771845856621577,0.5043782837127846,0.943075214344877,1.0,3/25,5.39%,KIT;LACC1;FZD5
prerank,negative regulation of cell death (GO:0060548),0.31763140292254394,0.9770418115223137,0.5,0.942603185135804,1.0,9/88,6.03%,BMP7;PPARGC1A;CCN2;PRKN;KANK2;SRGAP2;LRRK2;PM20D1;ATG5
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.2424527501784924,-0.9764407237193097,0.49504950495049505,0.7658051110708243,1.0,32/198,11.39%,PTPRB;PTPRD;PLCB4;INPP4B;PLA2G4A;PLCE1;PIP4K2A;STAT3;INPP5D;PLPP1;PLPPR1;GPI;PAK1;CALM1;PTPRC;PLCG2;LIMK2;EPHA7;ALPL;ENPP1;EPHB2;PPP3CA;TGFB1;ITPK1;PLCH1;TNFAIP8L3;PLPPR5;PLPPR4;GFPT2;DUSP3;LIMD1;PGM2L1
prerank,hexose metabolic process (GO:0019318),0.3608304883774252,0.9762581953133301,0.4916387959866221,0.9438132502921374,1.0,10/39,19.58%,SORD;CHST15;GALM;GALK2;GALK1;PGM1;BRAT1;FPGT;SLC37A4;GDPGP1
prerank,regulation of vasculature development (GO:1901342),-0.3507134570983046,-0.9759718434301851,0.47665847665847666,0.7662219045387183,1.0,15/26,33.71%,BMPER;TSPAN12;FGF2;ERBB2;CTNNB1;EMP2;PLXND1;SFRP1;HTATIP2;VASH1;NF1;HMOX1;VASH2;PROK2;RNH1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3452031160832703,0.9757406354568805,0.47480916030534354,0.9443320110740843,1.0,13/49,14.63%,KMT2A;TNRC6A;TNRC6B;RBM15;HDAC1;ASH2L;MOV10;KMT2C;RAB7B;KMT2D;SIN3A;KAT2B;TNRC6C
prerank,tRNA 5'-leader removal (GO:0001682),0.44389245976655,0.9756212169941629,0.48484848484848486,0.9438021046650427,1.0,5/13,20.86%,RPP21;RPP25L;PRORP;POP7;POP1
prerank,response to lipid (GO:0033993),-0.2601147379360445,-0.9753981181363804,0.49310344827586206,0.766974581006871,1.0,23/105,13.17%,ESR1;NOS3;ACER2;PPARD;STAT3;ANXA1;TNFRSF11A;FOXP1;ABCG1;GCH1;SOCS2;ALPL;FOXO1;TGFB1;IRAK3;STAT5B;SCD;ERBIN;RPS6KA3;TIRAP;CTNNB1;NOS1;SNCA
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.2714678002244363,-0.9750786144606015,0.5294117647058824,0.767032966362099,1.0,31/79,25.10%,SH3GL2;CTSD;MFSD6;DYNC1I1;DYNLL1;AP1S2;DYNC1LI2;AP2B1;KIF26A;DCTN4;CTSL;AP2M1;CAPZA2;CTSS;KIF3A;AP1S3;CAPZA1;CENPE;KIF15;CD74;SPTBN2;KIF11;AP1S1;KIF5A;KIF22;KIF4A;KIF3B;SAR1B;DCTN6;ACTR1A;KIF23
prerank,inner mitochondrial membrane organization (GO:0007007),0.3506834593973195,0.9748283633161428,0.5031645569620253,0.9450027739464353,1.0,14/47,20.02%,CHCHD3;SAMM50;OPA1;TMEM11;MICOS10;TOMM70;ATP5F1D;MICOS13;IMMT;ATP5F1C;TIMM10;MTX2;AFG3L2;DMAC2L
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3434014341731228,-0.9745761812051223,0.5086580086580087,0.7675138021492901,1.0,7/24,9.38%,RYR2;HTR2C;RYR3;PTPRC;PLCG2;HTR2A;FGF2
prerank,glucose metabolic process (GO:0006006),0.33703999208145435,0.9745423395605727,0.5201192250372578,0.9449339831229365,1.0,15/58,17.88%,PPARGC1A;SORD;PGAM2;GALM;GOT2;RBP4;SLC25A12;SLC25A11;PGM1;PER2;BRAT1;SLC25A10;GOT1;SLC37A4;CRY1
prerank,peptidyl-threonine modification (GO:0018210),0.3325953152003528,0.9744298891844664,0.49101796407185627,0.9443879318531828,1.0,17/66,13.77%,ROCK2;OXSR1;TGFBR1;LRRK2;CDC42BPG;TGFBR2;PDPK1;DYRK1A;PRKDC;GALNT11;CSNK2A2;CSNK2A1;PRKCA;HIPK3;WNK1;MAP2K1;CAD
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.31170103244746794,-0.9741872262988631,0.5065963060686016,0.7677916894143486,1.0,13/39,14.50%,PODXL;FXYD5;NEXMIF;JAG1;NOTCH1;MBP;BMP2;TGFB1;PTK2;RDX;CDH1;VEGFA;PPM1F
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.37180062203703723,0.9739523635631882,0.4816666666666667,0.9448239726948545,1.0,6/32,13.65%,DDX5;FHIT;TP53;SIRT1;PPP1R13B;PML
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.43517957197557156,0.9738739557337606,0.5151515151515151,0.9441634588124177,1.0,2/15,1.53%,KIT;WHRN
prerank,apoptotic DNA fragmentation (GO:0006309),0.4136861369393609,0.9736420475774511,0.4927797833935018,0.9439165768933465,1.0,6/16,24.41%,CASP3;DICER1;DFFB;DFFA;CECR2;H1-0
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.44638418200882757,0.9731988427307114,0.48314606741573035,0.9442831961312382,1.0,4/12,14.03%,PCGF5;RBM15;LRIF1;SMCHD1
prerank,regulation of response to external stimulus (GO:0032101),0.30213133923580915,0.97261769030287,0.49453551912568305,0.9449550085405913,1.0,28/121,16.97%,EFNB2;APPL2;NMT2;LACC1;METAP2;RNF135;F2;RHO;TKFC;PTPN22;SAMHD1;NR1D2;ADGRA2;HRG;CYRIB;NLRP6;FNTB;DHX58;FOXA2;IRF1;ERAP1;USP18;ZMPSTE24;BIRC3;PDGFRA;SAG;FNTA;CCR2
prerank,cellular defense response (GO:0006968),0.35752955997072416,0.9722680568798886,0.499194847020934,0.9450712106702663,1.0,6/40,11.92%,CCR9;DCDC2;VEZF1;BECN1;LY96;ZNF148
prerank,regulation of endocytosis (GO:0030100),0.3354945032877261,0.9721619495043131,0.5105421686746988,0.9444911892719446,1.0,5/61,3.71%,DAB2;SYT11;PICALM;SPHK1;STON1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2558592688283313,-0.9719865657680481,0.5480427046263345,0.7723910666938102,1.0,34/110,17.88%,GSN;TFRC;GSK3B;DAB2IP;APOE;RPS3;SH3GLB1;HSPA8;ULK1;SORL1;HSPA5;TGFB1;AIDA;RALB;HJURP;FNIP2;GNL3L;HSP90AA1;TIRAP;LCMT1;VEGFA;PINK1;NOP53;TAL1;ATF7IP;CDC42EP2;CLU;FBLIM1;IAPP;NAPB;TPPP;SVIP;SYK;STX1B
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.24253983033999849,-0.9717492706829589,0.5132743362831859,0.7722414333819911,1.0,34/172,14.41%,DGKH;DGKB;PIP5K1B;PIK3R1;INPP4B;PLA2G4A;PIP4K2A;PIK3C2B;INPP5D;CEPT1;BMX;PLCG2;PLEKHA1;PIK3R6;SLC44A5;MTMR6;SLC44A2;LPCAT2;MTMR2;FGF2;PLA2G12A;MTMR7;MFSD2A;MTMR9;ETNK1;SLC44A1;DGKG;DGKZ;PLEKHA3;PITPNM3;LPIN3;PNPLA3;CDS1;ABHD4
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.38756964505016134,-0.9714132419375656,0.5190156599552572,0.772328622304992,1.0,9/15,31.27%,TSEN34;FAM98B;TSEN54;RTCB;ERN1;CPSF4;TSEN15;CLP1;CPSF1
prerank,GPI anchor metabolic process (GO:0006505),0.39018716775482526,0.9711615055352891,0.5302013422818792,0.9462248608236307,1.0,3/26,6.37%,PIGN;PIGW;PIGQ
prerank,global genome nucleotide-excision repair (GO:0070911),-0.33933001035202043,-0.9707962826230715,0.5093457943925234,0.7730985536185553,1.0,12/26,30.10%,RAD23B;ERCC1;UBB;CETN2;GTF2H1;GTF2H4;GTF2H5;ERCC2;UBC;RPS27A;DDB1;ERCC3
prerank,cognition (GO:0050890),-0.3050649286313924,-0.9704725054515325,0.5248041775456919,0.7731627573252667,1.0,11/42,11.73%,GRM5;ST3GAL4;SHROOM4;DOP1B;APP;PTCHD1;STRA6;SLC1A4;GPR155;MFSD2A;FAM107A
prerank,regulation of nervous system process (GO:0031644),0.4123574806160105,0.9703854188212208,0.47491039426523296,0.9473873249198264,1.0,3/18,4.87%,ROCK2;SLC8A3;DLGAP4
prerank,central nervous system myelination (GO:0022010),-0.4179288967141145,-0.9700225871198499,0.5185185185185185,0.773509680004937,1.0,3/11,6.91%,PLP1;TENM4;B4GALT5
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3744079900519742,-0.9693918091812956,0.5270588235294118,0.7743641790969835,1.0,6/18,10.86%,APOE;CTSC;DACT1;RDX;HSP90AA1;MSN
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.38449869363551004,0.9691233887540557,0.4931740614334471,0.9498163498436483,1.0,6/25,12.71%,LDB1;RNF8;LARP7;ELL;NELFCD;WDR43
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.374298824482231,-0.9689824084479429,0.48444444444444446,0.774657439566444,1.0,9/18,30.83%,APOE;ABCG1;PSEN1;TMCC2;APH1A;LDLRAP1;ADAM19;BACE1;ACHE
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.35895321709817224,0.968926216133815,0.48333333333333334,0.9495089379237525,1.0,8/31,17.50%,DLG1;KANK2;PTEN;RBL2;RBL1;BRD7;RB1;GPNMB
prerank,eye photoreceptor cell development (GO:0042462),-0.38121163426244414,-0.9687864243332492,0.5238095238095238,0.7744059989392134,1.0,3/15,13.77%,RORB;RP1;VEGFA
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4241792049712959,0.9686762198555156,0.5091575091575091,0.9493233133858862,1.0,7/17,23.34%,CTR9;CPEB3;VIRMA;RNF20;CPSF7;ZC3H3;NUDT21
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.3148939008452421,0.9686254954334365,0.5197080291970803,0.9486273625590083,1.0,26/80,20.47%,SNX6;SNX32;DENND2A;VPS54;DENND5A;PIKFYVE;RAB7B;VPS50;CLTC;RGP1;SNX12;SNX8;VTI1A;STX5;SGSM2;RAB29;VPS51;HEATR5B;RAB9A;PHETA1;VPS35;TBC1D14;EVI5;TMEM87B;STX16;ANKFY1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4175737669253919,0.9684309204895961,0.4934579439252336,0.9482814504359349,1.0,5/16,22.10%,NUPR1;AK4;MLXIPL;ATP7A;PPIF
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.42482839608955403,0.968422614618728,0.48250460405156537,0.94747257244931,1.0,4/14,9.78%,KIT;GPRC5B;SIRT1;MAVS
prerank,establishment of melanosome localization (GO:0032401),0.4024771927841657,0.9683651847642778,0.4824399260628466,0.9467934835292767,1.0,6/19,15.83%,SHROOM2;BLOC1S6;RAB11B;MKKS;ARL6;BBS2
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.30170915940358534,-0.9682531397520543,0.5090439276485789,0.7749734716540194,1.0,8/46,14.41%,DGKH;DGKB;PLA2G4A;PLA2G12A;DGKG;DGKZ;PNPLA3;ABHD4
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3946320152117285,0.9682483338880852,0.4697508896797153,0.9462740243248404,1.0,2/24,6.89%,LPGAT1;SLC27A1
prerank,vitamin transport (GO:0051180),0.37542124395142223,0.968244931418867,0.49444444444444446,0.94545811987847,1.0,8/29,12.25%,PDPN;SLC35F3;SLC19A1;SLC27A1;TCN2;SLC19A2;GC;TCN1
prerank,catecholamine biosynthetic process (GO:0042423),0.45322683488138743,0.9679615249394513,0.4811320754716981,0.9453558181924667,1.0,1/11,1.04%,MOXD1
prerank,polyamine metabolic process (GO:0006595),0.4444849513686517,0.9678232352381403,0.4962962962962963,0.9448899693656726,1.0,3/13,8.05%,SMOX;SAT1;PAOX
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.24231475759509616,-0.9675560628434687,0.5721649484536082,0.7759775572322442,1.0,49/158,21.48%,ROR1;ATP2C1;MID2;NOD1;TFRC;TNFSF10;ALPK1;PLK2;TRAF5;FLNA;MAP3K7;TNFRSF19;ECM1;SLC44A2;SHISA5;NDFIP2;S100B;PLEKHG5;TRIM14;FKBP1A;TRIM27;REL;TIRAP;IKBKB;PRKD1;RBCK1;CARD16;PINK1;TERF2IP;PPM1A;MTDH;TMED4;EDAR;PELI1;PIM2;NOD2;CD74;TMEM101;MAP3K14;GPR89A;TIFA;TFG;ECT2;CCL19;NEK6;TRIM68;LGALS9;EEF1D;VAPA
prerank,inositol phosphate metabolic process (GO:0043647),0.34624412537552823,0.9671344118065061,0.47572815533980584,0.9458827433179626,1.0,9/46,11.18%,ISYNA1;NUDT4;INPPL1;PLCD3;PTEN;ITPKB;PLCD1;PPIP5K2;OCRL
prerank,histone H4 deacetylation (GO:0070933),0.44961621420220166,0.9668407462430378,0.4676524953789279,0.9458237437370416,1.0,3/10,9.56%,HDAC8;HDAC4;HDAC1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3200836878577267,-0.9663116035349276,0.5037593984962406,0.778320383136942,1.0,9/32,10.81%,PIK3R1;PLCE1;CARMIL1;ARHGEF7;ACTR2;OCLN;CORO1C;ACTR3;ENPP2
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.4735111334349061,0.9662741838119288,0.5122873345935728,0.9464904038523261,1.0,3/10,11.05%,BMP7;PHACTR4;ARHGAP12
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.34643820596395364,0.9660481786102296,0.4922360248447205,0.9462651629479959,1.0,9/46,9.99%,SMAD3;NEDD4;RAPGEF3;CAMK1;TP53;ZIC1;UBR5;MAVS;TCF7L2
prerank,mRNA modification (GO:0016556),-0.35449796238739106,-0.9660218582003477,0.5046948356807511,0.7783245890194339,1.0,13/22,37.75%,TRMT61B;METTL3;TRMT6;PUS1;PUS7;TRUB1;DKC1;ZC3H13;CBLL1;TRMT10C;RPUSD2;TRUB2;TRMT61A
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.28117093360501055,0.9656651308611857,0.5388409371146733,0.9464232758071455,1.0,17/214,6.37%,NOTCH2;TGFBR3;DUSP29;FBLN1;TIMP3;PRKCZ;CCN2;DLG1;FGFR2;SLC30A10;PKHD1;NPNT;EZR;TLR4;ARRB1;BRAF;PDGFRB
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3901132102344974,0.9656262401373071,0.4919210053859964,0.9448961534034849,1.0,4/23,9.41%,TFDP2;BID;TP53;TFDP1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3901132102344974,0.9656262401373071,0.4919210053859964,0.9448961534034849,1.0,4/23,9.41%,TFDP2;BID;TP53;TFDP1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.35784768011683954,0.9654730604981041,0.5216049382716049,0.9444820814599156,1.0,4/41,7.24%,BMP7;AFDN;PTPN23;PTPRU
prerank,positive regulation of RNA metabolic process (GO:0051254),0.35256377475106987,0.9654591045931407,0.5317829457364341,0.9437028454927661,1.0,14/45,19.71%,DDX5;POLR2A;TP53;ZC3H18;RIOK2;RIPK1;DYRK1A;WDR43;MAP2K1;MAP2K2;NFKB1;GRSF1;BUD23;DXO
prerank,chromatin remodeling (GO:0006338),0.3040393047006159,0.965326018649942,0.5020689655172413,0.9432067931016909,1.0,32/100,21.66%,JARID2;CHD4;ATRX;BAZ1B;SMARCD3;SMARCA4;SRCAP;SMARCC2;SMARCE1;HDAC4;SIRT1;HDAC1;BAHD1;BAZ1A;ZBTB1;HNRNPC;KAT2B;MTA2;RB1;ARID1B;KDM6B;PADI4;SATB2;EZH1;CHD8;MPND;TAF6L;CECR2;KDM6A;SMARCD2;MBD2;RUVBL1
prerank,regulation of cell motility (GO:2000145),0.3004768291402148,0.9651673768516018,0.5145228215767634,0.9428250623878734,1.0,17/121,10.63%,FGF1;ROCK2;FBLN1;KIF2A;PLXNA2;LMO4;ARHGAP18;MGAT3;TBCCD1;LDB2;LDB1;NRG1;DIAPH1;AMOTL2;HBEGF;CYRIB;ABL1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.36932980848714225,-0.965105978421851,0.5138248847926268,0.7797958496062786,1.0,10/20,13.58%,ENG;TGFB2;TBX3;ACVRL1;NOTCH1;HEYL;BMP2;HEY2;BMP4;SPRY1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.27349750065691614,-0.9648978300809135,0.5558823529411765,0.7795469499343537,1.0,12/70,14.41%,PLA2G4A;MBOAT1;CEPT1;SLC44A5;SLC44A2;LPCAT2;PLA2G12A;ENPP2;MFSD2A;SLC44A1;LPIN3;ABHD4
prerank,protein glycosylation (GO:0006486),-0.24998850344442414,-0.9645765200565497,0.5843137254901961,0.779587617083538,1.0,29/125,17.47%,MGAT4C;ST3GAL4;ST8SIA4;GCNT2;EOGT;FUT9;MGAT4A;ST3GAL1;ST8SIA1;FKTN;GALNT7;B4GALT5;AQP11;B3GALT1;ST3GAL6;MGAT5;ST8SIA6;B3GALNT1;GFPT2;DAD1;B3GALT5;GAL3ST1;NUS1;RPN1;GALNT2;MGAT5B;GALNT10;ALG6;TUSC3
prerank,positive regulation of protein modification process (GO:0031401),0.2824312621012719,0.964417618085709,0.5323383084577115,0.9438913117691131,1.0,32/203,11.94%,DAB2;FGF1;ROCK2;ACE;LEPR;FAM20A;FNIP1;TRABD2B;LRRK2;ITLN1;RAPGEF3;ATG10;F2;DDX3X;ARRB1;CAMK1;FBH1;CCND3;CDH5;SIRT1;RIPK1;MAVS;CRKL;PIK3R3;ATG7;IRGM;ABL1;DYRK1A;ADAM17;AXIN2;VEGFD;RALBP1
prerank,antibacterial humoral response (GO:0019731),0.42422595711020433,0.9641742524062024,0.5247148288973384,0.9437022940529166,1.0,4/16,16.61%,DEFB1;PLA2G6;CAMP;DMBT1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.28702807513167894,-0.9640221580361455,0.5167597765363129,0.7801712472660288,1.0,8/55,6.42%,VCAM1;NCK2;TFRC;IL6ST;SLC7A1;ANXA1;PTPRC;RPS3
prerank,positive regulation of interleukin-10 production (GO:0032733),0.379212902956052,0.9639510100454212,0.48845470692717585,0.9434731225634929,1.0,5/30,10.08%,PRKCZ;TLR4;CD28;IL12B;CD274
prerank,regulation of inflammatory response (GO:0050727),0.2824531806153458,0.963533555624563,0.5371287128712872,0.9437585585352034,1.0,21/190,9.73%,RORA;C1QTNF3;PPARA;IL18;LACC1;NAPEPLD;SPHK1;SNX6;METRNL;TLR3;TLR4;GPS2;IL12B;DAGLA;ENPP3;SERPINE1;NR1D2;GPRC5B;CDH5;IL17RA;RIPK1
prerank,regulation of tissue remodeling (GO:0034103),0.4213284062613841,0.9634595779926621,0.48677248677248675,0.9431429589287846,1.0,3/18,6.47%,LEPR;IL18;IL12B
prerank,pre-replicative complex assembly (GO:0036388),-0.28204752689927803,-0.9634539102691964,0.5292307692307693,0.7808437132887696,1.0,25/64,34.29%,PSMB2;PSMD14;PSMC6;UBB;PSMA4;PSMB9;ORC5;ORC2;PSMD11;PSMB10;PSMD2;PSMA2;UBC;RPS27A;PSMB3;MCM6;PSMB5;PSMA7;PSMF1;PSMD7;MCM4;MCM8;PSMA5;PSMD4;PSME4
prerank,cellular response to metal ion (GO:0071248),0.2967214205086706,0.9633762214505232,0.53077975376197,0.9425473656248196,1.0,8/123,1.98%,BMP6;SLC41A1;SYT9;SYT11;SYT12;PRKAA2;PRKN;ADCY1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3942462346777844,-0.9633128630459673,0.5183585313174947,0.7804693784893851,1.0,5/13,17.51%,MDFIC;APOD;UFM1;CABP1;BARD1
prerank,regulation of RNA splicing (GO:0043484),-0.2709962143255187,-0.9631672579323988,0.5189873417721519,0.7800592469744998,1.0,14/69,13.20%,QKI;MBNL1;AHNAK;PIK3R1;KHDRBS2;AHNAK2;HNRNPLL;SRRM4;TMBIM6;PRX;HNRNPK;RBM20;ZNF326;AFF2
prerank,purine nucleotide catabolic process (GO:0006195),-0.3992489285569655,-0.9627454969229601,0.5310492505353319,0.7803663039369118,1.0,6/13,16.14%,XDH;HINT1;GDA;NT5E;NT5C1A;GPX1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.46626118409158157,0.9625528436117128,0.5096899224806202,0.9437689118710939,1.0,2/10,11.12%,WHRN;IFT88
prerank,monoacylglycerol metabolic process (GO:0046462),-0.39449467519291687,-0.9624551685434002,0.5031185031185031,0.7803862894094828,1.0,2/13,4.65%,PLA2G4A;MGLL
prerank,iron ion homeostasis (GO:0055072),0.33127170441863385,0.9624401657366203,0.5263157894736842,0.9432593482681876,1.0,3/58,1.42%,BMP6;CP;PICALM
prerank,organelle organization (GO:0006996),0.26723404128219247,0.9623877578019024,0.5745164960182025,0.9425797095827699,1.0,90/388,17.30%,FAM174B;SYNE3;PPARGC1A;DYM;MICAL3;SH3D19;PRKN;OBSL1;FGD4;GABPB1;CAPZB;PHIP;PYROXD2;SEC31B;CLASP1;LRRK2;PEX11A;MYO18A;AFG1L;TPM1;RAB34;ATL1;ESRRA;SIRT5;BCAS3;CLUH;NIPSNAP2;OPA1;HUWE1;CNTNAP1;PEX11B;MTFR2;TWNK;TERT;SIRT3;HTT;TMEM11;DIAPH1;DNM1L;TRAPPC12;GOLPH3L;CSNK1A1;SSBP1;WASL;CATIP;ADCK1;PIKFYVE;CHMP1A;RAB43;CXADR;YTHDF3;AJUBA;FBXW8;ZFYVE16;FGD1;CDC42;PEX10;BRWD3;MIA3;TTC17;SIRT4;ROPN1;TRAPPC11;PRKCI;ZMYM6;PLEKHF1;WDPCP;TANGO2;CFAP410;ARHGAP21;SEC23IP;RAB29;PEX14;WTIP;ZMYM4;VPS51;PEX19;SLC25A36;MICAL1;GOLGA5;GOLGA8B;VPS4A;RAB30;PI4K2B;CHMP4C;MSTO1;OPTN;PEX16;MTX2;COG4
prerank,positive regulation of angiogenesis (GO:0045766),0.3073863314718397,0.9623380542402307,0.5355704697986577,0.9419012316807603,1.0,18/108,9.93%,FGF1;ADAM12;SMOC2;SASH1;HK2;SPHK1;FUT1;RAPGEF3;PRKCB;CTSH;FLT1;SERPINE1;PDPK1;CDH5;HYAL1;SIRT1;STIM1;FOXC2
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.3952594840444134,-0.962042624334418,0.5304347826086957,0.7806737813492107,1.0,4/15,18.79%,ANXA1;GPER1;FAM107A;BCL2L11
prerank,regulation of G0 to G1 transition (GO:0070316),0.3570404754472621,0.9616499285549538,0.5032679738562091,0.942813130825503,1.0,6/38,11.68%,TFDP2;PCGF2;MGA;TFDP1;RBBP8;CBX5
prerank,hexose transmembrane transport (GO:0008645),0.3985694343636463,0.9614594825211971,0.5167785234899329,0.942480727383847,1.0,3/21,9.53%,SLC2A12;SLC5A3;SLC45A3
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.4357982998838922,0.960419958834114,0.5181159420289855,0.9442718839104774,1.0,5/15,20.60%,GLI3;IL12B;CCR2;IHH;CD55
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.31394781215702067,0.9598981771220099,0.531437125748503,0.944786624838661,1.0,16/84,11.38%,CELF2;DDX5;SON;MBNL2;TIA1;RBM15;RBM39;JMJD6;NOVA1;LARP7;THRAP3;SRPK2;SAP18;SFSWAP;NUP98;HNRNPL
prerank,striated muscle cell development (GO:0055002),0.42533368978039554,0.9597623643572191,0.5055350553505535,0.9443315593986444,1.0,3/14,5.54%,TMOD2;TMOD3;KLHL41
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.35560590928628877,0.9596887670357274,0.5129449838187702,0.943695083234158,1.0,4/36,5.93%,AFDN;VAMP5;RILPL1;RAB34
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.27979483325275806,-0.9593130107353378,0.5205479452054794,0.7865120191564534,1.0,20/57,18.81%,MAP3K5;GRIN2B;NOD1;TNFSF10;CTSD;GRIN2A;PERP;GRAMD4;GPER1;SOX7;DAPK1;AIM2;PPM1F;USP50;GRIN1;SYK;HTRA2;CYCS;FOXL2;BCAP31
prerank,inorganic anion transport (GO:0015698),0.34081842165737336,0.9592111864459351,0.5092307692307693,0.9441192126675065,1.0,7/53,9.20%,SLC13A4;SLC5A5;CLCN2;ENPP3;ANO6;SLC26A1;NMUR1
prerank,sphingosine metabolic process (GO:0006670),-0.3861652068539535,-0.9591354956431044,0.5255813953488372,0.7862091196869384,1.0,4/17,5.65%,ACER3;ACER2;PLPP1;SPTLC2
prerank,mRNA processing (GO:0006397),0.27489801680772225,0.9589363527322554,0.5589988081048868,0.9439937354786612,1.0,79/287,23.46%,SRRM2;DDX5;PPARGC1A;POLR2A;SON;SNRNP70;PCBP2;PABPN1;HNRNPR;HNRNPH1;SRSF5;POLDIP3;SNIP1;HNRNPA2B1;RPRD2;POLR2D;RBM15;SPEN;NOVA1;GPKOW;CCAR1;CWC27;TBRG4;GTF2F1;PRPF18;HNRNPL;CWC15;IK;USP49;PHF5A;SRSF11;CMTR2;PRCC;RAMAC;HNRNPC;SCAF11;PRPF3;SARNP;SNRNP40;RBM4;TFIP11;HNRNPM;CPSF3;CWF19L1;FRG1;USP39;ALKBH5;ZCRB1;PRPF6;FUS;SRSF1;CSTF1;HNRNPH3;CDC40;PCF11;SRSF10;U2AF1;EFTUD2;SNRPC;SRSF7;SF1;PNN;POLR2G;WBP4;PRPF31;SNRPA1;U2AF2;SF3B2;SF3B1;PPWD1;SF3B5;CPSF7;GCFC2;PQBP1;CDC5L;RNPC3;NUDT21;POLR2F;CMTR1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.3876615052135461,0.9588968727335277,0.5156794425087108,0.943300491576204,1.0,4/22,13.22%,BMP7;MAP2K5;FLOT2;WNK1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.26188899147842853,0.9584719986112529,0.5740740740740741,0.9435553380303852,1.0,92/497,14.62%,BMP7;TFDP2;WNT4;ZIC2;FOXN3;ZNF423;JARID2;ZHX2;SNX6;FOXD1;ZNF568;DKK3;ARID4A;NR2F2;NCOR2;TSHZ3;GLI3;ZBTB38;NACC2;VGLL4;LOXL3;FOXP2;IGF2BP1;DDX3X;SFMBT1;CBFA2T2;HMGA1;LBH;ZNF318;TP53;EIF2AK2;BHLHE41;SMURF2;NIPBL;LDB1;FBXW11;BCOR;SAMD4A;SMARCA4;NR1D2;BTRC;RBM15;SPEN;LARP1;CPEB3;KAT6B;NRG1;IGF2BP2;CNOT10;SMARCC2;PDS5A;NIBAN2;SMARCE1;HDAC4;SCML4;SIRT1;TLE1;HDAC1;SOX13;CBY1;GTPBP4;SPINDOC;CHMP1A;TCF7L2;ZNF219;LSM14A;PRDM5;SAP18;BAHD1;WWP2;CBX5;WAPL;ZNF148;UIMC1;DDX6;BRD7;DEAF1;MLXIPL;IRF1;KAT7;CDAN1;KMT5A;SIN3A;PML;TLE2;BCL7A;NCOR1;CRYAB;PER2;TSC1;ZKSCAN3;HOXA7
prerank,calcium import into the mitochondrion (GO:0036444),0.46361748408638803,0.9581070775533551,0.5102040816326531,0.9436340345331573,1.0,3/10,6.75%,MCU;SLC25A23;MICU1
prerank,regulation of gene silencing by RNA (GO:0060966),0.34390972112895885,0.9578833329293898,0.5100775193798449,0.9426093672150239,1.0,26/50,30.67%,POLR2A;TNRC6A;POLR2D;NUP42;NUP98;NUP43;NUP155;EIF4G1;NUP188;POLR2G;FMR1;NUP153;AGO1;POLR2F;AAAS;NUP88;AGO2;PUM2;SEC13;POLR2K;IPO8;NUP160;RANBP2;NUP37;RAE1;NUP133
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.34390972112895885,0.9578833329293898,0.5100775193798449,0.9426093672150239,1.0,26/50,30.67%,POLR2A;TNRC6A;POLR2D;NUP42;NUP98;NUP43;NUP155;EIF4G1;NUP188;POLR2G;FMR1;NUP153;AGO1;POLR2F;AAAS;NUP88;AGO2;PUM2;SEC13;POLR2K;IPO8;NUP160;RANBP2;NUP37;RAE1;NUP133
prerank,lymphocyte differentiation (GO:0030098),-0.2717598411301933,-0.9575229168226701,0.5612535612535613,0.7893977225480562,1.0,14/68,10.15%,PTPRJ;TPD52;VCAM1;TOX;HDAC9;PTPRC;PLCG2;ITGB1;ITGA4;IKZF1;JAG2;RHOH;PBX1;LFNG
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.35160771809003893,0.9573776988325551,0.5023328149300156,0.9430530052405275,1.0,9/38,14.28%,PPARA;PKHD1;MAGI2;DAG1;PTEN;SIRT1;PHLPP2;FLCN;THEM4
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.37133529201848764,0.9572947902024318,0.5160714285714286,0.9424840554763904,1.0,7/30,12.65%,PRKCZ;CD300A;PARP14;SH3BP5;MVP;SOCS3;SRCIN1
prerank,cristae formation (GO:0042407),0.3844296003896196,0.9572135011325363,0.5197255574614065,0.941891761769417,1.0,10/27,23.87%,CHCHD3;SAMM50;ATP5F1D;MICOS13;IMMT;ATP5F1C;AFG3L2;DMAC2L;LETM1;CHCHD6
prerank,response to alcohol (GO:0097305),0.38159019862512283,0.9571247750186991,0.5070671378091873,0.9413296037350224,1.0,4/27,7.36%,TGFBR3;TGFBR1;TGFBR2;GOT2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.46629642476566496,0.9571200023420343,0.5209580838323353,0.9405476098411072,1.0,1/10,1.98%,PRKN
prerank,small GTPase mediated signal transduction (GO:0007264),0.30628087443227675,0.956795778436515,0.5339805825242718,0.9406105278332959,1.0,10/103,5.01%,RAPGEF5;KSR1;IGF1;RIN2;ARHGEF18;ARHGAP18;CCNA2;RGL1;ADRA2A;RREB1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.39586182433568906,0.9567567669102895,0.5099457504520796,0.9399265273318231,1.0,7/21,20.92%,OSBPL8;PLA1A;OSBPL10;PLA2G5;MBOAT2;LPCAT4;PLAAT3
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3178091848222982,0.9567353691414597,0.5215453194650818,0.9391815595131003,1.0,19/70,18.82%,SMAD3;CASP3;BID;IFI27;TLR3;DDX3X;CD27;PDPK1;RIPK1;RNF41;ITGAV;BLOC1S2;MLLT11;DEDD;ACVR1B;MCL1;TNFRSF1A;G0S2;DELE1
prerank,regulation of interleukin-17 production (GO:0032660),0.3696989706264291,0.9564617929415544,0.5090016366612111,0.9391189205011435,1.0,4/31,6.47%,IL18;SPHK1;TLR4;IL12B
prerank,cellular response to chemokine (GO:1990869),-0.2941177756168312,-0.9563766274918174,0.5093833780160858,0.7914906866606234,1.0,7/46,10.82%,LRCH1;CXCL12;PTK2B;SLC12A2;ACKR3;DOCK8;DUSP1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.4179216803086835,-0.9563505837608671,0.5163265306122449,0.7908286169785421,1.0,3/11,10.92%,SCARB1;LDLR;MFSD2A
prerank,axonal transport (GO:0098930),-0.31447182962851156,-0.955965887969408,0.5397590361445783,0.7910500664098343,1.0,17/36,26.88%,SYBU;DST;TMEM108;AP3S1;MAPT;HIF1A;KIF3A;AP3S2;SPAST;AP3B2;SOD1;KIF4A;NEFL;HAP1;KIF3B;AP3D1;KIF1A
prerank,B cell differentiation (GO:0030183),-0.29795271480941765,-0.9557806980173493,0.5013404825737265,0.7907570741590657,1.0,8/46,7.59%,PTPRJ;TPD52;VCAM1;HDAC9;PTPRC;PLCG2;ITGB1;ITGA4
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.2952483563989244,-0.9555235788750198,0.5322128851540616,0.7906198621645462,1.0,9/47,8.46%,SPOCK2;SERPINE2;SPOCK3;SERPINI1;SERPINF1;TIMP2;SORL1;BIN1;SPOCK1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.33083072087160426,-0.9554897950758365,0.5394456289978679,0.7899785998482282,1.0,7/26,9.38%,RYR2;HTR2C;RYR3;PTPRC;PLCG2;HTR2A;FGF2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.32315927424915447,-0.9554037764430348,0.5558312655086849,0.7894466948938412,1.0,8/33,8.32%,TEK;SEMA5A;NDNF;GAS6;KDR;RAMP2;ICAM1;GATA2
prerank,hyaluronan metabolic process (GO:0030212),-0.3433905061674585,-0.9552307680150888,0.5407407407407407,0.7891348403851923,1.0,5/23,9.92%,CEMIP;TGFB1;HEXB;FGF2;CD44
prerank,negative regulation of immune system process (GO:0002683),-0.3822429708443126,-0.9546336827356834,0.5248508946322068,0.7898313269098965,1.0,3/16,11.24%,CD200;LYN;GPER1
prerank,regulation of cytokine production (GO:0001817),0.2932982442454561,0.9544119299408955,0.540650406504065,0.9434599673474056,1.0,12/126,6.84%,C1QTNF3;LGR4;SYT11;ADRA2A;SRGN;IGF2BP1;TRIM56;CD28;IL12B;EIF2AK2;TWSG1;AFAP1L2
prerank,mitotic cytokinesis (GO:0000281),-0.3004737327522985,-0.9536481369303538,0.5266106442577031,0.791501300412224,1.0,21/47,25.10%,SPTBN1;ANK3;CIT;RHOB;ANLN;PDCD6IP;RASA1;TRIM36;STMN1;USP8;APC;NUSAP1;CHMP4B;EFHC2;SPAST;ECT2;CUL7;RHOC;KIF4A;CENPA;KIF23
prerank,zymogen activation (GO:0031638),0.34423321558573,0.9529405203374772,0.5173553719008265,0.9464129475601284,1.0,7/39,15.66%,KLK2;F11;CTSH;RIPK2;MMP14;ASPH;PLAT
prerank,folic acid-containing compound metabolic process (GO:0006760),0.394409210363614,0.9528779859650732,0.5357142857142857,0.9457808223981653,1.0,6/19,19.24%,SLC19A1;MTHFR;ALDH1L1;MTRR;MTHFD1;FOLR2
prerank,cardiac atrium morphogenesis (GO:0003209),0.4203639573015606,0.9528387810969178,0.5285451197053407,0.9451023576396811,1.0,1/16,0.19%,NOTCH2
prerank,neuron apoptotic process (GO:0051402),-0.3534101826542627,-0.9528338848976956,0.5121951219512195,0.7927322432249064,1.0,10/19,26.12%,CIT;SCN2A;APP;TNFRSF21;FAS;TRPC5;DIABLO;BNIP3;ERBB3;GAPDH
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.35135970004929784,0.9528138053048717,0.5176282051282052,0.944367234906487,1.0,8/43,9.87%,SORBS1;PRKCZ;PRKCB;TNS2;GKAP1;PIP4K2C;SIRT1;GRB10
prerank,lipid catabolic process (GO:0016042),0.4128002199141533,0.9527312473940501,0.5164835164835165,0.9437993479090904,1.0,3/18,7.25%,CEL;PLA1A;PNLIP
prerank,relaxation of muscle (GO:0090075),0.4306721560781494,0.9526434274071243,0.5272045028142589,0.9432364139399775,1.0,1/13,0.08%,ATP1A2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.44482245296318507,0.9526390288604627,0.5110294117647058,0.9424646490023219,1.0,2/12,6.47%,IL18;IL12B
prerank,telomere capping (GO:0016233),0.41795940714936364,0.9521350609821624,0.5054545454545455,0.9429549314729696,1.0,6/16,18.62%,ACD;PRKDC;RAD50;TFIP11;TINF2;NBN
prerank,pyruvate metabolic process (GO:0006090),0.34058815437029233,0.9519571846844876,0.5268987341772152,0.9426187098457485,1.0,7/52,8.99%,ME2;HK2;LDHB;PGAM2;GCK;SRR;DLD
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3020099115587152,0.9517789567688368,0.5508474576271186,0.9422926305001919,1.0,8/108,6.11%,UACA;ROBO1;SMAD3;COL4A3;CFLAR;BID;DDX3X;FAM162A
prerank,nuclear membrane disassembly (GO:0051081),0.4297874067360729,0.9511727711768967,0.533213644524237,0.9430076648745911,1.0,3/14,12.33%,PRKCB;CCNB2;PRKCA
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.29967728728253723,-0.9509277338882853,0.5218508997429306,0.7967392002453643,1.0,7/39,7.12%,UTRN;FGF12;CHRM3;FXYD5;NEDD4L;YWHAE;TRPC6
prerank,relaxation of cardiac muscle (GO:0055119),0.4269519537217047,0.9508501676581046,0.5100917431192661,0.9430469778795273,1.0,1/13,0.08%,ATP1A2
prerank,cellular response to glucagon stimulus (GO:0071377),0.4134045192914157,0.9507783812429532,0.5313653136531366,0.9424385388934186,1.0,5/17,13.48%,ADCY5;ADCY1;ADCY9;PRKAR1A;ADCY6
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4433670559181361,0.9507316121838711,0.515370705244123,0.9418056351509517,1.0,4/13,14.63%,TNRC6A;TNRC6B;CPEB3;TNRC6C
prerank,estrogen metabolic process (GO:0008210),-0.3736446182551759,-0.9507119213080047,0.5310492505353319,0.7965306338348784,1.0,3/15,27.67%,CYP1B1;HSD17B2;HSD17B7
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.42126466507334437,-0.950547634584965,0.5128205128205128,0.7962004452571508,1.0,3/10,19.39%,PLA2G4A;ENPP2;PLA2G15
prerank,protein transport (GO:0015031),-0.21972230837480333,-0.9504487056803372,0.672,0.7956860874422641,1.0,66/332,17.31%,LRP1B;SPTBN1;CALCRL;ANK3;TBC1D4;TBC1D1;ATP6V0A1;RABGAP1L;RAB31;TFRC;VAMP4;MYH9;VMP1;SYNDIG1;ARHGEF2;RAMP2;RAB3C;TBC1D8;TBC1D30;TBC1D5;STX3;APOE;ABCG1;SLC10A7;TXNIP;ATP6V0A4;LMAN2L;SGSM1;PREPL;MYO6;NSF;PPT1;MTTP;RAB18;TBC1D2B;ARL5A;ARL1;STX12;GCC2;TMED1;GOLGA7;TMED5;ARRDC4;TVP23B;VLDLR;ARL5B;SNX17;RAMP1;KIF3A;SCAMP3;LAPTM5;SCAMP1;RAB38;CLU;RAB6A;RAB32;SCG2;TMED4;ARF5;SNX27;ARF6;ERP29;NAPB;TMED7;STXBP3;CD74
prerank,positive regulation of autophagy (GO:0010508),0.3143379567795377,0.9500627392335927,0.5401459854014599,0.942719928889377,1.0,12/81,10.49%,RNF152;PRKAA2;PRKN;SESN1;TPCN1;LRRK2;SESN2;NPRL2;LARP1;HTT;SIRT1;IRGM
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.39328727000068275,-0.9489103700054152,0.5345911949685535,0.7985719143980589,1.0,5/13,17.44%,ELOVL7;ELOVL5;ELOVL6;TECRL;TECR
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.36114259684567424,-0.9488812953911475,0.52,0.7979317623572957,1.0,10/19,32.89%,CYBA;GPX1;CAT;PRDX1;SOD1;GPX3;PARK7;PRDX2;PRDX4;PRDX3
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3775491492463255,-0.948757753355195,0.5422993492407809,0.797477047292071,1.0,3/17,10.92%,PDE3B;SORL1;MFSD2A
prerank,negative regulation of neurogenesis (GO:0050768),0.3622031918968595,0.9487001285101486,0.5220228384991843,0.9452951978458447,1.0,4/34,7.93%,APPL2;LRP4;RUFY3;PTEN
prerank,microtubule polymerization (GO:0046785),-0.32094407681086423,-0.9486668987214466,0.5012165450121655,0.7969653296573261,1.0,12/28,25.63%,CLASP2;TUBGCP2;FGF13;TRPV4;MAPT;MAP7D3;TPPP;TPX2;TUBG2;NDEL1;NDE1;TPPP3
prerank,regulation of programmed cell death (GO:0043067),-0.23885613948130668,-0.9483801791225505,0.5867768595041323,0.7968984850653006,1.0,46/161,22.70%,MECOM;HIP1;ACTN4;RTN4;ACTN1;ACER3;TPT1;ACER2;APAF1;PHLPP1;RPS3;PERP;CALR;CTSB;TOX3;ANP32A;HSP90AA1;BCAR1;MAGED1;DAPK1;LCMT1;FAS;TM7SF3;LRP8;PINK1;NOP53;DNAJA3;CLU;CASP6;PAX2;CRADD;BCL3;CASP2;TNFRSF25;TIGAR;BCL2L11;PAX8;AGT;DAPK2;USP42;AKT1S1;BNIP3;ASAH1;CHM;TRIAP1;SLK
prerank,positive regulation of calcium ion transport (GO:0051928),0.3541772347142899,0.9480658234571947,0.5130434782608696,0.9460415295859732,1.0,4/36,6.37%,CACNA1D;ANK2;P2RX3;PDGFRB
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.46017308288423114,0.9479281567348838,0.5205479452054794,0.9456283004617091,1.0,4/10,12.26%,EPHA4;CDK5RAP3;ATRAID;RGP1
prerank,regulation of p38MAPK cascade (GO:1900744),0.36191154405989795,0.9477068227028916,0.5306451612903226,0.9454178968242402,1.0,8/35,14.38%,SASH1;DLG1;SPHK1;EZR;PTPN22;DUSP10;ULK4;GADD45A
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.36990315835597026,-0.9475072902933408,0.525974025974026,0.7982451116208441,1.0,7/17,31.52%,NUS1;ALG6;ALG8;ALG9;ALG13;ALG3;DPAGT1
prerank,regulation of cell death (GO:0010941),0.30448330642531407,0.9472908990887836,0.5576662143826323,0.9456704082188475,1.0,19/94,15.15%,BMP7;CCN2;PRKN;SRGAP2;PRODH;LRRK2;RILPL1;OLFM4;ATG5;RRAS2;LRP1;RIPK2;BECN1;IMPACT;AXIN2;CRYAB;TSC1;RAB29;FAF1
prerank,endosome organization (GO:0007032),0.3482863856621747,0.9469552038156128,0.5056,0.9457016985371066,1.0,18/41,23.24%,HOOK2;ALS2;ARFGEF2;RAB22A;PLEKHF1;HOOK3;EEA1;WASHC5;PI4K2B;PHETA1;SQSTM1;LAMTOR1;DNAJC13;SNX33;PI4K2A;VPS33B;HOOK1;RILP
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3942881885782948,0.9467182125049873,0.5238095238095238,0.9455407811464834,1.0,7/21,24.76%,MITF;MED12;MED17;MED1;MED13;MED24;BCLAF1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4059567796625418,0.946700667862031,0.5334507042253521,0.9448144046683892,1.0,9/20,26.19%,ZC3H7B;SNIP1;TERT;DICER1;AGO1;SPOUT1;AGO4;AGO2;PUM2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.27526541454103814,-0.946456063813515,0.5718654434250765,0.7999824351973169,1.0,13/69,10.79%,PLCB4;PIK3R1;PLCL1;PLCE1;NYAP2;PIK3C2B;NGF;PLEKHA1;PLCL2;HTR2A;PLCH1;ERBB2;EDN1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.41209445159643154,-0.9463348068668562,0.5201612903225806,0.7995576941591411,1.0,2/11,4.47%,MAP3K5;CYP1B1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.39014487273593484,0.9461917985383074,0.5391459074733096,0.9453065805385957,1.0,5/22,13.78%,APPL2;PTPN22;RAB7B;IFI35;ACOD1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.41515413066949614,0.946146881721475,0.5145067698259188,0.9446249730621155,1.0,2/17,6.18%,PRKCZ;CD28
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.37517181117408455,0.9461450196911617,0.5259391771019678,0.943853842992357,1.0,4/26,6.92%,GPR137;TLR3;TLR4;FBN1
prerank,positive regulation of protein deacetylation (GO:0090312),0.43050429464481144,0.9459818276119316,0.5104761904761905,0.943504516118624,1.0,6/14,25.14%,NIPBL;DYRK1A;FNTA;ZBTB7B;AKAP8;ING2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.3264957415623626,-0.9458432434383058,0.5639097744360902,0.7999771208691319,1.0,10/28,14.58%,DAB2IP;CTSC;PTK2;DDRGK1;PSMC6;AXIN1;ECSCR;LAPTM5;SMURF1;CLU
prerank,cell chemotaxis (GO:0060326),0.32526550229709145,0.9457803432388767,0.5318818040435459,0.9432171379101131,1.0,10/60,10.36%,LPAR1;KIT;CCR9;ACKR2;ARHGEF16;PDGFRB;HOXB9;HBEGF;CCL25;RAB13
prerank,positive regulation of dendrite development (GO:1900006),0.4541778786248409,0.9450673306728908,0.5462012320328542,0.9442133739638384,1.0,1/10,0.46%,BMP7
prerank,negative regulation of ossification (GO:0030279),0.3874134461201505,0.945026971298185,0.5089928057553957,0.9435487991407673,1.0,5/23,9.45%,LRP4;SMAD6;SRGN;BCOR;CHSY1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.35462591763105655,-0.9447191849897285,0.5330296127562643,0.801919040564672,1.0,6/20,13.87%,ENTPD1;HSP90AB1;APP;TXNIP;NT5E;TXN
prerank,regulation of neuroblast proliferation (GO:1902692),-0.3813213680777927,-0.9440592822492453,0.5311111111111111,0.8026975974215522,1.0,6/15,16.47%,TAFA1;DISC1;PTN;CTNNB1;VEGFA;CX3CR1
prerank,postreplication repair (GO:0006301),-0.29331605896676677,-0.9438783593903782,0.5549295774647888,0.8024001588761785,1.0,24/45,31.81%,UBE2V2;POLD3;RAD18;FAAP20;PRIMPOL;UBB;UBE2B;RPA1;RFC4;WDR33;NSMCE1;POLD4;POLD1;RFC2;POLK;DTL;UBC;RPS27A;RFC5;PCLAF;UBE2A;RPA3;BRCA1;RPA2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.374400284621467,0.9437716648894972,0.5369458128078818,0.9458453811509557,1.0,4/29,7.21%,ACSL1;ACSBG2;HACD1;SCD5
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.29419659244067736,0.9436475289746917,0.5431266846361186,0.9453515402888099,1.0,25/122,15.15%,SORBS1;IGF1;SMOC2;GLI2;LARP4B;SLC6A9;TLR4;DDX3X;NOX1;CD28;PDGFRB;POLDIP3;GCK;LDB1;SAMD4A;CPEB3;GLI1;SIRT1;YTHDF3;PRKDC;KAT7;PLD1;ZCCHC4;NFKB1;FAF1
prerank,glial cell differentiation (GO:0010001),-0.327219770872891,-0.9435235161723773,0.5386313465783664,0.8025363365632402,1.0,9/28,18.48%,CDH2;ADGRG6;STAT3;RELN;PTPRZ1;PAX2;TPPP;SOX2;SOX8
prerank,regulation of mast cell degranulation (GO:0043304),0.4227252614359542,0.9432125777190022,0.5446096654275093,0.9456523694403042,1.0,5/14,14.77%,CD300A;STXBP2;GAB2;FER;SPHK2
prerank,negative regulation of histone modification (GO:0031057),0.42062140530378234,0.9431455271011379,0.5351351351351351,0.9450295055677638,1.0,4/14,15.44%,JARID2;AASS;SPHK2;TAF7
prerank,myotube differentiation (GO:0014902),0.4102601950528226,0.9430034670824078,0.5018382352941176,0.9445977789784694,1.0,3/17,3.51%,ADAM12;IGF1;ADAMTS15
prerank,negative regulation of protein kinase activity (GO:0006469),0.3008017107056356,0.9429114088801402,0.5555555555555556,0.9440760695456277,1.0,14/88,11.28%,PRKAG2;SLC8A3;PPM1E;DEPTOR;DTNBP1;TRIB2;WWTR1;CDK5RAP3;SH3BP5;PDPK1;MVP;ABL1;DUSP10;TRIB1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.24762400740978102,-0.942680826914228,0.6013986013986014,0.803863349299191,1.0,33/113,20.22%,ESR1;TFRC;RASIP1;UNC13B;GSK3B;DAB2IP;RAP1B;RPS3;SH3GLB1;PIEZO1;TGFB1;FNIP2;GNL3L;PSMC6;HSP90AA1;TIRAP;ERCC1;SNCA;VEGFA;TAL1;CDC42EP2;TERF1;CLU;USP50;RPA1;SKAP1;TPPP;SYK;GTF2H1;BCL2L11;GTF2H4;GTF2H5;ERCC2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.31725579062446896,0.9422018283032111,0.5462555066079295,0.9450588844815803,1.0,6/73,6.11%,ROBO1;SMAD3;COL4A3;CFLAR;BID;FAM162A
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.33760478518350934,-0.9420511964640077,0.5448430493273543,0.8045943933097249,1.0,9/22,13.77%,RASSF2;PDGFC;CALM1;CALM2;RAP2A;PDGFA;CALM3;TNKS1BP1;VEGFA
prerank,negative regulation of T cell differentiation (GO:0045581),0.44818824334362445,0.9418814097431981,0.5145631067961165,0.9450949223812207,1.0,4/10,21.02%,GLI3;IRF1;IHH;CTLA4
prerank,regulation of ATP biosynthetic process (GO:2001169),0.40222801699770033,0.9411996460095171,0.5458015267175572,0.9460043492119659,1.0,5/16,14.77%,PPARGC1A;PPARA;AK4;FLCN;SPHK2
prerank,chemical homeostasis (GO:0048878),0.32543683688083264,0.9410778506965787,0.5388127853881278,0.9455315034183668,1.0,12/61,15.45%,WNK4;ZBTB20;RBP1;DDX3X;TLCD2;NR1D2;ADCK1;ACOXL;WNK1;ACOX3;SLC66A1;TENT4B
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2801716951003582,0.941021749876705,0.579415501905972,0.9449060390091597,1.0,18/170,10.64%,PRDM6;ROCK2;IGF1;AFF3;MTMR3;TBC1D16;PCBP2;ZNF462;IGF2BP1;AFF4;TOB2;GDNF;HRG;IGF2BP2;NOVA1;C1D;DHH;PRDM5
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4536229260134753,0.9409051127799709,0.5573122529644269,0.9444457385308019,1.0,4/11,8.82%,PCBP2;IGF2BP1;IGF2BP2;NOVA1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.40158495076641954,0.9406912451010556,0.5285961871750433,0.9441789630761035,1.0,4/18,11.94%,PRKN;MCU;DNM1L;RALBP1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.41922720654601153,-0.9406495806567782,0.550755939524838,0.8071251532652924,1.0,2/11,4.21%,FAP;PTGIS
prerank,glutathione biosynthetic process (GO:0006750),-0.4148363179376242,-0.9403762882574903,0.5526315789473685,0.8070184357932111,1.0,7/11,33.07%,GCLM;CHAC2;OPLAH;GGCT;MGST2;GCLC;GGT1
prerank,melanosome localization (GO:0032400),0.38566206111043483,0.9403411431632945,0.5267857142857143,0.9442574796360201,1.0,6/21,15.83%,SHROOM2;BLOC1S6;RAB11B;MKKS;ARL6;BBS2
prerank,RNA processing (GO:0006396),0.27795688059600604,0.9400387241465368,0.5935162094763092,0.9442194563803654,1.0,45/176,21.65%,CELF2;PPARGC1A;SON;RBMS2;PABPN1;HNRNPR;HNRNPH1;SRSF5;YJU2;TSEN2;HNRNPA2B1;TUT4;RBM39;NOVA1;TENT2;RBMS1;LUC7L3;SRPK2;PRPF18;HNRNPL;DICER1;SRSF11;HNRNPC;SCAF11;PRPF3;TENT4B;SNRNP40;RBM4;TFIP11;TUT7;USP39;ALKBH5;ZCRB1;PRPF6;FUS;SRSF1;HNRNPH3;U2AF1;SRSF7;WBP4;SNRPA1;U2AF2;SF3B2;SF3B1;TUT1
prerank,folic acid metabolic process (GO:0046655),0.3943973322830088,0.9399433331550179,0.5334538878842676,0.9436836483097711,1.0,6/18,19.24%,SLC19A1;MTHFR;ALDH1L1;MTRR;MTHFD1;FOLR2
prerank,proteasome assembly (GO:0043248),-0.41000202835402766,-0.9398649678615387,0.5152129817444219,0.8074705675506968,1.0,5/11,34.08%,PSMG2;PSMD11;POMP;ADRM1;PSMD4
prerank,actin filament polymerization (GO:0030041),0.3730154927470777,0.9396821570598829,0.5433628318584071,0.9435709895947205,1.0,7/29,12.56%,GAS7;ARHGAP6;DIAPH1;WASL;CATIP;VIL1;TTC17
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.39154789004305446,0.9393155345154374,0.4918918918918919,0.9437163250743708,1.0,3/20,7.34%,IL18;TLR4;PTPN22
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.37468778991243296,0.9392320722034321,0.5144312393887945,0.9431605544453062,1.0,6/23,11.30%,EFNB2;IGF1;NRG1;NIBAN2;MYLK3;MMP14
prerank,regulation of osteoblast proliferation (GO:0033688),0.40812807624843894,0.9391771394762276,0.5293072824156305,0.9425306994579703,1.0,4/17,12.16%,FGFR2;NPR3;EIF2AK2;ATRAID
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.32846462908880425,-0.9387843963778703,0.5346534653465347,0.8093719450302655,1.0,11/27,20.05%,PID1;GRB14;PIP4K2A;ENPP1;PTPRE;NCK1;KANK1;PTPN1;PRKCQ;PIP4K2B;IRS1
prerank,regulation of platelet activation (GO:0010543),-0.3554817396283414,-0.9381402196945026,0.569377990430622,0.8101830985426155,1.0,6/21,10.26%,PLA2G4A;NOS3;LYN;APOE;TEC;PDGFA
prerank,camera-type eye development (GO:0043010),-0.33554959674412976,-0.9378554387978507,0.5487528344671202,0.8101338135801942,1.0,9/25,19.86%,LAMA1;TENM3;CYP1B1;FBN2;STRA6;VEGFA;PAX2;FOXL2;ALDH1A3
prerank,inositol phosphate dephosphorylation (GO:0046855),0.43855108474799576,0.9378106675499873,0.5401869158878505,0.9442166179941854,1.0,3/11,11.18%,SYNJ2;PTEN;OCRL
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.43855108474799576,0.9378106675499873,0.5401869158878505,0.9442166179941854,1.0,3/11,11.18%,SYNJ2;PTEN;OCRL
prerank,pharyngeal system development (GO:0060037),0.4173155049054049,0.9377248196190557,0.5362035225048923,0.9436815066187899,1.0,3/15,3.46%,BMP7;BMPR1A;TGFBR1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.43566162356001303,0.9373760583297831,0.543233082706767,0.9437644155847909,1.0,1/13,1.44%,IGF1
prerank,regulation of cell population proliferation (GO:0042127),0.2521488275036494,0.9373192755750652,0.6642335766423357,0.9431427575467827,1.0,103/691,12.86%,FGF1;ALDH1A2;BMP6;EFNB2;KSR1;KIT;LAMC2;GSDME;IGF1;FGFBP1;IL13RA1;PTPN14;FGFR2;PKHD1;KANK2;GRK5;COL18A1;NUPR1;COL4A3;NPR3;PHIP;FGFR1;BMPR1A;ARID2;MAGI2;TGFBR1;IGFBP7;SPEG;ADRA2A;PDPN;IFIT3;NACC2;CDCA7L;DPP4;TNFSF13;SMAD6;TNS2;CTSH;PIAS1;MEIS1;CLMN;IFNK;KLHL41;NOX1;SOD2;FLT1;STAT2;HMGA1;PDGFRB;TP53;EIF2AK2;CACUL1;GAB2;WWTR1;SSTR3;DLG3;PTPRU;TGFBR2;PTEN;IGFBP3;GDNF;NRG1;HRG;NUPR2;NIBAN2;SULT2B1;HDAC4;GLI1;SIRT1;HDAC1;GTPBP4;ASH2L;CCAR1;HTR1A;TCF7L2;HBEGF;FLT3LG;FER;SLURP1;CRKL;TBRG4;NOX4;SRPK2;RNF41;RARG;MNT;PRKDC;TFAP2D;ADAM17;OSGIN1;GLMN;NOP2;AXIN2;VEGFD;ITGAV;CSNK2A1;NMI;BRD7;MLXIPL;TGFA;IRF1;FRK;KMT2D
prerank,cellular response to amino acid stimulus (GO:0071230),0.3592837355599199,0.937263121887631,0.540765391014975,0.9425151708433135,1.0,10/33,19.11%,CPEB4;SESN1;SESN2;UBR2;CPEB3;RPTOR;UBR1;NSMF;RRAGD;LAMTOR1
prerank,apoptotic nuclear changes (GO:0030262),0.3739710641303244,0.9370976500648823,0.5329861111111112,0.9421414709166934,1.0,8/24,20.69%,CASP3;CDK5RAP3;BLCAP;DICER1;DFFB;DFFA;ACIN1;CECR2
prerank,endoplasmic reticulum organization (GO:0007029),-0.2691687635459778,-0.9369434618380209,0.5794117647058824,0.8115260302426806,1.0,24/72,23.55%,RTN4;REEP1;CAV2;DOP1B;SHTN1;APP;REEP5;LMAN2L;RAB18;SEC61B;ATL2;EIF2AK3;VCPIP1;LMAN2;CYB5A;EMD;SPTSSB;ATL3;VAPA;TLE6;RTN3;TRAM1;REEP3;SEC16B
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.4001717347831547,-0.9366543902402346,0.5458422174840085,0.8114926833180371,1.0,5/12,22.63%,RPL26;CD44;TAF9B;CD74;TRIAP1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3992880719985011,0.936563960325322,0.5444839857651246,0.9426592812993951,1.0,5/19,12.06%,PRKN;FZD5;HTT;DNM1L;CSNK2A2
prerank,microtubule bundle formation (GO:0001578),-0.29517429954108854,-0.9362620941958576,0.5611702127659575,0.8117925988834952,1.0,20/42,33.41%,NCKAP5;DCX;MTCL1;RP1;CDK5RAP2;SPEF1;CLIP1;TPPP;CAPN6;SPAST;LRGUK;TPPP3;MARK4;KIF20A;PSRC1;RSPH9;CFAP206;FOXJ1;CCDC66;TTLL3
prerank,dermatan sulfate metabolic process (GO:0030205),0.4294288726254383,0.9362091735032485,0.5595667870036101,0.9427426752458345,1.0,2/13,6.71%,UST;DSE
prerank,cellular response to leucine starvation (GO:1990253),0.46011342909998143,0.9358514644654683,0.5431192660550459,0.9428366714410419,1.0,4/10,17.13%,SESN1;SESN2;IMPACT;RRAGD
prerank,protein localization to cell junction (GO:1902414),0.38766354930865105,0.9357869431426696,0.5263157894736842,0.9422478400388582,1.0,3/22,2.47%,CGNL1;ARHGEF18;NLGN2
prerank,cilium assembly (GO:0060271),0.26720343778392847,0.9356895947128105,0.6223021582733813,0.9417158338102513,1.0,71/296,19.22%,CFAP44;AVIL;CC2D2A;PKHD1;DCDC2;CEP250;TNPO1;CLASP1;CPLANE2;RILPL1;NINL;RAB3IP;KIF3C;CYS1;RHO;PTPN23;ASAP1;EXOC2;CCDC28B;SSTR3;CEP162;CDC14A;IFT122;WDR19;DYNC2I1;MKKS;TMEM231;SDCCAG8;CLUAP1;CDC14B;ATP6V1D;IFT88;OCRL;GALNT11;NPHP1;BBS10;PDE6D;UNC119B;GORAB;WDPCP;CFAP410;WDR35;ALMS1;EXOC4;E2F4;EXOC3;PARVA;CCDC39;CEP63;B9D2;ARL6;RP2;BBS2;STK36;RFX2;RAB8B;RILPL2;PIBF1;TMEM237;BBOF1;TRAPPC14;CCDC40;CEP57;ATP6V0D1;AKAP9;TMEM17;TCTN3;PCM1;CEP164;OFD1;PCNT
prerank,regulation of cell division (GO:0051302),0.3095806426223642,0.9355652087314023,0.5537313432835821,0.9412665262413871,1.0,8/72,10.54%,FGF1;FGFR2;NCOA3;UVRAG;PLK5;MYO19;BECN1;AURKB
prerank,cytosolic transport (GO:0016482),0.29174938192938143,0.9352749227876813,0.5636623748211731,0.9411802423116297,1.0,35/108,20.47%,HOOK2;SNX6;SNX32;DENND2A;PTPN23;VPS54;DENND5A;PIKFYVE;BECN1;VPS50;CLTC;RGP1;ANKRD27;VTI1A;STX5;AP2A1;RAB29;VPS13A;SNF8;VPS51;CCDC91;HOOK3;EEA1;HEATR5B;WDR91;RAB9A;PHETA1;VPS35;MON2;EVI5;AP4M1;TMEM87B;STX16;WDR81;ANKFY1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.37321897235441065,-0.9352331292934957,0.5460385438972163,0.8135815356082092,1.0,2/15,7.53%,NLGN1;CNTNAP4
prerank,long-chain fatty acid metabolic process (GO:0001676),0.31919134811118227,0.9349797735141646,0.5478395061728395,0.9412514297064357,1.0,7/64,8.40%,ACSL1;ALOX12;CPT1A;ACSBG2;EPHX1;DAGLA;CPT2
prerank,regulation of RNA metabolic process (GO:0051252),0.3177223001577038,0.93467522395384,0.5449010654490106,0.9412690834393126,1.0,20/59,18.37%,SON;OAS2;MITF;SNRNP70;PCBP2;MBNL2;IGF2BP1;HNRNPH1;CLK4;IGF2BP2;NOVA1;HNRNPL;OAS3;CLK1;CLK2;GRSF1;FASTK;MED1;FUS;HNRNPH3
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3906125594939322,0.9346300324740477,0.5568965517241379,0.9406400691672192,1.0,3/21,7.06%,PRKN;LRRK2;OPA1
prerank,peptidyl-amino acid modification (GO:0018193),0.46202466979872253,0.9343903820505297,0.5383064516129032,0.9404775988839664,1.0,4/10,19.95%,METAP2;FKBP10;TTLL4;ATP7A
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.339690375247675,0.9343779783701954,0.5387149917627677,0.9397687440024194,1.0,6/43,11.75%,SYT11;IGF1;TLR4;PTPN22;CD274;DICER1
prerank,regulation of cellular component biogenesis (GO:0044087),0.3516191231785366,0.9334087600329111,0.5578778135048231,0.9413439834636033,1.0,8/39,12.27%,ROCK2;SNCAIP;PARP10;EZR;HRG;IRGM;BBS10;PTPN11
prerank,blood circulation (GO:0008015),0.32948723656816226,0.9330835923779687,0.5585874799357945,0.9413934199641665,1.0,6/49,4.75%,ROCK2;ACE;NPR1;MYOF;COL4A3;BDKRB2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.34872446745153723,0.9327698049553328,0.5707472178060413,0.9413698629544927,1.0,9/36,14.80%,PRKN;PARP14;PARP9;RIPK1;MAVS;IRGM;ADAM17;AXL;AGPAT1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.44288832268296857,0.9325935789887582,0.5335892514395394,0.9410336614732231,1.0,1/10,0.65%,ACTN2
prerank,regulation of myeloid cell differentiation (GO:0045637),0.3193610491281914,0.9325430117300506,0.5527488855869243,0.9404318138048636,1.0,19/62,16.31%,KMT2A;TNRC6A;CTR9;PRKCB;MEIS1;TNRC6B;RBM15;HDAC1;ASH2L;MOV10;KMT2C;KMT2D;SIN3A;KAT2B;TNRC6C;PURB;LGALS3;HOXB8;CREBBP
prerank,mesenchymal cell development (GO:0014031),-0.3615887617809135,-0.9323628291369248,0.55,0.8196410786793613,1.0,4/18,9.18%,CDH2;NOTCH1;HEYL;HEY2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.34877364527376103,0.9321864389361105,0.5532258064516129,0.9405765307800528,1.0,3/38,5.16%,SMAD3;ROCK2;TLR4
prerank,positive regulation of transporter activity (GO:0032411),0.4226827911124539,0.9315912066644597,0.5204460966542751,0.9412805487521192,1.0,4/13,19.91%,KMT2A;RXRA;SGK2;NR1H3
prerank,protein phosphorylation (GO:0006468),0.25631548955270617,0.9312834258429145,0.6739606126914661,0.9412806261939987,1.0,78/478,13.88%,PRKAG2;TGFBR3;WNK4;ROCK2;OXSR1;PRKCZ;KIT;FAM20A;PRKAA2;FGFR2;EPHA4;GRK5;CCNA2;PRKAG3;STK32B;FGFR1;BMPR1A;TGFBR1;DMPK;AAK1;LRRK2;TP53RK;TLR3;SMG1;PRKCB;IKBKE;TLR4;ATM;PRRT1;CAMK1;BRAF;EPHA8;FLT1;NUAK2;TRIB2;PDGFRB;BAZ1B;CDC42BPG;SIK1;EIF2AK2;RICTOR;TGFBR2;IGFBP3;MAPKAPK3;RYK;COQ8B;PDPK1;CSNK1A1;RIOK2;PICK1;RIPK1;MKNK1;FER;BRSK1;AURKB;SRPK2;ABL1;DYRK1A;MYLK3;TRIB1;PRKDC;MAPK6;CSNK2A2;CSNK2A1;PRKCA;HIPK3;MAPK10;MAP3K1;FRK;PRKCI;EPHA3;WNK1;BMP2K;MAP2K1;ROS1;COQ8A;CAD;GRK3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3975872947315862,-0.931031319728799,0.5583333333333333,0.8212749616479379,1.0,5/12,15.66%,AKAP6;CAMTA1;LMCD1;SPPL3;STIMATE
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3975872947315862,-0.931031319728799,0.5583333333333333,0.8212749616479379,1.0,5/12,15.66%,AKAP6;CAMTA1;LMCD1;SPPL3;STIMATE
prerank,ncRNA transcription (GO:0098781),-0.3942458472976873,-0.9307978696701646,0.5646551724137931,0.8210823163230064,1.0,2/13,7.75%,CAVIN1;SPIN1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4388796259730743,0.9304647711887815,0.5648148148148148,0.9424395791897209,1.0,2/12,6.71%,UST;DSE
prerank,myeloid leukocyte differentiation (GO:0002573),-0.2712411317802144,-0.930407581472704,0.59375,0.8213108812705952,1.0,14/65,15.38%,LEF1;RUNX1;MYH9;TNFRSF11A;FOXP1;CAMK4;CBFA2T3;MT1G;BMP4;SBNO2;CDKN1A;THOC5;VEGFA;IL31RA
prerank,negative regulation of DNA recombination (GO:0045910),0.33556441709828594,0.9300613213709847,0.5616,0.9426759287598585,1.0,17/43,26.79%,POLR2A;ATRX;ACD;POLR2D;FBH1;MSH3;SMCHD1;TINF2;POLR2G;POLR2F;PARP3;MAD2L2;H1-0;SHLD2;UBQLN4;RTEL1;POLR2K
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4107680811053663,0.9299830050138999,0.5381750465549349,0.9421111004809917,1.0,1/14,1.09%,OSR1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3576121030900774,0.9297999994672443,0.5610561056105611,0.941810364971358,1.0,9/29,20.23%,TLR3;IKBKE;TLR4;RIPK1;LY96;BIRC3;CD14;TANK;TRAF3
prerank,regulation of monocyte differentiation (GO:0045655),-0.3869163331099749,-0.9295899053487673,0.5593952483801296,0.8225531118421698,1.0,4/14,17.31%,FOXP1;CTNNBIP1;FES;CD74
prerank,cellular response to inorganic substance (GO:0071241),-0.34768645039659074,-0.9295236328749863,0.5331695331695332,0.8219989368102126,1.0,3/21,7.13%,KCNC2;GUCY1B1;FOXO1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.30065546125650955,-0.929476810222495,0.5646766169154229,0.8213828322449235,1.0,8/37,14.23%,PRKG1;MEF2C;TGFB3;FGF2;GPER1;CDKN1A;FGF9;HTR1B
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.39512913708937836,-0.9289906081045874,0.5761316872427984,0.8218120296143158,1.0,8/12,22.94%,SIX1;VEGFA;PAX2;SOX8;PAX8;SIX4;AGT;LHX1
prerank,meiosis I (GO:0007127),0.39097972034677814,0.9289692551024906,0.5253940455341506,0.9430858430199833,1.0,4/23,12.98%,CCNA1;MOV10L1;MYBL1;FOXJ2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.2593021995495823,-0.9286475159773832,0.6180124223602484,0.8211247424825943,1.0,30/78,25.10%,SH3GL2;CTSD;DYNC1I1;DYNLL1;AP1S2;DYNC1LI2;AP2B1;KIF26A;DCTN4;CTSL;AP2M1;CAPZA2;CTSS;KIF3A;AP1S3;CAPZA1;CENPE;KIF15;CD74;SPTBN2;KIF11;AP1S1;KIF5A;KIF22;KIF4A;KIF3B;SAR1B;DCTN6;ACTR1A;KIF23
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.2593021995495823,-0.9286475159773832,0.6180124223602484,0.8211247424825943,1.0,30/78,25.10%,SH3GL2;CTSD;DYNC1I1;DYNLL1;AP1S2;DYNC1LI2;AP2B1;KIF26A;DCTN4;CTSL;AP2M1;CAPZA2;CTSS;KIF3A;AP1S3;CAPZA1;CENPE;KIF15;CD74;SPTBN2;KIF11;AP1S1;KIF5A;KIF22;KIF4A;KIF3B;SAR1B;DCTN6;ACTR1A;KIF23
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.4105577285340817,-0.9285080272493819,0.564755838641189,0.8207408412994257,1.0,2/10,13.39%,ASRGL1;QDPR
prerank,response to hydrogen peroxide (GO:0042542),-0.28914713988898927,-0.9284884692125844,0.5797101449275363,0.8200519168064319,1.0,12/45,16.43%,MAP3K5;CYP1B1;NET1;ANXA1;RPS3;PLEKHA1;RHOB;GLRX2;TRPM2;PAX2;GPX1;CAT
prerank,negative regulation of nervous system development (GO:0051961),-0.35784183867918884,-0.928451953972038,0.5714285714285714,0.819399704254191,1.0,4/17,7.85%,ROBO2;B2M;NOTCH1;SORL1
prerank,protein N-linked glycosylation (GO:0006487),0.3134428221886261,0.9284208678215111,0.5692771084337349,0.9437057255770798,1.0,7/66,6.30%,MAN1C1;ST6GAL1;MGAT3;ASGR1;PGM3;B4GALT1;FUT8
prerank,filopodium assembly (GO:0046847),-0.36493320246004723,-0.928379662314426,0.5548654244306418,0.8188419659383858,1.0,3/16,4.20%,DNM3;FGD5;SPATA13
prerank,establishment of epithelial cell polarity (GO:0090162),0.38946973059683343,0.9281069988049212,0.5152057245080501,0.9436707991954532,1.0,6/19,13.42%,CLASP1;MYO18A;EZR;OPHN1;CDC42;PARD3
prerank,embryonic axis specification (GO:0000578),0.4056279198933488,0.9279945556621227,0.5276190476190477,0.9432201734727487,1.0,3/15,5.39%,CXXC4;SMAD6;FZD5
prerank,organelle transport along microtubule (GO:0072384),0.3545358431596736,0.9275415611946851,0.5586206896551724,0.9435748171655352,1.0,9/31,18.50%,TRAK1;FBXW11;HTT;CDC42;KIF5B;ARHGAP21;PEX14;TRAK2;RHOT1
prerank,methylguanosine-cap decapping (GO:0110156),-0.41520523955783684,-0.9273742091399729,0.5628865979381443,0.8203793724569861,1.0,4/10,21.06%,DCP1B;PNRC2;LSM1;DCP2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.3267455890130136,-0.927150442993588,0.5443349753694581,0.8201664360172218,1.0,10/26,25.01%,NOD1;ALPK1;MAP3K7;UBB;NOD2;TIFA;AAMP;UBC;RPS27A;TAB1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.44069148923442425,0.9271290339441074,0.5317164179104478,0.9437952929414951,1.0,1/11,1.98%,PRKN
prerank,cellular response to hexose stimulus (GO:0071331),0.37741560742463703,0.9270742088500061,0.5497287522603979,0.9431866127115534,1.0,2/23,2.21%,PRKAA2;ZBTB20
prerank,lung epithelium development (GO:0060428),0.4543967338691807,0.9269104794747322,0.5447470817120622,0.9428569352629331,1.0,1/10,1.20%,ERRFI1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.4336274876019567,0.9267566781036941,0.5489443378119002,0.9424918247141711,1.0,1/11,1.93%,LRRC38
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.26087087627409405,-0.9264479721795901,0.6103896103896104,0.8210409937342839,1.0,32/82,26.46%,YWHAE;DYNLL1;PPP2R1A;YWHAG;TUBA1A;HAUS2;TUBB4A;CDK5RAP2;HSP90AA1;KCNH5;PRKAR2B;ATAD5;ATF5;HAUS5;CEP78;CETN2;TUBA4A;SSNA1;CEP131;NPM1;NEK10;CCP110;HMMR;TPX2;KIF14;NEDD1;HAUS4;CEP135;ACTR1A;NDE1;HAUS6;CEP76
prerank,negative regulation of B cell proliferation (GO:0030889),0.43098496260720365,0.9262994573562034,0.5368620037807184,0.9428247027373844,1.0,2/11,5.45%,CD300A;ATM
prerank,connective tissue development (GO:0061448),0.35026563521219567,0.9261347524739357,0.5750798722044729,0.9424811213249515,1.0,9/35,13.29%,SOX5;SULF2;CREB3L2;SH3PXD2B;RORC;SLC39A13;HYAL1;COL11A2;SULF1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3623428561402243,0.9260224621315735,0.5463576158940397,0.9419677254209089,1.0,6/25,12.87%,CCNT2;LDB1;ELL;SCAF8;WDR43;KAT7
prerank,peptidyl-serine phosphorylation (GO:0018105),0.2778180631258408,0.925531780680254,0.6343949044585987,0.9423659324815982,1.0,41/153,19.07%,ROCK2;PRKCZ;STK32B;TGFBR1;DMPK;LRRK2;SMG1;PRKCB;IKBKE;ATM;CAMK1;RICTOR;TGFBR2;MAPKAPK3;PDPK1;CSNK1A1;PIKFYVE;RIPK1;MKNK1;BRSK1;SRPK2;DYRK1A;PRKDC;CSNK2A2;CSNK2A1;PRKCA;HIPK3;PRKCI;WNK1;MAP2K2;STK4;MAPK9;TLK2;CLSPN;PKN2;PAK2;TAF1;MAPK14;SGK3;SGK2;CAMK1D
prerank,response to glucagon (GO:0033762),0.39685582694890054,0.9254526402178301,0.5652173913043478,0.9418146314085991,1.0,7/19,17.88%,ADCY5;ADCY1;ADCY9;PRKAR1A;ADCY6;PRKACB;CRY1
prerank,macromolecule catabolic process (GO:0009057),0.3651654904344695,0.9254191939583881,0.5342237061769616,0.9411687732716733,1.0,6/26,10.40%,NEDD4;UVRAG;TPP1;CLPX;CLN6;BECN1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.30535462293005583,0.9253881887634122,0.5823699421965318,0.9405179570715101,1.0,19/80,15.31%,ROCK2;PICALM;EPHA4;CASP3;LARP4B;DDX3X;CD28;POLDIP3;SAMD4A;CPEB3;SIRT3;PLA2G6;YTHDF3;PRKDC;PLD1;SPHK2;ZCCHC4;NSMAF;SMPD3
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3738427552769585,0.9247685980870386,0.5519591141396933,0.9412859460352301,1.0,5/26,8.76%,GBGT1;LARGE1;GK5;GK;GAL3ST4
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.4152774207040725,-0.9245719174091713,0.583864118895966,0.8246880024469466,1.0,5/10,21.60%,DISC1;CTNNB1;VEGFA;CX3CR1;DRD2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3266685579666683,0.9244750319578476,0.5909774436090226,0.9412473468766145,1.0,4/54,5.59%,SH3RF2;NXN;HDAC8;ARRB1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.32397428176364196,-0.9243827311628313,0.5710955710955711,0.8244300281835991,1.0,12/27,29.15%,MAP3K5;MAP3K7;IKBKB;CCDC88C;UBB;SKP1;MAP2K7;UBC;RPS27A;MAPK8;MAP3K8;MAPK3
prerank,calcium-mediated signaling (GO:0019722),0.2949825308544238,0.9241210563698087,0.5874125874125874,0.9413195293445064,1.0,11/93,5.51%,ANK2;NUDT4;CCR9;ACKR2;SPHK1;MCU;DMPK;LRRK2;CACNA1C;DEFB1;ADGRL1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.29471545562334744,-0.9237866312414761,0.5736434108527132,0.8251750700734757,1.0,20/39,31.81%,POLD3;ERCC1;UBB;RPA1;GTF2H1;GTF2H4;GTF2H5;RFC4;ERCC2;POLD4;POLD1;RFC2;POLK;UBC;RPS27A;RFC5;DDB1;RPA3;ERCC3;RPA2
prerank,protein localization to chromosome (GO:0034502),0.35178420350358075,0.9235835250422937,0.5592105263157895,0.9418244933604604,1.0,8/34,11.77%,ATRX;ACD;TPP1;TNKS2;LEMD2;XRCC4;IFFO1;WAPL
prerank,organelle assembly (GO:0070925),0.2580679435044034,0.9234977275468509,0.6708428246013668,0.9413218469463892,1.0,95/384,19.22%,CFAP44;AVIL;CC2D2A;PKHD1;DCDC2;CEP250;TMOD2;CPLANE2;RILPL1;RAB3IP;TMOD3;CYS1;DDX3X;KLHL41;RHO;PTPN23;ASAP1;ATG5;EXOC2;CCDC28B;SH3PXD2B;SSTR3;CEP162;WIPI1;CDC14A;AMBRA1;ATXN2;IFT122;WDR19;DYNC2I1;CHMP1A;RAB43;LSM14A;MKKS;YTHDF3;BECN1;ATG7;IRGM;TMEM231;HPS1;CLUAP1;CDC14B;ATP6V1D;IFT88;OCRL;GALNT11;MAPRE2;PDE6D;DDX6;UNC119B;ATG2A;NCOR1;WDPCP;CFAP410;WDR35;UBAP2L;EXOC4;E2F4;EXOC3;PARVA;LMOD3;CEP63;B9D2;VPS37A;ARL6;SNF8;RP2;BBS2;STK36;GOLGA8B;VPS4A;RFX2;RAB8B;CENPC;LMOD1;RILPL2;CHMP4C;ATXN2L;PIBF1;TMEM237;OGFOD1;ZFYVE1;TRAPPC14;TMEM41B;ATP6V0D1;CCDC61;GORASP2;TMEM17;TCTN3;PCM1;CENPT;CEP164;GOLGA2;OFD1;PCNT
prerank,embryonic organ morphogenesis (GO:0048562),0.3422776328049774,0.923481408514426,0.55,0.9406264750147075,1.0,12/42,13.00%,FGFR2;HOXB4;HOXB3;HOXB9;HOXA3;FBN1;NIPBL;RBP4;HOXC4;DYNC2I1;RARG;RBPMS2
prerank,telomere maintenance via recombination (GO:0000722),0.4317927346256522,0.9233767054805835,0.5414937759336099,0.9401329341715652,1.0,6/11,19.85%,TPRKB;TEP1;RAD50;NSMCE2;RAD51D;XRCC3
prerank,negative regulation of ATP metabolic process (GO:1903579),0.39333843836706756,0.9232558952774204,0.5537918871252204,0.9396808664162516,1.0,6/17,14.24%,PPARA;NUPR1;HDAC4;MLXIPL;NCOR1;FLCN
prerank,intraciliary retrograde transport (GO:0035721),0.4280189536875857,0.9230847703693253,0.5519713261648745,0.9393522794960996,1.0,4/12,14.33%,IFT122;WDR19;DYNC2I1;WDR35
prerank,phosphatidylinositol metabolic process (GO:0046488),0.28918058188515233,0.9229166158935819,0.609308885754584,0.9390249368079455,1.0,18/109,11.18%,PTPN13;LPGAT1;INPPL1;PI4KA;MTMR3;SYNJ2;PLEKHA2;PIGW;PDGFRB;SLC27A1;PIP4K2C;PTEN;PIK3CA;PLCD1;PIKFYVE;PLEKHA8;PIK3R3;OCRL
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.38015749000444754,0.9226414233163479,0.5448154657293497,0.9389395977494608,1.0,3/23,5.53%,ACSL1;ACSBG2;HACD1
prerank,hemidesmosome assembly (GO:0031581),0.43516985124451624,0.9223216906488132,0.5662431941923775,0.9389414698750413,1.0,2/11,2.04%,LAMC2;LAMC1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.372263812784486,0.9220517784087636,0.5751295336787565,0.9388334662562701,1.0,3/24,5.87%,RORA;SULF2;NOX1
prerank,striated muscle cell differentiation (GO:0051146),-0.3594915176599004,-0.9216541176573584,0.5681818181818182,0.8294636470003103,1.0,4/16,8.22%,MEF2C;MYEF2;SORT1;BMP2
prerank,phosphatidic acid metabolic process (GO:0046473),-0.28474531528198027,-0.9215061647320361,0.6,0.8290733552874757,1.0,8/48,14.41%,DGKH;DGKB;PLA2G4A;PLA2G12A;DGKG;DGKZ;PNPLA3;ABHD4
prerank,regulation of JNK cascade (GO:0046328),0.29039682884394147,0.9213809423907597,0.5886524822695035,0.9396643582094669,1.0,5/101,1.98%,TGFBR3;SH3RF2;TPD52L1;CCN2;PRKN
prerank,plasma membrane invagination (GO:0099024),-0.31779564578167435,-0.9213518277408298,0.5612009237875288,0.828718004446969,1.0,5/29,10.69%,GSN;MYH9;DOCK1;ARHGAP25;ELMO1
prerank,heterochromatin organization (GO:0070828),-0.3805671443334802,-0.9211786344586352,0.5739130434782609,0.8283743765057143,1.0,2/14,5.64%,MECOM;PRDM16
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.3241441231336454,0.9209250763140553,0.5498392282958199,0.9400713572792945,1.0,8/48,13.94%,ROBO1;PARP14;GPS2;STAT2;SAMHD1;YTHDF3;OAS3;USP18
prerank,gonad development (GO:0008406),0.3337158289100742,0.9208317374022729,0.5518945634266886,0.9395831111027947,1.0,3/41,3.08%,WNT4;KIT;NR2F2
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.33796065922137547,-0.9206315718335988,0.568075117370892,0.828914921425924,1.0,8/22,17.51%,MDFIC;APOD;UFM1;CABP1;DMTN;SIAH3;GDI1;BARD1
prerank,Fc receptor signaling pathway (GO:0038093),-0.24502654470661048,-0.9205379216910548,0.6441281138790036,0.8284285904274711,1.0,44/110,30.01%,PIK3R1;LYN;PSMB2;PAK1;CALM1;PLCG2;MAP3K7;PPP3R1;NFATC1;PPP3CA;PSMD14;TEC;PSMC6;IKBKB;PSMA4;PSMB9;VAV1;SKP1;SYK;PSMD11;BTK;PSMB10;PRKCQ;PSMD2;SHC1;SOS1;PSMA2;MAP2K7;RELA;PSMB3;TAB1;PLCG1;PSMB5;LCP2;CARD11;MAPK8;PSMA7;FOS;MAPK3;PSMF1;PSMD7;JUN;MAP2K4;MALT1
prerank,regulation of Golgi organization (GO:1903358),0.3987175909820483,0.9202851082859446,0.5665467625899281,0.9401145249181292,1.0,5/17,14.02%,STX18;ARMH3;MAP2K1;STX5;MAP2K2
prerank,negative regulation of cellular senescence (GO:2000773),0.41860883405451266,0.9201553575488326,0.5633528265107213,0.9397055923608452,1.0,5/13,14.54%,SLC30A10;TERT;SIRT1;RBL1;ZKSCAN3
prerank,protein K48-linked deubiquitination (GO:0071108),-0.33459560168051083,-0.9200905251208992,0.5723981900452488,0.8288039168022441,1.0,8/23,23.13%,OTUD7A;OTUD7B;YOD1;USP50;VCPIP1;USP8;MINDY1;BAP1
prerank,phagosome-lysosome fusion (GO:0090385),0.43426593077206704,0.9196213558250016,0.5378323108384458,0.9402456436776839,1.0,5/10,21.80%,RAB34;PIKFYVE;RAB7B;PLA2G5;RAB7A
prerank,"wound healing, spreading of cells (GO:0044319)",0.37649267395847097,0.9195896020932822,0.5614334470989761,0.939584189694082,1.0,2/24,3.73%,COL5A1;PDPN
prerank,carbohydrate transport (GO:0008643),-0.40796742990341167,-0.919393489169752,0.5798687089715536,0.8297196956701463,1.0,5/11,30.20%,AQP11;SLC50A1;SLC23A1;SLC23A2;AQP1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.43608668200059275,0.9193462792485487,0.5565693430656934,0.9394118590738514,1.0,3/12,16.97%,IL12B;ZBTB1;CCR2
prerank,presynaptic endocytosis (GO:0140238),-0.3276037127971648,-0.9191079846288871,0.5776699029126213,0.8296907584424291,1.0,4/24,7.30%,NLGN1;SYT1;STON2;AMPH
prerank,organic substance transport (GO:0071702),0.28467151587962247,0.9190810309411064,0.6299862448418156,0.9393225461962064,1.0,18/121,10.34%,SLC22A6;ABCA4;SLC35F3;PCTP;SLC22A18;ABCA9;SLC19A1;SLC22A5;TCN2;SLC48A1;HRG;SLC6A4;TOM1;PICK1;MFSD2B;CHMP1A;PLEKHA8;SLC19A2
prerank,telomere maintenance (GO:0000723),0.3271137376363519,0.9187803845588214,0.5964912280701754,0.9392809356055097,1.0,16/50,19.85%,POLD2;TPRKB;ATM;ACD;TEP1;TERT;PRKDC;HUS1;RAD50;NSMCE2;ZBTB48;SP100;TINF2;NBN;RAD51D;XRCC3
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.3292275435924462,-0.9185351452471066,0.5897435897435898,0.8302636906915355,1.0,13/23,26.88%,MYO10;CCDC88A;DYNC1I1;KIF5C;MAP6;TUBA1A;CCDC88C;CCDC186;KIF5A;TUBA1B;TUBA1C;F8A1;KIF1A
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.35743036629122005,-0.9181504841849704,0.5435684647302904,0.8303841944982969,1.0,3/16,10.92%,SCARB1;LDLR;MFSD2A
prerank,T cell differentiation in thymus (GO:0033077),0.4061219650412305,0.9178356888306586,0.5583482944344704,0.9407157486401225,1.0,4/14,20.03%,GLI3;ADAM17;ZFP36L1;LIG4
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.3167173184142766,-0.9168826838707835,0.5955056179775281,0.8325741221675576,1.0,10/29,20.20%,HSP90AB1;PPIA;HSP90AA1;TNKS1BP1;TERF2IP;TERF1;RPA1;ANKRD28;NHP2;PTGES3
prerank,smooth muscle contraction (GO:0006939),-0.3644371666823279,-0.9168202031347911,0.5765957446808511,0.8320012951919881,1.0,5/14,10.14%,SLC8A1;EDNRA;SMTN;MYH11;ACTA2
prerank,B cell homeostasis (GO:0001782),0.43935666880687413,0.9167000104152847,0.55765595463138,0.942698581493704,1.0,1/10,0.43%,DOCK11
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3799057496985281,0.9164562316847379,0.565,0.9425778393446274,1.0,6/21,16.40%,TUT4;SAMD4A;CNOT10;PAN3;PNLDC1;TUT7
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.26446160521456324,0.9164243729533025,0.6488095238095238,0.9419473116597996,1.0,67/241,23.35%,SRRM2;DDX5;POLR2A;SNRNP70;PCBP2;PABPN1;HNRNPR;HNRNPH1;SRSF5;SNIP1;HNRNPA2B1;POLR2D;RBM15;SPEN;NOVA1;GPKOW;CCAR1;CWC27;GTF2F1;HNRNPL;CWC15;IK;USP49;PHF5A;SRSF11;PRCC;HNRNPC;PRPF3;SNRNP40;RBM4;TFIP11;HNRNPM;CPSF3;CWF19L1;FRG1;USP39;ZCRB1;PRPF6;FUS;SRSF1;CSTF1;HNRNPH3;CDC40;PCF11;SRSF10;U2AF1;EFTUD2;SNRPC;SRSF7;SF1;PNN;POLR2G;WBP4;PRPF31;SNRPA1;U2AF2;SF3B2;SF3B1;PPWD1;SF3B5;CPSF7;GCFC2;PQBP1;CDC5L;RNPC3;NUDT21;POLR2F
prerank,chromatin assembly (GO:0031497),0.33899824520792887,0.9160889729874369,0.5602716468590832,0.9420496720208245,1.0,14/38,25.22%,CHAF1B;ATRX;TP53;KAT6B;SIRT1;BAHD1;CDAN1;PADI4;EZH1;ASF1A;NOC2L;NAP1L2;H1-0;M1AP
prerank,regulation of primary metabolic process (GO:0080090),0.28315179903162724,0.9160443643355306,0.617300131061599,0.9414489098892319,1.0,13/126,8.30%,ROCK2;NFYC;PPARA;CHD9;NCOR2;NFYB;GPS2;C1QTNF2;TBL1X;SMARCD3;ANGPTL8;NR1D2;TBL1XR1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3303890769081595,-0.9158871841037994,0.5818181818181818,0.8333597844454446,1.0,10/23,27.77%,RAD23B;UBB;COPS4;CETN2;COPS6;COPS5;UBC;RPS27A;DDB1;COPS2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.34884850923791494,0.9157988298189929,0.5758564437194127,0.9412879883584894,1.0,9/30,20.23%,TLR3;IKBKE;TLR4;RIPK1;LY96;BIRC3;CD14;TANK;TRAF3
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.39094640685297993,0.9155134389990637,0.554006968641115,0.9412465975760694,1.0,4/18,12.56%,PRKN;ADRA2A;MIDN;SIRT4
prerank,protein localization to lysosome (GO:0061462),-0.3202876100351733,-0.9154388679312969,0.5932584269662922,0.8336714240382996,1.0,12/28,25.73%,RTN4;SORL1;SH3BP4;GCC2;LAPTM5;NCOA4;M6PR;SCARB2;RNF128;CD81;LMBRD1;NAGPA
prerank,renal water homeostasis (GO:0003091),0.3795205428887683,0.9152504220108614,0.5891608391608392,0.9411129642682846,1.0,3/23,7.00%,ADCY5;ADCY1;ADCY9
prerank,cellular response to calcium ion (GO:0071277),0.3018108995367752,0.9152426836139346,0.5798816568047337,0.9404253942829255,1.0,9/67,9.25%,SYT9;SYT11;SYT12;PRKAA2;ADCY1;BRAF;CPNE3;MEF2A;ITPKB
prerank,cellular response to heat (GO:0034605),0.3407340448656122,0.9152147047300416,0.560200668896321,0.9397787764480374,1.0,3/35,7.88%,FGF1;POLR2D;HSBP1L1
prerank,nitrogen compound transport (GO:0071705),0.2767569158044802,0.9152038157116661,0.6223684210526316,0.9391005013704329,1.0,22/141,12.40%,SLC6A13;SLC6A12;SLC38A4;SLC38A3;SLC7A11;SLC7A2;PDPN;SLC35F3;SLC25A48;SLC22A5;TCN2;SLC38A1;SLC48A1;HRG;SLC6A4;TOM1;PICK1;CHMP1A;SLC19A2;RALBP1;TCN1;MIA3
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3215419722526063,-0.9149401664478535,0.6,0.8340694892037962,1.0,7/27,12.85%,DACH1;BMPR2;ACVRL1;FGF2;PDGFA;CDKN1A;SMG5
prerank,regulation of viral life cycle (GO:1903900),-0.33363318279122556,-0.9145497160847491,0.5727272727272728,0.8342546696222917,1.0,6/21,20.62%,HS3ST5;PPIA;TRIM14;TRIM27;TYRO3;TRIM68
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3331326589603583,0.9139505436410089,0.5900621118012422,0.9412347778136042,1.0,18/42,22.68%,CHD4;RNF8;SMARCA4;SRCAP;SMARCC2;SMARCE1;HDAC1;NASP;HNRNPC;MTA2;ARID1B;ACTR6;CHD8;CECR2;SMARCD2;MBD2;DMAP1;SMARCB1
prerank,sodium ion import across plasma membrane (GO:0098719),0.3943420956231946,0.9138685917574827,0.5815217391304348,0.9407229651654386,1.0,1/17,0.37%,SLC6A1
prerank,regulation of protein kinase activity (GO:0045859),0.2922819776127691,0.9138257279041999,0.6099585062240664,0.9401084578828466,1.0,14/106,11.28%,PRKAG2;ALS2;PPM1E;DEPTOR;DTNBP1;UVRAG;TRIB2;CACUL1;WWTR1;PDPK1;TAB2;SIRT1;JTB;TRIB1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.3871202318956222,-0.9137177781243198,0.5968819599109132,0.8354337923468845,1.0,2/13,9.29%,PRR5L;PNPT1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.42781569926172647,0.9136302402820282,0.5440900562851783,0.9398867333315977,1.0,3/11,17.98%,ITPKB;PPIP5K2;IP6K3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.32395429693996464,-0.9135537970962195,0.5868544600938967,0.8351180326533325,1.0,10/24,19.64%,EPN2;DAB2IP;TMEM204;ITGB3;HIF1A;MT3;HHEX;ITGA5;PTPN1;VTN
prerank,negative regulation of hemostasis (GO:1900047),0.4127142200840612,0.9135247202309195,0.5470249520153551,0.9394291030017232,1.0,3/12,7.12%,TFPI;KNG1;SERPINE1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.30241285825119224,-0.9130861559634008,0.5725593667546174,0.835454176285039,1.0,6/33,12.54%,PRKG1;MEF2C;TGFB3;APOD;GPER1;CDKN1A
prerank,negative regulation of protein catabolic process (GO:0042177),-0.289601358048936,-0.9130744993222297,0.6055979643765903,0.8347634145587176,1.0,10/40,13.87%,FMN2;CST3;NELL1;DAB2IP;FLNA;TIMP2;IRAK3;PTPN3;SNCA;ADGRB1
prerank,mRNA 3'-end processing (GO:0031124),0.30369933449968667,0.9129658915025727,0.60431654676259,0.940015306594511,1.0,23/78,22.14%,PABPN1;SRSF5;AHCYL1;POLDIP3;RPRD2;POLR2D;TENT2;SCAF8;SRSF11;SARNP;TENT4B;CPSF3;PAPOLG;GRSF1;SRSF1;CSTF1;CDC40;PCF11;U2AF1;SRSF7;U2AF2;TUT1;CPSF7
prerank,regulation of lymphocyte migration (GO:2000401),-0.41470955404910614,-0.9129461918157759,0.5925155925155925,0.8343352127476593,1.0,3/10,10.86%,STK10;JAM2;MSN
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.3470309875760829,0.9125917811097316,0.5557377049180328,0.9401584373916975,1.0,7/31,7.93%,SIPA1L1;EPHA4;NGEF;LRRK2;CUX2;CAPRIN2;PTEN
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.36887400170123935,0.9124898964824762,0.5707236842105263,0.9396771247074739,1.0,3/24,7.06%,PRKN;LRRK2;OPA1
prerank,protein destabilization (GO:0031648),0.3533578618347232,0.9120217534763694,0.6016528925619835,0.9400990422313232,1.0,7/32,10.49%,PRKN;CTSH;FBXW11;BTRC;HTT;SIRT1;IRGM
prerank,cell proliferation in forebrain (GO:0021846),0.4458734731878455,0.9119629214629915,0.5686274509803921,0.9395206099587793,1.0,7/10,30.63%,DOCK7;HOOK3;PCM1;CEP120;NUMBL;NUMB;AKNA
prerank,negative regulation of synaptic transmission (GO:0050805),0.3728180643866625,0.9117570576871662,0.564625850340136,0.939286101922115,1.0,5/23,9.70%,SYT11;LRRK2;PRRT1;PTEN;PICK1
prerank,regulation of protein kinase B signaling (GO:0051896),0.2686341801850689,0.9117119958850528,0.64,0.9386717713397195,1.0,32/193,12.47%,FGF1;OSBPL8;KIT;PPARA;FGFR2;KL;IL18;PKHD1;FRS2;FGFR1;MAGI2;TGFBR1;DAG1;CD28;PDGFRB;GAB2;RICTOR;PTEN;PIK3CA;NRG1;PDPK1;SIRT1;TCF7L2;HBEGF;FLT3LG;CASS4;RNF41;KLB;GDF15;PHLPP2;PTPN11;TGFA
prerank,cellular response to insulin stimulus (GO:0032869),0.28177430457995356,0.9116264208263872,0.6225626740947076,0.9381725405388325,1.0,19/124,11.33%,CPEB2;SORBS1;RHOQ;INSIG2;PHIP;ATP6V0E1;BAIAP2;ATP6V0B;SLC27A1;GCK;PDPK1;GRB10;FOXC2;FER;RAB13;PIK3R3;ATP6V1D;ATP6V1E1;PRKDC
prerank,embryonic digit morphogenesis (GO:0042733),0.3911724113394659,0.9114776373765034,0.575591985428051,0.9378419711611272,1.0,5/18,16.31%,OSR1;GLI3;HDAC1;WDPCP;CREBBP
prerank,peptidyl-lysine methylation (GO:0018022),0.35923556270137347,0.9114031934900868,0.5646853146853147,0.9372910415791686,1.0,8/26,22.70%,SMYD3;SETD7;KMT5A;EHMT2;EHMT1;SETD3;N6AMT1;EEF1AKMT1
prerank,positive regulation of T cell differentiation (GO:0045582),0.34203250695586945,0.9110960434781372,0.5838815789473685,0.9372733086045906,1.0,7/36,11.70%,GLI2;GLI3;IL12B;SOX12;DUSP10;ZBTB1;ZMIZ1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3978061766572447,0.9106559261939607,0.555765595463138,0.9376028562559907,1.0,3/15,9.53%,PPARA;ADM;SLC45A3
prerank,myelination in peripheral nervous system (GO:0022011),-0.3834960907331465,-0.9105649570238477,0.5867768595041323,0.8391815799276219,1.0,8/13,28.47%,ADGRG6;MYOC;PRX;SIRT2;LGI4;SOD1;NF1;NCMAP
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.260257080790479,0.910495555214337,0.6678966789667896,0.9372815645967931,1.0,29/234,11.27%,PPARGC1B;SMAD3;ZIC2;PRKCZ;KIT;PPARGC1A;ADCY1;IL18;SPHK1;CFLAR;EDA;NHLH2;PRKCB;IKBKE;SMO;TLR4;EIF2AK2;PTEN;SMARCA4;HDAC4;TAB2;TFDP1;RIPK2;RIPK1;MAVS;FER;RAB7B;ATF2;ANXA3
prerank,positive regulation of vascular permeability (GO:0043117),0.43587435763026694,0.9104383108250157,0.5538160469667319,0.9367033782663862,1.0,1/12,0.40%,BMP6
prerank,regulation of embryonic development (GO:0045995),0.34136318650266506,0.9101018859877202,0.5901116427432217,0.9368068668827279,1.0,10/34,13.86%,CLASP1;DAG1;NIPBL;TRIP12;NIBAN2;NR2C2;PHLDB2;FOXA2;TDG;WDPCP
prerank,regulation of feeding behavior (GO:0060259),0.4271001918867303,0.9098816585435373,0.5677179962894249,0.9366175184591398,1.0,1/11,0.73%,LEPR
prerank,regulation of cell morphogenesis (GO:0022604),0.35759253859413637,0.9096209297845627,0.5894909688013136,0.9365368774830283,1.0,11/30,18.47%,SH3D19;CAPZB;PHIP;PDPN;MOV10;VIL1;ZMYM6;WTIP;ZMYM4;MYO9A;LARP4
prerank,sphingoid biosynthetic process (GO:0046520),-0.4027658278981754,-0.9096037627394384,0.5682730923694779,0.8399893238771915,1.0,4/11,11.77%,ACER3;ACER2;SPTLC2;ASAH2
prerank,sphingosine biosynthetic process (GO:0046512),-0.4027658278981754,-0.9096037627394384,0.5682730923694779,0.8399893238771915,1.0,4/11,11.77%,ACER3;ACER2;SPTLC2;ASAH2
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.26137788494343733,-0.9095828837440407,0.6511627906976745,0.8393067088021531,1.0,21/68,24.37%,STAT3;MBP;ARHGEF2;IL33;APP;PLCG2;CYBA;TIRAP;TWIST1;LBP;DHX9;NOD2;CD74;SYK;TLR7;TYROBP;LGALS9;PYCARD;IL6R;F2R;HYAL2
prerank,histone monoubiquitination (GO:0010390),0.36912816888501726,0.9092342246150366,0.5530035335689046,0.9367372006623494,1.0,7/24,19.45%,CTR9;BCOR;KDM2B;DDB2;UBE2E1;RNF20;RNF2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.23441167331251897,-0.9091357803656942,0.7003610108303249,0.8396054997941513,1.0,28/136,14.71%,ESR1;TMSB4X;CD200;ID1;GAS6;PTGIS;CYP1B1;NFKBIA;SFRP4;DAB2IP;FLNA;HES1;PTCH1;CTNNBIP1;HEYL;PROX1;IRAK3;SMAD7;ERBIN;ID2;PKD1;HAVCR2;NLRC5;CMKLR1;AIM2;RBCK1;TRIM37;DAP
prerank,female gamete generation (GO:0007292),0.3639294008254442,0.9091317601972757,0.5918367346938775,0.9362805090117758,1.0,4/29,7.13%,SPO11;DIAPH2;USP9X;TOB2
prerank,response to organonitrogen compound (GO:0010243),-0.29141766290694326,-0.9086943819809471,0.6216867469879518,0.8398711620299073,1.0,11/38,21.60%,GLRB;GLRA3;IRAK3;GLRA1;GLRA2;TRPM2;RHBDD1;NR1H4;IRF5;RCN3;DRD2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.33429541595441814,0.9084498655681952,0.596989966555184,0.937143363089701,1.0,4/41,7.34%,SYT11;IGF1;TLR4;PTPN22
prerank,phospholipid dephosphorylation (GO:0046839),-0.304632813951238,-0.9081701122401569,0.6196808510638298,0.8403427615506347,1.0,9/37,11.53%,PLPP1;PLPPR1;MTMR6;MTMR2;PLPPR5;MTMR11;PLPPR4;MTMR7;MTMR9
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3713361491568561,0.9079135584788419,0.5799319727891157,0.9376514634791907,1.0,2/25,5.16%,SMAD3;TLR4
prerank,cardiac ventricle morphogenesis (GO:0003208),0.32929592634891486,0.9078954866342507,0.5806451612903226,0.9370010886498262,1.0,5/41,7.34%,TGFBR3;FGFR2;BMPR1A;TPM1;TGFBR2
prerank,response to growth factor (GO:0070848),0.33159567969769893,0.9078676641698031,0.5728155339805825,0.9363623270623348,1.0,7/41,7.34%,SPHK1;BMPR1A;TGFBR1;MAP2K5;PLK5;CPNE3;TGFBR2
prerank,regulation of keratinocyte migration (GO:0051547),-0.3810107639297057,-0.9077117347919378,0.5793814432989691,0.8406950698583056,1.0,4/12,16.21%,EPB41L4B;IQSEC1;FGF7;ARF6
prerank,response to chemokine (GO:1990868),-0.38501551733224204,-0.9076619738139569,0.6105032822757112,0.8400879689508739,1.0,5/13,10.82%,LRCH1;CXCL12;SLC12A2;DOCK8;DUSP1
prerank,integrated stress response signaling (GO:0140467),-0.3678460991313352,-0.9075242014289713,0.5846153846153846,0.8396850604584271,1.0,3/14,15.45%,HSPA5;ATF4;EIF2AK3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.3900351072233602,0.9071991116221365,0.5769230769230769,0.9372183157038785,1.0,4/16,17.07%,CPEB3;MOV10;ZFP36L1;PLEKHN1
prerank,regulation of cell cycle (GO:0051726),0.26176034684093547,0.9071714818635611,0.6781472684085511,0.9365931002756244,1.0,48/271,14.68%,NOTCH2;BMP7;SMAD3;FGFR2;GRK5;SON;FBXL17;NUPR1;MAGI2;TGFBR1;ATM;ANKRD17;IL12B;TP53;SIK1;AFAP1L2;CDC14A;CDK5RAP3;NUPR2;SND1;LIN52;CDC25A;SIRT1;CHMP1A;CCNB2;TCF7L2;HBP1;PHACTR4;TBRG4;FBXL12;SRPK2;ABL1;CDC14B;MYBL2;CSNK2A2;CSNK2A1;MLXIPL;IRF1;PPP1R13B;MAP2K1;PML;PRCC;MFN2;PER2;TSC1;KAT2B;GADD45A;MAP2K6
prerank,cellular response to interleukin-12 (GO:0071349),-0.28319368292545455,-0.9068486668296454,0.625,0.8405647788240259,1.0,16/48,25.99%,PPIA;RAP1B;RPLP0;JAK1;CD47;MSN;PITPNA;TALDO1;CFL1;CAPZA1;AIP;PDCD4;SOD1;MTAP;JAK2;STAT4
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.3620847369564456,0.9068004419519922,0.5872193436960277,0.9366908710579844,1.0,3/26,5.87%,RORA;SULF2;NOX1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3634848371506039,-0.9066752290694367,0.5868131868131868,0.8402045153828298,1.0,5/15,10.36%,NGF;NTRK2;SORT1;DDIT4;BCAR1
prerank,tRNA aminoacylation (GO:0043039),-0.291992530026123,-0.9062502018981645,0.6243523316062176,0.8404671809814634,1.0,4/37,12.10%,LARS2;WARS2;GARS1;DARS2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.351510235618975,0.906190579451113,0.5699831365935919,0.937338675635637,1.0,6/29,14.31%,WWOX;BID;PPP2R1B;RIPK1;PML;AGTR2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.3856653281221989,-0.9060545988576847,0.597872340425532,0.8401805008939837,1.0,4/13,12.21%,BMP5;APOE;BMP2;ERLIN1
prerank,fatty acid elongation (GO:0030497),-0.37437267847132066,-0.9056988759395229,0.5859872611464968,0.840259330106054,1.0,3/13,10.29%,ELOVL7;ELOVL5;ELOVL6
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3095466531265049,0.9055959117167252,0.6088235294117647,0.9379211390358296,1.0,11/66,9.78%,SMAD3;SESN2;F2;WWTR1;CDK5RAP3;ZIC1;TERT;PARP9;LARP7;UBR5;MAVS
prerank,cellular response to alcohol (GO:0097306),0.32845947670377396,0.9055681452098437,0.5887850467289719,0.9372944175417112,1.0,4/42,4.94%,ADCY5;ADCY1;GRAMD1B;SMO
prerank,regulation of mitochondrial fusion (GO:0010635),-0.39539022565256654,-0.9052842458577297,0.6036960985626283,0.8404512114089893,1.0,2/11,4.48%,PID1;TFRC
prerank,regulation of ion transmembrane transport (GO:0034765),-0.29642248903427515,-0.9047328205183792,0.6098765432098765,0.8409838317072093,1.0,7/33,8.00%,AKAP6;KCNJ3;CHRM3;KCNJ2;NEDD4L;YWHAE;KCNQ1
prerank,zinc ion transmembrane transport (GO:0071577),0.3675870602118707,0.9045325964986184,0.5716753022452504,0.9389570311804768,1.0,3/22,8.11%,SLC30A10;SLC30A2;SLC39A13
prerank,oligosaccharide biosynthetic process (GO:0009312),0.378547309772386,0.9045200506385866,0.5737122557726465,0.9382930514157404,1.0,5/20,6.51%,FUT1;ST3GAL3;B4GALT1;FUT8;ST6GALNAC6
prerank,histone H2A acetylation (GO:0043968),0.3928256152534684,0.9042403254614606,0.5894160583941606,0.9382282946930666,1.0,1/16,1.51%,BRD8
prerank,regulation of cell killing (GO:0031341),-0.3586413787191488,-0.9038011808766989,0.5914893617021276,0.8423136798604527,1.0,3/16,10.68%,TGFB2;ICAM1;CYBA
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.38506686382108457,0.9034664436339959,0.5871212121212122,0.9392951014278972,1.0,4/17,9.80%,IGF1;DOCK5;PDGFRB;DOCK7
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.23761245798091402,-0.903228231028204,0.724,0.8428841377122736,1.0,28/124,15.89%,LEF1;PRICKLE2;DAAM1;GNG2;SFRP4;PSMB2;NLK;ROR2;TIAM1;CALM1;FZD4;MAP3K7;PPP3R1;NFATC1;PPP3CA;PSMD14;AP2B1;PSMC6;FRZB;VANGL2;AP2M1;CTNNB1;CCDC88C;SMURF1;GNAO1;GNB1;PSMA4;PSMB9
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3662466522991409,0.9031116115086284,0.6076794657762938,0.9393783440848165,1.0,2/24,2.15%,DNMT3A;JARID2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.35898148815466124,0.9030119058468832,0.5936952714535902,0.9389222524598873,1.0,1/25,0.73%,LEPROT
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.297027444837102,0.9022261863591527,0.6048850574712644,0.9399812864208369,1.0,15/73,15.34%,DNMT3A;JARID2;TAF1D;BAZ1B;HDAC4;GLMN;MYO1C;TDG;POLR1G;PHF1;PHF2;TBP;KAT2B;SPHK2;MPHOSPH8
prerank,tRNA 5'-end processing (GO:0099116),0.399997996993686,0.9020684975632838,0.5694716242661448,0.9396406970233454,1.0,5/15,20.86%,RPP21;RPP25L;PRORP;POP7;POP1
prerank,lipid droplet formation (GO:0140042),-0.4069732718516767,-0.9020359559469421,0.606,0.8448108393845155,1.0,4/10,26.56%,CDS1;SQLE;AUP1;CDS2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.42290439894972415,0.9018838103429998,0.5846153846153846,0.9393610107448183,1.0,3/12,5.16%,SLC5A3;DUOXA1;TLR4
prerank,DNA repair (GO:0006281),0.2568867961812104,0.9014099534547163,0.7045191193511008,0.9397014904801445,1.0,65/284,20.25%,EYA1;POLD2;BABAM2;KMT5C;USP3;ATM;ASCC2;UVRAG;RAD54L;BAZ1B;KMT5B;TP53;PARP4;RNF8;FANCI;HUWE1;FBH1;XRCC4;FANCM;PDS5A;PARP9;SIRT1;ABL1;EME2;RBBP8;PRKDC;MSH3;ZBTB1;HUS1;IGHMBP2;UIMC1;FANCA;RAD50;PNKP;TDG;POLE2;BABAM1;DDB2;GADD45A;DOT1L;MGMT;INTS3;TDP2;TEX264;POLL;ALKBH5;MBD4;OGG1;USP1;NBN;SUMO1;FEN1;RAD51D;PIAS4;SLX4;MMS19;PDS5B;APTX;MTA1;XPA;ASF1A;FANCD2;XRCC3;LIG4;RAD9A
prerank,positive regulation of macrophage activation (GO:0043032),-0.3511060015756958,-0.9010698330703877,0.6013667425968109,0.8462619824022269,1.0,3/17,14.59%,THBS1;IL33;LBP
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.38608937551986827,0.9009927755259589,0.5577981651376147,0.9399594137733107,1.0,2/19,1.44%,PICALM;IGF1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.4255268464023069,0.9006200646707072,0.6042471042471043,0.9400887047628317,1.0,4/11,16.41%,ELOF1;ZMIZ2;ZMIZ1;ARID1B
prerank,regulation of dephosphorylation (GO:0035303),-0.3584026919983617,-0.9000013490160803,0.5908096280087527,0.8478903123396946,1.0,5/15,12.85%,PPP1R16B;PPP1R16A;MTMR2;MTMR9;SMG5
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.37216095479324135,0.8997922237624016,0.5933682373472949,0.9412326055340742,1.0,6/22,16.18%,NEDD4;PTPN23;RNF115;VPS37A;SNF8;VPS4A
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.41543992398569934,0.8996979856586667,0.5810055865921788,0.9407645230821844,1.0,3/12,13.22%,PPARA;MIA3;WNK1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.33273479420967444,0.8994029486026598,0.5954323001631321,0.9407272064035549,1.0,14/39,18.64%,TTC7B;PI4KA;SMG1;TMEM150A;PIP4K2C;PIK3CA;ITPKB;PIK3R3;SOCS3;PI4K2B;SOCS4;SOCS7;IP6K3;PI4KB
prerank,negative regulation of cell aging (GO:0090344),0.392156886572249,0.8992883450023541,0.5962962962962963,0.9403202698492679,1.0,5/16,14.54%,SLC30A10;TERT;SIRT1;RBL1;ZKSCAN3
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.34668496858220843,0.8987257314941846,0.5914742451154529,0.9408831777351068,1.0,9/29,17.97%,STAT2;SAMHD1;MAVS;YTHDF3;PTPN11;OAS3;USP18;IFNAR2;WNT5A
prerank,response to tumor necrosis factor (GO:0034612),0.2840741246224118,0.8987161038884726,0.6355685131195336,0.9402227184650905,1.0,12/91,10.18%,GSDME;AFF3;NPNT;SPHK1;CASP3;ZFAND6;GBP3;GBP2;HYAL1;SIRT1;RIPK1;CCL25
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3251085781920733,-0.8985911685132756,0.6032482598607889,0.8504347734391161,1.0,8/24,16.81%,NCKAP5;STMN2;FGF13;TRPV4;MAPT;STMN1;MAP7D3;TPPP
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.3643614610363186,0.8984765971307442,0.6076794657762938,0.9401071084119559,1.0,2/26,5.16%,SMAD3;TLR4
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.36509954576928794,-0.8981261405241183,0.6114790286975718,0.8508157321252862,1.0,8/14,31.27%,TSEN34;FAM98B;TSEN54;RTCB;CPSF4;TSEN15;CLP1;CPSF1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.31218168106743405,0.8981150248599514,0.6218354430379747,0.9402118519593129,1.0,7/57,7.83%,ADCY5;LPAR1;ADCY1;ADRA2A;AKAP12;ADCY9;GNAT3
prerank,glucose catabolic process to pyruvate (GO:0061718),0.36695249787206147,0.8974947501556441,0.5955249569707401,0.9402330229191823,1.0,3/24,7.27%,HK2;PGAM2;GCK
prerank,canonical glycolysis (GO:0061621),0.36695249787206147,0.8974947501556441,0.5955249569707401,0.9402330229191823,1.0,3/24,7.27%,HK2;PGAM2;GCK
prerank,positive regulation of rRNA processing (GO:2000234),0.43727420893948904,0.8974026766274066,0.5871212121212122,0.9397534131649936,1.0,5/10,28.95%,RIOK2;WDR43;BUD23;RIOK1;WDR75
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.3763454542772414,-0.8973035857324907,0.5987124463519313,0.8518931854047539,1.0,3/12,5.51%,PROM1;STAT3;RORB
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.36715775909916293,0.8971759313822056,0.5962199312714777,0.9395927045600393,1.0,7/23,16.92%,PLK5;CDK5RAP3;AURKB;PRCC;INTS3;VPS4A;CHMP4C
prerank,lipoxygenase pathway (GO:0019372),0.396993524559358,0.8964875076755863,0.5757575757575758,0.9404472592513679,1.0,2/14,7.66%,ALOX12;PON3
prerank,regulation of telomere capping (GO:1904353),0.37141580541982017,0.8961903978616168,0.6024734982332155,0.9404305871145718,1.0,6/23,12.69%,ATM;TNKS2;AURKB;RAD50;USP7;PNKP
prerank,homologous chromosome segregation (GO:0045143),-0.33399790182141376,-0.8951371729084685,0.5968468468468469,0.8559794843585261,1.0,4/20,21.61%,FMN2;ZCWPW1;MEI4;PRDM9
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.3201258433668266,0.8946538643590145,0.6303030303030303,0.9431170170181375,1.0,7/49,9.10%,KIT;IGF1;IL18;PARP14;IL12B;TNFRSF18;PARP9
prerank,histone methylation (GO:0016571),0.35274827648220985,0.8942640132614712,0.5719237435008665,0.9432834164286115,1.0,6/26,16.83%,SMYD3;NSD1;NSD3;EHMT2;CREBBP;EHMT1
prerank,vesicle organization (GO:0016050),-0.27232810417384345,-0.8941766904143622,0.6368563685636857,0.857460161925859,1.0,8/46,8.22%,CAV1;FNBP1L;CD34;CAV2;LAPTM4B;DNM1;SORT1;ALS2CL
prerank,snRNA 3'-end processing (GO:0034472),0.3820707815750741,0.8937216894935363,0.5680580762250453,0.9438254823554926,1.0,8/19,21.65%,EXOSC7;INTS2;INTS5;INTS7;INTS1;INTS8;EXOSC3;TUT1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.41357456025649,0.8936250521650744,0.6003717472118959,0.9433775252058678,1.0,1/11,0.73%,LEPROT
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.4043616701801122,0.8935534331225469,0.5831739961759083,0.9428548624972795,1.0,4/13,16.41%,ELOF1;ZMIZ2;ZMIZ1;ARID1B
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3154584229809121,0.8932533290637721,0.6234567901234568,0.9428116643820103,1.0,7/49,10.40%,GSDME;NUPR1;BID;DDX3X;TP53;DNM1L;BECN1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.34344663889025295,0.8932055499493329,0.618421052631579,0.9422418381034293,1.0,6/35,8.71%,ALOX12;ACSS3;BDH1;SCD5;BDH2;HMGCS2
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3693284935689901,0.892923527343711,0.5935919055649241,0.9422039702783672,1.0,3/22,6.47%,IL18;SPHK1;IL12B
prerank,heterocycle biosynthetic process (GO:0018130),-0.3573647460279443,-0.8928849495863196,0.6076759061833689,0.8595465794367658,1.0,2/14,6.40%,GPHN;GCH1
prerank,protein autophosphorylation (GO:0046777),0.2728901219820201,0.8928673944029247,0.6505102040816326,0.9416402216704564,1.0,25/157,10.71%,OXSR1;KIT;FGFR2;EPHA4;GRK5;FGFR1;AAK1;LRRK2;SMG1;ATM;EPHA8;FLT1;PDGFRB;SIK1;EIF2AK2;MAPKAPK3;PDPK1;RIOK2;PIKFYVE;RIPK1;MKNK1;FER;AURKB;ABL1;DYRK1A
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.29411299641390715,-0.8903989697603506,0.6614173228346457,0.8642771612866955,1.0,6/33,17.31%,LEF1;RUNX1;CTNNBIP1;ID2;FES;CD74
prerank,histone mRNA catabolic process (GO:0071044),0.3986025379043123,0.8903110919590287,0.5935251798561151,0.9466366270895303,1.0,7/15,24.20%,ATM;TUT4;TENT2;TENT4B;TUT7;TUT1;XRN1
prerank,retinol metabolic process (GO:0042572),-0.36070235461586597,-0.8899850815344343,0.5964523281596452,0.8644261842166512,1.0,3/14,10.97%,CYP1B1;RDH10;ADH1A
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.2849647029182355,-0.889978721105094,0.6508379888268156,0.8637128034217385,1.0,16/40,32.89%,PID1;SLC25A33;MAPT;PINK1;UBB;RNF122;SOD1;STOML2;PRELID1;PYCR1;PMAIP1;PARK7;SPART;PIP5KL1;SLC4A11;PRDX3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.2559926015374423,0.8895762063158033,0.7248803827751196,0.9475689680025866,1.0,58/259,17.05%,CFAP44;ACTN2;KIT;AVIL;CC2D2A;RHOD;PKHD1;DCDC2;SRGAP2;FGD4;CEP250;CPLANE2;RILPL1;EZR;RAB3IP;CYS1;RHO;PTPN23;ASAP1;EXOC2;CCDC28B;SSTR3;CEP162;ANO6;CDC14A;IFT122;WDR19;OPHN1;DYNC2I1;MKKS;TMEM231;CLUAP1;CDC14B;ATP6V1D;FGD1;IFT88;OCRL;MYLK;GALNT11;PDE6D;UNC119B;WDPCP;CFAP410;WDR35;EXOC4;EXOC3;PARVA;B9D2;ARFIP2;ARL6;RP2;BBS2;STK36;RFX2;RAB8B;RILPL2;PIBF1;TMEM237
prerank,mammary gland development (GO:0030879),0.3676843524547777,0.8894965978434515,0.6042031523642732,0.9470720613252939,1.0,4/21,8.47%,WNT4;GLI2;NRG1;APLN
prerank,male gonad development (GO:0008584),0.33941491858554124,0.8888604873144949,0.6209262435677531,0.9477917484022301,1.0,2/34,1.21%,WNT4;KIT
prerank,endodermal cell fate commitment (GO:0001711),0.4278097688803656,0.8887901984987573,0.6007462686567164,0.9472651716288176,1.0,2/10,10.74%,CTR9;RTF1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.33169097164097633,0.8884868933219092,0.6183333333333333,0.9472918558153015,1.0,8/37,14.33%,TNPO1;KIF3C;IFT122;WDR19;DYNC2I1;CLUAP1;IFT88;WDR35
prerank,stem cell development (GO:0048864),-0.3570600108678422,-0.888339331639505,0.6326086956521739,0.866617385643408,1.0,4/16,18.48%,CDH2;PTPRC;KLHL12;SOX8
prerank,positive regulation of chemokine production (GO:0032722),0.3244364077273214,0.8874148916557946,0.6325203252032521,0.948965931263963,1.0,9/44,13.35%,IL18;TLR3;TLR4;DDX3X;EIF2AK2;IL17RA;MAVS;ADAM17;OAS3
prerank,lymphocyte migration (GO:0072676),-0.29691942914142977,-0.887187290482502,0.635036496350365,0.8683801136858743,1.0,20/32,46.71%,S1PR1;MSN;RET;CCL13;CCL19;CCL2;MYO1G;CCL11;CCL4;GATA3;CRTAM;CCL8;CCL14;CKLF;CCR6;ADAM8;CCL1;CCL3;TBX21;XCL1
prerank,phosphorylation (GO:0016310),0.24635734268828255,0.8868898457051897,0.7615298087739033,0.9495019647048382,1.0,71/384,15.17%,PRKAG2;WNK4;ROCK2;OXSR1;PRKCZ;FAM20A;PRKAA2;GRK5;SPHK1;PI4KA;PRKAG3;FGFR1;BMPR1A;TGFBR1;DMPK;AAK1;LRRK2;TP53RK;PRKCB;GK5;IKBKE;ATM;PRRT1;CAMK1;BRAF;NUAK2;TRIB2;CDC42BPG;SIK1;EIF2AK2;TKFC;GK;TGFBR2;IGFBP3;PIK3CA;RYK;COQ8B;PDPK1;CSNK1A1;PICK1;MKNK1;FER;BRSK1;AURKB;SRPK2;ABL1;DYRK1A;MYLK3;TRIB1;PRKDC;MAPK6;CSNK2A1;PRKCA;HIPK3;PNKP;MAPK10;MAP3K1;FRK;PRKCI;WNK1;BMP2K;MAP2K1;ROS1;COQ8A;GRK3;ACVR2B;STK17B;SPHK2;CERK;ACVR1B;STK4
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.39872555272690147,-0.8868481005937371,0.6108695652173913,0.8683739070126942,1.0,4/10,18.23%,ACVRL1;ZBTB16;BMPR1B;PKDCC
prerank,TOR signaling (GO:0031929),0.3542134757253567,0.8868439463951749,0.612736660929432,0.9489277284239827,1.0,8/26,15.84%,FNIP1;NPRL3;SMG1;RICTOR;LARP1;MAPKAP1;FLCN;RPTOR
prerank,respiratory chain complex IV assembly (GO:0008535),0.3796179304539786,0.8861992359664599,0.6236933797909407,0.9496142768439051,1.0,12/21,30.07%,COX16;COX10;SMIM20;COX19;FASTKD3;COX15;TIMM21;COA5;SCO1;COX14;PET100;SURF1
prerank,rRNA 3'-end processing (GO:0031125),0.431509264634492,0.8849033554755755,0.600375234521576,0.9517230572784702,1.0,3/10,9.99%,ERI3;EXOSC7;ERI2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.37421550253154995,-0.8845880815981708,0.6271929824561403,0.8725906750883736,1.0,3/12,8.45%,ESR1;STAT3;TGFB1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.34105249240200336,0.8844488957874874,0.5968586387434555,0.9520457972861911,1.0,9/31,22.07%,CD300A;ATM;CD274;GLMN;SDC4;GPNMB;CTLA4;DLG5;ARG1
prerank,cellular response to interferon-gamma (GO:0071346),-0.24655493856146926,-0.8839988119772253,0.7459807073954984,0.8731285924932015,1.0,23/88,21.34%,CAMK2D;MID1;VCAM1;B2M;ICAM1;AQP4;SYNCRIP;IFNGR2;JAK1;CD47;GBP4;CD44;DAPK1;CCL13;RPL13A;IRF5;IRF2;CAMK2B;IRF8;CCL19;TRIM68;LGALS9;MT2A
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.34867485346202115,0.8839986245629361,0.6449399656946827,0.9523947133078052,1.0,7/26,14.43%,PCBP2;TRIB1;DHX58;NMI;MAPKBP1;ACOD1;PPM1B
prerank,positive regulation of neuron death (GO:1901216),0.31909142647112615,0.8839593719270453,0.6195826645264848,0.9517952110718061,1.0,4/46,5.16%,EFNB2;PICALM;NUPR1;TLR4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.3743537188197924,-0.8839322489962804,0.6188524590163934,0.8718076287631114,1.0,6/12,18.37%,ACTN4;EFNA5;CORO1C;DMTN;KANK1;SPRY4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.3743537188197924,-0.8839322489962804,0.6188524590163934,0.8718076287631114,1.0,6/12,18.37%,ACTN4;EFNA5;CORO1C;DMTN;KANK1;SPRY4
prerank,synaptic vesicle recycling (GO:0036465),-0.2917173653037724,-0.88388639371379,0.6573604060913706,0.8711836017836034,1.0,4/31,7.30%,NLGN1;SYT1;STON2;AMPH
prerank,regulation of phagocytosis (GO:0050764),-0.26519710214508674,-0.8837835723115728,0.6862745098039216,0.8706873833417103,1.0,11/53,10.68%,MERTK;SCARB1;GAS6;PTPRC;RAB27A;GATA2;DYSF;CALR;CD47;DOCK2;CYBA
prerank,axonal transport of mitochondrion (GO:0019896),0.40644320356653263,0.883782701079204,0.590316573556797,0.9515245848154202,1.0,2/11,7.06%,TRAK1;OPA1
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.3364694392955996,-0.8835049555056496,0.6179540709812108,0.8705825353075487,1.0,8/18,21.19%,PLCG2;DYSF;DOCK2;SBNO2;LBP;SYK;TYROBP;PYCARD
prerank,positive regulation of peptidase activity (GO:0010952),-0.33554307895034086,-0.8834217687284186,0.658256880733945,0.8700270004098207,1.0,9/20,27.30%,VSIR;DDRGK1;PINK1;MAPK12;APH1A;RCN3;PRELID1;NDUFA13;GRN
prerank,N-terminal protein amino acid modification (GO:0031365),0.3961342163807333,0.8833847486714513,0.5964912280701754,0.9517136614457831,1.0,7/14,31.35%,METAP2;NAA16;AANAT;NAA50;NAA15;NAA60;NAA40
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.40937231954165054,0.8832728264613278,0.56640625,0.9512875272691583,1.0,1/12,0.60%,CELSR1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4271811554908317,0.88323955019751,0.5849802371541502,0.950691866745092,1.0,4/10,16.85%,PRKAA2;SIRT1;FLCN;KLF15
prerank,positive regulation of cellular process (GO:0048522),0.23876307695478274,0.8831489336535778,0.7940552016985138,0.9502432566444458,1.0,77/565,12.47%,FGF1;BMP6;COLEC12;EFNB2;LAMC2;IGF1;PRKAA2;CCN2;IL13RA1;FGFR2;ECHDC3;EPHA4;RHOD;PKHD1;GRK5;SPHK1;NUPR1;PHIP;FGFR1;PRODH;TGFBR1;ADRA2A;PDPN;CDCA7L;SLC30A2;DPP4;TNFSF13;CTSH;PPP1R13L;TLR4;TPM1;MEIS1;ATM;DDX3X;P2RX3;NOX1;FLT1;ANKRD17;PDGFRB;IL12B;CACUL1;GAB2;WWTR1;TGFBR2;PTEN;TNFRSF18;GDNF;NRG1;NEUROD4;HDAC4;HYAL1;GLI1;SIRT1;LRP1;RIPK2;HDAC1;ASH2L;CCAR1;HTR1A;HBEGF;FLT3LG;FER;CRKL;TBRG4;SRPK2;MMP14;CDC42;ADAM17;DICER1;NOP2;AXIN2;VEGFD;ITGAV;CSNK2A1;PRKCA;MLXIPL;TGFA
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3706811010287978,0.8825015942874453,0.5792349726775956,0.9509817857051159,1.0,6/19,13.82%,CD27;MMP14;PRKDC;ZBTB1;ZMIZ1;AXL
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4185037653249455,0.882479352453203,0.6045627376425855,0.9503556865084832,1.0,2/11,7.34%,FGFR2;TGFBR2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.26529730270799423,-0.881998331429945,0.6620498614958449,0.872314054668286,1.0,22/56,25.10%,SPTBN1;ANK3;CIT;RHOB;ANLN;PDCD6IP;RASA1;TRIM36;STMN1;SEPTIN9;USP8;APC;NUSAP1;CHMP4B;EFHC2;SPAST;ECT2;CUL7;RHOC;KIF4A;CENPA;KIF23
prerank,protein localization to cell-cell junction (GO:0150105),0.4013274309612602,0.881936924335903,0.5940409683426443,0.9508718712103326,1.0,4/15,8.86%,CGNL1;ARHGEF18;MPP7;CDH5
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.27385286770259887,-0.8817929317904117,0.6916666666666667,0.8720308795938282,1.0,18/44,22.49%,PTPRJ;LYN;DAB2IP;APOE;SORL1;AIDA;IRAK3;UCHL1;DUSP1;BMP4;SPRY1;DNAJA1;PDCD4;SPRY4;PTPN1;AGT;STK38;PAQR3
prerank,transferrin transport (GO:0033572),0.33542149044488967,0.8816885085257052,0.6179001721170396,0.9507458277943097,1.0,11/33,18.72%,ATP6V0E1;ATP6V0B;RAB11B;ATP6V1D;ATP6V1E1;CLTC;DNM2;STEAP3;HFE;ATP6V0D1;ARHGAP1
prerank,regulation of protein metabolic process (GO:0051246),0.31730804376621063,0.881683600769106,0.6341463414634146,0.9500866588894697,1.0,4/44,7.39%,ROCK2;ACE;MAP2K5;ANGPTL8
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.3519115798867028,-0.8807429708621812,0.6434782608695652,0.8736242780759885,1.0,4/15,8.45%,CLASP2;CST3;FAP;TGFB1
prerank,regulation of protein binding (GO:0043393),-0.23500317493045028,-0.8805441225971714,0.76953125,0.8733606332015021,1.0,35/114,19.64%,CAV1;ACTB;CLDN5;EPB41;B2M;GSK3B;TIAM1;APP;DISC1;CTNNBIP1;PSEN1;CRK;DACT1;SORL1;BMP2;RALB;TMBIM6;GNL3L;ADD2;PKD1;FKBP1A;MARK2;BMP4;CDKN1A;CARD16;SPPL3;HIPK2;PPP1CA;ZFPM1;MEN1;CTSZ;HIP1R;RAN;LDLRAP1;VTN
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.37320221165946144,-0.8803088770746875,0.6236323851203501,0.8731455629049332,1.0,3/12,20.47%,ANO1;ADCY8;CFTR
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3930894424739944,0.8800493421248567,0.5930018416206262,0.9529828489345414,1.0,7/16,20.49%,PRPF39;SFSWAP;CWC15;PSIP1;SRSF1;SNRPC;WBP4
prerank,protein acylation (GO:0043543),0.3233848199065733,0.8790942518025094,0.6535947712418301,0.9543977553537079,1.0,10/38,17.92%,SPHK1;NAA80;GLUL;ZDHHC18;ZDHHC1;PORCN;KAT2B;CREBBP;ZDHHC8;ZDHHC23
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.39765586869091013,0.8790938185606646,0.6014362657091562,0.9530570428177148,1.0,4/15,15.26%,TNRC6B;CPEB3;TNRC6C;ZFP36L1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.39765586869091013,0.8790938185606646,0.6014362657091562,0.9530570428177148,1.0,4/15,15.26%,TNRC6B;CPEB3;TNRC6C;ZFP36L1
prerank,inositol phosphate catabolic process (GO:0071545),0.4043992686020436,0.8790475930591254,0.5948434622467772,0.9524971535055132,1.0,3/12,11.18%,SYNJ2;PTEN;OCRL
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.311558801243366,-0.8788992921345088,0.6447688564476886,0.8754590475829769,1.0,6/24,13.96%,TRPS1;ACVRL1;ZBTB16;WNT9A;PTHLH;BMPR1B
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2888888089420775,-0.8788231250857936,0.7036082474226805,0.8748782297382326,1.0,8/33,12.99%,ESR1;RUNX1;AR;CALR;DDRGK1;H3-3A;UFM1;AXIN1
prerank,inner ear morphogenesis (GO:0042472),0.362018941859178,0.8784858595569907,0.5970961887477314,0.9530696684069498,1.0,4/22,8.37%,FGFR2;HOXA1;CHD7;ZIC1
prerank,protein localization to kinetochore (GO:0034501),0.39995633826774285,0.8783116589233739,0.6072072072072072,0.9527688178218737,1.0,6/14,24.74%,AURKB;IK;CHAMP1;CENPT;MIS12;SPDL1
prerank,intracellular sterol transport (GO:0032366),-0.3692738462976963,-0.8783046177190258,0.6205533596837944,0.8752360396991902,1.0,5/13,21.00%,ABCG1;NPC2;STARD4;RELCH;OSBP
prerank,cGMP metabolic process (GO:0046068),0.4013319670454017,0.8779349884895264,0.6153846153846154,0.9528767369120582,1.0,2/12,6.12%,NPR1;NPR2
prerank,intracellular protein transport (GO:0006886),0.24661775975139508,0.8779097993117027,0.7465437788018433,0.9522653459724139,1.0,62/304,19.98%,RANBP3L;APPL2;WLS;TRAK1;KIF13B;SNX6;SEC31B;TBC1D16;TNPO1;LAMP2;STXBP2;ACD;FUT10;ARFGAP3;VPS26C;IPO13;PICK1;GRTP1;ARL4A;NUP42;RAB43;COPZ2;RANBP3;RAB22A;VPS45;MYO1C;DESI1;CLTC;SNX8;STX5;SGSM2;VIPAS39;SNX15;AP2A1;SEC23IP;RAB29;RAB21;ARFIP2;ARL6;SNF8;SCFD1;TBC1D25;NUP155;CCHCR1;CLIP3;FAM91A1;SGSM3;C2CD5;VPS35;TRAK2;KIF13A;TBC1D14;SEC31A;EVI5;KATNB1;NUP188;AP4M1;TBC1D22B;STX16;TSC2;LTBP2;EVI5L
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.39519681260014783,0.8776434144076969,0.592128801431127,0.9521890921505208,1.0,1/14,0.45%,WNK4
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.4155817647417987,0.8776321652400784,0.6064638783269962,0.951546760631269,1.0,1/11,0.55%,EFNB2
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3667816896476011,0.8775364962895121,0.6201413427561837,0.9510847396529971,1.0,3/22,9.72%,CACNA1D;CACNA1C;STIM1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.363264218761848,0.8775126833013203,0.6115107913669064,0.950478322370465,1.0,6/21,7.77%,CD300A;ELF1;PRKCB;GPS2;PTPN22;ELF2
prerank,nucleocytoplasmic transport (GO:0006913),-0.27694653238754524,-0.8774980429096856,0.7021276595744681,0.87616464162474,1.0,20/40,40.73%,BACH2;XPO1;ANP32A;RBM15B;SNRPF;NXT1;SNRPD3;NPM1;NCBP2;SNRPB;HTATIP2;MALT1;RITA1;SNRPG;GEMIN2;LSG1;NUP205;NCBP1;GEMIN6;HNRNPA1
prerank,proteoglycan metabolic process (GO:0006029),0.34504456144172396,0.8773234704269178,0.6110210696920584,0.9502277211499198,1.0,7/26,13.29%,IGF1;CHST11;SULF2;GAL3ST4;FOXL1;CNMD;SULF1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3753012887981504,-0.8772498720390705,0.6543478260869565,0.876000442276508,1.0,4/12,16.05%,CCN3;NOTCH1;TMEM119;BDNF
prerank,positive regulation of isotype switching (GO:0045830),0.3829104112153372,0.8770187579585496,0.6123595505617978,0.9502222210301292,1.0,3/15,6.47%,KMT5C;TNFSF13;KMT5B
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3982793440318064,-0.8768556514022806,0.6275303643724697,0.8761787781402481,1.0,6/10,28.97%,CSGALNACT1;XYLT1;B3GAT2;B3GAT3;B3GAT1;CSGALNACT2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4159683637366031,0.8767345698524258,0.6011787819253438,0.9501235867596398,1.0,4/10,17.39%,EZR;OPHN1;CDC42;MYO9A
prerank,ruffle organization (GO:0031529),-0.35071868163231845,-0.8766232698620273,0.62217659137577,0.8759756793500371,1.0,3/16,6.72%,CARMIL1;LIMA1;PLEKHA1
prerank,actin polymerization or depolymerization (GO:0008154),0.31334985441515256,0.8764954362190301,0.6318327974276527,0.9499614761169856,1.0,9/50,12.56%,MICAL3;GAS7;AVIL;ARHGAP6;DIAPH1;WASL;CATIP;VIL1;TTC17
prerank,positive regulation of lipid catabolic process (GO:0050996),0.37793026684716996,0.8761414266894278,0.5992779783393501,0.9500665829029726,1.0,1/19,1.76%,PPARA
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3397655187741712,0.8758849147246895,0.625,0.9499415151563861,1.0,13/31,25.50%,TIMM44;TOMM70;PEX10;PEX14;PEX16;PEX5;TIMM17B;TIMM17A;TIMM21;PEX26;DNAJC15;CHCHD4;GRPEL2
prerank,regulation of interleukin-4 production (GO:0032673),-0.32130462583027797,-0.8755705597522537,0.6381156316916489,0.8775935817074044,1.0,8/21,22.11%,LEF1;SLC7A5;HAVCR2;SYK;ZFPM1;PRKCQ;LGALS9;CD86
prerank,positive regulation of growth (GO:0045927),-0.2552796611103115,-0.8755684756361465,0.6886792452830188,0.8768753514727944,1.0,13/64,14.50%,AKAP6;TGFB2;RFTN1;LGI1;CXCL16;H3-3A;ERBB2;RPS6KA3;SLC25A33;MFSD2A;TAF9B;RPS6KA1;PPM1F
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3072226521010006,0.8754222372997925,0.657051282051282,0.9502690077796051,1.0,5/43,6.37%,IGF1;IL18;BMPR1A;NOX1;PDGFRB
prerank,establishment of spindle localization (GO:0051293),-0.360793251310723,-0.8748597764586826,0.6308724832214765,0.8777424737055974,1.0,6/14,24.14%,CLASP2;MAP4;CFL1;NUSAP1;TLE6;KPNB1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3822854976535754,0.8747482324138076,0.6236559139784946,0.9511275811792959,1.0,8/16,26.39%,ATM;HNRNPA2B1;TNKS2;TINF2;SLX4;SMG6;PINX1;RTEL1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.29240253495614366,0.8747260629078802,0.6467153284671533,0.950518915989834,1.0,9/69,8.44%,PPARGC1A;PRKN;SLC30A10;RETREG1;SNX6;CPEB4;SOD2;KDM2B;GDNF
prerank,negative regulation of lyase activity (GO:0051350),-0.3524612114804536,-0.8739038517134363,0.6320541760722348,0.87905918205527,1.0,8/16,32.38%,GRM3;GABBR2;EDNRB;PALM;DRD2;GNAI3;PHPT1;DRD3
prerank,protein localization to Golgi apparatus (GO:0034067),-0.30344320456836216,-0.8737728562936653,0.65,0.878618834022536,1.0,11/27,25.35%,SORL1;ARL5A;ARL1;GCC2;ARL5B;BICD2;RAB6A;TMED10;PAQR3;VPS13C;IFT20
prerank,negative regulation of hormone secretion (GO:0046888),-0.38888828924881397,-0.8734933594932944,0.6239669421487604,0.8784840064333838,1.0,4/10,33.17%,RAB11FIP1;RAB11FIP5;RAB11FIP3;LIF
prerank,insulin receptor signaling pathway (GO:0008286),0.2908145153558678,0.8734488694352689,0.6440422322775264,0.952576423179723,1.0,13/69,11.08%,SORBS1;RHOQ;PHIP;ATP6V0E1;BAIAP2;ATP6V0B;PIK3CA;GRB10;FOXC2;FER;PIK3R3;ATP6V1D;ATP6V1E1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3436728436139159,0.8734246261870725,0.6196213425129088,0.9519589347418339,1.0,7/28,15.81%,KMT5C;KMT5B;PARP9;PRKDC;PNKP;SMCHD1;TFIP11
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3073992373362477,-0.872816399492314,0.6819221967963387,0.8791817180781236,1.0,5/25,10.70%,GHR;STAT3;SOCS2;STAT5B;PKD1
prerank,protein complex oligomerization (GO:0051259),0.28677031268529174,0.8727686203036401,0.6544117647058824,0.9527393777513957,1.0,12/85,8.88%,UPB1;ALS2;RNF213;MCU;NACC2;RNF135;ATL1;MICU1;OPA1;TWNK;JMJD6;DNM1L
prerank,cardiocyte differentiation (GO:0035051),0.42859755685749323,0.8726501299134745,0.626953125,0.9523462216392228,1.0,4/10,9.63%,AKAP13;SIK1;NRG1;CBY1
prerank,skeletal muscle tissue development (GO:0007519),0.33514188125151306,0.8723993039539516,0.6388888888888888,0.9522395539555145,1.0,5/32,8.50%,IGSF8;CSRP3;CFLAR;KLHL41;LEMD2
prerank,proteoglycan biosynthetic process (GO:0030166),0.33711113267327925,0.8719230378650183,0.626057529610829,0.9526121583793025,1.0,6/31,10.27%,HS3ST3B1;IGF1;CHST11;PXYLP1;GAL3ST4;FOXL1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.36642403427972564,-0.8715854868472714,0.6705882352941176,0.8809986640087235,1.0,6/13,11.37%,ABHD2;ESR1;PLPP1;AR;GPER1;BMP4
prerank,regulation of interleukin-12 production (GO:0032655),-0.26670275218616407,-0.8708100845116117,0.6767955801104972,0.8818797552167532,1.0,13/47,21.93%,THBS1;FOXP1;PLCG2;IRAK3;CD47;TIRAP;CMKLR1;LAPTM5;SYK;IRF5;CCL19;LGALS9;MDK
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.3971749021480059,0.8707673888883111,0.627151051625239,0.9544770753878753,1.0,1/13,1.45%,ANAPC15
prerank,regulation of interleukin-10 production (GO:0032653),0.31335773103055853,0.8704048216650434,0.6104746317512275,0.9546558378274359,1.0,5/44,6.47%,PRKCZ;TLR4;CD28;TRIB2;IL12B
prerank,protein neddylation (GO:0045116),0.40576414316888865,0.8703886198916923,0.6126629422718808,0.9540259700741299,1.0,3/13,16.62%,UBE2M;DCUN1D5;RNF7
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2822537862602399,0.8703632485223765,0.6896551724137931,0.9534181767792383,1.0,11/80,10.46%,KIF2A;STX18;KIF3C;UVRAG;ARFGAP3;HTT;GOLPH3L;KIF1C;KLC1;PICK1;COPZ2
prerank,regulation of calcium ion transport (GO:0051924),0.3040275833150072,0.8703612449562056,0.6537842190016103,0.9527655261285191,1.0,3/54,3.65%,CACNA1D;ANK2;ADRA2A
prerank,negative regulation of cellular component organization (GO:0051129),0.2871728733933947,0.8700711860758417,0.672992700729927,0.9527133500293994,1.0,17/74,15.81%,BMP6;PRKCZ;SYT11;RAPGEF3;APOM;DDX3X;WASL;TMC8;CDC42;IMPACT;EPHA3;DNM2;CRYAB;DNAJB2;CARMIL2;LGALS3;TFIP11
prerank,establishment of spindle orientation (GO:0051294),0.3471207293849555,0.8700293849223689,0.6178451178451179,0.9521612811712691,1.0,6/28,14.46%,PKHD1;CLASP1;FBXW11;HTT;MISP;LLGL2
prerank,pinocytosis (GO:0006907),-0.39443926525545203,-0.8698779807829409,0.6699801192842942,0.8831676413262884,1.0,3/10,9.80%,CARMIL1;PPT1;DOCK2
prerank,negative regulation of coagulation (GO:0050819),-0.3617119307618788,-0.8698101950243717,0.632258064516129,0.882613125694466,1.0,5/14,10.79%,SERPINE2;HS3ST5;CD34;APOE;EDN1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.40036988853678895,0.8695135427820524,0.6066790352504638,0.9526144999840864,1.0,4/12,14.35%,PLK5;TP53;PRKDC;SDE2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.3518248959035301,0.8694038642428464,0.6354166666666666,0.9521900580556808,1.0,5/25,11.96%,PICALM;RIN3;ATXN2;NEU3;ITGAV
prerank,exit from mitosis (GO:0010458),-0.3697962152736237,-0.8692451506274173,0.6652806652806653,0.8830754203983221,1.0,5/12,18.57%,CLASP2;EPS8;PPP2R2D;CHMP4B;SPAST
prerank,histone H3 acetylation (GO:0043966),-0.27671408042781087,-0.8692377727293914,0.6730769230769231,0.8823686320048281,1.0,9/40,19.41%,LEF1;MAP3K7;YEATS2;JADE3;JADE1;MBIP;BRPF3;MEAF6;TAF5
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.2900506426690528,-0.8691741526331458,0.6947890818858561,0.8817791303629767,1.0,5/31,11.06%,TFRC;GPI;PTPRC;EPHB2;HMCES
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.2486883981782158,-0.8690288653918407,0.6887417218543046,0.8813702369077115,1.0,28/72,34.29%,PSMB2;CARD14;MAP3K7;PSMD14;PSMC6;REL;TIRAP;RELB;PSMA4;PSMB9;SKP1;MAP3K14;PSMD11;PSMB10;PSMD2;PSMA2;RELA;PSMB3;PSMB5;PSMA7;PSMF1;PSMD7;MALT1;CARD10;TNFSF15;PSMA5;PSMD4;PSME4
prerank,negative regulation of response to external stimulus (GO:0032102),0.27154294225461467,0.8687137883979859,0.6952789699570815,0.9529825180214865,1.0,17/105,14.43%,RORA;C1QTNF3;PPARA;EPHA4;PCBP2;METRNL;GPS2;ENPP3;SERPINE1;PTEN;CDH5;TRIB1;DHX58;NMI;MAPKBP1;ACOD1;PPM1B
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.273241679755882,-0.8685926774066969,0.7002652519893899,0.8815975685133516,1.0,15/46,25.99%,PPIA;RAP1B;RPLP0;JAK1;MSN;PITPNA;TALDO1;CFL1;CAPZA1;AIP;PDCD4;SOD1;MTAP;JAK2;STAT4
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.4202642903148863,0.8680914100864174,0.6185770750988142,0.9536776018347901,1.0,2/10,9.28%,ATRX;SSBP1
prerank,negative regulation of potassium ion transport (GO:0043267),0.3909221819460158,0.8679166955804796,0.6107899807321773,0.9533758895937846,1.0,1/13,0.65%,ACTN2
prerank,response to interleukin-1 (GO:0070555),-0.24974575080197808,-0.8679117583327478,0.7092651757188498,0.8822639124981616,1.0,17/73,21.19%,IL1R1;PTGIS;ANXA1;TNFRSF11A;DAB2IP;APP;IRAK3;CD47;HIF1A;SNCA;CCL13;YTHDC2;CCL19;LGALS9;HAS2;SFRP1;PYCARD
prerank,carboxylic acid metabolic process (GO:0019752),0.340096423993486,0.8668539582308508,0.6429780033840947,0.9548541574481035,1.0,2/33,1.70%,DDO;ST6GAL1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3667034604810594,-0.8667739116333696,0.6561844863731656,0.8839401329052998,1.0,7/12,28.99%,MAOA;SMS;DDC;AMD1;SLC22A3;OAZ2;ODC1
prerank,cellular response to reactive oxygen species (GO:0034614),-0.25620949507986684,-0.8667510533443571,0.7044776119402985,0.8832754942333815,1.0,8/59,6.96%,MAP3K5;PTPRK;CYP1B1;NET1;ANXA1;RPS3;PLEKHA1;RHOB
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.4137179822880539,0.8666362377204345,0.6146435452793835,0.9546455116624906,1.0,2/11,6.05%,STX18;ATL1
prerank,establishment of protein localization to organelle (GO:0072594),0.28965753185748244,0.8663297958608975,0.6701183431952663,0.954656826434982,1.0,4/72,3.98%,APPL2;HK2;TNPO1;LAMP2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3442420005498048,0.8662390270260386,0.6256410256410256,0.9542014708439436,1.0,4/25,8.60%,ITPR1;LRRK2;P2RX3;HTT
prerank,regulation of programmed necrotic cell death (GO:0062098),0.37165548288510475,0.8661399696757979,0.6484517304189436,0.9537473941348528,1.0,6/20,16.01%,NUPR1;CFLAR;RIPK1;FLOT2;OGT;BIRC3
prerank,negative regulation of type I interferon production (GO:0032480),0.31990010775480215,0.8659818401525782,0.6650406504065041,0.9534225844996816,1.0,12/40,21.99%,PCBP2;IKBKE;RNF135;MAVS;DHX58;ACOD1;PPM1B;UFD1;NPLOC4;TAX1BP1;SIRPA;YY1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3830620162765009,-0.8659109380442148,0.6536885245901639,0.8835447444106946,1.0,6/11,27.82%,CCT8;CCT2;CCT6A;CCT7;MEPCE;DKC1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3830620162765009,-0.8659109380442148,0.6536885245901639,0.8835447444106946,1.0,6/11,27.82%,CCT8;CCT2;CCT6A;CCT7;MEPCE;DKC1
prerank,negative regulation of macroautophagy (GO:0016242),0.3412328490573727,0.8656601235206077,0.6433566433566433,0.9534884876563361,1.0,6/26,15.86%,NUPR1;LRRK2;SMG1;PIK3CA;TSC1;SCFD1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3609738752909568,-0.8655794201547738,0.65,0.8834401552414809,1.0,5/13,34.07%,PIK3AP1;TLR7;IRAK4;PIK3R4;MYD88
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3050286681615578,0.8652661589644479,0.6498516320474778,0.9536676969805505,1.0,12/50,17.51%,CCNA2;CCNA1;CCNT2;CCND3;CDK5RAP3;CDC25A;GTPBP4;CCNB2;GADD45A;CCNG1;CCNE1;CNPPD1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.2932073412757572,-0.8647555246325631,0.6856368563685636,0.8844288614912342,1.0,11/32,17.56%,NAV3;CLASP2;ARHGEF2;STMN2;FGF13;TUBB4A;SPEF1;SNCA;STMN1;APC;FKBP4
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3568953274378496,0.8644581374077979,0.6073943661971831,0.9547682778102757,1.0,4/20,10.00%,FKBP5;NKTR;PPIC;CWC27
prerank,mammary gland epithelium development (GO:0061180),0.3980913081399836,0.8639344216217987,0.6355140186915887,0.9552356944935121,1.0,1/14,1.03%,WNT4
prerank,high-density lipoprotein particle assembly (GO:0034380),0.41793409146458266,0.8633221736900814,0.6044624746450304,0.9559065639844009,1.0,4/10,17.91%,APOM;BMP1;PRKACB;ZDHHC8
prerank,regulation of lysosomal lumen pH (GO:0035751),0.4052825871584101,0.8630062495980381,0.6298449612403101,0.9559123764528823,1.0,4/12,21.21%,LRRK2;CLN6;CCDC115;ATP6AP2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.22242738883768196,-0.8626439550121171,0.8062015503875969,0.8880510075350141,1.0,54/125,32.40%,CLASP2;PLK2;DYNC1I1;DYNLL1;XPO1;DYNC1LI2;CEP126;RPS27;SETD2;MAP4;BUB3;CLIP1;STMN1;NUSAP1;CENPE;EFHC2;TBCE;EML1;KIF11;RAN;PPP1CC;NUP107;NEK6;MAD2L1;CENPH;BCCIP;NSL1;NDC80;SUN2;KIF4A;KIF3B;KPNB1;KNTC1;MECP2;TUBG2;DCTN6;CENPA;NUP85;CDCA8;NDEL1;NDE1;RANGAP1;TNKS;CENPF;NUDC;PTPA;STIL;DLGAP5;NUF2;AURKA;CENPI;SPC24;CDC20;BUB1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.33326869947847165,0.8624102458273213,0.6452173913043479,0.9565655436878813,1.0,5/30,12.06%,LEPROT;FZD5;HUWE1;NPEPPS;CSNK2A2
prerank,regulation of lipase activity (GO:0060191),-0.3590508038843405,-0.862289303740039,0.6680672268907563,0.8880214762205871,1.0,3/13,13.17%,PCSK5;PCSK6;SNCA
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3878029455619976,0.8620800841422765,0.6518518518518519,0.9565930960361937,1.0,4/14,11.35%,EZR;OPHN1;PATJ;CDC42
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.30625912039775777,0.8620131129645657,0.6770833333333334,0.9560856794999725,1.0,10/54,14.70%,TFDP2;ATM;ARID3A;TP53;RBL2;CNOT10;TFDP1;PML;GADD45A;E2F4
prerank,DNA damage checkpoint signaling (GO:0000077),0.3425969725758393,0.8613393009797363,0.6363636363636364,0.9569160249860059,1.0,14/28,29.24%,ATM;DONSON;HUS1;DOT1L;CEP63;CLSPN;INTS7;NBN;RAD9A;CDC5L;TIPRL;USP28;CHEK1;E2F1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.327323650238934,0.8610560394881059,0.6548387096774193,0.956861198466448,1.0,6/33,11.69%,SMAD3;TP53;SMARCA4;TERT;APLN;TEAD1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.41007809919713034,0.8608846587584795,0.6184971098265896,0.9565173886631088,1.0,3/10,17.02%,PARP14;SOCS3;PIBF1
prerank,kinetochore organization (GO:0051383),-0.3586878982776222,-0.8606254805968979,0.6588486140724946,0.8907003059656162,1.0,8/13,32.23%,CENPE;CENPH;NDC80;CENPA;CENPF;DLGAP5;NUF2;POGZ
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.30534719358586865,0.8606212196071432,0.6823899371069182,0.9564564001472521,1.0,10/49,13.91%,PRKCZ;PMEPA1;SMAD6;DDX3X;LDLRAD4;TMC8;CDC42;IMPACT;ANKRD27;CRYAB
prerank,negative regulation of cilium assembly (GO:1902018),-0.3729953534077823,-0.8602898954682107,0.6384297520661157,0.8906397448563579,1.0,5/12,23.57%,TBC1D30;LIMK2;MAP4;ODF2L;CCP110
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2579480376947867,-0.859762994171964,0.7358490566037735,0.8910028635914735,1.0,22/54,22.58%,RPL3;RPL26;RPL7;RPL35A;RPLP0;RPL5;RPL14;RPL7A;RPL23A;RPL10A;RPL6;MDN1;MALSU1;NOP53;BRIX1;MRPL20;NHP2;RPL24;RPL11;RSL24D1;NPM1;RRP15
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.4130129999477116,0.8593780287465974,0.6431297709923665,0.9584181110467351,1.0,2/10,7.78%,UBAC2;ERLEC1
prerank,positive regulation of inflammatory response (GO:0050729),0.2848815594524727,0.8591821076687423,0.7034965034965035,0.9581934929750404,1.0,11/86,9.73%,IL18;NAPEPLD;NUPR1;C2CD4B;TLR3;TLR4;IL12B;SERPINE1;GPRC5B;IL17RA;RIPK1
prerank,regulation of interleukin-6 production (GO:0032675),0.2748029485928941,0.8591457529286286,0.6952789699570815,0.957630907469041,1.0,11/96,10.58%,C1QTNF3;SYT11;TLR3;TLR4;IL17D;ARRB1;AFAP1L2;PTPN22;IL17RA;MAVS;RAB7B
prerank,NAD biosynthetic process (GO:0009435),0.361470246852429,0.8589981140178489,0.623574144486692,0.9572754103999934,1.0,9/20,24.37%,PARP10;NMNAT1;SLC5A8;PARP9;QPRT;NMNAT2;PARP16;NMNAT3;NAPRT
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.24118454617632007,0.8589346334570798,0.793918918918919,0.9567485676917096,1.0,75/341,19.44%,RNF43;ASB2;ANAPC15;PRKN;FBXL17;SPSB1;RNF213;NEDD4;IFI27;PCBP2;DCAF11;FBXL19;ARRB1;USP9X;ANAPC2;PTPN23;SPSB4;UBR4;TBL1X;SMURF2;TTC3;RNF8;FBXW11;HUWE1;TRIP12;RNF217;BTRC;TBL1XR1;RNF19A;RNF34;SIRT1;FBXO22;ZSWIM8;AURKB;RNF13;WWP2;CUL4A;UBA6;FZR1;FBXO10;NUB1;PML;FBXO11;UBE2H;RNF115;RMND5A;FAF1;AMFR;VPS37A;ANAPC16;RNF146;BIRC6;MAEA;VPS4A;RNF19B;WDR91;RNF7;UFD1;UBE2E1;KCTD13;SYVN1;CDC34;NPLOC4;SQSTM1;NDFIP1;RNF20;TAF1;ARIH1;KCTD21;NHLRC3;USP33;UBE4B;FBXL22;MIB1;MTA1
prerank,sulfur compound biosynthetic process (GO:0044272),0.27669020070424877,0.8589301314636019,0.7146853146853147,0.9561103380099036,1.0,13/104,10.04%,UST;OGN;CHST15;CHST11;GSTT1;ST3GAL3;FMOD;B4GALT1;DSE;SLC26A1;CHSY1;CTH;GSTA3
prerank,inner dynein arm assembly (GO:0036159),0.4150619677832329,0.8585463860838548,0.6033519553072626,0.9562771917421662,1.0,5/10,27.22%,CCDC39;CCDC40;DNAAF5;CFAP73;DNAH1
prerank,positive regulation of wound healing (GO:0090303),0.32352913713300047,0.8582352592513537,0.6481481481481481,0.956287225737659,1.0,8/36,11.49%,SMOC2;ADRA2A;RREB1;F2;SERPINE1;FOXC2;HBEGF;MYLK
prerank,chemokine-mediated signaling pathway (GO:0070098),0.3085391618413943,0.8580478055616999,0.6645468998410174,0.9560334120939015,1.0,7/42,16.97%,OXSR1;FOXC1;RBM15;CCL25;WNK1;CCL15;CCR2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.31666178096256126,0.8576648139424264,0.628140703517588,0.9561282509564887,1.0,9/38,12.65%,ACE;EPHA4;DLG3;SH3BP5;GPRC5B;MVP;NOX4;CASS4;SRCIN1
prerank,nucleotide catabolic process (GO:0009166),0.37550188451889666,0.8573408769419212,0.6486486486486487,0.9561654876802178,1.0,4/16,10.01%,NT5C1B;DERA;SAMHD1;NT5C2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3766810640176778,0.8570567288045835,0.631484794275492,0.956103935821539,1.0,1/16,1.27%,DDX5
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3675507460257005,0.8569624795520098,0.6474694589877836,0.9556716389661829,1.0,3/18,9.35%,PRKN;SOD2;SIRT1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3265661608411339,-0.8569454939686041,0.6738095238095239,0.895995558616855,1.0,7/17,12.51%,RUNX1;TGFB3;VSIR;TGFB1;CREB3L1;BMP4;VIM
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.3769430131077944,-0.8568860967849774,0.6440329218106996,0.8953907960764361,1.0,1/10,3.67%,RUNX1
prerank,DNA metabolic process (GO:0006259),0.24515628039742707,0.8558188609036234,0.7765830346475507,0.9574331048942041,1.0,70/270,21.92%,TOP2B;POLD2;KMT5C;DNTT;USP3;POLG;ATM;UVRAG;RAD54L;ACD;KMT5B;DNASE1L1;PARP4;SAMHD1;TERT;PDS5A;TCF7L2;SRPK2;RBBP8;PRKDC;MSH3;ZBTB1;HUS1;AXIN2;IGHMBP2;FANCA;RAD50;TOP3A;USP7;PNKP;TDG;POLE2;MCM7;MCM2;ORC3;DDB2;DFFB;POLA2;GADD45A;DOT1L;MGMT;INTS3;LRWD1;POLL;DNASE1L2;SP100;MBD4;CDC34;OGG1;TINF2;NBN;SUMO1;FEN1;RAD51D;SLX4;MMS19;PDS5B;RFC1;XPA;ASF1A;XRCC3;LIG4;RAD9A;ZNF445;EID3;MCM5;TOP1MT;LIG1;ORC6;CBS
prerank,myotube cell development (GO:0014904),0.403776399749508,0.85554884170044,0.6187845303867403,0.9573521501223815,1.0,1/10,1.44%,IGF1
prerank,negative regulation of bone mineralization (GO:0030502),-0.3535141118372049,-0.8554517262239305,0.6356107660455487,0.8976643273886472,1.0,3/13,7.47%,PTK2B;ENPP1;ECM1
prerank,membrane fusion (GO:0061025),-0.2852190911514572,-0.854981802112216,0.7248803827751196,0.8979104239799619,1.0,5/33,9.51%,DNM3;RIMS1;DNM1;DYSF;NSF
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.34999106575592476,-0.8545887892787626,0.6560509554140127,0.8979833059516404,1.0,4/13,11.37%,TOX;CAMK4;CLPTM1;BMP4
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3471540261670319,0.8545834780399273,0.6578947368421053,0.9587239596672005,1.0,2/24,5.14%,ACE;TAPBPL
prerank,regulation of centrosome duplication (GO:0010824),0.3272410154207728,0.8540299632306545,0.6666666666666666,0.9592584276514845,1.0,9/29,20.40%,PKHD1;SIRT1;CHMP1A;ALMS1;CHMP4C;CEP120;XRCC3;CEP295;CHMP2A
prerank,protein polyubiquitination (GO:0000209),0.24353572772221815,0.8540239934327096,0.8029953917050692,0.9586249252692777,1.0,62/297,19.14%,RNF152;UBE2E2;SASH1;PRKN;FBXL17;SPSB1;RNF213;NEDD4;IFI27;NHLRC4;RNF135;FBXL19;TRIM56;ANAPC2;UBR2;SMURF2;TTC3;RNF8;FBXW11;HUWE1;TRIP12;RNF217;TNKS2;BTRC;RNF19A;RNF34;HERC6;NPEPPS;UBR5;FBXO22;FBXL12;RNF41;FBXW8;FBXO4;WWP2;FZR1;FBXO10;TRIM62;DDB2;FBXO11;FBXL20;DZIP3;LONRF1;UBE2H;RNF115;RMND5A;AMFR;RNF31;HECTD1;RNF146;RNF19B;UBE2E1;SYVN1;CDC34;FBXW10;RNF20;TAF1;ARIH1;MIB2;NHLRC3;UBE4B;FBXL22
prerank,JNK cascade (GO:0007254),-0.27235122346934687,-0.8538686304879515,0.7375328083989501,0.8986977011829,1.0,14/40,25.01%,MAP3K5;NOD1;MINK1;MAP3K7;TNFRSF19;MAP4K3;UBB;NOD2;MAP3K11;SH2D3C;MAP2K7;UBC;RPS27A;TAB1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3456520186704521,0.8538227305873779,0.6468590831918506,0.9583808805077801,1.0,3/25,7.27%,HK2;PGAM2;GCK
prerank,response to reactive oxygen species (GO:0000302),-0.25844964950728594,-0.8537532393110175,0.747093023255814,0.8981980753752328,1.0,25/54,32.89%,PTPRK;APOE;RPS3;APOD;CAMKK2;GLRX2;MAPT;HIF1A;GPX1;CAT;ROMO1;SOD1;FYN;PLK3;HYAL2;HMOX1;MAPK8;FOS;MAPK3;JUN;COA8;HP;STK25;NCF1;PRDX3
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3529215175920525,0.853246355107369,0.655536028119508,0.9582914827138337,1.0,2/20,10.04%,GSTT1;GSTA3
prerank,glutathione derivative metabolic process (GO:1901685),0.3529215175920525,0.853246355107369,0.655536028119508,0.9582914827138337,1.0,2/20,10.04%,GSTT1;GSTA3
prerank,mitotic spindle assembly (GO:0090307),0.3108532158537624,0.8531253196026427,0.6759259259259259,0.9578872452907111,1.0,14/42,19.66%,KIF2A;CLASP1;LSM14A;AURKB;MISP;KIFC1;STAG2;SMC3;PIBF1;MAP9;CCDC61;GOLGA2;OFD1;ARHGEF10
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.3630687680881501,-0.8528004729238413,0.670995670995671,0.8994292163318762,1.0,3/13,9.41%,STAT3;IL6ST;JAK1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.29098183686565177,-0.8525974002162701,0.706766917293233,0.899087716266957,1.0,5/32,10.04%,CDK14;CDK17;POLA1;BACH1;ID2
prerank,coenzyme A metabolic process (GO:0015936),0.3813504840182333,0.8517754259401868,0.6266666666666667,0.9600319364803118,1.0,7/14,27.45%,PANK1;DCAKD;ACLY;CROT;SLC25A16;ACOT7;ACAT1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.3817941874791999,-0.8516924974677955,0.6443965517241379,0.900239396603475,1.0,3/10,7.03%,CAV1;ENG;ENPP1
prerank,myeloid cell differentiation (GO:0030099),-0.26546671269431765,-0.8516603627898127,0.7313432835820896,0.8995942790939516,1.0,12/47,19.20%,SNRK;RUNX1;ZBTB16;LYN;RPS19;IKZF1;MFHAS1;TIRAP;TAL1;HIPK2;ZFPM1;INHBA
prerank,cellular response to estrogen stimulus (GO:0071391),-0.34732506432875,-0.8516327017199337,0.6501079913606912,0.8989459783423962,1.0,5/14,21.03%,AR;SERPINB9;NCOA4;ARID5A;SFRP1
prerank,DNA-dependent DNA replication (GO:0006261),-0.22132703320024055,-0.8515114244120126,0.8745247148288974,0.8984502268661212,1.0,46/128,29.72%,POLA1;REV3L;PSMB2;PRIM2;POLD3;PSMD14;PSMC6;WRNIP1;PRIMPOL;TEFM;UBB;PSMA4;PSMB9;RPA1;ORC5;ORC2;CDC45;PSMD11;DNA2;PSMB10;PSMD2;RFC4;POLD4;POLD1;RFC2;BLM;RECQL5;PSMA2;UBC;RPS27A;PSMB3;RECQL;MCM6;RFC5;PRIM1;PSMB5;TOPBP1;HELB;PSMA7;CDC7;MGME1;PSMF1;RAD51;CDK2AP1;PSMD7;RPA3
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.36546230206522745,0.8513724918381756,0.6714285714285714,0.9602295014958531,1.0,6/18,11.58%,COL4A3;FGFR1;FLT1;APLN;PDPK1;ADAM17
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.328684243477663,-0.8505355466052957,0.6882217090069284,0.8996315493428985,1.0,6/18,10.86%,NELL1;DAB2IP;DACT1;RDX;HSP90AA1;MSN
prerank,hippo signaling (GO:0035329),0.33807900747207464,0.8505071816483575,0.658703071672355,0.9613339952875672,1.0,8/26,15.17%,CASP3;TEAD3;WWTR1;TEAD2;AMOTL2;TEAD1;SAV1;STK4
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3412462970636863,-0.85031619179537,0.647982062780269,0.8993780813306727,1.0,1/15,0.47%,LEF1
prerank,protein stabilization (GO:0050821),0.25177234695149414,0.8502022991040806,0.7529411764705882,0.9612932355711842,1.0,12/168,6.59%,ATP1B3;ANK2;PPARGC1A;IGF1;STXBP4;PRKN;EPHA4;AAK1;LAMP2;USP9X;CREBL2;TBL1X
prerank,cellular protein catabolic process (GO:0044257),-0.2564173148791479,-0.8500344753287574,0.775,0.8992081514285106,1.0,20/59,22.24%,FAP;DAB2IP;CTSC;UBE2G1;SIAH2;CTSB;AP2B1;CAPN2;CTSL;AP2M1;CTSS;VLDLR;CTSO;RSPRY1;HTRA2;CHEK2;CTSZ;UBE2G2;BNIP3;MYLIP
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3562245305327011,0.8495891815543228,0.6447602131438721,0.9618812255935116,1.0,2/22,2.32%,SASH1;SPHK1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.2935652227239627,-0.8494404180124497,0.6885644768856448,0.8996845845295014,1.0,8/26,20.44%,HECW2;CUL3;CDK5RAP2;DUSP1;LCMT1;CENPE;CDC23;NEK6
prerank,development of primary male sexual characteristics (GO:0046546),0.32584269837903124,0.8490214694391561,0.6631944444444444,0.9623637217338565,1.0,2/34,1.21%,WNT4;KIT
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.270616403977921,0.8489944897630097,0.7293447293447294,0.9617806381514562,1.0,5/93,2.32%,SH3RF2;TPD52L1;SASH1;CCN2;SPHK1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.37546531224471286,-0.848841075850439,0.6336032388663968,0.900180383370435,1.0,2/10,5.96%,DLGAP1;DLGAP2
prerank,cAMP metabolic process (GO:0046058),0.39392384321119106,0.848828083699548,0.6615087040618955,0.9614591255973901,1.0,3/13,7.00%,ADCY5;ADCY1;ADCY9
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.38013567505625284,-0.8488202653582136,0.6894409937888198,0.8995109218591077,1.0,5/10,35.64%,NHP2;DKC1;NAF1;RPUSD3;RPUSD2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3468818439332618,0.8487586926539793,0.6490299823633157,0.9609768213348101,1.0,10/25,22.89%,AMPD3;PRPSAP1;AMPD2;APRT;PRPSAP2;MTHFD1;GART;GMPR2;ADSL;GMPS
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.24325454496279666,0.8480294523413611,0.8052256532066508,0.9618050589200534,1.0,69/264,23.35%,SRRM2;DDX5;POLR2A;SNRNP70;PCBP2;PABPN1;HNRNPR;HNRNPH1;SRSF5;SNIP1;HNRNPA2B1;POLR2D;RBM15;SPEN;NOVA1;GPKOW;CCAR1;CWC27;GTF2F1;SRPK2;HNRNPL;CWC15;IK;USP49;PHF5A;SRSF11;PRCC;HNRNPC;SCAF11;PRPF3;SNRNP40;RBM4;TFIP11;HNRNPM;CPSF3;CWF19L1;FRG1;USP39;ZCRB1;PRPF6;FUS;SRSF1;CSTF1;HNRNPH3;CDC40;PCF11;SRSF10;U2AF1;EFTUD2;SNRPC;SRSF7;SF1;PNN;POLR2G;WBP4;PRPF31;SNRPA1;U2AF2;SF3B2;SF3B1;PPWD1;SF3B5;CPSF7;GCFC2;PQBP1;CDC5L;RNPC3;NUDT21;POLR2F
prerank,peptidyl-lysine monomethylation (GO:0018026),0.4111437555208544,0.8478660129344278,0.6434108527131783,0.9614943506470729,1.0,4/10,18.15%,SETD7;KMT5A;EHMT1;SETD3
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.23611096893655592,-0.8477224440631304,0.825503355704698,0.9009929984379703,1.0,16/73,20.19%,KITLG;RUNX1;LMO2;PSMB2;GATA2;PSMD14;PSMC6;TCF12;TAL1;METTL3;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;YTHDF2
prerank,regulation of transposition (GO:0010528),0.3974583596908539,0.8475165474553844,0.6340996168582376,0.9615821645181108,1.0,2/13,10.12%,UBR2;MYBL1
prerank,miRNA metabolic process (GO:0010586),0.3570851887367574,0.847187415515902,0.6637630662020906,0.9616196546516171,1.0,5/20,16.40%,TUT4;SND1;DICER1;TENT4B;TUT7
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2920895595300008,0.8471656312511846,0.7202898550724638,0.9610378530614171,1.0,12/63,14.70%,TFDP2;ATM;ARID3A;TP53;RBL2;CNOT10;TFDP1;PRKDC;PML;SDE2;GADD45A;E2F4
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.38540027327760673,0.8467890980263009,0.6178107606679035,0.9611797439456896,1.0,2/13,7.34%,GLI3;TGFBR2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.3593258352603249,-0.846374962178491,0.6616052060737527,0.9029536721723772,1.0,4/12,14.31%,TASOR;APOBEC1;TRIM28;ATF7IP
prerank,protein palmitoylation (GO:0018345),-0.2879317226242119,-0.8458819457933612,0.7367088607594937,0.9032188240231427,1.0,6/30,12.49%,ZDHHC9;HHAT;ZDHHC2;SELENOK;GOLGA7;ZDHHC14
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.3853959183847736,0.8458109011025816,0.6496212121212122,0.9624675957815658,1.0,5/13,17.74%,YJU2;SIRT1;DYRK1A;SNAI1;KDM1A
prerank,protein localization to cell surface (GO:0034394),0.34515058413940136,0.8456890862726004,0.6736111111111112,0.9620721080057775,1.0,3/26,7.24%,ANK2;PRRT1;PTPRU
prerank,negative regulation of viral release from host cell (GO:1902187),-0.35416593729352347,-0.8456376437838492,0.6681318681318681,0.903005043181338,1.0,2/13,14.20%,MID2;TRIM28
prerank,cell-cell junction maintenance (GO:0045217),0.40697424306007196,0.8448311368196836,0.6440677966101694,0.9631733422418017,1.0,1/11,2.47%,NLGN2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.31529646501242015,-0.8446369785301752,0.6986301369863014,0.904246867648789,1.0,5/20,18.10%,HSP90AB1;PROX1;PKD1;CCNY;RGCC
prerank,protein monoubiquitination (GO:0006513),0.32125454627435457,0.844577681688426,0.6613162118780096,0.9630861959984749,1.0,4/36,7.66%,PRKN;CTR9;MGRN1;HUWE1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.2644903102349825,-0.8445301513648827,0.7401960784313726,0.9037491263667466,1.0,11/43,16.11%,PTPRJ;SH3KBP1;SH3GL2;ARHGEF7;DAB2IP;DUSP3;PTPN3;SPRY1;SOCS5;ZFYVE28;CBL
prerank,glucan biosynthetic process (GO:0009250),0.39470529145980426,0.8444677606722371,0.6335877862595419,0.9620480336684862,1.0,3/12,14.09%,GYS1;PGM1;PER2
prerank,glycogen biosynthetic process (GO:0005978),0.39470529145980426,0.8444677606722371,0.6335877862595419,0.9620480336684862,1.0,3/12,14.09%,GYS1;PGM1;PER2
prerank,non-motile cilium assembly (GO:1905515),0.3229204299123076,0.8443859965261649,0.6627118644067796,0.9615669348982754,1.0,9/30,20.99%,CEP250;IFT122;IFT88;BBS10;GORAB;PIBF1;TMEM17;PCM1;FUZ
prerank,nuclear pore organization (GO:0006999),-0.34971046274895184,-0.8442545665538808,0.6818181818181818,0.9035762562831019,1.0,8/14,39.60%,RTN4;NUP107;NUP93;NUP54;AHCTF1;TMEM170A;NUP205;NUP35
prerank,negative regulation of immune response (GO:0050777),-0.21506501866543073,-0.8441137268813088,0.8823529411764706,0.903138100801933,1.0,43/154,23.55%,CALCRL;ADCY2;ADCY7;MYH9;GNG2;RAMP2;LYN;PLK2;ADCY4;PLCG2;PTGDR;IRAK3;HTR7;PTH1R;TRIM27;CYSLTR1;PRKAR1B;CYSLTR2;PRKAR2B;HAVCR2;HTR4;PTHLH;SAMSN1;RAMP1;IAPP;GNB1;VIPR2;TYRO3;SYK;SIRT2;GPR45;ADCY3;ADCY8;PRKAR2A;GPR176;HRH2;ADCYAP1R1;YES1;MC5R;NPSR1;FYN;LHCGR;RHBDF2
prerank,vitamin D metabolic process (GO:0042359),0.38479229578075314,0.8438586829558999,0.6363636363636364,0.9619981618994877,1.0,4/13,22.04%,CYP2R1;GC;PIAS4;CUBN
prerank,tRNA modification (GO:0006400),0.28643561278744456,0.8430730186899874,0.71580547112462,0.9629373709015238,1.0,12/62,19.97%,TRMT9B;TPRKB;TRMT44;TYW1;METTL6;PUS10;LCMT2;PUSL1;WDR4;DTWD2;DUS2;ADAT2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3020447780256389,-0.8423552617475504,0.7364532019704434,0.9058307523755813,1.0,7/25,13.96%,BMPR2;ENG;ACVRL1;NOTCH1;CCN1;BMP4;BMPR1B
prerank,embryonic eye morphogenesis (GO:0048048),-0.3826720631495759,-0.8423459565648137,0.6706349206349206,0.9051421646231671,1.0,6/11,24.12%,MFAP5;FBN2;ALDH1A3;LRP6;TBX2;MFAP2
prerank,negative regulation of DNA binding (GO:0043392),-0.2998637978907276,-0.8423395987780048,0.7168949771689498,0.9044355579093379,1.0,3/28,9.18%,LEF1;NFKBIA;HEY2
prerank,response to molecule of bacterial origin (GO:0002237),0.28073332152662317,0.8421709251178123,0.7125925925925926,0.9641666571763364,1.0,14/69,11.59%,CPS1;SMAD6;TLR4;FZD5;PTPN22;SRR;MAPKAPK3;TAB2;FER;CYRIB;LY96;TRIB1;ADAM17;NOCT
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.29339246483253445,0.8419939229857115,0.7001499250374813,0.9638782496251648,1.0,7/57,9.10%,KIT;IGF1;IL18;PARP14;IL12B;TNFRSF18;PARP9
prerank,negative regulation of autophagosome assembly (GO:1902902),0.37644799508001825,0.8412325184334617,0.6413662239089184,0.9648143821931916,1.0,2/13,3.86%,NUPR1;LRRK2
prerank,RNA 3'-end processing (GO:0031123),0.28512381489497823,0.8411497773864262,0.7035928143712575,0.9643352500198813,1.0,20/69,22.14%,PABPN1;SRSF5;POLDIP3;RPRD2;TUT4;TENT2;SRSF11;SARNP;TENT4B;CPSF3;TUT7;SRSF1;CSTF1;CDC40;PCF11;U2AF1;SRSF7;U2AF2;TUT1;CPSF7
prerank,protein-containing complex subunit organization (GO:0043933),-0.2235609939471389,-0.8411470664294397,0.8456375838926175,0.9059756461858194,1.0,27/109,18.45%,SLC2A1;REPS2;RIMS1;IL1RAP;LIN7A;PTK2B;SKAP2;HES1;OCLN;CD2AP;PPP2R1A;ELOB;TUBGCP2;ADD2;CAPZA2;CLDN14;FAS;LPXN;MDN1;DMTN;SHANK1;WASF1;CAPZA1;APC;CD74;TRAF1;FANCC
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.31754118633484385,-0.8407201935392511,0.6958637469586375,0.9060696750242548,1.0,12/21,38.60%,RAD51B;ATAD5;NPM1;DTL;MECP2;CCND1;CDC7;CDK1;BRD4;CCNB1;CDC25C;RAB11A
prerank,negative regulation of immune effector process (GO:0002698),0.38897034207456127,0.8403326167829606,0.6473880597014925,0.9653849459682119,1.0,4/13,15.10%,CD300A;ENPP3;FER;LGALS3
prerank,protein import (GO:0017038),0.2713558426665343,0.8402850517445087,0.7298444130127298,0.9648463617436611,1.0,26/84,24.39%,APPL2;TNPO1;LAMP2;SAMM50;PEX11B;IPO13;PXMP2;HSPA4;PEX14;ACBD5;PEX19;NUP155;RAB8B;SLC25A17;PEX16;PEX5;NUP188;TSC2;TNPO2;NUP153;SNX33;PEX26;HEATR3;PRICKLE1;PPP1R10;HIKESHI
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2958732477255992,0.8391962674383014,0.7067082683307332,0.9664300945327017,1.0,13/52,17.83%,TUT4;POLR2D;SAMD4A;EXOSC7;CNOT10;PAN3;PNLDC1;DDX6;DCP1A;DIS3;TUT7;NT5C3B;EXOSC3
prerank,purine nucleotide metabolic process (GO:0006163),0.34030025810852416,0.8390640527097718,0.6794425087108014,0.966104307256067,1.0,9/24,20.77%,FHIT;NT5C1B;NT5C2;PRPSAP1;PRPSAP2;MTHFD1;NT5C;GART;ADSL
prerank,histone H2A ubiquitination (GO:0033522),0.3754387637474354,0.8390211342270019,0.666030534351145,0.9655468630574275,1.0,5/17,13.60%,UBR2;RNF8;BCOR;KDM2B;DDB2
prerank,copper ion homeostasis (GO:0055070),-0.3267477943450173,-0.8389445784423609,0.6806167400881057,0.9087478108015886,1.0,6/17,24.63%,APP;ATOX1;SLC31A1;COMMD1;MT2A;CUTC
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.33391599002674666,0.8387389413389629,0.6568457538994801,0.9654446043741292,1.0,2/23,4.33%,ALOX12;ACSBG2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.32774169029390815,-0.8383525993508606,0.6973684210526315,0.9091549507229929,1.0,5/16,14.83%,SCARB1;APOE;GCH1;HIF1A;NUS1
prerank,regulation of lamellipodium assembly (GO:0010591),0.3218231949256621,0.8377212683541893,0.6753246753246753,0.9668127131018466,1.0,7/34,11.35%,AUTS2;AVIL;CAPZB;PIK3CA;HRG;FER;CDC42
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3797691945133614,0.8365671173657804,0.6518375241779497,0.9684701413331451,1.0,4/13,19.09%,NFU1;CISD3;ISCA1;MMS19
prerank,regulation of telomerase activity (GO:0051972),-0.2643596359719583,-0.836154511415843,0.7845744680851063,0.9127414196196134,1.0,20/45,31.44%,PARM1;HSP90AB1;NEK7;HSP90AA1;XRCC5;CTNNB1;TERF1;CCT2;MEN1;PRKCQ;HMBOX1;PTGES3;MAP2K7;KLF4;TNKS;DKC1;NAF1;MAPK3;PIF1;PKIB
prerank,mitochondrial fission (GO:0000266),0.3683969466633668,0.8359709851825541,0.6691729323308271,0.96905873736017,1.0,5/16,13.53%,PRKN;OPA1;MTFR2;DNM1L;DNM2
prerank,positive regulation of protein catabolic process (GO:0045732),0.26723431209919046,0.8355113181829956,0.7318116975748931,0.9693821044252534,1.0,24/84,17.97%,SH3D19;PRKN;ADRA2A;NEDD4;VGLL4;EZR;APC2;TIPARP;SMURF2;HUWE1;ATG7;RNF41;WWP2;CSNK2A1;FZR1;ASB5;STX5;NKD1;FAF1;NRDC;SNF8;VPS35;GPC3;WNT5A
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.30510934537167045,0.8354422236059247,0.674496644295302,0.9688909328054787,1.0,6/40,9.70%,DAB2;MAGI2;ARRB1;SERPINE1;WASL;PICK1
prerank,membrane protein proteolysis (GO:0033619),0.3119732241720823,0.8351555043828093,0.6736,0.9688480920035366,1.0,11/37,19.70%,BACE2;DAG1;CTSH;APH1B;ADAM17;MBTPS1;ERAP1;NFKB1;CLPP;NCSTN;AFG3L2
prerank,tryptophan catabolic process (GO:0006569),0.39825508410745664,0.834892726939181,0.6752988047808764,0.9687503954887838,1.0,11/11,60.20%,AFMID;KMO;HAAO;KYAT1;KYNU;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,protein polymerization (GO:0051258),0.2915816850132063,0.8347494300108914,0.7421383647798742,0.9684264634104557,1.0,9/55,12.56%,GAS7;PRKN;ARHGAP6;RNF135;DIAPH1;WASL;CATIP;VIL1;TTC17
prerank,negative regulation of axonogenesis (GO:0050771),-0.28830505688760344,-0.8346524303985388,0.7033492822966507,0.91487323332486,1.0,13/27,21.40%,RTN4;DCC;DIP2B;ULK1;ULK2;FGF13;LINGO1;SEMA3G;MT3;ARHGDIA;GDI1;RTN4R;MCF2
prerank,positive regulation of macroautophagy (GO:0016239),0.3001759719687679,0.834246851929645,0.703416149068323,0.9687872065805052,1.0,10/48,10.49%,PRKAA2;SESN1;SESN2;FYCO1;UVRAG;PIP4K2C;LARP1;HTT;SIRT1;IRGM
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3837011486005022,0.8339799309962003,0.6574585635359116,0.968693476002865,1.0,3/12,11.78%,RNF8;LARP7;NELFCD
prerank,positive regulation of protein kinase activity (GO:0045860),0.2536853140462801,0.8338168357127316,0.7878395860284605,0.9684137761283955,1.0,18/148,11.01%,PRKAG2;ACE;EPHA4;ALS2;ADRA2A;DDX3X;CAMK1;IL12B;CACUL1;SLC27A1;DLG3;TGFBR2;GPRC5B;TAB2;NOX4;IRGM;CASS4;JTB
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.29698356806497406,-0.8337493157087352,0.7126168224299065,0.9158494978866689,1.0,13/24,31.81%,POLD3;UBB;RPA1;RFC4;POLD4;POLD1;RFC2;POLK;UBC;RPS27A;RFC5;RPA3;RPA2
prerank,cellular iron ion homeostasis (GO:0006879),0.28930708499070756,0.8333454846597387,0.706060606060606,0.9687222036339382,1.0,2/55,1.26%,BMP6;CP
prerank,negative regulation of interleukin-8 production (GO:0032717),0.35788683289635226,0.8328281940418052,0.6464088397790055,0.9691402506527768,1.0,5/17,12.90%,SSC5D;ARRB1;MAP2K5;PTPN22;MAPKBP1
prerank,tryptophan metabolic process (GO:0006568),0.3982550841074567,0.8326622369686753,0.6531440162271805,0.9688558348539276,1.0,11/11,60.20%,ATP7A;KMO;HAAO;KYAT1;KYNU;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3488391010426761,0.8323375076211984,0.6649122807017543,0.9688498910258584,1.0,4/21,12.55%,HK2;DERA;GCK;PGD
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.25410551335780346,0.8315847962371579,0.7940026075619296,0.9696870363725733,1.0,11/140,6.96%,ADCY5;LPAR1;CCR9;ACKR2;JPH1;LPAR2;BDKRB2;CACNA1C;P2RX3;CACNB3;KNG1
prerank,response to organic cyclic compound (GO:0014070),0.2971477761839778,0.8314256203446,0.7275693311582382,0.969358180392201,1.0,6/52,5.86%,IL18;SPP1;PAQR7;LRRK2;TLR3;TIPARP
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.37776400754857414,0.8309744250843645,0.6777163904235728,0.9696381655234971,1.0,1/14,1.14%,PPP2R2B
prerank,regulation of sequestering of calcium ion (GO:0051282),0.3823407906752814,0.8308921640997443,0.6691176470588235,0.9691890262494512,1.0,1/12,0.80%,ANK2
prerank,chromatin organization (GO:0006325),0.2546922090413406,0.8303445466895663,0.7715404699738904,0.9696469662821348,1.0,34/132,20.78%,JARID2;HDAC8;ATRX;BAZ1B;SETD7;SMARCD3;SMARCA4;SMARCC2;SMARCE1;HDAC4;SIRT1;HDAC1;BAZ1A;ZBTB1;PHF1;CDAN1;HMGN3;SNAI1;KAT2B;MTA2;LRWD1;SETDB2;RB1;EHMT1;TCF7L1;KDM6B;PADI4;SATB2;EZH1;BRWD1;MPND;TAF6L;KDM6A;SMARCD2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.2568416840234206,-0.829957047215691,0.7528409090909091,0.9223868649026468,1.0,29/45,41.95%,STAT3;APP;EGR1;AIM2;USP50;NOD2;PANX1;HSPB1;TYROBP;CCL19;LGALS9;PYCARD;JAK2;TRIM16;P2RX7;CD36;MALT1;TLR8;MYD88;TMEM106A;GBP5;ISL1;CASP8;INAVA;TNF;NLRP12;LPL;GSDMD;IL6
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3536147899869892,0.8290926502287715,0.6578483245149912,0.9714344403782287,1.0,4/18,9.56%,FRS2;BHLHE41;HDAC4;HDAC1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.35070934467375997,0.8290566141143515,0.6566371681415929,0.9708811925237134,1.0,3/20,6.89%,WNT4;SIK1;SLC27A1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.30387747313209856,-0.8289818427661622,0.7234513274336283,0.9234728431430403,1.0,6/21,13.74%,PDE4D;XDH;HINT1;PDE2A;NT5E;NT5C1A
prerank,histone H4-K16 acetylation (GO:0043984),0.3471097534631658,0.8287959529806541,0.6654740608228981,0.970772695315255,1.0,7/19,24.56%,KMT2A;KAT7;OGT;KANSL1;KANSL3;MSL3;PHF20
prerank,alanine transport (GO:0032328),-0.3732005351270624,-0.828710870738976,0.7154639175257732,0.9232601068605045,1.0,2/10,7.84%,SLC6A6;SLC1A4
prerank,response to lipopolysaccharide (GO:0032496),-0.20804561413066008,-0.8283955035536245,0.9246031746031746,0.9231358044921105,1.0,26/138,18.10%,MEF2C;PDE4B;NOS3;SCARB1;TNFRSF11A;DAB2IP;FOXP1;GCH1;TNFRSF1B;IRAK3;ERBIN;RPS6KA3;SBNO2;TIRAP;VIM;NOS1;SNCA;CARD16;LBP;CX3CR1;PELI1;NOD2;CD180;TRIM41;PDCD4;CDC73
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3400347946471443,-0.82837799751253,0.7076923076923077,0.9224505839031928,1.0,5/14,24.15%,GAS6;CCDC3;CARD16;RFFL;NLRP2B
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.33819672694243486,0.8283291367474174,0.6791171477079796,0.9710988346117906,1.0,2/24,1.92%,AUTS2;AVIL
prerank,regulation of centriole replication (GO:0046599),-0.3162828773735449,-0.8279269840941371,0.7276887871853547,0.9225704478716823,1.0,7/17,31.17%,PLK2;CDK5RAP2;TRIM37;NPM1;CEP76;STIL;BRCA1
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.28539407279967266,-0.8275487647077613,0.75,0.9225956569412146,1.0,4/29,8.69%,CXCL12;GAS6;JAM2;CALR
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3023948655276851,-0.8270633749473965,0.6877828054298643,0.922096430666427,1.0,10/21,31.81%,ERCC1;RPA1;GTF2H1;GTF2H4;GTF2H5;ERCC2;DDB1;RPA3;ERCC3;RPA2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3023948655276851,-0.8270633749473965,0.6877828054298643,0.922096430666427,1.0,10/21,31.81%,ERCC1;RPA1;GTF2H1;GTF2H4;GTF2H5;ERCC2;DDB1;RPA3;ERCC3;RPA2
prerank,indolalkylamine catabolic process (GO:0046218),0.3982300884955753,0.8266861059782615,0.6558704453441295,0.973665961932694,1.0,10/10,60.20%,KMO;HAAO;KYAT1;KYNU;ACMSD;IDO1;TDO2;IL4I1;IDO2;AADAT
prerank,vasculature development (GO:0001944),0.35942517433423704,0.826344233984098,0.6630630630630631,0.9737290945006253,1.0,4/16,8.86%,ERRFI1;PDGFRB;PIK3CA;CDH5
prerank,sterol homeostasis (GO:0055092),0.2800675663310603,0.8263251063778676,0.739067055393586,0.9731416528945135,1.0,4/65,5.04%,RORA;IL18;GRAMD1B;APOM
prerank,lipoprotein catabolic process (GO:0042159),-0.36421811460204134,-0.8259892934816366,0.7234927234927235,0.9233955345147048,1.0,4/11,13.32%,APOE;CTSD;PPT1;ABHD17B
prerank,regulation of chemotaxis (GO:0050920),0.325551646913499,0.8256233148224917,0.6897746967071057,0.9738101781060043,1.0,5/30,10.37%,EFNB2;PDGFRB;ADGRA2;CYRIB;ZSWIM8
prerank,negative regulation of interleukin-10 production (GO:0032693),0.35908578094657145,0.8248954415215205,0.6672661870503597,0.9746544129211191,1.0,3/16,10.08%,TRIB2;IL12B;CD274
prerank,myeloid cell development (GO:0061515),0.35281617396664033,0.8246523022379394,0.687037037037037,0.9745107887130745,1.0,1/18,1.21%,KIT
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.36027523131427,-0.8244514380073865,0.7018255578093306,0.9255336529432606,1.0,5/10,32.38%,CALM1;CALM3;DRD2;CRHR1;DRD3
prerank,P-body assembly (GO:0033962),0.37899720755300675,0.8244268680772783,0.6516634050880626,0.974300375943751,1.0,3/12,12.03%,ATXN2;LSM14A;DDX6
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.22756912019276254,-0.8244130983551143,0.8327974276527331,0.9248961142486685,1.0,22/83,24.88%,CDK14;CDK17;USP29;POLA1;PLK2;BACH1;CUL3;E2F3;CDKN1A;ACVR1;KLF11;EIF4E;PIM2;CDC45;NPAT;INHBA;PHF8;CDK18;PLK3;CDKN3;CCNE2;HINFP
prerank,phospholipid metabolic process (GO:0006644),-0.23865311982075924,-0.8243921901929306,0.822289156626506,0.924218679944261,1.0,9/71,10.81%,PLA2G4A;PIP4K2A;PLPP1;MBOAT1;PLPPR1;TNFAIP8L3;PLPPR5;PLPPR4;ENPP2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.28341034733264125,-0.8242025491360675,0.736318407960199,0.9238437730826261,1.0,9/29,23.18%,SMAD7;RPS2;ARRDC4;AXIN1;PINK1;DCUN1D3;BAG5;TRIB3;ARRDC3
prerank,positive regulation of exosomal secretion (GO:1903543),0.3654541874254707,0.8242005578133871,0.6704980842911877,0.9741436525668891,1.0,7/15,22.43%,SDC4;SMPD3;SNF8;VPS4A;CHMP2A;RAB7A;SDCBP
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.33778247774585884,-0.8237227176935802,0.7041666666666667,0.9240041788197288,1.0,8/14,36.50%,ELAVL4;TIRAP;YBX3;HNRNPA0;ELAVL1;MYD88;DAZL;ANGEL2
prerank,GPI anchor biosynthetic process (GO:0006506),0.3210600967399839,0.8235736661100325,0.7154340836012861,0.9747345412701436,1.0,3/30,6.37%,PIGN;PIGW;PIGQ
prerank,positive regulation of transport (GO:0051050),-0.22772171484930287,-0.8231914488368215,0.8485804416403786,0.9242508069689545,1.0,17/85,14.36%,ACTB;MERTK;GAS6;ACSL3;NEDD4L;GSK3B;ANXA1;APOE;RAB27A;GATA2;CALR;CD47;DOCK2;CYBA;CAPN10;SNCA;CD151
prerank,regulation of rRNA processing (GO:2000232),0.35885588387741085,0.8222571401947222,0.6702702702702703,0.9767161347348661,1.0,4/16,18.25%,RIOK2;WDR43;KAT2B;BUD23
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.35451672775585596,0.8219899431655318,0.6990990990990991,0.976612715576216,1.0,4/19,5.70%,CUX1;OBSL1;CUX2;CAPRIN2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.37849511886746684,0.821833477884614,0.6839186691312384,0.9762944525131865,1.0,4/13,11.58%,FGFR1;APLN;PDPK1;ADAM17
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.31390440572412237,0.8217210457688581,0.6919104991394148,0.9759074299920741,1.0,4/31,9.41%,TFDP2;BID;TP53;TFDP1
prerank,synaptic vesicle transport (GO:0048489),-0.3610135592371324,-0.8216776793289368,0.7,0.9263482070835244,1.0,5/11,25.77%,RAB27A;KIF5C;TMEM230;KIF5A;SYNJ1
prerank,cholesterol homeostasis (GO:0042632),0.2801492370830583,0.8215519553175581,0.7562776957163959,0.9755991958040748,1.0,4/64,5.04%,RORA;IL18;GRAMD1B;APOM
prerank,regulation of calcium ion import (GO:0090279),-0.30800904621835995,-0.8210302773632351,0.712742980561555,0.9268451420855757,1.0,7/21,26.53%,CXCL12;TRIM27;CTNNB1;SLC30A1;PLN;FYN;CCL2
prerank,nuclear pore complex assembly (GO:0051292),-0.36881017266952404,-0.8208078941484582,0.7202380952380952,0.9265494152505178,1.0,6/10,36.86%,RTN4;NUP107;NUP93;AHCTF1;TMEM170A;NUP205
prerank,positive regulation of lipid kinase activity (GO:0090218),0.325551932670764,0.8207472827454239,0.7004991680532446,0.9765396243434924,1.0,6/29,7.55%,KIT;F2;EPHA8;FLT1;PDGFRB;AMBRA1
prerank,sphingoid metabolic process (GO:0046519),0.3824693145489626,0.820518555284981,0.660952380952381,0.9763553948491545,1.0,2/12,5.15%,SPHK1;NAAA
prerank,positive regulation of cell cycle (GO:0045787),0.27432472648928663,0.8202418203325755,0.7350299401197605,0.976285566891934,1.0,9/62,12.33%,SMOC2;FGFR2;SPHK1;NUPR1;ANKRD17;CCND3;SRPK2;ADAM17;PRKCA
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.35696844694230945,0.8200035835967555,0.7066420664206642,0.976134069524414,1.0,3/18,6.50%,CD300A;PARP10;TP53
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2764151527479838,0.819939841828038,0.7443502824858758,0.9756419153736337,1.0,9/72,9.41%,TFDP2;SESN2;ATM;ARID3A;ATRX;TP53;RBL2;CNOT10;TFDP1
prerank,axoneme assembly (GO:0035082),-0.28383293746402793,-0.8197901039721325,0.7523364485981309,0.9276496706314359,1.0,17/30,41.98%,DCX;RP1;SPEF1;DNAAF3;LRGUK;CCDC65;RSPH9;CFAP206;SPAG1;FOXJ1;TTLL3;DNAAF2;RSPH1;TTC12;CFAP74;DNAAF1;RSPH4A
prerank,regulation of intracellular transport (GO:0032386),0.30525311152780144,0.8193988679493225,0.7319932998324958,0.976060161278688,1.0,8/38,15.86%,LRRK2;GAS1;MAP2;RAB11B;GRIPAP1;CRYAB;RBM4;SCFD1
prerank,regulation of response to oxidative stress (GO:1902882),0.3951994615031232,0.8192849216115694,0.6914285714285714,0.9756588056528868,1.0,1/11,1.98%,PRKN
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.31278534153391546,-0.8192104307863416,0.737417943107221,0.9280160640048648,1.0,4/18,9.41%,ST18;STAT3;IL6ST;JAK1
prerank,neurotrophin signaling pathway (GO:0038179),0.33990648482201313,0.8185787987551554,0.6748251748251748,0.9764057585604998,1.0,3/21,3.53%,FRS2;MAGI2;CASP3
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.29371956268229965,-0.8180469928920974,0.7521739130434782,0.9293384229812343,1.0,7/23,20.71%,GAS6;VSIR;HAVCR2;LAPTM5;NR1H4;INHBA;LGALS9
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.24827026154119808,-0.8179344021922881,0.7909604519774012,0.9288145060362915,1.0,15/56,19.43%,NOD1;ALPK1;SFTPA1;SFTPA2;PLCG2;MAP3K7;CTSB;RPS6KA3;CTSL;CTSS;LBP;UBB;NOD2;TIFA;TLR7
prerank,nerve growth factor signaling pathway (GO:0038180),-0.3712731019821075,-0.8179227300115804,0.7172995780590717,0.9281235685112031,1.0,3/10,16.05%,NGF;RAP1A;BDNF
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.3623919295555602,0.8179191254831346,0.6529080675422139,0.9770410732594846,1.0,3/16,8.00%,IGF1;PHIP;IGFBP3
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.28846065593533954,0.817837480653526,0.7254901960784313,0.9765839392088379,1.0,8/52,11.38%,CELF2;DDX5;MBNL2;RBM15;NOVA1;THRAP3;SAP18;HNRNPL
prerank,copper ion transport (GO:0006825),-0.3535911136209263,-0.817690859992777,0.743801652892562,0.9278047283444947,1.0,6/11,31.79%,ATOX1;SLC31A1;COX17;CUTC;STEAP4;ATP7B
prerank,positive regulation of protein metabolic process (GO:0051247),0.2555176066448101,0.8175844898721711,0.8002735978112175,0.9764578281715839,1.0,19/110,12.53%,ROCK2;PRKN;IL18;NEDD4;SLC6A9;IL17D;MAP2K5;APC2;TIPARP;IL12B;SMURF2;LDB1;HUWE1;ATG7;RNF41;WWP2;CSNK2A1;FZR1;ASB5
prerank,inorganic ion transmembrane transport (GO:0098660),-0.341970415830606,-0.8173140873871023,0.6924731182795699,0.92778184616921,1.0,3/12,15.36%,ABCC9;KCNJ8;CACNA1H
prerank,mitochondrion disassembly (GO:0061726),0.31266509524941666,0.8171485423676966,0.7222222222222222,0.9766857882781119,1.0,7/34,13.75%,PRKN;ATG5;WIPI1;AMBRA1;BECN1;ATG7;ATG2A
prerank,protein heterotetramerization (GO:0051290),-0.33907836175050865,-0.8167020200155207,0.7149425287356321,0.9281464550588885,1.0,3/13,15.27%,GRIN2B;PKD1;GRIN1
prerank,regulation of neurogenesis (GO:0050767),-0.24140086781921133,-0.8166285696405902,0.8259668508287292,0.927560793067438,1.0,11/55,12.06%,B2M;NOTCH1;HES1;SERPINF1;SORL1;HEYL;MME;HEY2;NAP1L1;GPER1;CTNNB1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.35141470857802254,0.8165913628678242,0.6983546617915904,0.9771446020172294,1.0,1/17,0.64%,ROCK2
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.355307260384122,0.8165822157052184,0.6757246376811594,0.9765412277484747,1.0,6/18,17.63%,ANKRD17;DDX60;DHX58;BIRC3;UFD1;NPLOC4
prerank,cellular senescence (GO:0090398),-0.29038857042913746,-0.8165581426724507,0.7559241706161137,0.9269760265836197,1.0,6/27,12.54%,TBX3;SMC5;CALR;ECRG4;ID2;CDKN1A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.2907059629722619,-0.8165153707248035,0.7470997679814385,0.9263396965139464,1.0,6/26,14.59%,CAV1;RTN4;MFHAS1;CYBA;TIRAP;LBP
prerank,nuclear membrane organization (GO:0071763),-0.311644891824927,-0.8160233480457852,0.7228144989339019,0.9264889800738174,1.0,5/19,18.57%,GPER1;TMEM43;EMD;CHMP4B;SPAST
prerank,regulation of myotube differentiation (GO:0010830),0.3284689671824308,0.8159149794418042,0.6923076923076923,0.9772061681299065,1.0,7/24,11.30%,DMPK;SIK1;BHLHE41;HDAC4;HDAC1;FBXO22;MMP14
prerank,positive regulation of cellular respiration (GO:1901857),0.3827877140504052,0.8157512100847136,0.6748971193415638,0.9768832670610342,1.0,1/11,2.92%,NUPR1
prerank,cellular response to UV-A (GO:0071492),-0.35058013648359687,-0.8157234673987016,0.7217573221757322,0.9262826779909688,1.0,7/11,45.74%,MME;MMP1;MMP3;PPID;MMP2;OPN5;MMP9
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3194520763601193,0.8155045486297225,0.7135135135135136,0.9767132684109188,1.0,4/32,4.05%,SNCAIP;SYT11;LRRK2;DTNBP1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.360184400339859,0.8154716066048758,0.7074954296160878,0.9761618786112087,1.0,3/15,9.01%,TLR4;IL17D;IL17RA
prerank,negative regulation of complement activation (GO:0045916),-0.36836351101741605,-0.8152217979640227,0.7286012526096033,0.926456738211412,1.0,4/10,31.88%,SUSD4;A2M;SERPING1;CR1L
prerank,cellular response to cAMP (GO:0071320),0.32105291191520746,0.8150697632083893,0.697171381031614,0.9762959469154019,1.0,4/30,5.60%,SLC5A5;RAPGEF3;EZR;SLC26A3
prerank,positive regulation of protein export from nucleus (GO:0046827),0.35949338844894685,0.8149805819810326,0.6945454545454546,0.9758500043865577,1.0,4/15,9.99%,RAPGEF3;CAMK1;TP53;TCF7L2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.33767379441230694,0.8141283258747242,0.6912028725314183,0.9768436597906693,1.0,8/22,21.02%,SOX12;TNFRSF18;DUSP10;FANCA;IRF1;CD46;BCL6;CTLA4
prerank,Golgi to lysosome transport (GO:0090160),-0.35775399691658183,-0.8136093588784656,0.7086776859504132,0.9286540339266488,1.0,3/11,16.54%,SORT1;LAPTM5;EHD3
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3009884399298437,0.813566308758199,0.7433070866141732,0.9773064196381407,1.0,6/38,14.43%,RORA;SIRT1;TLE1;RIPK1;MAPKBP1;PPM1B
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3061314232391343,0.8133922244871833,0.7103109656301145,0.9770017530969615,1.0,12/35,23.81%,POLD2;POLG;PNKP;TDG;POLL;MBD4;OGG1;FEN1;RFC1;LIG1;ADPRS;SMUG1
prerank,regulation of centrosome cycle (GO:0046605),0.3333729508251423,0.8132251535811574,0.7347294938917975,0.9767203629145981,1.0,6/21,20.40%,PKHD1;SIRT1;CHMP1A;CHMP4C;XRCC3;CHMP2A
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.36334215748310017,-0.8131250690827972,0.7044534412955465,0.928705430454407,1.0,4/10,20.05%,PTH1R;SNCA;IRS2;IRS1
prerank,superoxide metabolic process (GO:0006801),0.31458410644172236,0.813059864633018,0.7087542087542088,0.9764116280039091,1.0,6/29,10.42%,ALOX12;SOD3;NOX1;SOD2;SH3PXD2B;NOX4
prerank,positive regulation of histone acetylation (GO:0035066),0.33074890392183254,0.812617650721801,0.7072727272727273,0.9766532649755149,1.0,6/23,16.98%,PPARGC1A;ARRB1;BRD7;KAT7;SPHK2;SMAD4
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3262463485268724,0.8123900330850997,0.7123966942148761,0.9764874801143503,1.0,4/26,5.98%,OGN;ST3GAL3;FMOD;B4GALT1
prerank,regulation of translation (GO:0006417),-0.20143054003279323,-0.8122365402455096,0.9386792452830188,0.9295809850194997,1.0,42/173,21.61%,GRM5;PRR16;THBS1;NIBAN1;YBX1;RPL26;APP;RPS3;SYNCRIP;RPL5;CALR;ERBB2;RPS6KA3;FXR1;EIF4ENIF1;RPS4X;DAPK1;VIM;SHFL;MALSU1;EIF3B;RPS6KA1;MTG2;GLE1;EIF1;METTL3;EIF2AK3;BCL3;DHX9;EIF4E;RPL13A;HSPB1;PUM3;RPS27L;EEF2;RBM4B;BTG2;RBM3;EIF4A3;EIF3D;CNOT7;NPM1
prerank,positive regulation of myelination (GO:0031643),-0.3479892454442795,-0.8122040645142722,0.6728395061728395,0.9289380328457214,1.0,2/11,7.20%,TENM4;TNFRSF1B
prerank,actin crosslink formation (GO:0051764),-0.34666916534035885,-0.8121737811009728,0.716589861751152,0.92827760809026,1.0,4/12,14.12%,FLNA;GAS2;EPS8;GAS2L3
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.24558021308830866,-0.8116489032983217,0.7875354107648725,0.928495850516084,1.0,30/51,41.95%,STAT3;APP;EGR1;AIM2;USP50;NOD2;PANX1;HSPB1;TYROBP;CCL19;LGALS9;PYCARD;TMED10;JAK2;TRIM16;P2RX7;CD36;MALT1;TLR8;MYD88;TMEM106A;GBP5;ISL1;CASP8;INAVA;TNF;NLRP12;LPL;GSDMD;IL6
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3671993047338562,0.8115913408678529,0.6824196597353497,0.9773423707577509,1.0,5/14,16.79%,NMNAT1;AK3;AK4;AK8;NMNAT2
prerank,response to X-ray (GO:0010165),0.3659090685414184,0.811270700690488,0.6721915285451197,0.9773613495671667,1.0,3/14,8.69%,ATM;NIPBL;XRCC4
prerank,morphogenesis of an epithelium (GO:0002009),-0.28995337849046343,-0.8111670684913169,0.7506361323155216,0.928669711811772,1.0,10/25,23.25%,ACTB;ACTG1;TBX18;LAMA3;AHI1;SOX8;VCL;LRP6;LHX1;SOX10
prerank,regulation of pH (GO:0006885),0.38502968498394763,0.8105312087438552,0.6966067864271457,0.9781642079397631,1.0,1/11,2.05%,LACC1
prerank,DNA packaging (GO:0006323),0.3502660156615937,0.8102032091458296,0.705989110707804,0.9781646546503171,1.0,7/16,27.76%,CHAF1B;TP53;CDAN1;NOC2L;H1-0;M1AP;RBBP4
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.27650483329195646,-0.8100458879850992,0.7909738717339667,0.9299181208278947,1.0,5/29,10.70%,GHR;STAT3;SOCS2;STAT5B;PKD1
prerank,response to UV-A (GO:0070141),-0.32426583599551617,-0.8100300808739881,0.7037815126050421,0.9292421602093189,1.0,8/14,45.74%,MME;MMP1;CCND1;MMP3;PPID;MMP2;OPN5;MMP9
prerank,negative regulation of innate immune response (GO:0045824),0.30565154570819586,0.8093169519898487,0.7353896103896104,0.9792094015551877,1.0,9/34,13.94%,STAT2;SAMHD1;FAM3A;YTHDF3;DHX58;NMI;OAS3;ACOD1;USP18
prerank,protein insertion into membrane (GO:0051205),-0.27584403150028625,-0.8093144371080614,0.7591240875912408,0.9297866417889974,1.0,10/32,29.59%,REEP1;APP;SEC61B;CYB5A;EMD;VAPA;TRAM1;STX1A;HMOX1;WDR83OS
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.2654663102429965,-0.8092541564290294,0.7818181818181819,0.9291988379714539,1.0,9/35,19.95%,STAT3;LYN;STAT5B;HIF1A;TAL1;ZFPM1;INHBA;FAM210B;MAFB
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.2388154155065408,-0.8087082288761934,0.8452722063037249,0.9293938526062792,1.0,15/62,18.11%,CXCL12;TPT1;ARHGEF2;PPIA;ACKR3;RTKN2;TMBIM6;CREB3L1;YBX3;ARMC10;PINK1;CLU;DNAJA1;HSPB1;HTRA2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.28869786025619515,-0.8086860618061122,0.7437641723356009,0.9287410577367121,1.0,12/25,26.21%,CACNB2;AKAP6;CEMIP;TRPC1;GPER1;SNCA;APLNR;NPSR1;THY1;F2R;CXCL10;PLCG1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.24583467246456428,0.8085896091823515,0.8204456094364351,0.9799928327360069,1.0,17/144,9.99%,SMAD3;TFDP2;LEPROT;BID;RAPGEF3;RUFY3;FZD5;CAMK1;TP53;BCAS3;HUWE1;ZIC1;TFDP1;NPEPPS;UBR5;MAVS;TCF7L2
prerank,phagolysosome assembly (GO:0001845),0.36554667723050077,0.8082517619146461,0.6819085487077535,0.9800023185243242,1.0,5/12,21.80%,RAB34;PIKFYVE;RAB7B;PLA2G5;RAB7A
prerank,protein localization to condensed chromosome (GO:1903083),0.3800332113659981,0.8081717481780445,0.6839186691312384,0.9795366909766338,1.0,5/12,24.74%,AURKB;IK;CHAMP1;MIS12;SPDL1
prerank,protein-containing complex assembly (GO:0065003),0.22967052293433474,0.8075279035708847,0.8683574879227053,0.9801085616156892,1.0,74/259,22.95%,AFDN;PPARGC1A;PICALM;KMT2A;LAMC1;PLEKHA7;MCU;MITF;CAND2;LRRK2;SAMM50;TP53;TRAPPC9;SH3PXD2B;OPA1;ANO6;SMARCA4;TERT;WDR19;DNM1L;TEAD2;CSNK1A1;WASL;TCF7;TLE1;HDAC1;RIPK1;ASH2L;TCF7L2;VIL1;TEAD1;AXIN2;FANCA;TGFA;KMT2D;PARD3;PML;TLE2;STX5;SEC23IP;F8;PEX14;DNAJB14;SCFD1;CREBBP;TRAPPC5;PPP6R3;TCF7L1;RANBP9;HFE;ZNHIT6;TNFRSF1A;SEC31A;BET1;GOLGA2;YAP1;ITGB1BP1;FOLR1;AFG3L2;PYGO2;TUBGCP4;GPAA1;SEC24C;DBNL;RUVBL1;CD247;CLDN1;SEC24A;EP300;GORASP1;BOK;SNX9;F5;BCL9
prerank,defense response to protozoan (GO:0042832),0.3775597186557333,0.8074671878799587,0.6833013435700576,0.9796111752889992,1.0,3/12,13.87%,GBP7;GBP2;GBP6
prerank,activation of GTPase activity (GO:0090630),0.26128261742277953,0.8072485892049559,0.8002773925104022,0.9794094481767782,1.0,13/89,11.11%,ARHGAP29;SIPA1L1;ARHGEF16;SYDE2;NGEF;TBC1D16;GMIP;APC2;BCAS3;GRTP1;DOCK7;RALGAPB;MTSS2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.26434447448367016,0.8066533479314378,0.7588757396449705,0.9798908010209916,1.0,16/78,17.75%,CCNA2;NR2F2;CCNA1;CCNT2;PTEN;CCND3;CDK5RAP3;CDC25A;GTPBP4;CCNB2;ADAM17;GADD45A;CCNG1;CCNE1;CNPPD1;HEXIM2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3342754346986215,0.8064934731127789,0.7101200686106347,0.9795978848976986,1.0,4/21,13.43%,BACE2;DAG1;ADAM17;ERAP1
prerank,thymus development (GO:0048538),-0.34515880274542476,-0.806347619257469,0.7270742358078602,0.9320878087154025,1.0,3/13,8.27%,TBX1;HES1;SIX1
prerank,regulation of hemopoiesis (GO:1903706),0.3920482503708377,0.8055820731179637,0.6710775047258979,0.9806818166077607,1.0,5/10,16.31%,PRKCB;IL17D;PURB;LGALS3;CREBBP
prerank,response to UV-B (GO:0010224),-0.33620177742245044,-0.8055615343316077,0.7306930693069307,0.9326718789683236,1.0,6/12,24.37%,MME;MFAP4;CDKN1A;CRIP1;RELA;HYAL2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.36276587517675607,0.8053285936604648,0.6804733727810651,0.9805281834225854,1.0,4/14,15.22%,TGFBR1;PTPN11;RFLNA;ADAMTS7
prerank,negative regulation of organelle assembly (GO:1902116),-0.2624583670576287,-0.8052442287135536,0.8100961538461539,0.9325240188647859,1.0,11/35,19.43%,TBC1D30;LIMK2;FEZ1;CDK5RAP2;TMEM39A;PINK1;FEZ2;TRIM37;CHMP4B;CHMP4A;ODF2L
prerank,negative regulation of microtubule polymerization (GO:0031115),0.38175097398252034,0.8051701554076309,0.680073126142596,0.9802205317365924,1.0,4/12,10.71%,EML2;MAP2;CDH5;DYRK1A
prerank,regulation of mRNA catabolic process (GO:0061013),-0.20969885900910987,-0.8050596057438485,0.9205020920502092,0.9321617619303577,1.0,41/121,29.91%,PRR5L;PSMB2;YWHAB;HSPA8;XPO1;PSMD14;PNPT1;ANP32A;PSMC6;FXR1;VIM;UBB;PSMA4;PSMB9;ZC3H14;PABPC1;HSPB1;PSMD11;PSMB10;PSMD2;YTHDF2;DCP2;CNOT7;PSMA2;EXOSC4;UBC;RPS27A;EXOSC1;PSMB3;SET;RBM24;PSMB5;ELAVL1;YWHAZ;YTHDF1;PSMA7;RC3H2;HNRNPD;PSMF1;PSMD7;APEX1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.257483527650212,-0.8045417326968639,0.8102981029810298,0.9323473147271296,1.0,17/42,26.41%,POLA1;POLD3;WRNIP1;FAAP20;PRIMPOL;UBB;RPA1;RFC4;POLD4;POLD1;RFC2;POLK;DTL;UBC;RPS27A;RFC5;PCLAF
prerank,cellular response to mechanical stimulus (GO:0071260),-0.2536832072938838,-0.8043692385887876,0.8117977528089888,0.9319389070607612,1.0,21/46,34.59%,PIEZO2;F11R;PIEZO1;PDE2A;FAS;TMEM150C;CRADD;CASP2;MAP3K14;TLR7;BNIP3;CD40;MAPK8;MAPK3;MAP2K4;AQP1;BCL10;PTGER4;TLR8;MYD88;BAD
prerank,amide biosynthetic process (GO:0043604),-0.24620858498570256,-0.8043686474225867,0.7821522309711286,0.9312400463228068,1.0,20/47,29.49%,SGMS1;SGMS2;SPTLC2;DEGS2;PAM;PCSK5;CERS4;ASAH2;SPTSSB;ASAH1;PCSK1;DMD;CLN8;TLCD3B;NANP;SPTLC3;ASS1;SPTLC1;NMRAL1;CERS2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3006217001441718,0.8034554523648602,0.7185840707964601,0.982793216517724,1.0,3/36,3.46%,TPD52L1;DEPTOR;TGFBR1
prerank,autophagy of nucleus (GO:0044804),0.35114335879774916,0.8033617085745545,0.6979362101313321,0.9823614491041628,1.0,8/16,26.10%,ATG5;WIPI1;ATG7;ATG2A;ATG2B;ATG12;ATG3;ATG9B
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3649016483613314,0.8033110391055573,0.7005444646098004,0.9818458252705567,1.0,1/14,1.76%,PPARA
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.25219513740453947,-0.8032395942216825,0.8130081300813008,0.9325536021947586,1.0,14/47,20.71%,EPHB1;MID1;TGFB2;DAB2IP;PPIA;PHLPP1;FOXO1;RAP2A;FAS;SEMA4C;NOD2;KLHDC10;COPS5;LGALS9
prerank,positive regulation of defense response (GO:0031349),0.2622488340515085,0.8031254806291125,0.7958620689655173,0.981560095220447,1.0,11/89,9.73%,IL18;NAPEPLD;TLR3;TLR4;IFNK;IL12B;SERPINE1;PLSCR1;GPRC5B;IL17RA;RIPK1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.3814886111505049,0.8027623448021065,0.7047244094488189,0.9816166101862954,1.0,3/10,20.37%,RHO;SAG;PDE6B
prerank,positive regulation of endocytosis (GO:0045807),0.2924686044851995,0.8025124163264622,0.7394822006472492,0.9814618773680166,1.0,2/45,0.68%,DAB2;APPL2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.293343499002746,0.8025082562412967,0.7457627118644068,0.9808686403534759,1.0,9/42,17.10%,TLR4;DEFB1;F2;IL12B;SERPINE1;IRGM;CAMP;DMBT1;OPTN
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.29594043432319167,0.8022733709189236,0.739413680781759,0.9807210761903727,1.0,6/40,11.47%,ATRX;DONSON;FBH1;FANCM;EME2;MSH3
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.35196796626795224,0.8016863618307225,0.6939130434782609,0.9811847419663904,1.0,3/16,10.94%,WNT4;F2;SUCO
prerank,protein alkylation (GO:0008213),-0.2930827761768356,-0.8015934918444112,0.7566964285714286,0.9346048299727887,1.0,11/22,35.22%,LCMT1;FAM98B;METTL22;SNRPD3;SNRPB;PRMT8;PRMT1;PRMT3;ETFBKMT;EEF1AKMT2;FAM98A
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3079329926481923,0.8008705987015187,0.7654723127035831,0.9820656031225867,1.0,3/30,6.30%,ST6GAL1;ASGR1;FUT8
prerank,7-methylguanosine RNA capping (GO:0009452),0.3054588381562742,0.8007362896832477,0.7168874172185431,0.9811024795978633,1.0,5/31,13.80%,POLR2A;POLR2D;GTF2F1;CMTR2;RAMAC
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3054588381562742,0.8007362896832477,0.7168874172185431,0.9811024795978633,1.0,5/31,13.80%,POLR2A;POLR2D;GTF2F1;CMTR2;RAMAC
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3255864171548268,0.8007235877570702,0.7021276595744681,0.9805228719983419,1.0,3/22,8.32%,DDX5;ATM;CDK5RAP3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3615410486258689,0.8000474604620784,0.6957328385899815,0.9811516962619306,1.0,3/13,11.78%,RNF8;LARP7;NELFCD
prerank,cellular response to gamma radiation (GO:0071480),0.34761561841384264,0.7994960222374178,0.6914893617021277,0.9815673772343398,1.0,6/17,19.10%,ATM;TP53;CRYAB;TLK2;KDM1A;YAP1
prerank,protein deneddylation (GO:0000338),-0.3590726547561949,-0.7994942964615225,0.7305389221556886,0.9374078982459535,1.0,4/10,27.77%,COPS4;COPS6;COPS5;COPS2
prerank,purine-containing compound catabolic process (GO:0072523),0.3671358672633486,0.7993447542562867,0.7038461538461539,0.9812538526024954,1.0,3/13,10.01%,DPYD;NT5C1B;NT5C2
prerank,regulation of DNA binding (GO:0051101),0.28882585318388976,0.7991800759356714,0.7358184764991896,0.9809572097506508,1.0,4/44,4.94%,IGF1;PRKN;FOXC1;SMO
prerank,regulation of defense response (GO:0031347),-0.22570382129977498,-0.7990227099549976,0.8535031847133758,0.9374898507685693,1.0,15/76,13.07%,IL1R1;TMSB4X;SEMA7A;MGLL;ANXA1;FOXP1;APOE;PTGES;AGTR1;PTGS2;PIK3AP1;SBNO2;TIRAP;ACE2;LRP8
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.19680857480336186,-0.7984117253633982,0.97,0.9378600782301748,1.0,62/184,27.70%,HECW2;YWHAE;PSMB2;DYNLL1;PPP2R1A;YWHAG;CUL3;ANLN;PSMD14;TUBA1A;HAUS2;PSMC6;ID2;TUBB4A;CDK5RAP2;HSP90AA1;KCNH5;PKD1;PRKAR2B;BUB3;UBB;HAUS5;PSMA4;PSMB9;CEP78;CENPE;CDC23;SKP1;CETN2;RGCC;PSMD11;SIRT2;PSMB10;TUBA4A;SSNA1;PSMD2;ERCC2;NEK6;MAD2L1;CEP131;PSMA2;CCP110;HMMR;TFAP4;TPX2;UBC;RPS27A;KIF14;KNTC1;NEDD1;HAUS4;CEP135;PSMB3;ACTR1A;NDE1;HAUS6;CEP76;PSMB5;UBE2D1;DDB1;PSMA7;CENPF
prerank,spermatid development (GO:0007286),0.3079230927817472,0.7983659504318471,0.717687074829932,0.9818868903324379,1.0,9/32,25.14%,TOPAZ1;RNF8;MKKS;ACRBP;RFX2;CEP57;NECTIN2;TTC21A;ING2
prerank,inositol lipid-mediated signaling (GO:0048017),0.2817934766591881,0.7981321652272342,0.7668711656441718,0.981700856894262,1.0,9/50,9.26%,IGF1;PI4KA;FGFR1;EZR;PLCD3;PDGFRB;GAB2;PIK3CA;PLCD1
prerank,ncRNA catabolic process (GO:0034661),0.3144585321892861,0.7977837372000132,0.7474048442906575,0.981727949527615,1.0,8/28,20.86%,TUT4;EXOSC7;SND1;DIS3;TENT4B;DIS3L;EXOSC3;POP1
prerank,response to nutrient levels (GO:0031667),0.3344895102290031,0.797345891946624,0.7080979284369114,0.981917817989653,1.0,1/17,1.62%,PRKAA2
prerank,reticulophagy (GO:0061709),-0.34031224792158266,-0.7973376107775659,0.7297297297297297,0.9389419170880106,1.0,4/12,9.99%,ULK1;ULK2;DDRGK1;UFM1
prerank,peptidyl-asparagine modification (GO:0018196),0.30666215301411137,0.7969643117088255,0.7680921052631579,0.9820346170176172,1.0,6/31,15.71%,ST6GAL1;ASGR1;FUT8;MAGT1;ASGR2;HIF1AN
prerank,histone H4 acetylation (GO:0043967),0.283606895301401,0.7965419260166441,0.7669421487603306,0.9822152608250451,1.0,7/47,13.91%,BRD8;KMT2A;ZZZ3;ATF2;KAT7;BEND3;OGT
prerank,translational termination (GO:0006415),0.25584045962013124,0.7964670870328612,0.8316970546984572,0.9817380135479973,1.0,29/95,25.77%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;ETF1;GSPT2;MRPS26;MTRF1L;MRPL48;MRPL1;GFM2;MTRF1;MRPL45;MRPS17;CHCHD1;N6AMT1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;GSPT1;MRPS25;MRPL50;MRPL33;MRPS18B;MRPL19
prerank,regulation of cytokinesis (GO:0032465),0.26324359557443383,0.7964296996432739,0.7913446676970634,0.9812003705439265,1.0,18/78,18.00%,PKP4;UVRAG;PLK5;CDC14A;MYO19;BECN1;AURKB;CDC14B;CDC42;FLCN;ZFYVE26;BIRC6;VPS4A;CHMP4C;CENPV;KIF13A;MAP9;PKN2
prerank,regulation of lipid kinase activity (GO:0043550),0.37747138873583636,0.7962471592473379,0.6866537717601547,0.980924138156054,1.0,7/11,19.96%,F2;RBL2;RBL1;PIK3R3;RB1;WDR91;WDR81
prerank,cell junction maintenance (GO:0034331),0.3571324003443701,0.7961652502009304,0.6948529411764706,0.9805047677215513,1.0,1/14,2.47%,NLGN2
prerank,pre-miRNA processing (GO:0031054),0.3617696946531203,0.7954552283846557,0.7134935304990758,0.9811610190064297,1.0,7/14,28.23%,TUT4;DICER1;TUT7;AGO1;AGO4;AGO2;ADAR
prerank,L-serine metabolic process (GO:0006563),0.3906727613510376,0.7952517495125013,0.7203883495145631,0.9809321064530057,1.0,3/10,21.92%,SRR;PHGDH;CBS
prerank,phagosome maturation (GO:0090382),0.2924838832136297,0.7944986997934529,0.7309644670050761,0.981684334095877,1.0,7/35,11.08%,ATP6V0E1;RAB34;ATP6V0B;PIKFYVE;RAB43;ATP6V1D;ATP6V1E1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3547834277579702,0.7939933454500232,0.7215189873417721,0.9819753082862948,1.0,5/15,20.25%,EME2;ATF2;HUS1;FANCD2;RAD9A
prerank,peptidyl-serine modification (GO:0018209),0.23732353571104772,0.793929094649032,0.8690629011553274,0.9814993571760817,1.0,27/166,13.22%,ROCK2;PRKCZ;STK32B;TGFBR1;DMPK;LRRK2;SMG1;PRKCB;IKBKE;ATM;CAMK1;RICTOR;TGFBR2;MAPKAPK3;PDPK1;CSNK1A1;MKNK1;BRSK1;SRPK2;DYRK1A;PRKDC;CSNK2A2;CSNK2A1;PRKCA;HIPK3;PRKCI;WNK1
prerank,regulation of organelle organization (GO:0033043),0.2660757030972231,0.793902135380997,0.8130434782608695,0.9809510489078448,1.0,17/80,18.58%,SYT11;STX18;PRKN;CPLANE2;EZR;ARMH3;DIAPH1;DNM1L;MAVS;STX5;TBC1D25;CENPV;VPS35;SQSTM1;PAK2;RHOT1;AKAP9
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.34671491027834117,0.7932593506794798,0.6985815602836879,0.9815130912229278,1.0,3/17,6.47%,IL18;TLR4;IL12B
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.3726185391180446,0.7931698269765369,0.70703125,0.981078496802197,1.0,5/12,22.89%,LHPP;ADSS1;GART;ADSL;GMPS
prerank,positive regulation of T cell migration (GO:2000406),0.32741508162451016,0.7929007229964897,0.6924428822495606,0.9809659235364353,1.0,5/20,17.97%,OXSR1;ADAM17;WNK1;CCR2;WNT5A
prerank,endocytic recycling (GO:0032456),0.28112480326792366,0.7928639415236762,0.7852664576802508,0.9804343994924298,1.0,15/50,18.46%,PTPN23;VPS26C;EIPR1;RAB11B;RAB13;VPS50;ANKRD27;SNX12;MICALL1;SNF8;VPS51;VPS35;VPS35L;CCDC93;CCDC22
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2945995623984631,0.7920802956221599,0.7738287560581584,0.981286250927133,1.0,7/35,12.69%,ATM;ACD;HNRNPA2B1;TNKS2;AURKB;FBXO4;PNKP
prerank,RNA transport (GO:0050658),0.2633539180095179,0.7918611083386492,0.7949479940564635,0.9810737620528693,1.0,21/71,21.34%,NXF2;SRSF5;SIDT2;POLDIP3;HNRNPA2B1;SIDT1;TGFBR2;ATXN2;NXF1;SRSF11;ZFP36L1;SARNP;NUP155;SRSF1;CDC40;NUP188;U2AF1;SRSF7;FMR1;U2AF2;NUP153
prerank,negative regulation of telomere maintenance (GO:0032205),0.349668615285009,0.7908727895080271,0.7287822878228782,0.9822013396346395,1.0,8/15,26.39%,ATM;TNKS2;RAD50;NBN;SLX4;SMG6;PINX1;RTEL1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.27345346405289517,-0.7908408308003612,0.7680180180180181,0.948891516420303,1.0,8/28,22.80%,NOTCH3;BEND6;GATA2;LFNG;METTL3;DLL4;YTHDF2;TSPAN15
prerank,telomere maintenance via telomerase (GO:0007004),-0.2743509179634165,-0.7905976112158469,0.7901785714285714,0.9485917595622297,1.0,9/28,20.20%,HSP90AB1;HSP90AA1;TNKS1BP1;TERF2IP;TERF1;RPA1;ANKRD28;NHP2;PTGES3
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.3145762593378313,-0.790223604816339,0.7450549450549451,0.9484901808877314,1.0,5/15,13.47%,DACT1;SMAD7;FKBP1A;LEMD3;ACVR1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.27270487279336975,-0.789979565645028,0.8220551378446115,0.9481525976869484,1.0,1/29,0.39%,CADM1
prerank,selective autophagy (GO:0061912),0.27374940268573816,0.7897450192160759,0.7635542168674698,0.9836126591798823,1.0,16/56,19.96%,PRKN;RETREG1;ATM;ATG5;AMBRA1;BECN1;IFT88;ATG2A;ACBD5;TEX264;PEX5;DYNC1LI1;SQSTM1;PCNT;UBA5;WDR81
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.3028953433635723,0.7891591485667648,0.723916532905297,0.9840595426544577,1.0,8/31,20.17%,CYP21A2;FDXR;DHRS11;MOCOS;SRD5A2;NFS1;LIAS;MOCS1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.37427493872334144,0.7889766247790851,0.7118320610687023,0.9837919575611221,1.0,4/10,17.63%,TKFC;DHX58;UFD1;NPLOC4
prerank,positive regulation of exocytosis (GO:0045921),-0.25651785212167993,-0.7888267154952587,0.7885572139303483,0.949369839265533,1.0,6/35,13.17%,CADPS;CLASP2;RAB27A;PDCD6IP;RAB27B;SNCA
prerank,negative regulation of secretion (GO:0051048),0.3810929553420678,0.7886851228273188,0.7142857142857143,0.9837107496701404,1.0,4/10,22.37%,NRG1;SPX;NR1H3;VAMP8
prerank,nucleotide-sugar metabolic process (GO:0009225),0.3632046984812115,0.7882260323230004,0.6986301369863014,0.9839157941757993,1.0,2/12,6.30%,GMDS;FUT8
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.26985278969571014,-0.7882222804035277,0.794044665012407,0.9495948906238996,1.0,9/29,33.16%,PLA2G4A;LPCAT2;PLA2G12A;PLA2G4E;PLA2G4F;MBOAT7;DBI;PLBD1;PLB1
prerank,telomere organization (GO:0032200),0.28451858029180427,0.7878818361073732,0.7691107644305772,0.9839202884121876,1.0,12/43,18.95%,POLD2;ATM;ACD;TERT;PRKDC;HUS1;RAD50;DOT1L;SP100;TINF2;NBN;RAD51D
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3134300510240583,0.7877739795381986,0.75809199318569,0.9835128402630466,1.0,4/28,9.78%,SMAD3;ZIC1;UBR5;MAVS
prerank,outer dynein arm assembly (GO:0036158),0.35215789947242754,0.7874365124394503,0.714795008912656,0.9835169931846128,1.0,1/14,2.99%,ODAD1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.26542500697940985,0.7873182658758869,0.8137535816618912,0.9831374369074768,1.0,1/74,0.14%,EPAS1
prerank,response to interferon-gamma (GO:0034341),-0.23007559675848396,-0.7869064840407335,0.8739495798319328,0.9509734048284593,1.0,21/67,26.53%,GCH1;AQP4;SYNCRIP;CXCL16;CD47;GBP4;IFITM3;DAPK1;SHFL;SNCA;CD74;CCL13;RPL13A;IRF8;CCL19;LGALS9;IFITM1;IFITM2;CD40;GAPDH;CCL2
prerank,nucleus organization (GO:0006997),-0.24230836093856925,-0.7868783590501515,0.8523002421307506,0.9503084835897954,1.0,6/47,12.31%,SYNE1;RPS19;BIN1;PITPNB;PDCD6IP;LEMD3
prerank,negative regulation of protein binding (GO:0032091),0.26394825001774114,0.7860227175435007,0.7973950795947902,0.9848449188942232,1.0,19/71,19.18%,DAB2;IFIT1;IFIT2;LRRK2;MAP2;CAMK1;GTF2F1;AURKB;TMC8;STYX;DNAJB2;EFHB;PEX14;TFIP11;KDM1A;HFE;GOLGA2;USP33;ITGB1BP1
prerank,negative regulation of reproductive process (GO:2000242),0.3472633815047035,0.7852861798010315,0.7279693486590039,0.985568578001304,1.0,1/17,1.44%,IGF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3559788382600826,-0.7850246153015277,0.7432150313152401,0.9511106088927381,1.0,4/10,22.82%,ERCC1;TERF1;DNA2;BLM
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3559788382600826,-0.7850246153015277,0.7432150313152401,0.9511106088927381,1.0,4/10,22.82%,ERCC1;TERF1;DNA2;BLM
prerank,t-circle formation (GO:0090656),-0.3559788382600826,-0.7850246153015277,0.7432150313152401,0.9511106088927381,1.0,4/10,22.82%,ERCC1;TERF1;DNA2;BLM
prerank,positive regulation of receptor internalization (GO:0002092),0.31840561426700614,0.7849129353318232,0.7412587412587412,0.9856130193654584,1.0,4/22,9.70%,MAGI2;ARRB1;APLN;PICK1
prerank,bone morphogenesis (GO:0060349),0.35196957568915604,0.7845644446413477,0.7231329690346083,0.9856320422342585,1.0,2/14,4.67%,FGFR2;CYP26B1
prerank,regulation of intracellular protein transport (GO:0033157),0.2993504858340448,0.7841562258547666,0.731023102310231,0.985739767344276,1.0,4/32,6.72%,PTPN14;IFI27;RUFY3;BCAS3
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.3303790693676808,-0.7840974250430783,0.7787610619469026,0.95198129841518,1.0,6/14,24.44%,PNPT1;TFAM;SLC25A33;TEFM;TFB1M;FASTKD5
prerank,regulation of fibroblast proliferation (GO:0048145),0.2851372068426981,0.7838489009201873,0.7678855325914149,0.9856688680430019,1.0,5/45,6.50%,IGF1;SPHK1;CD300A;PARP10;TP53
prerank,regulation of chromosome organization (GO:0033044),0.3203697128750853,0.7835860647042738,0.7522123893805309,0.9855393580030734,1.0,8/22,22.90%,HDAC8;SMG1;WAPL;RB1;CENPV;LIG4;YLPM1;SMG6
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.22845878807802442,0.7832788182048387,0.8911483253588517,0.9855238732465973,1.0,20/208,9.78%,RORA;WLS;LPAR1;PRKN;CFLAR;AKAP13;CXXC5;ZFAND6;PRKCB;IKBKE;ANKRD17;LGALS1;GPRC5B;PDPK1;TAB2;SIRT1;TLE1;RIPK2;RIPK1;MAVS
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.2796463234184337,-0.7827990288534673,0.7785388127853882,0.9532479256922503,1.0,13/23,31.93%,SLIT2;MPP1;TIRAP;CD74;DAPK2;CCL19;MDK;THBS4;MOSPD2;JAM3;BST1;C5AR2;RAC2
prerank,mitotic DNA replication (GO:1902969),-0.3540823719620291,-0.7827441430975431,0.7450592885375494,0.9526249038766997,1.0,1/10,2.33%,POLA1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.3522442109193874,-0.7824900983812032,0.7532467532467533,0.9523315141173271,1.0,3/10,16.20%,PODXL;PIEZO1;SKAP1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3729719729658756,0.7822275553611755,0.7229601518026565,0.9867539099904246,1.0,5/12,19.92%,IDH1;ACO2;SIRT4;IDH2;ACLY
prerank,regulation of establishment of planar polarity (GO:0090175),-0.21260432096108609,-0.7815538227149144,0.9225589225589226,0.9531277306435307,1.0,20/88,19.45%,PRICKLE2;DAAM1;PSMB2;ROR2;TIAM1;FZD4;DACT1;PSMD14;AP2B1;PSMC6;VANGL2;AP2M1;SPEF1;SMURF1;PSMA4;PSMB9;PSMD11;ARRB2;PSMB10;PSMD2
prerank,ureteric bud morphogenesis (GO:0060675),-0.3033460167732712,-0.7815311132266385,0.7564102564102564,0.9524632970454693,1.0,6/16,19.19%,BMP2;SIX1;FGF2;BMP4;PAX2;PAX8
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.34270772167490837,-0.7813882272622892,0.7240663900414938,0.9520078522109334,1.0,2/11,7.83%,RUNX1;VSIR
prerank,DNA dealkylation (GO:0035510),0.38888181029445257,0.781155791644899,0.7195121951219512,0.9873932109442621,1.0,3/10,16.87%,ASCC2;MGMT;ALKBH5
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.38888181029445257,0.781155791644899,0.7195121951219512,0.9873932109442621,1.0,3/10,16.87%,ASCC2;MGMT;ALKBH5
prerank,negative regulation of inflammatory response (GO:0050728),0.2297365404326905,0.7810757165414276,0.8898847631241997,0.9869555389837563,1.0,13/182,9.26%,RORA;C1QTNF3;ADCY5;IGF1;PPARA;ADCY1;METRNL;GPS2;ENPP3;ADCY9;MC2R;CDH5;ADM
prerank,regulation of sensory perception of pain (GO:0051930),-0.34978160612477616,-0.7809489574770557,0.7322515212981744,0.9519905871825207,1.0,3/11,7.17%,CCN3;MGLL;TMEM100
prerank,regulation of humoral immune response (GO:0002920),-0.24205842945056652,-0.7809212626448131,0.8534704370179949,0.9513315704185367,1.0,15/44,26.26%,SUSD4;C1QB;C4B;PROS1;C1QC;CLU;C3AR1;C1QA;GATA6;VTN;C6;C7;CD81;CFH;C3
prerank,dendritic cell migration (GO:0036336),-0.30922027897979,-0.7807075013366144,0.7649572649572649,0.9509626937286808,1.0,4/16,23.09%,EPS8;TRPM2;CCL19;CXCR4
prerank,bile acid biosynthetic process (GO:0006699),0.31200531517124414,0.7795939247950131,0.7525951557093425,0.9888836152636665,1.0,3/24,5.91%,CYP27A1;AMACR;OSBPL9
prerank,positive regulation of proteolysis (GO:0045862),0.27107437069433454,0.779553553666157,0.784688995215311,0.9883573276018924,1.0,7/55,8.12%,SH3D19;ADRA2A;CTSH;ANGPTL8;FBXW11;CLN6;BTRC
prerank,amino sugar metabolic process (GO:0006040),-0.3517631961800904,-0.779547817399902,0.7527352297592997,0.9520756555552922,1.0,3/10,10.96%,CSGALNACT1;ST3GAL1;GFPT2
prerank,positive regulation of ATPase activity (GO:0032781),0.2862101644556719,0.7794297397193164,0.7815533980582524,0.9879834337176343,1.0,7/41,13.96%,ATP1B3;TPM1;PLSCR1;MYL4;SSBP1;MSH3;DNAJB2
prerank,ether lipid metabolic process (GO:0046485),-0.3270535873070213,-0.7788118591227208,0.744920993227991,0.9524674472648075,1.0,5/14,24.51%,AGPS;NCEH1;LIPE;GNPAT;DHRS7B
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.2574686313477187,-0.7786743011311159,0.8067010309278351,0.9519674681222419,1.0,3/33,4.40%,HIP1;BCAR3;CCDC88A
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.25065429724591587,0.7786286018018123,0.844574780058651,0.9887781804391083,1.0,14/94,13.65%,DDX5;ITPR1;FHIT;PRODH;IKBKE;ATM;DDX3X;TP53;ABL1;PRKDC;CUL4A;PPP1R13B;MLLT11;PML
prerank,"base-excision repair, AP site formation (GO:0006285)",0.33057757557047585,0.7784521704951592,0.7304832713754646,0.9885057292538457,1.0,5/17,18.07%,ACD;TDG;MBD4;OGG1;TINF2
prerank,protein mannosylation (GO:0035268),0.325128611468899,0.7783717296180364,0.7473867595818815,0.9880295109474432,1.0,5/22,12.42%,TMTC4;LARGE1;DPY19L3;TMTC1;LARGE2
prerank,response to cAMP (GO:0051591),0.2956851660747893,0.7782018719987733,0.7628205128205128,0.9877344032680075,1.0,4/37,5.60%,SLC5A5;RAPGEF3;EZR;SLC26A3
prerank,extracellular transport (GO:0006858),0.3523022575453947,0.7763494666437807,0.7188679245283018,0.9902358563048674,1.0,3/12,17.79%,ROPN1L;WWP2;CCDC40
prerank,peptidyl-tyrosine modification (GO:0018212),0.27525788252751227,0.7763268282084527,0.803125,0.9896909791789812,1.0,11/56,13.10%,KIT;FGFR2;EPHA4;FGFR1;FLT1;PDGFRB;FER;ABL1;DYRK1A;TPST1;EPHA3
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.35081845950734264,0.7761274429706998,0.7367458866544789,0.9894592878207744,1.0,2/15,6.71%,UST;DSE
prerank,protein prenylation (GO:0018342),0.3755293011594244,0.7757018090975336,0.7156673114119922,0.9896120439453215,1.0,4/10,16.78%,RABGGTA;RCE1;FNTB;FNTA
prerank,DNA biosynthetic process (GO:0071897),-0.31167465859180743,-0.7756457699332729,0.7790178571428571,0.9559418576184938,1.0,4/16,12.02%,POLA1;PPIA;POLD3;WRNIP1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2647573092637972,-0.775580652135079,0.8028846153846154,0.9553254398691324,1.0,8/31,19.27%,OTUD7A;OTUD7B;USP13;PSMD14;YOD1;USP50;USP8;SPATA2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.32406252754498643,0.7752976063087954,0.7618181818181818,0.9897207559019694,1.0,4/22,7.34%,CD300A;EZR;GPS2;PTPN22
prerank,regulation of collagen biosynthetic process (GO:0032965),0.33094521711135094,0.7752024532653496,0.7190635451505016,0.989304431270155,1.0,2/19,5.34%,WNT4;F2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3085112996395215,0.775103919285461,0.7693631669535284,0.9888812026226038,1.0,5/27,7.55%,KIT;EPHA8;FLT1;PDGFRB;AMBRA1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.26466972375813785,0.7743321516286813,0.8047244094488188,0.9895923447637377,1.0,7/59,10.97%,ROCK2;TLR3;TLR4;TAB2;RIPK2;RIPK1;LY96
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3234563499951503,0.7743070816378562,0.724561403508772,0.9890580584530231,1.0,4/22,11.53%,FZD5;IL12B;CYRIB;ZBTB1
prerank,positive regulation of lipid transport (GO:0032370),0.35515520659150035,0.7735500385739573,0.7420560747663552,0.989722818491827,1.0,2/12,9.36%,SPP1;LRP1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.33176582054074377,-0.7734521195430619,0.7510288065843621,0.9577854929991819,1.0,2/12,8.55%,LYN;PTK2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.29353843799715557,-0.7732737672523151,0.7898230088495575,0.9573581002907746,1.0,6/20,13.96%,ACVRL1;DSCAML1;PTCH1;AIDA;ACVR1;BMPR1B
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3095295971798569,-0.7730202120996035,0.7880658436213992,0.957025613278254,1.0,3/15,11.37%,PRKCH;SFRP4;BMP4
prerank,keratan sulfate metabolic process (GO:0042339),0.2981294485812616,0.772907324634734,0.768,0.9902346677790541,1.0,4/31,5.98%,OGN;ST3GAL3;FMOD;B4GALT1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2613937628949293,0.7724984275315262,0.8167155425219942,0.9903351885596611,1.0,14/63,18.90%,LEPR;TIMP3;NUPR1;PTPN22;CDK5RAP3;TAB2;ATRAID;RGP1;ZKSCAN3;TLK2;MCL1;TBC1D14;EIF4G1;GOLGA2
prerank,cellular copper ion homeostasis (GO:0006878),-0.3182337408068106,-0.7724321600341622,0.7864923747276689,0.957223358861008,1.0,3/14,12.88%,APP;ATOX1;SLC31A1
prerank,coenzyme A biosynthetic process (GO:0015937),0.36165067455758826,0.771837899521949,0.723404255319149,0.9896710707372391,1.0,2/11,9.41%,PANK1;DCAKD
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.36165067455758826,0.771837899521949,0.723404255319149,0.9896710707372391,1.0,2/11,9.41%,PANK1;DCAKD
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.36165067455758826,0.771837899521949,0.723404255319149,0.9896710707372391,1.0,2/11,9.41%,PANK1;DCAKD
prerank,protein targeting (GO:0006605),0.2425825234997713,0.7711313131756133,0.8654646324549237,0.9902635088648111,1.0,28/118,19.17%,TRAK1;KIF13B;ZFAND6;LAMP2;RAB3IP;FUT10;TIMM44;PIKFYVE;TOMM70;ZDHHC18;ZDHHC1;MYO1C;PRKCI;PARD3;MFN2;MICALL1;PITRM1;VPS37A;TIMM10;ARL6;PEX19;PEX16;RABGEF1;TRAK2;ZDHHC23;KATNB1;TIMM17B;AP4M1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.34598419282312265,0.7709996397535727,0.7408088235294118,0.989902728106507,1.0,2/13,10.26%,IL12B;CYRIB
prerank,autophagy of mitochondrion (GO:0000422),0.28799366202584986,0.7708872167756231,0.7996661101836394,0.9895050618750887,1.0,6/38,10.46%,PRKN;ATG5;WIPI1;AMBRA1;BECN1;ATG7
prerank,nuclear transport (GO:0051169),-0.3079458940399076,-0.7703230810261508,0.7688787185354691,0.9597234524053224,1.0,6/16,21.61%,XPO1;ANP32A;RBM15B;NXT1;BANF1;NPM1
prerank,positive regulation of protein import (GO:1904591),0.30337641461001064,0.7700695166483142,0.7734241908006815,0.9902603934053245,1.0,4/30,9.78%,SMAD3;ZIC1;UBR5;MAVS
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.32514300336436436,0.7688719939936729,0.7666666666666667,0.9916573915595154,1.0,3/22,7.95%,APPL2;LRRK2;KDM2B
prerank,positive regulation of immune system process (GO:0002684),-0.2993187000776486,-0.7688703806191466,0.7839643652561247,0.9611550099958711,1.0,2/16,5.42%,TGFB2;ANXA1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.3016831873133412,0.7688254891929208,0.8013816925734024,0.9911544353898688,1.0,2/26,2.32%,SMOC2;SPHK1
prerank,peptidyl-arginine modification (GO:0018195),0.3423212453499604,0.768548470332915,0.7481751824817519,0.9910163950075136,1.0,4/15,17.45%,ART5;ART4;NDUFAF5;PADI4
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.3483086095446129,0.7685321508106255,0.727810650887574,0.9904715674648983,1.0,6/13,23.81%,TDG;MBD4;OGG1;NT5C;UPP2;SMUG1
prerank,negative regulation of protein processing (GO:0010955),0.35373483041286957,0.7684816720031511,0.75,0.9899741330858359,1.0,4/12,12.85%,LRRK2;GAS1;SERPINE1;SNX12
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.20231113413123605,-0.7683944299879862,0.9534883720930233,0.9611867279347833,1.0,39/132,25.53%,CELF4;HSP90AB1;RPL3;RPL38;RPS19;RPS28;RPLP0;RPS15;RPL5;RPL23A;HSP90AA1;RPS27;XRCC5;SART1;RPS5;RPL6;CLNS1A;MDN1;NOP53;RPSA;DHX9;SNRPF;BRIX1;CDC73;COIL;RPS27L;MRPL20;PTGES3;RPL24;RPL11;SNRPD3;LSM4;RSL24D1;PUF60;ABT1;SRSF6;SNRPB;RRS1;WDR77
prerank,protein depolymerization (GO:0051261),0.30619758412759973,0.7683688677227279,0.76592082616179,0.9895679211652114,1.0,2/27,1.82%,MICAL3;KIF2A
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.2586447277012353,-0.768126455144357,0.8477157360406091,0.9608888508350708,1.0,10/33,20.20%,HSP90AB1;HSP90AA1;TNKS1BP1;TERF2IP;TERF1;STN1;RPA1;ANKRD28;NHP2;PTGES3
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.3393988523637307,-0.7671967323936512,0.78125,0.9616270375955771,1.0,1/10,0.66%,PRKCH
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.3105645988716921,0.7671058102464643,0.7746478873239436,0.9910982695948019,1.0,5/23,11.35%,PARP14;PIAS1;PARP9;IRGM;SOCS3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.36557395475671184,0.7667169225916476,0.7413479052823315,0.9911687251210394,1.0,1/11,1.98%,PRKN
prerank,innate immune response in mucosa (GO:0002227),0.3668491414570681,0.7662953680371791,0.7312859884836852,0.9912565201099369,1.0,2/10,12.19%,DEFB1;CAMP
prerank,protein processing (GO:0016485),0.24364696753838438,0.7661674427606558,0.8641618497109826,0.9908752215235304,1.0,14/102,15.27%,AEBP1;KLK2;SRGN;CTSH;METAP2;RCE1;APH1B;MMP14;ADAM17;PCSK7;OGT;SDE2;PITRM1;ZMPSTE24
prerank,cell cycle G2/M phase transition (GO:0044839),0.23533769455697298,0.7655899210526272,0.8668442077230359,0.9912415089935953,1.0,15/129,10.68%,TPD52L1;FBXL17;CCNA2;CEP250;PPP1CB;CLASP1;NINL;FBXW11;BTRC;CDC25A;CCNB2;BRSK1;FBXL12;AJUBA;SDCCAG8
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.22152364562883828,-0.765544161494453,0.89375,0.9633113768192155,1.0,19/65,30.34%,FBXL7;PSMB2;PSMD14;PSMC6;PSMA4;PSMB9;SKP1;PSMD11;PSMB10;PSMD2;PSMA2;PSMB3;FHL1;PSMB5;PSMA7;ZFYVE19;PSMF1;PSMD7;AURKA
prerank,pseudouridine synthesis (GO:0001522),-0.32021765766880866,-0.7654379997583466,0.8070539419087137,0.9627767382082694,1.0,8/13,38.31%,NHP2;PUS1;PUS7;TRUB1;DKC1;RPUSD2;TRUB2;PUS7L
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2567471716770439,0.7654350827943524,0.8361408882082695,0.9908864705704269,1.0,19/68,19.62%,PCCA;SLC19A1;MTHFR;TCN2;ALDH1L1;MCCC1;SLC19A2;FLAD1;TCN1;MTRR;HLCS;THTPA;TPK1;SLC25A19;MTHFD1;MMACHC;MCCC2;FOLR2;AASDHPPT
prerank,lymphocyte mediated immunity (GO:0002449),-0.31951058775341856,-0.7652820619924733,0.7789473684210526,0.9622881730852892,1.0,2/12,14.73%,JAG1;BTN3A3
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.3105383818510671,-0.7644302095667089,0.7880794701986755,0.962826801733757,1.0,5/15,27.99%,ENTPD1;CMPK1;ENTPD2;CMPK2;ENTPD3
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.31030561161177284,0.763510460617588,0.7838827838827839,0.9934771159582602,1.0,4/22,12.87%,CCNT2;ELL;SCAF8;KAT7
prerank,positive regulation of viral life cycle (GO:1903902),0.3096679725534319,0.7632375831542534,0.7703180212014135,0.9933268394173184,1.0,6/22,21.07%,LGALS1;KPNA6;AXL;VPS4A;CHMP2A;FMR1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.331047420176385,-0.7630687825744857,0.7787234042553192,0.9641933662172398,1.0,3/11,14.31%,TASOR;TRIM28;ATF7IP
prerank,regulation of type I interferon production (GO:0032479),0.24795634386142673,0.7630348288099003,0.8359941944847605,0.9930591315632489,1.0,27/84,24.20%,PCBP2;IKBKE;RNF135;TRIM56;PTPN22;MAVS;PRKDC;DHX58;IRF1;POLR3A;DHX33;ACOD1;NFKB1;STAT6;CREBBP;UFD1;NPLOC4;TAX1BP1;CD14;TRAF3;EP300;PQBP1;POLR2F;POLR3H;POLR3G;ZBP1;DDX41
prerank,regulation of interleukin-8 production (GO:0032677),0.2585676517029335,0.7630158816702998,0.8132530120481928,0.9925124429135569,1.0,11/69,9.78%,TLR3;SSC5D;TLR4;IL17D;ARRB1;MAP2K5;AFAP1L2;SERPINE1;PTPN22;RIPK1;MAVS
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.27548827678224097,-0.7627937015773893,0.7919621749408984,0.9638794995738778,1.0,7/22,25.02%,ERBB2;ATF4;EIF2AK3;NOL11;UTP15;PHF8;LYAR
prerank,actin filament depolymerization (GO:0030042),-0.34342167084882724,-0.7624283376855305,0.7933884297520661,0.9637008176086598,1.0,4/11,13.38%,GSN;MICAL2;WDR1;CFL1
prerank,positive regulation of organelle assembly (GO:1902117),-0.23974365032989076,-0.7623315711813932,0.8692098092643051,0.9631429762861987,1.0,13/44,23.61%,PIP4K2A;CCDC88A;G3BP2;SH3GLB1;RALB;CNOT2;PDCD6IP;KCTD17;PIP4K2B;LRSAM1;CNOT6L;CCP110;SPAG5
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.33655895672265274,0.7623303913507826,0.7428023032629558,0.9930353630181239,1.0,2/14,6.47%,KMT5C;KMT5B
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.28329378140794337,-0.7622771756219947,0.8167420814479638,0.9625309052872222,1.0,6/22,18.37%,SLC7A5;TNFRSF1B;LAPTM5;TRIL;NOD2;BTK
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3393820937841918,0.7622537359799292,0.7707581227436823,0.9925810086428888,1.0,10/18,30.07%,COX16;SMIM20;COX19;FASTKD3;TIMM21;COA5;SCO1;COX14;PET100;SURF1
prerank,microtubule anchoring (GO:0034453),0.36108486938653106,0.7616584283313186,0.7279549718574109,0.9929887418423339,1.0,5/12,18.75%,CLASP1;DAG1;PEX14;SAXO2;PCM1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3434691914937633,0.7615155225328828,0.7457627118644068,0.992629312551938,1.0,3/13,9.10%,PARP10;SLC5A8;PARP9
prerank,regulation of defense response to virus (GO:0050688),0.34289056494917275,0.7609041824979536,0.7835820895522388,0.993033754033302,1.0,4/14,20.23%,PCBP2;PPM1B;ZMPSTE24;TRAF3
prerank,negative regulation of cartilage development (GO:0061037),0.3459231961748827,0.7606261753909309,0.7602339181286549,0.9928866630272842,1.0,3/13,15.22%,TGFBR1;PTPN11;ADAMTS7
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3100892948449699,-0.7596918733426038,0.814,0.9655006467164142,1.0,6/14,25.58%,FLT4;DGKG;VEGFA;MYADM;GPD1L;CD40
prerank,fluid transport (GO:0042044),-0.3246004626917715,-0.7595202327529746,0.7825112107623319,0.965051865713269,1.0,2/12,7.57%,AQP4;AQP11
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.295760285781544,-0.7593775945955894,0.798728813559322,0.9645549169839578,1.0,10/16,41.47%,APOE;MYOCD;CLU;CYP51A1;HMGCR;IFNGR1;IL4;ABCA7;TNF;LRPAP1
prerank,somite development (GO:0061053),0.3600737182797606,0.7591851985704599,0.7238658777120316,0.9945837310485887,1.0,2/11,4.94%,LOXL3;SMO
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.3073101330602606,-0.7591051556090195,0.7923387096774194,0.9642522832187393,1.0,5/14,18.37%,THBS1;FGF2;CREB3L1;SPRY1;SPRY4
prerank,protein import into mitochondrial matrix (GO:0030150),0.3270939579487913,0.7587654153933071,0.7614678899082569,0.9947005397527938,1.0,7/18,25.50%,TIMM44;TOMM70;TIMM17B;TIMM17A;TIMM21;DNAJC15;GRPEL2
prerank,glycolytic process (GO:0006096),0.3003628647511837,0.7586537918153993,0.7860780984719864,0.9942932761586772,1.0,3/28,7.27%,HK2;PGAM2;GCK
prerank,ATP transport (GO:0015867),0.36490881906510914,0.7583415074962014,0.744916820702403,0.9942309359375201,1.0,3/10,16.57%,ABCC6;SLC25A42;SLC25A17
prerank,DNA replication (GO:0006260),0.23890911762626008,0.7581927353929181,0.8817663817663818,0.9938972698341973,1.0,29/105,21.76%,POLD2;POLG;ATM;REV1;DONSON;RBMS1;RBBP8;BAZ1A;HUS1;IGHMBP2;RAD50;TOP3A;PNKP;KAT7;POLE2;MCM7;MCM2;ORC3;POLA2;POLL;CLSPN;NBN;FEN1;RFC1;RAD9A;MCM9;MCM5;TOP1MT;ORC6
prerank,membrane lipid metabolic process (GO:0006643),-0.27745072613895105,-0.7579634111337793,0.8290398126463701,0.9651611042445314,1.0,7/22,19.10%,CYP1B1;ST3GAL6;SERINC1;GAL3ST1;B4GALT4;TECR;SMPDL3B
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3110879672197771,0.7579170449500419,0.7773851590106007,0.993755748047906,1.0,1/23,1.44%,IGF1
prerank,protein O-linked mannosylation (GO:0035269),0.3272553695361874,0.7576922044182091,0.770197486535009,0.9935510626780267,1.0,4/18,12.42%,TMTC4;LARGE1;TMTC1;LARGE2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.33885887078153665,-0.7573661773711201,0.7754677754677755,0.9652831625334113,1.0,5/10,19.64%,ITGB3;HIF1A;MT3;ITGA5;VTN
prerank,cholesterol biosynthetic process (GO:0006695),-0.26208385712117516,-0.756749340512262,0.8519480519480519,0.9654217771748766,1.0,15/31,27.67%,HMGCS1;IDI1;SC5D;PMVK;LSS;SQLE;DHCR7;DHCR24;CYP51A1;MSMO1;ACAT2;EBP;HMGCR;FDPS;HSD17B7
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3360689740124088,0.7565462381702937,0.7791970802919708,0.9948178410159971,1.0,2/15,9.35%,PRKN;SIRT1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.2826692801249671,0.7563103937267986,0.8086816720257235,0.9946277602170808,1.0,13/37,22.59%,PRKN;RIN3;SIRT5;ATXN2;ITGAV;NCOR1;NFKB1;OPTN;PTX3;ANKRD13D;ANKRD13B;SDCBP;ABCA2
prerank,regulation of cell aging (GO:0090342),-0.3259542665689646,-0.7559783766006595,0.7827004219409283,0.9657311930353594,1.0,4/11,26.99%,PNPT1;NUAK1;NEK6;VASH1
prerank,nuclear envelope organization (GO:0006998),0.31478330325523673,0.7557651318921383,0.7889908256880734,0.9949292209083533,1.0,6/20,18.30%,DMPK;LEMD2;REEP4;VPS4A;NUP155;TOR1AIP1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.26626804581571717,-0.7555000623463657,0.8723404255319149,0.965739419206796,1.0,6/25,19.31%,STAT3;STAT5B;HIF1A;TAL1;INHBA;FAM210B
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.35449514557448725,0.7553584478119258,0.7601626016260162,0.9949870314413429,1.0,5/11,23.64%,UFD1;TOR1A;DERL1;BAG6;RNF5
prerank,heme biosynthetic process (GO:0006783),-0.27742788805795965,-0.7553098609827145,0.8113207547169812,0.9653051884487811,1.0,1/22,0.78%,ABCG2
prerank,negative regulation of catabolic process (GO:0009895),-0.23429778440928722,-0.7552364307738149,0.8475935828877005,0.9647138409697259,1.0,13/47,22.06%,PDE3B;FMN2;CST3;FLNA;IRAK3;CBFA2T3;PFKFB1;ADGRB1;SIRT2;TIGAR;CYP51A1;MAD2L1;GIT1
prerank,response to interferon-alpha (GO:0035455),-0.3032459338585034,-0.7546741666055715,0.8149779735682819,0.9647871941300514,1.0,3/16,11.74%,GAS6;RO60;IFITM3
prerank,regulation of mast cell activation (GO:0033003),0.36264831017940224,0.7542086054959682,0.7490706319702602,0.9962029821864601,1.0,2/10,7.38%,HAVCR1;PLSCR1
prerank,RNA stabilization (GO:0043489),0.2862546815003348,0.7540278408351709,0.8225538971807629,0.9959162184030373,1.0,7/33,11.87%,PHAX;LARP1;GDNF;TENT2;THRAP3;NOCT;AXIN2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.24771562751646733,0.7540028875713859,0.8481751824817518,0.9953786029766294,1.0,24/87,22.92%,NDUFAF4;SAMM50;NDUFAB1;UQCC1;NDUFS1;COX16;NDUFV2;FOXRED1;LYRM7;SDHAF4;SMIM20;NDUFAF5;COX19;TIMMDC1;DMAC2;NDUFS4;TMEM126B;NDUFA2;FASTKD3;NDUFAF7;NDUFS5;TIMM21;NDUFA9;NDUFB2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.23218527224400476,0.7539586108688087,0.8801597869507324,0.9948769943576731,1.0,15/128,10.68%,TPD52L1;FBXL17;CCNA2;CEP250;PPP1CB;CLASP1;NINL;FBXW11;BTRC;CDC25A;CCNB2;BRSK1;FBXL12;AJUBA;SDCCAG8
prerank,regulation of complement activation (GO:0030449),-0.2389344075896453,-0.753934798820842,0.8753117206982544,0.965102014102782,1.0,17/40,31.88%,SUSD4;C1QB;C4B;PROS1;C1QC;CLU;C3AR1;C1QA;VTN;C6;C7;CD81;CFH;C3;SERPING1;C5AR2;CR1L
prerank,peptidyl-proline modification (GO:0018208),0.30027704339403694,0.7537868090000542,0.7632933104631218,0.9945616451672187,1.0,4/25,10.00%,FKBP5;NKTR;PPIC;CWC27
prerank,negative regulation of transmembrane transport (GO:0034763),-0.3416783106353299,-0.753197849424937,0.7762096774193549,0.9653846001124947,1.0,1/10,2.37%,THBS1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.26329699776173804,0.7531110012410944,0.8390461997019374,0.9950044277788889,1.0,11/54,19.49%,PRKN;SPHK1;CFLAR;GPS2;RIPK1;ADAM17;RNF31;BIRC3;CLIP3;TNFRSF1A;TAX1BP1
prerank,microtubule anchoring at centrosome (GO:0034454),0.37112754308140355,0.7527528398460623,0.749003984063745,0.9949515642140415,1.0,3/10,18.75%,NINL;HOOK3;PCM1
prerank,leukotriene metabolic process (GO:0006691),0.31639263169002363,0.752383407079283,0.7712665406427222,0.99495337727229,1.0,2/19,7.73%,ALOX12;ABCC10
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.21717994362344206,-0.7523093141955535,0.9247648902821317,0.9658732227354914,1.0,30/72,31.81%,POLD3;AQR;ERCC1;ERCC6;POLR2J;UBB;RPA1;COPS4;GTF2H1;COPS6;GTF2H4;GTF2H5;RFC4;COPS5;ERCC2;POLD4;POLD1;RFC2;POLR2C;POLR2L;POLK;UBC;RPS27A;RFC5;DDB1;COPS2;RPA3;ERCC3;XAB2;RPA2
prerank,B cell activation involved in immune response (GO:0002312),0.34507187675628,0.7517577245238505,0.7519083969465649,0.9953863518382225,1.0,3/13,20.03%,RNF8;EXOSC3;LIG4
prerank,cellular protein localization (GO:0034613),0.21274532390395104,0.7512674348797523,0.9591598599766628,0.9955510227159831,1.0,57/285,18.14%,CELSR1;ANK2;WLS;CSRP3;SNX6;CEP250;SEC31B;TBC1D16;LRRK2;CPLANE2;DUOXA1;STXBP2;PRRT1;ACD;SH3PXD2B;WIPI1;PTPRU;ARFGAP3;NIPBL;CNTNAP1;VPS26C;PICK1;GRTP1;ARL4A;RAB43;COPZ2;RAB22A;NPHP1;AXIN2;VPS45;CLTC;SNX8;STX5;SGSM2;VIPAS39;MFN2;SNX15;AP2A1;SEC23IP;RAB29;RAB21;ARFIP2;ARL6;BBS2;SCFD1;TBC1D25;FAM91A1;SGSM3;CORO1B;RRAGD;MYO7A;VPS35;KIF13A;TBC1D14;WNT5A;SEC31A;EVI5
prerank,body fluid secretion (GO:0007589),0.32524826361376646,0.7510548577850853,0.76,0.9953008063946669,1.0,2/15,8.47%,NPR1;APLN
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.2569591800483559,0.7509853310303262,0.8438438438438438,0.9948455723748324,1.0,15/59,18.21%,TNRC6A;MITF;TP53;MED12;TNRC6B;PTEN;TCF7L2;MOV10;MED17;TNRC6C;NFKB1;MED23;MED26;MED1;MED8
prerank,positive regulation of translation (GO:0045727),-0.20625863088855284,-0.7506533386733547,0.9392857142857143,0.9673729668548381,1.0,25/94,21.61%,PRR16;THBS1;NIBAN1;RPL26;RPL5;RPS9;ERBB2;UHMK1;FXR1;EIF5A2;RPS4X;YBX3;VIM;METTL3;BCL3;RCC1L;PKM;DHX9;RPS27L;EEF2;YTHDF2;RBM3;EIF4A3;EIF3D;NPM1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3059763969187191,0.7504984633509812,0.7835420393559929,0.9950350244347107,1.0,4/23,11.97%,PKHD1;FBXW11;HTT;MISP
prerank,mitochondrial translational termination (GO:0070126),0.2439154792838476,0.7501847934916915,0.8796033994334278,0.9949499177028756,1.0,25/88,25.77%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MTRF1L;MRPL48;MRPL1;GFM2;MTRF1;MRPL45;MRPS17;CHCHD1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;MRPS25;MRPL50;MRPL33;MRPS18B;MRPL19
prerank,mitochondrial genome maintenance (GO:0000002),0.35500282363335245,0.750059905030729,0.7461832061068703,0.9945747882300063,1.0,4/11,16.03%,OPA1;MEF2A;TOP3A;SLC25A36
prerank,positive regulation of DNA replication (GO:0045740),0.3245121498479087,0.7497391777458452,0.7783687943262412,0.9944785092753818,1.0,4/16,15.15%,GLI2;GLI1;KAT7;FAF1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.24859971803503594,-0.7496488043588062,0.855036855036855,0.968000675936536,1.0,6/32,13.68%,CEPT1;SLC44A5;SLC44A2;MFSD2A;SLC44A1;LPIN3
prerank,mRNA polyadenylation (GO:0006378),0.294984956466484,0.7496243964889301,0.7805695142378559,0.9935254706614964,1.0,9/26,21.65%,AHCYL1;TENT2;SCAF8;TENT4B;CPSF3;PAPOLG;GRSF1;PCF11;TUT1
prerank,RNA polyadenylation (GO:0043631),0.294984956466484,0.7496243964889301,0.7805695142378559,0.9935254706614964,1.0,9/26,21.65%,AHCYL1;TENT2;SCAF8;TENT4B;CPSF3;PAPOLG;GRSF1;PCF11;TUT1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3221259928020267,0.7492337479120983,0.7974910394265233,0.9935374050844696,1.0,4/19,9.78%,ELF1;MAP2K5;PARP9;MAVS
prerank,regulation of steroid biosynthetic process (GO:0050810),0.35406815591178104,0.7491249631473925,0.7651663405088063,0.9931422330363394,1.0,1/11,1.03%,WNT4
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2601126371202346,-0.7488969531151157,0.8378378378378378,0.9683218856747666,1.0,13/27,29.69%,CD47;CD44;SKAP1;ITGB2;PRKCQ;HAS2;PYCARD;MDK;THY1;RELA;CCL2;NR4A3;RHOA
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2985077543953396,-0.7486159340361727,0.8333333333333334,0.9680190492926191,1.0,10/18,38.60%,RAD51B;DTL;MECP2;CCND1;CDC7;CDK1;BRD4;CCNB1;CDC25C;RAB11A
prerank,protein-DNA complex assembly (GO:0065004),-0.1976238937696943,-0.7486063913558261,0.9689922480620154,0.9673406494469655,1.0,40/116,32.86%,PSMB2;PSMD14;H3-3A;NAP1L1;PSMC6;RAD23B;UBB;SMARCA5;PSMA4;PSMB9;RPA1;ORC5;ORC2;CETN2;PSMD11;GTF2H1;NAP1L4;PSMB10;GTF2H4;PSMD2;GTF2H5;ERCC2;NPM1;PSMA2;UBC;RPS27A;PSMB3;MCM6;PSMB5;DDB1;PSMA7;PSMF1;RAD51;PSMD7;RPA3;ERCC3;RPA2;MCM4;MCM8;PSMA5
prerank,positive regulation of cytokine production (GO:0001819),0.2126365324537824,0.7485957839859095,0.9636150234741784,0.9933394582913816,1.0,36/292,13.29%,RORA;C1QTNF3;ROCK2;PRKCZ;IL18;LACC1;SPHK1;ADRA2A;SULF2;TLR3;TLR4;FZD5;IL17D;NOX1;CD28;IL12B;EIF2AK2;AFAP1L2;SERPINE1;PTPN22;IL17RA;RIPK2;RIPK1;MAVS;CD274;CYRIB;RAB7B;PRKDC;DHX58;ADAM17;GLMN;PTPN11;IRF1;POLR3A;DHX33;SULF1
prerank,DNA modification (GO:0006304),0.30043918588352325,0.7480655512090202,0.7846975088967971,0.9935769578074864,1.0,8/22,23.98%,ACD;TDG;MBD4;EXOSC3;OGG1;TINF2;SMUG1;PARP3
prerank,acute-phase response (GO:0006953),-0.3220262440962094,-0.7477376254494915,0.7865853658536586,0.9677407036815204,1.0,4/12,21.73%,LBP;SIGIRR;IL22;IL6R
prerank,positive regulation of double-strand break repair (GO:2000781),0.2750147093682828,0.7475886621339858,0.8311688311688312,0.9937075281217045,1.0,10/39,19.09%,ARID2;KMT5C;KMT5B;PARP9;PRKDC;PNKP;SMCHD1;MGMT;FUS;MMS19
prerank,response to interferon-beta (GO:0035456),0.31162059519825164,0.7475719956390705,0.7548500881834215,0.9931639202646579,1.0,7/22,17.39%,IKBKE;PLSCR1;IRGM;IRF1;ACOD1;IFNAR2;CDC34
prerank,neurogenesis (GO:0022008),0.2721139997243347,0.7473871684439473,0.8260162601626017,0.9928689720091967,1.0,4/43,8.28%,LPAR1;TRAK1;DAGLA;RYK
prerank,acute inflammatory response (GO:0002526),0.30572919793606534,0.747183150949944,0.7746478873239436,0.9926082130551767,1.0,4/23,10.73%,C2CD4B;ANO6;PLSCR1;MYLK3
prerank,regulation of actin nucleation (GO:0051125),0.3391821250975598,0.7468639974549253,0.7513812154696132,0.9925294773646617,1.0,5/12,17.04%,PICK1;VIL1;ARFIP2;WASHC5;CORO1B
prerank,lysosome localization (GO:0032418),0.2787262960063381,0.7466550209653079,0.8308457711442786,0.9922768426422928,1.0,5/37,14.24%,KIT;RAB34;BLOC1S2;KIF5B;FLCN
prerank,regulation of chemokine production (GO:0032642),0.27840655929248426,0.7466242846209626,0.8370253164556962,0.9917617518942281,1.0,4/36,6.57%,IL18;TLR3;TLR4;EIF2AK2
prerank,transport along microtubule (GO:0010970),-0.32114467980002603,-0.7466129239140966,0.7809110629067245,0.9685622982256661,1.0,2/13,7.28%,APP;DYNC1I1
prerank,positive regulation of innate immune response (GO:0045089),0.28682246304559494,0.746182818455835,0.8315972222222222,0.9918835712112213,1.0,11/30,24.64%,IFNK;PLSCR1;MAVS;NMI;TRIM62;IFI35;WNT5A;PLA2G5;POLR3G;ZBP1;FADD
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.30264560871892493,-0.7457248131970619,0.8048289738430584,0.9690391099475626,1.0,3/14,12.05%,CARD14;MAP3K7;TIRAP
prerank,protein localization to microtubule organizing center (GO:1905508),-0.2930642271672835,-0.7456400147311664,0.82560706401766,0.9684686069167711,1.0,6/15,31.20%,CEP83;CEP131;SPAG5;NEDD1;STIL;CSNK1D
prerank,negative regulation of catalytic activity (GO:0043086),0.30535212714196047,0.7450318662626843,0.8038194444444444,0.9930370639601575,1.0,4/24,9.35%,IFIT1;TP53;PARP9;SIRT1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.27539788502375845,-0.7450120137671388,0.8407960199004975,0.9679580222006514,1.0,4/22,12.49%,ZDHHC9;ZDHHC2;GOLGA7;ZDHHC14
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.27539788502375845,-0.7450120137671388,0.8407960199004975,0.9679580222006514,1.0,4/22,12.49%,ZDHHC9;ZDHHC2;GOLGA7;ZDHHC14
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.2958727266489272,0.7447060493709029,0.8023255813953488,0.9929604850978849,1.0,1/27,0.97%,LPAR1
prerank,negative regulation of bone remodeling (GO:0046851),-0.3252013666184266,-0.7440273778319709,0.8020833333333334,0.9685388748053688,1.0,7/11,30.81%,UBASH3B;TMEM119;SFRP1;P2RX7;CARTPT;CALCA;TNFAIP3
prerank,regulation of protein localization to centrosome (GO:1904779),0.3622334327793524,0.7439988071501442,0.7747035573122529,0.9934534305740558,1.0,1/10,2.95%,CEP250
prerank,bile acid metabolic process (GO:0008206),0.2914349994537381,0.7432388889897249,0.8192567567567568,0.99403170249643,1.0,3/27,5.91%,CYP27A1;AMACR;OSBPL9
prerank,establishment of mitotic spindle localization (GO:0040001),0.29280197067129987,0.7429777476391405,0.8034782608695652,0.9938411499349018,1.0,5/28,11.97%,PKHD1;CLASP1;FBXW11;HTT;MISP
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.20881532391603608,-0.7428749115407123,0.9553264604810997,0.9693803822523402,1.0,24/70,29.52%,RUNX1;LMO2;PSMB2;GATA2;PSMD14;PSMC6;N4BP2L2;TCF12;TAL1;METTL3;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;YTHDF2;PSMA2;PSMB3;PUS7;TCF3;PSMB5;PSMA7;PSMF1;PSMD7
prerank,negative regulation of insulin secretion (GO:0046676),0.3192153121364467,0.7426308386418721,0.7841726618705036,0.993792523626503,1.0,4/17,12.56%,PRKN;ADRA2A;MIDN;SIRT4
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.33519125181700926,-0.7426039809332887,0.8032454361054767,0.9683305280094452,1.0,3/10,12.91%,AP2B1;AP2M1;VLDLR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.33519125181700926,-0.7426039809332887,0.8032454361054767,0.9683305280094452,1.0,3/10,12.91%,AP2B1;AP2M1;VLDLR
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.33477709438749303,-0.7420698973601825,0.8080808080808081,0.9676332880086317,1.0,3/10,16.95%,CDC42EP3;CDC42EP2;APC
prerank,regulation of pseudopodium assembly (GO:0031272),-0.33477709438749303,-0.7420698973601825,0.8080808080808081,0.9676332880086317,1.0,3/10,16.95%,CDC42EP3;CDC42EP2;APC
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.28394579583998203,-0.7417377385412048,0.8372591006423983,0.9673757427479815,1.0,7/19,20.71%,PIK3AP1;TIRAP;LBP;TRIL;NR1H4;ITGB2;LGALS9
prerank,positive regulation of catalytic activity (GO:0043085),0.2743529477954581,0.7406893368998132,0.8391959798994975,0.9961229203728809,1.0,8/37,11.47%,SLC5A3;NHEJ1;BCAS3;XRCC4;SSBP1;PHACTR4;ABL1;MSH3
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.2531689054959549,-0.7402799498543797,0.8825,0.9685860378587029,1.0,9/29,28.16%,NSF;COG5;RAB6A;GABARAPL2;COPE;TRAPPC3;COG1;NAPG;COPG2
prerank,negative regulation of hippo signaling (GO:0035331),0.33749502986027646,0.7397006614233669,0.7610294117647058,0.9970048051527752,1.0,6/12,21.38%,VGLL4;WWC2;AJUBA;WTIP;MAPK14;DLG5
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.25545746569369676,0.7393170784081392,0.861904761904762,0.9970309048162918,1.0,13/55,14.81%,PRKN;F2;PDGFRB;TP53;SIRT5;TGFBR2;PIKFYVE;RIPK1;RNF41;ACOD1;GADD45A;SPHK2;COQ7
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2507344396584734,0.7389410165742554,0.8677325581395349,0.9969811327740007,1.0,12/68,18.67%,POLR2A;TAF1D;PABPN1;TTF2;SCAF8;POLR1G;MTERF2;TBP;TTF1;CPSF3;CSTF1;PCF11
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.29323809021229696,0.7388590327617958,0.7945205479452054,0.9965453802789047,1.0,2/27,2.32%,IGF1;SPHK1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2106965003920826,-0.7387087360276715,0.9305993690851735,0.9697730045930808,1.0,18/72,19.27%,LIFR;RUNX1;GAS6;HSP90AB1;PTPRC;IRAK3;IFNGR2;JAK1;HIPK1;IKBKB;RBCK1;ABCE1;SIGIRR;CD74;SYK;TRAF1;PTPN1;SPATA2
prerank,positive regulation of RNA splicing (GO:0033120),-0.24711389494385194,-0.7386011543284385,0.8728179551122195,0.9692187318919159,1.0,3/29,4.99%,PIK3R1;CELF4;HNRNPLL
prerank,mitotic spindle organization (GO:0007052),-0.18540194651260916,-0.7379601016994058,0.9819004524886877,0.969326330502242,1.0,62/153,32.40%,CLASP2;PLK2;FLNA;DYNC1I1;DYNLL1;XPO1;DYNC1LI2;CEP126;RPS27;MAP4;BUB3;CLIP1;MZT1;STMN1;CENPE;EFHC2;CHEK2;STAG1;SPAST;TBCE;EML1;KIF11;RAN;PPP1CC;NUP107;NEK6;MAD2L1;CENPH;BCCIP;NSL1;NDC80;SUN2;KIF4A;KIF3B;TPX2;KPNB1;KNTC1;MECP2;TUBG2;DCTN6;CENPA;PRC1;NUP85;CDCA8;KIF23;NDEL1;NDE1;RANGAP1;TNKS;CENPF;NUDC;PTPA;STIL;RHOA;DLGAP5;NUF2;AURKA;TOGARAM2;CENPI;SPC24;CDC20;BUB1
prerank,regulation of leukocyte migration (GO:0002685),-0.2889097624322659,-0.737585679437427,0.8189845474613686,0.9690625482352303,1.0,8/16,31.93%,ANXA1;RHOH;VEGFA;CD81;RHOG;HMOX1;BST1;RAC2
prerank,I-kappaB phosphorylation (GO:0007252),0.3574804855815715,0.7373833048725501,0.7701612903225806,0.9981263350075426,1.0,2/10,5.16%,TLR3;TLR4
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.33602853647408104,0.7363386608841453,0.7702448210922788,0.9990776232632533,1.0,4/14,13.56%,ENPP3;AK3;AK4;AK8
prerank,adipose tissue development (GO:0060612),-0.3262519501671351,-0.7362746658621853,0.8021739130434783,0.9699938180174282,1.0,5/11,25.00%,SPTLC2;NAMPT;SOX8;PGRMC2;DGAT2
prerank,mRNA export from nucleus (GO:0006406),0.2337462003305036,0.7358963708947098,0.9151599443671766,0.9991284290195475,1.0,24/102,21.34%,NXF2;PABPN1;SMG1;SRSF5;POLDIP3;HNRNPA2B1;POLR2D;NUP42;NUP98;NXF1;SRSF11;NUP43;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;CDC40;NUP188;U2AF1;UPF2;SRSF7;U2AF2;NUP153
prerank,negative regulation of JUN kinase activity (GO:0043508),0.35448793691808445,0.7352439261882363,0.7547169811320755,0.9994530636449359,1.0,3/10,12.34%,PTPN22;DUSP10;HIPK3
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.35475149895269703,0.7352200509602791,0.7744916820702403,0.9989291419175954,1.0,3/11,16.01%,NUPR1;RIPK1;BIRC3
prerank,positive regulation of bone resorption (GO:0045780),0.3542843265849739,0.7351911927731536,0.7773512476007678,0.9984085062190992,1.0,2/11,12.33%,SPP1;PRKCA
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.24345805489651035,0.7349039898029384,0.8841642228739003,0.9982756719561662,1.0,12/76,15.15%,BMP7;PKHD1;PARP10;ARRB1;MAP2K5;CDK5RAP3;SIRT1;USP7;LRRC14;ACOD1;NWD1;FAF1
prerank,DNA strand elongation (GO:0022616),0.3203092795913918,0.7345824067072727,0.7681159420289855,0.9981472985925822,1.0,4/18,13.34%,POLD2;TERT;RAD50;MCM7
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.29107419028875153,0.7344625081595758,0.8101933216168717,0.9977572629096699,1.0,10/27,24.43%,ZC3H12B;DICER1;ZC3H12C;NYNRIN;CPSF3;POP7;PCF11;POP1;XRN1;LACTB2
prerank,calcineurin-mediated signaling (GO:0097720),-0.32796627099772724,-0.7339230814953824,0.8208955223880597,0.9714441229531041,1.0,4/10,15.08%,PPP3R1;NFATC1;PPP3CA;PPP3CC
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.32796627099772724,-0.7339230814953824,0.8208955223880597,0.9714441229531041,1.0,4/10,15.08%,PPP3R1;NFATC1;PPP3CA;PPP3CC
prerank,protein localization to nucleus (GO:0034504),0.2335156260334617,0.7337550102542394,0.9102564102564102,0.9981612570046846,1.0,3/102,3.53%,BMP7;APPL2;TNPO1
prerank,positive regulation of viral transcription (GO:0050434),0.2909418493248968,0.7337106883596872,0.8181818181818182,0.9976721028522482,1.0,5/25,14.71%,POLR2A;POLR2D;GTF2F1;NELFCD;CTDP1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.24126395553696245,0.7328515555525286,0.8769448373408769,0.998372016040043,1.0,11/84,10.14%,IGF1;SPHK1;IGF2BP1;DDX3X;EIF2AK2;SAMD4A;LARP1;CPEB3;IGF2BP2;CNOT10;LSM14A
prerank,polarized epithelial cell differentiation (GO:0030859),0.33654762025873264,0.7327984000898881,0.8051181102362205,0.9978875908564063,1.0,4/13,17.39%,EZR;OPHN1;CDC42;MYO9A
prerank,gastrulation (GO:0007369),-0.28824705867286093,-0.7326147149340259,0.8434782608695652,0.9723606304841464,1.0,5/15,27.13%,TASOR;LHX1;UGDH;LMBRD1;NR4A3
prerank,cellular response to glucose stimulus (GO:0071333),0.2816538801862536,0.7317308939156965,0.817717206132879,0.9987826763691513,1.0,2/30,2.21%,PRKAA2;ZBTB20
prerank,eosinophil chemotaxis (GO:0048245),-0.29557084795958,-0.7315959042005327,0.8253012048192772,0.9722036606571787,1.0,8/14,45.45%,SCG2;CCL13;CCL2;CCL11;CCL4;CCL8;CCL1;CCL3
prerank,eosinophil migration (GO:0072677),-0.29557084795958,-0.7315959042005327,0.8253012048192772,0.9722036606571787,1.0,8/14,45.45%,SCG2;CCL13;CCL2;CCL11;CCL4;CCL8;CCL1;CCL3
prerank,cellular response to pH (GO:0071467),0.3251141995034864,0.7315166971122912,0.7820738137082601,0.9985160037514806,1.0,3/17,11.45%,HYAL1;RAB11B;IMPACT
prerank,iron ion transport (GO:0006826),0.2630029138003967,0.7314547515843058,0.8589743589743589,0.9980484069425728,1.0,12/47,18.72%,CP;ATP6V0E1;ATP6V0B;RAB11B;ATP6V1D;ATP6V1E1;CLTC;DNM2;STEAP3;HFE;ATP6V0D1;ARHGAP1
prerank,positive regulation of response to stimulus (GO:0048584),-0.23780784566677315,-0.7312567859075261,0.8773841961852861,0.9719598843191547,1.0,12/40,23.12%,TGFB2;B2M;FXR1;ABI3;HOMER1;ILK;SELENON;DHX9;CDKN2AIP;NSMCE1;NSMCE4A;CGAS
prerank,anterograde synaptic vesicle transport (GO:0048490),0.32391239450326337,0.7310191289331625,0.7720306513409961,0.9975349959447959,1.0,3/15,12.08%,DTNBP1;BLOC1S6;BLOC1S2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.32391239450326337,0.7310191289331625,0.7720306513409961,0.9975349959447959,1.0,3/15,12.08%,DTNBP1;BLOC1S6;BLOC1S2
prerank,regulation of mitotic cell cycle (GO:0007346),0.22036904168097138,0.730509264832469,0.9548306148055207,0.9976949542632157,1.0,13/171,9.35%,SMAD3;ANAPC15;SMOC2;SPHK1;OBSL1;FOXC1;GAS1;ANAPC2;SIK1;AFAP1L2;BTRC;CDK5RAP3;SIRT1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.31693379515354136,-0.7302755921600045,0.8055555555555556,0.9724184994718237,1.0,4/11,10.81%,ARHGEF7;CORO1C;CD44;ENPP2
prerank,regulation of immune effector process (GO:0002697),-0.23082870089254814,-0.7301282783016362,0.8960396039603961,0.9719324363369398,1.0,17/41,31.88%,SUSD4;C1QB;C4B;PROS1;C1QC;CLU;C3AR1;C1QA;VTN;C6;C7;CD81;CFH;C3;SERPING1;C5AR2;CR1L
prerank,regulation of melanin biosynthetic process (GO:0048021),0.3369463987503265,0.7300142591839212,0.7575150300601202,0.9978231460649336,1.0,4/10,30.35%,CTNS;ATP7A;RAPGEF2;CDH3
prerank,spliceosomal snRNP assembly (GO:0000387),-0.2342061266079482,-0.7291196401906025,0.9104859335038363,0.9724724298626,1.0,15/38,35.88%,SART1;CLNS1A;SNRPF;COIL;SRSF12;SNRPD3;LSM4;SNRPB;WDR77;PRMT5;SNRPG;LSM2;USP4;PRPF8;GEMIN2
prerank,innate immune response (GO:0045087),0.21175801246278594,0.7290270905955785,0.973170731707317,0.9986404020505278,1.0,28/217,13.65%,COLEC12;IFIT1;IFI27;KRT1;TLR3;TLR4;RNF135;DEFB1;DDX3X;TRIM56;ANKRD17;COLEC11;TKFC;RIPK2;MAVS;FER;IRGM;SRPK2;ZDHHC1;ANKHD1;DHX58;CAMP;NUB1;FRK;AKAP1;TRIM62;POLR3A;PML
prerank,regulation of stem cell differentiation (GO:2000736),-0.2006948332039112,-0.7285698951627354,0.9734848484848485,0.9724410185241561,1.0,20/89,20.19%,RUNX1;LMO2;JAG1;NOTCH1;PSMB2;HES1;GATA2;PTN;PSMD14;PSMC6;TCF12;TAL1;NELFB;METTL3;PSMA4;PSMB9;PSMD11;PSMB10;PSMD2;YTHDF2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2921414750400971,0.7284936862550855,0.8058419243986255,0.998820870712944,1.0,5/25,13.62%,BID;FAM162A;TP53;DNM1L;MLLT11
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.32545335314138135,-0.7277006678455343,0.8004158004158004,0.9728021140340047,1.0,3/11,11.90%,HSPA5;CREB3L1;ATF4
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.23786223617075816,-0.7276533886761196,0.8944591029023746,0.9721859188036668,1.0,4/34,7.96%,SLC7A5;GPI;PTPRC;EPHB2
prerank,cholesterol metabolic process (GO:0008203),-0.2102653021776084,-0.727487547799236,0.9276729559748428,0.9717186563596943,1.0,27/68,27.67%,PPARD;APOE;ABCG1;SCARF1;HMGCS1;IDI1;SNX17;PMVK;MT3;LSS;SQLE;DHCR7;DHCR24;LDLRAP1;CH25H;CYP51A1;MSMO1;GBA2;STARD3;ACAT2;CLN8;EBP;ABCA1;ABCA5;HMGCR;FDPS;HSD17B7
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.29635144874352615,0.7269174397728576,0.8082191780821918,1.0,1.0,5/23,13.57%,MTMR3;SYNJ2;PTEN;OCRL;PIP4P2
prerank,regulation of immune response (GO:0050776),0.2225473657054239,0.7266144171833898,0.9389920424403183,1.0,1.0,12/135,11.40%,COLEC12;APPL2;CD300A;RNF135;TKFC;PTPN22;PLSCR1;SAMHD1;COL1A2;RSAD2;CXADR;DHX58
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.336846336824627,0.7265061209894008,0.8088803088803089,0.9998939164676693,1.0,2/12,12.92%,CLCN2;MBTPS1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3266095524704298,0.7264953642633002,0.8007590132827325,0.9993529103385074,1.0,6/14,25.37%,SAP18;SFSWAP;SRSF10;SRSF7;U2AF2;SRSF4
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.29570840537341786,0.7259216265213131,0.8171334431630972,0.9995895483582388,1.0,6/22,18.08%,PPM1E;DUSP10;DUSP2;PPM1B;DUSP18;DUSP4
prerank,negative regulation of B cell activation (GO:0050869),-0.27143359466141087,-0.7257886508933721,0.8293736501079914,0.9730011853298967,1.0,8/21,21.03%,LYN;TNFRSF21;ID2;SAMSN1;LAPTM5;INHBA;TYROBP;SFRP1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.32711286104010096,-0.7256760107768638,0.8016194331983806,0.9724552905872353,1.0,3/10,16.59%,PTPRC;IRAK3;SIGIRR
prerank,mitochondrial transport (GO:0006839),-0.2207220300788389,-0.7253705819108283,0.9028571428571428,0.9721262883960533,1.0,17/53,28.97%,SLC25A13;HSP90AA1;TOMM7;FBXO7;AIP;GDAP1;BCAP31;TOMM22;TIMM8B;TOMM20;STARD3;BNIP3;TIMM13;SPG7;TOMM5;PMAIP1;FIS1
prerank,sulfur compound catabolic process (GO:0044273),0.26952616042955785,0.7252102705281122,0.8431372549019608,1.0,1.0,6/38,10.66%,OGN;FMOD;HYAL1;CTH;ARSB;MLYCD
prerank,positive regulation of cilium assembly (GO:0045724),-0.2881215758435213,-0.724968749064815,0.8163265306122449,0.9718947155138395,1.0,7/18,28.89%,CCDC88A;KCTD17;SEPTIN9;CCP110;HAP1;CEP135;MARK4
prerank,negative regulation of histone acetylation (GO:0035067),0.3427940618252818,0.7247643430070464,0.7934782608695652,1.0,1.0,4/11,21.12%,SIRT1;SIN3A;TAF7;NOC2L
prerank,regulation of cell cycle process (GO:0010564),-0.194545744248796,-0.7237810514984081,0.9759450171821306,0.9725950675486021,1.0,44/104,32.59%,CAV2;CALM1;PLK2;CALM2;SH3GLB1;CALM3;GPER1;PRPF40A;CTNNB1;SETD2;TXLNG;ATF5;E4F1;TIPIN;APC;CETN2;KIF11;RAB11FIP4;DCUN1D3;ECT2;BORA;YTHDF2;CUL7;SFRP1;GIT1;TTL;CCDC8;PLK3;CCP110;SPAG5;PRC1;CDKN2B;KLHL13;HMGA2;RPRD1B;MARK4;KIF20A;NUDT16;AURKA;PRMT5;RAB11FIP3;KNSTRN;BUB1;PIK3R4
prerank,regulation of isotype switching (GO:0045191),0.3219481650512207,0.7224961049962669,0.7972166998011928,1.0,1.0,2/14,6.47%,KMT5C;KMT5B
prerank,maintenance of protein localization in organelle (GO:0072595),0.3023888322363101,0.7223137101274171,0.8118279569892473,1.0,1.0,8/19,25.41%,HK2;TAPT1;PML;TAF3;TAF8;HK1;SUPT7L;ARL2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.30142258379862247,0.722201549574318,0.8003663003663004,1.0,1.0,3/20,8.47%,SMOC2;SULF2;APLN
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.2903434842051036,-0.7221602584948948,0.8508403361344538,0.9737492875287012,1.0,3/15,10.92%,SCARB1;LDLR;MFSD2A
prerank,positive regulation of chromatin organization (GO:1905269),0.3329844562074244,0.7216122853052919,0.78125,1.0,1.0,4/12,18.07%,ATRX;ACD;SIN3A;TINF2
prerank,mRNA catabolic process (GO:0006402),0.2643149565573716,0.721098166339421,0.8626198083067093,1.0,1.0,4/44,10.60%,DDX5;TUT4;CNOT10;THRAP3
prerank,replication fork processing (GO:0031297),0.2697714957005812,0.721032952654838,0.8308457711442786,1.0,1.0,5/38,10.84%,ATRX;SAMHD1;FBH1;FANCM;EME2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.282638931844158,-0.7206608936803733,0.8414376321353065,0.9748095343254262,1.0,1/17,0.34%,CTNNA2
prerank,aerobic respiration (GO:0009060),0.31406921353219874,0.7206604271820775,0.8198529411764706,1.0,1.0,7/20,22.96%,MTFR2;SIRT3;UQCRC2;ATP5F1D;SDHB;UQCRC1;UQCRH
prerank,regulation of response to stress (GO:0080134),-0.32363072278951927,-0.7199117722202145,0.8171806167400881,0.9749877296462182,1.0,5/10,36.68%,CORO2B;ADCY8;OPRM1;CRHBP;MLC1
prerank,protein targeting to mitochondrion (GO:0006626),-0.21775331682951424,-0.7174765402326712,0.9350282485875706,0.9769812581553496,1.0,15/52,22.12%,IMMP2L;AIFM1;HSP90AA1;TOMM7;FBXO7;AIP;TIMM29;GDAP1;BCAP31;TOMM22;TIMM8B;ROMO1;DNLZ;TOMM20;TIMM13
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.24674289407292896,0.7165134954731881,0.9076682316118936,1.0,1.0,9/60,12.69%,SMOC2;ATM;ACD;DSCC1;PDGFRB;TNKS2;AURKB;FBXO4;PNKP
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.20423127867800694,-0.7162046198107987,0.9507692307692308,0.97774808920924,1.0,39/66,41.95%,STAT3;FOXP1;APP;EGR1;AIM2;CARD16;USP50;CX3CR1;NOD2;PANX1;HSPB1;TYROBP;CCL19;LGALS9;PYCARD;GIT1;NLRP2B;F2R;JAK2;TRIM16;P2RX7;CD36;MALT1;TNFAIP3;CD33;TLR8;MYD88;TMEM106A;GBP5;CPTP;ISL1;CASP8;INAVA;TNF;NLRP12;ZC3H12A;LPL;GSDMD;IL6
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.23862600996902472,-0.7157455446989879,0.9012658227848102,0.9775810065602857,1.0,7/33,19.31%,STAT3;STAT5B;HIF1A;TAL1;FES;INHBA;FAM210B
prerank,phasic smooth muscle contraction (GO:0014821),-0.3176717907872302,-0.7153540219928872,0.8289205702647657,0.9773279477570157,1.0,4/10,21.60%,EDN1;EDN3;EDNRB;DRD2
prerank,ncRNA export from nucleus (GO:0097064),0.2730260516247396,0.7152613563735557,0.8628099173553719,1.0,1.0,19/36,30.67%,PHAX;NUP42;NUP98;NUP43;TSC1;NUP155;NUP188;NUP153;XPOT;AAAS;NUP88;SEC13;NUP160;NOL6;RANBP2;NUP37;SSB;RAE1;NUP133
prerank,regulation of protein localization to nucleus (GO:1900180),0.2603666814968394,0.7151625756285761,0.8847402597402597,1.0,1.0,9/43,14.24%,SESN2;F2;WWTR1;CDK5RAP3;PARP9;GLUL;KAT7;SIN3A;FLCN
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.2492923759811664,0.7151444494888446,0.8641390205371248,1.0,1.0,16/56,22.92%,NDUFAF4;NDUFAB1;NDUFS1;NDUFV2;FOXRED1;NDUFAF5;TIMMDC1;DMAC2;NDUFS4;TMEM126B;NDUFA2;NDUFAF7;NDUFS5;TIMM21;NDUFA9;NDUFB2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.2492923759811664,0.7151444494888446,0.8641390205371248,1.0,1.0,16/56,22.92%,NDUFAF4;NDUFAB1;NDUFS1;NDUFV2;FOXRED1;NDUFAF5;TIMMDC1;DMAC2;NDUFS4;TMEM126B;NDUFA2;NDUFAF7;NDUFS5;TIMM21;NDUFA9;NDUFB2
prerank,regulation of cellular senescence (GO:2000772),0.28148309070905386,0.7147739782791,0.8450946643717728,1.0,1.0,7/28,14.54%,SLC30A10;HMGA1;TERT;SIRT1;RBL1;RSL1D1;ZKSCAN3
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.22690530195860104,-0.714713153010967,0.9307692307692308,0.9773585039575506,1.0,4/42,12.10%,LARS2;WARS2;GARS1;DARS2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.25451251532898,-0.7146778697204386,0.8768115942028986,0.9767134446097359,1.0,1/24,0.78%,ABCG2
prerank,regulation of cilium assembly (GO:1902017),0.24701614128694577,0.7143893751560665,0.8963414634146342,1.0,1.0,20/62,21.60%,DCDC2;TBC1D16;ATG5;RABEP2;HTT;SDCCAG8;IFT88;TAPT1;TCHP;SGSM3;TBC1D14;TBC1D7;EVI5;YAP1;TBC1D22B;CEP120;EVI5L;TBC1D24;FUZ;USP6NL
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.23291190809336884,0.7138273533557132,0.9122807017543859,1.0,1.0,20/88,15.76%,IGF2BP1;F2;DDX3X;TM4SF20;EIF2AK2;KNG1;SAMD4A;LARP1;CPEB3;CDK5RAP3;IGF2BP2;CNOT10;LSM14A;DDX6;ATRAID;RGP1;TSC1;NFKB1;PLAT;RBM4
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.27741073055736,-0.7135480093717138,0.844017094017094,0.9772095213140646,1.0,9/16,30.51%,GPER1;GRP;CHGA;NECAB2;MRAP2;C3;SLC39A14;PDE6G;PRMT5
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.28780501909074796,-0.7135477647340663,0.8403361344537815,0.9765355837131583,1.0,2/15,8.47%,PRKCH;AGTR1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3091486359072334,0.7133744986273961,0.8054545454545454,1.0,1.0,5/18,20.39%,ABL1;PRKDC;ZFP36L1;CCR2;IKZF3
prerank,nucleoside salvage (GO:0043174),-0.32075583389702866,-0.7132196942908979,0.8178294573643411,0.9762309695805766,1.0,4/10,30.35%,HPRT1;UCK2;UPP1;TK2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.32281817213075914,0.7126451640548465,0.7901701323251418,1.0,1.0,3/13,10.95%,NEDD4;NIBAN2;CNMD
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2354469813607015,0.7126431625612816,0.922971114167813,1.0,1.0,1/86,0.14%,EPAS1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.344025611748722,0.7125785198339676,0.7823639774859287,1.0,1.0,4/10,21.12%,SIRT1;TAF7;KLF15;NOC2L
prerank,regulation of hippo signaling (GO:0035330),0.3035898466742494,0.7112500560482446,0.8010752688172043,1.0,1.0,7/17,21.38%,VGLL4;WWC2;AJUBA;MOB3B;WTIP;MAPK14;DLG5
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.25301784292060664,-0.7111276268225419,0.8957345971563981,0.9778904352749684,1.0,5/24,14.09%,TGFB2;EPHA7;ATF4;CTNNB1;CDK5R1
prerank,pentose-phosphate shunt (GO:0006098),-0.31423138369344294,-0.7103046397166063,0.8472803347280334,0.9780840644961475,1.0,4/11,21.82%,TKT;TALDO1;RPE;RPIA
prerank,regulation of exit from mitosis (GO:0007096),0.26110376537325386,0.7102973979678244,0.8774509803921569,1.0,1.0,6/38,16.68%,ANAPC15;ANAPC2;CDC14A;CDC14B;ANAPC16;UBE2E1
prerank,cellular response to acid chemical (GO:0071229),0.2816604938056891,0.709750970580678,0.8615916955017301,1.0,1.0,7/27,19.11%,CPEB4;SESN2;CPEB3;RPTOR;NSMF;RRAGD;LAMTOR1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.25302734400377114,0.7092999010750136,0.9014308426073132,1.0,1.0,12/52,19.51%,CXXC1;TLN1;TPP1;WIPI1;EXTL1;CTDSP2;GFPT1;SYVN1;SEC31A;ATP6V0D1;FKBP14;PARP16
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.23473759616320664,0.7088939654619033,0.889739663093415,1.0,1.0,6/71,6.32%,PRKN;FBXL17;NGLY1;CTSH;USP9X;CLPX
prerank,cellular response to ATP (GO:0071318),-0.2940644278997755,-0.7085789626977693,0.853448275862069,0.9792553640525663,1.0,3/14,14.40%,RYR3;P2RY12;P2RY1
prerank,mRNA stabilization (GO:0048255),-0.22598507195580778,-0.7084647077507814,0.9342105263157895,0.9786905178997508,1.0,10/40,17.73%,YBX1;ELAVL4;SYNCRIP;TAF15;EIF4ENIF1;TIRAP;YBX3;TENT5A;DHX9;PABPC1
prerank,protein kinase B signaling (GO:0043491),0.2886023706209933,0.7077574584161043,0.8405797101449275,1.0,1.0,5/23,15.26%,IGF1;PTEN;PIK3R3;THEM4;ZFP36L1
prerank,mitotic cytokinetic process (GO:1902410),0.28454867534378797,0.7075156539713864,0.839572192513369,1.0,1.0,6/20,21.80%,KLHDC8B;CHMP1A;VPS4A;CHMP4C;CHMP2A;MITD1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.2809107673526496,0.7069357922341585,0.8303886925795053,1.0,1.0,2/27,2.00%,PPARA;IL18
prerank,positive regulation of histone modification (GO:0031058),0.26872523963368494,0.7067457447865505,0.8590604026845637,1.0,1.0,3/33,7.38%,PPARGC1A;ARRB1;NIPBL
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.260433259062728,0.706385406093501,0.8747967479674796,1.0,1.0,5/35,8.60%,CD300A;PPP4R4;MAGI2;PDGFRB;HTT
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.29357733071940173,-0.7062506308936758,0.8609958506224067,0.9803763852243943,1.0,3/14,13.17%,ACTR2;WDR48;ERCC6
prerank,steroid hormone biosynthetic process (GO:0120178),0.27690551938566377,0.7054528699854195,0.8501683501683501,1.0,1.0,4/29,12.67%,CYP21A2;FDXR;TSPOAP1;SRD5A2
prerank,regulation of lipid catabolic process (GO:0050994),-0.26773626651322346,-0.7053676846001906,0.8833693304535637,0.980604754419864,1.0,1/19,2.06%,PDE3B
prerank,water transport (GO:0006833),-0.3073169990188205,-0.7052050707233336,0.830316742081448,0.9801118761370943,1.0,2/12,7.57%,AQP4;AQP11
prerank,positive regulation of interleukin-12 production (GO:0032735),0.27381127922077586,0.7048448476468642,0.8705281090289608,1.0,1.0,4/31,9.53%,TLR3;TLR4;IL12B;RIPK2
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2868325323355775,0.7026816638920264,0.8654867256637168,1.0,1.0,4/26,8.44%,NPR3;POR;TERT;GDNF
prerank,sensory perception (GO:0007600),-0.22045149787902643,-0.7023351369408242,0.9228650137741047,0.9822827675981638,1.0,17/45,28.82%,GNAS;PCDH15;PTGES;MME;SCN9A;GNAL;TMEM150C;CHRNA7;TRPA1;TTC8;PENK;OPRM1;PNOC;CCL2;OPRL1;P2RX7;CDH23
prerank,protein import into peroxisome matrix (GO:0016558),-0.295454548756913,-0.7019734475952054,0.8473895582329317,0.9819420872671945,1.0,1/12,2.23%,PEX5L
prerank,cytoplasmic microtubule organization (GO:0031122),0.24376292664067237,0.7012442976950347,0.8972099853157122,1.0,1.0,4/54,4.66%,DLG1;HOOK2;CLASP1;EZR
prerank,regulation of multicellular organismal development (GO:2000026),0.27702995857564827,0.7003131450702809,0.8385416666666666,1.0,1.0,5/25,16.83%,OAS2;NIPBL;TRIP12;TDG;EHMT1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.2634403483159058,-0.7001235449954855,0.8938679245283019,0.9831326108046808,1.0,7/19,21.19%,DDIT4;HIPK1;PHLDA3;BCL3;HIPK2;RPS27L;PYCARD
prerank,regulation of mRNA stability (GO:0043488),0.21522061501363007,0.7000282340606141,0.9729032258064516,1.0,1.0,17/145,12.33%,ROCK2;TNPO1;TNFSF13;IGF2BP1;SAMD4A;LARP1;EXOSC7;GDNF;IGF2BP2;CSDC2;YTHDF3;TBRG4;THRAP3;NOCT;AXIN2;DCP1A;PRKCA
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.186218908831817,-0.699282788060809,0.989247311827957,0.9833142366882577,1.0,17/101,18.10%,MEF2C;PDE4B;LYN;DAB2IP;TNFRSF1B;TGFB1;SBNO2;VIM;CARD16;LBP;MTDH;CX3CR1;NOD2;CD180;TRIM41;PDCD4;CDC73
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.27864430607171187,0.6988065905871825,0.8624161073825504,1.0,1.0,4/26,9.35%,PRKN;LRRK2;SOD2;SIRT1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.29656260970637455,-0.6985527894693687,0.8607068607068608,0.9833288136312215,1.0,2/13,7.46%,GRIN2A;PERP
prerank,negative regulation of cholesterol transport (GO:0032375),-0.30942749622911925,-0.6978186242182235,0.8509316770186336,0.9833888306730616,1.0,1/10,7.44%,SREBF2
prerank,regulation of neutrophil migration (GO:1902622),-0.3081393346042602,-0.697749993497079,0.8162393162393162,0.982797617038268,1.0,6/10,31.93%,MPP1;RHOH;RHOG;JAM3;BST1;RAC2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3168686597435497,-0.697457907065998,0.8330019880715706,0.9824053758156553,1.0,7/10,41.17%,APC;SIRT2;ECT2;SPAG5;KNSTRN;CCNB1;NEK2
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.22287661509468343,-0.697443692020847,0.9428571428571428,0.9817573095220947,1.0,10/40,19.59%,PGLYRP1;RPL39;GBP4;DROSHA;TIRAP;MPEG1;LBP;RARRES2;PPP1R11;ROMO1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.19480397248871045,-0.697292661212276,0.993006993006993,0.9812432560978038,1.0,31/87,30.34%,FBXL7;PSMB2;DACT1;PSMD14;PSMC6;FAM107A;CDKN1A;JADE1;MYO16;PSMA4;PSMB9;APC;SKP1;RGCC;CDC73;PSMD11;PSMB10;PSMD2;DCUN1D3;PSMA2;CDKN2B;PSMB3;KLF4;FHL1;CCL2;PSMB5;PSMA7;PSMF1;PSMD7;WEE1;AURKA
prerank,base-excision repair (GO:0006284),0.2490694948923859,0.6971713340026333,0.9088050314465409,1.0,1.0,14/48,23.81%,POLD2;POLG;HUWE1;PNKP;TDG;POLL;MBD4;OGG1;FEN1;RFC1;XPA;LIG1;ADPRS;SMUG1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.2913141144873859,0.6969274555533748,0.8313253012048193,1.0,1.0,5/20,15.53%,CTR9;MEIS1;LDB1;ZFP36L1;HOXB8
prerank,regulation of secretion (GO:0051046),-0.2980150894868828,-0.6966970832312563,0.8555555555555555,0.9811333352875247,1.0,3/13,8.98%,ACSL3;KCNQ1;MYO6
prerank,positive regulation of interleukin-8 production (GO:0032757),0.24840457936764498,0.6966677634014371,0.8939873417721519,1.0,1.0,7/49,9.78%,TLR3;TLR4;IL17D;AFAP1L2;SERPINE1;RIPK1;MAVS
prerank,mitotic metaphase plate congression (GO:0007080),0.24390767816736791,0.696510465168885,0.8996913580246914,1.0,1.0,9/51,17.02%,EML4;CHMP1A;BECN1;CHAMP1;KIFC1;VPS4A;CENPC;CHMP4C;PIBF1
prerank,regulation of B cell differentiation (GO:0045577),0.29965474973768946,0.6963003550565412,0.8384030418250951,1.0,1.0,5/17,20.39%,CD27;MMP14;ZFP36L1;INHA;IKZF3
prerank,response to gamma radiation (GO:0010332),0.28723079921988937,0.6945686044969863,0.8513986013986014,1.0,1.0,8/24,20.03%,ATM;TP53;CRYAB;TLK2;KDM1A;YAP1;FANCD2;LIG4
prerank,vacuolar acidification (GO:0007035),-0.2549973901178154,-0.6942459269070044,0.8959276018099548,0.9828345424957846,1.0,3/21,9.53%,ATP6V0A1;ATP6V0A4;PPT1
prerank,response to laminar fluid shear stress (GO:0034616),0.3408677878208166,0.6940742289837961,0.7893700787401575,1.0,1.0,2/10,5.70%,SMAD6;MAP2K5
prerank,negative regulation of centrosome duplication (GO:0010826),-0.29960183317648253,-0.6938429517637046,0.8231578947368421,0.9825613866259542,1.0,3/11,21.61%,CDK5RAP2;TRIM37;NPM1
prerank,regulation of actin filament depolymerization (GO:0030834),0.3171914311882859,0.6925790995556245,0.8316633266533067,1.0,1.0,3/12,11.40%,PLEKHH2;PIK3CA;VIL1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.2695066583319597,-0.6925188251904969,0.8896247240618101,0.9832186968107095,1.0,6/16,29.69%,ST3GAL4;ITGB2;MDK;RELA;SELP;RHOA
prerank,response to UV (GO:0009411),-0.18730049149594583,-0.6924677038445118,0.9826989619377162,0.9825978193972953,1.0,35/95,30.20%,PTPRK;RPL26;MAP4K3;MFAP4;ATF4;ERCC6;SDF4;PRIMPOL;METTL3;UBE2B;BCL3;GPX1;CAT;RHBDD1;MEN1;DCUN1D3;ERCC2;POLD1;NPM1;TRIAP1;N4BP1;POLK;DTL;MAP2K7;RUVBL2;RELA;CCAR2;PCLAF;UBE2A;CCND1;MAPK8;CIRBP;BMF;ERCC3;AQP1
prerank,cellular response to ionizing radiation (GO:0071479),0.24837286712553944,0.6911993299937197,0.9102362204724409,1.0,1.0,18/47,24.07%,ATM;TP53;NIPBL;SIRT1;HUS1;CRYAB;GADD45A;TLK2;INTS7;KDM1A;MAPK14;YAP1;LIG4;TANK;RAD9A;FIGNL1;TSPYL5;NUCKS1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.28745290979036875,-0.6908104553335017,0.8326086956521739,0.9835143722123917,1.0,3/14,9.41%,HSP90AB1;IFNGR2;JAK1
prerank,protein targeting to lysosome (GO:0006622),-0.25901730190282857,-0.6907225318935735,0.8903508771929824,0.9829292303112421,1.0,7/20,16.30%,HSPA8;SORL1;GCC2;LAPTM5;CLU;NCOA4;M6PR
prerank,positive regulation of mRNA processing (GO:0050685),-0.25161838298730727,-0.6899780891703237,0.8865740740740741,0.9829804414787956,1.0,9/21,33.67%,CELF4;CDC73;TRA2A;RBM3;NCBP2;RBMXL1;CIRBP;SF3B4;CELF3
prerank,cellular response to light stimulus (GO:0071482),0.2354685505058333,0.6899180758077127,0.9373134328358209,1.0,1.0,20/66,23.79%,NEDD4;RHO;TP53;CDC25A;AURKB;ZBTB1;SDE2;CREBBP;SAG;KDM1A;TAF1;PDE6B;FMR1;NOC2L;OPN1SW;YY1;CASP9;EP300;OPN1MW;OPN1MW3
prerank,histone acetylation (GO:0016573),0.2272724393516091,0.689373805159484,0.9505247376311844,1.0,1.0,21/69,25.13%,BRD8;CPA4;ZZZ3;KAT6B;ATF2;BRD1;KAT14;KAT7;BEND3;KAT2B;CREBBP;SGF29;TAF6L;RUVBL1;EP300;DMAP1;SUPT7L;MSL3;TAF12;PHF20;ING3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2885258603660047,0.6893519058102004,0.8492366412213741,1.0,1.0,2/20,7.93%,NR2F2;PTEN
prerank,protein-containing complex disassembly (GO:0032984),-0.21238437242035746,-0.688982817841526,0.9354005167958657,0.9832304190099027,1.0,10/54,17.21%,CAV1;GSK3B;HSPA8;RPL23;CTNNB1;AXIN1;MAP1LC3A;GABARAPL2;APC;PPP1CA
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.26268173995518357,0.6887294518443533,0.8925081433224755,1.0,1.0,6/32,12.69%,ATM;ACD;TNKS2;AURKB;FBXO4;PNKP
prerank,protein polyglutamylation (GO:0018095),0.33273243956403115,0.6883828122633939,0.7954545454545454,1.0,1.0,2/11,7.04%,TTLL6;TTLL9
prerank,regulation of hormone secretion (GO:0046883),0.2929114436909766,0.6878526320070926,0.8215613382899628,1.0,1.0,1/15,2.62%,SNX6
prerank,protein localization to centrosome (GO:0071539),-0.26262304090199834,-0.6877532256501419,0.8968609865470852,0.9836830479692061,1.0,6/17,31.20%,CEP83;CEP131;SPAG5;NEDD1;STIL;CSNK1D
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.23927707336820975,-0.6874228194800317,0.9128205128205128,0.9833229408056097,1.0,14/30,27.67%,HMGCS1;IDI1;PMVK;LSS;SQLE;DHCR7;DHCR24;CYP51A1;MSMO1;ACAT2;EBP;HMGCR;FDPS;HSD17B7
prerank,anterograde axonal transport (GO:0008089),0.2543670366749053,0.6871974199078298,0.8986710963455149,1.0,1.0,8/37,15.24%,TRAK1;DTNBP1;KIF1B;KIF1C;BLOC1S6;BLOC1S2;KIF5B;RAB21
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3190073836095325,0.6871177897567108,0.8547169811320755,1.0,1.0,2/12,12.62%,INSIG2;TAPT1
prerank,regulation of lymphocyte activation (GO:0051249),0.32144874772456244,0.6871065550050636,0.820952380952381,1.0,1.0,12/12,67.88%,LAT;IKZF3;PAG1;DCAF15;SIT1;KAT2A;CCL5;CD4;CD19;LCK;CRTAM;THEMIS2
prerank,determination of bilateral symmetry (GO:0009855),-0.24175570189496365,-0.6870754997782007,0.9,0.9829825925103733,1.0,2/24,5.71%,NOTCH1;TBX1
prerank,negative regulation of translational initiation (GO:0045947),0.32298022667166193,0.6870342847751808,0.8287795992714025,1.0,1.0,6/13,29.96%,LARP1;RBM4;FMR1;AGO2;EIF4EBP1;EIF2AK1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2588563025723733,0.6869844682747445,0.8890728476821192,1.0,1.0,9/36,20.25%,ATM;DONSON;HUS1;DOT1L;CEP63;CLSPN;INTS7;NBN;RAD9A
prerank,transcription by RNA polymerase III (GO:0006383),-0.23711595558333054,-0.6864949684602497,0.920863309352518,0.982820316678903,1.0,3/27,10.80%,IVNS1ABP;RO60;GTF3C5
prerank,chromosome condensation (GO:0030261),-0.2238594736031714,-0.6862526511252225,0.9376693766937669,0.9823831100559178,1.0,14/36,27.96%,AIFM1;SMC4;GPER1;NCAPG2;TOP2A;NUSAP1;BANF1;MCPH1;PHF8;NCAPH;TTN;SET;NCAPH2;CSNK2B
prerank,vesicle coating (GO:0006901),-0.20439127983175828,-0.6862247552143746,0.9563953488372093,0.9804233961256292,1.0,18/61,25.52%,GRIA1;CTSC;CUL3;NSF;CNIH1;KLHL12;ANKRD28;CTSZ;TFG;MCFD2;TRAPPC2L;TMED10;COL7A1;SEC16B;TMED2;SAR1B;TRAPPC3;RAB1B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.20439127983175828,-0.6862247552143746,0.9563953488372093,0.9804233961256292,1.0,18/61,25.52%,GRIA1;CTSC;CUL3;NSF;CNIH1;KLHL12;ANKRD28;CTSZ;TFG;MCFD2;TRAPPC2L;TMED10;COL7A1;SEC16B;TMED2;SAR1B;TRAPPC3;RAB1B
prerank,COPII vesicle coating (GO:0048208),-0.20439127983175828,-0.6862247552143746,0.9563953488372093,0.9804233961256292,1.0,18/61,25.52%,GRIA1;CTSC;CUL3;NSF;CNIH1;KLHL12;ANKRD28;CTSZ;TFG;MCFD2;TRAPPC2L;TMED10;COL7A1;SEC16B;TMED2;SAR1B;TRAPPC3;RAB1B
prerank,organic cation transport (GO:0015695),0.28588715525874564,0.6861056666161568,0.8634751773049646,1.0,1.0,8/20,19.67%,SLC22A18;SLC22A5;RALBP1;SLC25A42;SLC25A29;SLC25A19;SLC25A26;SLC22A4
prerank,regulation of receptor internalization (GO:0002090),0.25696568142643134,0.6857964772210461,0.9055649241146712,1.0,1.0,5/35,9.70%,MAGI2;ARRB1;RIN3;ATXN2;PICK1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.30260424688204823,-0.6857605356309942,0.8487394957983193,0.9801887435407768,1.0,4/11,22.63%,CD44;TAF9B;CD74;TRIAP1
prerank,fatty acid biosynthetic process (GO:0006633),0.23145669010766734,0.6848533437779757,0.9281524926686217,1.0,1.0,6/63,7.40%,ALOX12;ACSBG2;HACD4;HACD1;SCD5;NDUFAB1
prerank,triglyceride catabolic process (GO:0019433),0.28951641517238486,0.6847152954363485,0.8516483516483516,1.0,1.0,1/19,4.38%,CPS1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.27237339406614824,0.6836381962205582,0.8444444444444444,1.0,1.0,8/29,20.28%,ACOT11;MLYCD;ACOT8;THEM4;ACOT12;ACLY;CROT;ACSF2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.27237339406614824,0.6836381962205582,0.8444444444444444,1.0,1.0,8/29,20.28%,ACOT11;MLYCD;ACOT8;THEM4;ACOT12;ACLY;CROT;ACSF2
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.30057771009402057,0.6818158158264951,0.8483245149911817,1.0,1.0,6/17,24.74%,AURKB;IK;CHAMP1;RB1;MIS12;SPDL1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.31144968885552504,0.6817367063625337,0.8333333333333334,1.0,1.0,1/12,1.76%,PPARA
prerank,histone mRNA metabolic process (GO:0008334),0.27391847754786625,0.6815405798126251,0.862876254180602,1.0,1.0,6/27,16.40%,ATM;TUT4;TENT2;TENT4B;CPSF3;TUT7
prerank,intracellular pH reduction (GO:0051452),-0.22679182075409243,-0.6814573498396286,0.937799043062201,0.9834838050788859,1.0,9/33,21.63%,ATP6V0A1;ATP6V0A4;RAB38;CLCN3;RAB39A;GPR89A;GPR89B;ATP6V1F;ATP6V1B2
prerank,microtubule depolymerization (GO:0007019),0.2936377821641944,0.6808576078892566,0.8394160583941606,1.0,1.0,1/17,1.82%,KIF2A
prerank,regulation of gene silencing by miRNA (GO:0060964),0.23320458717733986,0.6796161989012646,0.9316493313521546,1.0,1.0,22/62,26.79%,POLR2A;TNRC6A;POLR2D;NUP42;AJUBA;NUP98;NUP43;WTIP;NUP155;EIF4G1;NUP188;POLR2G;FMR1;NUP153;AGO1;POLR2F;AAAS;NUP88;AGO2;PUM2;SEC13;POLR2K
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.2085795312115676,-0.6794068663049706,0.9619565217391305,0.9845828252215144,1.0,13/48,18.84%,TNFRSF1B;FNIP2;DDIT4;HIPK1;CRIP1;PHLDA3;BCL3;HIPK2;CASP2;HTRA2;CHEK2;BCL2L11;RPS27L
prerank,determination of left/right symmetry (GO:0007368),0.25212297654634497,0.6794000170382555,0.8972267536704731,1.0,1.0,10/36,21.09%,SMO;MKKS;GALNT11;CCDC39;ARL6;ENKUR;CCDC40;OFD1;CITED2;DAND5
prerank,RNA modification (GO:0009451),0.23548034652779012,0.6788846356286174,0.9369369369369369,1.0,1.0,9/54,19.97%,TRMT9B;RBM15;JMJD6;NOP2;LCMT2;WDR4;DTWD2;NSUN4;ADAT2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.2297023332505898,-0.6783064317226695,0.9348370927318296,0.9848666045654928,1.0,6/33,14.09%,PTPRJ;RPS3;CEACAM1;DUSP3;DGKZ;LAPTM5
prerank,purine nucleotide biosynthetic process (GO:0006164),0.31103394531394474,0.6781441888418145,0.8093457943925234,1.0,1.0,6/12,20.77%,PRPSAP1;AMPD2;PRPSAP2;MTHFD1;GART;ADSL
prerank,regulation of microtubule nucleation (GO:0010968),0.319280474032299,0.6780122468300925,0.8310679611650486,1.0,1.0,1/10,2.50%,EML2
prerank,B cell mediated immunity (GO:0019724),0.32718619980754243,0.6780117759816554,0.8263358778625954,1.0,1.0,1/10,5.67%,CD27
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.2958905446529736,-0.6778236283013676,0.8666666666666667,0.9846253459251149,1.0,3/11,19.59%,CAMK4;ITGB2;TYROBP
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3289091906442524,0.6773117922530321,0.8391472868217055,1.0,1.0,6/10,33.22%,ATP5F1D;ATP5F1C;ATP5MC3;VPS9D1;ATP5MG;ATP5MC2
prerank,microtubule-based transport (GO:0099111),0.3159238735556487,0.6770966201773452,0.8214285714285714,1.0,1.0,2/12,8.60%,ROPN1L;HTT
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.23175635852802923,-0.6765530041391322,0.9180722891566265,0.9850511287203312,1.0,6/28,17.56%,MAP1B;CLASP2;STMN2;MAPT;STMN1;FKBP4
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.31371338385905034,0.6764825644103796,0.8365384615384616,1.0,1.0,3/13,18.50%,VDAC2;BLOC1S2;RHOT1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3102079449732791,0.6763049634896529,0.8625678119349005,1.0,1.0,2/13,7.78%,UBAC2;ERLEC1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.30248826194138345,0.6760629739572511,0.8673469387755102,1.0,1.0,2/15,5.82%,RAPGEF3;CAMK1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.32069393122757184,0.6755784483217497,0.8204633204633205,1.0,1.0,2/11,15.44%,SIRT1;TAF7
prerank,regulation of axon regeneration (GO:0048679),0.31971580070152994,0.6752386110906845,0.8615984405458089,1.0,1.0,1/12,2.17%,EPHA4
prerank,regulation of mRNA metabolic process (GO:1903311),0.320430570094426,0.6740633205517925,0.8484251968503937,1.0,1.0,2/11,10.61%,SLTM;SRPK2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.28225601725345917,-0.6738333497997812,0.9153674832962138,0.9867352459215981,1.0,6/14,31.27%,NCBP2;ERN1;CPSF4;CPSF4L;CSTF2T;CPSF1
prerank,monocyte chemotaxis (GO:0002548),-0.22741595982414448,-0.6736374368959309,0.9245742092457421,0.9862257584685747,1.0,3/32,5.86%,ANXA1;TNFRSF11A;RPS19
prerank,endoderm development (GO:0007492),0.3116727335679899,0.6721836824685908,0.8276450511945392,1.0,1.0,1/13,2.04%,LAMC1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.3107641221415259,0.6719544433735335,0.8352490421455939,1.0,1.0,2/12,7.28%,CYP26B1;DHRS3
prerank,regulation of necroptotic process (GO:0060544),-0.2405728549092757,-0.6714658053819437,0.8917647058823529,0.9873701477045428,1.0,9/23,24.31%,ARHGEF2;HSP90AA1;PDCD6IP;MLKL;YBX3;PELI1;SPATA2;FLOT1;STUB1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.2885746680862506,0.6714243337296455,0.867513611615245,1.0,1.0,4/18,10.63%,POR;SIRT3;GDNF;ABL1
prerank,proteasomal protein catabolic process (GO:0010498),0.19786571092499788,0.6711506463076338,0.9915151515151515,1.0,1.0,23/201,11.88%,PRKN;FBXL17;SPSB1;NEDD4;IFI27;PCBP2;DCAF11;FBXL19;ARRB1;SPSB4;TBL1X;SMURF2;FBXW11;HUWE1;ERLEC1;BTRC;TBL1XR1;RNF34;SIRT1;ZSWIM8;RNF41;WWP2;CUL4A
prerank,cell cycle checkpoint signaling (GO:0000075),-0.27641701576346367,-0.670696177140165,0.8837209302325582,0.9873901791465527,1.0,6/12,37.88%,PLK2;WEE1;BUB1;ZWILCH;WEE2;ZW10
prerank,mitochondrial translational elongation (GO:0070125),0.21811184774300607,0.6706197185214978,0.9661495063469676,1.0,1.0,24/88,26.23%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MRPL48;MRPL1;GFM2;MRPL45;MRPS17;CHCHD1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;MRPS25;MRPL50;MRPL33;MRPS18B;MRPL19;TSFM
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.18423508311112732,-0.6705248460229327,0.9895833333333334,0.9868558541142106,1.0,32/84,34.29%,PSMB2;CUL3;PSMD14;ECRG4;PSMC6;BUB3;UBB;FBXO31;PSMA4;PSMB9;CDC23;PSMD11;PSMB10;PSMD2;MAD2L1;PSMA2;UBC;RPS27A;PSMB3;PSMB5;UBE2D1;PSMA7;PSMF1;PSMD7;AURKA;CDK1;CDC20;PSMA5;UBE2C;PSMD4;ANAPC10;PSME4
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.32402786899574804,0.6694964767946666,0.8266666666666667,1.0,1.0,2/10,15.81%,ACD;TFIP11
prerank,stress-activated MAPK cascade (GO:0051403),-0.19561415146271893,-0.6694247502199164,0.9796511627906976,0.9871154281229809,1.0,17/61,25.01%,MAP3K5;NOD1;MINK1;MAP3K7;TNFRSF19;MAP4K3;IKBKB;UBB;NOD2;SKP1;LGALS9;MAP3K11;SH2D3C;MAP2K7;UBC;RPS27A;TAB1
prerank,regulation of cellular response to stress (GO:0080135),0.20974821977734756,0.6692712319709381,0.9668965517241379,1.0,1.0,18/115,16.75%,ROCK2;PRKN;NUPR1;SMG1;ATM;SIRT1;NUP42;AJUBA;ABL1;NUP98;NUP43;CRYAB;RSL1D1;AMFR;RPTOR;NUP155;CREBBP;MCL1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2932301025237109,-0.6692489212930977,0.8845360824742268,0.9865953988710734,1.0,8/11,38.78%,TIMM29;TIMM8B;ROMO1;TIMM13;NDUFA13;TIMM10B;AGK;TIMM9
prerank,toll-like receptor signaling pathway (GO:0002224),0.21700085473667832,0.6680702449364133,0.9519650655021834,1.0,1.0,13/84,16.08%,COLEC12;TLR3;TLR4;MAPKAPK3;TAB2;RIPK2;RIPK1;LY96;NMI;MAP3K1;TLR5;BIRC3;SCARA3
prerank,immunoglobulin mediated immune response (GO:0016064),0.32620559137557653,0.6666626949324689,0.8421052631578947,1.0,1.0,1/10,5.67%,CD27
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3073612202603565,0.6665848996163962,0.859375,1.0,1.0,1/13,2.89%,NFAT5
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.23447202280051282,-0.6663511794436278,0.9391727493917275,0.9882184707125272,1.0,8/28,26.53%,SH3KBP1;CD47;NOD2;PRKCQ;TYROBP;PYCARD;THY1;CCL2
prerank,mRNA transport (GO:0051028),0.21160087388100554,0.6663105596899456,0.9680998613037448,1.0,1.0,26/101,22.90%,NXF2;SMG1;SRSF5;POLDIP3;HNRNPA2B1;NUP42;NUP98;NXF1;SRSF11;NUP43;ZFP36L1;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;CDC40;NUP188;U2AF1;UPF2;SRSF7;FMR1;U2AF2;NUP153;FYTTD1;SMG6
prerank,regulation of cell size (GO:0008361),0.2706268883227128,0.6659894387070455,0.9036144578313253,1.0,1.0,6/23,15.84%,DEPTOR;EZR;PTEN;RARG;VAV3;RPTOR
prerank,negative regulation of protein transport (GO:0051224),-0.2312515881017158,-0.6640336897843365,0.9103139013452914,0.989399914350342,1.0,8/25,23.55%,APOE;NDFIP2;PPM1F;ERP29;PKDCC;CYP51A1;DRD2;RHBDF2
prerank,regulation of translational initiation (GO:0006446),0.2276912702625389,0.6638979169254199,0.9511494252873564,1.0,1.0,15/63,21.07%,CTIF;MIF4GD;DDX3X;POLR2D;LARP1;YTHDF3;EIF4A2;IMPACT;RBM4;EIF4G1;BOLL;EIF5;POLR2G;RPS6KB2;FMR1
prerank,positive regulation of actin nucleation (GO:0051127),0.3084817225102002,0.6638817392622093,0.8596153846153847,1.0,1.0,1/11,2.14%,FCHSD2
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.28705745288803053,-0.6638110840209706,0.8659574468085106,0.9889082582962029,1.0,2/10,11.13%,TSNAX;DROSHA
prerank,regulation of acrosome reaction (GO:0060046),-0.2930149117703638,-0.663662626292101,0.8697478991596639,0.9883715403547513,1.0,2/10,15.36%,GLRA1;CACNA1H
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.213152325588304,0.6632757619805675,0.9716312056737588,1.0,1.0,24/96,22.90%,NXF2;SMG1;SRSF5;POLDIP3;HNRNPA2B1;NUP42;NUP98;NXF1;SRSF11;NUP43;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;CDC40;NUP188;U2AF1;UPF2;SRSF7;U2AF2;NUP153;FYTTD1;SMG6
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.28860795752144847,0.6629255977919466,0.8673835125448028,1.0,1.0,2/15,9.30%,STXBP4;GLI1
prerank,melanosome transport (GO:0032402),-0.25611257905498713,-0.6619015681462218,0.9069264069264069,0.9883847455931252,1.0,4/18,16.83%,MYO5A;RAB27A;RAB27B;MREG
prerank,pigment granule transport (GO:0051904),-0.25611257905498713,-0.6619015681462218,0.9069264069264069,0.9883847455931252,1.0,4/18,16.83%,MYO5A;RAB27A;RAB27B;MREG
prerank,sensory perception of taste (GO:0050909),0.31386850883870304,0.6616397569163727,0.8502879078694817,1.0,1.0,1/10,7.83%,GNAT3
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.20736155274981954,-0.6615080345277301,0.9572192513368984,0.9880333509354905,1.0,3/45,6.25%,GRM5;GCNT2;APP
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.24748095181155166,-0.6609161889435923,0.9260089686098655,0.9878206112566614,1.0,4/20,17.19%,DCC;GSK3B;FAS;CASP2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.25676724541581536,-0.6602963740994701,0.9046563192904656,0.9876207718785988,1.0,3/18,18.79%,ANXA1;FAM107A;BCL2L11
prerank,nucleotide-excision repair (GO:0006289),-0.17758777507660717,-0.6600977119416427,0.9892086330935251,0.9871290751840907,1.0,29/101,23.94%,POLA1;POLD3;RAD23B;AQR;ERCC1;ERCC6;POLR2J;UBB;RPA1;COPS4;BRIP1;CETN2;GTF2H1;FANCC;COPS6;GTF2H4;COMMD1;GTF2H5;RFC4;COPS5;ERCC2;POLD4;POLD1;RFC2;POLR2C;POLR2L;POLK;UBC;RPS27A
prerank,cytoplasmic translational initiation (GO:0002183),-0.2603803897278915,-0.6600083427104477,0.916289592760181,0.9865463211374158,1.0,4/17,20.88%,EIF3M;EIF2B3;EIF4A1;EIF3D
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.27158264891082123,0.6599357706441891,0.8963210702341137,1.0,1.0,5/22,18.39%,ERI3;EXOSC7;ERI2;EXOSC3;WDR12
prerank,regulation of chromatin binding (GO:0035561),0.31440126713661204,0.6592371716297049,0.8657314629258517,1.0,1.0,2/10,11.77%,PARP9;WAPL
prerank,positive regulation of DNA recombination (GO:0045911),0.2581920754918945,0.6589209355217394,0.8861646234676007,1.0,1.0,3/27,6.47%,ARID2;KMT5C;KMT5B
prerank,cellular response to superoxide (GO:0071451),0.3233839841589785,0.6586318010653217,0.8386491557223265,1.0,1.0,2/10,5.89%,SOD3;SOD2
prerank,protein hydroxylation (GO:0018126),0.28983231477134036,0.6586307173572992,0.8814531548757171,1.0,1.0,6/15,22.65%,VIPAS39;ASPH;HIF1AN;OGFOD1;P3H4;VPS33B
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.29585428760050425,0.658432901315283,0.8662900188323918,1.0,1.0,1/13,2.92%,NUPR1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3050498657123459,0.6584256039619738,0.8558558558558559,1.0,1.0,3/13,9.52%,PRODH;ALDH4A1;GLUL
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.25761635300984376,-0.6579612679853019,0.9022222222222223,0.9874041267973807,1.0,2/18,8.42%,POLA1;POLD3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.20663340604726366,-0.6569172292490074,0.9702380952380952,0.9874854481660028,1.0,16/51,23.46%,NEK7;GNL3L;XRCC5;CTNNB1;SMG5;TERF1;CCT8;STN1;CCT2;PRKCQ;CCT6A;HMBOX1;CCT7;DCP2;EXOSC10;MAP2K7
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.29527465667925473,0.6567555414322829,0.8794063079777366,1.0,1.0,5/14,22.89%,LHPP;ADSS1;GART;ADSL;GMPS
prerank,regulation of trophoblast cell migration (GO:1901163),0.29846003233828544,0.6566505387059794,0.8675373134328358,1.0,1.0,4/14,16.16%,SMURF2;YTHDF3;ACVR1B;NODAL
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.17729107023551038,-0.6566111494526573,0.9900990099009901,0.9870782846719142,1.0,16/95,18.68%,MEF2C;PDE4B;DAB2IP;TNFRSF1B;SBNO2;TIRAP;VIM;CARD16;LBP;CX3CR1;NOD2;CD180;TRIM41;PDCD4;CDC73;SIRT2
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.22452972117245307,-0.6565880799418146,0.9429928741092637,0.9864468331441485,1.0,8/30,22.64%,CAVIN1;TAF1B;GTF2H1;GTF2H4;GTF2H5;ERCC2;POLR1F;POLR2L
prerank,phosphate ion transmembrane transport (GO:0035435),0.30497631293723004,0.6560147027637231,0.8589511754068716,1.0,1.0,5/12,22.63%,SLC20A2;SLC25A11;SLC25A10;SLC37A4;SLC25A3
prerank,regulation of B cell apoptotic process (GO:0002902),0.3071420051281515,0.6556318000845286,0.8537549407114624,1.0,1.0,5/12,22.31%,FNIP1;AURKB;BCL6;NOC2L;ORMDL3
prerank,mitotic cell cycle phase transition (GO:0044772),0.19246664350625575,0.6548908807005992,0.9949811794228356,1.0,1.0,44/203,20.83%,TPD52L1;FBXL17;CCNA2;CEP250;PPP1CB;CLASP1;NINL;CCNA1;CACUL1;FBXW11;BTRC;CCND3;CDC25A;CCNB2;BRSK1;FBXL12;AJUBA;SDCCAG8;CUL4A;NASP;DNM2;ALMS1;CTDP1;ACVR1B;CCNG1;CEP63;RB1;CCNE1;USP37;OPTN;CDC34;CEP57;AKAP9;PCM1;CEP164;OFD1;FBXL22;PCNT;TAF2;CHMP2A;UBE2S;DCTN3;CUL5;CCNG2
prerank,sister chromatid segregation (GO:0000819),0.25262095396548623,0.6545510709382362,0.9139966273187183,1.0,1.0,6/31,17.46%,TOP2B;CHAMP1;DSN1;KIFC1;RB1;CENPK
prerank,pancreas development (GO:0031016),-0.27679603871491154,-0.6538136371244061,0.8993839835728953,0.9878515729496289,1.0,2/12,8.60%,MET;PROX1
prerank,protein modification by small protein removal (GO:0070646),0.18873794724880444,0.6535134900300188,0.9975961538461539,1.0,1.0,62/252,23.65%,SMAD3;PRKN;SENP3;CCNA2;TGFBR1;BABAM2;USP3;CCNA1;USP9X;USP24;TP53;USP11;SMURF2;PTEN;RCE1;CDC25A;RIPK1;BECN1;INO80D;USP34;USP49;UIMC1;DESI1;DESI2;USP12;USP7;BABAM1;DDB2;MBD6;OGT;USP18;KAT2B;BIRC3;USP37;UFD1;CLSPN;SMAD4;ASXL2;USP48;USP1;RHOT1;COPS8;USP33;USP21;USP16;USP35;INO80E;TRAF3;OTUD3;USP5;RUVBL1;YY1;EP300;RNF123;USP20;OTUD4;TOR1A;USPL1;PSMC4;USP9Y;OTUB2;PSMD10
prerank,protein localization to chromatin (GO:0071168),0.2738746034481013,0.6529409057049637,0.8841121495327103,1.0,1.0,6/18,20.38%,NIPBL;LEMD2;WAPL;LRWD1;SGF29;MCM9
prerank,protein targeting to membrane (GO:0006612),0.2143520997097211,0.6527341420954959,0.9641833810888252,1.0,1.0,21/83,17.92%,RAB3IP;PEX11B;PIKFYVE;PXMP2;ZDHHC18;ZDHHC1;MYO1C;PRKCI;PARD3;MICALL1;PEX14;ACBD5;VPS37A;ARL6;PEX19;RAB8B;SLC25A17;PEX16;RABGEF1;PEX5;ZDHHC23
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.2659706526704791,-0.6524846552110518,0.9010752688172043,0.98817364883234,1.0,6/14,25.38%,ATP2B4;PRKAR1B;PRKAR2B;PRKAR2A;PKIG;ADRB2
prerank,mismatch repair (GO:0006298),0.252958019075185,0.6514422229199699,0.9169435215946844,1.0,1.0,8/27,21.43%,POLD2;ABL1;MSH3;TDG;MSH4;MCM9;MLH1;LIG1
prerank,cochlea morphogenesis (GO:0090103),-0.29818104864863165,-0.651351636636156,0.8739837398373984,0.9883092444723667,1.0,7/10,34.33%,TBX1;TBX18;PAX2;MYO3B;MYO3A;HPN;TIFAB
prerank,phagosome acidification (GO:0090383),0.25456266544138606,0.6511409729017932,0.8928571428571429,1.0,1.0,4/26,11.08%,ATP6V0E1;ATP6V0B;ATP6V1D;ATP6V1E1
prerank,RNA export from nucleus (GO:0006405),0.20778618540600313,0.6509369048299471,0.9704641350210971,1.0,1.0,25/100,22.90%,NXF2;SMG1;SRSF5;POLDIP3;HNRNPA2B1;NUP42;NUP98;NXF1;SRSF11;NUP43;SARNP;CPSF3;NUP155;ALKBH5;SRSF1;CDC40;NUP188;U2AF1;UPF2;SRSF7;U2AF2;NUP153;FYTTD1;XPO5;SMG6
prerank,positive regulation of lipid storage (GO:0010884),0.2709662877162004,0.6499731340410168,0.8792792792792793,1.0,1.0,4/21,14.88%,IKBKE;OSBPL11;PLIN3;NFKB1
prerank,regulation of histone deacetylation (GO:0031063),-0.2814619612455871,-0.649921011366823,0.8742004264392325,0.9887016245050209,1.0,1/13,2.27%,CAMK2D
prerank,positive regulation of calcium ion import (GO:0090280),0.29894419036352066,0.6494220700774234,0.8763326226012793,1.0,1.0,3/12,15.10%,PDGFRB;SPHK2;LGALS3
prerank,cellular response to interferon-beta (GO:0035458),-0.2636925924186602,-0.6491856332404466,0.89587852494577,0.9885527589843363,1.0,6/14,25.52%,PNPT1;AIM2;HTRA2;UBE2G2;IFITM2;NDUFA13
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.2108063559181419,-0.6480625893994979,0.9728260869565217,0.9886481960127234,1.0,13/37,24.23%,HSP90AB1;RYBP;RPL5;RPS7;DDRGK1;RPL23;NOP53;HIPK2;PDCL3;RPL11;BAG5;N4BP1;CCAR2
prerank,regulation of protein kinase A signaling (GO:0010738),0.27006451082659644,0.6473342571443963,0.8823529411764706,1.0,1.0,5/20,17.74%,LRRK2;AKAP12;PRKAR1A;AKAP7;ADGRV1
prerank,modulation by host of symbiont process (GO:0051851),0.2495991123597547,0.647087343848593,0.9045138888888888,1.0,1.0,10/31,24.07%,NAPEPLD;SMARCA4;HDAC1;TAF11;CTDP1;REST;SP1;EP300;SMARCB1;NUCKS1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.24775099773356746,-0.6468433890276593,0.9266666666666666,0.9888519278874176,1.0,10/20,33.07%,GATM;GCLM;GAMT;CHAC2;FPGS;OPLAH;GGCT;MGST2;GCLC;GGT1
prerank,negative regulation of receptor internalization (GO:0002091),0.2958887948533662,0.6462849807598385,0.8685185185185185,1.0,1.0,5/12,22.43%,RIN3;ATXN2;ANKRD13D;ANKRD13B;SDCBP
prerank,oligodendrocyte differentiation (GO:0048709),0.27414142228900207,0.6461078344853218,0.8738229755178908,1.0,1.0,3/19,15.17%,SLC8A3;SOX13;EIF2B1
prerank,secondary alcohol metabolic process (GO:1902652),0.2362808790763164,0.6458917861953326,0.9317460317460318,1.0,1.0,4/42,9.11%,CYP27A1;IDH1;CLN6;SULT2B1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.21977642794009888,0.645338523995048,0.9465875370919882,1.0,1.0,14/60,18.21%,TNRC6A;TP53;MED12;TNRC6B;PTEN;TCF7L2;MOV10;MED17;TNRC6C;NFKB1;MED23;MED26;MED1;MED8
prerank,regulation of T cell mediated immunity (GO:0002709),0.31336556962486484,0.6452014732022935,0.8522954091816367,1.0,1.0,3/10,18.04%,ZBTB1;CCR2;AGER
prerank,regulation of mitochondrial translation (GO:0070129),-0.24078362361511318,-0.6445375110502366,0.9369369369369369,0.9897159048906425,1.0,12/21,37.60%,MALSU1;MTG2;RCC1L;FASTKD2;NSUN3;RPUSD3;COA3;NGRN;TRMT10C;TRUB2;C1QBP;MTG1
prerank,mitochondrial protein processing (GO:0034982),-0.2811065766015267,-0.6445131190953375,0.8928571428571429,0.9890815956853429,1.0,3/11,26.61%,IMMP2L;STOML2;SPG7
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.24474847211246237,-0.6443674426048297,0.9168646080760094,0.9885285809610923,1.0,3/18,9.21%,ESR1;TGFB1;TMBIM6
prerank,histone exchange (GO:0043486),0.2397904443117084,0.6436906729312111,0.9201277955271565,1.0,1.0,17/37,29.42%,RNF8;SRCAP;NASP;CENPO;CENPC;CENPK;ACTR6;CENPT;ITGB3BP;RUVBL1;DMAP1;RBBP7;RSF1;RBBP4;CENPS;CENPN;CENPQ
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.250459261889037,0.6435511986281583,0.9296,1.0,1.0,6/31,12.24%,PTEN;BTRC;CDC14B;MAGEC2;DCUN1D5;FZR1
prerank,T cell homeostasis (GO:0043029),-0.2935277545436833,-0.6433952943343597,0.890495867768595,0.9885294484583413,1.0,8/10,56.44%,FAS;PMAIP1;FOXP3;RIPK3;NCKAP1L;AKT1;JAK3;PPP2R3C
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2132699874416966,0.6426403941889266,0.9786324786324786,1.0,1.0,24/76,24.86%,SPHK1;LRRK2;PIAS1;FANCI;HUWE1;CDK5RAP3;HDAC4;RIPK2;FBXO4;DCUN1D5;PIAS3;BIRC3;CRY1;TBC1D7;NDFIP1;PIAS4;TANK;GSK3A;DERL1;PRICKLE1;PSMD10;TSPYL5;RCHY1;PHF23
prerank,mitotic sister chromatid segregation (GO:0000070),0.20640320931377715,0.6425922970740238,0.9748251748251748,1.0,1.0,19/98,19.19%,EML4;NIPBL;PDS5A;CHMP1A;BECN1;CSNK2A2;CSNK2A1;DSN1;KIFC1;KMT5A;REC8;NCAPD3;VPS4A;RB1;CHMP4C;PIBF1;CENPK;NCAPD2;PDS5B
prerank,response to glucose (GO:0009749),0.22811664920663496,0.6421139194211845,0.9540412044374009,1.0,1.0,4/46,9.99%,PRKAA2;ZBTB20;GCK;TCF7L2
prerank,toxin transport (GO:1901998),0.2997968724955403,0.6417787920044178,0.8827977315689981,1.0,1.0,2/10,14.78%,ANTXR2;RAB29
prerank,establishment of vesicle localization (GO:0051650),0.28214651278547775,0.6411923645510711,0.8910133843212237,1.0,1.0,1/18,1.31%,SYT11
prerank,regulation of protein sumoylation (GO:0033233),0.2832522740081672,0.6411890007979268,0.8700361010830325,1.0,1.0,5/17,18.96%,PIAS1;HDAC4;ZMIZ1;PIAS3;PIAS4
prerank,axonemal dynein complex assembly (GO:0070286),0.25283940754028744,0.6404708999283689,0.8945634266886326,1.0,1.0,7/27,22.40%,ODAD1;CCDC39;CCDC40;DNAI4;DNAAF5;CFAP73;DNAL1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.3088246437024029,0.6403776722108543,0.8715083798882681,1.0,1.0,2/10,16.82%,MTHFR;MTHFD1
prerank,positive regulation of leukocyte migration (GO:0002687),-0.22452591485605872,-0.6403262047362528,0.9387254901960784,0.9899538626451787,1.0,7/27,23.72%,ICAM1;PTN;EDN3;VEGFA;IL6R;MDK;THY1
prerank,neutrophil activation (GO:0042119),-0.2718648397049591,-0.6401109458065715,0.891213389121339,0.9894602064570834,1.0,3/12,19.59%,SYK;PREX1;TYROBP
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.25128939570856595,0.6400628401946444,0.9285714285714286,1.0,1.0,4/28,10.49%,LACC1;TAB2;RIPK2;IRGM
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.24696471394065578,-0.6397700963580275,0.9297872340425531,0.9890336112424626,1.0,4/17,18.10%,PROX1;PKD1;CCNY;RGCC
prerank,mitotic nuclear division (GO:0140014),0.215538350413929,0.639506711246227,0.9631811487481591,1.0,1.0,19/71,20.41%,KIF2A;CLASP1;KLHDC8B;LSM14A;MISP;DSN1;KIFC1;STAG2;CTDP1;SMC3;PIBF1;CENPK;MAP9;CCDC61;GOLGA2;OFD1;ARHGEF10;CHMP2A;UBE2S
prerank,cardiolipin metabolic process (GO:0032048),0.2959493547908096,0.6389847529846677,0.8697318007662835,1.0,1.0,5/13,21.29%,SLC27A1;PLA2G6;PLA2G5;HADHA;TAMM41
prerank,cellular component maintenance (GO:0043954),0.29708751763621916,0.6386591913170929,0.862708719851577,1.0,1.0,6/12,29.31%,PICK1;ITGA3;CLDN1;IGF1R;PRNP;INSR
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.26883790372886524,0.6385632176921827,0.9106830122591943,1.0,1.0,4/20,13.36%,PTGES3L;MKKS;BBS10;HSPA4
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.29369718421224605,0.6380867109164017,0.8711433756805808,1.0,1.0,4/13,20.52%,PRPF3;PRPF6;SRSF10;PRPF31
prerank,recombinational repair (GO:0000725),-0.1784143194054546,-0.6380001124501736,0.9932203389830508,0.9895581998206212,1.0,26/77,32.76%,REV3L;SMC5;RAD51B;PSMD14;RPA1;KDM4D;EXD2;RFWD3;MMS22L;NSMCE1;BLM;RECQL5;POLQ;AP5S1;RAD54B;RECQL;PALB2;HUS1B;SWI5;RAD51;MEIOB;RPA3;BRCA1;RPA2;SFR1;MCM8
prerank,positive regulation of protein ubiquitination (GO:0031398),0.20943685399394937,0.6359933572740792,0.9743954480796586,1.0,1.0,11/80,11.60%,SPHK1;LRRK2;SPSB4;FANCI;HUWE1;CDK5RAP3;FANCM;RIPK2;FBXO4;MAGEC2;DCUN1D5
prerank,cellular response to radiation (GO:0071478),0.23228562732947153,0.6356367693097995,0.9486356340288925,1.0,1.0,14/40,23.79%,RHO;TP53;SIRT1;HUS1;GADD45A;INTS7;MAPK14;LIG4;TANK;RAD9A;FIGNL1;OPN1SW;OPN1MW;OPN1MW3
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.24161613947614657,-0.6353202118059165,0.9299065420560748,0.9906071951633024,1.0,8/19,27.94%,SLC26A2;ENPP1;TPST2;BPNT1;SULT4A1;SLC35B3;PAPSS1;BPNT2
prerank,aggrephagy (GO:0035973),0.24644157260577135,0.6352787809862074,0.9259259259259259,1.0,1.0,8/27,19.96%,PRKN;ATG5;IFT88;ACBD5;DYNC1LI1;SQSTM1;PCNT;WDR81
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.28537822195206247,-0.6351553139217456,0.9094922737306843,0.9900564039081351,1.0,1/10,1.54%,PDE8A
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.29875326077054565,0.6338175435246651,0.8835877862595419,1.0,1.0,3/13,12.05%,ABHD14B;SULT2B1;TPST1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.26716494290877624,-0.632735256127551,0.9122807017543859,0.9909456913899987,1.0,4/12,21.36%,AKR1B1;STARD3NL;CACNA1H;STARD3
prerank,dendritic cell chemotaxis (GO:0002407),-0.2581409295885419,-0.6315872497993673,0.9245689655172413,0.9910608224899253,1.0,11/14,54.22%,TRPM2;CCL19;CXCR4;CCR1;PIK3CG;CCR6;CXCR2;HMGB1;CCR7;GPR183;CCL5
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.24337694685604386,0.6310259030615416,0.9163934426229509,1.0,1.0,17/32,30.67%,NUP42;NUP98;NUP43;NUP155;NUP188;NUP153;XPOT;AAAS;NUP88;SEC13;NUP160;NOL6;RANBP2;NUP37;SSB;RAE1;NUP133
prerank,tRNA export from nucleus (GO:0006409),0.24337694685604386,0.6310259030615416,0.9163934426229509,1.0,1.0,17/32,30.67%,NUP42;NUP98;NUP43;NUP155;NUP188;NUP153;XPOT;AAAS;NUP88;SEC13;NUP160;NOL6;RANBP2;NUP37;SSB;RAE1;NUP133
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.21034354535512403,0.6304106930300506,0.9719350073855244,1.0,1.0,15/72,19.71%,SPO11;POLD2;DNASE1L1;FBH1;DICER1;CUL4A;DCP1A;RAD50;DDB2;DNASE1L2;OGG1;FEN1;RFC1;XPA;DXO
prerank,erythrocyte development (GO:0048821),-0.2771815105580868,-0.6303229424196582,0.9260780287474333,0.9911696014051495,1.0,7/10,47.95%,DMTN;LYAR;ALAS1;SH2B3;ABCB10;GATA1;NCKAP1L
prerank,negative regulation of T cell proliferation (GO:0042130),0.25106685032486803,0.6301561327488397,0.9306049822064056,1.0,1.0,7/28,22.07%,CD274;GLMN;PRKAR1A;SDC4;GPNMB;DLG5;ARG1
prerank,nucleosome assembly (GO:0006334),0.24070159909267458,0.6301242685421823,0.9429530201342282,1.0,1.0,6/31,19.57%,CHAF1B;ATRX;KAT6B;NASP;PADI4;ASF1A
prerank,cellular response to estradiol stimulus (GO:0071392),-0.2413544193966925,-0.6298324886724341,0.9365750528541226,0.9908423168545626,1.0,6/18,24.16%,ESR1;GPER1;FAM210B;SFRP1;RUVBL2;NRIP1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.24447253642225164,0.6289536318411669,0.9303482587064676,1.0,1.0,5/32,12.19%,DEFB1;F2;HRG;FAM3A;CAMP
prerank,positive regulation of leukocyte activation (GO:0002696),0.27249058054166586,0.6287930135217141,0.911504424778761,1.0,1.0,2/18,5.16%,HAVCR1;TLR4
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.24204000606180465,0.6280299333356029,0.9273021001615509,1.0,1.0,9/29,27.15%,TEX12;REC8;STAG3;P3H4;FANCD2;SYCE2;BAG6;TRIP13;TERB1
prerank,phospholipid biosynthetic process (GO:0008654),0.23496732418485067,0.6276993874212922,0.9253731343283582,1.0,1.0,4/36,8.48%,AGPAT4;GPAT2;CPNE3;SAMD8
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.20242608357805392,0.6274070715448733,0.9873949579831933,1.0,1.0,20/101,15.57%,LARP4B;VGLL4;EZR;ATG10;DDX3X;CD28;POLDIP3;FBXW11;SAMD4A;CLN6;BTRC;CPEB3;YTHDF3;ATG7;PRKDC;PLD1;OGT;ZCCHC4;FAF1;ASPH
prerank,natural killer cell activation (GO:0030101),-0.22772268690587466,-0.6268089612244289,0.9396984924623115,0.9919655196128998,1.0,6/23,18.31%,TOX;PTPRC;PBX1;SNX27;PRDX1;NFIL3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.25781927485123146,0.6260740581528377,0.9180952380952381,1.0,1.0,2/22,7.93%,NR2F2;PTEN
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.2351291613563945,-0.6258769274870272,0.9568181818181818,0.9918657926207658,1.0,4/20,15.25%,YWHAB;MET;SNCA;STMN1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.24450581930272855,-0.6256715437758421,0.9284116331096197,0.9913263134012553,1.0,5/17,22.10%,PPIA;HSPB1;HTRA2;BAG5;SOD1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.1777228812862832,0.6256502470577073,1.0,1.0,1.0,51/314,17.63%,ANAPC15;PRKN;FBXL17;SPSB1;NEDD4;IFI27;PCBP2;DCAF11;FBXL19;ARRB1;ANAPC2;SPSB4;TBL1X;UBR2;SMURF2;FBXW11;HUWE1;BTRC;TBL1XR1;FBXO48;RNF34;SIRT1;ECPAS;ZSWIM8;FBXL12;AURKB;FBXO4;WWP2;CUL4A;FZR1;PML;DNAJB2;FBXL20;RMND5A;FAF1;AMFR;ANAPC16;DNAJB14;MAEA;RB1;NEMF;UBR1;UFD1;UBE2E1;KCTD13;ERLIN2;SYVN1;DMAC2;CDC34;DNAJC18;NPLOC4
prerank,negative regulation of protein secretion (GO:0050709),0.23399140411330266,0.6255350069874627,0.9545454545454546,1.0,1.0,5/38,9.33%,PRKN;ADRA2A;IL12B;MIDN;RSAD2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2058779282762172,0.6251953759937916,0.9856938483547926,1.0,1.0,6/85,8.28%,CELSR1;MAGI2;VANGL1;FZD5;SMURF2;RYK
prerank,receptor recycling (GO:0001881),0.30292000109730943,0.6248765826277274,0.8932806324110671,1.0,1.0,3/10,17.37%,ARFGEF2;RAB11B;PHETA1
prerank,regulation of myoblast fusion (GO:1901739),0.2935877302107235,0.624700784575467,0.8863198458574181,1.0,1.0,1/11,3.02%,CFLAR
prerank,mucosal immune response (GO:0002385),-0.25690263129333446,-0.624241475834241,0.9319148936170213,0.9915080610120526,1.0,2/15,7.90%,OTUD7B;RPL39
prerank,regulation of nuclear division (GO:0051783),0.26165068368307737,0.6240665804114027,0.9063063063063063,1.0,1.0,1/20,2.45%,OBSL1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.22129077094435656,-0.6235580713559294,0.9481481481481482,0.9912825239381654,1.0,8/24,25.01%,NOD1;MAP3K7;UBB;NOD2;AAMP;UBC;RPS27A;TAB1
prerank,renal filtration (GO:0097205),-0.27785221121435383,-0.6232777774140851,0.9024390243902439,0.9908007244868268,1.0,2/10,8.44%,CD34;MCAM
prerank,regulation of phospholipid metabolic process (GO:1903725),0.30911156488436947,0.6232075100513758,0.8835877862595419,1.0,1.0,1/10,2.72%,MTMR3
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.2841229144065441,0.6230597248900465,0.8916827852998066,1.0,1.0,3/12,13.35%,TLR4;MAP2K5;OAS3
prerank,Golgi ribbon formation (GO:0090161),0.2891876721980989,0.6226473947926021,0.8927911275415896,1.0,1.0,5/13,19.50%,MYO18A;VTI1A;OPTN;GOLGA2;STX16
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.20909321090398025,-0.6225868703760906,0.9574468085106383,0.9905773102026112,1.0,8/32,22.64%,CAVIN1;TAF1B;GTF2H1;GTF2H4;GTF2H5;ERCC2;POLR1F;POLR2L
prerank,ncRNA metabolic process (GO:0034660),0.2301306466118592,0.6214330378196885,0.929159802306425,1.0,1.0,8/37,22.33%,MOV10L1;TUT4;DICER1;TENT4B;TUT7;EXD1;ASZ1;XPO5
prerank,glutamate metabolic process (GO:0006536),0.2637078154709869,0.6210563206120551,0.9175257731958762,1.0,1.0,3/19,9.52%,PRODH;GOT2;GLUL
prerank,positive regulation of stem cell proliferation (GO:2000648),0.2687993405083034,0.6200773084058067,0.9048473967684022,1.0,1.0,5/17,19.88%,TERT;KAT7;CCNE1;KDM1A;LTBP3
prerank,peptidyl-glutamic acid modification (GO:0018200),0.2548771752990523,0.6199810637426253,0.9300341296928327,1.0,1.0,3/24,7.04%,TTLL6;NAA80;TTLL9
prerank,gas transport (GO:0015669),-0.27792889004105437,-0.6192251588586141,0.9096774193548387,0.9917695753673867,1.0,2/10,13.77%,CA2;CYGB
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.2874450954080059,0.6190367615390393,0.8920454545454546,1.0,1.0,3/12,13.82%,NCOR2;TERT;NCOR1
prerank,negative regulation of mRNA processing (GO:0050686),0.27063567395505084,0.618472337022448,0.9119850187265918,1.0,1.0,6/15,25.37%,SAP18;SFSWAP;SRSF10;SRSF7;U2AF2;SRSF4
prerank,T cell activation involved in immune response (GO:0002286),-0.25636459744270984,-0.6179199245335789,0.9238900634249472,0.9918347421007802,1.0,3/12,21.93%,ICAM1;CD74;MDK
prerank,glycerophospholipid metabolic process (GO:0006650),0.203085255246869,0.6177847878342673,0.9835820895522388,1.0,1.0,9/75,10.53%,PIGN;PIGW;PLA1A;PIGQ;PDGFRB;CPNE3;PLA2G6;PLCD1;ABHD12
prerank,termination of RNA polymerase II transcription (GO:0006369),0.23618562366106116,0.6173163867925238,0.9325842696629213,1.0,1.0,8/33,23.34%,PABPN1;TTF2;SCAF8;CPSF3;CSTF1;PCF11;CPSF7;NUDT21
prerank,myeloid dendritic cell activation (GO:0001773),-0.2629025836384357,-0.6166568845151744,0.9264413518886679,0.9918840878316533,1.0,2/12,9.80%,CAMK4;DOCK2
prerank,protein autoprocessing (GO:0016540),-0.23554587663427307,-0.616351124788171,0.9232505643340858,0.991410295807122,1.0,10/17,47.77%,CTSL;HTRA2;CASP4;FAM111A;MYRF;TMPRSS2;HJV;PCSK9;OMA1;CASP1
prerank,rRNA catabolic process (GO:0016075),0.267551069108162,0.6159481868331407,0.9212007504690432,1.0,1.0,4/16,17.83%,EXOSC7;DIS3;DIS3L;EXOSC3
prerank,DNA duplex unwinding (GO:0032508),-0.18847156995151257,-0.6158493011924518,0.9888268156424581,0.9910389305586288,1.0,20/50,30.71%,ANXA1;RAD23B;UBB;RPA1;DHX9;CETN2;GTF2H1;GTF2H4;GTF2H5;ERCC2;BLM;RECQL5;UBC;RPS27A;RECQL;MCM6;DDB1;RAD51;ERCC3;PIF1
prerank,positive regulation of cellular senescence (GO:2000774),-0.2810367714701877,-0.615031374683081,0.9087221095334685,0.9908469580742689,1.0,2/10,12.06%,B2M;ABI3
prerank,regulation of lipid storage (GO:0010883),0.25140389860688095,0.6150245088624714,0.9220338983050848,1.0,1.0,4/22,14.88%,IKBKE;SIRT1;ITGAV;NFKB1
prerank,Golgi inheritance (GO:0048313),0.2880574391239409,0.6149862608720056,0.8915187376725838,1.0,1.0,3/11,18.90%,PLK5;STX5;GOLGA2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.2690439181895531,0.6147419927127642,0.9075785582255084,1.0,1.0,4/16,20.39%,IL12B;PTPN22;LGALS3;IKZF3
prerank,negative regulation of T cell activation (GO:0050868),0.22933355337842246,0.6147042698687959,0.947008547008547,1.0,1.0,10/35,22.96%,PTPN22;CD274;GLMN;SDC4;LGALS3;GPNMB;LAX1;DLG5;ARG1;RIPOR2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.2962527567866383,0.6136450528161206,0.8913043478260869,1.0,1.0,3/11,19.57%,ATRX;NASP;ASF1A
prerank,positive regulation of histone deacetylation (GO:0031065),-0.26290287790356365,-0.6132152728185147,0.9327902240325866,0.9911663748792635,1.0,3/12,15.94%,PRKD1;VEGFA;APLNR
prerank,translesion synthesis (GO:0019985),0.22187833847541363,0.6131055990171301,0.9439252336448598,1.0,1.0,9/42,19.36%,POLD2;PARP10;REV1;POLDIP2;ZBTB1;POLE2;UFD1;NPLOC4;RFC1
prerank,DNA replication initiation (GO:0006270),-0.20148185524043802,-0.6128875956312245,0.9851116625310173,0.9906949516637418,1.0,14/37,32.76%,POLA1;PRIM2;RPA1;ORC5;ORC2;CDC45;MCM6;PRIM1;TOPBP1;CDC7;RPA3;RPA2;MCM4;MCM8
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.2975369019176928,0.6115239116640891,0.8923679060665362,1.0,1.0,3/10,14.02%,RNF13;MAP2K1;MAP2K2
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2713072939970677,-0.6095532464122376,0.9196078431372549,0.9918291894254266,1.0,3/10,13.10%,HOMER1;SARAF;CD84
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.2899884432191901,0.6091706316460979,0.9108159392789373,1.0,1.0,3/12,18.75%,NINL;HOOK3;PCM1
prerank,protein modification process (GO:0036211),0.20057311285874105,0.6071417692660157,0.9827833572453372,1.0,1.0,19/76,20.99%,MSRA;PARP4;RABGGTA;MANBA;FBXO22;ABL1;UBE2M;ARAF;PRKDC;WWP2;FBXO11;PLAT;PPP4R2;CDC34;PADI4;NTAQ1;GNMT;UBE2S;UBE2I
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.28671083828444643,0.6063852395064847,0.914396887159533,1.0,1.0,2/10,13.22%,MAP2K5;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.28671083828444643,0.6063852395064847,0.914396887159533,1.0,1.0,2/10,13.22%,MAP2K5;WNK1
prerank,protein import into nucleus (GO:0006606),0.20525772351511415,0.6055696094216906,0.9864457831325302,1.0,1.0,2/66,3.53%,APPL2;TNPO1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2315250973059089,0.6054098671147435,0.9501661129568106,1.0,1.0,3/32,8.48%,PICALM;ATXN2;SAMD8
prerank,mRNA methylation (GO:0080009),-0.24022689087045837,-0.6052784117632056,0.9211711711711712,0.9933365759830185,1.0,7/15,37.75%,TRMT61B;METTL3;TRMT6;ZC3H13;CBLL1;TRMT10C;TRMT61A
prerank,tRNA transport (GO:0051031),-0.19830439647623072,-0.6044491825436775,0.9765013054830287,0.9931369347975915,1.0,10/35,26.71%,YBX1;NUP210;RAN;NUP107;TOMM20;POM121;NUP93;NUP85;NUP50;NUP54
prerank,phosphate ion transport (GO:0006817),0.2651918102537655,0.6043691878153604,0.9197207678883071,1.0,1.0,4/16,17.77%,SLC20A2;SLC25A11;SLC25A10;SLC37A4
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.262534038358213,-0.6042957783701722,0.9467213114754098,0.9925661427047703,1.0,5/12,30.35%,DHODH;UCK2;UMPS;UPP1;TK2
prerank,microtubule nucleation (GO:0007020),-0.2219108317314635,-0.6040899283049427,0.9560185185185185,0.9920253164811371,1.0,9/19,31.53%,CLASP2;TUBGCP2;TPPP;TPX2;TUBG2;NDEL1;NDE1;CSNK1D;TUBGCP6
prerank,protein deubiquitination (GO:0016579),0.17485718924359384,0.6040357751045293,1.0,1.0,1.0,44/242,19.79%,SMAD3;PRKN;CCNA2;TGFBR1;BABAM2;USP3;CCNA1;USP9X;USP24;TP53;USP11;SMURF2;PTEN;RCE1;CDC25A;RIPK1;BECN1;INO80D;USP34;USP49;UIMC1;DESI2;USP12;USP7;BABAM1;DDB2;MBD6;OGT;USP18;KAT2B;BIRC3;USP37;UFD1;CLSPN;SMAD4;ASXL2;USP48;USP1;RHOT1;USP33;USP21;USP16;USP35;INO80E
prerank,regulation of double-strand break repair (GO:2000779),-0.19451187283664712,-0.6038834080009118,0.9920212765957447,0.9914885826516997,1.0,5/39,14.04%,FMN2;ACTR2;SETD2;TWIST1;TERF2IP
prerank,regulation of viral transcription (GO:0046782),0.2222163380093718,0.6036921093238,0.9532258064516129,1.0,1.0,7/39,14.71%,POLR2A;POLR2D;LARP7;GTF2F1;NELFCD;TRIM62;CTDP1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.24096616350671407,-0.603465383219538,0.9397849462365592,0.9910394408487092,1.0,8/14,40.25%,RPL7;RPL35;NOL9;RPL7L1;RPF2;PES1;NIFK;URB1
prerank,sulfur amino acid catabolic process (GO:0000098),0.2979370762523137,0.6020839719280904,0.9092741935483871,1.0,1.0,5/10,29.77%,CTH;MTRR;CBS;TST;BLMH
prerank,nucleotide biosynthetic process (GO:0009165),0.2579993637803171,0.6019975557028223,0.9284403669724771,1.0,1.0,8/18,22.77%,NMNAT1;PRPSAP1;PRPSAP2;NMNAT2;MTHFD1;GART;ADSL;NMNAT3
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.1973532238342403,-0.6012914264245732,0.9720670391061452,0.9914444124999326,1.0,15/36,29.52%,HSP90AB1;RYBP;AQP11;DDRGK1;NOP53;GABARAPL2;RPL11;BAG5;N4BP1;PSME3IP1;CCAR2;WAC;F8A1;PSMF1;PARK7
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.22813803417412915,-0.6012123411889062,0.946058091286307,0.9908487384523232,1.0,6/18,29.50%,MAN1B1;UBB;RNF103;UBC;RPS27A;UGGT2
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.22128537023814096,0.599996280007151,0.9811912225705329,1.0,1.0,17/40,28.60%,SMG1;WDR76;ABL1;KMT5A;MCL1;CRY1;USP1;FMR1;FBXO5;CASP9;BCLAF1;PRKCD;ING2;UBE2V1;FXR2;FEM1B;UBE2N
prerank,rRNA methylation (GO:0031167),0.2454693905718813,0.5994225081478285,0.9394463667820069,1.0,1.0,10/22,29.04%,NOP2;ZCCHC4;BUD23;NSUN4;FDXACB1;MTERF4;METTL5;MRM1;FBLL1;MRM2
prerank,histone H4-K8 acetylation (GO:0043982),-0.2406853787249588,-0.5986790638087357,0.9460043196544277,0.9907865124569037,1.0,4/15,20.12%,JADE3;JADE1;MEAF6;MCRS1
prerank,histone H4-K5 acetylation (GO:0043981),-0.2406853787249588,-0.5986790638087357,0.9460043196544277,0.9907865124569037,1.0,4/15,20.12%,JADE3;JADE1;MEAF6;MCRS1
prerank,tRNA processing (GO:0008033),0.20475053063199483,0.5975849862953859,0.9819277108433735,1.0,1.0,10/61,21.86%,TRMT9B;TSEN2;RPP21;LCMT2;POP7;WDR4;DTWD2;ADAT2;POP1;KARS1
prerank,cobalamin metabolic process (GO:0009235),0.2605996302549642,0.5975706639407402,0.914018691588785,1.0,1.0,5/17,22.04%,TCN2;TCN1;MTRR;MMACHC;CUBN
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.21816692439601726,-0.5972425501144851,0.9553571428571429,0.9908211038392185,1.0,15/23,38.78%,HSP90AA1;TIMM29;BCL2L11;TOMM22;TIMM8B;ROMO1;TIMM13;NDUFA13;PMAIP1;BMF;TIMM10B;BAD;MAIP1;AGK;TIMM9
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.28955662633678936,0.5971333254066848,0.9247524752475248,1.0,1.0,2/10,13.23%,CD274;PRKAR1A
prerank,DNA recombination (GO:0006310),0.22128526601043635,0.5971062445850809,0.9585987261146497,1.0,1.0,8/37,20.03%,RAD54L;FBH1;MSH3;IGHMBP2;RAD50;RAD51D;XRCC3;LIG4
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.24708586869427202,0.596455586514754,0.9513888888888888,1.0,1.0,7/25,18.47%,EPHA4;OPHN1;CSNK2A2;CSNK2A1;PML;HFE;TAF1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.2579520309157649,0.5958283085351902,0.9113680154142582,1.0,1.0,2/17,8.88%,MCU;DNM1L
prerank,positive regulation of cell aging (GO:0090343),-0.2683865741278646,-0.5926598232430565,0.9347368421052632,0.9922684730662422,1.0,2/11,12.06%,B2M;ABI3
prerank,regulation of cholesterol transport (GO:0032374),0.24593979513815925,0.5917504356650485,0.9417808219178082,1.0,1.0,10/20,26.86%,LRP1;ARV1;TTC39B;NFKB1;LAMTOR1;NR1H3;ABCA2;NR1H2;YJEFN3;ABCA13
prerank,protein methylation (GO:0006479),0.21403325339083196,0.5915024861289466,0.967373572593801,1.0,1.0,12/40,23.75%,NSD1;NSD3;ETF1;EHMT2;EHMT1;SETD3;N6AMT1;CAMKMT;EEF1AKMT1;GSPT1;ICMT;PCMT1
prerank,RNA catabolic process (GO:0006401),-0.18499682581228571,-0.5909659527454355,0.9795918367346939,0.99239331615096,1.0,20/46,34.69%,PNPT1;RNASEH2A;METTL3;RNASEH2B;XRN2;DNA2;YTHDF2;DCP2;MTREX;RNASEH2C;ERN1;HNRNPD;NUDT16;LSM5;LSM2;ZC3H12D;AGO3;RNH1;RNASEH1;PABPC4
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.2556448415153008,-0.5905298740312335,0.9404517453798767,0.9919512968759541,1.0,7/12,33.07%,GCLM;CHAC2;OPLAH;GGCT;MGST2;GCLC;GGT1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.2414554344564847,0.588775138271896,0.9322638146167558,1.0,1.0,7/22,24.29%,TP53;MED12;MED17;MED1;MED13;PSMC4;MED24
prerank,RNA splicing (GO:0008380),0.187739848859549,0.5876411326725611,0.9958217270194986,1.0,1.0,31/95,25.99%,PPARGC1A;YJU2;NOVA1;LUC7L3;SRPK2;PRPF18;SRSF11;HNRNPC;SCAF11;PRPF3;SNRNP40;USP39;ZCRB1;PRPF6;FUS;HNRNPH3;SRSF10;U2AF1;SRSF7;WBP4;SNRPA1;SF3B2;SF3B1;RNPC3;NRDE2;SRSF4;RP9;LSM6;SF3B3;DHX8;RRAGC
prerank,DNA double-strand break processing (GO:0000729),0.26047287222914256,0.5873361536174052,0.9275092936802974,1.0,1.0,5/18,19.02%,ATM;RBBP8;RAD50;NBN;SLX4
prerank,tetrapyrrole metabolic process (GO:0033013),0.2508517863450566,0.5863690389162979,0.9166666666666666,1.0,1.0,5/18,22.04%,TCN2;TCN1;MTRR;MMACHC;CUBN
prerank,protein secretion (GO:0009306),0.2011519980728882,0.5862089889152922,0.9788519637462235,1.0,1.0,9/56,16.87%,WLS;ARFGAP3;RAB13;PORCN;MIA3;MON1A;TANGO2;RAB8B;STEAP3
prerank,positive regulation of neutrophil migration (GO:1902624),0.25047531800448397,0.5854477308021447,0.9224952741020794,1.0,1.0,2/18,8.88%,MCU;DNM1L
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.21801248736527784,-0.5852554999275693,0.9728506787330317,0.9935706742606063,1.0,5/20,19.16%,APOE;SREBF2;NR1H4;RAN;LDLRAP1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.18576746201371594,0.5850017970949696,0.9973579920739762,1.0,1.0,22/95,21.99%,RAD54L;NIPBL;SAMHD1;FBH1;FANCM;RBBP8;HUS1;RAD50;NSMCE2;REC8;MCM7;MCM2;ZFYVE26;POLL;NBN;FEN1;RAD51D;SLX4;XRCC3;MCM9;MCM5;YY1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2360035052250985,0.5849703935307788,0.9485420240137221,1.0,1.0,4/27,13.56%,NUDT13;AK4;CTPS2;AK8
prerank,response to light stimulus (GO:0009416),-0.1759949007861884,-0.5843271790308222,1.0,0.9932977891560334,1.0,22/55,32.24%,MAP4K3;ERCC6;PRIMPOL;UBE2B;CRY2;MEN1;ERCC2;POLD1;DRD2;DTL;MAP2K7;CCAR2;PCLAF;GPR52;TYR;UBE2A;MAPK8;CIRBP;ERCC3;GPR88;TRIM32;USF1
prerank,tRNA methylation (GO:0030488),-0.19103658849863772,-0.5840474750945958,0.9877149877149877,0.9927549153622071,1.0,18/34,44.64%,METTL1;TRMT61B;MTO1;THADA;THUMPD2;METTL2A;METTL2B;TRDMT1;TRMT10C;TRMT5;GTPBP3;TRMT61A;TRMT10A;NSUN6;TRMT13;BCDIN3D;ALKBH8;FTSJ1
prerank,regulation of stem cell population maintenance (GO:2000036),0.25380145255252157,0.5838707055328538,0.9261363636363636,1.0,1.0,5/18,20.94%,NCOA3;WDR43;NODAL;TAF6L;REST
prerank,regulation of glycogen metabolic process (GO:0070873),0.2667899093506715,0.5836903663997383,0.9178082191780822,1.0,1.0,1/12,5.83%,PPP1R3B
prerank,centromere complex assembly (GO:0034508),-0.1897457793325888,-0.5834151735604861,0.9922480620155039,0.9923852081491031,1.0,14/36,32.23%,HJURP;SMARCA5;CENPE;CENPH;NPM1;CENPA;MIS18BP1;CENPF;MIS18A;CENPX;OIP5;DLGAP5;CENPI;POGZ
prerank,negative regulation of interferon-beta production (GO:0032688),-0.2662076999112635,-0.5821505992474656,0.9313929313929314,0.9922610525668437,1.0,3/10,21.19%,REL;RELB;PYCARD
prerank,spindle assembly (GO:0051225),0.20004962560722525,0.5814148849209343,0.9956958393113343,1.0,1.0,18/67,20.06%,KIF2A;CLASP1;LSM14A;MAPRE2;MISP;KIFC1;NCOR1;STAG2;CEP63;GOLGA8B;SMC3;PIBF1;MAP9;CCDC61;GOLGA2;OFD1;ARHGEF10;TUBGCP4
prerank,cilium movement (GO:0003341),0.2110235718212789,0.5808264309522414,0.9704510108864697,1.0,1.0,10/47,22.18%,ODAD1;ROPN1L;CFAP251;CCDC39;CCDC40;DNAI4;GAS8;DNAAF5;CFAP73;RSPH6A
prerank,autophagosome assembly (GO:0000045),0.20442220023241225,0.5802168223289105,0.9776357827476039,1.0,1.0,20/52,27.01%,ATG5;WIPI1;AMBRA1;RAB43;BECN1;ATG7;IRGM;ATG2A;MFN2;TMEM41B;RAB7A;ATG16L1;UBXN2A;PIK3C3;ATG2B;ATG12;ATG3;ATG9B;TRAPPC8;GABARAPL1
prerank,cellular response to UV (GO:0034644),0.19144734342024988,0.5793609861395724,0.9943582510578279,1.0,1.0,20/76,22.24%,NEDD4;TP53;HYAL1;CDC25A;SIRT1;AURKB;IMPACT;ZBTB1;DDB2;SDE2;CREBBP;KDM1A;TAF1;XPA;FMR1;NOC2L;OPN1SW;YY1;CASP9;EP300
prerank,osteoclast differentiation (GO:0030316),0.24047152946807998,0.5784059739072719,0.9441340782122905,1.0,1.0,2/22,6.71%,OSTM1;GAB2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.27708130204477466,0.5775040820731062,0.9130434782608695,1.0,1.0,5/11,27.48%,TP53;SP100;MAD2L2;FOXM1;MUC1
prerank,inflammatory response (GO:0006954),0.1707375257390991,0.577357911469113,1.0,1.0,1.0,17/195,11.08%,KIT;ADCY1;IL18;LOXL3;BDKRB2;TLR4;IL17D;NOX1;AFAP1L2;PARP4;HDAC4;HYAL1;ADM;RIPK2;CCL25;NOX4;NFATC3
prerank,autophagosome organization (GO:1905037),0.20586171373622392,0.5766177534669552,0.9822294022617124,1.0,1.0,19/50,27.01%,ATG5;WIPI1;AMBRA1;RAB43;BECN1;ATG7;IRGM;ATG2A;TMEM41B;RAB7A;ATG16L1;UBXN2A;PIK3C3;ATG2B;ULK3;ATG12;ATG3;ATG9B;GABARAPL1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.24783641245272905,0.5763668614509815,0.9356060606060606,1.0,1.0,2/19,8.88%,MCU;DNM1L
prerank,mitochondrial transcription (GO:0006390),-0.2656287584477038,-0.5762552235708592,0.9325396825396826,0.9939786972060304,1.0,4/10,22.42%,TFAM;SLC25A33;TEFM;TFB1M
prerank,macrophage differentiation (GO:0030225),-0.24313719162298647,-0.576129065498498,0.9473684210526315,0.993387011625651,1.0,3/13,15.38%,BMP4;VEGFA;IL31RA
prerank,ncRNA 3'-end processing (GO:0043628),0.2599294720079543,0.5759142619690379,0.9085820895522388,1.0,1.0,4/14,17.42%,INTS2;INTS5;INTS7;INTS8
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.22916142634301628,0.5758394103673488,0.9734982332155477,1.0,1.0,6/28,18.82%,BID;DDX3X;BLOC1S2;DEDD;TNFRSF1A;DELE1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.25955568380421934,0.5751096505279456,0.9264150943396227,1.0,1.0,2/13,12.26%,KPNA6;RGPD1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.25584406936424825,0.5738756720326007,0.9323308270676691,1.0,1.0,2/14,6.89%,ETNK2;SLC27A1
prerank,mitotic chromosome condensation (GO:0007076),0.2312284183202451,0.5736169092515935,0.9563025210084034,1.0,1.0,7/26,18.42%,CHMP1A;CSNK2A2;CSNK2A1;KMT5A;NCAPD3;RB1;NCAPD2
prerank,import into nucleus (GO:0051170),0.19268257183311774,0.5727189855081047,0.9940652818991098,1.0,1.0,2/73,3.53%,APPL2;TNPO1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2050718120039179,0.5714991296908807,0.976303317535545,1.0,1.0,12/46,24.06%,HK2;TIMM44;TOMM70;MFN2;PITRM1;TIMM10;TIMM17B;TIMM17A;TIMM21;HK1;DNAJC15;CHCHD4
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.23636561540185475,0.5709016761511286,0.9487632508833922,1.0,1.0,9/21,24.19%,PTEN;BTRC;CDC14B;FZR1;GOLGA2;UBE2S;FBXO5;GORASP1;MAD2L2
prerank,regulation of microtubule-based movement (GO:0060632),0.2715379902116529,0.5705039411702644,0.9190751445086706,1.0,1.0,1/11,5.21%,MAP2
prerank,regulation of biosynthetic process (GO:0009889),-0.24758017364432083,-0.5695086679143765,0.9484536082474226,0.9952321251885731,1.0,2/11,13.17%,SLC25A33;SNCA
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.2753056712336778,0.5694651773720665,0.918918918918919,1.0,1.0,3/10,19.91%,PTPN22;IFI35;NR1H3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.23644515504034014,-0.5679576120605645,0.9466950959488273,0.9951575159618767,1.0,3/13,17.31%,GAS6;DHX9;CD74
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.23617456094781428,0.5679405013276996,0.9630931458699473,1.0,1.0,2/19,7.64%,CHRNA5;RAPSN
prerank,regulation of chromosome segregation (GO:0051983),0.2424343822751237,0.5678309233929819,0.9332129963898917,1.0,1.0,3/16,12.06%,AURKB;CSNK2A2;CSNK2A1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.23240810307603266,-0.5675276973751805,0.9486652977412731,0.9946722522916879,1.0,7/14,36.05%,RPS3;CD81;RELA;CARD11;BCL10;TRAT1;LCK
prerank,early endosome to Golgi transport (GO:0034498),-0.25503334830038016,-0.5665820439197613,0.9446808510638298,0.9943814465985172,1.0,3/11,19.88%,RAB6A;EHD3;TMED9
prerank,regulation of T cell differentiation (GO:0045580),0.21721228753275712,0.5661822437831131,0.9751243781094527,1.0,1.0,6/33,12.11%,TNFRSF18;TCF7;ABL1;ZBTB1;ZMIZ1;FANCA
prerank,transcription preinitiation complex assembly (GO:0070897),0.2650062368537079,0.5659443825154381,0.9336016096579477,1.0,1.0,6/12,26.04%,TAF11;TBP;TAF7;TAF1;TAF12;BDP1
prerank,intracellular protein transmembrane transport (GO:0065002),0.20607478683446562,0.5658846727752422,0.9758842443729904,1.0,1.0,15/42,25.50%,TIMM44;TOMM70;PEX10;PEX14;C2CD5;PEX16;PEX5;TIMM17B;RTN2;TIMM17A;TIMM21;PEX26;DNAJC15;CHCHD4;GRPEL2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.2546159144291254,0.5653511099055178,0.9241622574955908,1.0,1.0,1/14,6.47%,IL12B
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2652002633717978,0.5651061952715577,0.9307692307692308,1.0,1.0,3/11,17.83%,LARP7;TENT4B;EXOSC3
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.2418166761849267,-0.5649165551409485,0.9415584415584416,0.9943102003938334,1.0,4/12,26.24%,WRNIP1;TIPIN;BLM;WDR18
prerank,autophagosome maturation (GO:0097352),0.21654152548246924,0.5646328187579658,0.9730700179533214,1.0,1.0,5/32,16.36%,LAMP2;UVRAG;LIX1L;VIPAS39;SNX14
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.2289695099722383,-0.5646156707632515,0.959731543624161,0.9937781656462756,1.0,2/16,8.90%,PTPRC;CEACAM1
prerank,tyrosine metabolic process (GO:0006570),0.27083856389656036,0.5642913779812754,0.9317773788150808,1.0,1.0,11/11,72.93%,FAH;DCT;GSTZ1;TAT;PAH;TH;HGD;IYD;IL4I1;THAP4;TYR
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.2698378693981897,0.5636845105551052,0.9497098646034816,1.0,1.0,2/10,16.40%,TUT4;TUT7
prerank,regulation of receptor recycling (GO:0001919),-0.22266695541495235,-0.5621740411033416,0.9736263736263736,0.9940039617686248,1.0,4/16,17.18%,ECE1;NSF;SNCA;SCRIB
prerank,error-free translesion synthesis (GO:0070987),-0.20431433954542905,-0.5603961192847556,0.9731051344743277,0.993942456463827,1.0,10/22,31.81%,UBB;RPA1;RFC4;POLD1;RFC2;UBC;RPS27A;RFC5;RPA3;RPA2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.2280278944026389,0.5600752867878154,0.9523809523809523,1.0,1.0,6/24,19.02%,ACD;TNKS2;HNRNPC;TENT4B;TINF2;SLX4
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.2739035582379955,0.5600272385473625,0.924643584521385,1.0,1.0,3/10,22.54%,TGFBR2;CD55;ZBTB7B
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.25922176800323293,0.5599707191378622,0.9187145557655955,1.0,1.0,2/11,15.26%,AHCYL1;ZFP36L1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.2695440982357732,0.5591935292738351,0.9303571428571429,1.0,1.0,1/11,6.47%,IL12B
prerank,mitochondrial translation (GO:0032543),0.17877603505464976,0.5587130486827012,0.9958904109589041,1.0,1.0,27/104,26.77%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MTRF1L;MRPL48;MRPL1;GFM2;MTRF1;MRPL45;MRPS17;CHCHD1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;MRPS25;MRPL50;MRPL33;MRPS18B;MRPL19;TSFM;MRRF
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.21821793439099488,0.5579456649434176,0.9823434991974318,1.0,1.0,10/30,23.60%,FHIT;STYX;USP7;OGT;TLK2;HFE;CAMLG;TRIM39;SDCBP;BAG6
prerank,glycine transport (GO:0015816),0.26981269727753804,0.5574689012833166,0.9390962671905697,1.0,1.0,1/10,4.88%,SLC6A9
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.18178247057399674,0.5567893009548309,0.9941775836972343,1.0,1.0,18/94,19.22%,CC2D2A;CEP250;CLASP1;NINL;RAB3IP;CEP162;SDCCAG8;NPHP1;ALMS1;CEP63;B9D2;CEP57;AKAP9;TCTN3;PCM1;CEP164;OFD1;PCNT
prerank,positive regulation of immune response (GO:0050778),0.18915280051161987,0.5557986418222652,0.9926686217008798,1.0,1.0,9/64,14.77%,IFNK;IL12B;PLSCR1;HRG;RSAD2;SIRT1;NMI;IFI35;SPHK2
prerank,regulation of cell cycle phase transition (GO:1901987),-0.15332351545380854,-0.5550991249455485,1.0,0.9950310385463162,1.0,41/91,39.13%,PSMB2;PSMD14;PSMC6;ATP2B4;CDKN1A;BUB3;PSMA4;PSMB9;CDC23;SKP1;PSMD11;PSMB10;PSMD2;ERCC2;MAD2L1;PSMA2;NEK10;TFAP4;PSMB3;PSMB5;UBE2D1;DDB1;PSMA7;PSMF1;PSMD7;ERCC3;TCIM;CDK1;CDC20;PSMA5;UBE2C;PSMD4;ANAPC10;PSME4;CCNB1;ANAPC1;PSMD3;CDKN1B;GTSE1;FBXW7;PSMC2
prerank,negative regulation of double-strand break repair (GO:2000780),0.2168074889331573,0.5544103842885055,0.9761092150170648,1.0,1.0,10/30,25.91%,TRIP12;FBH1;UBR5;SMCHD1;TFIP11;OGG1;OTUB2;MAD2L2;SHLD2;UBQLN4
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.2464426284330683,0.5543698004485739,0.95703125,1.0,1.0,6/15,27.08%,UFD1;SYVN1;NPLOC4;DERL1;SELENOS;OS9
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.21744909879042373,-0.5535826933934576,0.9593679458239278,0.9948680651288776,1.0,9/16,39.65%,CELF4;TRA2A;RBM3;RBMXL1;CIRBP;SF3B4;CELF3;NCBP1;RBMX
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.23472109438043814,-0.5513878420543595,0.9651416122004357,0.9949229891104264,1.0,5/13,31.27%,NCBP2;CPSF4;CPSF4L;CSTF2T;CPSF1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.16212064281369137,-0.5481581276877151,1.0,0.9952607971682423,1.0,15/69,24.31%,HSPA5;DNAJC10;PSMC6;SEC61B;ERLIN1;SGTB;YOD1;MAN1B1;RNF103;RNF121;UBE2G2;UBQLN2;FAM8A1;AUP1;STUB1
prerank,C-terminal protein amino acid modification (GO:0018410),0.25973453305100985,0.5465596841422428,0.9534450651769087,1.0,1.0,7/11,26.71%,ATG5;ATG7;FOLH1;ICMT;AGTPBP1;ATG12;GPLD1
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.2353111735822485,-0.5455087138477288,0.971677559912854,0.9953994360091846,1.0,2/11,10.04%,TGFB1;ID2
prerank,protein localization to phagophore assembly site (GO:0034497),0.2573603776145548,0.5445125582150233,0.9488188976377953,1.0,1.0,2/11,13.99%,WIPI1;MFN2
prerank,transcription by RNA polymerase I (GO:0006360),-0.1805883068384226,-0.544382223624761,0.988009592326139,0.9950726822045385,1.0,8/34,22.64%,CAVIN1;TAF1B;GTF2H1;GTF2H4;GTF2H5;ERCC2;POLR1F;POLR2L
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.23375663914296385,0.5438392057689828,0.9587242026266416,1.0,1.0,2/17,7.30%,SERPINE1;ANO6
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.24276739459051194,-0.5436269751101027,0.9553752535496958,0.9946770680472106,1.0,6/11,34.55%,UQCRB;UQCR11;CYCS;UQCC3;UQCR10;CYC1
prerank,response to acidic pH (GO:0010447),0.2527249212815699,0.5434933364943987,0.9562737642585551,1.0,1.0,2/13,11.45%,RAB11B;IMPACT
prerank,dopaminergic neuron differentiation (GO:0071542),-0.20372383205926792,-0.5434098292278892,0.9778761061946902,0.9941015583106443,1.0,7/19,30.02%,CTNNB1;VEGFA;MANF;LRP6;LMX1A;WNT2;LMX1B
prerank,response to hexose (GO:0009746),-0.19536033791217933,-0.5432758017832711,0.9927710843373494,0.9935114728341843,1.0,12/25,44.78%,THBS1;EIF2B3;IRS2;EIF2B2;KHK;EIF2B5;ZBED3;SLC2A5;NEUROD1;LPL;SELENOT;HNF4A
prerank,neuron fate commitment (GO:0048663),0.24353083434979197,0.5427592937971659,0.937984496124031,1.0,1.0,1/14,3.46%,TGFBR1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.22542636846947384,0.5423849424333209,0.9569120287253142,1.0,1.0,2/20,10.73%,FDXR;TSPOAP1
prerank,regulation of cilium movement (GO:0003352),0.2623485846984246,0.54227287266157,0.9312977099236641,1.0,1.0,10/10,73.78%,CCDC39;CCDC40;DNAH11;ODAD2;DRC1;DNAAF1;CFAP298;CFAP206;CCDC65;CFAP43
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.1484939536123424,-0.5403931779085537,1.0,0.9936873416033374,1.0,14/88,20.30%,FBXL7;PSMB2;FBXL5;PSMD14;FBXL2;PSMC6;FBXO31;PSMA4;PSMB9;SKP1;PSMD11;PSMB10;PSMD2;AMN1
prerank,sensory perception of pain (GO:0019233),0.22950729821423718,0.5387149589642356,0.965034965034965,1.0,1.0,1/21,2.13%,RETREG1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.2235702174873309,0.5384874391288096,0.9602169981916817,1.0,1.0,7/22,24.36%,NFU1;CIAO3;ISCA1;NFS1;MMS19;ABCB7;IBA57
prerank,cell cycle G1/S phase transition (GO:0044843),-0.1595072575340997,-0.5383519334430543,0.9942196531791907,0.9936198168881394,1.0,15/61,24.88%,USP29;PLK2;CUL3;E2F3;CDKN1A;ACVR1;EIF4E;PIM2;INHBA;PHF8;MAP3K11;PLK3;CDKN3;CCNE2;HINFP
prerank,acyl-CoA biosynthetic process (GO:0071616),0.23403089697002882,0.5379195102049745,0.9572192513368984,1.0,1.0,3/16,13.24%,SCD5;MLYCD;GCDH
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.18772784129424352,0.5373277091831562,0.9921259842519685,1.0,1.0,14/51,22.03%,LEMD2;CCNB2;NUP98;NUP43;LBR;REEP4;VPS4A;NUP155;CHMP4C;SUMO1;NUP188;CHMP2A;UBE2I;CC2D1B
prerank,mitotic nuclear membrane organization (GO:0101024),0.18772784129424352,0.5373277091831562,0.9921259842519685,1.0,1.0,14/51,22.03%,LEMD2;CCNB2;NUP98;NUP43;LBR;REEP4;VPS4A;NUP155;CHMP4C;SUMO1;NUP188;CHMP2A;UBE2I;CC2D1B
prerank,defense response to tumor cell (GO:0002357),0.25204852398159133,0.5364974544314378,0.965183752417795,1.0,1.0,3/10,17.54%,PLK5;DLEC1;RBMS3
prerank,tRNA metabolic process (GO:0006399),0.22955561030633165,0.5356745253718233,0.9728682170542635,1.0,1.0,9/17,33.70%,RPP21;POP7;POP1;KARS1;THG1L;SSB;DTD2;AARS1;DTD1
prerank,negative regulation of cell division (GO:0051782),0.25360729061602544,0.5353772998075933,0.9497991967871486,1.0,1.0,4/11,21.76%,AURKB;VPS4A;CHMP4C;ORC6
prerank,negative regulation of RNA splicing (GO:0033119),-0.20436550165482856,-0.534369726476508,0.9762419006479481,0.99402380817814,1.0,7/19,28.18%,TMBIM6;RPS26;RNPS1;SRSF12;RPS13;SRSF6;PTBP2
prerank,positive regulation of telomere capping (GO:1904355),0.23516713655512078,0.5342669072113678,0.9605263157894737,1.0,1.0,3/17,12.69%,TNKS2;AURKB;PNKP
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.21675231401297063,-0.5342401804086944,0.9849462365591398,0.9934299456031843,1.0,3/16,14.45%,IRAK3;SHFL;GLE1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.2468749309403507,0.5312879191012159,0.9342629482071713,1.0,1.0,2/13,14.77%,GAB2;SPHK2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.1819885047524645,-0.5303005190484681,0.9874371859296482,0.9937778439514717,1.0,9/29,23.94%,DCP1B;HBS1L;LSM1;DCP2;CNOT7;LSM4;LSM7;EXOSC4;EXOSC1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.23627053019582236,-0.5283564236285307,0.9600840336134454,0.9936242759883498,1.0,5/10,31.81%,THOC5;RFWD3;CCAR2;ETAA1;RPA2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.2316014299043259,0.5265827367253023,0.9628318584070796,1.0,1.0,3/17,14.56%,AFG1L;COX10;COX8A
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.20391674273218258,0.5256426071302887,0.9807692307692307,1.0,1.0,5/27,13.89%,TLR4;TAB2;LY96;MAP3K1;TLR5
prerank,amyloid precursor protein catabolic process (GO:0042987),0.23166614016221496,0.5248814085778499,0.9497307001795332,1.0,1.0,3/14,11.58%,APH1B;DYRK1A;ADAM17
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.25166299243151613,0.5243712505857427,0.9616122840690979,1.0,1.0,5/10,29.93%,ZNHIT6;RUVBL1;PIH1D2;PIH1D1;NUFIP1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.22633493494190543,-0.5235086873994574,0.9739130434782609,0.9941318982654317,1.0,5/12,31.17%,CEACAM1;ERLIN1;TRIB3;ACADVL;BRCA1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.24704055420052465,0.523318509357485,0.9416342412451362,1.0,1.0,4/11,23.78%,P4HA1;OGFOD1;EGLN1;CRTAP
prerank,negative regulation of lymphocyte activation (GO:0051250),0.216273439825872,0.523214965316673,0.978494623655914,1.0,1.0,5/21,17.62%,PTPN22;LGALS3;PIBF1;GPNMB;LAX1
prerank,nuclear membrane reassembly (GO:0031468),0.18260588582803314,0.5228092476733849,0.9919871794871795,1.0,1.0,16/54,23.82%,LEMD2;CCNB2;NUP98;NUP43;LBR;REEP4;VPS4A;NUP155;CHMP4C;SUMO1;NUP188;CHMP2A;UBE2I;CC2D1B;IST1;UBXN2A
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.23130533057072894,0.521443795580193,0.9834862385321101,1.0,1.0,16/16,76.89%,FBH1;SMCHD1;MAD2L2;SHLD2;UBQLN4;KLHL15;FANCB;SHLD1;RADX;RMI2;PARPBP;RIF1;HELB;SHLD3;POLQ;CGAS
prerank,Golgi to endosome transport (GO:0006895),0.2257171594854876,0.5212953090032353,0.975609756097561,1.0,1.0,7/16,25.11%,WIPI1;AP2A1;VPS13A;MON2;AP4M1;KLHL20;KIF16B
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.20775223017967087,0.5182631256364564,0.9820143884892086,1.0,1.0,25/25,79.26%,SCAF11;PRPF3;SNRNP40;PRPF6;SRSF10;SF3B1;SRSF4;SF3B3;KHSRP;SMNDC1;PRPF4;DBR1;SRRM1;WDR83;TRA2B;TXNL4A;GEMIN2;PRPF8;DDX23;SLU7;SF3B4;MPHOSPH10;BCAS2;SF3A3;LSM1
prerank,regulation of spindle organization (GO:0090224),-0.20301185701404537,-0.5166378962800933,0.9794520547945206,0.9950267621222226,1.0,6/18,33.45%,GNAI1;BORA;TPX2;SENP6;PSRC1;DCTN1
prerank,defense response to fungus (GO:0050832),0.2246962389027768,0.5159150217801436,0.972027972027972,1.0,1.0,2/17,9.00%,HRG;FAM3A
prerank,acetyl-CoA metabolic process (GO:0006084),-0.21000450536859372,-0.5135415990514279,0.9689578713968958,0.9950380738160021,1.0,3/15,13.30%,HMGCS1;DIP2A;PMVK
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.21896389324960758,0.5127493644796948,0.9749552772808586,1.0,1.0,18/18,78.13%,THEM4;PPIF;SLC25A4;SLC25A31;BCL2;MUL1;BCL2L1;SLC25A5;HEBP2;NAIF1;BAK1;TMEM102;BAD;ALKBH7;CAMK2A;PMAIP1;SPG7;BNIP3
prerank,negative regulation by host of viral transcription (GO:0043922),0.23884250831711765,0.5116629436561169,0.9473684210526315,1.0,1.0,12/12,76.13%,HDAC1;REST;TARDBP;POU2F3;CCL5;CCL3;PSMC3;CCL4;INPP5K;JUN;HMGA2;TFAP4
prerank,midbody abscission (GO:0061952),0.2112890855094197,0.5088683770863532,0.9830827067669173,1.0,1.0,5/17,21.80%,CHMP1A;VPS4A;CHMP4C;CHMP2A;MITD1
prerank,nuclear body organization (GO:0030575),0.23991895274847322,0.5081825513408158,0.9682539682539683,1.0,1.0,5/12,24.42%,SRPK2;PML;DYRK3;USPL1;ZPR1
prerank,chromatin remodeling at centromere (GO:0031055),0.19561514239645128,0.5076898435993749,0.9917218543046358,1.0,1.0,14/31,29.42%,NASP;CENPO;CENPC;CENPV;CENPK;CENPT;ITGB3BP;RUVBL1;RBBP7;RSF1;RBBP4;CENPS;CENPN;CENPQ
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.247401929931723,0.5062720161710995,0.9602272727272727,1.0,1.0,2/10,16.59%,TP53;SP100
prerank,positive regulation of cell killing (GO:0031343),0.2293637507191511,0.505774437803404,0.9781746031746031,1.0,1.0,1/13,5.87%,NOX1
prerank,natural killer cell mediated immunity (GO:0002228),0.2228825145416544,0.5035449425014232,0.974169741697417,1.0,1.0,4/15,22.69%,KIF5B;CEBPG;ULBP1;LYST
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.20092909649367008,-0.5011110589453484,0.9775280898876404,0.996783381345264,1.0,7/16,34.62%,ATP5F1E;ATP5PF;STOML2;ATP5MF;ATP5PD;ATP5MC1;ATP5F1B
prerank,phospholipid homeostasis (GO:0055091),-0.2147272671627565,-0.5006109792685003,0.9798792756539235,0.9962524952873603,1.0,3/11,26.81%,ABCG1;RCN3;ABCA1
prerank,regulation of oxidoreductase activity (GO:0051341),0.23365206565578367,0.5004734544055608,0.9675572519083969,1.0,1.0,3/13,19.95%,ABL1;SIRT4;ATP7A
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.18528120585301716,0.5000359932051062,0.9952830188679245,1.0,1.0,6/37,16.11%,SIDT2;DNASE1L1;EXOSC7;SND1;DFFB;DNASE1L2
prerank,COPII-coated vesicle budding (GO:0090114),0.16672823984855792,0.4953739801811748,0.9984984984984985,1.0,1.0,20/68,23.59%,SEC31B;TRAPPC9;MIA3;TGFA;STX5;SEC23IP;F8;SCFD1;TRAPPC5;PPP6R3;SEC31A;BET1;GOLGA2;SCAP;FOLR1;SEC24C;SEC24A;GORASP1;F5;SEC16A
prerank,aerobic electron transport chain (GO:0019646),0.16777541975888086,0.4934130268591798,1.0,1.0,1.0,16/68,22.96%,AFG1L;NDUFAB1;UQCRC2;NDUFS1;NDUFV2;COX10;COX8A;NDUFS4;NDUFA2;UQCRC1;COX15;NDUFS5;NDUFA9;NDUFB2;SDHD;UQCRH
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.2131838240012594,-0.4933151430767608,0.9775967413441955,0.9968585675029101,1.0,4/12,28.38%,STK33;CHEK2;TOPBP1;HUS1B
prerank,establishment of protein localization to extracellular region (GO:0035592),0.18113059259159697,0.491506485753379,0.9901639344262295,1.0,1.0,10/39,21.45%,ARFGAP3;RAB13;MIA3;MON1A;TANGO2;RAB8B;STEAP3;LTBP2;MIA2;AFM
prerank,RNA interference (GO:0016246),-0.18968448160424345,-0.4904979538868174,0.988558352402746,0.9966727342426215,1.0,3/17,16.58%,TSNAX;DROSHA;DHX9
prerank,mitochondrial gene expression (GO:0140053),0.17754770108575485,0.4874475646450722,0.9952380952380953,1.0,1.0,11/42,23.20%,MRPS6;MRPL2;TWNK;MRPS7;FOXO3;GFM2;MRPS17;MRPL23;MRPS34;PTCD3;POLRMT
prerank,ERAD pathway (GO:0036503),0.15927223559559497,0.4873612140156614,1.0,1.0,1.0,30/83,28.98%,PRKN;ERLEC1;ECPAS;DNAJB2;AMFR;DNAJB14;UFD1;ERLIN2;SYVN1;DNAJC18;NPLOC4;UBE4B;UBE2J2;GET4;TOR1A;DERL1;SELENOS;BAG6;RNF5;FBXO17;UBXN4;USP19;TMEM67;ANKZF1;TRIM13;OS9;TMUB2;UBE4A;SGTA;UBXN8
prerank,negative regulation of transferase activity (GO:0051348),0.19562609152627758,0.48602404605566857,0.9857651245551602,1.0,1.0,4/28,10.90%,NPRL2;TP53;ABL1;EIF4A2
prerank,multivesicular body assembly (GO:0036258),0.18974647992049012,0.48579667422485917,0.9882154882154882,1.0,1.0,12/30,28.83%,CHMP1A;VPS37A;SNF8;VPS4A;CHMP4C;CHMP2A;IST1;MVB12A;VTA1;STAM2;CHMP1B;VPS36
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.16524964009751839,0.4857748201711803,1.0,1.0,1.0,16/69,22.96%,AFG1L;NDUFAB1;UQCRC2;NDUFS1;NDUFV2;COX10;COX8A;NDUFS4;NDUFA2;UQCRC1;COX15;NDUFS5;NDUFA9;NDUFB2;SDHD;UQCRH
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.20957706396438283,0.4845846317084986,0.9814814814814815,1.0,1.0,1/18,3.84%,BID
prerank,translational elongation (GO:0006414),0.15352643870575955,0.48393009791572267,1.0,1.0,1.0,26/101,26.23%,MRPS23;MRPS6;MRPL37;MRPL2;MRPL53;MRPS7;MRPS26;MRPL48;NEMF;MRPL1;GFM2;MRPL45;MRPS17;CHCHD1;MRPL32;MRPL14;MRPL23;MRPS34;PTCD3;MRPS25;MRPL50;LTN1;MRPL33;MRPS18B;MRPL19;TSFM
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.1865979666430347,0.4838904341274318,0.9983050847457627,1.0,1.0,10/31,25.85%,EXOSC7;DDX6;DCP1A;DIS3;NT5C3B;EXOSC3;POLR2G;EDC4;LSM6;LSM3
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.1861016938877616,-0.4821004895766644,0.9882903981264637,0.9972520697893216,1.0,5/19,26.06%,AR;MAF1;POLR3F;POLR3C;NAB2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.23557196267714045,0.47865057292807367,0.9726027397260274,1.0,1.0,1/10,8.32%,CPEB3
prerank,regulation of mitotic spindle assembly (GO:1901673),0.19851316477098327,0.47837292223460204,0.9829642248722317,1.0,1.0,9/19,32.33%,CHMP1A;CHMP4C;CHMP2A;EML3;DRG1;CHMP1B;HSPA1A;CEP97;PLK1
prerank,glutathione metabolic process (GO:0006749),0.17463326163383025,0.4783607370007505,0.9900662251655629,1.0,1.0,7/38,20.02%,GSTT1;CTNS;GSTA3;MMACHC;GSTT2;ETHE1;CNDP2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.20277548261297434,-0.47451669709216165,0.9978902953586498,0.9976290233476568,1.0,6/11,37.47%,CTNNB1;LRP6;LMX1A;WNT2;FZD1;NR4A2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.22241922879979736,0.47433953910051774,0.9866156787762906,1.0,1.0,1/11,7.97%,SMARCA4
prerank,regulation of T cell activation (GO:0050863),0.17244629362768762,0.4733988190555481,0.9935691318327974,1.0,1.0,8/42,17.62%,PTPN22;CYRIB;ABL1;LAT;LGALS3;CCR2;GPNMB;LAX1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2001229064550425,0.4722734222236124,0.9803921568627451,1.0,1.0,8/20,25.80%,APH1B;ADAM17;MBTPS1;NFKB1;NCSTN;ADAM9;PSEN2;SPPL2A
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.18606119226908005,0.4719025408378887,0.9932885906040269,1.0,1.0,5/29,11.87%,LARP1;GDNF;THRAP3;NOCT;AXIN2
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.18659251097694135,-0.4705252347500851,0.9861431870669746,0.9974799392605846,1.0,7/17,34.62%,ATP5F1E;ATP5PF;STOML2;ATP5MF;ATP5PD;ATP5MC1;ATP5F1B
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2118531504537659,0.46796136723304005,0.9866156787762906,1.0,1.0,3/14,20.23%,MPV17L2;RPUSD4;FASTKD3
prerank,DNA replication checkpoint signaling (GO:0000076),-0.1850187725181947,-0.46540707822493177,0.9938775510204082,0.9974514907619636,1.0,5/16,28.38%,TIPIN;CDC45;DNA2;TOPBP1;HUS1B
prerank,regulation of histone modification (GO:0031056),0.21299418796203656,0.4628538107598035,0.9788461538461538,1.0,1.0,2/13,14.24%,MTHFR;FLCN
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.1725015912665082,0.46047036211255044,1.0,1.0,1.0,16/38,29.42%,ATRX;NASP;CENPO;CENPC;CENPK;CENPT;ASF1A;ITGB3BP;RUVBL1;RBBP7;RSF1;RBBP4;CENPS;IPO4;CENPN;CENPQ
prerank,protein insertion into ER membrane (GO:0045048),0.16985254578077794,0.4604139267494132,0.9983333333333333,1.0,1.0,9/37,23.60%,TRAM2;EMC2;STX5;EMC1;EMC3;UBE2J2;CAMLG;GET4;BAG6
prerank,regulation of macrophage differentiation (GO:0045649),0.20173463454455587,0.46025580048365805,0.9833641404805915,1.0,1.0,5/15,24.64%,RIPK1;PRKCA;INHA;IL34;FADD
prerank,double-strand break repair via break-induced replication (GO:0000727),0.21467222521406318,0.4588345942382899,0.9941634241245136,1.0,1.0,3/12,21.23%,MCM7;MCM2;MCM5
prerank,regulation of DNA metabolic process (GO:0051052),0.1677340379461507,0.45775445561924033,0.9953846153846154,1.0,1.0,7/44,18.62%,HDAC8;SMG1;WDR70;KAT7;MPHOSPH8;USP1;NBN
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.2188083172087848,0.45609466647040564,0.9662288930581614,1.0,1.0,3/10,19.76%,IMPACT;HIF1AN;CITED2
prerank,cellular response to misfolded protein (GO:0071218),0.192974290189169,0.4554437057734325,0.9904030710172744,1.0,1.0,7/20,23.64%,DNAJB14;UFD1;DNAJC18;TOR1A;DERL1;BAG6;RNF5
prerank,DNA geometric change (GO:0032392),-0.16369684792347705,-0.45230461606123284,0.9976525821596244,0.9981591400783804,1.0,6/24,25.56%,ANXA1;DHX9;DNA2;BLM;RECQL5;RECQL
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.1881570454140642,-0.4487549427490929,0.9917184265010351,0.9966079563105233,1.0,2/12,17.47%,CUL3;CDC23
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.1881570454140642,-0.4487549427490929,0.9917184265010351,0.9966079563105233,1.0,2/12,17.47%,CUL3;CDC23
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.1881570454140642,-0.4487549427490929,0.9917184265010351,0.9966079563105233,1.0,2/12,17.47%,CUL3;CDC23
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.1822158812640423,0.4464888826681741,0.996268656716418,1.0,1.0,8/23,27.08%,UFD1;SYVN1;NPLOC4;DERL1;SELENOS;SEC16A;SEC13;OS9
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.19591570006861508,0.4451527221144955,0.9942528735632183,1.0,1.0,4/16,22.69%,KIF5B;CEBPG;ULBP1;LYST
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.18670206858860106,0.44230913080919626,0.9895470383275261,1.0,1.0,2/20,11.67%,ATM;IK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.18670206858860106,0.44230913080919626,0.9895470383275261,1.0,1.0,2/20,11.67%,ATM;IK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.18670206858860106,0.44230913080919626,0.9895470383275261,1.0,1.0,2/20,11.67%,ATM;IK
prerank,macrophage migration (GO:1905517),0.20214656621946903,0.4402112650118907,0.9865642994241842,1.0,1.0,4/13,21.81%,LGALS3;CCR2;CXCL17;P2RX4
prerank,rRNA modification (GO:0000154),0.17975128752669278,0.4385676608436988,0.9930313588850174,1.0,1.0,21/21,82.05%,ZCCHC4;BUD23;NSUN4;MTERF4;METTL5;FBLL1;MRM2;TSR3;THUMPD1;NOP10;GAR1;TRMT112;FTSJ3;TFB2M;DIMT1;NAT10;NSUN3;DKC1;TFB1M;NHP2;FBL
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.17179819074709682,0.4373094460532912,0.994991652754591,1.0,1.0,13/29,29.42%,NASP;CENPO;CENPC;CENPK;CENPT;ITGB3BP;RUVBL1;RBBP7;RSF1;RBBP4;CENPS;CENPN;CENPQ
prerank,CENP-A containing chromatin organization (GO:0061641),0.17179819074709682,0.4373094460532912,0.994991652754591,1.0,1.0,13/29,29.42%,NASP;CENPO;CENPC;CENPK;CENPT;ITGB3BP;RUVBL1;RBBP7;RSF1;RBBP4;CENPS;CENPN;CENPQ
prerank,regulation of viral release from host cell (GO:1902186),0.18045923510368703,0.4372860020893051,0.9926605504587156,1.0,1.0,7/21,26.35%,TRIM62;PML;VPS4A;CHMP2A;TRIM5;TRIM8;TRIM13
prerank,iron-sulfur cluster assembly (GO:0016226),0.17942837066695283,0.4353793817616447,0.9891696750902527,1.0,1.0,7/24,24.36%,NFU1;CIAO3;ISCA1;NFS1;MMS19;ABCB7;IBA57
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.15776354474457863,0.4335111250279307,0.9984,1.0,1.0,14/42,27.91%,ARID2;FBH1;SMCHD1;PPP4R2;KDM1A;FUS;MMS19;FIGNL1;MAD2L2;SHLD2;UBQLN4;RTEL1;RAD51AP1;CHEK1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.20807856594489751,0.431593291505429,0.9847619047619047,1.0,1.0,2/10,17.97%,RYK;WNT5A
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.16158440741905084,0.4310703978343348,0.9982788296041308,1.0,1.0,38/38,83.88%,NDUFAB1;NDUFS1;NDUFV2;NDUFS4;NDUFA2;NDUFS5;NDUFA9;NDUFB2;NDUFS2;NDUFA12;NDUFB4;NDUFS8;NDUFV3;NDUFB9;NDUFA1;NDUFAF1;NDUFA10;NDUFV1;NDUFA5;NDUFS3;NDUFB6;NDUFA4;NDUFA3;NDUFC1;NDUFB3;NDUFC2;NDUFB10;NDUFA8;NDUFA13;NDUFA7;NDUFA11;NDUFA6;NDUFB5;NDUFB8;NDUFS7;NDUFS6;NDUFB7;NDUFB11
prerank,aromatic amino acid family catabolic process (GO:0009074),0.1877919207662091,0.4269698163117719,0.987037037037037,1.0,1.0,14/15,60.20%,FAH;KMO;HAAO;KYAT1;GSTZ1;TAT;KYNU;ACMSD;IDO1;HGD;TDO2;IL4I1;IDO2;AADAT
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.18316133823882602,0.42577785916303823,0.9945054945054945,1.0,1.0,4/18,19.12%,ROPN1L;CCDC39;CCDC40;OFD1
prerank,multivesicular body organization (GO:0036257),-0.1442865829629914,-0.42026834295482957,1.0,0.9979783968641202,1.0,5/31,18.29%,RAB27A;PDCD6IP;VPS37C;CHMP4B;CHMP4A
prerank,RNA methylation (GO:0001510),0.144233101268283,0.41970057309639675,0.9984779299847792,1.0,1.0,10/60,18.40%,TRMT44;RBM15;NOP2;WTAP;METTL6;ZCCHC4;LCMT2;VIRMA;BUD23;NSUN4
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.18235153285745426,0.4184478645955267,0.998062015503876,1.0,1.0,6/17,27.08%,UFD1;SYVN1;NPLOC4;DERL1;SELENOS;OS9
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.19440779711882572,0.4179964450341343,0.9901574803149606,1.0,1.0,3/12,22.54%,CHAMP1;CENPC;MIS12
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.17725849084479808,0.41604197027819895,0.9946043165467626,1.0,1.0,4/19,18.07%,ACD;HNRNPC;TENT4B;TINF2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.1727228872600139,0.4145915918063019,0.9913344887348353,1.0,1.0,2/21,11.67%,ATM;IK
prerank,interstrand cross-link repair (GO:0036297),0.14536404192179575,0.4143144600865247,1.0,0.9999245390973822,1.0,10/53,20.38%,RNF8;FANCI;FANCM;FANCA;USP1;SLX4;XPA;FANCD2;XRCC3;MCM9
prerank,regulation of DNA recombination (GO:0000018),0.13914878390469654,0.36400174932995716,1.0,1.0,1.0,11/32,28.29%,MSH3;RAD50;PPP4R2;KDM1A;FIGNL1;H1-0;SHLD2;RTEL1;RAD51AP1;CHEK1;KPNA1
prerank,regulation of mitotic spindle organization (GO:0060236),0.13771272844795318,0.3628340036855298,1.0,1.0,1.0,15/35,32.33%,CHMP1A;CLTC;CHMP4C;MAP9;CHMP2A;EML3;PARP3;DRG1;FSD1;CHMP1B;NUMA1;RAE1;HSPA1A;CEP97;PLK1
prerank,cranial nerve development (GO:0021545),0.1710015689121413,0.3625537583003414,0.99609375,1.0,1.0,1/11,7.55%,CHD7
prerank,regulation of chromatin organization (GO:1902275),0.16353820076589876,0.36220406260611776,1.0,1.0,1.0,14/14,83.66%,TLK2;SETD1A;METTL4;TLK1;CDK9;MKI67;ALKBH4;PARG;IGF2;HNRNPU;SSRP1;SETD5;MLLT3;HPF1
prerank,organophosphate catabolic process (GO:0046434),0.16282304139976686,0.3406344321554143,1.0,1.0,1.0,2/11,20.67%,ABHD12;PLBD2
prerank,macrophage chemotaxis (GO:0048246),0.15251365091319888,0.31593283484285584,0.9979381443298969,1.0,1.0,10/10,84.76%,LGALS3;CXCL17;TAFA4;EDN2;SAA1;CCL5;CCL3;CKLF;CCL2;EDNRB
prerank,regulation of spindle assembly (GO:0090169),0.10889457054062472,0.2732530936834747,1.0,0.9999950826165129,1.0,10/25,32.33%,CHMP1A;CHMP4C;CHMP2A;EML3;DRG1;CHMP1B;NUMA1;HSPA1A;CEP97;PLK1
